Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.6819493188334388,-2.295777320536419,0.0,0.001922452040628479,0.002,15/35,7.70%,PDE7B;RIMS2;AKAP6;PDE4D;CD36;PDE9A;PDE7A;ADCY2;ADGRG6;HTR2C;RAPGEF2;GUCY1B1;APOE;HTR2B;EPHA5
prerank,regulation of cation channel activity (GO:2001257),-0.5475818594441649,-2.2415868002746686,0.0,0.002883678060942718,0.006,29/89,8.82%,DLG2;FGF14;NLGN1;AHNAK;DMD;ANK3;GRIA4;ANK2;LRRC7;PDE4D;FGF12;SHISA9;GRIA1;GRIN2A;GRIN2B;SHISA6;APP;DLG3;CACNG2;GRIA2;GRIA3;CALM1;HOMER1;NETO1;DAPK1;OPRM1;GSG1L;FGF11;ACTN2
prerank,glutamate receptor signaling pathway (GO:0007215),-0.6621499039292058,-2.230144861045612,0.0,0.0022428607140665587,0.007,16/37,7.14%,GRM7;GRIK2;GRID2;PLCB1;GRIA4;GRM8;GRM5;GRIN2A;GRIN2B;GRM1;APP;GRIA2;GRIA3;HOMER1;GRIK4;GRIN3A
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.8611392446295529,-2.164686514174797,0.0,0.007209195152356795,0.027,6/11,7.72%,TMEM106A;CIITA;PF4;JAK2;TAF7;SIRT1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.5759136748056259,-2.146896164357968,0.0,0.007497562958451067,0.036,21/57,9.81%,DLG2;NLGN1;GRIA4;LRRC7;SHISA9;GRIA1;GRIN2A;GRIN2B;SHISA6;APP;DLG3;CACNG2;GRIA2;GRIA3;NETO1;DAPK1;OPRM1;GSG1L;ACTN2;DLGAP1;DLGAP2
prerank,regulation of NMDA receptor activity (GO:2000310),-0.6564822302609981,-2.113064686816292,0.0,0.01361736862111839,0.075,15/32,8.82%,DLG2;NLGN1;GRIA4;LRRC7;CCR2;GRIA1;GRIN2A;GRIN2B;APP;DLG3;GRIA2;GRIA3;DAPK1;OPRM1;ACTN2
prerank,cellular response to copper ion (GO:0071280),0.7805997747677493,2.0879472110362,0.0,0.048377068051389346,0.044,9/16,8.98%,MT1B;MT1G;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A;MT2A
prerank,regulation of synapse assembly (GO:0051963),-0.5767895198717582,-2.072836234300751,0.0,0.019773792417892923,0.119,20/46,15.32%,NRXN1;NLGN1;PDLIM5;GRID2;LRFN5;GPC6;PTPRD;BDNF;CLSTN2;SLITRK1;APP;IL1RAPL1;IL1RAPL2;SYNDIG1;SETD5;LHFPL4;IL1RAP;MDGA1;SNCA;GPC4
prerank,cellular zinc ion homeostasis (GO:0006882),0.682228856856592,2.062992422170068,0.0,0.03756942518884491,0.066,12/26,8.98%,SLC30A5;SLC30A10;MT1B;MT1G;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A;SLC30A8;MT2A
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.6673939515434761,-2.0609534229646567,0.0,0.020786512689295426,0.141,7/22,8.29%,AKAP6;ANK2;HTT;RYR2;CALM1;PKD2;VMP1
prerank,neuron cell-cell adhesion (GO:0007158),-0.7841541035377756,-2.043463767797749,0.0,0.023710241834417906,0.177,8/14,14.09%,NRXN1;NLGN1;NRXN3;ASTN2;RET;NCAM2;ASTN1;NRXN2
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.6432122838844102,-2.02701526194835,0.0,0.02614534775254731,0.209,9/26,4.69%,NRXN1;NLGN1;RIMS2;LRRK2;SLC8A3;APP;PRKCZ;SHANK3;MTMR2
prerank,chemical synaptic transmission (GO:0007268),-0.42027851483342443,-2.0204969425809387,0.0,0.026826944385133774,0.234,104/284,19.09%,DLG2;NRXN1;NLGN1;GRM7;GRIK2;PDE7B;KCND2;GRID2;GRIA4;RIT2;PTPRN2;CACNA1E;GRM5;SYN3;SYN1;DTNA;GABRB1;GRIA1;CDH8;GRIN2A;GRIN2B;SHISA6;GRM1;SYN2;GPR176;NAPB;HRH1;SYT1;NOVA1;KIF1B;HTR2C;UNC13C;CAMK4;GABBR2;SNPH;LRP6;GLRA1;SLC5A7;GRIA2;APOE;GABRA3;SYT10;APBA2;GABRG3;GRIA3;CALM1;HTR2B;KCNQ3;GABRG1;SLC1A6;ERC2;CHAT;HOMER1;SDCBP;GABRA2;SLC12A4;SNAP25;GRIK4;GIPC1;CHRM2;CHRM3;HTR1D;GABRG2;SLC12A5;GRIN2D;GABRB3;HCRTR2;RAB3A;DLGAP1;DLGAP2;CHRNA4;HTR4;UNC119;GRIK1;GLRA2;KCNMB4;UNC13B;PDLIM4;GABRA5;HTR6;NRXN2;PCDHB16;HSPA8;KCNIP2;CRHBP;SNCA;GABRQ;GRIK3;CACNB3;CACNA1B;RIMS1;HTR1F;SLC1A1;PTCHD1;SLC18A3;CRH;NTSR1;SLC1A4;PCDHB13;PCDHB6;RPS6KA2;BSN;MAPK1;SYPL1
prerank,cGMP-mediated signaling (GO:0019934),-0.7799224762845093,-2.0022072168782574,0.0,0.0313199478285723,0.282,7/13,5.41%,CD36;KCNC2;PDE9A;HTR2C;GUCY1B1;APOE;HTR2B
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.42590130251812974,-1.9974537619051154,0.0,0.031202875428662236,0.299,83/224,19.09%,DLG2;NRXN1;NLGN1;GRM7;GRIK2;PDE7B;KCND2;GRIA4;RIT2;CACNA1E;GRM5;SYN1;DTNA;GABRB1;GRIA1;GRIN2A;GRIN2B;GRM1;SYN2;GPR176;HRH1;SYT1;NOVA1;HTR2C;UNC13C;CAMK4;GABBR2;LRP6;GLRA1;GRIA2;GABRA3;SYT10;APBA2;GABRG3;GRIA3;CALM1;HTR2B;KCNQ3;GABRG1;SLC1A6;HOMER1;SDCBP;GABRA2;SLC12A4;SNAP25;GRIK4;GIPC1;CHRM2;CHRM3;HTR1D;GABRG2;SLC12A5;GABRB3;HCRTR2;DLGAP1;CHRNA4;HTR4;UNC119;GRIK1;GLRA2;KCNMB4;UNC13B;GABRA5;HTR6;NRXN2;PCDHB16;KCNIP2;SNCA;GABRQ;CACNB3;CACNA1B;HTR1F;SLC1A1;PTCHD1;SLC18A3;CRH;NTSR1;PCDHB13;PCDHB6;RPS6KA2;BSN;MAPK1;SYPL1
prerank,zinc ion homeostasis (GO:0055069),0.6462212504553604,1.9906393285492976,0.0,0.1087626281722725,0.237,12/28,8.98%,SLC30A5;SLC30A10;MT1B;MT1G;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A;SLC30A8;MT2A
prerank,receptor clustering (GO:0043113),-0.6161170780083304,-1.9780805119284364,0.0,0.037419155790804313,0.377,9/27,4.64%,DLG2;MAGI2;NRXN1;NLGN1;ITGA4;LRRC7;ITGB7;DLG3;ITGAL
prerank,synapse assembly (GO:0007416),-0.506621628116921,-1.9698102002623257,0.0,0.038769449486007655,0.411,24/67,14.33%,NRXN1;NLGN1;GRID2;DNM3;ADGRL3;KIRREL3;NRCAM;GPM6A;BDNF;SLITRK1;SHANK3;PLXND1;GABRA2;GABRG2;GABRB3;LRRTM3;PLXNB2;SDK1;OBSL1;ACHE;CDH1;NRXN2;PLXNB1;PCDHB16
prerank,response to copper ion (GO:0046688),0.6986581279554951,1.9662538015677553,0.0,0.12403056808920034,0.34,9/20,8.98%,MT1B;MT1G;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A;MT2A
prerank,cAMP-mediated signaling (GO:0019933),-0.641033989531758,-1.96465585651431,0.0,0.03856919406510886,0.428,11/24,13.67%,PDE7B;RIMS2;AKAP6;PDE4D;PDE7A;ADCY2;ADGRG6;RAPGEF2;EPHA5;AHR;PDE2A
prerank,synaptic membrane adhesion (GO:0099560),-0.7264266058748589,-1.9646403668301369,0.0,0.03630041794363186,0.428,5/14,2.29%,LRRC4C;LRFN5;GPC6;PTPRD;SLITRK1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5291504268484245,1.9540780610564719,0.0,0.12228075924478839,0.4,16/65,6.58%,TGFBR1;LDLRAD4;TGFBR2;SMAD3;SMAD7;PMEPA1;SKI;SMURF1;TGFB1I1;SKIL;RPS27A;UBC;SPRY2;PDPK1;EID2;ASPN
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.6396496143400654,-1.943243648829348,0.0,0.04581844030164541,0.525,7/21,5.23%,DMD;AKAP6;ANK2;PDE4D;RYR2;CALM1;CACNA1C
prerank,cellular response to cadmium ion (GO:0071276),0.6495021619148943,1.9342375300132928,0.0017667844522968198,0.13466666106503772,0.492,13/24,14.70%,SUMO1;MT1B;MT1G;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A;MT2A;JUN;MAPK8;AKT1
prerank,positive regulation of synapse assembly (GO:0051965),-0.6012576802759514,-1.9310205102300846,0.0,0.05114734244935242,0.587,9/27,8.32%,NRXN1;NLGN1;GRID2;PTPRD;BDNF;CLSTN2;IL1RAPL1;SEMA4A;SYNDIG1
prerank,response to cadmium ion (GO:0046686),0.6416588651530768,1.9273697166702723,0.003590664272890485,0.12660381638980617,0.518,13/26,14.70%,SUMO1;MT1B;MT1G;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A;MT2A;JUN;MAPK8;AKT1
prerank,regulation of axonogenesis (GO:0050770),-0.5230858454486582,-1.9270467644681428,0.0,0.05156977598985894,0.605,20/51,16.15%,LRRC4C;ROBO1;SLIT2;ARHGAP35;PLXNC1;LINGO1;SLITRK1;NTRK2;PLXND1;GSK3B;PLXNA2;RTN4;CHN1;PAK3;PLXNB2;PLXNB1;THY1;PAK1;TIAM1;ARHGDIA
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.5351677751474989,-1.9257795073345592,0.0,0.049846435053438415,0.615,15/46,7.40%,NRXN1;NLGN1;GRM7;GRM8;LRRK2;GRM5;CCR2;GRM1;SYT1;DGKI;ATAD1;CACNG2;SHANK3;HOMER1;TPRG1L
prerank,central nervous system neuron development (GO:0021954),-0.6917369137624191,-1.9251581061311023,0.002079002079002079,0.047842840556549644,0.616,7/15,8.42%,B4GALT5;ARHGAP35;B4GALT6;RAPGEF2;NTRK2;MAP2;ATP7A
prerank,nerve growth factor signaling pathway (GO:0038180),-0.7919919481192393,-1.8791877958155807,0.0021598272138228943,0.08182958903370785,0.82,4/10,5.81%,MAGI2;BDNF;RAPGEF2;KIDINS220
prerank,endocrine system development (GO:0035270),0.6564352159656651,1.8762350361698186,0.0,0.2319783342996143,0.776,4/21,2.80%,TGFBR1;SALL1;TG;FOXE1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.6535483651073113,-1.8670425763234932,0.0,0.0911562675931337,0.855,11/18,18.23%,GRIK2;GRID2;CDH8;NAPB;UNC13C;GRIA2;GRIK4;GRIK1;UNC13B;GRIK3;SLC1A4
prerank,cardiolipin metabolic process (GO:0032048),0.7179589016597604,1.863200498644226,0.0019569471624266144,0.24611690412905404,0.837,8/13,18.64%,PLA2G4A;PLSCR3;PLA2G6;PLA2G5;PGS1;CRLS1;HADHB;TAMM41
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.4845706232434314,1.8547207260662255,0.0,0.24744355658625528,0.869,28/87,16.38%,TGFBR1;ITGB5;F11R;TGFBR2;SMAD3;SMAD7;ARRB2;SKI;SMURF1;SRC;ID1;RPS27A;UBC;HPGD;EID2;CGN;GCNT2;LEFTY1;LPXN;JUN;APPL1;ZYX;ENG;SMAD9;USP9Y;ZMIZ2;LTBP2;ZMIZ1
prerank,cellular response to zinc ion (GO:0071294),0.7119615504971343,1.852366248918349,0.0036429872495446266,0.23206021038190636,0.877,10/15,11.35%,MT1B;MT1G;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A;MT2A;HVCN1
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.43878258844936924,-1.850543744006334,0.0,0.10673453729569314,0.908,39/107,17.19%,LRRC4C;NLGN1;GRM7;GRIK2;RIMS2;GRID2;NRG3;GRM8;LRRK2;GRM5;SYN3;SYN1;MCTP2;GRM1;SLC8A3;BDNF;CLSTN2;APP;SYT1;DGKI;HOMER1;CPLX2;CNTNAP4;GRIK4;TPRG1L;LGI1;DLGAP1;DLGAP2;GRIK1;MCTP1;KCNMB4;SLC4A8;TMEM108;RELN;ABR;GRIK3;CACNA1B;RIMS1;ITGB1
prerank,neuron migration (GO:0001764),-0.5079524796006125,-1.8401007863581953,0.0,0.1160125866056186,0.937,20/48,15.67%,AUTS2;ADGRL3;SPOCK1;NRCAM;CDKL5;NAV1;GPM6A;MAP1B;ASTN2;RAPGEF2;NTRK2;SH3RF1;NR4A2;DCDC2;DDIT4;ASTN1;TUBB2A;MDGA1;RELN;POMGNT2
prerank,regulation of exocytosis (GO:0017157),-0.5060073436759389,-1.837237028633553,0.0,0.11499111280055531,0.943,12/46,9.04%,RIMS2;STXBP5L;CADPS;RAB3C;SYT1;IL1RAPL1;STXBP5;STXBP6;CPLX2;RAB3D;RAB8A;RAB3A
prerank,axonal fasciculation (GO:0007413),-0.7224428531394155,-1.8323800682414266,0.0020876826722338203,0.11744122198196473,0.95,10/12,26.23%,NRCAM;ARHGAP35;SEMA5A;RTN4;EPHB2;EPHA4;CNTN4;MEGF8;AMIGO1;EPHA3
prerank,regulation of macrophage migration (GO:1905521),0.7721151723302281,1.829787562103392,0.0018796992481203006,0.285201686650478,0.931,4/10,5.49%,CX3CR1;P2RY12;MTUS1;PTK2B
prerank,positive regulation of synaptic transmission (GO:0050806),-0.46359491981069517,-1.825377990253887,0.0,0.12273861907667684,0.96,26/72,15.39%,NRXN1;NLGN1;GRIK2;RIMS2;CCR2;GRIN2A;ADRA1A;GRIN2B;SLC8A3;CLSTN2;APP;SYT1;NPTN;SLC24A2;PRKCZ;CACNG2;SHANK3;PLK2;LGI1;GRIN2D;ADCY8;DTNBP1;TSHZ3;EIF2AK4;MPP2;RELN
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.7237813899638679,1.8253069157261215,0.001834862385321101,0.27822752394857964,0.937,6/13,6.26%,TLR7;UNC93B1;IRAK2;EPG5;PIK3C3;PIK3AP1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.6016914876656007,-1.8250594531078868,0.0020964360587002098,0.11915998565162188,0.961,9/22,5.92%,MAGI2;BDNF;RAPGEF2;NTRK2;EHD1;NTRK3;SH3GL2;KIDINS220;WASF1
prerank,regulation of presynapse assembly (GO:1905606),-0.6458193455966266,-1.8230134367243789,0.0,0.1142357048517204,0.967,7/18,3.74%,LRFN5;GPC6;PTPRD;SLITRK1;APP;IL1RAPL1;IL1RAPL2
prerank,regulation of presynapse organization (GO:0099174),-0.6458193455966266,-1.8230134367243789,0.0,0.1142357048517204,0.967,7/18,3.74%,LRFN5;GPC6;PTPRD;SLITRK1;APP;IL1RAPL1;IL1RAPL2
prerank,synapse organization (GO:0050808),-0.4226792913479201,-1.821851134514921,0.0,0.11205565151966299,0.969,26/125,5.91%,NRXN1;LRRC4C;NLGN1;CTNND2;ANK3;GPHN;LRFN5;GPC6;DNM3;PTPRD;ADGRL3;LRRK2;KIRREL3;GRM5;NRCAM;GPM6A;SLC8A3;BDNF;PPFIA2;SLITRK1;APP;UNC13C;SHANK3;PLXND1;CDC42;CAST
prerank,cyclooxygenase pathway (GO:0019371),0.7574438200642496,1.8085114843701753,0.0055762081784386614,0.32128843067564045,0.97,5/10,12.96%,TBXAS1;HPGDS;PTGS1;CBR1;PTGES2
prerank,cytosolic calcium ion transport (GO:0060401),-0.5512701095471322,-1.782997043901486,0.002207505518763797,0.1656135890294357,0.994,15/28,22.68%,ADRA1A;MCU;ATP2B1;RYR2;ATP2A2;CACNA1C;MCUB;MICU2;ATP2A3;MICU3;SLC35G1;CACNB3;ITPR3;SMDT1;JPH4
prerank,regulation of actin filament-based movement (GO:1903115),-0.7263134721804433,-1.7790695479393497,0.00631578947368421,0.16736318193699928,0.994,3/10,1.22%,PDE4B;ANK2;PDE4D
prerank,negative regulation of interleukin-17 production (GO:0032700),0.7577689158728611,1.7786621818858943,0.00375234521575985,0.429286436495733,0.994,5/10,10.24%,DDIT3;VSIR;TLR4;IL12B;NCKAP1L
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.6198965221237088,-1.7757112488687357,0.006756756756756757,0.16850826150564346,0.997,5/18,4.64%,NRXN1;NLGN1;RIMS2;PRKCZ;SHANK3
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.6827336436810998,1.773060438301803,0.005639097744360902,0.4287674980884441,0.995,6/14,8.25%,RASAL3;IL18;TGFBR2;LGALS9;EBI3;IL12B
prerank,positive regulation of cellular component movement (GO:0051272),0.5961961154777129,1.7712515470538581,0.003656307129798903,0.4105693347390127,0.995,6/24,8.05%,TGFBR1;CSF1R;ETS1;LYN;DUOX1;CCR7
prerank,detection of calcium ion (GO:0005513),-0.6621478464244444,-1.7634863810807353,0.004454342984409799,0.18463333314522432,0.999,10/13,26.53%,SYT1;RYR2;KCNMB2;CALM1;KCNMB4;KCNIP2;KCNMB3;CASQ2;KCNMB1;CALM3
prerank,anterior/posterior axis specification (GO:0009948),0.6870427545953874,1.7619263673791445,0.003766478342749529,0.42847443369865285,0.997,6/15,24.70%,DDIT3;SKI;SHH;TASOR;WLS;FZD5
prerank,regulation of potassium ion transport (GO:0043266),-0.5396803797160378,-1.75843427064923,0.004618937644341801,0.18888091299174806,0.999,11/31,10.54%,KCNIP4;DPP6;ANK3;DPP10;ANK2;KCNIP1;KCNN2;KCNAB2;KIF5B;ACTN2;ADRA2A
prerank,positive regulation of locomotion (GO:0040017),0.5822377289276792,1.7544322767626848,0.0034602076124567475,0.4415152347355243,0.999,13/27,23.10%,CSF1R;P2RY12;AIF1;PDGFB;DUOX1;CCR7;PDGFRB;STX4;CFAP20;PPM1F;THBS1;TWIST1;TGFB1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.6132121942016064,1.7522076436860876,0.0073937153419593345,0.42962953626914707,0.999,7/20,15.83%,FDXR;HSD3B2;CYP46A1;AKR1D1;TSPO;FDX1;HSD17B10
prerank,PERK-mediated unfolded protein response (GO:0036499),0.7546583506721705,1.7517723926832234,0.003780718336483932,0.4112295855634819,0.999,4/10,5.50%,QRICH1;NFE2L2;DDIT3;EIF2S1
prerank,icosanoid metabolic process (GO:0006690),0.525873664076461,1.7491995787676624,0.0,0.4035789062004686,0.999,16/40,20.73%,TBXAS1;DAGLB;PTGS1;ALOXE3;PLA2G4A;HPGD;PLA2G4B;DPEP1;PON2;FADS1;PON3;GPX4;ABCC10;PTGR1;DAGLA;GGT5
prerank,neuron projection fasciculation (GO:0106030),-0.7248322310466677,-1.7475462809974975,0.004098360655737705,0.20474114232693297,0.999,8/10,25.81%,NRCAM;ARHGAP35;SEMA5A;RTN4;EPHB2;EPHA4;CNTN4;AMIGO1
prerank,tRNA processing (GO:0008033),0.49630072237331846,1.74603524959519,0.0,0.4002184269968315,0.999,26/61,20.39%,FAM98B;ADAT1;QTRT1;KARS1;POP1;TRNT1;SSB;TRMT6;CSTF2;AARS2;ANKRD16;THUMPD1;CTU2;SARS1;TSEN2;NSUN6;CPSF1;TRMT10B;RPP21;TSEN54;ELAC2;CDKAL1;TYW5;QTRT2;TRMT61A;RTCB
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.5685807664115116,1.7453481922469238,0.007233273056057866,0.38658766969434716,0.999,13/27,21.41%,BAG6;BRD8;TAF6L;TAF6;CPA4;MORF4L1;ATAT1;MRGBP;NAA50;KAT5;MORF4L2;PHF20;KAT6B
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.4354249401528469,1.7438397574018607,0.0,0.3772587868552175,0.999,29/112,13.03%,TGFBR1;ITGB5;F11R;TGFBR2;SMAD3;SMAD7;MEF2C;ARRB2;SKI;SMURF1;SRC;ID1;RPS27A;UBC;HPGD;CGN;GCNT2;ZFP36L1;ZFP36L2;OVOL2;LEFTY1;LPXN;JUN;LIMS1;APPL1;ZYX;ENG;SMAD9;USP9Y
prerank,neurotransmitter secretion (GO:0007269),-0.49330004583534826,-1.7431969341441778,0.002288329519450801,0.20812946404854066,0.999,12/44,6.42%,NRXN1;RIMS2;PTPRN2;SYN3;SYN1;SYN2;SYT1;SNPH;SYT10;PCLO;CPLX2;SNAP25
prerank,positive regulation of endocytosis (GO:0045807),-0.47752827626457583,-1.7401323490248788,0.00477326968973747,0.2095003833543425,0.999,16/45,13.16%,NLGN1;DAB2;HIP1;STAP1;BICD1;B2M;SGIP1;NEDD4L;APOE;CDC42;TOR1A;ANO6;GPC3;CD151;TFR2;CBLL1
prerank,response to zinc ion (GO:0010043),0.5891688048998291,1.7391307854124116,0.005263157894736842,0.3796926838632366,1.0,12/25,11.35%,SLC30A5;MT1B;MT1G;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A;SLC30A8;MT2A;HVCN1
prerank,neurotrophin signaling pathway (GO:0038179),-0.5823213288756136,-1.7328886083174306,0.010940919037199124,0.21865603328767244,0.999,7/21,10.60%,MAGI2;BDNF;RAPGEF2;NTRK2;KIDINS220;BCAR1;DDIT4
prerank,response to sterol (GO:0036314),0.715401590771787,1.7277449874268356,0.009433962264150943,0.41305400499354106,1.0,3/11,4.17%,TGFBR1;TGFBR2;CCL3
prerank,positive regulation of cation channel activity (GO:2001259),-0.47936977504013883,-1.7256011956560156,0.0024509803921568627,0.22926358289169393,1.0,9/40,8.82%,ANK3;AKAP6;ANK2;CCR2;HTT;SHANK3;CALM1;PKD2;ACTN2
prerank,axon extension (GO:0048675),-0.5571658649464856,-1.7251007298078118,0.0091324200913242,0.22514534921269433,1.0,5/23,3.06%,AUTS2;ALCAM;SLIT2;MAP1B;SEMA5A
prerank,positive regulation of cell projection organization (GO:0031346),-0.3981357936523683,-1.7244490243751929,0.0,0.22157327797154677,1.0,39/115,16.15%,MAGI2;ROBO1;PTPRD;RIT2;LRRC7;TENM3;CDKL5;SLIT2;ARHGAP35;PLXNC1;FUT9;BDNF;SLITRK1;IL1RAPL1;RAPGEF2;ROR1;NTRK2;GRIP1;NPTN;NTRK3;APOE;PLXND1;PLXNA2;KIDINS220;RET;CARMIL1;CUL7;PLXNB2;SCARF1;P3H1;SERPINI1;STMN2;MAP3K13;CX3CL1;OBSL1;PLXNB1;RELN;TIAM1;ARHGDIA
prerank,arachidonic acid metabolic process (GO:0019369),0.5350188419154533,1.7210861592389104,0.0019047619047619048,0.42664456824044433,1.0,10/35,13.56%,TBXAS1;HPGDS;DAGLB;PTGS1;ALOXE3;PLA2G4A;CBR1;PLA2G4B;PTGES2;GPX4
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5016627423934691,-1.7197429354571172,0.006696428571428571,0.22751801976481387,1.0,13/37,10.02%,NLGN1;GRID2;PTPRD;ALCAM;TENM3;IL1RAPL1;TENM2;ITGAL;JAML;FAT4;NECTIN1;TENM4;VCAM1
prerank,toll-like receptor signaling pathway (GO:0002224),0.4550807419750193,1.7191764674396617,0.0,0.41988313649885245,1.0,16/84,6.26%,ITGAM;TLR7;UNC93B1;LGALS9;IRAK2;RIPK2;TLR4;ITGB2;PLCG2;EPG5;RPS27A;UBC;CTSS;LGMN;PIK3C3;PIK3AP1
prerank,acylglycerol homeostasis (GO:0055090),0.6046050345230782,1.717106074781431,0.01098901098901099,0.41398418660146374,1.0,5/20,11.03%,IL18;LIPC;MLXIPL;MTLN;APOC4
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.5863367823329846,1.7166765945675195,0.010948905109489052,0.4024892374186284,1.0,10/24,23.69%,LPCAT4;PLA2G4A;PLA2G15;PLA2G4B;PLA2G5;PGS1;CRLS1;SERAC1;LPCAT1;PLA2G3
prerank,primary alcohol metabolic process (GO:0034308),-0.5522696944463957,-1.7094824842226,0.00641025641025641,0.2463397322273407,1.0,9/25,18.69%,GPD2;RETSAT;NAPEPLD;GDPD1;RDH10;RBP4;ALDH3A2;DHRS9;RDH12
prerank,neuron projection morphogenesis (GO:0048812),-0.39283156167715516,-1.7092608805015086,0.0,0.24182844627739072,1.0,40/137,14.84%,CNTNAP2;NLGN1;CTNND2;CTNNA2;ANK3;IQGAP1;NYAP2;DCC;ALCAM;LRRK2;NRCAM;GPM6A;MAP1B;BDNF;SLITRK1;APP;CTTN;PLPPR4;DCLK1;MAP2;SHANK3;CDC42;PAK3;DCDC2;ZDHHC17;ATP7A;ACTB;RAB8A;RAB3A;CNTNAP1;SPTBN4;DTNBP1;NEFH;PARD3;PLXNB1;NTNG1;NTNG2;EIF2AK4;MYO16;PAK1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.5712966766576763,-1.7000285276728773,0.021686746987951807,0.25733393743841204,1.0,6/20,5.23%,DMD;ANK2;RYR2;ATP2A2;CALM1;CACNA1C
prerank,triglyceride metabolic process (GO:0006641),0.4953489386745807,1.6987253612620585,0.0016891891891891893,0.4681060314839555,1.0,12/48,11.48%,LIPC;LIPH;AGMO;SEL1L;LPIN2;DGAT1;LMF1;GK5;PNPLA1;MOGAT1;MOGAT2;APOH
prerank,mitochondrion morphogenesis (GO:0070584),-0.6793956011047607,-1.6956033523926866,0.018218623481781375,0.26295299011716333,1.0,5/11,9.46%,PID1;DNM1L;WASF1;FIS1;MFF
prerank,positive regulation of cell adhesion (GO:0045785),0.44546913695516477,1.6916180863968917,0.0016155088852988692,0.4875135871329565,1.0,19/74,10.24%,ZFHX3;SMAD7;P2RY12;RAC1;MAGI1;TGM2;PRKCA;NPNT;ITGAV;ATM;FLCN;TFE3;PDGFB;C1QBP;CCR7;IL12B;FUT7;LIMS1;NCKAP1L
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.4863092034042784,-1.6876105933058356,0.004524886877828055,0.2768707889885525,1.0,12/39,8.47%,FGF14;DMD;ANK3;FGF12;UTRN;HECW2;HECW1;NEDD4L;FXYD5;PTPN3;NETO1;FGF11
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.5457258037098665,1.6870669251233565,0.013816925734024179,0.49270136579246654,1.0,9/29,9.07%,LPCAT2;TMEM86B;LPCAT4;MBOAT2;PLA2G4A;PLA2G6;PLA2G4B;PLB1;PLA2G5
prerank,skeletal muscle organ development (GO:0060538),0.5547449083030981,1.6842463535852703,0.0074211502782931356,0.49224034349188744,1.0,5/26,6.30%,BASP1;LARGE1;CFLAR;MEF2C;ZBTB18
prerank,regulation of plasminogen activation (GO:0010755),0.6744128740333941,1.6807442662847605,0.012612612612612612,0.49503578974099,1.0,7/12,19.13%,PLGRKT;F12;SERPINE1;RUNX1;SERPINE2;HPN;THBS1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.7066830824554793,-1.6806818449362302,0.015317286652078774,0.28336217625263543,1.0,6/10,25.64%,PFKFB1;HDAC4;TIGAR;CBFA2T3;NCOR1;PPARA
prerank,negative regulation of glycolytic process (GO:0045820),-0.7066830824554793,-1.6806818449362302,0.015317286652078774,0.28336217625263543,1.0,6/10,25.64%,PFKFB1;HDAC4;TIGAR;CBFA2T3;NCOR1;PPARA
prerank,response to fatty acid (GO:0070542),-0.604238333523452,-1.679176965325885,0.008583690987124463,0.2819596326255102,1.0,9/17,22.19%,PID1;CD36;IRS1;FFAR1;NR1H4;GLDC;FOXO1;PDK3;PDK4
prerank,integrated stress response signaling (GO:0140467),0.6576429126759896,1.6786067524085668,0.00945179584120983,0.4915877915676257,1.0,5/14,5.50%,QRICH1;NFE2L2;DDIT3;IMPACT;EIF2S1
prerank,protein localization to kinetochore (GO:0034501),-0.6317872505264007,-1.6759670794712334,0.013605442176870748,0.28412093476815614,1.0,7/14,10.64%,KNL1;MTBP;CENPT;ZW10;SPDL1;AURKB;TTK
prerank,positive regulation of neuron death (GO:1901216),0.4896084331948341,1.6742149064374043,0.0017421602787456446,0.4992372571417453,1.0,10/46,6.19%,ITGAM;DDIT3;PICALM;TLR4;ITGB2;EGR1;CLU;CCL3;EIF2S1;C1QA
prerank,phagosome-lysosome fusion (GO:0090385),0.7145103223051916,1.6727293741821532,0.01967799642218247,0.49343025875001373,1.0,6/10,17.20%,PLA2G5;RAB39A;RAB34;CLN3;RAB20;RAB7B
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.5377158468345926,-1.6719631047248629,0.018691588785046728,0.2897066566225666,1.0,5/24,6.54%,DMD;AKAP6;PDE4D;CALM1;PKD2
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.4028907372872112,-1.6708130907027032,0.0,0.2870861714005195,1.0,40/91,21.68%,RPL36A;RPS29;RPL30;RPL35A;RPS3;RPL4;RPS7;RPS2;RPLP2;RPL7A;RPL41;RPL26;SRP68;RPS27;RPL18A;RPS25;SEC62;RPL38;RPL37;RPS15A;RPS14;RPL24;RPS9;SRP19;RPLP0;RPLP1;RPL8;RPL22;RPS12;RPS10;RPL19;RPS6;RPL13A;RPL18;RPS5;RPS19;RPL23A;SSR2;RPL29;RPS23
prerank,neuron fate commitment (GO:0048663),0.6550180095256444,1.6703828748721519,0.012773722627737226,0.4922366674228865,1.0,6/14,11.32%,TGFBR1;EPOP;PAX6;SHH;POU4F1;DLL1
prerank,water transport (GO:0006833),-0.6649913940996526,-1.6701897167504505,0.015053763440860216,0.2836776860296351,1.0,5/12,29.37%,AQP4;AQP11;CFTR;AQP1;SLC5A1
prerank,prostaglandin biosynthetic process (GO:0001516),0.5994994676011395,1.6695503481153084,0.007352941176470588,0.48399662426711737,1.0,7/18,8.15%,TBXAS1;HPGDS;DAGLB;PTGS1;PLA2G4A;CBR1;EDN2
prerank,phagolysosome assembly (GO:0001845),0.6785542301128284,1.6685069884923758,0.020446096654275093,0.4774723489590773,1.0,6/12,17.20%,PLA2G5;RAB39A;RAB34;CLN3;RAB20;RAB7B
prerank,protein localization to condensed chromosome (GO:1903083),-0.6474593035426135,-1.6651796092723905,0.01956521739130435,0.2907301412289424,1.0,6/12,10.64%,KNL1;MTBP;ZW10;SPDL1;AURKB;TTK
prerank,regulation of smooth muscle contraction (GO:0006940),-0.5736779149628629,-1.6640928811808322,0.010917030567685589,0.28852801043099086,1.0,6/20,7.56%,KCNB2;ATP2B1;CTTN;ZDHHC21;CHRM2;CHRM3
prerank,microglial cell activation (GO:0001774),0.5938067090374943,1.6633871057085603,0.007207207207207207,0.4902576599507695,1.0,7/21,6.19%,CX3CR1;ITGAM;AIF1;AGER;ITGB2;CLU;C1QA
prerank,axon development (GO:0061564),-0.41823015795942636,-1.6626026561458491,0.0,0.2877690095570269,1.0,23/78,14.58%,GRM7;CTNNA2;ANK3;DCC;NRCAM;ARHGAP35;MAP1B;SLITRK1;APP;PLPPR4;SEMA5A;RTN4;PAK3;ZDHHC17;ACTB;RAB8A;RAB3A;SPTBN4;VASH2;NEFH;PARD3;NTNG1;NTNG2
prerank,regulation of mast cell degranulation (GO:0043304),0.6479090989199381,1.661091408905386,0.014285714285714285,0.48926807461064226,1.0,4/14,2.98%,CD84;LGALS9;GAB2;LYN
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.45089824027491443,-1.6609512569867904,0.005012531328320802,0.28704999622771193,1.0,12/54,3.89%,KCNIP4;DPP6;AKAP6;DPP10;KCNIP1;KCNN2;KCNJ3;KCNMB2;GABBR1;GABBR2;YWHAE;NEDD4L
prerank,response to histamine (GO:0034776),-0.6921199568446973,-1.6597369342519444,0.020964360587002098,0.285041658912867,1.0,4/10,8.85%,GABRB1;HRH1;GABRG2;GABRB3
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.5828847681865367,-1.6578815842072494,0.013333333333333334,0.28513868743227866,1.0,7/17,11.36%,KNL1;MTBP;ZW10;SPDL1;AURKB;TTK;CTCF
prerank,postsynaptic membrane organization (GO:0001941),-0.585810085376331,-1.6554468728992606,0.02197802197802198,0.28684463255438925,1.0,5/17,4.64%,NRXN1;NLGN1;GPHN;APOE;SHANK3
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.4507420344340346,1.6548730832654261,0.0016722408026755853,0.5067126186961836,1.0,16/67,8.05%,TBC1D16;TWF2;SDCCAG8;TBC1D17;RAC1;PLD1;TBC1D9B;TBC1D10B;TBC1D8;CAPZB;TBC1D15;TRPM2;FSCN1;ABITRAM;DYNLT2B;CCR7
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.6492764586507869,-1.6546398591185398,0.013761467889908258,0.2845811581354581,1.0,5/12,7.72%,SORBS1;IRS1;PRKCZ;ZBTB7B;SIRT1
prerank,regulation of secretion (GO:0051046),-0.6418507111453056,-1.6527177258183356,0.03184713375796178,0.2848815684385052,1.0,6/13,13.79%,OAS2;FGF10;ACSL3;ERBB3;KCNQ1;MYO6
prerank,cell differentiation in spinal cord (GO:0021515),-0.6873012021072737,-1.648828738599785,0.029545454545454545,0.29027612245813095,1.0,4/10,20.70%,MDGA2;SOX13;MDGA1;SOX6
prerank,lipid catabolic process (GO:0016042),0.6100755844523673,1.6474385490349348,0.01824817518248175,0.5299325174195438,1.0,4/18,6.74%,LIPC;LIPH;SIRT2;PPT1
prerank,cell junction assembly (GO:0034329),-0.3935940646524725,-1.6452570662005663,0.0,0.29449736332526116,1.0,31/100,14.33%,NRXN1;NLGN1;CTNND2;DNM3;ADGRL3;KIRREL3;NRCAM;GPM6A;CDH8;BDNF;SLITRK1;FN1;SHANK3;PLXND1;CDH22;CDC42;CDH7;CDH20;PKP4;VMP1;CDH10;ACTB;CDH11;SDK1;CDHR3;CDH5;OBSL1;ACHE;CDH1;NRXN2;PCDHB16
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.5823577656884632,-1.6433763934252361,0.020737327188940093,0.2951513154376323,1.0,8/18,13.45%,NLGN1;RIMS2;LRRK2;SYN1;GSK3B;RIMS4;DTNBP1;SLC4A8
prerank,cellular calcium ion homeostasis (GO:0006874),-0.3764725132177815,-1.641772573730925,0.0,0.29493392750064373,1.0,38/133,14.96%,ANK2;CCR2;SLC8A3;MCU;TRPC5;ATP2B1;CCR1;RYR2;TRPC4;HTR2C;CD40;YWHAE;ATP2A2;NPTN;PDZD8;SLC24A2;LETM1;SLC8B1;TPT1;HTR2B;ATP13A3;MCUB;RMDN3;TMEM165;MICU2;STIM2;TRPC3;HCRTR2;DMPK;BAK1;ATP2A3;ADCY8;MICU3;CDH5;SLC35G1;CCL5;CCL14;BCL2
prerank,membrane assembly (GO:0071709),-0.49231263918537704,-1.6399332102766402,0.009456264775413711,0.295176490404831,1.0,6/34,2.81%,NRXN1;NLGN1;ANK3;PTPRD;SPTBN1;IL1RAPL1
prerank,androgen receptor signaling pathway (GO:0030521),0.6716914384022459,1.6385885938078246,0.02099236641221374,0.5613842292572723,1.0,7/11,18.40%,PMEPA1;DDX5;DDX17;PLPP1;KDM3A;ZMIZ1;ARID1A
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.40307184529053536,-1.636346103900908,0.0,0.2995338289055934,1.0,38/87,21.68%,RPL36A;RPS29;RPL30;RPL35A;RPS3;RPL4;RPS7;RPS2;RPLP2;RPL7A;RPL41;RPL26;SRP68;RPS27;RPL18A;RPS25;RPL38;RPL37;RPS15A;RPS14;RPL24;RPS9;SRP19;RPLP0;RPLP1;RPL8;RPL22;RPS12;RPS10;RPL19;RPS6;RPL13A;RPL18;RPS5;RPS19;RPL23A;RPL29;RPS23
prerank,positive regulation of cell junction assembly (GO:1901890),-0.4350139319391956,-1.6359174926915114,0.0,0.2963693632363471,1.0,8/56,2.81%,CNTNAP2;NRXN1;NLGN1;GRID2;PTPRD;BDNF;CLSTN2;IL1RAPL1
prerank,protein targeting to ER (GO:0045047),-0.38921991279032814,-1.6331660563474557,0.0025188916876574307,0.2991848029095414,1.0,41/99,21.68%,RPL36A;RPS29;RPL30;RPL35A;RPS3;RPL4;RPS7;SPCS2;RPS2;RPLP2;RPL7A;RPL41;RPL26;SRP68;RPS27;RPL18A;RPS25;GET3;SEC62;RPL38;RPL37;RPS15A;RPS14;RPL24;RPS9;SRP19;RPLP0;RPLP1;RPL8;RPL22;RPS12;RPS10;RPL19;RPS6;RPL13A;RPL18;RPS5;RPS19;RPL23A;RPL29;RPS23
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.6441691054012156,-1.6328745488873928,0.015317286652078774,0.29603231883519854,1.0,5/12,7.72%,CD74;CD44;ING2;RPL26;SIRT1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.6076220216747713,1.6324315834843646,0.024691358024691357,0.5810394662767934,1.0,8/17,23.69%,LPCAT4;PLA2G4A;PLA2G4B;PLA2G5;CRLS1;SERAC1;LPCAT1;PLA2G3
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.5730792263782177,-1.6302367785193743,0.023206751054852322,0.2981298677551255,1.0,5/18,4.64%,NRXN1;NLGN1;CCR2;CACNG2;SHANK3
prerank,signal release from synapse (GO:0099643),-0.4579685383931332,-1.6274271621128855,0.0066518847006651885,0.3013320339579972,1.0,12/43,9.04%,NRXN1;PTPRN2;SYN3;SYN1;SYN2;SYT1;SNPH;SYT10;PCLO;CPLX2;SNAP25;RAB3A
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.48555550549578497,-1.6266514355791248,0.004629629629629629,0.29950099354474685,1.0,14/34,9.95%,GRID2;LRRK2;GRIN2A;GRIN2B;GLRA1;GABRA3;GABRG3;GSK3B;GABRG1;GABRA2;GABRG2;INSYN2A;GRIN2D;CHRNA4
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.5620833957853275,-1.6248881887941837,0.013100436681222707,0.2996501965077102,1.0,9/20,32.51%,WNT4;SIK1;CDA;C1QTNF3;CRY1;NCOR1;UGT1A8;C1QTNF12;GCK
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.500188775133596,1.624844620118632,0.010434782608695653,0.6086940082175897,1.0,22/37,26.81%,SIRPA;ABCD2;TLR4;NOS2;APPL1;PLD4;PYCARD;MAPK14;GBP5;ADCY7;TICAM1;NOD2;ZC3H12A;MYD88;ABCD1;PDCD4;HIF1A;MEFV;APPL2;STAT3;CARD9;CUEDC2
prerank,B cell homeostasis (GO:0001782),0.6934768056796005,1.6247567820615125,0.010948905109489052,0.5969112617949299,1.0,5/10,10.24%,MEF2C;LYN;TNFRSF13B;DOCK10;NCKAP1L
prerank,ceramide catabolic process (GO:0046514),0.62680510889445,1.6231616926948225,0.022018348623853212,0.5936837020440838,1.0,6/14,11.12%,HEXB;HEXA;NEU3;ACER3;ACER2;ASAH1
prerank,axonogenesis (GO:0007409),-0.34012694170342805,-1.6213043035052812,0.0,0.30463744651218316,1.0,47/237,9.59%,NRXN1;DAB1;AUTS2;CTNNA2;ANK3;ROBO1;UNC5C;DCC;SPTBN1;B4GALT5;KIF5C;NRXN3;NRCAM;SLIT2;ARHGAP35;DOK6;B4GALT6;MAP1B;SHC3;BDNF;SLITRK1;APP;PLPPR4;SEMA5A;CNTN6;EMB;NPTN;SHANK3;PALLD;SEMA4A;DOK5;NCAM1;GFRA2;DOK1;PAK3;RET;EPHA5;ZDHHC17;LGI1;SPTBN2;DOK2;KIF5B;ACTB;RAB8A;RAB3A;GRB10;SPTBN4
prerank,regulation of regulated secretory pathway (GO:1903305),-0.4851017054409775,-1.6206297779138104,0.01201923076923077,0.3026689737135812,1.0,13/34,17.17%,RIMS2;LRRK2;SYN1;SYT1;SYT10;GSK3B;RAB3D;RAB3A;RIMS4;DTNBP1;SYT3;RIMS1;TRPV6
prerank,heart process (GO:0003015),-0.6057523205999549,-1.6202263498920382,0.021321961620469083,0.2999720045563787,1.0,6/14,20.91%,SGCZ;SGCD;PPCS;ACE;NOX4;FYN
prerank,protein trimerization (GO:0070206),-0.5971062373611622,-1.61718829223505,0.03303964757709251,0.30019654041484467,1.0,6/14,16.74%,DISP1;ALOX5AP;SLC1A5;MLKL;SCARA5;STEAP4
prerank,protein homotrimerization (GO:0070207),-0.5971062373611622,-1.61718829223505,0.03303964757709251,0.30019654041484467,1.0,6/14,16.74%,DISP1;ALOX5AP;SLC1A5;MLKL;SCARA5;STEAP4
prerank,regulation of dendrite development (GO:0050773),-0.4657474864712428,-1.6166007719694688,0.014457831325301205,0.2982594924661102,1.0,12/37,13.00%,ADGRB3;DCC;CDKL5;BCL11A;HECW2;HECW1;NEDD4L;GSK3B;ALK;MFSD2A;SARM1;ZDHHC15
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.5073602211153855,-1.6162665863465613,0.018561484918793503,0.2954720397846403,1.0,6/27,5.23%,AHNAK;DMD;ANK2;PDE4D;YWHAE;CALM1
prerank,phosphatidylserine metabolic process (GO:0006658),0.5080351168384483,1.613126734985138,0.0136986301369863,0.6342463234462428,1.0,10/32,13.84%,ABHD12;LPCAT4;MBOAT2;PLA2G4A;PLA2G15;PLA2G4B;PLA2G5;MBOAT1;OSBPL5;PTDSS2
prerank,prostaglandin metabolic process (GO:0006693),0.5360450484744684,1.6130268769659595,0.01607142857142857,0.6227843509722816,1.0,7/26,8.15%,TBXAS1;HPGDS;DAGLB;PTGS1;PLA2G4A;HPGD;EDN2
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.6740417574642501,1.6124221244180166,0.020446096654275093,0.614606060775807,1.0,3/11,8.46%,GREM1;MEF2C;GPER1
prerank,granulocyte differentiation (GO:0030851),-0.5774105524818679,-1.6117826345968669,0.012875536480686695,0.30285173453673414,1.0,10/18,19.30%,LBR;JAGN1;RARA;CEBPA;CDKN1A;CBFA2T3;CDK2;E2F1;CDK4;LEF1
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.6279106087532108,-1.6100604866613555,0.034324942791762014,0.3037474224192996,1.0,4/12,9.59%,B4GALT5;ARHGAP35;B4GALT6;SPTBN4
prerank,chondroitin sulfate catabolic process (GO:0030207),0.6308948944491561,1.6088569746413888,0.031598513011152414,0.6237179590006592,1.0,6/13,12.28%,HEXB;ARSB;HEXA;BGN;BCAN;CSPG5
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.6022014350946225,1.6085447135233166,0.025096525096525095,0.6140689462495694,1.0,8/17,20.07%,LYN;SEMA4C;MID1;ARL6IP5;TAOK2;PDCD10;EIF2AK2;NOD2
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3921278268774781,1.6082965201946875,0.0015082956259426848,0.6045056849900372,1.0,26/140,6.27%,SRGAP3;SRGAP2;ARHGAP5;CHN2;FGD2;ARHGAP22;ARHGAP45;OPHN1;ARHGAP39;ARHGEF2;PREX1;VAV2;RAC1;TGM2;ARAP3;CYRIB;ARHGAP25;ITGAV;RHOQ;SRC;RHOB;FLCN;ARHGAP30;ARHGAP28;RHOH;ARHGAP17
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.5301561915462205,-1.6078515208168775,0.015418502202643172,0.3055737518578967,1.0,7/21,13.67%,XDH;PDE4D;AMPD3;PDE9A;HINT1;NUDT3;PDE2A
prerank,stress-activated MAPK cascade (GO:0051403),0.448789132159349,1.6059457364747782,0.0033783783783783786,0.6052280003024879,1.0,24/61,20.07%,LGALS9;IRAK2;RIPK2;GPS2;MAP4K3;RPS27A;UBC;ADORA2B;ZFP36L1;TAB2;MAP3K8;MAP4K2;TAOK2;MAP3K10;MAP3K11;GPS1;MAPK8;TNIP2;TNFRSF19;MAPK14;CCM2;TRIB1;CRKL;NOD2
prerank,nuclear export (GO:0051168),0.42162266025009165,1.6054729519940731,0.0031847133757961785,0.597586761281028,1.0,37/80,29.61%,SRRM1;NCBP1;SMURF1;MAGOHB;MAGOH;STRADA;U2AF2;NUP42;EGR2;RANBP3;NUP62CL;DHX38;SRSF5;RBM8A;U2AF1L4;SLU7;ALYREF;NEMF;NUP62;CSE1L;THOC6;WASHC4;SRSF9;DDX39B;NUP153;TGFB1;XPO5;HNRNPA1;XPO1;NUP188;THOC3;ZC3H11A;THOC5;RANBP17;CALR;POLDIP3;XPO6
prerank,glucose import (GO:0046323),0.6268761800804392,1.6043875338923985,0.029038112522686024,0.5929621834029336,1.0,5/13,13.67%,SORT1;TRARG1;SLC27A4;ZDHHC7;RAB4B
prerank,presynapse assembly (GO:0099054),-0.5961694651069935,-1.6033187595066405,0.01182033096926714,0.31341249723894277,1.0,5/16,9.22%,NLGN1;PTPRD;IL1RAPL1;PCLO;LRRTM3
prerank,skeletal muscle tissue development (GO:0007519),0.5124022948532113,1.60251981353743,0.0213903743315508,0.592724544625446,1.0,6/32,8.04%,CFLAR;MEF2C;SKI;ZBTB18;EGR2;KLHL40
prerank,regulation of tissue remodeling (GO:0034103),0.5895613024111005,1.6013229918376104,0.026119402985074626,0.5885101871495197,1.0,7/18,15.43%,IL18;CST3;IL12B;CEACAM1;RUNX1;DDR2;GPNMB
prerank,mononuclear cell differentiation (GO:1903131),0.5408243833704544,1.601040961609489,0.016216216216216217,0.5804431261944307,1.0,10/24,13.25%,IKZF1;CSF1R;LYN;MYH9;TRPM2;MT1G;IRF8;AXL;PDE1B;RELB
prerank,AMP metabolic process (GO:0046033),-0.6243887695813535,-1.600817582233009,0.0378619153674833,0.3159717098515568,1.0,5/13,16.20%,XDH;AMPD3;AK3;AK4;ADSS2
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.40887368027440607,1.5990499032831202,0.006535947712418301,0.5811198802861871,1.0,19/95,6.58%,TGFBR1;LDLRAD4;TGFBR2;SMAD3;SMAD7;PMEPA1;SKI;SMURF1;TGFB1I1;LTBP4;SKIL;FLCN;RPS27A;UBC;SPRY2;PDPK1;NREP;EID2;ASPN
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.574752591930537,-1.5983295475492656,0.026607538802660754,0.3185379002157478,1.0,4/16,3.77%,ANK2;LRRK2;RYR2;VAPA
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.4749729156714211,-1.5979664458520686,0.012254901960784314,0.31603884450884984,1.0,13/33,16.67%,LRRC4C;NLGN1;GRIK2;GRID2;NRG3;BDNF;GRIK4;GRIK1;SLC4A8;RELN;ABR;GRIK3;CACNA1B
prerank,regulation of cation transmembrane transport (GO:1904062),-0.49601488316974135,-1.5977952477084862,0.02054794520547945,0.31312696474383966,1.0,8/29,6.40%,KCNIP4;DPP6;DPP10;KCNIP1;FGF12;KCNN2;HOMER1;KCNAB2
prerank,actin cytoskeleton reorganization (GO:0031532),-0.41809566530791253,-1.5973286075768194,0.007281553398058253,0.31098665588479124,1.0,30/63,24.26%,AUTS2;NEDD9;MKLN1;FGF10;GSN;MCU;CTTN;THSD7B;CDC42BPA;BCAR1;FGF7;PHACTR1;THSD7A;KIT;DTNBP1;PDLIM4;CDC42BPG;FER;PAK1;PARVG;S1PR2;NRK;PARVB;EFS;EZR;MICALL2;FLNA;TNIK;ANXA1;SYDE1
prerank,positive regulation of protein maturation (GO:1903319),-0.6354276495325956,-1.596047839014196,0.03728070175438596,0.3108129291459394,1.0,3/11,11.69%,NLRC4;CCBE1;TFR2
prerank,negative regulation of protein ubiquitination (GO:0031397),0.45923554617755763,1.594868515020233,0.006825938566552901,0.5923855118606952,1.0,16/50,17.49%,IVNS1ABP;SENP2;SMAD7;ARRB2;U2AF2;SPRY2;KLHL40;TAF1;GNL3L;ABL1;AKT1;USP4;DTX3L;HDAC8;ARRB1;SPOPL
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.6251712608026094,-1.594022767795176,0.018691588785046728,0.3122905638855619,1.0,5/13,7.72%,SORBS1;IRS1;PRKCZ;ZBTB7B;SIRT1
prerank,positive regulation of histone methylation (GO:0031062),-0.5091536475452427,-1.5938742702358975,0.02304147465437788,0.30951477854118503,1.0,13/24,23.57%,AUTS2;MTF2;JARID2;SIRT1;TET1;DNMT3B;RIF1;DNMT1;SNW1;MYB;CHTOP;FAM47E;CTNNB1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5969812491110142,-1.593468182606172,0.01882845188284519,0.30749620389852517,1.0,5/15,6.18%,GRM7;GRM8;GRM5;GRM1;HOMER1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.3931495691110017,1.5926527848147756,0.0,0.5940616622222834,1.0,31/128,16.38%,TGFBR1;ITGB5;F11R;TGFBR2;SMAD3;SMAD7;ARRB2;DDX5;SKI;SMURF1;TGFB1I1;SRC;ID1;RPS27A;UBC;HPGD;EID2;CGN;GCNT2;LEFTY1;LPXN;JUN;APPL1;ZYX;ENG;SMAD9;USP9Y;ZMIZ2;LTBP2;ACVR2B;ZMIZ1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.5336811274000963,-1.5912177749577798,0.027972027972027972,0.31003821845323737,1.0,6/21,4.82%,HS6ST3;HS3ST5;SULF2;EXT1;HS6ST2;HS3ST4
prerank,long-term synaptic potentiation (GO:0060291),-0.5311610509555423,-1.5894643769160544,0.03002309468822171,0.3113147213831461,1.0,10/21,15.02%,GRIN2A;GRIN2B;SLC8A3;NPTN;SLC24A2;PRKCZ;PLK2;GRIN2D;TSHZ3;MPP2
prerank,regulation of neuron projection development (GO:0010975),-0.35049907259302826,-1.5884695676173841,0.0,0.3106439858077678,1.0,46/163,14.84%,MAGI2;LRRC4C;PDLIM5;CTNNA2;DCC;RIT2;LRRC7;LRRK2;TENM3;SPOCK1;CDKL5;ARHGAP35;FUT9;BDNF;PPFIA2;IL1RAPL1;RAPGEF2;ROR1;NTRK2;NPTN;NTRK3;APOE;SHANK3;GSK3B;KIDINS220;CHN1;PAK3;RET;ABI2;PLXNB2;SCARF1;CCDC88A;P3H1;SERPINI1;KANK1;MFSD2A;STMN2;SRCIN1;PAQR3;FBXO7;MINAR1;ZDHHC15;CX3CL1;NTNG1;NTNG2;PAK1
prerank,triglyceride catabolic process (GO:0019433),0.5765664932219431,1.5883947951702495,0.02702702702702703,0.6067949932974837,1.0,3/19,8.06%,LIPC;LIPH;PNPLA1
prerank,cellular metal ion homeostasis (GO:0006875),-0.3758517861793881,-1.5883266830277527,0.0,0.3079805139318374,1.0,25/102,12.38%,ANK2;CCR2;SLC8A3;ATP2B1;CCR1;RYR2;HTR2C;CD40;NEDD4L;ATP2A2;NPTN;SLC24A2;LETM1;SLC8B1;TPT1;HTR2B;ATP13A3;RMDN3;TMEM165;ATP1B3;STIM2;DMPK;ATP2A3;ATP1A1;CDH5
prerank,glycosphingolipid metabolic process (GO:0006687),0.48047119231534613,1.5878785894837235,0.015957446808510637,0.6000966404559858,1.0,16/42,20.62%,HEXB;LARGE1;ST3GAL5;CPTP;HEXA;NEU3;SMPD2;CERK;ASAH1;B4GALNT1;ARSA;CTSA;NEU4;GLB1;SMPD3;SUMF2
prerank,calcium ion homeostasis (GO:0055074),-0.3813716687465413,-1.586799062295094,0.0,0.30850777985323685,1.0,28/95,18.20%,ANK2;CCR2;SLC8A3;ATP2B1;CCR1;RYR2;HTR2C;CD40;ATP2A2;NPTN;SLC24A2;SLC8B1;TPT1;HTR2B;ATP13A3;RMDN3;TMEM165;STIM2;DMPK;ATP2A3;CDH5;CCL5;CCL14;SNCA;TMTC2;ATP13A5;TRPV6;CCL7
prerank,positive regulation of T cell activation (GO:0050870),0.44167541054243564,1.5860798473190265,0.011764705882352941,0.6000665863198235,1.0,16/62,10.24%,DOCK8;SIRPA;CCDC88B;LGALS9;AIF1;CYRIB;TNFRSF13C;RHOH;IL6ST;CD86;PNP;CCR7;PDCD1LG2;IL12B;FLOT2;NCKAP1L
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.6576416010723501,1.5828179418927808,0.03177570093457944,0.6081835597791838,1.0,3/11,1.04%,TGFBR1;TGFBR2;SMAD7
prerank,mRNA polyadenylation (GO:0006378),-0.4945991683982163,-1.5785377499162248,0.026200873362445413,0.3216513799752462,1.0,13/26,26.34%,SCAF8;PAPOLA;APP;CSTF3;CDC73;GRSF1;PABPC1;TENT2;TUT1;PAPOLG;PAPOLB;WDR33;SSU72
prerank,RNA polyadenylation (GO:0043631),-0.4945991683982163,-1.5785377499162248,0.026200873362445413,0.3216513799752462,1.0,13/26,26.34%,SCAF8;PAPOLA;APP;CSTF3;CDC73;GRSF1;PABPC1;TENT2;TUT1;PAPOLG;PAPOLB;WDR33;SSU72
prerank,ruffle organization (GO:0031529),0.5960562732468883,1.5781004564028933,0.02772963604852686,0.6228420661348039,1.0,8/16,10.91%,CSF1R;RAC1;AIF1;PLEK;ARFIP2;CCR7;INPP5K;CYFIP1
prerank,transport along microtubule (GO:0010970),-0.5983502726705934,-1.5778639862826394,0.038461538461538464,0.3202573693422896,1.0,7/13,12.29%,BORCS5;APP;DYNC1I2;CDC42;BAG3;COPG2;ARHGAP21
prerank,purine-containing compound catabolic process (GO:0072523),-0.6028138127625315,-1.5728878969636388,0.032679738562091505,0.32985044095260374,1.0,3/13,1.56%,DPYD;XDH;GDA
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.5645637173715958,-1.572381721889453,0.05084745762711865,0.3280402254781504,1.0,5/16,5.23%,DMD;ANK2;RYR2;CALM1;CACNA1C
prerank,regulation of chemokine production (GO:0032642),0.4885131612098744,1.5717230559588184,0.018456375838926176,0.6459996900431978,1.0,8/36,3.82%,IL18;TLR7;CSF1R;LGALS9;AIF1;AGER;TLR4;EGR1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.5526545496304567,-1.570855765557968,0.03455723542116631,0.32905104792703127,1.0,5/16,10.71%,RBPJ;AKAP6;ZFPM2;ERBB4;PIM1
prerank,negative regulation of leukocyte migration (GO:0002686),-0.650210942325244,-1.5700891293353483,0.03736263736263736,0.3278638966789694,1.0,4/10,17.75%,SLIT2;HMOX1;CD200R1;ADTRP
prerank,negative regulation of interferon-gamma production (GO:0032689),0.5370425465737177,1.5675490737401385,0.026737967914438502,0.6600628640890963,1.0,9/23,11.93%,DDIT3;LGALS9;VSIR;TLR4;C1QBP;PDCD1LG2;INHA;AXL;HAVCR2
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.566186330332204,1.5668147547340365,0.030927835051546393,0.655176836234788,1.0,6/19,10.27%,ITGAM;LGALS9;TLR4;ITGB2;PIK3AP1;TICAM2
prerank,monoacylglycerol metabolic process (GO:0046462),0.6066610718127389,1.5658430528790273,0.03180212014134275,0.6518072255411873,1.0,5/13,11.37%,ABHD12;DGAT1;PLA2G4A;MOGAT2;ABHD6
prerank,negative regulation of myoblast differentiation (GO:0045662),0.611150909462306,1.5648647411535845,0.028735632183908046,0.648079356213629,1.0,9/13,30.49%,SOX8;ANKRD2;EID2B;DLL1;TGFB1;SOX9;PRICKLE1;SRA1;NOTCH1
prerank,regulation of receptor binding (GO:1900120),-0.6565039683617201,-1.564539873318826,0.046255506607929514,0.3384706491000318,1.0,4/10,10.26%,BDNF;B2M;ATP2A2;ATP2A3
prerank,regulation of interleukin-17 production (GO:0032660),0.49514467681524177,1.5641095173813324,0.026041666666666668,0.643205134962338,1.0,13/31,23.35%,IL18;DDIT3;SLC7A5;VSIR;TLR4;IL12B;NCKAP1L;LY9;OSM;NOD2;SLAMF6;TGFB1;MYD88
prerank,regulation of platelet activation (GO:0010543),0.5477066693121311,1.561873733594317,0.033216783216783216,0.6462548155157365,1.0,7/21,8.45%,TLR4;PRKCA;LYN;PLEK;PLA2G4A;PDGFB;SELP
prerank,cortical actin cytoskeleton organization (GO:0030866),0.5479291657467652,1.560257562238439,0.02029520295202952,0.646895079114323,1.0,9/20,18.02%,PLEK;FMNL3;RHOQ;NCKAP1L;FHOD1;LLGL1;FMNL2;RAB13;ROCK2
prerank,diol biosynthetic process (GO:0034312),0.6001319902319976,1.557572584905868,0.033807829181494664,0.6526143677581441,1.0,5/15,11.12%,QDPR;SPTLC3;ACER3;ACER2;ASAH1
prerank,import into nucleus (GO:0051170),0.41396130068479503,1.5568016599392622,0.006644518272425249,0.6486110605408496,1.0,37/73,28.42%,BACH2;SPRN;PHB2;FAM53A;SNRPF;PTTG1IP;SEC13;NUP62CL;TNPO1;APPL1;NUP50;SMN1;GEMIN6;SNUPN;NUP88;IPO4;DDX20;RPAIN;AKT1;TNPO3;NUP62;CSE1L;NUP107;E2F3;GEMIN2;IPO7;NUP153;HNRNPA1;IPO5;PRICKLE1;NUP188;APPL2;STAT3;IPO9;RANBP17;HIKESHI;SNRPG
prerank,positive regulation of GTPase activity (GO:0043547),0.36966305560532997,1.556640609817409,0.0,0.6413790008183161,1.0,45/188,14.52%,SRGAP2;DOCK8;TBC1D16;ARHGAP22;F11R;ARHGAP45;SIPA1L2;ITGA6;TBC1D17;ARHGAP27;MAP4K4;RAP1GDS1;ASAP3;TBC1D9B;PICALM;TGM2;RGS10;TBC1D10B;TBC1D7;SNX18;ARHGAP25;TBCK;TBC1D8;GARNL3;TBC1D15;CCL3;FLCN;SIPA1;TAX1BP3;SGSM2;RAB3GAP1;CCR7;DOCK10;LIMS1;SLC27A4;TBC1D9;RUNDC1;RAPGEF3;CCDC125;PIN1;SEMA4D;GMIP;TBC1D30;EZH2;RTN4R
prerank,regulation of proteolysis (GO:0030162),0.4515445394311857,1.556299750438005,0.008488964346349746,0.6353381057187334,1.0,16/48,20.41%,BAG6;CST3;CAPN3;GSAP;ITCH;ASPH;LTBP4;SHH;CLN3;SERPINE2;AKT1;DNAJC1;SPOPL;STUB1;IST1;FGFR4
prerank,JNK cascade (GO:0007254),0.47079242311779873,1.554827124534806,0.015306122448979591,0.6351266948428603,1.0,17/40,20.07%,IRAK2;RIPK2;GPS2;MAP4K3;RPS27A;UBC;ADORA2B;TAB2;MAP4K2;MAP3K10;MAP3K11;GPS1;MAPK8;TNFRSF19;TRIB1;CRKL;NOD2
prerank,spliceosomal snRNP assembly (GO:0000387),0.47619930132469745,1.5545499943891878,0.012773722627737226,0.6290956351283424,1.0,18/38,28.42%,SNRPC;COIL;SART3;SNRPF;SMN1;GEMIN6;SNUPN;TGS1;PRPF31;DDX20;USP4;PRPF3;GEMIN2;WDR77;CD2BP2;SRSF10;CLNS1A;SNRPG
prerank,negative regulation of bone remodeling (GO:0046851),0.6497053154147358,1.5524599356709545,0.03759398496240601,0.6317145049036074,1.0,5/11,16.79%,TMEM119;GREM1;UBASH3B;GPR137;CARTPT
prerank,cellular response to cAMP (GO:0071320),-0.47548484650878475,-1.551785992472386,0.0200445434298441,0.3681748612019409,1.0,17/30,25.09%,AKAP6;HCN1;RAPGEF2;PKD2;AHR;KCNQ1;PDE2A;HCN2;CRHBP;CFTR;SLC26A3;EZR;AQP1;HCN4;SLC5A5;WT1;HCN3
prerank,response to muscle stretch (GO:0035994),-0.5798815838972576,-1.549954506292372,0.048728813559322036,0.36966245195145697,1.0,3/15,2.60%,DMD;GSN;RYR2
prerank,chloride transmembrane transport (GO:1902476),-0.41964758357676785,-1.549910996273931,0.009708737864077669,0.366608289575367,1.0,21/48,17.66%,GABRB1;GLRA1;GABRA3;GABRG3;GABRG1;SLC12A8;ANO3;GABRA2;SLC12A4;GABRG2;SLC12A5;ANO6;GABRB3;ANO5;GLRA2;GABRA5;SLC4A8;CFTR;GABRQ;SLC1A1;SLC12A1
prerank,regulation of acrosome reaction (GO:0060046),-0.6347439490873665,-1.549541636399656,0.04721030042918455,0.3642717992710518,1.0,2/10,4.13%,PLCB1;GLRA1
prerank,negative regulation of protein depolymerization (GO:1901880),0.5266569956794098,1.5489442609878927,0.028517110266159697,0.6413126316443166,1.0,11/24,22.36%,NAV3;ARHGEF2;FGF13;CAMSAP1;CAMSAP2;PLEKHH2;CIB1;ATXN7;TTBK2;KATNB1;PIK3CA
prerank,cilium movement (GO:0003341),-0.4270140281791567,-1.547967874292438,0.0125,0.365314763618749,1.0,23/47,30.30%,ODAD2;DNAI4;CFAP53;DNAH9;DNAAF5;DNAI3;CFAP61;CFAP206;CFAP91;ODAD3;SPA17;DNAH17;SPEF2;DNAAF1;CCDC39;TEKT5;CFAP100;CFAP70;DNAH11;ODAD4;DNAAF4;CCDC63;TEKT2
prerank,regulation of defense response to virus (GO:0050688),0.6052623705557667,1.547850088616076,0.051330798479087454,0.6393118437023305,1.0,5/14,7.28%,RNF216;ITCH;PCBP2;DHX9;C1QBP
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.537805989872295,1.546540960844268,0.03917910447761194,0.6390445307787639,1.0,5/22,4.13%,GSAP;AGER;PICALM;LYN;CLU
prerank,negative regulation of complement activation (GO:0045916),-0.6423742554679758,-1.5463218975557902,0.05470459518599562,0.36610595079598807,1.0,5/10,14.67%,SERPING1;VSIG4;CR1L;CR2;CD46
prerank,negative regulation of transmembrane transport (GO:0034763),0.6661644467092952,1.5461897623436294,0.03824091778202677,0.6336137882229487,1.0,6/10,24.67%,CTTNBP2NL;INPP5K;PRKCB;AKT1;THBS1;OAZ3
prerank,glycolipid metabolic process (GO:0006664),0.45631291177127575,1.545524266012857,0.023809523809523808,0.6298859400621393,1.0,17/47,21.90%,ST3GAL6;HEXB;CPTP;HEXA;NEU3;SMPD2;CERK;ASAH1;B4GALNT1;ARSA;CTSA;NEU4;GLB1;SMPD3;SUMF2;ST6GALNAC4;GBGT1
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.5139242080047884,1.5454332812409148,0.04088586030664395,0.6236099435976852,1.0,3/24,4.17%,ITGAM;DDIT3;CCL3
prerank,positive regulation of chemokine production (GO:0032722),0.4628757633593216,1.5449866499998202,0.01818181818181818,0.6189630589736786,1.0,12/44,14.63%,IL18;TLR7;CSF1R;LGALS9;AIF1;AGER;TLR4;EGR1;IL6R;IL33;MAVS;PYCARD
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.42678703699916526,1.544508643920524,0.008802816901408451,0.6146449940834284,1.0,20/59,18.02%,TGFBR1;TGFBR2;PRKCA;CSNK2A2;CSNK2A1;PRKCD;PDPK1;WNK1;TAF1;MAP3K10;MARK2;MAPK8;DYRK1A;AKT1;DYRK4;STK39;MAP2K1;ULK1;CDC42BPB;ROCK2
prerank,negative regulation of bone mineralization (GO:0030502),0.6144531718712215,1.5443625790129303,0.045283018867924525,0.6088901389366133,1.0,5/13,5.98%,GREM1;TRPM4;CCL3;PTK2B;BCOR
prerank,histone modification (GO:0016570),0.39044868060894317,1.5431702737848256,0.006349206349206349,0.6082194014519423,1.0,45/109,23.75%,BRD8;PRMT2;SIRT2;MTA1;HDAC10;PRKCD;SUDS3;RPS6KA5;RBM14;PADI2;TAF6L;TAF6;SIN3A;MIDEAS;CPA4;PRMT8;EYA3;PRMT1;EHMT2;USP36;MORF4L1;KDM4A;BAZ1B;UBE2U;PRMT6;BRMS1L;MRGBP;NAA50;EZH2;HDAC5;ATXN7;UBE2A;RPS6KA4;SIN3B;KAT5;CARM1;MIER3;TAF10;MORF4L2;PHF20;KAT6B;PARK7;EYA4;BRMS1;PHC1
prerank,outer dynein arm assembly (GO:0036158),-0.5897979604480079,-1.5428883702427143,0.03524229074889868,0.3723709500529004,1.0,10/14,29.84%,ODAD2;DNAH8;DNAAF5;ODAD3;DNAH17;DNAAF1;DNAL1;ODAD4;DNAAF4;CCDC63
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.5922128515908062,-1.5392646969380293,0.023454157782515993,0.37904875668837956,1.0,5/13,14.19%,PLXNC1;PLXND1;PLXNA2;PLXNB2;PLXNB1
prerank,positive regulation of cell communication (GO:0010647),-0.474242780425002,-1.537563090731544,0.024553571428571428,0.3803145901685929,1.0,8/28,8.12%,GRIK2;RIMS2;ANK3;CLSTN2;SYT1;SOX11;HOMER1;LGI1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.5096521339333021,-1.536966543898734,0.03282275711159737,0.37876212623227834,1.0,5/22,5.65%,AHNAK;DMD;PDE4B;GPR35;CBARP
prerank,cardiac muscle cell action potential (GO:0086001),-0.461687980841393,-1.5348302035645531,0.03488372093023256,0.38158347459651965,1.0,10/30,14.73%,DMD;ANK2;FGF12;YWHAE;KCND3;CACNA1C;ATP1A1;KCNQ1;HCN2;KCNIP2
prerank,membrane lipid metabolic process (GO:0006643),0.52097633045481,1.5337908769855546,0.041237113402061855,0.6458481837858656,1.0,3/22,1.93%,ST3GAL6;AGMO;ALOXE3
prerank,"phagocytosis, engulfment (GO:0006911)",0.47236253367455755,1.5330064765955798,0.02,0.6431860384999958,1.0,10/36,5.85%,ELMO1;ITGAM;BIN2;RAC1;AIF1;ARHGAP25;ITGB2;MYH9;RHOBTB1;RHOH
prerank,osteoclast differentiation (GO:0030316),0.532260601962317,1.531223896982896,0.052100840336134456,0.6454018646804309,1.0,11/22,24.34%,CSF1R;GAB2;SBNO2;SRC;OSTM1;CSF1;OSCAR;MAPK14;EPHA2;TYROBP;EFNA2
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.43709696980462864,1.5296440118480956,0.02040816326530612,0.6461941132481326,1.0,11/56,9.60%,TLR7;UNC93B1;IRAK2;TLR4;PLCG2;RPS27A;UBC;CTSS;LGMN;TAB2;CLEC4E
prerank,aminoglycan biosynthetic process (GO:0006023),-0.4103179242895505,-1.5290223008442492,0.007751937984496124,0.3938258352349876,1.0,18/49,17.44%,B3GALT1;GPC6;HS3ST5;HS3ST2;EXT1;SDC3;GPC5;HS6ST2;HS3ST1;HSPG2;GPC3;PXYLP1;NDST1;B3GALT2;GPC4;EXT2;AGRN;B4GALT7
prerank,response to cholesterol (GO:0070723),0.5703721750891761,1.528819430089315,0.045787545787545784,0.6440458330827159,1.0,4/17,4.17%,TGFBR1;TGFBR2;GRAMD1A;CCL3
prerank,error-prone translesion synthesis (GO:0042276),0.5243070022869201,1.5286625894938846,0.03308823529411765,0.6384481313048188,1.0,5/21,5.24%,PCNA;PRIMPOL;RFC2;RPS27A;UBC
prerank,macrophage activation involved in immune response (GO:0002281),0.6143763789897642,1.5283026355504117,0.024691358024691357,0.6337685717453237,1.0,3/13,4.12%,CX3CR1;SBNO2;PLCG2
prerank,sphingoid biosynthetic process (GO:0046520),0.6388756595199434,1.5278791898032689,0.05688073394495413,0.6237259795148429,1.0,4/11,11.12%,SPTLC3;ACER3;ACER2;ASAH1
prerank,sphingosine biosynthetic process (GO:0046512),0.6388756595199434,1.5278791898032689,0.05688073394495413,0.6237259795148429,1.0,4/11,11.12%,SPTLC3;ACER3;ACER2;ASAH1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.5492128853852916,1.5275184479777701,0.04129263913824058,0.6193760107703471,1.0,7/18,20.91%,SEL1L;RPS27A;UBC;OS9;RNF103;MAN1B1;SYVN1
prerank,ethanol metabolic process (GO:0006067),0.6102074415160416,1.527109743176758,0.05420560747663551,0.6154632757860191,1.0,4/12,18.30%,ACSS1;SULT2A1;ALDH1B1;ACSS2
prerank,regulation of secretion by cell (GO:1903530),-0.41400504980718716,-1.5268276855259757,0.00954653937947494,0.3966354226045868,1.0,16/54,12.32%,RIMS2;STXBP5L;SYN1;DISP1;MCTP2;RAB3C;SYT1;RIC1;STXBP5;CPLX2;RAB3D;RAB8A;RAB3A;P3H1;MCTP1;KCNMB4
prerank,protein kinase B signaling (GO:0043491),0.5215242956365691,1.5262517489481948,0.03185840707964602,0.6135577003570416,1.0,10/23,23.10%,SIRT2;CCL3;THEM4;ZFP36L1;PAX2;PLK3;AKT1;PIK3R3;EPHA2;TGFB1
prerank,ceramide metabolic process (GO:0006672),0.44171655381233205,1.5258585127442803,0.014010507880910683,0.6097795807828256,1.0,15/49,13.47%,ALOXE3;CERS3;DEGS2;PLA2G15;SPTLC3;PNPLA1;FUT7;SMPD2;ACER3;ACER2;PLPP1;CERK;ASAH1;PLPP2;CERS2
prerank,in utero embryonic development (GO:0001701),0.5146281060751221,1.5254013250182326,0.046511627906976744,0.6062385850896349,1.0,5/25,4.69%,TGFBR1;SOX8;FLCN;CHD7;ZNF568
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.6240252292045019,-1.5248586898347019,0.042316258351893093,0.39874985554516046,1.0,6/11,14.73%,KCNJ3;YWHAE;KCND3;ATP1A1;KCNQ1;KCNIP2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.6151912123809435,-1.5239950244701408,0.050955414012738856,0.3979625915666625,1.0,5/11,14.96%,CD74;CD44;ING2;SIRT1;BCL2
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.6120872604522377,1.5234512497990733,0.05333333333333334,0.6096882973568714,1.0,3/11,7.10%,BIN1;CACNB2;NOS1AP
prerank,membrane repolarization during action potential (GO:0086011),-0.5859153894387874,-1.5229238876333995,0.040632054176072234,0.3978730587651095,1.0,6/13,17.16%,YWHAE;KCND3;ATP1A1;KCNQ1;KCNIP2;KCNE3
prerank,calcium ion transmembrane transport (GO:0070588),-0.3708286762950474,-1.5218717567330904,0.005235602094240838,0.3976000522335199,1.0,25/86,11.02%,GRIN2A;GRIN2B;SLC8A3;MCU;TRPC5;ATP2B1;RYR3;NALCN;TRPC4;TRPM3;ATP2A2;SLC24A2;LETM1;SLC8B1;CACNA1C;PARL;MCUB;PKD2;TMEM165;MICU2;TRPC3;GRIN2D;ANO6;ATP2A3;MICU3
prerank,regulation of histone modification (GO:0031056),0.6100134825310699,1.519768459167474,0.041666666666666664,0.621402703906296,1.0,5/13,4.36%,AKAP8;AKAP8L;CDK9;HPF1;FLCN
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.3577864801169819,-1.5190622020024018,0.007751937984496124,0.40174845087210104,1.0,47/110,21.68%,RPL36A;PPP2R2A;RPS29;RPL30;RPL35A;RPS3;RPL4;RPS7;RPS2;RPLP2;RPL7A;SMG7;RPL41;EIF3E;RPL26;EIF4A3;SMG6;PABPC1;RPS27;RPL18A;RPS25;SMG5;RPL38;RPL37;PPP2R1A;RPS15A;RPS14;RPL24;HELZ2;RPS9;RPLP0;RPLP1;RPL8;RPL22;RPS12;SMG1;RPS10;RPL19;RPS6;RPL13A;RPL18;RPS5;RPS19;RPL23A;UPF1;RPL29;RPS23
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5322173852089743,1.5186588849684848,0.0456140350877193,0.6205672928271613,1.0,7/21,13.37%,LPCAT4;MBOAT2;PLA2G4A;PLA2G4B;PLA2G5;MBOAT1;OSBPL5
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.653058460177781,1.5183516910602002,0.046125461254612546,0.6163426271728241,1.0,3/10,2.98%,NBR1;GREM1;LYN
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.6208590126031673,1.5168311029571677,0.03656307129798903,0.6179197084425194,1.0,6/12,16.93%,SOX8;GDNF;PAX2;SMO;NOG;AGT
prerank,negative regulation of biomineral tissue development (GO:0070168),0.5289593908745814,1.5166950078089627,0.034050179211469536,0.6131429571443513,1.0,6/21,6.58%,GREM1;TRPM4;CCL3;PTK2B;BCOR;ASPN
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.5122881435643246,1.5160272674208843,0.0433996383363472,0.6109375324293023,1.0,12/25,25.89%,ETS1;PRMT1;NCKAP1L;ARNT;TAL1;MAPK14;HMGB2;STAT5B;ACVR1B;BRD1;HIF1A;STAT3
prerank,inorganic anion transmembrane transport (GO:0098661),-0.38733647284144845,-1.515502891386272,0.01804123711340206,0.40848464855702465,1.0,31/63,23.14%,SLC25A30;GABRB1;GLRA1;GABRA3;GABRG3;GABRG1;SLC12A8;SLC37A4;ANO3;GABRA2;SLC12A4;GABRG2;SLC12A5;ANO6;GABRB3;ANO5;XPR1;GLRA2;GABRA5;SLC4A8;SLC26A2;CFTR;GABRQ;SLC1A1;SLC12A1;SLC5A6;SLC6A1;SLC37A3;ANO2;SLC5A5;SLC12A3
prerank,cell part morphogenesis (GO:0032990),-0.5688218515766362,-1.5154082685857704,0.046370967741935484,0.4055795624661239,1.0,5/13,9.46%,PID1;DNM1L;WASF1;FIS1;MFF
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.522696363003729,1.5153992201442028,0.05244122965641953,0.6085514159042874,1.0,9/21,22.27%,NAV3;ARHGEF2;FGF13;CAMSAP1;CAMSAP2;CIB1;ATXN7;TTBK2;KATNB1
prerank,lipid oxidation (GO:0034440),-0.6056060130799641,-1.5147884324519882,0.05908096280087528,0.4044250880544515,1.0,3/12,5.83%,PLA2G7;ADIPOR2;ALOX5
prerank,peptidyl-threonine modification (GO:0018210),0.4093306972856231,1.5129305792489338,0.006872852233676976,0.6139554205892485,1.0,25/66,20.37%,TGFBR1;TGFBR2;PRKCA;CSNK2A2;CSNK2A1;PRKCD;PDPK1;GALNT1;WNK1;GALNT11;TAF1;MAP3K10;MARK2;GALNT3;MAPK8;DYRK1A;AKT1;DYRK4;STK39;MAP2K1;ULK1;CDC42BPB;ROCK2;WNK3;GALNT2
prerank,phagosome maturation (GO:0090382),0.47692009252181017,1.5121880644873409,0.0328719723183391,0.6119956433330812,1.0,11/35,16.86%,ATP6V0B;MCOLN1;ATP6V1D;TCIRG1;ATP6V0A2;RAB39A;RAB34;ATP6V0A4;RAB20;RAB32;ATP6V0E2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.46349291635245804,-1.5105462676877526,0.02857142857142857,0.4126721310027606,1.0,11/30,16.84%,SH3BP5;PRKCZ;CADM4;PARP14;PTPN2;PPP2R1A;SRCIN1;INPP5F;THY1;SFRP1;SFRP2
prerank,sphingosine metabolic process (GO:0006670),0.5651506153252438,1.5084911132576315,0.036101083032490974,0.6239000003680409,1.0,6/17,11.49%,SPTLC3;ACER3;ACER2;PLPP1;ASAH1;PLPP2
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.5214918438890193,-1.5080033901116199,0.03695652173913044,0.4165571908769142,1.0,11/20,27.16%,HECW2;HECW1;YWHAE;NEDD4L;ACTN2;ADRA2A;PRKCE;CAB39;CASQ2;MMP9;TCAF2
prerank,positive regulation of potassium ion transport (GO:0043268),-0.44134605410612576,-1.5065311348559334,0.02112676056338028,0.41790879889034344,1.0,12/38,13.54%,AKAP6;ANK2;KCNN2;KCNJ3;KCNMB2;GABBR1;GABBR2;KIF5B;ACTN2;ADRA2A;KCNMB4;KCNQ1
prerank,epithelial cell-cell adhesion (GO:0090136),0.6263442071336469,1.5052974419819356,0.04036697247706422,0.632749101799459,1.0,2/11,2.16%,ITGB5;DSP
prerank,negative regulation of macrophage activation (GO:0043031),-0.5502405825027459,-1.5048717601572752,0.04697986577181208,0.4192895762234489,1.0,4/16,13.31%,LRFN5;LDLR;FCGR2B;CX3CL1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.46231303616397423,-1.5047491884365667,0.039627039627039624,0.41667419156844737,1.0,9/27,14.58%,CTNNA2;IL1RAPL1;GSK3B;HOMER1;CCDC88A;FCGR2B;FBXO7;NTNG1;NTNG2
prerank,activation of GTPase activity (GO:0090630),0.391880014699284,1.5042150714709763,0.015100671140939598,0.6326425090269909,1.0,23/89,13.63%,TBC1D16;ARHGAP22;ARHGAP45;SIPA1L2;TBC1D17;TBC1D9B;TBC1D10B;TBC1D7;ARHGAP25;TBCK;TBC1D8;GARNL3;TBC1D15;SIPA1;TAX1BP3;SGSM2;CCR7;SLC27A4;TBC1D9;RUNDC1;CCDC125;GMIP;TBC1D30
prerank,regulation of vasoconstriction (GO:0019229),-0.4693215055869271,-1.5021445421210653,0.02097902097902098,0.4209277401957505,1.0,13/27,21.48%,ADRA1A;ATP2B1;KCNMB2;ZDHHC21;PER2;CHRM3;KCNMB4;SMTNL2;ADM;AVPR2;ACE;ADRA1B;ACE2
prerank,neurotransmitter transport (GO:0006836),-0.3830185353624379,-1.5019959419620204,0.014778325123152709,0.41836510383450043,1.0,18/73,9.04%,NRXN1;PTPRN2;SYN3;SYN1;SYN2;PPFIA2;SYT1;SNPH;SLC5A7;GLS;SLC1A6;CHAT;GABRA2;SNAP25;SLC28A2;CASK;SLC6A15;RAB3A
prerank,T cell activation involved in immune response (GO:0002286),-0.5941599436800804,-1.5002177020450436,0.0853932584269663,0.4202520775997811,1.0,3/12,4.64%,CD74;LILRB1;ITGAL
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.6326775277667689,1.4999246256353862,0.046875,0.6472051508062416,1.0,4/10,11.84%,PDE3B;ACER2;WNK1;SERPINE1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.47740049598732426,-1.4997567503938152,0.029411764705882353,0.41861729277699217,1.0,9/25,9.95%,GRID2;LRRK2;GRIN2A;GRIN2B;GLRA1;GSK3B;INSYN2A;GRIN2D;CHRNA4
prerank,synaptic vesicle membrane organization (GO:0048499),0.5547705918422864,1.4990208538324707,0.04066543438077634,0.6457329871526639,1.0,6/17,13.15%,SNAP47;SYNGR1;AP3D1;STX1A;STX19;STX4
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.6273267088469434,1.4988400561202493,0.04830053667262969,0.6414086883132281,1.0,3/11,5.26%,TGFBR2;LRP5;CTNNBIP1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.3335940654205505,-1.497495985100686,0.0,0.42201159882143424,1.0,43/159,14.74%,LRRC4C;NLGN1;GRID2;LRFN5;GPC6;ROBO1;PTPRD;ADGRL3;ALCAM;TENM3;KIRREL3;PTPRT;CDH8;SLITRK1;IL1RAPL1;TENM2;CNTN6;EMB;NPTN;ITGAL;PALLD;CDH22;JAML;FAT4;CDH4;CDH7;CDH20;NECTIN1;CDH10;TENM4;CDH11;PLXNB2;CDH13;VCAM1;SDK1;CDHR3;CDH5;OBSL1;CDH1;PECAM1;PCDHB16;NTNG1;PKD1
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.5393473796214738,-1.4974720076888866,0.041666666666666664,0.41917409459662053,1.0,10/18,23.92%,IRS1;PRKN;ADRA2A;CRHBP;SFRP1;CCN3;FFAR4;CRH;INHBB;REST
prerank,organelle fission (GO:0048285),-0.4808619914073623,-1.496587774458009,0.03153153153153153,0.4187587741238849,1.0,12/24,20.52%,DNM3;TMCC1;PEX11A;DNM1L;DNM1;PRKN;FIS1;MFF;MTFR2;WASHC5;MTFR1;PEX19
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.4289394529507755,1.4956172060418356,0.033444816053511704,0.6506144270218347,1.0,13/50,9.69%,TLR7;LGALS9;AGER;TLR4;PHB2;CD27;LRRC19;TRADD;TRIM44;CD86;IL12B;LIMS1;RTKN2
prerank,lymphocyte mediated immunity (GO:0002449),-0.600965096952028,-1.4955105858046447,0.049891540130151846,0.4186825908483022,1.0,9/12,27.05%,MYO1G;BTN3A3;KLRD1;JAG1;CD46;KLRC2;MSH2;CD8A;SLA2
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.6337849390246023,1.4953165695529786,0.072992700729927,0.6468422501638476,1.0,3/10,6.86%,TGFBR2;LRP5;SHH
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.5087652094128368,1.4945399336208023,0.04838709677419355,0.6450036368250306,1.0,7/23,11.76%,PREB;SEL1L;TMED9;SEC13;OS9;UFD1;AUP1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.3811471199495556,1.4944222546513628,0.008169934640522876,0.6405092139255634,1.0,17/104,6.58%,TGFBR1;LDLRAD4;TGFBR2;SMAD3;GREM1;SMAD7;PMEPA1;SKI;SMURF1;TGFB1I1;SKIL;RPS27A;UBC;SPRY2;PDPK1;EID2;ASPN
prerank,plasma membrane invagination (GO:0099024),0.48247907283703867,1.4933589967369207,0.0425531914893617,0.6406327540201362,1.0,8/29,3.78%,ELMO1;ITGAM;BIN2;AIF1;SNX18;ARHGAP25;ITGB2;MYH9
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.42764921722352434,1.4924892923543414,0.017035775127768313,0.6398342910845747,1.0,15/54,17.49%,IVNS1ABP;SENP2;SMAD7;CAPN3;ARRB2;U2AF2;SPRY2;KLHL40;GNL3L;PIAS3;AKT1;USP4;HDAC8;ARRB1;SPOPL
prerank,dendritic cell differentiation (GO:0097028),0.519636782426316,1.489484748190271,0.06115107913669065,0.6484430935673988,1.0,7/22,10.66%,TGFBR2;LGALS9;LYN;TRPM2;CCR7;IRF8;AXL
prerank,phosphatidylcholine metabolic process (GO:0046470),0.3981916023989901,1.487824432904329,0.01589825119236884,0.6507168851866301,1.0,16/70,9.65%,LIPC;LPCAT2;PCTP;TMEM86B;LPCAT4;MBOAT2;LPIN2;CSNK2A2;CSNK2A1;PLA2G4A;PLA2G15;PLA2G6;PLA2G4B;PLB1;PLA2G5;CHKB
prerank,autophagy of peroxisome (GO:0030242),0.5996015215972588,1.487737952646057,0.06072106261859583,0.6463008553998614,1.0,5/12,14.81%,NBR1;ATM;PIK3C3;RB1CC1;TRAPPC8
prerank,regulation of histone methylation (GO:0031060),-0.5687983931774572,-1.4876456737682782,0.058823529411764705,0.43826710710003297,1.0,8/13,23.54%,JARID2;TET1;NSD1;TTLL12;AASS;PIH1D1;CHTOP;FAM47E
prerank,acylglycerol catabolic process (GO:0046464),0.4797672869048678,1.486950708599358,0.03374777975133215,0.6450830754524592,1.0,5/30,11.37%,LIPC;LIPH;ABHD12;PNPLA1;ABHD6
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.5046296669598711,-1.4853200879131871,0.05530973451327434,0.4417704472825423,1.0,5/19,4.40%,HS6ST3;HS3ST5;NDST4;EXT1;HS6ST2
prerank,positive regulation of nervous system development (GO:0051962),-0.42212259078768877,-1.4836397906723615,0.010582010582010581,0.4437403800178655,1.0,12/42,8.32%,NRXN1;NLGN1;GRID2;PTPRD;BDNF;CLSTN2;MME;IL1RAPL1;SOX11;OPRM1;LIG4;SYNDIG1
prerank,glycerophospholipid catabolic process (GO:0046475),0.4904197908608304,1.4836050681174568,0.05765765765765766,0.6557913902676767,1.0,7/27,9.07%,LIPC;ABHD12;PLA2G4A;PLA2G15;PLA2G6;PLA2G4B;PLA2G5
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.6277850210561963,1.483294538423731,0.06769825918762089,0.6523967604562015,1.0,3/10,3.42%,HK2;PFKL;GFPT1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.498964310688173,-1.4832244704370188,0.047619047619047616,0.4418520483180905,1.0,9/21,17.71%,CENPF;ZW10;BUB1B;KNTC1;BUB1;TTK;TEX14;MAD1L1;TRIP13
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.5043402772368144,-1.4826752442617248,0.060085836909871244,0.4348486648263144,1.0,9/20,17.71%,CENPF;ZW10;BUB1B;KNTC1;BUB1;TTK;TEX14;MAD1L1;TRIP13
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.5043402772368144,-1.4826752442617248,0.060085836909871244,0.4348486648263144,1.0,9/20,17.71%,CENPF;ZW10;BUB1B;KNTC1;BUB1;TTK;TEX14;MAD1L1;TRIP13
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.5043402772368144,-1.4826752442617248,0.060085836909871244,0.4348486648263144,1.0,9/20,17.71%,CENPF;ZW10;BUB1B;KNTC1;BUB1;TTK;TEX14;MAD1L1;TRIP13
prerank,telomere capping (GO:0016233),0.5582207021211989,1.4818777588020875,0.0625,0.6540049400322449,1.0,8/16,19.08%,NBN;CTC1;DCLRE1B;DCLRE1C;TERF1;TEN1;DCLRE1A;ACD
prerank,protein localization to synapse (GO:0035418),-0.5898320858385526,-1.4811270771211185,0.06437768240343347,0.4364524263464249,1.0,7/12,18.81%,NRXN1;NLGN1;PCLO;ZDHHC15;NRXN2;MPP4;BSN
prerank,cortical cytoskeleton organization (GO:0030865),0.4388836041876959,1.4806511179633686,0.023890784982935155,0.6546417198121214,1.0,14/41,13.29%,RAC1;RND1;PLEK;FMNL3;RHOQ;RHOB;RHOBTB1;RND2;RHOH;NCKAP1L;FHOD1;LLGL1;FMNL2;TRPV4
prerank,prostanoid biosynthetic process (GO:0046457),0.5597019475367158,1.480101650765956,0.05807622504537205,0.6523932691541594,1.0,5/15,8.15%,TBXAS1;DAGLB;PTGS1;PLA2G4A;EDN2
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.6286218242544555,1.4798300613611544,0.0570902394106814,0.6489587242392623,1.0,3/10,6.42%,RPS27A;UBC;DIS3L2
prerank,transcription by RNA polymerase III (GO:0006383),0.4948384664656877,1.4773284634740689,0.03281519861830743,0.6549582730546154,1.0,7/27,12.26%,IVNS1ABP;POLR3G;GTF3C2;GTF3A;BRF1;POLR3H;GTF3C6
prerank,cytoplasmic translation (GO:0002181),-0.361653105289343,-1.4766516901983946,0.02056555269922879,0.44653261837277314,1.0,37/91,21.68%,RPL36A;RPS29;RPL30;RPL35A;RPS3;RPL4;RPS7;RPS2;EIF3M;RPL7A;RPL41;RPL26;RPS27;RPL18A;RPS25;RWDD1;RPL38;RPL37;RPS15A;RPS14;RPL24;RPS9;RPLP0;RPLP1;RPL8;RPL22;RPS12;RPS10;RPL19;RPS6;RPL13A;RPL18;RPS5;RPS19;RPL23A;RPL29;RPS23
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.616591331223899,1.4760962432351055,0.07462686567164178,0.6559066960005302,1.0,3/10,10.24%,TGFBR2;LGALS9;NCKAP1L
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.5636369716228772,-1.4745012417941756,0.05844155844155844,0.4497619406261423,1.0,3/13,5.88%,MDFIC;SP100;BARD1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.5268103887720004,1.4742116740044868,0.06088560885608856,0.6598731462833531,1.0,10/19,25.05%,SRC;CTC1;HNRNPC;GNL3L;TERF1;EXOSC10;TEN1;ACD;HNRNPA1;STN1
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.5823673055034593,1.4738215629721436,0.07208872458410351,0.6572710659328226,1.0,3/13,3.43%,ITGAM;GAB2;ITGB2
prerank,anterior/posterior pattern specification (GO:0009952),0.4201659113167634,1.472871173225607,0.02337228714524207,0.6569730477622893,1.0,7/53,2.27%,TGFBR1;BASP1;LRP5;HEYL;HOXD9;DDIT3;SKI
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.48741792362046416,1.4719774608781278,0.04317789291882556,0.6567903324665192,1.0,7/28,8.92%,IRAK2;RIPK2;OTULIN;ITCH;RPS27A;UBC;TAB2
prerank,cardiac muscle tissue development (GO:0048738),-0.39869766247972005,-1.4712733863295788,0.03051643192488263,0.45608349551213856,1.0,21/50,32.25%,SGCZ;SGCD;SIK1;RBP4;HEY2;BMP4;SMAD1;GJA5;MSX1;NOTCH2;CACNA1G;HCN4;SHOX2;CBY1;ZFPM1;TTN;ADAMTS9;NRG1;NPPA;MYOCD;TBX18
prerank,positive regulation of integrin activation (GO:0033625),0.6104177101710521,1.4707593393286917,0.056672760511883,0.657742989782234,1.0,4/11,11.16%,P2RY12;PLEK;SRC;RASIP1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.6086394196746397,1.4707143953186745,0.05434782608695652,0.6535090004173213,1.0,4/11,17.33%,ARRB2;GTF2H2;GRK2;ARRB1
prerank,I-kappaB phosphorylation (GO:0007252),0.624671056677332,1.469930175870961,0.07344632768361582,0.6524871538603692,1.0,2/10,2.88%,TLR7;TLR4
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.5534914364959762,-1.4689646788137796,0.06881720430107527,0.4598106281703191,1.0,3/14,6.63%,PPP2R2B;PPP2R2A;PPTC7
prerank,neuron development (GO:0048666),-0.3299934049611267,-1.468682749988004,0.00273224043715847,0.4576757542473711,1.0,30/141,9.18%,CNTNAP2;NLGN1;FRY;TENM3;B4GALT5;GPM6A;B4GALT6;APP;ETV1;TENM2;RAPGEF2;NTRK2;VAPA;EHD1;MYT1L;MAP2;APOE;STMN4;GSK3B;SH3GL2;TOR1A;PBX1;EPHA5;ERCC6;LGI1;ALK;ATP7A;TENM4;RASGRF1;PBX3
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.5381224486564257,1.4680337987219707,0.054945054945054944,0.656293435657405,1.0,7/18,9.01%,MTUS1;LYN;CAMK1D;PTK2B;EDN3;EDN2;IL6R
prerank,regulation of actin filament polymerization (GO:0030833),0.39256304365565053,1.4675345905936428,0.01824212271973466,0.6542239934353302,1.0,24/69,20.53%,BIN1;SSH2;TWF2;BAIAP2L2;DBN1;CDC42EP2;CYRIB;PRKCD;ARHGAP28;ABITRAM;PTK2B;SSH1;CCR7;NCKAP1L;HIP1R;PYCARD;TENM1;FCHSD2;CDC42EP3;DBNL;VASP;CCL24;SSH3;FCHSD1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.4991779904377853,1.4666095689747956,0.05555555555555555,0.6540662479194405,1.0,12/24,25.05%,SRC;CTC1;HNRNPC;SLX4;ERCC4;GNL3L;TERF1;EXOSC10;TEN1;ACD;HNRNPA1;STN1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.5420522616808326,1.466222617467034,0.055970149253731345,0.6516062354803744,1.0,5/16,11.24%,SALL1;NPNT;SHH;GDNF;PAX2
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.42490249588583684,-1.4661923809364357,0.037383177570093455,0.462528826209717,1.0,8/41,3.53%,ANK3;AKAP6;ANK2;KCNN2;KCNJ3;KCNMB2;GABBR1;GABBR2
prerank,defense response to fungus (GO:0050832),0.5448316322159237,1.4659494161277498,0.04440497335701599,0.6486565139296353,1.0,4/17,9.60%,CX3CR1;PLCG2;GAPDH;CLEC4E
prerank,ganglioside biosynthetic process (GO:0001574),-0.5373383675424865,-1.465495711823045,0.0684931506849315,0.46165549697869995,1.0,7/15,16.56%,B4GALT5;ST3GAL1;B4GALT6;ST8SIA4;ST8SIA2;B3GALT4;ST8SIA3
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.5566642603242481,1.4652755173002083,0.06355140186915888,0.6475735054581898,1.0,10/16,26.81%,SIRPA;ABCD2;PYCARD;ADCY7;ZC3H12A;ABCD1;PDCD4;MEFV;APPL2;CUEDC2
prerank,retinol metabolic process (GO:0042572),-0.5487818469271653,-1.4648235294975471,0.044585987261146494,0.460722118337979,1.0,5/14,18.69%,RETSAT;RDH10;RBP4;DHRS9;RDH12
prerank,central nervous system myelination (GO:0022010),-0.5972585859077746,-1.4646274672929267,0.0728051391862955,0.4584051724072986,1.0,5/11,9.57%,B4GALT5;B4GALT6;MYRF;TENM4;CNTNAP1
prerank,centromere complex assembly (GO:0034508),-0.4269829773185796,-1.464558030728516,0.04555808656036447,0.4559007630166773,1.0,13/36,16.87%,KNL1;CENPF;CENPT;CENPP;MIS18BP1;CENPE;DLGAP5;HELLS;CENPW;RBBP7;NASP;NPM1;CENPS
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.5336337145308437,-1.4642016900204622,0.08176100628930817,0.4541155988983368,1.0,8/15,29.14%,LRP6;EDA;FOXC1;WNT6;MSX1;HDAC1;TBX1;AMELX
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3521479231936016,1.4639878332654208,0.007739938080495356,0.649513929283547,1.0,32/150,12.81%,CX3CR1;TGFBR1;IL18;P2RY12;RAC1;PIK3R1;GAB2;IGF1R;SRC;PIK3CG;CCL3;THEM4;SPRY2;PDPK1;PIK3AP1;CD86;PDGFB;GCNT2;MET;MTDH;C1QBP;CCR7;RASD2;CALCR;PIK3CD;FRS2;PIK3CB;AXL;PDGFRB;PINK1;ENG;PTPN11
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.560626190583957,1.4638446340453821,0.05565529622980251,0.6460503997581365,1.0,6/15,16.93%,SOX8;GDNF;PAX2;SMO;NOG;AGT
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.6295021273117382,1.4629075237061466,0.06111111111111111,0.6461233489198659,1.0,4/10,9.34%,SIRT2;VHL;IMPACT;JUN
prerank,covalent chromatin modification (GO:0016569),-0.5581080293581894,-1.4626075188022514,0.041666666666666664,0.45601253105039474,1.0,5/14,10.43%,SIRT1;HLCS;AURKB;SETD5;HELLS
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.46532906591152523,-1.461964510522692,0.0447427293064877,0.4552034580367891,1.0,6/25,5.18%,PDE4B;SPTBN1;CCR2;PDE4D;RPS3;IRF4
prerank,chondroitin sulfate metabolic process (GO:0030204),0.46670690965119876,1.4613073145101518,0.04770318021201413,0.6490723154467232,1.0,10/30,12.28%,HEXB;ARSB;CHST11;HEXA;BGN;CHPF;CHPF2;CHST7;BCAN;CSPG5
prerank,negative regulation of B cell proliferation (GO:0030889),0.6144407138867602,1.4599490863556714,0.06923076923076923,0.6511398329449017,1.0,4/11,7.21%,LYN;ATM;TNFRSF21;TNFRSF13B
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.44399138635419216,1.4597319014962213,0.02456140350877193,0.6480670591277883,1.0,9/38,9.52%,CX3CR1;SIRPA;SMAD3;RAC1;TLR4;CLU;AGTR2;NOS1AP;CD34
prerank,response to ethanol (GO:0045471),-0.5587175298673424,-1.458877321531231,0.0502092050209205,0.46141692839048914,1.0,5/14,11.78%,GRIN2A;GRIN2B;GLRA1;GRIN3A;GLRA2
prerank,response to hexose (GO:0009746),0.4850607379585039,1.4583136212901535,0.05555555555555555,0.6501845309786818,1.0,16/25,35.74%,PFKL;EIF2B3;SLC30A8;EIF2B4;KHK;SELENOT;THBS1;EIF2B2;GPLD1;TCF7L2;EIF2B5;LPL;ZBED3;SELENOS;EIF2B1;VAMP2
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.463732358646595,-1.4579241426502614,0.06605922551252848,0.46125844152455714,1.0,8/26,5.29%,PLCB1;EGFR;FGF10;MTBP;KMT2E;ANKRD17;CCND2;UBE2E2
prerank,regulation of bone mineralization (GO:0030500),0.4116617388092847,1.4577903085094661,0.032758620689655175,0.6486332407282219,1.0,10/55,5.98%,TMEM119;NBR1;GREM1;BMP2K;MEF2C;TRPM4;CCL3;SLC8A1;PTK2B;BCOR
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3648178839723262,-1.4570845398742271,0.005050505050505051,0.4609275509574678,1.0,21/75,14.58%,CTNNA2;ANK3;DCC;NRCAM;MAP1B;SLITRK1;APP;PLPPR4;MAP2;PAK3;DCDC2;ZDHHC17;ACTB;RAB8A;RAB3A;SPTBN4;MFSD2A;NEFH;PARD3;NTNG1;NTNG2
prerank,positive regulation of endothelial cell migration (GO:0010595),0.38613823559163574,1.4570624452140553,0.022690437601296597,0.6479377214942298,1.0,34/84,25.29%,SMOC2;ANXA3;ETS1;RAC1;PRKCA;PIK3CG;RHOB;SPARC;PTK2B;LGMN;PDPK1;PDGFB;MET;GATA2;PIK3CD;PIK3CB;PDCD6;ABL1;AKT1;PROX1;MAPK14;AGT;SCARB1;GATA3;ROCK2;THBS1;ADAM17;ZC3H12A;TGFB1;ITGB3;FGF1;GPLD1;HIF1A;PLCG1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.619004843112763,1.4565998383640122,0.07904411764705882,0.6422215080145306,1.0,2/10,22.32%,REEP6;CACNA2D4
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.619004843112763,1.4565998383640122,0.07904411764705882,0.6422215080145306,1.0,2/10,22.32%,REEP6;CACNA2D4
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.42682154765525493,1.4560232947677856,0.02975206611570248,0.6409306784992957,1.0,15/47,17.42%,NBR1;GREM1;MAP4K4;LGALS9;AGER;SEMA4C;IGF1R;MID1;ARL6IP5;TAOK2;MAPK8IP1;MAP2K1;PDCD10;QARS1;EIF2AK2
prerank,telomere maintenance via telomere trimming (GO:0090737),0.6311320479998243,1.4554507941830828,0.07289719626168224,0.6322889975474635,1.0,5/10,14.67%,NBN;SLX4;EXO1;TERF1;BLM
prerank,t-circle formation (GO:0090656),0.6311320479998243,1.4554507941830828,0.07289719626168224,0.6322889975474635,1.0,5/10,14.67%,NBN;SLX4;EXO1;TERF1;BLM
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.6311320479998243,1.4554507941830828,0.07289719626168224,0.6322889975474635,1.0,5/10,14.67%,NBN;SLX4;EXO1;TERF1;BLM
prerank,error-free translesion synthesis (GO:0070987),0.4944977141266505,1.4552227118030874,0.06306306306306306,0.6295801512721517,1.0,11/22,27.47%,PCNA;RFC2;RPS27A;UBC;UFD1;POLDIP2;RFC1;RPA3;SPRTN;NPLOC4;RPA1
prerank,regulation of RNA export from nucleus (GO:0046831),0.6102591932532211,1.4544691772009657,0.06629834254143646,0.6290379414747602,1.0,6/11,25.49%,AKAP8L;DHX9;SETD2;KHDRBS1;NUP153;IWS1
prerank,glucan biosynthetic process (GO:0009250),-0.5700311194311506,-1.4544528701201016,0.08496732026143791,0.4630164621436214,1.0,5/12,22.19%,GBE1;PER2;GYG1;UGP2;PGM2L1
prerank,glycogen biosynthetic process (GO:0005978),-0.5700311194311506,-1.4544528701201016,0.08496732026143791,0.4630164621436214,1.0,5/12,22.19%,GBE1;PER2;GYG1;UGP2;PGM2L1
prerank,negative regulation of innate immune response (GO:0045824),-0.4261128810696592,-1.4511842249458522,0.044444444444444446,0.46955891092350593,1.0,13/34,25.35%,USP15;SERPING1;VSIG4;PTPN2;TRAFD1;TTLL12;SAMHD1;OAS3;IRAK3;RPS19;LYAR;NMI;NLRC3
prerank,positive regulation of immune system process (GO:0002684),0.532914575355768,1.4496008202415902,0.08566433566433566,0.6449883626158488,1.0,5/16,10.24%,LGALS9;MIA3;PIK3CD;PIK3CB;NCKAP1L
prerank,atrioventricular valve development (GO:0003171),0.5627151563826431,1.4489492540296567,0.08620689655172414,0.6439319940602364,1.0,3/14,6.10%,TGFBR2;HEYL;MDM4
prerank,positive regulation of cytokinesis (GO:0032467),-0.43635667779131554,-1.4489267331859021,0.060267857142857144,0.4732472724814546,1.0,8/32,9.30%,CUL3;KIF23;RACGAP1;CDC42;GIPC1;KIF14;PKP4;AURKB
prerank,axon guidance (GO:0007411),-0.31053029226069767,-1.4483122354509046,0.0029850746268656717,0.47244805049592775,1.0,40/201,9.60%,NRXN1;DAB1;ROBO1;UNC5C;NFIB;DCC;SPTBN1;ALCAM;KIF5C;NRXN3;SLIT2;ARHGAP35;DOK6;PLXNC1;SHC3;BDNF;SEMA5A;CNTN6;EMB;NPTN;SHANK3;PALLD;SEMA4A;PLXND1;PLXNA2;CHN1;DOK5;NCAM1;GFRA2;DOK1;RET;EPHA5;LGI1;SPTBN2;DOK2;KIF5B;GRB10;PLXNB2;SPTBN4;TMEFF1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5090449648197346,1.4481638462571254,0.07102803738317758,0.6433004446506604,1.0,8/21,12.04%,ABCD2;COA8;SIRT2;SLC30A10;AATF;BRCA1;PAX2;PINK1
prerank,tRNA metabolic process (GO:0006399),0.5405589461557117,1.4478428521650772,0.0647985989492119,0.641033738453839,1.0,7/17,16.14%,ADAT1;KARS1;POP1;SSB;SARS1;RPP21;DARS2
prerank,regulation of interleukin-1 production (GO:0032652),0.5616583504035136,1.4476183343123772,0.05947955390334572,0.6382978348874802,1.0,5/15,11.23%,SIRPA;TLR4;CCR7;ORM2;CEACAM1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.5573228857803387,-1.4472194885148104,0.07472527472527472,0.47291777133912377,1.0,6/12,27.24%,DPYD;DPYSL5;CTPS1;CDA;ALDH6A1;DPYSL4
prerank,establishment of protein localization to organelle (GO:0072594),0.3854769674734639,1.4471010092148406,0.02195945945945946,0.6367417144905739,1.0,35/72,27.91%,HK2;SPRN;NEURL1B;PHB2;FAM53A;LAMP5;PTTG1IP;SEC13;NUP62CL;TNPO1;APPL1;NUP50;PINK1;NUP88;IPO4;IL10RA;RPAIN;AKT1;TNPO3;NUP62;CSE1L;NUP107;E2F3;LAMP2;IPO7;NUP153;IPO5;PRICKLE1;NUP188;APPL2;STAT3;CD68;IPO9;RANBP17;HIKESHI
prerank,regulation of amyloid fibril formation (GO:1905906),-0.5324514011918279,-1.4470746647549197,0.06363636363636363,0.47065514059835867,1.0,4/15,4.62%,APP;IAPP;LDLR;APOE
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.49987049513299225,1.4466628099714214,0.06049149338374291,0.6349013917556618,1.0,9/22,20.91%,SEL1L;RPS27A;UBC;OS9;RNF103;MAN1C1;EDEM1;MAN1B1;SYVN1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.37461969294490904,1.446070341062428,0.022764227642276424,0.633765606730745,1.0,24/87,13.69%,F11R;ABI3;CSF1R;TWF2;RAC1;RND1;RHOQ;RHOB;PRKCD;RHOBTB1;TRPM2;FSCN1;PTK2B;RND2;RHOH;ARHGAP17;MTOR;LRP1;MLST8;RAPGEF3;PDGFRB;HIP1R;TAOK2;ABL1
prerank,positive regulation of cellular respiration (GO:1901857),0.6055363890272916,1.445772401318599,0.08743169398907104,0.6316973041334191,1.0,6/11,32.47%,ISCU;IL10RB;PINK1;PARK7;IFNAR1;VCP
prerank,regulation of superoxide anion generation (GO:0032928),0.5621407800804129,1.4454714535796214,0.0625,0.6295396027251682,1.0,8/14,23.52%,ITGAM;ITGB2;PRKCD;AATF;SOD1;MAPT;TGFB1;TYROBP
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.5089594290377899,-1.4443993370518842,0.07623318385650224,0.47554375114495967,1.0,5/18,7.25%,MDFIC;CTNNA1;LATS1;GSK3B;ILRUN
prerank,hemidesmosome assembly (GO:0031581),0.6052243908524552,1.4442149348910776,0.07208872458410351,0.6314055857172995,1.0,5/11,19.37%,DST;ITGA6;LAMA3;LAMC2;ITGB4
prerank,cellular response to lipopolysaccharide (GO:0071222),0.37040927897368603,1.4440143858340617,0.022082018927444796,0.6288022750564252,1.0,36/101,23.35%,CX3CR1;IL18;SIRPA;MEF2C;SBNO2;TLR4;LYN;CCL3;CASP1;CTR9;CD86;NLRP3;MTDH;PDCD1LG2;CXCL1;TICAM2;PABPN1;AXL;CD180;SERPINE1;CCR5;MAPK8;PYCARD;TNIP2;MAPK14;HMGB2;TICAM1;NOD2;IL1A;ZC3H12A;ACOD1;SHPK;CXCL10;IL36G;TGFB1;MYD88
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.4836289291044441,-1.4430106084012218,0.06888888888888889,0.47677878636497734,1.0,5/22,5.28%,CCR2;GABBR2;PALM;CACNA1C;EDNRB
prerank,negative regulation of insulin secretion (GO:0046676),-0.5104015725292664,-1.442611187866641,0.06751054852320675,0.47526519467393497,1.0,10/17,29.17%,IRS1;PRKN;ADRA2A;PIM3;SFRP1;CCN3;INHBB;REST;KLF7;FAM3D
prerank,intestinal lipid absorption (GO:0098856),-0.5788033352153567,-1.4421782970331487,0.06382978723404255,0.47387914655326996,1.0,3/11,13.49%,CD36;LDLR;UGCG
prerank,histone H3-K4 trimethylation (GO:0080182),0.5939715633600775,1.4421258154252812,0.0737410071942446,0.6329915605768318,1.0,3/11,6.69%,KMT2D;CTR9;TET3
prerank,tryptophan metabolic process (GO:0006568),-0.5860604474900832,-1.4419574399946546,0.08798283261802575,0.47196197597429157,1.0,4/11,20.17%,KMO;ATP7A;IDO2;KYAT1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.5747991521184362,1.4418763797343024,0.09622641509433963,0.6306319835254901,1.0,5/13,12.07%,TGFBR2;SHH;PNP;NCKAP1L;RUNX1
prerank,positive regulation of neuron projection development (GO:0010976),-0.3531540942441404,-1.4418380374793447,0.01634877384196185,0.4697104085027946,1.0,23/85,13.31%,MAGI2;RIT2;LRRC7;TENM3;ARHGAP35;FUT9;BDNF;RAPGEF2;ROR1;NTRK2;NPTN;NTRK3;APOE;KIDINS220;RET;ALK;PLXNB2;SCARF1;P3H1;SERPINI1;STMN2;ZDHHC15;CX3CL1
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.43936799176396835,-1.4414767905992318,0.043373493975903614,0.468215792403229,1.0,10/32,7.81%,ADGRB3;PTPRD;CDKL5;IL1RAPL1;HECW2;HECW1;RAPGEF2;NEDD4L;GSK3B;CUL7
prerank,intracellular protein transport (GO:0006886),0.3208168370536861,1.440939402786293,0.001358695652173913,0.6310966340122819,1.0,120/304,25.98%,TBC1D16;HPS4;UNC93B1;ARHGEF2;PREB;HERC2;TBC1D17;TRAK1;SPRN;YWHAH;TBC1D9B;ARFIP1;COPA;ARFGAP3;SMURF1;TBC1D10B;AP2A1;VPS26B;ARL5C;TBCK;TBC1D8;VIPAS39;TBC1D15;FAM91A1;PHB2;AP3D1;STXBP1;FAM53A;STX1A;STRADA;STX12;ARFIP2;TMED9;NUP42;SGSM2;RAB3GAP2;EGR2;RANBP3;PTTG1IP;TMED4;SEC13;STX19;NUP62CL;TRARG1;AP1M2;RAB1A;TNPO1;APPL1;CLIP3;NUP50;TICAM2;SAR1A;TBC1D9;SNX31;RUNDC1;SEC31B;NUP88;PDCD6;IPO4;STX4;TBC1D30;RAB20;RPAIN;SLU7;SCG5;AKT1;RAB32;PICK1;NAPG;TNPO3;LTBP2;SNX13;VPS36;ADPRH;SGSM3;GGA3;NUP62;BCS1L;EIF2D;CTSA;CSE1L;NUP107;VPS29;ARL11;STX5;RAB6B;GRTP1;E2F3;AP4M1;ACD;VPS26A;MAIP1;LAMP2;VPS35;ARF1;SEC31A;KATNB1;IPO7;SNX6;KIF13B;STX8;ARF4;NUP153;SIL1;KIF13A;TGFB1;STX16;XPO5;IPO5;WLS;XPO1;PRICKLE1;NUP188;APPL2;HDAC6;COG7;TBC1D22A;STAT3;TBC1D13;VPS45
prerank,RNA modification (GO:0009451),0.4133236189320929,1.4400314707117587,0.041050903119868636,0.6316809928327157,1.0,26/54,29.56%,QTRT1;SSB;TRMT6;AARS2;ANKRD16;THUMPD1;NSUN5;JMJD6;CTU2;NSUN6;BCDIN3D;FTSJ3;CDKAL1;TYW5;QTRT2;NSUN3;TRMT61A;TFB1M;NSUN4;TRDMT1;FTSJ1;PARN;NOP2;TRMT9B;PUS7;TRUB1
prerank,triglyceride homeostasis (GO:0070328),0.4771024412883728,1.4399121881481274,0.061946902654867256,0.6288102716395582,1.0,5/26,11.03%,IL18;LIPC;MLXIPL;MTLN;APOC4
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.38532760014091555,1.4393904486553457,0.03565640194489465,0.6276259823856778,1.0,11/74,7.82%,TGFBR1;LDLRAD4;TGFBR2;SMAD3;GREM1;SMAD7;TGFB1I1;PHLDB1;SPRY2;GCNT2;OVOL2
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.5444200873496889,1.439104876367539,0.06591337099811675,0.6254993304384521,1.0,3/16,8.46%,MRAP;PRKCA;GPER1
prerank,fatty acid transport (GO:0015908),-0.5177568961228138,-1.4387523968999552,0.06561085972850679,0.4733469683046368,1.0,6/17,14.53%,PPARG;CD36;FABP4;APOE;MFSD2A;CPT1B
prerank,regulation of membrane repolarization (GO:0060306),-0.5448702993833079,-1.4375038355981646,0.08278867102396514,0.47425452573397153,1.0,5/13,16.57%,AKAP6;YWHAE;NEDD4L;KCNQ1;CACNB3
prerank,positive regulation of lipid catabolic process (GO:0050996),0.5158528622977037,1.436268043349088,0.06643356643356643,0.6336875959405284,1.0,4/19,5.61%,DAGLB;ABCD2;PRKCD;MTLN
prerank,membrane repolarization (GO:0086009),-0.5342771956202622,-1.4361068962688364,0.07126948775055679,0.47592447685590605,1.0,6/15,17.16%,KCND3;ATP1B3;ATP1A1;KCNQ1;KCNIP2;KCNE3
prerank,nucleotide metabolic process (GO:0009117),0.4852499021460094,1.4360906995738587,0.059813084112149535,0.6310554955534915,1.0,6/23,10.64%,FHIT;GUK1;PNP;CMPK1;REXO2;DCTD
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.49361239807304014,1.4353855165347882,0.0726950354609929,0.6304983489198659,1.0,7/23,12.02%,LPCAT4;MBOAT2;PLA2G4A;PLA2G6;PLA2G4B;PLA2G5;MBOAT1
prerank,regulation of interferon-alpha production (GO:0032647),0.4902909962156096,1.4349695353085663,0.05989110707803993,0.6288966597984156,1.0,8/23,17.11%,TLR7;RIPK2;TLR4;DHX9;HAVCR2;SETD2;MAVS;IRF3
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.4070586388642534,-1.4349079703678864,0.05609756097560976,0.4767935353356594,1.0,12/43,14.36%,PID1;SORBS1;IRS1;PRKCZ;ZBTB7B;TNS2;SIRT1;PTPN2;GRB10;KANK1;PRKCQ;NUCKS1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.4489812860677585,-1.4343241450166921,0.05829596412556054,0.4758827663203101,1.0,7/27,5.23%,CTNNA3;PDE4B;ANK2;PDE4D;RYR2;ATP2A2;CACNA1C
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.45083291842967227,-1.4336842861429093,0.0625,0.4750721208986591,1.0,9/25,18.26%,ST13;DNAJB4;ERO1A;DNAJB13;HSPA2;HSPA1B;HSPA5;HSPA8;SDF2
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.525185056806523,-1.4333026333698897,0.07021276595744681,0.47368417259402124,1.0,7/15,16.06%,CD74;CD44;ING2;PRKN;SIRT1;BCL2;MDM2
prerank,negative regulation of cartilage development (GO:0061037),0.5712212236178904,1.4329888690075663,0.07276119402985075,0.6331542424658303,1.0,3/13,2.99%,TGFBR1;GREM1;EFEMP1
prerank,amide transport (GO:0042886),-0.456590598525769,-1.432294957896774,0.057777777777777775,0.47417827431128545,1.0,14/26,24.56%,DISP1;PLTP;PLEKHA3;TAP1;SLC14A1;AQP11;SLC46A1;SLC14A2;CERT1;SLC5A6;ABCB9;FOLR2;FOLR1;SLC25A32
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.5129345740187539,-1.4322544357707956,0.07142857142857142,0.4718529709616786,1.0,5/17,7.84%,SLIT2;FSTL1;DOK5;CASK;ZDHHC17
prerank,phospholipid translocation (GO:0045332),-0.4441290907471993,-1.4318082561423546,0.06511627906976744,0.4706754119163325,1.0,12/28,15.82%,ATP8B4;ATP11A;ANO6;ATP11C;MFSD2A;PLSCR4;PLSCR2;ATP9B;ABCA4;ATP10B;ATP8B2;ABCC1
prerank,protein localization to membrane (GO:0072657),-0.30751071276532027,-1.4315648625856336,0.0031847133757961785,0.4689458841248361,1.0,52/187,17.63%,DLG2;MAGI2;KCNIP4;NRXN1;NLGN1;DPP6;ANK3;KCNB2;ITGA4;DPP10;ANK2;LRRC7;SPTBN1;RAB3C;FRMPD1;MYO5A;RAPGEF2;EHD1;LRP6;ITGB7;DLG3;ITGAL;SHANK3;RAB40B;RAB3D;ATP1B3;PIGW;ACTN2;RAB8A;MYADM;RAB3A;SPTBN4;P2RY1;ITGB1BP1;ZDHHC23;TM9SF2;TESC;ZDHHC15;CDH1;EFR3A;NUP54;NRXN2;THY1;TMED2;NUP155;AGRN;ARL5B;CACNB3;PLEKHF1;EHD2;WDR19;S100A10
prerank,mammary gland development (GO:0030879),-0.481016984955988,-1.4312871598736725,0.06775700934579439,0.467336380709023,1.0,5/21,7.48%,ARHGAP35;JAK2;ERBB4;WNT4;ZBTB7B
prerank,regulation of endothelial cell migration (GO:0010594),0.374584426665442,1.4311488614033796,0.0272,0.6373586906409068,1.0,33/85,24.65%,PTPRM;SMOC2;ANXA3;ETS1;RAC1;PRKCA;PIK3CG;RHOB;SPARC;PTK2B;PIK3CD;PIK3CB;CEACAM1;APOH;PDCD6;ABL1;AKT1;PROX1;PRCP;AGT;SCARB1;GATA3;ROCK2;THBS1;KRIT1;EPHA2;SYNJ2BP;ZC3H12A;STC1;DNAJA4;ITGB3;FGF1;GPLD1
prerank,endocardial cushion morphogenesis (GO:0003203),0.5191854106523697,1.4310573569295433,0.08178438661710037,0.6345270054531857,1.0,12/18,35.10%,TGFBR2;HEYL;MDM4;ENG;NOG;BMP2;SOX9;ACVR1;NOTCH1;BMPR1A;HEY1;ISL1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.40492511774000367,-1.4303071705863224,0.0332541567695962,0.4676704416209693,1.0,18/41,20.91%,NEDD9;DOCK3;GRM5;STAP1;BDNF;NTRK2;DLG3;ERBB3;ADRA2A;UNC119;SRCIN1;LILRA5;RELN;DOK7;ACE;EPHA4;NOX4;FYN
prerank,reticulophagy (GO:0061709),0.5775958816161436,1.4301357795862517,0.059961315280464215,0.6350315925602508,1.0,7/12,27.30%,ULK2;RB1CC1;RETREG1;UBA5;ULK1;UFC1;ATG2A
prerank,cranial nerve development (GO:0021545),0.5974886684812724,1.4301226694392986,0.08170515097690942,0.6319592093816525,1.0,5/11,15.88%,SALL1;CHD7;POU4F1;PAX2;TMEM126A
prerank,striated muscle cell differentiation (GO:0051146),0.5482693947706517,1.4299378084636225,0.08317214700193423,0.629652309788238,1.0,6/16,14.67%,MEF2C;SKI;MTLN;SORT1;AKAP13;MYEF2
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.4145754057974218,-1.4298861391340874,0.03764705882352941,0.4665472304025716,1.0,16/38,20.91%,NEDD9;SH3BP5;GRM5;NCK2;APP;DLG3;ERBB3;UNC119;SRCIN1;LILRA5;THY1;RELN;DOK7;ACE;EPHA4;NOX4
prerank,negative regulation of cytokine production (GO:0001818),0.33960003215550844,1.4296259602240584,0.016717325227963525,0.6278069927440783,1.0,44/163,17.86%,NAV3;SIRPA;ABCD2;CD84;RAC1;DDIT3;LGALS9;VSIR;RNF216;AGER;ITCH;TLR4;OTUD5;UBA7;TNFRSF21;RPS6KA5;PCBP2;C1QBP;SARS1;CCR7;PDCD1LG2;IL12B;INHA;CD34;UFD1;NCKAP1L;AXL;CEACAM1;DLL1;HAVCR2;CD33;PIN1;MAVS;PYCARD;NLRX1;GPNMB;SLAMF1;LGALS7;RPS6KA4;IRF3;ARRB1;ADCY7;SLC11A1;KAT5
prerank,phosphatidylcholine catabolic process (GO:0034638),0.6108888205214643,1.4288703077593212,0.09276437847866419,0.6277621239573541,1.0,5/10,9.07%,LIPC;PLA2G4A;PLA2G15;PLA2G6;PLA2G5
prerank,acylglycerol biosynthetic process (GO:0046463),0.4905099660689599,1.42805739360877,0.05400696864111498,0.627882578545103,1.0,7/23,8.94%,AGMO;LPIN2;DGAT1;PLA2G4A;PLA2G15;MOGAT1;MOGAT2
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.5633943367819686,-1.4279039931470359,0.0963855421686747,0.46980402355868606,1.0,4/11,16.91%,ZFPM2;JAG1;HEY2;BMP4
prerank,fatty acid beta-oxidation (GO:0006635),0.41874701989696306,1.42776881947152,0.05110732538330494,0.6258090142468502,1.0,21/51,24.99%,ABCD2;ACAD10;PPARD;ACOX3;ECHS1;MTLN;IVD;ACADM;CROT;ECI1;ECHDC2;HADHB;HSD17B10;CRAT;ACAA2;ACOT8;SCP2;ABCD1;ETFDH;ETFA;ETFB
prerank,regulation of nervous system process (GO:0031644),-0.49698063000242576,-1.4276637435025827,0.07947019867549669,0.46812185411204116,1.0,6/18,13.59%,SLC8A3;APP;HTR2C;DLGAP1;DLGAP2;TMEM108
prerank,central nervous system neuron differentiation (GO:0021953),-0.4317831156231157,-1.427056514082332,0.04926108374384237,0.46763170033822243,1.0,8/33,8.42%,MDGA2;GRID2;SPOCK1;NTRK2;LRP6;MAP2;NR4A2;ATP7A
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5547160477088502,1.4262835646472216,0.07169117647058823,0.6284713604331524,1.0,10/15,28.95%,TLR4;APPL1;GBP5;TICAM1;NOD2;MYD88;HIF1A;STAT3;CARD9;TLR6
prerank,positive regulation of ruffle assembly (GO:1900029),-0.5488879490803293,-1.4261814183301376,0.07628865979381444,0.4677429987127152,1.0,3/13,6.72%,NLGN1;EPS8;FAM98A
prerank,fatty acid catabolic process (GO:0009062),0.3931584005149696,1.4247649250547976,0.03150912106135987,0.6316351914754035,1.0,24/67,23.42%,ABCD2;ACAD10;PPARD;LPIN2;ECHS1;NUDT19;PLA2G15;MTLN;PHYH;ACADM;HAO1;SLC27A4;CROT;ECI1;ECHDC2;HADHB;HSD17B10;LPIN1;MMUT;ACAA2;HACL1;ACOT8;SCP2;ABCD1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.5473903918994751,1.4245579343577963,0.08037383177570094,0.6295684785135518,1.0,2/15,0.47%,TGFBR1;TGFBR2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.47644112930464555,-1.4239695988351029,0.07972665148063782,0.47183946677562405,1.0,9/21,11.02%,SLC8A3;MCU;PDZD8;LETM1;SLC8B1;MCUB;MICU2;FIS1;MICU3
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.5568091545582572,1.4233993085864285,0.07289719626168224,0.6312239058833949,1.0,8/14,24.06%,TGFBR1;GREM1;EFEMP1;PTPN11;CHADL;RFLNA;PTHLH;SOX9
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.429435147053158,1.4224962987639291,0.050933786078098474,0.6321645693058108,1.0,12/39,12.55%,SALL1;TGFBR2;LRP5;NPNT;PKHD1;SHH;MET;GDNF;NOTCH4;RASIP1;PAX2;ENG
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.571846009192801,1.4224838180707793,0.09306569343065693,0.6292498168326504,1.0,4/12,13.15%,SNAP47;STX1A;STX19;STX4
prerank,mesenchymal to epithelial transition (GO:0060231),0.6016356024032778,1.422169671166443,0.08957952468007313,0.6274878005552051,1.0,2/10,0.58%,SALL1;BASP1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.4433865910172494,1.4219405655208595,0.07550644567219153,0.625344817714852,1.0,14/33,20.94%,PDE3B;P2RY12;FERMT3;LYN;PIK3CG;EPHA8;ACER2;NCKAP1L;SERPINE1;PTPN11;CIB1;EPHA2;RAC3;EFNA1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.494449848147553,-1.4210314420837278,0.07218683651804671,0.4779075105779913,1.0,6/19,13.38%,DLG2;LRRC7;DLG3;PATJ;MTCL1;PARD3
prerank,regulation of mRNA metabolic process (GO:1903311),0.6010600716589751,1.420848853083984,0.09176029962546817,0.6269242956962997,1.0,8/11,26.68%,NCBP1;DHX9;SLTM;CDK11B;SAFB;SAFB2;IWS1;PTCD2
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.4653795720582289,1.4207581638192959,0.05169340463458111,0.6244052221999061,1.0,12/30,24.43%,ARHGEF2;CFLAR;TRADD;RFFL;BRCA1;SERPINE1;DDX3X;BCL2L1;RNF34;PARK7;FADD;FAIM
prerank,protein modification by small protein conjugation (GO:0032446),0.31190148645318166,1.4204054309566634,0.0,0.6229243941202321,1.0,91/361,17.93%,HERC2;SUMO1;NFE2L2;RNF38;KLHL7;TRIM69;ARRB2;PJA2;SMURF1;PCNA;OTULIN;ITCH;TRIM11;VHL;RANBP2;UBA2;TRIM5;SPSB1;FBXL15;UBA7;FBXO24;RNF41;TRPM4;PEX10;STX1A;ENC1;KLHL24;RPS27A;UBC;UBE2H;RNF138;CTR9;HLTF;TRIM44;ZSWIM8;NUP42;SPSB2;TRIM72;ARRDC1;EGR2;CDC34;CUL4B;DTX4;ANKRD9;OS9;ASB11;CRBN;RNF8;RNF103;NUP50;MSL2;RNF20;ASB5;RNF25;MYLIP;NUP35;DTX1;AREL1;BRCA1;FBXL2;MIB2;USP5;UHRF2;PINK1;NUP88;TRIM62;UBE2V2;RNF187;ZNRF3;WWP2;KLHL18;PIAS3;RRAGA;PIAS2;RNF7;MKRN3;DTX3;UBA5;CCDC22;FBXO11;ANAPC11;DTX3L;DET1;UBE2A;NUP62;ARRB1;SEH1L;TNFAIP1;LZTR1;NUP107;TRIM47
prerank,regulation of AMPA receptor activity (GO:2000311),-0.4579634730989228,-1.4193472351461913,0.0518018018018018,0.4802303862072858,1.0,6/25,7.68%,NLGN1;SHISA9;SHISA6;CACNG2;SHANK3;GSG1L
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.4710252762961188,-1.4188577102024367,0.05200945626477541,0.47941960393866184,1.0,6/22,14.73%,MDFIC;LRRK2;SP100;BARD1;ITGB1BP1;LMAN1
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.3679727826707738,1.418754680410031,0.025682182985553772,0.6264296863007215,1.0,35/95,24.70%,CX3CR1;SIRPA;MEF2C;SBNO2;SIRT2;CYRIB;TLR4;CASP1;CTR9;CD86;NLRP3;PDCD1LG2;CXCL1;TICAM2;PABPN1;AXL;CD180;SERPINE1;CCR5;MAPK8;PYCARD;TNIP2;MAPK14;HMGB2;TICAM1;NOD2;IL1A;ZC3H12A;ACOD1;SHPK;CXCL10;IL36G;MYD88;PDCD4;FZD5
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.5314805215753368,-1.4168856895785413,0.1108695652173913,0.48295137730269183,1.0,3/13,5.23%,ANK3;PDE4D;CALM1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.3686410022331474,1.4168382352278956,0.02773246329526917,0.6307078371117593,1.0,37/94,26.75%,SDCCAG8;TUBA4A;CSNK1E;PRKACA;CEP162;ODF2;TUBB;CEP164;TUBG1;HAUS7;MKS1;CNTRL;TUBA1A;CEP63;CEP57;HAUS6;HAUS2;SFI1;TCTN1;MAPRE1;CEP135;ACTR1A;OFD1;B9D1;CEP43;DCTN2;MARK4;CEP70;TTBK2;CSNK1D;CEP97;DYNLL1;NDE1;CCP110;TCTN2;CC2D2A;HAUS5
prerank,muscle cell development (GO:0055001),-0.4468431262953431,-1.4166765676937454,0.05263157894736842,0.48125689361570345,1.0,5/30,3.39%,SGCZ;DMD;MYOF;ANK2;NEBL
prerank,synaptic vesicle localization (GO:0097479),-0.5334986357968565,-1.4158230066292665,0.0746606334841629,0.4815284635097999,1.0,5/13,8.62%,NLGN1;KIF5C;TOR1A;SYNDIG1;KIF5B
prerank,prostanoid metabolic process (GO:0006692),0.5685694636460583,1.4152981859107066,0.08522727272727272,0.6338294805088596,1.0,3/13,5.60%,HPGDS;PTGS1;HPGD
prerank,positive regulation of protein acetylation (GO:1901985),0.5805812169988476,1.4142721472985933,0.08302583025830258,0.6352677764099205,1.0,6/12,21.70%,DIP2B;CEP295;RAPGEF3;KAT5;CAMK1;DDX3X
prerank,regulation of microtubule depolymerization (GO:0031114),0.47294654994193963,1.4135134069428807,0.06204379562043796,0.6353407750345997,1.0,8/25,16.28%,NAV3;ARHGEF2;FGF13;CAMSAP1;CAMSAP2;TRPV4;CIB1;ATXN7
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.5750735956082507,1.412672621935083,0.09108159392789374,0.6356842319746582,1.0,5/12,14.97%,CSF1R;LYN;IL12B;IL34;CSF1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.4608078333559484,-1.4124926563592417,0.07029478458049887,0.488603486174329,1.0,10/24,18.17%,CD74;CD44;TPT1;ING2;SIRT1;CCAR2;BCL2;SNAI2;SFRP2;DDIAS
prerank,adherens junction organization (GO:0034332),-0.3875318092761036,-1.4115639109724958,0.03940886699507389,0.4891370899599064,1.0,17/48,13.60%,CADM2;CTNNA1;CDH8;AFDN;CDH22;CDH4;CDH7;CDH20;NECTIN1;CDH10;ACTB;CDH11;CDH13;CDHR3;CDH5;CDH1;JAM3
prerank,neuron apoptotic process (GO:0051402),-0.4920824538863194,-1.4114964144842037,0.07191011235955057,0.48707985000270804,1.0,6/19,8.93%,TRPC5;SCN2A;APP;DIABLO;LIG4;ERBB3
prerank,cellular response to cytokine stimulus (GO:0071345),0.3068021592929243,1.4114443203237128,0.0013333333333333333,0.6380466372954589,1.0,108/416,18.51%,ST3GAL6;INPP5D;SELPLG;DOCK8;IL18;ITGAM;SIRPA;CSF3R;ARHGEF2;CSF1R;SMAD3;NFE2L2;IL1RL2;LGALS9;AIF1;PIK3R1;IRAK2;GAB2;SBNO2;CRNN;LRCH1;TLR4;PRKACA;NPNT;CDK9;ITGB2;EGR1;CCL3;TNFRSF21;FSCN1;CASP1;STX1A;EBI3;RPS27A;UBC;MT1X;MMP2;TRADD;CSK;IL6ST;SOCS6;DHX9;CD86;CDC34;ZFP36L1;ZFP36L2;DUOX1;CNTF;CCR7;NOS2;EDN2;IL12B;GPER1;CTF1;CXCL1;POU4F1;MT2A;IL6R;GAPDH;PIK3CD;INPP5K;IRF8;IL12RB2;PIK3CB;WNK1;AXL;PDE1B;BRCA1;GBP6;ASAH1;IL10RB;PTPN11;STX4;IL10RA;IL34;IL18BP;CCR5;IFNGR2;GHR;LDLRAP1;MAPK8;BAG4;PYCARD;IL4R;AKT1;NDUFA13;CIB1;CSF1;STK39;IL1R2;TEC;OSM;ZEB1;AIM2;GBP5;TXLNA;STAT6;PTPN5;EPRS1;CSF2RA;PTPN23;POU2F1;GATA3;IL20RA;GBP7;PTPRJ;HTRA2;TYK2
prerank,regulation of mitochondrial fusion (GO:0010635),-0.5719836010234064,-1.411276777680249,0.09502262443438914,0.4854954993350709,1.0,6/11,28.33%,PID1;PRKN;TFRC;VAT1;ADCK1;BNIP3
prerank,signal peptide processing (GO:0006465),-0.5695436361423912,-1.4102454736204262,0.08733624454148471,0.4861747086188448,1.0,3/11,5.80%,PCSK5;SPCS2;PARL
prerank,response to acidic pH (GO:0010447),0.5642966916964571,1.4101182941975592,0.0865561694290976,0.640538432292925,1.0,4/13,16.89%,CTSS;IMPACT;LGMN;GPR4
prerank,cellular response to fatty acid (GO:0071398),-0.5604307948022762,-1.410082484003881,0.08278867102396514,0.48444456387698337,1.0,7/12,29.87%,PID1;IRS1;NR1H4;PDK3;PDK4;DGAT2;AKR1C1
prerank,cellular response to pH (GO:0071467),0.5198355391554428,1.4080301963696489,0.08468468468468468,0.6458739875564625,1.0,8/17,35.51%,MCOLN1;IMPACT;HVCN1;GPLD1;KCNK4;ASIC1;GPR68;CHP1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.45166348111186233,1.4075919323898838,0.054365733113673806,0.644770249188464,1.0,13/34,17.85%,SMAD3;SIRT2;CCDC85B;GPS2;FLCN;ZFP36L2;GATA2;WNT10B;GPER1;TRIO;BBS12;ANKRD26;GATA3
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.4793056625955292,1.4071525787832553,0.07599309153713299,0.6436941294842952,1.0,6/24,8.92%,IRAK2;RIPK2;ITCH;RPS27A;UBC;TAB2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.5474132210727514,1.407045628831172,0.07526881720430108,0.6413116542986353,1.0,5/14,12.95%,FAM98B;CSTF2;TSEN2;CPSF1;TSEN54
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.4921778429550182,-1.4068579485470227,0.08172043010752689,0.4912440813495353,1.0,11/18,32.27%,RFX3;AQP4;CFAP53;NPHP3;SPA17;SPEF2;DNAAF1;CCDC39;ODAD4;DNAAF4;ROPN1L
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.3142744324055322,1.406629502966582,0.005689900426742532,0.6402330888731533,1.0,86/264,24.58%,SRRM1;SNRNP70;NCBP1;SNRPA;DDX5;POLR2H;SRRT;FUS;POLR2J;CSTF2;RBM19;HNRNPA3;SF3B1;SF3B2;MAGOHB;MAGOH;HNRNPC;SNRPC;U2AF2;POLR2D;ZMAT2;RBM14;COIL;SART3;PCBP2;SNRPF;SNRPA1;DHX9;CWC25;HNRNPH1;SNRNP48;DHX38;HNRNPR;DDX17;PABPN1;SRSF5;SRRM2;CPSF1;SMN1;GEMIN6;RBM8A;TRA2B;SNUPN;DCPS;TGS1;RBM17;PRPF31;DDX20;LSM5;U2AF1L4;SLU7;SF3A1;FIP1L1;BUD13;ALYREF;TRA2A;POLR2E;METTL14;CCAR1;PCF11;PRPF4;PRPF3;SCNM1;ZCCHC8;SNRPN;SNRNP40;RBMX;GEMIN2;LSM7;WBP4;SRSF9;HNRNPH3;SNIP1;HNRNPA2B1;DDX39B;POLR2I;HNRNPUL1;ELAVL1;DDX46;SNRNP25;LSM8;NOVA2;HNRNPA1;WDR77;PNN;SYF2
prerank,neuromuscular junction development (GO:0007528),-0.45876619960926524,-1.4063090918583303,0.07643312101910828,0.4906529718463652,1.0,10/24,19.26%,ANK3;GPHN;LRRK2;UNC13C;PDZRN3;UNC13B;AGRN;CACNB3;DNAJA3;DOK7
prerank,negative regulation of protein secretion (GO:0050709),-0.41148763297467483,-1.4056012692451707,0.04878048780487805,0.4904403391958575,1.0,18/38,29.32%,IRS1;RSAD2;APOE;OPRM1;PRKN;ADRA2A;HMGCR;RAB11FIP1;SFRP1;CCN3;ADTRP;CYP51A1;INHBB;SERGEF;REST;DPH3;FAM3D;IL12A
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.42370410337353426,1.4054578514222387,0.055357142857142855,0.6422250995761981,1.0,15/35,18.74%,PMEPA1;DDX5;SRC;CALCOCO1;PADI2;GPER1;DDX17;PLPP1;KDM3A;DDX54;SAFB;UBE3A;ZMIZ1;ARID1A;NCOA4
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.4741045388194235,1.4051328077216858,0.08214285714285714,0.6407631236159184,1.0,8/23,14.25%,SMAD3;SMAD7;LTBP4;NREP;EID2;BCL9;ENG;LATS2
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.5393041128233829,1.4046070082783815,0.1001890359168242,0.6400966144544578,1.0,6/14,25.45%,ENTPD1;NUDT15;ENTPD7;NUDT16;ENTPD6;ADPRM
prerank,regulation of cell differentiation (GO:0045595),0.3390965602081817,1.4041922395950839,0.015015015015015015,0.6389627380237918,1.0,32/148,12.92%,TGFBR1;BIN1;ZFHX3;GREM1;SMAD7;YWHAH;DDX5;RPS6KA1;PRKACA;GPS2;VHL;MBOAT2;CDK9;LTBP4;TAF8;PHLDB1;NREP;SHH;ZFP36L1;EDN3;BCL6B;GDNF;NEUROD4;FLOT2;CDK5RAP1;DDX17;NOTCH4;PRKCB;DLL1;RUNX1;FADS1;PLEKHB1
prerank,DNA biosynthetic process (GO:0071897),-0.5021610547912942,-1.4039000751647315,0.08771929824561403,0.49316137893140377,1.0,8/16,21.17%,POLA1;POLL;PPIA;SIRT1;POLD1;POLD3;TERT;POLH
prerank,regulation of Notch signaling pathway (GO:0008593),0.3748258244531124,1.4038073151200101,0.0352,0.6377250733326811,1.0,25/76,20.18%,MAML3;TSPAN14;BMP2K;SRC;IL6ST;ARRDC1;RFNG;GATA2;JAG2;NOTCH4;POFUT1;DTX1;GALNT11;MAML2;DLL1;LLGL1;WWP2;AKT1;NOTCH3;PDCD10;ZMIZ1;ARRB1;NEPRO;NOD2;SYNJ2BP
prerank,regulation of cellular senescence (GO:2000772),0.45707992418232335,1.403698987684984,0.05755395683453238,0.635425123398036,1.0,6/28,7.09%,NUAK1;ABI3;MAP3K3;SLC30A10;NEK6;CGAS
prerank,supramolecular fiber organization (GO:0097435),0.30911625624696754,1.4036009030073238,0.001388888888888889,0.6330969281161078,1.0,71/333,16.79%,TGFBR1;ELMO1;DST;TSPAN14;ARHGEF2;CST3;FGF13;COL27A1;KIF2A;HOOK2;GREM1;CAPN3;CCDC88B;ITGA6;MYO1B;RAC1;SERF1A;MYO1F;RND1;FLII;DSP;SNCAIP;PPP1R9B;DBN1;CDC42EP2;ARHGAP25;MYO1E;PPP1R9A;GFAP;RHOB;RHOBTB1;CAMSAP1;KLHL24;LOXL3;RPS27A;UBC;RND2;TUBGCP5;MARCKS;RHOH;ARHGAP17;MYO7A;MPRIP;WDR73;CAMSAP2;TLE6;AVIL;P4HA1;P3H2;CLIP3;SHROOM2;PSENEN;ERMN;MYO5B;LAMA3;DDR2;HIP1R;TRPV4;PIN1;PLK3;KASH5;MYO15A;CIB1;LTBP3;LTBP2;CD2AP;COL11A1;LAMC2;MARCKSL1;BFSP2;ADAM10
prerank,peptidyl-serine modification (GO:0018209),0.33078304763842137,1.4026082818626366,0.01592356687898089,0.634194808787634,1.0,54/166,20.61%,TGFBR1;TGFBR2;ULK2;CSNK1E;RPS6KA1;PRKCA;PRKACA;HPF1;NEK6;CSNK2A2;CSNK2A1;ATM;MKNK1;PRKCD;CAMK1D;ULK3;RPS6KA5;PDPK1;PKN3;PDGFB;GALNT1;VRK3;NAA11;MTOR;WNK1;GRK2;PRKCB;TAF1;PINK1;UHMK1;MAP3K10;MARK2;GALNT3;MORC3;LATS2;MAST3;MAPK8;DYRK1A;AKT1;DYRK4;MAPK14;STK39;AURKA;MASTL;ULK1;RPS6KA4;VRK2;ROCK2;CAMK1;CAMK1G;EIF2AK3;CSNK1G2;GALNT2;PRKCH
prerank,positive regulation of macrophage migration (GO:1905523),0.5143820168102805,1.4024551848588858,0.0797872340425532,0.6321741987569987,1.0,8/19,19.13%,CSF1R;P2RY12;CCL3;AKIRIN1;IL34;CSF1;CXCL17;THBS1
prerank,protein deubiquitination (GO:0016579),0.3188746363161988,1.4023613880209427,0.008797653958944282,0.629918371133695,1.0,56/242,17.01%,TGFBR1;USP35;SMAD3;SMAD7;UCHL5;UCHL1;ARRB2;USP8;USP12;OTULIN;OTUD6B;OTUD5;ZRANB1;INO80C;DDB2;INO80E;SUDS3;WDR48;JOSD2;MYSM1;RPS27A;UBC;FOXK2;MDM4;USP28;USP25;NLRP3;USP19;RCE1;STAMBPL1;NFRKB;PSMD3;OTULINL;UFD1;USP36;ACTL6A;BRCA1;PSMB3;USP5;MINDY2;IL33;OTUB2;USP9Y;ABRAXAS1;PSMA7;INO80B;PSMC1;PSMC2;TNIP2;USP4;PSME4;ATXN7;SNX3;PSMB9;TOMM20;INO80D
prerank,lytic vacuole organization (GO:0080171),0.4473695647237145,1.4013102769911936,0.06776859504132231,0.6313773070002145,1.0,17/32,28.03%,HPS4;HOOK2;ARSB;MYO7A;MBTPS1;AKTIP;MTOR;CLN3;ACP4;ACP2;GAA;HOOK3;ABCA1;GNPTAB;VPS18;HPS1;TMEM106B
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.5200991634395136,-1.4004946245007144,0.10021786492374728,0.5008726970468199,1.0,4/13,10.71%,RBPJ;ZFPM2;ERBB4;PIM1
prerank,activin receptor signaling pathway (GO:0032924),0.5426009213813751,1.4003792526460939,0.07913669064748201,0.6323074676041718,1.0,2/15,0.87%,TGFBR1;SMAD3
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.39991833696493473,-1.3998948588179532,0.03800475059382423,0.5002661854103014,1.0,7/40,3.88%,MAGI2;DAB2;HIP1;BICD1;B2M;ATAD1;SGIP1
prerank,rRNA modification (GO:0000154),0.4867392072223574,1.399458357662681,0.0670391061452514,0.633251096140069,1.0,9/21,21.08%,BUD23;THUMPD1;METTL5;NHP2;FTSJ3;NSUN3;TFB1M;NSUN4;FBL
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.5363589751157906,-1.398235770087512,0.1004566210045662,0.502859142403047,1.0,5/15,9.90%,NTRK3;VEGFD;F7;IL16;CDH13
prerank,regulation of platelet aggregation (GO:0090330),0.5097343970298718,1.3982127229070687,0.08394160583941605,0.6354557905438902,1.0,7/17,13.17%,F11R;CD9;PRKCA;LYN;PRKCD;CEACAM1;SERPINE2
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.37321753709642935,-1.3982068363051252,0.018604651162790697,0.5007429711450397,1.0,15/57,11.25%,GRM7;GRM8;ADCY2;GABBR1;ADCY5;CHRM2;OPRM1;CHRM3;HTR1D;HTR4;ADCY3;ADCY8;ADRA2A;GNAI1;RGS1
prerank,negative regulation of secretion by cell (GO:1903531),-0.4102279632864032,-1.3975555992773956,0.07936507936507936,0.5003245517470304,1.0,13/38,23.76%,GRM7;LILRB1;RSAD2;IL1RAPL1;APOE;STXBP6;HMGCR;SNCA;ADTRP;CYP51A1;HRH3;SERGEF;ANXA1
prerank,negative regulation of interleukin-1 production (GO:0032692),0.4792376535144271,1.3974579041015804,0.08534322820037106,0.6356760131212009,1.0,6/23,12.86%,CX3CR1;PYDC1;CPTP;NLRP3;CEACAM1;CD33
prerank,regulation of mRNA processing (GO:0050684),0.44058463447683877,1.3973121173312821,0.08261617900172118,0.6336316608967054,1.0,11/32,14.25%,SON;NCBP1;QKI;DHX9;JMJD6;RBM39;SLTM;ZFP36L1;PABPN1;CDK11B;SAFB
prerank,dendrite self-avoidance (GO:0070593),-0.5135905590029515,-1.39724031496343,0.09803921568627451,0.4990421798297816,1.0,11/16,31.99%,CNTN6;EMB;NPTN;PALLD;TNN;BSG;DSCAML1;CNTN4;DSCAM;ROBO4;ROBO3
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.5776270365315852,-1.3968185908967266,0.11475409836065574,0.4981564436468197,1.0,3/10,3.89%,HECW2;HECW1;NEDD4L
prerank,signal transduction by p53 class mediator (GO:0072331),0.45183952586525267,1.3966466053301925,0.06502636203866433,0.6336706948251519,1.0,8/30,10.36%,GREM1;FHIT;DDX5;NBN;MDM4;POU4F1;ACER2;PDK2
prerank,regulation of myoblast differentiation (GO:0045661),0.4448701599737494,1.3964333124680632,0.07875457875457875,0.6319608465033197,1.0,12/32,15.33%,MEF2C;SOX8;IGFBP3;ZFP36L1;AKIRIN1;RBM24;ANKRD2;FLOT2;EID2B;DLL1;LRRC8A;MAPK14
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.5166840246341384,-1.3964129097792162,0.09782608695652174,0.4970002274420383,1.0,7/15,27.66%,REEP3;ATL2;RTN4;REEP4;ATL1;REEP2;RTN3
prerank,mitochondrial fission (GO:0000266),-0.4920164264352149,-1.3963288606112776,0.07905982905982906,0.4950775728907566,1.0,7/16,12.16%,DNM3;DNM1L;DNM1;PRKN;FIS1;MFF;MTFR2
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.4266847494129349,1.3962465805076132,0.057391304347826085,0.6300217623284851,1.0,10/39,11.57%,TANC2;MYO1B;TRAK1;MYO1F;MYO1E;BICDL2;MYO7A;RAB1A;CLN3;MYO5B
prerank,protein modification by small protein removal (GO:0070646),0.31452663575258744,1.3956546176547824,0.010130246020260492,0.629709741106658,1.0,58/252,17.01%,TGFBR1;USP35;SMAD3;SENP2;SMAD7;UCHL5;UCHL1;ARRB2;USP8;USP12;OTUD6B;OTUD5;ZRANB1;INO80C;DDB2;INO80E;COPS4;SUDS3;WDR48;JOSD2;MYSM1;RPS27A;UBC;FOXK2;MDM4;USP28;USP25;NLRP3;USP19;RCE1;STAMBPL1;NFRKB;PSMD3;OTULINL;UFD1;USP36;ACTL6A;BRCA1;PSMB3;USP5;IL33;OTUB2;USP9Y;ABRAXAS1;PSMA7;INO80B;GPS1;PSMC1;PSMC2;TNIP2;USP4;PSME4;COPS6;ATXN7;SNX3;PSMB9;TOMM20;INO80D
prerank,ureteric bud morphogenesis (GO:0060675),0.5160346775207879,1.3956386417650168,0.09611829944547134,0.6272721607443444,1.0,5/16,11.24%,SALL1;NPNT;SHH;GDNF;PAX2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.49936293837373696,1.3947159831299811,0.1039426523297491,0.6282183973724065,1.0,7/19,17.11%,TLR7;RIPK2;TLR4;DHX9;SETD2;MAVS;IRF3
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.4422116491194955,1.3947095101201612,0.0686456400742115,0.6257775154715779,1.0,10/32,16.28%,NAV3;ARHGEF2;FGF13;CAMSAP1;CAMSAP2;CLIP3;DYRK1A;CIB1;MAPRE1;ATXN7
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3896812580950127,1.3934621018333828,0.04152823920265781,0.6280865181477125,1.0,5/56,1.32%,TGFBR1;LDLRAD4;GREM1;SMAD7;PMEPA1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.5810721061502035,-1.393421625977183,0.11451942740286299,0.5014507185801058,1.0,3/10,3.89%,HECW2;HECW1;NEDD4L
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.41985665546352696,-1.3929476817379733,0.06619385342789598,0.5007571450676879,1.0,11/30,18.26%,CCT2;ST13;DNAJB4;ERO1A;DNAJB13;HSPA2;HSPA1B;HSPA5;HSPA8;CHCHD4;SDF2
prerank,long-chain fatty acid transport (GO:0015909),-0.4239261223786908,-1.3926237412686537,0.09808612440191387,0.4993776336312713,1.0,9/30,14.53%,PPARG;CD36;FABP4;PRKAG2;ACSL3;APOE;MFSD2A;ABCD4;CPT1B
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.5565502305438039,1.392297329270742,0.08208955223880597,0.6299713909930007,1.0,3/12,15.23%,NELFB;RNF8;NELFE
prerank,secondary palate development (GO:0062009),0.5367454205140221,1.3907349358582717,0.1037037037037037,0.6336318554743113,1.0,2/14,4.49%,TGFBR2;CHD7
prerank,actin filament polymerization (GO:0030041),-0.4264597908084516,-1.3904576802521877,0.0639269406392694,0.503558671637754,1.0,8/29,8.29%,ARHGAP6;PSTPIP1;GSN;PSTPIP2;DIAPH3;JAK2;WASF1;MSRB1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.39022150231535985,-1.3902319173601134,0.05542725173210162,0.5020393132424149,1.0,13/44,14.73%,AKAP6;ANK2;KCNN2;KCNJ3;KCNMB2;GABBR1;GABBR2;ATP1B3;ACTN2;ANO6;KCNMB4;KCNQ1;KCNIP2
prerank,negative regulation of type I interferon production (GO:0032480),0.41809935737856346,1.3895359489002945,0.06463195691202872,0.6356242465076286,1.0,19/40,24.85%,SIRPA;RNF216;ITCH;OTUD5;UBA7;PCBP2;UFD1;HAVCR2;RELB;PIN1;MAVS;PYCARD;NLRX1;IRF3;NLRC5;PPM1B;ACOD1;YY1;NPLOC4
prerank,calcium ion transport into cytosol (GO:0060402),-0.46572249975864755,-1.389306478816043,0.09513742071881606,0.502520782773303,1.0,10/21,22.68%,GRIN2A;ADRA1A;GRIN2B;RYR2;CACNA1C;GRIN2D;CACNB3;MS4A1;ITPR3;JPH4
prerank,kinetochore organization (GO:0051383),-0.5282779856995322,-1.389246247851982,0.09322033898305085,0.5005910340115322,1.0,6/13,11.00%,CENPF;CENPT;CENPE;NDC80;DLGAP5;CENPW
prerank,peptide catabolic process (GO:0043171),-0.44721375648822903,-1.3891439766893177,0.08604651162790698,0.4987667977812823,1.0,6/23,10.09%,CPQ;NPEPPS;TRHDE;ENPEP;GGT7;ANPEP
prerank,neuron projection extension (GO:1990138),-0.41411809673182126,-1.3890979184493109,0.06451612903225806,0.49682461202914213,1.0,6/32,5.58%,AUTS2;IQGAP1;ALCAM;MAP1B;SEMA5A;SH3GL2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.5719168311283237,-1.388811786586586,0.10920770877944326,0.4955582649332189,1.0,4/10,13.40%,GPR35;CALM1;CBARP;GNB5
prerank,regulation of cell adhesion (GO:0030155),0.3397488189132576,1.3880667341392525,0.016717325227963525,0.6387140083038851,1.0,37/129,18.35%,PDE3B;ZFHX3;NUAK1;IL18;RND1;TGM2;PRKCA;LYN;ITGAV;SRC;PIK3CG;ATM;PKHD1;FLCN;TFE3;PTK2B;SIPA1;C1QBP;MIA3;EPHA8;CCR7;IL12B;FUT7;LPXN;DLL1;PTPN11;STX4;SEMA4D;ABL1;ADGRG1;PPP1CB;ADAM10;GPR4;FES;ROCK2;CD164;PTPRJ
prerank,regulation of interferon-gamma production (GO:0032649),0.37584302108785594,1.3879960190379321,0.04180602006688963,0.6365305761684729,1.0,19/71,12.91%,IL18;TLR7;SIRPA;DDIT3;SLC7A5;LGALS9;VSIR;CYRIB;TLR4;EBI3;C1QBP;CCR7;PDCD1LG2;IL12B;INHA;IL12RB2;AXL;HAVCR2;CEBPG
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.48595940362217993,-1.3874467590861927,0.09438202247191012,0.49734234801900545,1.0,7/18,20.36%,AOAH;SAMHD1;MANBA;NAGA;OGA;FUCA1;DERA
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.5220908747062133,-1.38709814637998,0.10805084745762712,0.49624788982364176,1.0,2/14,0.46%,DMD;ANK3
prerank,positive regulation of myelination (GO:0031643),-0.5592122217321972,-1.3867914344391732,0.10766045548654245,0.4950790645620141,1.0,4/11,13.38%,TPPP;MYRF;TENM4;PARD3
prerank,platelet aggregation (GO:0070527),0.4299429559086422,1.3866786581428518,0.08561643835616438,0.6393368501905182,1.0,7/33,4.94%,P2RY12;FERMT3;PLEK;PIK3CG;MYH9;STXBP1;UBASH3B
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.386962336595438,1.386381270336997,0.04974271012006861,0.6380752202129693,1.0,17/59,18.16%,TLR7;IRAK2;RIPK2;TLR4;RPS27A;UBC;TRADD;TAB2;RNF31;TICAM2;RELB;AKT1;NKIRAS1;TBKBP1;TICAM1;ROCK2;MAP3K14
prerank,positive regulation of axonogenesis (GO:0050772),-0.39518821055921965,-1.3863324188464796,0.05378973105134474,0.4942877358864462,1.0,15/43,16.15%,ROBO1;CDKL5;SLIT2;PLXNC1;BDNF;SLITRK1;NTRK2;PLXND1;PLXNA2;PLXNB2;MAP3K13;PLXNB1;SEMA7A;TIAM1;ARHGDIA
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5033234068354949,1.3863309116245592,0.08964143426294821,0.6358251945445204,1.0,7/18,19.40%,PAG1;MIA3;WNK1;TNFAIP8L2;AKT1;GPNMB;IL4I1
prerank,positive regulation of immune response (GO:0050778),0.3816877843623587,1.3855337891152189,0.04180064308681672,0.6365163603212178,1.0,13/64,8.25%,SASH3;ITGAM;POLR3G;LGALS9;KARS1;ITGB2;SLC15A4;AKIRIN2;IL6ST;DHX9;NLRP3;CCR7;IL12B
prerank,regulation of axon regeneration (GO:0048679),0.5609921819890744,1.3854847495665157,0.10516252390057361,0.6342853143203478,1.0,5/12,14.52%,RTN4RL1;KLK8;CNTF;CERS2;RTN4R
prerank,receptor-mediated endocytosis (GO:0006898),-0.3179180610353896,-1.3852425787864404,0.0,0.49550413457018455,1.0,39/132,17.46%,MRC1;DAB2;CD163;LRP1B;DNM3;DNAJC6;CD36;MSR1;STAB1;LILRB1;CTTN;AP2A2;SNAP91;LDLR;SGIP1;LRP6;APOE;WASF1;DNM1;CLEC9A;HSPG2;SNX9;SCARF1;FCGR2B;TFR2;EPS15;HPX;JCHAIN;TMEM108;INPP5F;AP2B1;IGF2R;SNCA;AP1G2;HPR;HP;ITGB1;TFRC;AP4E1
prerank,positive regulation of cyclase activity (GO:0031281),0.5387648633478005,1.3852150532104195,0.10131332082551595,0.6329184737447966,1.0,7/14,20.35%,AKAP5;NOS2;MAPK8;MAPK14;ORAI1;CACNA1D;NOS1
prerank,chromatin remodeling at centromere (GO:0031055),-0.4180434527858124,-1.3847758326736552,0.08577878103837472,0.49482346177172454,1.0,10/31,16.87%,KNL1;CENPT;CENPP;MIS18BP1;HELLS;CENPW;RBBP7;NASP;NPM1;CENPS
prerank,positive regulation of calcium ion import (GO:0090280),0.5620444504563122,1.3846683350699458,0.10326086956521739,0.6326914023901521,1.0,4/12,11.46%,CCL3;PDGFB;CALCR;PDGFRB
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.49416498643144524,1.384451364571694,0.09764918625678119,0.6312062861312905,1.0,13/20,31.01%,MBTPS1;MBTPS2;PSENEN;PSEN2;SPPL2B;ADAM10;APH1B;ADAM17;TGFB1;APH1A;TRAF6;NFKB1;ADAM9
prerank,regulation of glucose import (GO:0046324),-0.4244422063904702,-1.384070379235642,0.0645933014354067,0.49465238044569304,1.0,5/30,3.46%,PID1;SORBS1;IRS1;PRKAG2;CREBL2
prerank,sister chromatid segregation (GO:0000819),-0.4267018320493668,-1.382604512136768,0.08297872340425531,0.49684488760947065,1.0,13/31,20.67%,LATS1;TOP2A;SMC4;CDCA8;ZW10;RAN;NDC80;NUSAP1;SPAG5;KIF18B;NCAPG2;KIFC1;KNSTRN
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.2947172812338384,-1.3819611308132704,0.0,0.4965585095424938,1.0,56/248,15.49%,CTNND2;DAB2;LRRK2;CCDC88C;EGFR;SHISA6;FGF10;CDK14;CSNK1G1;CUL3;SEMA5A;LIMD1;PPM1A;HECW1;PSMD14;LATS1;APC2;RBMS3;LRP6;GPC5;UBR5;APOE;ATP6AP2;GSK3B;PSMD8;MLLT3;IGFBP4;PSMA2;FRZB;PSMF1;PSMD6;PRKN;TLE4;BTRC;AXIN1;PSME2;SOX13;ZEB2;CCAR2;TLE1;GPC3;LGR5;KANK1;PSMD5;TNKS2;PSMD12;MCC;NPHP3;IGFBP2;LGR4;PSMD11;COL1A1;NKD1;SCYL2;SFRP1;PSMD1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3156996488271914,1.3818797390142832,0.01300578034682081,0.6384640370891974,1.0,63/234,18.23%,CX3CR1;IL18;ARHGEF2;SMAD3;CAPN3;ANXA3;CFLAR;DDIT3;LGALS9;IRAK2;RIPK2;AGER;CRNN;TLR4;TRIM5;TRAF5;PHB2;PLCG2;CLU;CAMK1D;RPS27A;UBC;TRADD;TAF12;RPS6KA5;DHX9;SHH;FZD2;NLRP3;MTDH;ABRA;EDA2R;TSSK4;TAB2;FLOT2;RTKN2;MBTPS2;RNF31;RNF25;LAMTOR5;PRKCB;CRTC1;TAF1;DDR2;TRIM62;CEBPG;MAVS;PYCARD;AKT1;SMO;CIB1;HDAC5;TCF3;AIM2;AGT;RPS6KA4;FZD1;RAB7B;FANK1;EIF2AK2;KDM1A;TICAM1;PPRC1
prerank,sensory perception of taste (GO:0050909),-0.5784966840843163,-1.3817793528273024,0.13347921225382933,0.4951124677165586,1.0,5/10,34.85%,CD36;ASIC3;TAS1R3;TAS1R1;PKD2L1
prerank,protein transport (GO:0015031),0.30581808634315605,1.3815045871180236,0.004098360655737705,0.6375060645413464,1.0,103/332,20.14%,TBC1D16;UNC93B1;ARHGEF2;DNM2;PREB;HERC2;TBC1D17;YWHAH;TBC1D9B;KIF3B;SEL1L;ATP6V0B;ARFIP1;COPA;ARFGAP3;TBC1D10B;AP2A1;VPS26B;ARL5C;TBCK;TBC1D8;NEURL1B;VIPAS39;MYH9;TBC1D15;FAM91A1;AP3D1;CLU;STXBP1;MCOLN1;ATP6V1D;STX1A;STX12;ARFIP2;TMED9;PPT1;ARRDC1;SGSM2;MACF1;RAB3GAP2;PPY;ARL6IP5;TCIRG1;ATP6V0A2;TMED4;MIA3;SEC13;STX19;RD3;GOLGA4;RAB1A;SCAMP2;RAB34;LRP1;TICAM2;SAR1A;TBC1D9;SCAMP5;SNX31;RUNDC1;PRKCB;BBS2;ATP6V0A4;SEC31B;PDCD6;STX4;IL10RA;OPTN;TBC1D30;RAB20;ARRDC2;SLU7;TVP23B;SCG5;RAB32;TOM1;PICK1;NAPG;LTBP2;SNX13;KIF3A;ADPRH;TANGO2;ATP6V0E2;SGSM3;GGA3;RAB13;EIF2D;CTSA;CHMP1A;VPS29;ARL11;PDIA4;STX5;RAB6B;GRTP1;AP4M1;ACD;VPS26A;CHMP2A;LAMP2;CMTM6;VPS35
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.5417256581483669,-1.3807142420004128,0.08791208791208792,0.49410464071316373,1.0,5/12,16.42%,KANK1;SPRY4;ITGB1BP1;EFNA5;RCC2
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.5417256581483669,-1.3807142420004128,0.08791208791208792,0.49410464071316373,1.0,5/12,16.42%,KANK1;SPRY4;ITGB1BP1;EFNA5;RCC2
prerank,monocarboxylic acid catabolic process (GO:0072329),0.48641826806145344,1.3804543628349668,0.11091234347048301,0.6389176127399397,1.0,8/21,18.34%,PPARD;LPIN2;NUDT19;PLA2G15;HAO1;AGXT;LPIN1;FAH
prerank,positive regulation of protein polymerization (GO:0032273),0.3759790438603379,1.379917416420587,0.042704626334519574,0.6385629183613654,1.0,21/65,21.19%,BIN1;NAV3;RAC1;BAIAP2L2;CDC42EP2;NUMA1;PTK2B;MET;CCR7;NCKAP1L;PINK1;PYCARD;TENM1;MAPRE1;FCHSD2;CDC42EP3;FES;VASP;CCL24;FCHSD1;MAPT
prerank,positive regulation of nervous system process (GO:0031646),-0.4869284457981961,-1.379097107054317,0.09978308026030369,0.4965991143282982,1.0,7/18,17.14%,RIMS2;TPPP;MYRF;TENM4;UNC13B;PARD3;RIMS1
prerank,serine family amino acid catabolic process (GO:0009071),-0.5717923993252876,-1.3790311553765575,0.1206896551724138,0.4948148396588376,1.0,5/10,17.08%,GCSH;SHMT1;DAO;AMT;GLDC
prerank,negative regulation of cell differentiation (GO:0045596),0.3217635564915625,1.3789762641294925,0.017069701280227598,0.6397189533485569,1.0,33/181,11.42%,TGFBR1;LDLRAD4;LRP5;SMAD3;NBR1;GREM1;SMAD7;SOX8;NELFB;SKI;SIRT2;CCDC85B;GPS2;EFEMP1;ITGAV;TRPM4;HOXB8;PTK2B;CTR9;SPRY2;SHH;ZFP36L2;OVOL2;GATA2;WNT10B;GPER1;ANKRD2;TWIST2;EID2B;NOTCH4;DTX1;DLL1;TRIO
prerank,glial cell differentiation (GO:0010001),-0.4239071862950973,-1.3788135990572288,0.08009708737864078,0.49355928659607645,1.0,7/28,4.19%,NFIB;FGF10;SLC8A3;TPPP;ADGRG6;MYRF;SOX11
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.4192704139940382,-1.3779473933798045,0.09026128266033254,0.4940550963862984,1.0,12/31,19.85%,YWHAQ;TFDP2;YWHAE;GSK3B;ZNF205;BAK1;PPP3CC;BCL2;E2F1;BOK;TFDP1;CHCHD10
prerank,mesenchyme morphogenesis (GO:0072132),0.5052335499844234,1.377866684878272,0.0947176684881603,0.6416404028977758,1.0,11/17,35.10%,HEYL;MDM4;ENG;NOG;BMP2;SOX9;ACVR1;NOTCH1;BMPR1A;HEY1;ISL1
prerank,translational termination (GO:0006415),0.35429805169789225,1.3772325495440099,0.03475513428120063,0.641702625305257,1.0,49/95,32.84%,MRPL50;ETF1;MRPS24;MRPL17;MRPL37;MRPL2;MRPL43;MRPS34;MRPL34;ABCE1;MRPL9;MRPS5;MRPL30;CHCHD1;GSPT2;MRPS21;MRPL13;MRPS16;MRPS18B;MRPS11;MRPS35;MRPS28;MRPS10;MRPS18A;MRPL46;MRPL11;MRPL41;MRPL27;MRPL54;MRPL38;DAP3;MRPL47;MRPL36;MRPS25;MRPL28;MRPL21;MRPL20;MRPL49;MRPS18C;MRPL45;OXA1L;MRPL14;MRPL32;MRPL10;MRPL19;MRPL15;MRPS17;MRPS27;AURKAIP1
prerank,O-glycan processing (GO:0016266),0.39600950692343084,1.3771112362559754,0.05901639344262295,0.6398475133090441,1.0,16/54,13.57%,XXYLT1;B3GNT2;GALNT12;GALNT5;POMGNT1;GALNT10;GALNT1;MUC6;B3GNT4;POFUT1;GALNT11;GALNT7;GALNT15;GXYLT2;GALNT3;ST3GAL3
prerank,nervous system development (GO:0007399),-0.27274893935829186,-1.376155789630478,0.004166666666666667,0.49701392912873144,1.0,96/429,15.56%,LSAMP;RBFOX1;NRXN1;NLGN1;ZBTB16;DNM3;ROBO1;ADGRL3;KIRREL3;SPOCK1;NRCAM;FGF12;NAV1;GPM6A;GDA;DPYSL5;RBFOX2;GSN;TRPC5;SCN2A;BDNF;JARID2;SLITRK1;ADAM22;GSS;WWP1;ST8SIA4;ADGRG6;SEMA5A;MSI1;CNTN6;APC2;IL1RAPL2;DCLK1;MYT1L;ACVR1C;FN1;SHANK3;APBA2;PLXND1;EDNRB;POU6F2;SH3GL2;CDK5RAP2;RBFOX3;HDAC4;SDHA;FAT4;PKD2;ERBB4;GFRA2;CHRM2;CHRM3;PRKN;NINJ1;ERCC6;ECRG4;LIG4;LGI1;MAB21L2;ST8SIA2;VCAN;FGF11;ZEB2;NAB1;ERBB3;RAPGEFL1;PRX;SERPINI1;UNC119;SRRM4;INTU;GRIK1;SDK1;DPF3;MAL;TMEM223;AHI1;EFNA5;ALDH3A2;OBSL1;HMGCR;ACHE;GDF11;CDH1;JAG1;NRXN2;PCDHB16;LY6H;ZIC5;FKTN;PKD1;CYP26C1;POU3F2;RELN;POU3F1
prerank,keratan sulfate catabolic process (GO:0042340),0.5763618439666108,1.3760078753666325,0.1102803738317757,0.6416733711795158,1.0,3/11,6.12%,HEXB;PRELP;HEXA
prerank,neuron maturation (GO:0042551),-0.48929325021594855,-1.375359477271139,0.12527472527472527,0.49735779184173784,1.0,9/18,17.17%,ADGRB3;B4GALT5;B4GALT6;APP;SCARF1;SRRM4;CX3CL1;LGI4;CLN5
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.45751319012359387,1.374866583420222,0.10424028268551237,0.6436786241899577,1.0,7/24,14.34%,HMBS;PPOX;FECH;SUCLA2;NFE2L1;UROD;TSPO
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.5772959058504749,-1.3744158381800085,0.09050772626931568,0.4980566544482486,1.0,5/10,21.97%,MLLT3;SFRP1;HOXB4;ACE;SP7
prerank,phagosome acidification (GO:0090383),0.46337290742977355,1.3739450536495155,0.09700176366843033,0.6448504902645045,1.0,8/26,16.86%,ATP6V0B;ATP6V1D;TCIRG1;ATP6V0A2;RAB39A;ATP6V0A4;RAB20;ATP6V0E2
prerank,histone H2A ubiquitination (GO:0033522),0.5148075475363808,1.373897806290333,0.10242085661080075,0.6427055237663113,1.0,9/17,23.15%,DDB2;BCOR;CUL4B;RNF8;DTX3L;UBE2A;RNF2;KDM2B;RING1
prerank,regulation of erythrocyte differentiation (GO:0045646),0.43004243276006715,1.3736754714003356,0.11209964412811388,0.6412168466419217,1.0,14/35,25.89%,ETS1;LYN;ZFP36L1;PRMT1;NCKAP1L;ARNT;TAL1;MAPK14;HMGB2;STAT5B;ACVR1B;BRD1;HIF1A;STAT3
prerank,regulation of stem cell population maintenance (GO:2000036),0.5048975501954257,1.3733919905231136,0.09473684210526316,0.6398372774462389,1.0,7/18,23.33%,CNOT1;TAF6L;CNOT3;NCOA3;TAF5L;ELAVL1;CNOT2
prerank,retinoid metabolic process (GO:0001523),-0.3462593375107905,-1.3733567086811191,0.0375,0.49901733384336794,1.0,26/71,25.49%,GPC6;SDC3;GPC5;APOE;RETSAT;NAPEPLD;HSPG2;RDH13;GPC3;RDH10;RBP4;DHRS9;ABCA4;GPC4;AGRN;DHRS13;RDH12;RBP1;GPC1;CYP2S1;RARRES2;SDC2;UGT1A1;UGT1A7;UGT1A8;LRP2
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.5918578042001116,1.3718726094601155,0.11524163568773234,0.6431520427483068,1.0,3/10,2.10%,CX3CR1;LGALS9;ARRB2
prerank,sulfur compound catabolic process (GO:0044273),0.42477333120974614,1.3712311105326134,0.08070175438596491,0.6434280525396504,1.0,12/38,18.05%,HEXB;ARSB;PRELP;HEXA;MPST;BGN;DPEP1;BCAN;CSPG5;GADL1;GLB1;TXN2
prerank,neuromuscular synaptic transmission (GO:0007274),-0.48308705870642044,-1.3693561232473175,0.09598214285714286,0.5079524963887497,1.0,5/18,6.03%,DTNA;KIF1B;SLC5A7;ERC2;CHAT
prerank,histone H2A acetylation (GO:0043968),0.515589563787264,1.3690958756985134,0.0900562851782364,0.6492820112088595,1.0,6/16,21.16%,BRD8;ACTL6A;MORF4L1;NAA40;EPC1;MORF4L2
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.47150716233425055,1.3690677616168345,0.09156193895870736,0.6470909712572388,1.0,8/23,16.93%,SOX8;GDNF;PIK3CD;PAX2;GJA1;SMO;NOG;AGT
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.5344744504435615,-1.3680809529142095,0.10993657505285412,0.5093393050170855,1.0,4/13,5.28%,CCR2;GABBR2;PALM;EDNRB
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.441211433905651,-1.3664552679555606,0.09176470588235294,0.5118638622221453,1.0,12/24,27.71%,RPS3;DACH1;ZRANB3;CDKN1A;ACVRL1;XRCC5;NIBAN2;MSH6;MSH2;DFFA;ERCC1;H1-0
prerank,positive regulation of epithelial cell migration (GO:0010634),0.35126934922540515,1.3661947145256652,0.04107424960505529,0.6559936166022445,1.0,27/92,19.13%,RREB1;SMOC2;ANXA3;ETS1;RAC1;MAP4K4;PRKCA;SRC;PIK3CG;RHOB;SPARC;PLCG2;PTK2B;PIK3CD;PIK3CB;MTOR;PDCD6;INSL3;ABL1;AKT1;PROX1;AGT;SCARB1;GATA3;ROCK2;PPM1F;THBS1
prerank,sphingolipid metabolic process (GO:0006665),0.345235687104493,1.3658487006985207,0.042993630573248405,0.6550775382147794,1.0,33/108,21.23%,HEXB;ALOXE3;CPTP;CERS3;DEGS2;PLA2G15;SPTLC3;PPM1L;HACD3;HEXA;NEU3;PPT1;FUT7;SMPD2;ACER3;ACER2;PLPP1;CERK;ASAH1;PLPP2;B4GALNT1;ARSA;PRKD3;CERS2;VAPB;CTSA;NEU4;GLB1;ORMDL2;SMPD3;CSNK1G2;SUMF2;SERINC1
prerank,regulation of osteoblast proliferation (GO:0033688),0.5068596821559542,1.3657828244927275,0.1038961038961039,0.6530458988269637,1.0,3/17,1.99%,TMEM119;GREM1;SOX8
prerank,synaptic vesicle endocytosis (GO:0048488),-0.4046942635795132,-1.3657507578392178,0.07093821510297482,0.5119058511682624,1.0,7/33,6.54%,NLGN1;DNM3;DNAJC6;SYT1;ITSN1;SNAP91;DNM1
prerank,amino acid import (GO:0043090),0.4858820998564631,1.364371362321522,0.09913043478260869,0.6559937526384397,1.0,5/21,8.51%,SLC7A8;SLC1A3;SLC7A5;SLC36A1;SLC22A2
prerank,response to growth factor (GO:0070848),0.4097877390125137,1.3643165546253402,0.06806282722513089,0.653990613460085,1.0,13/41,20.35%,TGFBR1;TGFBR2;TWF2;TBC1D7;PDGFB;PLK5;AKT1;CIB1;ACVR2B;MAPK7;HTRA2;EPHA2;NOS1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.34975057751060845,-1.3633787998651978,0.05392156862745098,0.5166298578576819,1.0,28/66,25.86%,MTSS1;ROBO1;NFIB;XDH;B2M;KLF9;APOE;ALOX5;CASK;CDC73;DUSP10;MCC;AQP11;RGCC;SFRP1;SNAI2;SFRP2;CDKN1C;PTPRK;CAV2;TGFBR3;GHRL;FBXW7;MARVELD3;TNMD;BRCA2;NLRC3;CNMD
prerank,polyamine metabolic process (GO:0006595),0.530394156262047,1.3628030320913762,0.10780669144981413,0.6576588156767496,1.0,9/13,34.59%,HDAC10;SMOX;DHPS;OAZ2;PAOX;HDAC6;SRM;ODC1;SAT2
prerank,mitochondrial translational elongation (GO:0070125),0.3550461466212788,1.36239509062184,0.038580246913580245,0.6569564388368506,1.0,48/88,32.84%,MRPL50;MRPS24;MRPL17;MRPL37;MRPL2;MRPL43;MRPS34;MRPL34;MRPL9;MRPS5;MRPL30;CHCHD1;MRPS21;MRPL13;MRPS16;MRPS18B;MRPS11;MRPS35;MRPS28;MRPS10;MRPS18A;MRPL46;MRPL11;MRPL41;MRPL27;MRPL54;MRPL38;TUFM;DAP3;MRPL47;MRPL36;MRPS25;MRPL28;MRPL21;MRPL20;MRPL49;MRPS18C;MRPL45;OXA1L;TSFM;MRPL14;MRPL32;MRPL10;MRPL19;MRPL15;MRPS17;MRPS27;AURKAIP1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.4305080164517688,1.3623077612302437,0.09040590405904059,0.6550544898456472,1.0,15/33,25.89%,ETS1;PRMT1;NCKAP1L;PITHD1;ARNT;TAL1;MAPK14;RAB7B;FES;HMGB2;STAT5B;ACVR1B;BRD1;HIF1A;STAT3
prerank,positive regulation of signaling (GO:0023056),-0.39475403141379073,-1.36172937993078,0.07177033492822966,0.5194284050378091,1.0,12/37,17.14%,GRIK2;RIMS2;CLSTN2;SYT1;SOX11;HOMER1;LGI1;CD80;INPP5F;ANXA2;SNCA;RIMS1
prerank,negative regulation of hydrolase activity (GO:0051346),0.39125677961269356,1.3617024463481393,0.0693950177935943,0.6550844680548358,1.0,11/49,13.34%,F11R;CST3;LRCH1;FICD;RASA4;ZCCHC9;EGLN1;GPATCH2;WNK1;SH2D4A;GMIP
prerank,regulation of fibroblast migration (GO:0010762),0.4782357236841138,1.3615867752004165,0.12014787430683918,0.6532816736350173,1.0,11/20,25.59%,GNA12;RAC1;RFFL;APPL1;CLN3;DDR2;THBS1;DMTN;TGFB1;APPL2;ARHGEF7
prerank,regulation of interleukin-1 beta production (GO:0032651),0.3784231151665048,1.3613093379248835,0.054365733113673806,0.6520628522006522,1.0,14/66,8.53%,CX3CR1;SIRPA;LGALS9;RIPK2;AGER;PYDC1;TLR4;CPTP;EGR1;CCL3;CASP1;NLRP3;CCR7;ORM2
prerank,gland development (GO:0048732),0.3793602846413165,1.3612877201850893,0.0686106346483705,0.6499852506102062,1.0,13/59,15.27%,TGFBR1;SALL1;PRKCSH;TG;FOXE1;NKX2-8;SHH;MET;LSR;NOTCH4;CEBPG;SOD1;PROX1
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.4661348975162316,-1.3608710973102809,0.0787746170678337,0.5198859589871014,1.0,7/19,19.58%,CIITA;VIM;WNT4;RGCC;SCX;BMP4;SUCO
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.525719834763075,-1.3599420672243845,0.135632183908046,0.5207792974554192,1.0,6/12,29.60%,NFIB;SPTBN4;EPHB2;EPHA4;CHRNB2;TSKU
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.3908920576566951,-1.3595391967025305,0.06779661016949153,0.519890570412572,1.0,9/39,7.56%,ANK2;FGF12;UTRN;YWHAE;NEDD4L;FXYD5;PTPN3;HOMER1;CHRM3
prerank,regulation of protein kinase B signaling (GO:0051896),0.3160346542062863,1.3592768654634422,0.017857142857142856,0.6552953224215662,1.0,42/193,12.81%,CX3CR1;TGFBR1;IL18;P2RY12;RAC1;DDIT3;PIK3R1;ARRB2;GAB2;IGF1R;SRC;PIK3CG;RNF41;PKHD1;CCL3;FLCN;THEM4;SPRY2;PDPK1;PIK3AP1;CD86;PDGFB;GCNT2;MET;MTDH;C1QBP;CCR7;RASD2;GPER1;CALCR;GRM2;PIK3CD;FRS2;INPP5K;PIK3CB;AXL;PDGFRB;PPP2R5B;PINK1;ENG;PDCD6;PTPN11
prerank,chloride transport (GO:0006821),-0.343873277509859,-1.3590930406101507,0.03617571059431524,0.5190834909552725,1.0,29/74,23.14%,GABRB1;GLRA1;GABRA3;GABRG3;SLC4A10;GABRG1;SLC12A8;ANO3;GABRA2;SLC12A4;GABRG2;SLC12A5;ANO6;GABRB3;SLC26A7;ANO5;GLRA2;GABRA5;SLC4A8;ANO10;CFTR;GABRQ;SLC1A1;SLC12A1;SLC6A1;SLC26A8;SLC4A1;ANO2;SLC12A3
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.540324011264121,1.359026670170637,0.11351351351351352,0.6540270810751766,1.0,5/13,15.15%,ALG12;ALG6;ALG11;ALG2;ALG8
prerank,regulation of autophagosome maturation (GO:1901096),-0.508011070806087,-1.3583503094805676,0.1271551724137931,0.5193753394503843,1.0,5/13,9.43%,TBC1D25;UVRAG;IRGM;SMCR8;RUBCN
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.4306033721737282,-1.3583473774928725,0.0855106888361045,0.5174694661611243,1.0,7/26,13.40%,YWHAE;GPR35;CALM1;CBARP;PKD2;ADRA2A;GNB5
prerank,"wound healing, spreading of cells (GO:0044319)",-0.44236445838184285,-1.3576245408421213,0.0989010989010989,0.5176661528887182,1.0,11/24,23.00%,CD44;ARHGAP35;TMEFF2;TOR1A;MMP12;CD151;ACVRL1;COL5A1;WNT7A;FLNA;DDR1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.38310465743656424,-1.3575130961686928,0.08083140877598152,0.5160480968547112,1.0,12/41,10.89%,ITPR1;GRIN2A;GRIN2B;SLC8A3;RYR3;RYR2;HTR2C;SLC24A2;HTR2B;PKD2;GRIN2D;ERO1A
prerank,regulation of glycogen metabolic process (GO:0070873),0.5480357283114619,1.357215596729003,0.10896309314586995,0.6585840046006309,1.0,5/12,19.23%,PPP1R3E;INPP5K;AKT1;KHK;PPP1R3F
prerank,endothelial cell proliferation (GO:0001935),-0.4843401057651864,-1.356607549769292,0.09307875894988067,0.5165081365799492,1.0,9/17,24.36%,ERN1;SEMA5A;ITGB1BP1;HMOX1;ACVRL1;TEK;BMP4;ANGPT4;DLG1
prerank,protein homooligomerization (GO:0051260),-0.31569922407678175,-1.355820906885215,0.024930747922437674,0.5167865668270545,1.0,29/114,15.63%,NLRC4;DISP1;HCN1;KCNC2;RYR3;B2M;EHD1;GLS;LETM1;AQP4;ATL2;TRMT61B;ALOX5AP;PKD2;SLC1A5;NINJ1;MLKL;SCARA5;ADCY8;ACOT13;AQP11;GNMT;G3BP2;SHMT1;SAMHD1;SOD2;MPP2;ALDH9A1;NACC2
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.44250820872826535,-1.3556607490123098,0.12053571428571429,0.5154191436608172,1.0,6/23,5.14%,CD74;SLIT2;DPP4;MCU;RIPOR2;DNM1L
prerank,positive regulation of interleukin-12 production (GO:0032735),0.4290056859772833,1.355625645431948,0.09880749574105621,0.662401828438465,1.0,7/31,8.25%,LGALS9;RIPK2;AGER;TLR4;PLCG2;CCR7;IL12B
prerank,regulation of chemotaxis (GO:0050920),0.437697476327493,1.3555795693606298,0.07470288624787776,0.6603719470532923,1.0,11/30,23.10%,P2RY12;AIF1;CYRIB;ZSWIM8;PDGFB;PDGFRB;STX4;PPM1F;THBS1;ZSWIM4;TGFB1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.49341524178456964,1.3539326921833559,0.10877192982456141,0.6646531067813468,1.0,5/20,3.69%,NUMB;MRAP;ABI3;PICALM;RHOQ
prerank,endocardial cushion development (GO:0003197),0.4743183810129169,1.3535111093171122,0.0852575488454707,0.6641511679465242,1.0,12/21,35.10%,HEYL;MDM4;ENG;NOG;BMP2;SOX9;ACVR1;NOTCH1;BMPR1A;HEY1;BMPR2;ISL1
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.516588580362915,1.3534879540246503,0.11858407079646018,0.65992168046898,1.0,1/14,0.06%,SLCO2B1
prerank,heme catabolic process (GO:0042167),0.516588580362915,1.3534879540246503,0.11858407079646018,0.65992168046898,1.0,1/14,0.06%,SLCO2B1
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.5101325460911745,-1.3524688814165613,0.11751662971175167,0.5223586745050629,1.0,4/14,8.09%,IRS1;SLC45A3;SIRT1;PTPN2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.47689744899762354,1.3524298926557383,0.09760589318600368,0.6617425483694295,1.0,8/21,14.29%,FOXJ2;ADAMTS1;MEF2D;MMP2;PDGFB;JUN;GJA1;LDLRAP1
prerank,peptide metabolic process (GO:0006518),-0.33935273707384317,-1.3523760808896057,0.045112781954887216,0.5207424676814617,1.0,24/75,24.71%,DMD;CPQ;NPEPPS;PCSK5;MME;SPCS2;PARL;MGAT3;TRHDE;ENPEP;ANPEP;AEBP1;GSTT1;CLN5;LNPEP;GSTP1;RHD;ABCB9;ACE;CPXM2;GSR;GSTZ1;SPCS1;GSTK1
prerank,negative regulation of receptor binding (GO:1900121),-0.5615591025176261,-1.351986439791144,0.13404255319148936,0.5199957149535787,1.0,3/10,10.26%,B2M;ATP2A2;ATP2A3
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.5624638772494792,1.3518649263334253,0.12318840579710146,0.6617495241402608,1.0,3/11,9.72%,GREM1;MEF2C;FRS2
prerank,homotypic cell-cell adhesion (GO:0034109),0.40231839354117227,1.3508332292542267,0.09075907590759076,0.6633535290126885,1.0,17/39,26.33%,P2RY12;FERMT3;PLEK;PIK3CG;MYH9;STXBP1;UBASH3B;PIK3CB;TJP2;GNAS;DSC2;MYL12A;MEGF10;MEGF11;ITGB3;FIBP;RAP2B
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.484975245678438,1.3497984034566617,0.1164021164021164,0.6649902441147569,1.0,5/20,7.27%,IL18;TLR4;LYN;CCL3;MTDH
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.31801156687852206,1.3495383020808012,0.031203566121842496,0.6637759972138358,1.0,40/172,15.59%,INPP5D;LIPH;LPCAT2;PI4KB;PLD1;PCTP;PIK3R1;LPCAT4;LPIN2;CSNK2A2;CSNK2A1;PIK3CG;PLCG2;PLA2G4A;PLD2;PIK3C3;RAB4A;PISD;DGKD;INPP4B;PLA2G4B;PLA2G5;PIK3CD;CHKB;INPP5K;PIK3CB;INPP5E;CLN3;MTMR14;PLEKHA4;MTMR4;GPD1;BMX;PTDSS2;IMPA1;PGS1;CRLS1;CDS1;PIK3R3;PITPNM1
prerank,peptidyl-serine phosphorylation (GO:0018105),0.3220834638099946,1.3484399303642252,0.02576489533011272,0.6659402177156313,1.0,48/153,19.82%,TGFBR1;TGFBR2;ULK2;CSNK1E;RPS6KA1;PRKCA;PRKACA;NEK6;CSNK2A2;CSNK2A1;ATM;MKNK1;PRKCD;CAMK1D;ULK3;RPS6KA5;PDPK1;PKN3;PDGFB;VRK3;MTOR;WNK1;GRK2;PRKCB;TAF1;PINK1;UHMK1;MAP3K10;MARK2;MORC3;LATS2;MAST3;MAPK8;DYRK1A;AKT1;DYRK4;MAPK14;STK39;AURKA;MASTL;ULK1;RPS6KA4;VRK2;ROCK2;CAMK1;CAMK1G;EIF2AK3;CSNK1G2
prerank,translational elongation (GO:0006414),0.3464190726883968,1.3478439710145833,0.03576982892690513,0.6661041712458646,1.0,54/101,32.84%,MRPL50;MRPS24;MRPL17;MRPL37;MRPL2;MRPL43;MRPS34;MRPL34;MRPL9;EEF1B2;MRPS5;MRPL30;EEF2K;CHCHD1;MRPS21;MRPL13;MRPS16;MRPS18B;MRPS11;NEMF;MRPS35;MRPS28;MRPS10;MRPS18A;MRPL46;MRPL11;MRPL41;MRPL27;MRPL54;MRPL38;TUFM;DAP3;LTN1;MRPL47;MRPL36;GTPBP1;MRPS25;MRPL28;MRPL21;MRPL20;MRPL49;MRPS18C;MRPL45;OXA1L;TSFM;MRPL14;MRPL32;MRPL10;EEFSEC;MRPL19;MRPL15;MRPS17;MRPS27;AURKAIP1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.34948484057486945,1.3477801832608336,0.05110732538330494,0.6642640346479424,1.0,27/86,22.85%,BIN1;NAV3;RAC1;BAIAP2L2;CDC42EP2;PLEK;CLU;NUMA1;PTK2B;MET;CCR7;NCKAP1L;TRPV4;WDR1;PYCARD;PROX1;TENM1;MAPRE1;FCHSD2;CDC42EP3;FES;VASP;CCL24;FCHSD1;MAPT;KATNB1;EVL
prerank,exit from mitosis (GO:0010458),-0.5290858079657423,-1.3472959658232702,0.125,0.5313760428799291,1.0,2/12,11.45%,EPS8;UBE2C
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.3577287280512584,-1.3469220487561333,0.047619047619047616,0.530542031482766,1.0,19/54,18.77%,GPC6;HS3ST5;HS3ST2;HGSNAT;EXT1;SDC3;GPC5;HS6ST2;HS3ST1;HSPG2;GPC3;PXYLP1;NDST1;B3GAT2;GPC4;EXT2;AGRN;B4GALT7;FUCA1
prerank,negative regulation of transferase activity (GO:0051348),0.4416359265896054,1.346630525005295,0.10172413793103448,0.6665071398965351,1.0,12/28,23.86%,SMAD7;EIF4A2;SRC;INPP5K;ERCC4;TERF1;ABL1;DTX3L;MAPT;PARK7;CDKN1B;TP53
prerank,T cell activation (GO:0042110),-0.3435180682029046,-1.3465172100451186,0.05275779376498801,0.5298127845444096,1.0,32/69,27.81%,CD74;CD44;DPP4;NCK2;PTPN22;IRF4;JAML;PTPN2;CD2;LFNG;ICOSLG;KIT;CTPS1;EIF2AK4;ITK;TNFRSF4;CD3E;MSN;FOXP3;CRTAM;DLL4;LCK;IL2;CD8B;CD4;RASGRP1;NLRC3;CCL19;CD276;CD8A;SLA2;SOX4
prerank,response to nutrient levels (GO:0031667),0.49786235297918746,1.3463900095413694,0.1150278293135436,0.6652455669755453,1.0,7/17,28.53%,EIF4G1;RPTOR;MTOR;ULK1;KCNB1;CD68;SCTR
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.41658262787403666,1.3463806168453996,0.10017574692442882,0.6631956780578961,1.0,13/37,19.09%,PCNA;DDB2;RFC2;RPS27A;UBC;GTF2H2;ERCC2;CUL4B;POLD2;ERCC4;RFC1;NTHL1;CUL4A
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.5471918947354799,1.3463658850892637,0.1252371916508539,0.6611586411083828,1.0,3/12,15.51%,FDXR;TSPO;FDX1
prerank,cellular transition metal ion homeostasis (GO:0046916),0.3468811415135853,1.3450386529921363,0.059113300492610835,0.6638948449959249,1.0,24/91,16.01%,SLC30A5;FRRS1;SLC30A10;SLC40A1;MT1B;MT1G;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A;ISCU;ATP6V0A2;SLC30A8;HAMP;ANKRD9;TMPRSS6;MT2A;TMEM199;COX19;SOD1;CYB561A3;CCDC22
prerank,regulation of actin filament-based process (GO:0032970),0.36216708626662975,1.34481980932037,0.04591836734693878,0.662567347481844,1.0,19/70,13.69%,F11R;TWF2;RAC1;RND1;RHOQ;RHOB;PRKCD;RHOBTB1;FSCN1;RND2;RHOH;ARHGAP17;MTOR;LRP1;MLST8;PDGFRB;HIP1R;TAOK2;ABL1
prerank,positive regulation of superoxide anion generation (GO:0032930),0.535467040039271,1.3447817259751975,0.12172284644194757,0.6606471379268395,1.0,7/13,23.52%,ITGAM;ITGB2;PRKCD;SOD1;MAPT;TGFB1;TYROBP
prerank,Golgi to lysosome transport (GO:0090160),0.5589419890096886,1.344703521708707,0.1420863309352518,0.6589077125299863,1.0,10/11,33.07%,SORT1;CLN3;RBSN;AP4M1;CCDC91;ANKFY1;GAK;EHD3;LAPTM5;AP1G1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.5483534756614712,1.344685881331687,0.143646408839779,0.6569566448441725,1.0,5/12,26.92%,TLR4;MUC6;NOD2;SOX9;TLR9
prerank,epiboly involved in wound healing (GO:0090505),-0.5053293440753972,-1.3442224549774073,0.10044642857142858,0.534268442817558,1.0,5/16,10.58%,CD44;ARHGAP35;TMEFF2;TOR1A;CD151
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.5588924094953193,-1.3432410522109237,0.14346895074946467,0.5350644334487236,1.0,4/10,13.94%,PARP14;PTPN2;PPP2R1A;INPP5F
prerank,regulation of leukocyte migration (GO:0002685),0.502456020512041,1.3424659697616432,0.11992619926199262,0.6632044721681989,1.0,4/16,10.24%,RAC1;RHOH;MIA3;NCKAP1L
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.5254632006505036,1.3424000609910618,0.14285714285714285,0.661410061972402,1.0,11/13,36.85%,SART3;PRPF31;DDX20;USP4;PRPF3;CD2BP2;SRSF10;PRPF8;LSM2;PRPF19;PRPF6
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.45954296380671233,-1.3419816238626083,0.10596026490066225,0.5367688460807409,1.0,8/20,11.02%,SLC8A3;MCU;LETM1;SLC8B1;PARL;MCUB;MICU2;MICU3
prerank,cellular response to hydroxyurea (GO:0072711),0.5752658432051049,1.3415607378895007,0.14411247803163443,0.6624847423061819,1.0,7/10,34.84%,SPIDR;BLM;NSMCE3;RTF2;DDX11;ATRX;DDI2
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.41403035119248216,1.3411292155730108,0.09137931034482759,0.6620246112691521,1.0,15/38,25.00%,ARHGEF2;CFLAR;TRADD;RFFL;BRCA1;SERPINE1;STX4;THBS1;PMAIP1;DDX3X;BCL2L1;RNF34;FADD;FAIM;MADD
prerank,calcium import into the mitochondrion (GO:0036444),-0.5622262230748052,-1.341075795498787,0.1279317697228145,0.5375034746531305,1.0,4/10,11.02%,MCU;MCUB;MICU2;MICU3
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.4599232331101966,1.3410445156749093,0.12792792792792793,0.6603659067461073,1.0,8/23,19.09%,DDB2;COPS4;RPS27A;UBC;CUL4B;GPS1;COPS6;CUL4A
prerank,synaptonemal complex organization (GO:0070193),0.5110709757573745,1.3405206723779148,0.12267657992565056,0.6582602377871183,1.0,6/15,27.17%,BAG6;STAG3;TEX12;SYCE2;SYCP2;HORMAD1
prerank,synaptonemal complex assembly (GO:0007130),0.5110709757573745,1.3405206723779148,0.12267657992565056,0.6582602377871183,1.0,6/15,27.17%,BAG6;STAG3;TEX12;SYCE2;SYCP2;HORMAD1
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.5549465257567311,-1.340097685152167,0.1350210970464135,0.5383870479634634,1.0,6/10,12.92%,GABRA3;GABRG3;GABRG1;GABRA2;GABRG2;GABRA5
prerank,C-terminal protein amino acid modification (GO:0018410),-0.5312656114565348,-1.3400608063125614,0.13793103448275862,0.5366378017439073,1.0,4/11,9.21%,AGBL4;AGBL1;TTL;ATG7
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.30180903337828147,1.3394729775036056,0.010043041606886656,0.6600629914986508,1.0,76/241,24.58%,SRRM1;SNRNP70;NCBP1;SNRPA;DDX5;POLR2H;SRRT;FUS;POLR2J;CSTF2;RBM19;HNRNPA3;SF3B1;SF3B2;MAGOHB;MAGOH;HNRNPC;SNRPC;U2AF2;POLR2D;ZMAT2;RBM14;SART3;PCBP2;SNRPF;SNRPA1;DHX9;CWC25;HNRNPH1;SNRNP48;DHX38;HNRNPR;PABPN1;SRSF5;SRRM2;CPSF1;GEMIN6;RBM8A;TRA2B;RBM17;PRPF31;LSM5;U2AF1L4;SLU7;SF3A1;FIP1L1;BUD13;ALYREF;TRA2A;POLR2E;METTL14;CCAR1;PCF11;PRPF4;PRPF3;ZCCHC8;SNRPN;SNRNP40;RBMX;LSM7;WBP4;SRSF9;HNRNPH3;SNIP1;HNRNPA2B1;DDX39B;POLR2I;HNRNPUL1;ELAVL1;DDX46;SNRNP25;LSM8;NOVA2;HNRNPA1;PNN;SYF2
prerank,gonad development (GO:0008406),0.40665488314598297,1.3394368505629435,0.10921501706484642,0.6581735500214995,1.0,7/41,8.62%,SALL1;BASP1;SOX8;WNT2B;ADAM29;FSHR;LHCGR
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.42694492890469304,-1.3392927738517784,0.08674698795180723,0.536939524530897,1.0,8/26,6.54%,ITPR1;RYR3;RYR2;HTR2C;LETM1;SLC8B1;HTR2B;PKD2
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.37842975149083524,1.3388846558342298,0.08391608391608392,0.6582769778433604,1.0,17/55,16.93%,TGFBR2;RAC1;COQ7;SIRT2;BCO2;RNF41;AATF;CBR1;DHRS4;PDGFB;BRCA1;PAX2;PDGFRB;PINK1;NOXO1;MAPK14;AGT
prerank,inositol lipid-mediated signaling (GO:0048017),0.39208080283194124,1.3384463405784113,0.08609271523178808,0.6579649959223067,1.0,13/50,11.60%,ADAP2;CSF1R;PI4KB;PLCL1;PIK3R1;GAB2;IGF1R;PIK3CG;PIK3C3;PIK3CD;PIK3CB;PDGFRB;PLCL2
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.5686249404820137,1.3363596532311108,0.1442125237191651,0.6636223563812357,1.0,4/10,17.61%,CX3CR1;SMARCD3;DRD2;KDM1A
prerank,cytoplasmic translational initiation (GO:0002183),0.4967179408104288,1.3358766434460638,0.12937062937062938,0.6634338078569628,1.0,9/17,20.58%,EIF4A2;EIF4G1;EIF2B3;EIF4H;EIF2S2;EIF3D;EIF2D;EIF5;DHX29
prerank,hemopoiesis (GO:0030097),0.3510863977308742,1.3345230118161402,0.04746835443037975,0.6662642318871536,1.0,19/87,12.07%,SELPLG;TGFBR2;CSF1R;LYL1;PLEK;FLCN;ARMC6;PDGFB;WNT2B;TNFRSF13B;ZFP36L2;WNT10B;CD34;RTKN2;PLD4;NOTCH4;MFAP5;DLL1;RUNX1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.5645766725374087,1.3343399168858634,0.14311926605504588,0.6649212883141816,1.0,4/11,16.35%,LGALS9;VSIR;RUNX1;LGALS7
prerank,mitochondrial translational termination (GO:0070126),0.34763881293078974,1.3337315841074708,0.04889589905362776,0.6650030446500902,1.0,46/88,32.84%,MRPL50;MRPS24;MRPL17;MRPL37;MRPL2;MRPL43;MRPS34;MRPL34;MRPL9;MRPS5;MRPL30;CHCHD1;MRPS21;MRPL13;MRPS16;MRPS18B;MRPS11;MRPS35;MRPS28;MRPS10;MRPS18A;MRPL46;MRPL11;MRPL41;MRPL27;MRPL54;MRPL38;DAP3;MRPL47;MRPL36;MRPS25;MRPL28;MRPL21;MRPL20;MRPL49;MRPS18C;MRPL45;OXA1L;MRPL14;MRPL32;MRPL10;MRPL19;MRPL15;MRPS17;MRPS27;AURKAIP1
prerank,regulation of protein ubiquitination (GO:0031396),0.33612287076952513,1.3336605375756836,0.04390243902439024,0.663312477778802,1.0,25/108,18.34%,TGFBR1;IVNS1ABP;SENP2;SMAD7;ARRB2;RIPK2;TBC1D7;NDFIP2;U2AF2;SPRY2;PTTG1IP;KLHL40;BRCA1;PINK1;GNL3L;AKT1;UBE3A;FANCI;USP4;XIAP;PHF23;HDAC8;ARRB1;SPOPL;STUB1
prerank,lipoprotein localization (GO:0044872),-0.5376921462989295,-1.3333952937451257,0.10300429184549356,0.5526817596733007,1.0,5/11,10.55%,PPARG;CD36;ZDHHC17;VMP1;UNC119
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3278013516408219,1.331846624495111,0.02975206611570248,0.6680242877786755,1.0,36/136,17.61%,SUMO1;SMAD7;PRMT2;HEYL;DDIT3;IRAK2;ARRB2;PYDC1;OTULIN;ITCH;PHB2;PKHD1;ID1;CTNNBIP1;EGLN1;NLRP3;MDFI;NFKBIE;COMMD6;TBX6;TAF1;HAVCR2;FZD6;CEBPG;MAP3K10;NWD1;WWP2;ID3;PYCARD;PROX1;AIM2;COMMD7;TRIB1;ARRB1;HES6;KDM1A
prerank,positive regulation of viral transcription (GO:0050434),0.443830296544791,1.3317285686485658,0.10193321616871705,0.6664638076752719,1.0,6/25,6.66%,NELFB;POLR2H;POLR2J;CDK9;POLR2D;DHX9
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.31368040506928263,-1.3310298044374587,0.04736842105263158,0.5577158890786832,1.0,31/118,15.32%,LRRC4C;PID1;PDLIM5;ADGRB3;LRRK2;ARHGAP35;PPFIA2;HECW2;HECW1;NEDD4L;PDZD8;SP100;SHANK3;PLXND1;GSK3B;CHN1;PAK3;ABI2;LFNG;BCL9L;HTATIP2;SH3D19;SRCIN1;SARM1;VASH2;EFNA5;ZDHHC15;HMOX1;PAK1;DAG1;SFRP1
prerank,regulation of macroautophagy (GO:0016241),0.3413331968767746,1.3306178922484935,0.06070287539936102,0.6686436101664875,1.0,36/105,22.92%,SCOC;EXOC7;UCHL1;ATP6V0B;PRKACA;VPS26B;ATP6V1D;LAMTOR2;ATP6V0A2;RPTOR;GAPDH;SH3GLB1;MTOR;USP36;MLST8;LAMTOR5;CLN3;RB1CC1;PINK1;ATG101;MAPK8;AKT1;RRAGA;SNX5;SNX32;ULK1;ATP6V0E2;VPS26A;VPS35;EXOC1;LARP1;SESN1;PIK3CA;SNX6;ATP6V0C;EXOC8
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.4191787077770655,-1.3305504600795544,0.09333333333333334,0.5571884885288657,1.0,8/27,13.72%,PID1;IRS1;PRKCZ;TNS2;PTPN2;GRB10;KANK1;PRKCQ
prerank,spindle assembly (GO:0051225),0.3630885380906653,1.3301291880146455,0.08482871125611746,0.6684657637571441,1.0,37/67,34.45%,KIF2A;KIF3B;CHEK2;GOLGA8B;NEK6;NUMA1;STARD9;TUBGCP5;HAUS7;ABRAXAS1;NEK7;CEP63;HAUS6;HAUS2;KASH5;MAPRE1;OFD1;WRAP73;RCC1;CSNK1D;HAUS5;ARHGEF10;SPICE1;BCCIP;HAUS8;KIFC2;MAPRE3;HAUS1;RAB11A;CLASP1;MAPRE2;STAG1;TUBGCP3;SMC1A;CEP192;TOGARAM1;TNKS
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.29811871130123335,-1.3300441131798748,0.013262599469496022,0.5568024746478292,1.0,37/161,16.13%,DAB2;CCDC88C;SHISA6;CUL3;LIMD1;HECW1;PSMD14;LATS1;APC2;RBMS3;LRP6;APOE;GSK3B;PSMD8;MLLT3;IGFBP4;PSMA2;FRZB;PSMF1;PSMD6;PRKN;TLE4;AXIN1;PSME2;SOX13;TLE1;PSMD5;PSMD12;MCC;NPHP3;IGFBP2;PSMD11;NKD1;SCYL2;SFRP1;PSMD1;SNAI2
prerank,regulation of intracellular signal transduction (GO:1902531),0.2863278757278937,1.3298563091452913,0.007832898172323759,0.6676404272929042,1.0,87/420,14.70%,SRGAP3;SRGAP2;ARHGAP5;CHN2;NUAK1;FGD2;ARHGAP22;GNA12;ARHGAP45;OPHN1;ARHGAP39;ARHGEF2;PREX1;VAV2;CAPN3;RAC1;MAP4K4;PJA2;AGER;RHNO1;CRNN;ARAP3;CHEK2;ARHGAP25;LYN;TBCK;CSNK2A2;CSNK2A1;ITGAV;AKAP5;RHOQ;RFC2;RNF41;RHOB;ATM;TRAF5;NBN;SLC15A4;PKHD1;PLCG2;FLCN;ARHGAP30;ARHGAP28;NEK8;TAF12;RHOH;RAD17;RFFL;MDM4;PDPK1;ARHGAP17;TAF6;PIP4P1;ARHGAP8;RASD2;FSHR;GRM2;POU4F1;CHD3;AKAP13;ARAF;EHMT2;AKAP12;BOP1;MTOR;PRDM1;MLST8;PRDM11;BRCA1;FBXL2;CEACAM1;FGD3;TRIO;PPP2R5B;TAF1;EXO1;RAD1;TAOK2;PIN1;GMIP;OPTN;PLK3;TAF4;ARHGAP36;PYCARD;BLM;AKT1
prerank,regulation of developmental growth (GO:0048638),-0.409582591026144,-1.3284293806453882,0.09048723897911833,0.559512011253117,1.0,9/29,11.28%,PLCB1;NRCAM;APP;CTTN;LATS1;APOE;GSK3B;FGFR3;MFSD2A
prerank,negative regulation of cilium assembly (GO:1902018),0.5416019993405632,1.32842592025038,0.14231499051233396,0.670957809055369,1.0,5/12,25.08%,TBC1D7;MAP4;TBC1D30;CEP97;CCP110
prerank,regulation of macrophage chemotaxis (GO:0010758),0.477033323289292,1.327725681823311,0.10707803992740472,0.6715468202981014,1.0,8/21,15.14%,CSF1R;MTUS1;PTK2B;AKIRIN1;DDT;IL34;CSF1;CXCL17
prerank,mitochondrial translation (GO:0032543),0.337136416338558,1.3269049584092982,0.05674846625766871,0.6727488559976966,1.0,53/104,32.84%,MRPL50;MRPS24;MRPL17;MRPL37;MRPL2;MRPL43;MRPS34;MRPL34;MRPL9;MRPS5;MRPL30;CHCHD1;MRPS21;MRPL13;MRPS16;MRPS18B;MRPS11;MRPS35;MRPS28;MTIF2;MRPS10;MRPS18A;IARS2;MRPL46;MRPL11;MRPL41;MRPL27;MRPL54;FASTKD2;MRPL38;TUFM;DAP3;MRPL47;MRPL36;MRPS25;MRPL28;MRPL21;MRPL20;GATC;NOA1;MRPL49;MRPS18C;MRPL45;OXA1L;TSFM;MRPL14;MRPL32;MRPL10;MRPL19;MRPL15;MRPS17;MRPS27;AURKAIP1
prerank,ventricular septum development (GO:0003281),0.4122987507624131,1.3264901711175334,0.09407665505226481,0.6723677245342946,1.0,5/37,1.47%,TGFBR1;SALL1;TGFBR2;SMAD7;HEYL
prerank,positive regulation of nuclear division (GO:0051785),0.44612746981529766,1.3255447225180055,0.13584905660377358,0.6739916463434062,1.0,8/25,21.24%,LRP5;SIRT2;PDGFB;EDN3;PDGFRB;AURKA;NUP62;IL1A
prerank,protein tetramerization (GO:0051262),-0.3404652226385658,-1.3249408246016634,0.05808080808080808,0.5682051385574158,1.0,16/67,15.29%,HCN1;GRIN2B;RYR3;B2M;GLS;AQP4;HOMER1;PKD2;ACOT13;GNMT;SHMT1;SAMHD1;SOD2;PKD1;ALDH9A1;SNCA
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.48897846067996714,1.3247551302969403,0.11003861003861004,0.6750156638732362,1.0,7/18,23.10%,SMAD3;FSCN1;RUNX1;DDR2;IER3IP1;BMP2;TGFB1
prerank,regulation of protein processing (GO:0070613),-0.44250053193071226,-1.3244823073311132,0.10120481927710843,0.5675065434394455,1.0,3/21,1.42%,LRRK2;NLRC4;CCBE1
prerank,regulation of ion transmembrane transport (GO:0034765),-0.3884396992253871,-1.324323146602958,0.08411214953271028,0.5660488501714472,1.0,6/33,8.83%,AKAP6;KCNJ3;YWHAE;NEDD4L;CHRM3;ANO6
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.47402596464391467,1.3242826260122578,0.1200750469043152,0.6750220754563699,1.0,4/19,7.25%,CX3CR1;PYDC1;CPTP;NLRP3
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.38618168631958977,1.324190701887578,0.09947643979057591,0.6734059959551492,1.0,23/47,23.86%,ITGAM;TGFBR2;TLR4;ITGB2;RNF41;PRKCD;PLCG2;CBR1;DHRS4;PDGFB;PDGFRB;SOD1;MAPK14;RAB27A;SLC5A3;AGT;THBS1;MAPT;ZC3H12A;ACOD1;TGFB1;TYROBP;TP53
prerank,macrophage activation (GO:0042116),0.4190357594974732,1.3236074813771501,0.11716171617161716,0.6737503406835778,1.0,10/34,8.15%,ITGAM;AIF1;AGER;SBNO2;TLR4;ITGB2;PLCG2;CLU;C1QA;EDN2
prerank,regulation of tau-protein kinase activity (GO:1902947),0.5709124561179726,1.3235078570467798,0.13949275362318841,0.6722076296640995,1.0,2/10,4.13%,EGR1;CLU
prerank,focal adhesion assembly (GO:0048041),-0.4429994926421527,-1.323373459744473,0.12688172043010754,0.5670523889906129,1.0,9/21,22.45%,SORBS1;CTTN;TRIP6;THSD1;ACTN2;THY1;RCC2;PTPRK;PEAK1
prerank,response to lipopolysaccharide (GO:0032496),0.32419727209299043,1.3233720910097595,0.057488653555219364,0.6708811510622583,1.0,42/138,22.03%,CX3CR1;SIRPA;MEF2C;LGALS9;SBNO2;TLR4;OTUD5;CASP1;SLPI;CTR9;CD86;NLRP3;SELE;NOS2;PDCD1LG2;SELP;CXCL1;TAB2;TICAM2;PABPN1;AXL;CD180;SERPINE1;CCR5;MAPK8;PYCARD;TNIP2;MAPK14;TRIB1;SCARB1;SLC11A1;HMGB2;TICAM1;NOD2;NOS1;ADAM17;GGT5;IL1A;ZC3H12A;ACOD1;SHPK;CXCL10
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.31991382666296525,1.3226957332178144,0.047400611620795105,0.6716264318714161,1.0,29/149,11.15%,CX3CR1;IL18;ARHGEF2;CAPN3;CFLAR;LGALS9;IRAK2;RIPK2;AGER;CRNN;TLR4;TRIM5;TRAF5;CLU;RPS27A;UBC;TRADD;RPS6KA5;DHX9;NLRP3;MTDH;EDA2R;TAB2;FLOT2;RTKN2;RNF31;RNF25;LAMTOR5;PRKCB
prerank,pre-miRNA processing (GO:0031054),-0.5016742657426886,-1.3226247168605543,0.13733905579399142,0.5673933954158573,1.0,9/14,37.45%,AGO4;TUT4;DROSHA;LIN28B;ADAR;AGO2;TARBP2;PRKRA;MRPL44
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.3921800943043678,-1.3224653355346292,0.0761904761904762,0.5659506562406179,1.0,7/34,5.23%,PDE4B;ANK2;PDE4D;ADRA1A;RYR2;ATP2A2;CALM1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.44240078416686496,-1.3217695280316812,0.11136890951276102,0.5661461587554473,1.0,11/23,32.51%,PFKFB1;HDAC4;SIK1;TIGAR;CBFA2T3;C1QTNF3;CRY1;NCOR1;PPARA;C1QTNF12;GCK
prerank,thymus development (GO:0048538),0.5210533478945043,1.321590820879669,0.1569767441860465,0.6738011252112226,1.0,3/13,6.86%,TGFBR1;FOXE1;SHH
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.4800888107936369,1.321545354700358,0.1512455516014235,0.6720752728226702,1.0,10/20,17.83%,NUMB;MRAP;ABI3;PICALM;RHOQ;CSK;PKDCC;PPP2R5A;MRAP2;TMEM59
prerank,positive regulation of dendrite development (GO:1900006),-0.543207242104305,-1.3212867174755902,0.13215859030837004,0.565675147219696,1.0,2/10,13.00%,ALK;ZDHHC15
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.48033332119323213,-1.3205227750730202,0.13986013986013987,0.56609867870302,1.0,2/16,1.62%,DPYD;DPYSL5
prerank,negative regulation of viral life cycle (GO:1903901),-0.49373940933147886,-1.3204121932501454,0.13742071881606766,0.5645084377788228,1.0,8/15,16.09%,GSN;CIITA;MID2;IFITM3;PPIA;LY6E;IFITM2;IFITM1
prerank,neuronal action potential (GO:0019228),-0.4451437898529908,-1.3200431751249897,0.12875536480686695,0.5637354242088838,1.0,10/22,23.89%,ANK3;SCN2A;KCNMB2;SCN3A;KCNMB4;SCN9A;KCNMB3;CACNA1G;SCN1A;KCNA1
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.4791405505525145,1.3197545308336645,0.13296903460837886,0.6767657286816569,1.0,7/19,20.61%,F11R;PRKACA;TJP1;RUNX1;ROCK2;EPHA2;PRKCH
prerank,development of primary male sexual characteristics (GO:0046546),0.4119739467473351,1.3189307848005896,0.11188811188811189,0.6779101804793785,1.0,6/34,8.62%,LHFPL2;SOX8;WNT2B;ADAM29;FSHR;LHCGR
prerank,positive regulation of embryonic development (GO:0040019),-0.4543255757357404,-1.3187237539276953,0.13675213675213677,0.56572549061599,1.0,7/19,19.90%,PLCB1;B4GALT5;WNT4;TENM4;SCX;NIBAN2;NR2C2
prerank,heart looping (GO:0001947),0.3971218897076227,1.3177135971562026,0.09363957597173145,0.6807014438476395,1.0,11/39,17.51%,TGFBR2;MEF2C;SHH;SOX17;DLL1;TBX6;ENG;NDRG4;CCDC40;SMO;VANGL2
prerank,action potential (GO:0001508),-0.36871239333259215,-1.3175501244857213,0.10426540284360189,0.5673174758070934,1.0,7/44,5.85%,KCND2;DMD;ANK3;AKAP6;SCN2A;KCNMB2;SCN3A
prerank,diterpenoid metabolic process (GO:0016101),-0.35277827144139906,-1.3168977974296514,0.0916030534351145,0.5673511750356705,1.0,25/55,32.49%,GPC6;SDC3;GPC5;APOE;NAPEPLD;HSPG2;GPC3;RDH10;RBP4;ALDH3A2;ABCA4;GPC4;AGRN;RDH12;RBP1;GPC1;RARRES2;SDC2;LRP2;AKR1C1;OPN1MW;APOA2;RBP2;LRAT;STRA6
prerank,protein catabolic process (GO:0030163),0.37053150073760055,1.3164825347497477,0.09152542372881356,0.683446265404749,1.0,10/59,11.23%,BAG6;CTSD;CAPN3;CHEK2;RNF41;SOCS6;PPT1;CUL4B;MTOR;CEACAM1
prerank,regulation of interferon-beta production (GO:0032648),0.380022756318698,1.3161235451822422,0.09421487603305785,0.6829189489947513,1.0,11/46,14.63%,TLR7;SIRPA;POLR3G;RNF216;RIPK2;TLR4;DHX9;PTPN11;RELB;MAVS;PYCARD
prerank,negative regulation of phosphorylation (GO:0042326),-0.32357800273226306,-1.3158392331225022,0.06443298969072164,0.5685045311213868,1.0,23/85,15.76%,PID1;LRRK2;XDH;STAP1;SLIT2;LRP6;PFKFB1;NTRK3;PPIA;CADM4;SH3GL2;HDAC4;PRKN;SIRT1;MYADM;TIGAR;PAQR3;CDKN2A;PTPN13;CDKN1A;CBFA2T3;PRR5L;PLPP3
prerank,atrioventricular valve morphogenesis (GO:0003181),0.472519919510465,1.315636736868655,0.13761467889908258,0.6829007268756377,1.0,3/19,6.10%,TGFBR2;HEYL;MDM4
prerank,regulation of cartilage development (GO:0061035),-0.46403191185376463,-1.3150594178006758,0.13777777777777778,0.5689031704875315,1.0,3/18,3.64%,TRPS1;ZBTB16;SOX5
prerank,positive regulation of interleukin-8 production (GO:0032757),0.3808906936962591,1.314524061824879,0.11734693877551021,0.6852412981422519,1.0,11/49,14.63%,TLR7;DDIT3;LGALS9;TLR4;AFAP1L2;NOS2;RAB1A;LAMTOR5;SERPINE1;MAVS;PYCARD
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.45603531825644605,1.3143241259930403,0.14285714285714285,0.6840169474544067,1.0,6/22,7.30%,DDB2;RPS27A;UBC;GTF2H2;ERCC2;CUL4B
prerank,7-methylguanosine mRNA capping (GO:0006370),0.41227784686740176,1.3142006751827526,0.11336717428087986,0.6807674428480559,1.0,7/31,7.26%,NCBP1;POLR2H;POLR2J;GTF2H2;POLR2D;ERCC2;RNMT
prerank,7-methylguanosine RNA capping (GO:0009452),0.41227784686740176,1.3142006751827526,0.11336717428087986,0.6807674428480559,1.0,7/31,7.26%,NCBP1;POLR2H;POLR2J;GTF2H2;POLR2D;ERCC2;RNMT
prerank,tRNA transport (GO:0051031),0.4069853119651567,1.3133158693550042,0.10839160839160839,0.6821119430587018,1.0,13/35,17.82%,TOMM20L;XPOT;RANBP2;SSB;NUP42;SEC13;NUP50;NUP35;NUP88;TOMM20;NUP62;SEH1L;NUP107
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.3221094623711941,-1.3129386483152439,0.049586776859504134,0.5734408631928685,1.0,41/85,30.89%,GRM7;PCDH15;ROR1;RIPOR2;USP53;NDUFB9;BIRC5;DCDC2;MYO3B;SPTBN4;CCDC50;TPRN;CLRN1;PAX3;LHFPL4;LHFPL3;KCNQ1;COL1A1;TIMM10;SNAI2;TSPEAR;EPS8L2;PIEZO2;LOXHD1;SLC26A4;PDZD7;TMIE;COL4A3;LRP2;LHFPL5;CHRNB2;TIMM9;TBX1;TFAP2A;COL2A1;ESPNL;PJVK;ATP6V1B1;MYO1A;OTOS;GRXCR1
prerank,sensory perception of sound (GO:0007605),-0.3215588344747418,-1.3121964573618143,0.0546448087431694,0.5737718319592414,1.0,43/88,30.89%,GRM7;PCDH15;ROR1;RIPOR2;USP53;NDUFB9;BIRC5;DCDC2;MYO3B;SPTBN4;CCDC50;TPRN;CLRN1;PAX3;KIT;LHFPL4;LHFPL3;KCNQ1;COL1A1;TIMM10;SNAI2;TSPEAR;EPS8L2;TMC1;LOXHD1;SLC26A4;PDZD7;TMIE;MKKS;COL4A3;LRP2;LHFPL5;CHRNB2;TIMM9;TBX1;TFAP2A;COL2A1;ESPNL;PJVK;ATP6V1B1;MYO1A;OTOS;GRXCR1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.4381318779079978,1.3117283422122876,0.1134020618556701,0.6861110049512076,1.0,6/26,8.92%,IRAK2;RIPK2;ITCH;RPS27A;UBC;TAB2
prerank,positive regulation of glial cell differentiation (GO:0045687),0.4878439459234276,1.3104901441590033,0.14849624060150377,0.6889737798486384,1.0,4/17,13.51%,BIN1;EGR2;SERPINE2;IL34
prerank,placenta development (GO:0001890),-0.5191331032491969,-1.3102113630885337,0.16411378555798686,0.5778718857588832,1.0,8/12,33.91%,PPARG;CUL7;E2F7;PLAC1;PTK2;ADAM19;CITED1;E2F8
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.40527414421827446,1.3102069211993022,0.12136752136752137,0.6881581511497127,1.0,6/36,8.04%,BAG6;OPHN1;FHIT;UCHL5;USP25;KLHL40
prerank,regulation of ruffle assembly (GO:1900027),-0.4310688937677931,-1.3101639202748427,0.11818181818181818,0.5761570398387367,1.0,5/23,10.32%,NLGN1;EPS8;STAP1;FAM98A;KANK1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.516140430261216,1.310098845247129,0.15584415584415584,0.6867183136856199,1.0,7/14,20.70%,PSENEN;CLN3;PSEN2;DYRK1A;ADAM10;APH1B;ADAM17
prerank,cell-matrix adhesion (GO:0007160),-0.3125006769580308,-1.309945612861012,0.045454545454545456,0.5750389719749096,1.0,35/95,20.73%,SORBS1;ITGA4;LYVE1;CD44;MKLN1;PPFIA2;CTTN;SIGLEC1;ITGB7;FN1;ITGAL;TRIP6;THSD1;COL13A1;ACTN2;VCAM1;ITGB1BP1;ITGA8;ITGB6;THY1;PKD1;ITGBL1;TIAM1;ANGPTL3;RCC2;ITGA11;PARVG;ITGB1;TNN;CD96;ADAMTS12;CD63;ITGA10;TSC1;PTPRK
prerank,sensory perception of pain (GO:0019233),-0.4387351595329182,-1.308655728149502,0.12560386473429952,0.5769242071672128,1.0,7/21,17.09%,CCR2;MME;OPRM1;NIPSNAP1;CHRNA4;PTGES;SCN9A
prerank,regulation of autophagy (GO:0010506),0.30201445515986747,1.3085278854220928,0.043478260869565216,0.6906488938898325,1.0,73/216,23.43%,EXOC7;PIM2;DDIT3;UCHL1;ATP6V0B;SIRT2;PRKACA;VPS26B;TRIM5;CPTP;GFAP;CSNK2A2;ATM;FLCN;EIF4G1;ATP6V1D;FOXK2;MET;MTDH;LAMTOR2;ATP6V0A2;RPTOR;TAB2;ACER2;DRAM2;GAPDH;SH3GLB1;PIK3CB;MTOR;USP36;MLST8;LAMTOR5;WDR24;FBXL2;RASIP1;BMF;TPCN1;RB1CC1;PINK1;MTMR4;KDM4A;ATG101;IL10RA;OPTN;ABL1;MAPK8;AKT1;RRAGA;VDAC1;SNX5;GPR137;SNX32;ULK1;ATP6V0E2;CTSA;TMEM59;KAT5;TICAM1;VPS29;HTRA2;DCAF12;VPS26A;VPS35;EXOC1;WDR6;MAPT;ZC3H12A;SNX6;ATP6V0C;EIF4G2;EXOC8;RMC1;DEPDC5
prerank,lipoprotein transport (GO:0042953),-0.5451912245770878,-1.3078977236275704,0.13247863247863248,0.5773996768524201,1.0,5/10,10.55%,PPARG;CD36;ZDHHC17;VMP1;UNC119
prerank,response to hydroxyurea (GO:0072710),0.5410631669248877,1.307426954940957,0.18230088495575222,0.692939591713907,1.0,7/11,34.84%,SPIDR;BLM;NSMCE3;RTF2;DDX11;ATRX;DDI2
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.350431297440123,1.3071107440871246,0.0845771144278607,0.6921820087503668,1.0,20/72,19.09%,POLR2H;PCNA;POLR2J;RFC2;COPS4;RPS27A;UBC;GTF2H2;POLR2D;ERCC2;CUL4B;HMGN1;LIG1;POLD2;ERCC4;GPS1;COPS6;POLR2E;RFC1;CUL4A
prerank,positive regulation of T cell proliferation (GO:0042102),0.37288040668711125,1.3066484504154299,0.09411764705882353,0.6920041794064004,1.0,12/55,10.24%,IL18;CCDC88B;AIF1;AGER;EBI3;TNFRSF13C;IL6ST;CD86;PNP;PDCD1LG2;IL12B;NCKAP1L
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.35492138917741634,-1.3064364122645895,0.0979381443298969,0.5798399490528918,1.0,11/48,13.66%,ROBO1;PPARG;STAP1;SLIT2;PARP14;NLRP2B;PTPN2;PELI3;TTLL12;SAMHD1;OAS3
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.541065716459405,-1.3063530230383809,0.16705882352941176,0.5782301830539852,1.0,5/11,21.74%,DAB2;MTMR2;PRKN;MSN;EZR
prerank,P-body assembly (GO:0033962),-0.5204772684632621,-1.305244387168764,0.152,0.5798806235737592,1.0,9/12,39.95%,LIMD1;LSM3;ATXN2;PATL1;DYNC1H1;LSM4;EIF4ENIF1;PATL2;EDC3
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.48341279357706113,-1.3048747470451578,0.14163090128755365,0.5792330031572105,1.0,4/15,6.44%,NLGN1;SYN3;ADRA1A;CNTNAP4
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.42151195459519464,1.3042537406917873,0.12571428571428572,0.6990215465183591,1.0,8/29,12.65%,SSH2;TWF2;CYRIB;PRKCD;SSH1;TJP1;PLEKHH2;HIP1R
prerank,artery morphogenesis (GO:0048844),0.41892531047900927,1.3036868823464327,0.13250883392226148,0.6992805633862579,1.0,7/30,15.62%,TGFBR1;SMAD7;HPGD;LRP1;PDGFRB;ENG;NOG
prerank,response to calcium ion (GO:0051592),-0.3130969253624727,-1.3025476911367517,0.055401662049861494,0.584025407038256,1.0,39/102,24.15%,NLGN1;IQGAP1;SYT1;RYR3;RYR2;KCNMB2;KCNH1;CARF;SYT10;CALM1;HOMER1;ALOX5AP;PKD2;CPNE8;CPNE4;RASGRP2;SLC25A24;TRPC3;ADCY8;KCNMB4;CHP2;KCNIP2;CRHBP;SYT3;SLC25A12;TRPV6;HPCA;CPNE2;ITPR3;ALOX15;CPNE6;BRAF;KCNMB3;NEUROD2;PRKAA1;PPIF;SYT5;CASQ2;KCNMB1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.43236844094511456,1.302216288360803,0.14186851211072665,0.7029332952011973,1.0,14/26,25.89%,VSIR;AGER;PICALM;LYN;PSENEN;PYCARD;AIM2;APH1B;ROCK2;USP50;EFNA1;EFNA3;MEFV;STAT3
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4062062518615076,-1.3016222366363488,0.1336405529953917,0.5849967992857336,1.0,8/28,13.72%,PID1;IRS1;PRKCZ;TNS2;PTPN2;GRB10;KANK1;PRKCQ
prerank,intermediate filament organization (GO:0045109),0.4744321547454097,1.300953887345934,0.16342412451361868,0.7057660879533115,1.0,3/17,5.00%,DSP;GFAP;KLHL24
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.34985230130175,1.2991445224233744,0.08666666666666667,0.7108115946367204,1.0,16/72,13.33%,IL18;PIK3R1;LYN;IGF1R;SRC;PIK3CG;PIK3AP1;PDGFB;SELP;GPER1;FSHR;PIK3CD;PIK3CB;PDGFRB;HCST;SEMA4D
prerank,protein heterotetramerization (GO:0051290),-0.49681716996460806,-1.299024466421439,0.16952789699570817,0.5909018290002735,1.0,6/13,26.67%,GRIN2B;PKD2;PKD1;CBR4;KRT10;CPSF7
prerank,CENP-A containing chromatin organization (GO:0061641),-0.39741562377915834,-1.2989119465453203,0.12641083521444696,0.5876334384802044,1.0,9/29,16.87%,KNL1;CENPT;CENPP;MIS18BP1;CENPW;RBBP7;NASP;NPM1;CENPS
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.39741562377915834,-1.2989119465453203,0.12641083521444696,0.5876334384802044,1.0,9/29,16.87%,KNL1;CENPT;CENPP;MIS18BP1;CENPW;RBBP7;NASP;NPM1;CENPS
prerank,ganglioside metabolic process (GO:0001573),0.4525439429140457,1.2987490890175948,0.14576271186440679,0.710443778869077,1.0,5/20,11.65%,HEXB;ST3GAL5;HEXA;NEU3;B4GALNT1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.5253431378910269,1.2984165669579373,0.16785714285714284,0.7098698757557247,1.0,6/13,30.67%,CYRIB;IL12B;NECTIN2;FADD;IL12RB1;STX7
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.34733586659497223,1.2980454710827247,0.08771929824561403,0.709413305141073,1.0,24/72,22.36%,NAV3;SSH2;ARHGEF2;FGF13;TWF2;CYRIB;PRKCD;CLU;CAMSAP1;SSH1;CAMSAP2;CLIP3;PLEKHH2;HIP1R;DYRK1A;CIB1;MAPRE1;ATXN7;CHADL;VBP1;SSH3;TTBK2;KATNB1;PIK3CA
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.5056174925371821,-1.297948203346029,0.14099783080260303,0.5887230119158876,1.0,5/12,19.63%,CD74;FOXP1;KLF4;OAS3;MAP2K5
prerank,regulation of mononuclear cell migration (GO:0071675),0.44270672366462627,1.297001787550034,0.1362126245847176,0.7115933514496945,1.0,8/23,19.13%,CSF1R;AIF1;LYN;AKIRIN1;IL34;CSF1;CXCL17;THBS1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.43772005531614167,1.2966601895857046,0.13982300884955753,0.7110262111522802,1.0,6/24,11.36%,PCNA;RFC2;RPS27A;UBC;LIG1;POLD2
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.38497950311556006,1.296557214803808,0.10416666666666667,0.7095831160009023,1.0,13/43,14.70%,IL18;AIF1;FOXJ2;ADAMTS1;MEF2D;MMP2;PDGFB;IL6R;JUN;PDGFRB;GJA1;LDLRAP1;AKT1
prerank,protein alkylation (GO:0008213),0.447234426493337,1.2963615414753937,0.12937062937062938,0.7084159152765511,1.0,6/22,9.48%,FAM98B;PRMT2;ETF1;EEF2KMT;PRMT8;PRMT1
prerank,positive regulation of tissue remodeling (GO:0034105),0.5460322353420575,1.29620248096273,0.15934065934065933,0.7071627679329148,1.0,3/10,18.02%,IL18;IL12B;ROCK2
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.4910205952543319,-1.2957629647790014,0.1425438596491228,0.5936127483196098,1.0,5/13,9.04%,GRIK2;SHISA9;SHISA6;SLC4A10;RAB3A
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.40900740674254366,-1.2956171953720115,0.14084507042253522,0.5922554681761096,1.0,8/29,11.28%,SORBS1;LDLR;CREBL2;ZBTB20;APOE;SLC45A3;ELOVL5;MFSD2A
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.4961903134226463,-1.2954833030185409,0.16556291390728478,0.5908947627483846,1.0,6/14,14.87%,CD74;LILRB1;CAMK4;SIRT1;KIT;SEMA7A
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.4806912617100416,-1.2950474773309997,0.15898617511520738,0.5904134809368218,1.0,7/15,14.73%,KCNN2;KCNJ3;YWHAE;KCND3;ATP1A1;KCNQ1;KCNIP2
prerank,phosphatidylinositol metabolic process (GO:0046488),0.3260143334387921,1.2948876117195347,0.0713128038897893,0.7101667684046489,1.0,27/109,15.59%,INPP5D;CSF1R;MTMR10;PI4KB;PIK3R1;PLEK;PIK3CG;PLCG2;PLA2G4A;PIK3C3;RAB4A;PIP4P1;INPP4B;PLA2G5;PIK3CD;INPP5K;PIK3CB;INPP5E;MTMR14;PDGFRB;PLEKHA4;MTMR4;BMX;IMPA1;CDS1;PIK3R3;PITPNM1
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.4664833924054963,-1.2948873463195403,0.13695652173913042,0.5890954732750541,1.0,6/16,16.51%,FGF10;PTPN22;SOX11;IKZF3;AHR;TNFSF9
prerank,positive regulation of lyase activity (GO:0051349),0.5007272921105324,1.294810087043829,0.16666666666666666,0.7086621322475499,1.0,7/14,22.68%,AKAP5;ISCU;NOS2;ORAI1;CACNA1D;NOS1;PARK7
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.4545383802177257,1.2937342989457914,0.14606741573033707,0.7108132639908394,1.0,7/21,17.78%,RASAL3;CYRIB;ARHGAP25;SPRY2;CD2AP;SYNGAP1;LZTR1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.4311786539611574,1.2936850608927286,0.13532513181019332,0.7092418157018242,1.0,10/26,25.86%,SPTLC3;NOS2;ACER3;ACER2;ASAH1;AKT1;NQO1;NOS1;SPR;ASAH2
prerank,regulation of viral transcription (GO:0046782),0.3942267114016238,1.2930267704351903,0.11578947368421053,0.7098198488614192,1.0,8/39,6.66%,NELFB;POLR2H;UBP1;TRIM11;POLR2J;CDK9;POLR2D;DHX9
prerank,mRNA processing (GO:0006397),0.28607868123805175,1.2921359677380773,0.027359781121751026,0.7113311742009351,1.0,78/287,22.16%,SRRM1;SNRNP70;SON;NCBP1;SNRPA;DDX5;POLR2H;SRRT;FUS;PRKACA;AKAP8L;POLR2J;CSTF2;RBM19;HNRNPA3;SF3B1;SF3B2;MAGOHB;MAGOH;GTF2H2;HNRNPC;SNRPC;U2AF2;POLR2D;ZMAT2;RBM14;SART3;PCBP2;SNRPF;SNRPA1;DHX9;ERCC2;CWC25;HNRNPH1;SNRNP48;RNMT;DHX38;HNRNPR;PABPN1;SRSF5;SRRM2;CPSF1;GEMIN6;RBM8A;TRA2B;RBM17;PRPF31;LSM5;U2AF1L4;SLU7;SF3A1;FIP1L1;BUD13;ALYREF;TRA2A;ALKBH5;POLR2E;METTL14;CCAR1;PCF11;PRPF4;PRPF3;ZCCHC8;SNRPN;SNRNP40;RBMX;GEMIN2;THOC6;LSM7;WBP4;SRSF9;HNRNPH3;SNIP1;HNRNPA2B1;DDX39B;POLR2I;HNRNPUL1;ELAVL1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.4222584500179093,-1.2915470940056362,0.13617021276595745,0.597573722220521,1.0,6/22,11.62%,APOE;PTPN3;SNX9;ADRA2A;TIMP3;SH3D19
prerank,genitalia development (GO:0048806),0.5190051836214897,1.2907725906846599,0.18164794007490637,0.7146923062068555,1.0,4/12,12.81%,CHD7;SHH;LHCGR;PTPN11
prerank,protein autoubiquitination (GO:0051865),0.35751598374745797,1.2904840990008655,0.09407665505226481,0.7139657537411879,1.0,18/61,18.34%,ITCH;DDB2;RNF41;KLHL24;RNF141;ASB4;RNF8;BFAR;BRCA1;UHRF2;RNF187;WWP2;UBE3A;RNF11;DTX3L;UBE2A;RNF4;STUB1
prerank,regulation of protein localization (GO:0032880),0.3578346169936189,1.2903285951194001,0.1024793388429752,0.7126832557720754,1.0,16/58,19.78%,CTSD;SUMO1;CSNK1E;MMD;USP8;PICALM;TRIM5;PLEKHM2;ZDHHC7;MAPK8;VIP;KDM1A;CAMK1;PPM1F;ATCAY;VPS4A
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.3842480673272804,1.2896015660339255,0.1343804537521815,0.7136884958384705,1.0,9/43,12.17%,TMEM119;LRP5;MEF2C;NPNT;CTNNBIP1;IL6ST;IL6R;WNT7B;DDR2
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.40370360615484413,-1.289491854481726,0.12643678160919541,0.6020814731493445,1.0,8/25,15.71%,B3GALT1;NDST4;FUT9;EXT1;NDST1;B3GALT2;CSGALNACT2;EXT2
prerank,homeostasis of number of cells (GO:0048872),0.5227231223047342,1.2884811425552978,0.1646586345381526,0.7161190389798108,1.0,2/12,5.03%,CX3CR1;LRRC19
prerank,dendrite morphogenesis (GO:0048813),-0.3779206548056759,-1.2880667639066565,0.1325581395348837,0.604674292068543,1.0,8/35,10.34%,CTNND2;CTNNA2;MAP2;SHANK3;CDC42;PAK3;DCDC2;PHACTR1
prerank,zinc ion transport (GO:0006829),0.4459260778235743,1.287188971005868,0.14389799635701275,0.7191337280485125,1.0,5/21,12.74%,SLC30A5;SLC30A10;TRPM2;SLC30A8;SLC39A2
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.48094916539056565,1.2870921316342447,0.13246268656716417,0.717698647507436,1.0,5/17,8.25%,IL18;BACH2;TLR4;EBI3;IL12B
prerank,negative regulation of protein localization to membrane (GO:1905476),0.4405720459344902,1.2867138236277538,0.15358361774744028,0.7174571192889099,1.0,5/24,3.69%,NUMB;MRAP;ABI3;PICALM;RHOQ
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.5350578993133712,-1.2866973170982077,0.17832957110609482,0.6073003110011548,1.0,5/10,9.42%,RAPGEF2;GIPC1;ATP7A;ZEB2;MFSD12
prerank,microtubule-based transport (GO:0099111),-0.5122703020901396,-1.2863226057394868,0.15157894736842106,0.6066648247439066,1.0,7/12,32.27%,HTT;DYNC1I2;SPA17;SPEF2;DYNC1I1;DNAAF4;ROPN1L
prerank,monocyte differentiation (GO:0030224),0.5468301014329519,1.286304502097355,0.14512922465208747,0.7172774737242484,1.0,4/10,10.83%,CSF1R;MYH9;MT1G;PDE1B
prerank,regulation of viral entry into host cell (GO:0046596),-0.393176438845942,-1.285967737811428,0.10185185185185185,0.6059733776170959,1.0,6/30,4.65%,CD74;HS3ST5;GSN;CIITA;MID2;IFITM3
prerank,insulin secretion (GO:0030073),-0.44582347680621814,-1.2850356336135813,0.1415525114155251,0.6069390917413084,1.0,3/19,3.87%,RIMS2;PTPRN2;SNX19
prerank,regulation of signal transduction (GO:0009966),-0.2794093036865974,-1.284243152617543,0.03754266211604096,0.6075683503577998,1.0,53/190,19.60%,MDFIC;PLCB1;LRRK2;GRK5;CD36;SLC8A3;NCK2;APP;FRMPD1;SHARPIN;SEMA5A;RASGRP4;SP100;PPIA;KCTD8;HOMER1;IGFBP4;DOK5;NCAM1;SIRT1;AXIN1;DCDC2;ZDHHC17;RGS20;PTPN2;ERBB3;LFNG;ITGB1BP1;INTU;PPP2R1A;LIFR;RGS6;DTNBP1;IGFBP2;CD80;IFT81;YJEFN3;CX3CL1;UGCG;TMEM108;NUCKS1;CD46;CDC42SE2;TSPEAR;CD3E;VEPH1;FOXP3;IGFBP7;RGS3;USP33;SNW1;CD63;SOCS2
prerank,potassium ion transmembrane transport (GO:0071805),-0.29473038677730484,-1.2841033289844173,0.04843304843304843,0.6061981763067971,1.0,23/135,8.27%,KCND2;KCNT2;KCNB2;KCNK10;KCNN2;HCN1;KCNC2;KCNQ5;KCNJ3;NALCN;KCNH1;SLC24A2;KCND3;KCNA6;KCNQ3;SLC12A8;KCNH7;KCNAB2;SLC12A4;PKD2;ATP1B3;KCNH5;SLC12A5
prerank,negative regulation of secretion (GO:0051048),-0.5382111106902775,-1.2840924280496864,0.16968325791855204,0.6044650154529304,1.0,8/10,37.92%,CD74;ERBB3;SPX;NRG1;VAMP3;PTGER3;VAMP8;EGF
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.49814194561909153,-1.2830328047798278,0.1609442060085837,0.6058582384366649,1.0,2/12,5.23%,PDE4D;CALM1
prerank,organelle assembly (GO:0070925),0.27773619566556745,1.2826205953713212,0.02316076294277929,0.7294730057500721,1.0,135/384,27.45%,HPS4;ASAP1;EXOC7;CAPN3;ULK2;BIN2;RILPL1;KIF3B;FLII;BBS9;GOLGA8B;ATG9A;ATG14;EHD4;NEK6;TTLL3;CEP162;PKHD1;ATXN2L;UBXN10;HYLS1;RP2;ATP6V1D;EIF2S1;EIF2A;STARD9;TUBGCP5;CEP164;PIK3C3;STX12;RBM14;DYNLT2B;MIS12;HAUS7;CFAP52;TTC36;NME8;AVIL;CFAP221;RAB1A;CD34;MKS1;G3BP1;NUDCD3;INPP5E;CCDC28B;GALNT11;IFT52;BBS2;CDC14B;RB1CC1;AUP1;KIF27;BSCL2;ATAT1;IFT20;WDR90;ATG101;NEK7;POGZ;CEP63;VPS37D;HAUS6;HAUS2;GABARAPL1;KASH5;CFAP20;PDE6D;VPS37A;RAB32;ATG9B;CDS1;TCTN1;KIF3A;VPS36;ARL3;MAPRE1;UBXN2A;ULK1;PTPN23;CCDC66;NUP62;ATG5;EXOC6;OFD1;CHMP1A;B9D1;CPLANE2;DBNL;SSX2IP;TMEM17;IST1;VPS37B;TP53INP2;CHMP2A;VPS4A;PACS2;EXOC1;RCC1;DHX29;RAB8B;MAPT;HGS;TSG101;DDX3X;TTBK2;CSNK1D;ARF4;PDCD6IP;EXOC8;TRAPPC6A;SH3PXD2B;PLA2G3;ACTR2;KLHL41;TRAPPC14;EXOC4;DYNLL1;DYNC2H1;IFT122;PGM5;HDAC6;TCTN2;IFT140;YTHDF3;GORASP2;VTA1;CC2D2A;HAUS5;WDR45B;ANLN;ATG2A;RAB23;GBF1;HPS1
prerank,carboxylic acid transmembrane transport (GO:1905039),0.38207445864794876,1.2822204338860232,0.11009174311926606,0.7291088292485235,1.0,19/40,26.83%,SLC7A8;SLC7A5;SLC36A1;SLC16A7;SLC38A10;SLC25A11;SLC38A1;SLC25A14;SLC23A2;SLC23A1;SLC19A1;SLC25A10;SLC38A7;SLC25A21;SLC38A11;SLC38A6;ABCC5;SLC7A7;SLC16A1
prerank,negative regulation of growth (GO:0045926),0.31833072595983863,1.2819963719390368,0.08333333333333333,0.7281062552502464,1.0,28/121,14.85%,SMAD3;PPP1R9B;CCDC85B;OSGIN2;AGTR2;FLCN;MT1B;MT1G;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A;SIPA1;NDUFS3;PPT1;APBB2;SOX17;MT2A;NME6;PRDM11;SMARCA2;OSGIN1;GJA1;TSPYL2;NDUFA13;DACT3
prerank,positive regulation of protein binding (GO:0032092),-0.34184135856163966,-1.2818945169125988,0.09976798143851508,0.6075954382593298,1.0,18/56,19.57%,LRRK2;BDNF;APP;B2M;RAPGEF2;MARK3;APOE;GSK3B;HIPK2;RAN;PRKN;EPB41;PKD1;TIAM1;ADD2;BMP4;USP33;TERT
prerank,RNA splicing (GO:0008380),0.3271655950328458,1.281702593058574,0.09355828220858896,0.7274992429112255,1.0,30/95,23.25%,IVNS1ABP;SRRM1;NCBP1;PPP1R9B;FUS;SF3B1;SF3B2;MAGOHB;MAGOH;HNRNPC;SNRPF;SNRPA1;SNRNP48;RBM8A;TRA2B;TARDBP;LUC7L3;SLU7;PRPF4;PRPF3;SCNM1;SNRPN;SNRNP40;GEMIN2;WBP4;HNRNPH3;DDX39B;DDX47;MPHOSPH10;SNRNP25
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.47395192264220254,1.2811994725600673,0.1721170395869191,0.7276546602276215,1.0,4/16,18.81%,CLDN11;CLDN12;CLDN10;CLDN1
prerank,sulfation (GO:0051923),-0.5188590292615589,-1.2811621656188779,0.15768463073852296,0.6080855112626764,1.0,2/11,2.06%,HS3ST5;UST
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.4430360567059479,1.2810466806083092,0.145985401459854,0.7264535408252651,1.0,9/22,23.38%,NFE2L2;ENC1;PSMB3;PSMA7;PSME4;PSMB9;PSMB5;PSMB7;PSMB8
prerank,mRNA export from nucleus (GO:0006406),0.32542111788791667,1.2792335501556833,0.07919254658385093,0.7314986618398485,1.0,39/102,27.64%,SRRM1;NCBP1;RANBP2;MAGOHB;MAGOH;U2AF2;POLR2D;NUP42;SEC13;DHX38;NUP50;PABPN1;SRSF5;CPSF1;NUP35;RBM8A;NUP88;U2AF1L4;SLU7;FIP1L1;ALYREF;ALKBH5;NUP62;SEH1L;NUP107;THOC6;SRSF9;DDX19B;HNRNPA2B1;DDX39B;NUP153;PCID2;NUP188;IWS1;NDC1;THOC3;ZC3H11A;THOC5;ENY2
prerank,DNA repair (GO:0006281),0.28407055999997605,1.2789550432276373,0.02510460251046025,0.7307653137821635,1.0,77/284,20.56%,HERC2;SUMO1;CSNK1E;RHNO1;PCNA;EID3;CHEK2;MTA1;RAD51AP2;PRIMPOL;HPF1;DDB2;FAM111A;RFC2;ATM;NBN;REXO4;WDR48;MPG;RPS27A;UBC;GTF2H2;RAD17;FANCM;POLN;RAD51B;MGMT;ERCC2;SLX4;CUL4B;INTS3;FAAP24;EYA3;RNF8;LIG1;MMS19;SMARCA5;BRCA1;FANCG;TNKS1BP1;APTX;POLD2;KMT5C;DCLRE1B;KDM4A;EXO1;BAZ1B;ERCC4;RAD1;UBE2U;UBE2V2;ABRAXAS1;DCLRE1C;PRMT6;ABL1;SETD2;RPAIN;MAPK8;BLM;CIB1;FANCI;PSME4;ALKBH5;NEIL2;DTX3L;NABP1;UBE2A;KAT5;FANCA;FBH1;BABAM1;DCLRE1A;RAD9A;PWWP3A;FAAP100;UBE2T;PARP4
prerank,protein localization to cell-cell junction (GO:0150105),0.49690743242588,1.2783781593932493,0.19618055555555555,0.7310821106970214,1.0,5/15,14.60%,F11R;DSP;LSR;TJP1;TJP2
prerank,embryonic skeletal system development (GO:0048706),-0.3743106941321464,-1.2781249924011289,0.1223529411764706,0.6156097038135643,1.0,10/35,15.65%,HOXC4;SULF2;PCSK5;HOXC9;SOX11;HOXB3;RBP4;COL1A1;WNT9A;HOXB4
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.45648903953935643,1.2778909530254277,0.17148014440433212,0.7310789718657379,1.0,6/20,14.27%,TMEM35A;CLU;PSMG1;HSPA4;NDUFAF1;BBS12
prerank,fluid transport (GO:0042044),-0.5053090757566943,-1.2774543678039134,0.1830065359477124,0.615791305734395,1.0,4/12,31.60%,AQP4;AQP11;AQP1;SLC4A11
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.4648681550161209,1.2773616017319291,0.1408199643493761,0.7312802304536954,1.0,8/19,22.39%,CSF1R;CAMK1D;AKIRIN1;IL34;CSF1;CXCL17;THBS1;MPP1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.3252703779780739,1.2769019957307495,0.06924315619967794,0.731153805684211,1.0,41/113,24.86%,ASAP1;SUMO1;CDC42EP2;TLR4;DDB2;PLEK;SRC;ATM;CLU;EIF4G1;FSCN1;GTF2H2;SPIDR;MTLN;ERCC2;CUL4B;SH3GLB1;RASIP1;BMF;ERCC4;GNL3L;TERF1;PSMC2;TAL1;MED25;GBP5;STUB1;CUL4A;SLF2;PIEZO1;USP50;DDX3X;RPA3;PARK7;TGFB1;MYD88;BCL2L11;TP53;BRK1;RHOC;AJUBA
prerank,protein homotetramerization (GO:0051289),-0.34609869387821784,-1.2766474827691048,0.12560386473429952,0.6164690498386021,1.0,12/49,15.24%,HCN1;RYR3;B2M;GLS;AQP4;PKD2;ACOT13;GNMT;SHMT1;SAMHD1;SOD2;ALDH9A1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.44107100009738537,1.2766404393763127,0.15970961887477314,0.7303564876666134,1.0,10/22,25.96%,IL18;SLC7A5;IL12B;LY9;OSM;NOD2;SLAMF6;TGFB1;MYD88;CARD9
prerank,cilium assembly (GO:0060271),0.28491139744773936,1.2765862019298493,0.044630404463040445,0.7288197103679745,1.0,74/296,18.98%,ASAP1;EXOC7;SDCCAG8;TUBA4A;CSNK1E;RILPL1;KIF3B;BBS9;PRKACA;EHD4;TTLL3;CEP162;ODF2;PKHD1;UBXN10;HYLS1;RP2;ATP6V1D;TUBB;CEP164;TUBG1;DYNLT2B;CFAP74;LRGUK;JHY;HAUS7;CFAP52;TTC36;NME8;AVIL;CFAP221;RAB1A;TNPO1;MKS1;CFAP46;NUDCD3;INPP5E;CNTRL;CCDC28B;GALNT11;IFT52;BBS2;CDC14B;KIF27;ATAT1;TUBA1A;IFT20;WDR90;CEP63;CEP57;HAUS6;CCDC40;HAUS2;CFAP20;PDE6D;SFI1;TCTN1;TTC21B;KIF3A;ARL3;MAPRE1;CEP135;RSPH9;ACTR1A;PTPN23;CCDC66;VANGL2;EXOC6;OFD1;B9D1;CPLANE2;SSX2IP;TMEM17;CEP43
prerank,L-amino acid transport (GO:0015807),0.4135082709512078,1.2763763525003458,0.14583333333333334,0.7280317021403094,1.0,5/28,7.21%,SLC7A8;SLC1A3;SLC7A5;SLC36A1;ARL6IP5
prerank,axoneme assembly (GO:0035082),0.40846958454081106,1.2759244831035808,0.14359861591695502,0.7279506525887799,1.0,9/30,16.63%,DRC1;TTLL3;CFAP74;LRGUK;JHY;CFAP46;TTC12;CCDC40;RSPH9
prerank,defense response to protozoan (GO:0042832),-0.4922502873631071,-1.2756787021186817,0.17713004484304934,0.6176744762743627,1.0,5/12,12.02%,CD40;PF4;IRF4;GBP4;GBP2
prerank,dendritic spine morphogenesis (GO:0060997),-0.4721099986745649,-1.2747467253808982,0.16666666666666666,0.6187164720357535,1.0,4/15,6.93%,CTNND2;SHANK3;CDC42;PAK3
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5080624872500294,1.2745970340984891,0.1801125703564728,0.7313778568505835,1.0,6/13,23.52%,IL18;IL12B;AXL;TICAM1;ZBTB1;TYROBP
prerank,negative regulation of GTPase activity (GO:0034260),0.43487318666452957,1.2741795471679305,0.14954954954954955,0.7312505653114514,1.0,6/22,13.34%,F11R;LRCH1;FICD;RASA4;WNK1;GMIP
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.4036751792802569,-1.273767218605292,0.1310344827586207,0.62009484745816,1.0,6/26,8.82%,ANK2;YWHAE;NEDD4L;NETO1;ATP1B3;ACTN2
prerank,positive regulation of immunoglobulin production (GO:0002639),0.41047630463314755,1.273651414489171,0.12283737024221453,0.7314113986600825,1.0,7/31,13.15%,SASH3;DNAJB9;PHB2;CD86;KMT5C;SHLD2;STX4
prerank,double-strand break repair (GO:0006302),0.3054301198189691,1.273493903646045,0.07174887892376682,0.730264967609958,1.0,45/158,19.83%,ZFYVE26;HERC2;SUMO1;IFFO1;CHEK2;MTA1;RAD51AP2;HPF1;ATM;NBN;RNF138;SPIDR;RAD54B;POLN;RAD51B;SWSAP1;SLX4;EYA3;RNF8;SMARCA5;BRCA1;MORF4L1;TNKS1BP1;APTX;DCLRE1B;KDM4A;BAZ1B;ERCC4;UBE2V2;ABRAXAS1;DCLRE1C;MAPK8;BLM;CIB1;DTX3L;AP5Z1;NABP1;KAT5;HMGB2;FBH1;BABAM1;DCLRE1A;PALB2;XRCC6;KDM2A
prerank,regulation of immune response (GO:0050776),-0.2901507230843081,-1.2734568335914702,0.04519774011299435,0.6193244787022394,1.0,53/135,27.05%,ITGA4;CLEC2D;LILRB1;RSAD2;PTPN22;B2M;CD40;DENND1B;ITGB7;FOXP1;CD226;ITGAL;SLAMF7;IRF4;CD300LF;JAML;CD300LD;VCAM1;SPN;FCGR2B;AHR;KLRD1;SAMHD1;COL1A1;CD300E;CD300LG;IFITM1;NPDC1;CD3E;CD200R1;ITGB1;KLRK1;TREML4;FOXP3;IRF7;CD96;FCRLB;CD300C;SELL;CD247;CRTAM;ICAM1;CD3D;CD19;RIPK3;CD8B;IRF1;CD22;CD276;PLSCR1;CD8A;KLRC1;SLA2
prerank,regulation of cytoskeleton organization (GO:0051493),0.32017456939701694,1.2733645286624151,0.06614173228346457,0.7289916239418123,1.0,25/108,13.69%,F11R;TWF2;RAC1;RND1;RHOQ;RHOB;PRKCD;RHOBTB1;FSCN1;TRIM36;PHLDB1;RND2;RHOH;ARHGAP17;TJP1;MTOR;LRP1;MLST8;CLN3;PDGFRB;HIP1R;TAOK2;MARK2;SORBS3;ABL1
prerank,positive regulation of chemotaxis (GO:0050921),0.38215437669678876,1.273150162253364,0.14144736842105263,0.7281416946537563,1.0,11/43,13.15%,SMOC2;P2RY12;AIF1;LGMN;PDGFB;MET;EDN3;EDN2;IL6R;PDGFRB;STX4
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4101281155406784,1.2728888814516666,0.16022099447513813,0.7274896097924811,1.0,9/29,23.77%,LDLRAD4;SMAD7;SPRY2;OVOL2;HPN;GATA3;EFNA1;SPRED2;ADIPOR1
prerank,protein ubiquitination (GO:0016567),0.2729417430871216,1.27228583405931,0.014844804318488529,0.7280322454196595,1.0,108/471,17.93%,HERC2;FBXL18;NFE2L2;RNF38;KLHL7;TRIM69;ARRB2;PJA2;FBXO22;SMURF1;PCNA;OTULIN;ITCH;TRIM11;VHL;TRIM5;FBXL20;DDB2;SPSB1;FBXL15;FBXO24;RNF41;UNKL;PEX10;TRIM36;ENC1;KLHL24;RPS27A;UBC;UBE2H;RNF138;CTR9;HLTF;RNF141;TRIM44;ZSWIM8;FBXW4;SPSB2;TRIM72;ARRDC1;AKTIP;CDC34;CUL4B;DTX4;ASB4;HECTD2;ANKRD9;OS9;ASB11;CRBN;RNF8;RNF103;PSMD3;RNF31;MSL2;KBTBD8;BFAR;RNF20;ASB5;RNF25;MYLIP;DTX1;AREL1;RNF166;FBXL8;BRCA1;FBXL2;MIB2;PSMB3;USP5;WSB1;TAF1;UHRF2;PINK1;TRIM62;UBE2U;UBE2V2;PSMA7;RNF187;ZNRF3;WWP2;KLHL18;PSMC1;FBXO21;PSMC2;UBE3A;RRAGA;RNF7;MKRN3;FBXL22;RNF144B;DTX3;PSME4;CCDC22;FBXO11;RNF11;ANAPC11;PSMB9;DTX3L;DET1;PELI2;UBE2A;ARRB1;UBE4A;RNF4;TNFAIP1;LZTR1;TRIM47
prerank,determination of heart left/right asymmetry (GO:0061371),0.37643829598796086,1.2722769316719345,0.12413793103448276,0.7263731946027683,1.0,11/42,17.51%,TGFBR2;MEF2C;SHH;SOX17;DLL1;TBX6;ENG;NDRG4;CCDC40;SMO;VANGL2
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.36965960153935074,1.270891096276743,0.12054329371816638,0.7298730577087383,1.0,13/46,16.06%,DDIT3;PLCL1;PCTP;TLR4;LAMA4;FLCN;TFE3;ID1;WNT10B;ABHD6;PLCL2;NRDC;ACVR2B
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.4148967571631936,-1.2704941216671741,0.1360381861575179,0.6268310090602747,1.0,8/23,13.83%,PPARG;JAK2;PARP14;PTPN2;IRGM;IFNGR1;PIAS1;TXK
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.34620212013980994,1.2702564315347888,0.11258278145695365,0.7305724666023202,1.0,12/69,7.31%,NCBP1;POLR2H;SRRT;POLR2J;CDK9;INTS11;TAF8;POLR2D;ELL2;TAF6;RPAP2;INTS3
prerank,primary miRNA processing (GO:0031053),0.5342283799241306,1.2698848347211313,0.17343173431734318,0.7301636419319014,1.0,2/10,2.57%,SMAD3;SRRT
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.3392916833174638,-1.2695101113900153,0.12531328320802004,0.6280688831321615,1.0,20/59,18.68%,ROBO1;TENM3;KIRREL3;PTPRT;CNTN6;EMB;NPTN;PALLD;CDH4;NECTIN1;PLXNB2;CDH13;SDK1;OBSL1;CDH1;PECAM1;PKD1;ITGB1;BSG;PCDHB6
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.3775818727684502,1.2695049140922614,0.1127946127946128,0.7299904096514936,1.0,14/42,18.96%,KARS1;AARS2;CARS2;NARS1;SARS1;SARS2;RARS1;FARSA;IARS1;DARS2;EPRS1;QARS1;WARS2;IARS2
prerank,positive regulation of filopodium assembly (GO:0051491),-0.41129514939690415,-1.2693179379951507,0.14908256880733944,0.6268980720542946,1.0,6/24,5.76%,NLGN1;GPM6A;TENM2;PALM;RIPOR2;CDC42
prerank,axonemal dynein complex assembly (GO:0070286),-0.4039412737157784,-1.269174308257669,0.15207373271889402,0.6255259329387636,1.0,14/27,22.28%,ODAD2;DNAH8;DNAI4;DNAAF5;DNAI3;ODAD3;SPAG1;DNAH17;DNAAF3;DNAAF1;CCDC65;CCDC39;DNAL1;CFAP100
prerank,cellular response to amino acid starvation (GO:0034198),0.34452270248353717,1.2691271545493357,0.11038961038961038,0.7297355320355077,1.0,21/71,17.54%,ATP6V0B;FLCN;ATP6V1D;IMPACT;EIF2S1;LAMTOR2;TCIRG1;SEC13;RPTOR;SH3GLB1;MTOR;MLST8;LAMTOR5;WDR24;GCN1;MAPK8;RRAGA;ATP6V0E2;EIF2AK2;SEH1L;CASTOR1
prerank,mRNA metabolic process (GO:0016071),0.32951078548764756,1.2690392996778934,0.08293460925039872,0.7284102189519452,1.0,26/90,21.20%,SON;NCBP1;DDX5;PRKACA;AKAP8L;SSB;DXO;SF3B2;U2AF2;DIS3L2;PCBP2;SNRPF;ZFP36L2;NANOS2;HNRNPR;SRSF5;LSM5;SF3A1;ALKBH5;RIDA;PCF11;PRPF3;NUDT16;GEMIN2;SRSF9;HNRNPA2B1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.5303804367503364,1.268830308488537,0.19378427787934185,0.7274801548736841,1.0,5/11,10.11%,MEF2C;LGALS9;LYN;PIK3CD;PIK3CB
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.3798053369698612,-1.2686569031115356,0.1308641975308642,0.6253084900778122,1.0,4/32,4.29%,PID1;APP;PFKFB1;ZBTB20
prerank,"transcription, DNA-templated (GO:0006351)",0.2960882540591099,1.2685899030874985,0.04888888888888889,0.7267882500231067,1.0,39/207,12.95%,IVNS1ABP;POLR3G;RREB1;GTF3C2;NCBP1;ARRB2;DDX5;NELFB;POLR2H;TTF2;POLR2J;CDK9;DEAF1;NKX2-8;GTF2H2;CTR9;TAF12;POLR2D;GTF3A;TAF6;ERCC2;THAP1;RNMT;BRF1;BRF2;PAX1;PKNOX1;MBD1;POLR3H;MMS19;MEF2A;SMARCA5;DTX1;SMN1;NFYA;TAF1;HSF2BP;GTF3C6;MED4
prerank,actin filament organization (GO:0007015),0.3082531691397433,1.2683143264864722,0.06431852986217458,0.7261368272560327,1.0,38/151,16.53%,ELMO1;ARHGEF2;MYO1B;RAC1;BAIAP2L2;MYO1F;AIF1;RND1;FLII;PPP1R9B;DBN1;CDC42EP2;ARHGAP25;MYO1E;PPP1R9A;RHOB;RHOBTB1;RND2;MARCKS;RHOH;ARHGAP17;MYO7A;MPRIP;TLE6;AVIL;SHROOM2;FHOD1;SPIRE1;ERMN;MYO5B;HIP1R;TRPV4;KASH5;MYO15A;PROX1;CD2AP;MARCKSL1;WASL
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.44462809649552304,-1.2679397310921618,0.14498933901918976,0.6257581392245698,1.0,7/18,13.91%,MCU;DNM1L;DDHD1;PRKN;FIS1;MFF;RALBP1
prerank,melanocyte differentiation (GO:0030318),0.5231424785914496,1.267139690110248,0.21755027422303475,0.728899943741649,1.0,2/11,1.74%,LRMDA;MEF2C
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.40271546988398477,1.2671354414010334,0.1556350626118068,0.7272754826810183,1.0,11/30,18.10%,SMAD3;SMAD7;LTBP4;NREP;EID2;BCL9;ENG;LATS2;FST;XIAP;DKK3
prerank,icosanoid secretion (GO:0032309),0.5201751201716055,1.2663056511061892,0.18972332015810275,0.7285885965368459,1.0,5/12,18.00%,NOS2;PLA2G5;NMUR2;DRD2;BDKRB2
prerank,embryonic appendage morphogenesis (GO:0035113),0.5114371940621691,1.266175696714551,0.17297297297297298,0.727397734002621,1.0,3/12,6.86%,SKI;FBXW4;SHH
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.37740674868876223,1.265772646307562,0.13703703703703704,0.7272807443615366,1.0,14/41,23.42%,DAGLB;PTGS1;ALOXE3;PLA2G4A;PLA2G4B;FADS1;GPX4;SCD5;PTGR1;SCD;DAGLA;ACOT8;SCP2;ABCD1
prerank,regulation of protein sumoylation (GO:0033233),0.47271723345916616,1.2656176226795273,0.18666666666666668,0.7261879405537842,1.0,7/17,16.38%,CAPN3;UBA2;EGR1;RASD2;GNL3L;PIAS3;ZMIZ1
prerank,translesion synthesis (GO:0019985),0.3775123176359966,1.2655785674575275,0.1474820143884892,0.7247140280893685,1.0,16/42,24.85%,PCNA;PRIMPOL;RFC2;RPS27A;UBC;POLN;UFD1;POLD2;PCLAF;POLDIP2;RFC1;RPA3;ZBTB1;SPRTN;POLD4;NPLOC4
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.4354551065641905,-1.265263994971411,0.16346153846153846,0.6320824173860802,1.0,5/21,8.99%,STAP1;RPS3;FOXP1;CD226;TESPA1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.3287263041587408,-1.265202375331343,0.08121827411167512,0.630502857663732,1.0,23/66,19.75%,PLCB1;EGFR;FGF10;KMT2E;ANKRD17;CCND2;UBE2E2;PKD2;KIF14;CDC73;PSME2;E2F7;KLF4;RGCC;DCUN1D3;CDKN2A;CDKN1A;PKD1;MYO16;RBL1;E2F1;CDK4;TFDP1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3409739254912318,1.2648849908642514,0.11869918699186992,0.725681237457973,1.0,16/77,14.77%,CX3CR1;TGFBR1;ITGA6;CFLAR;CSNK2A2;CSNK2A1;ITGAV;SRC;CLU;NDUFS3;ZMYND11;RTKN2;PINK1;TMBIM6;AKT1;NDUFA13
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.38448528932828663,1.264701735950407,0.12207357859531773,0.72471135272804,1.0,13/39,20.07%,MAML3;TSPAN14;BMP2K;SRC;IL6ST;JAG2;NOTCH4;MAML2;DLL1;PDCD10;ZMIZ1;NEPRO;NOD2
prerank,zinc ion transmembrane transport (GO:0071577),0.4341749550558951,1.264556934664144,0.1853211009174312,0.723659043153962,1.0,5/22,12.74%,SLC30A5;SLC30A10;TRPM2;SLC30A8;SLC39A2
prerank,synaptic vesicle cycle (GO:0099504),-0.38594135499060384,-1.2644975311534967,0.1313364055299539,0.6310382256464068,1.0,11/30,20.69%,NLGN1;SYT10;PCLO;CPLX2;SNAP25;SYNDIG1;RAB3A;SNCA;RIMS1;RAB5A;WNT7A
prerank,mesenchyme development (GO:0060485),0.4804361084701979,1.2642248514267713,0.15384615384615385,0.7233218796132109,1.0,1/15,0.06%,TGFBR1
prerank,mesonephros development (GO:0001823),-0.5102038075174206,-1.2640605201825768,0.17857142857142858,0.6306412736205861,1.0,2/11,1.81%,ZBTB16;FGF10
prerank,fatty acid oxidation (GO:0019395),0.3637938788351797,1.2638251967260787,0.1273031825795645,0.7231861568390445,1.0,18/57,23.77%,ABCD2;ACAD10;PPARD;ECHS1;MTLN;PHYH;ACADM;HAO1;CROT;ECI1;ECHDC2;HADHB;HSD17B10;ACAA2;HACL1;SCP2;ABCD1;ADIPOR1
prerank,response to amino acid starvation (GO:1990928),0.34282885163818244,1.263488046204303,0.11783960720130933,0.7228515202000478,1.0,26/72,23.43%,ATP6V0B;FLCN;ATP6V1D;IMPACT;EIF2S1;LAMTOR2;TCIRG1;SEC13;RPTOR;SH3GLB1;MTOR;MLST8;LAMTOR5;WDR24;GCN1;MAPK8;RRAGA;ATP6V0E2;EIF2AK2;SEH1L;CASTOR1;EIF2AK3;LARP1;SESN1;ATP6V0C;DEPDC5
prerank,pinocytosis (GO:0006907),0.5263220178107079,1.2633355109050277,0.1978021978021978,0.7218148114394743,1.0,6/10,26.16%,PPT1;RAB34;PYCARD;SNX5;DOCK2;SNX33
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.3953439323593959,-1.2630710974977177,0.13734939759036144,0.6321530726655034,1.0,4/25,1.66%,RIT2;LRRK2;ITPR1;HTT
prerank,negative regulation of ossification (GO:0030279),0.43303574157575003,1.2629766103823188,0.14492753623188406,0.7215320517838166,1.0,6/23,5.98%,GREM1;MEF2C;TRPM4;CCL3;PTK2B;BCOR
prerank,superoxide anion generation (GO:0042554),-0.48791432612424634,-1.262938973843863,0.18105263157894738,0.6307517612147188,1.0,5/13,20.91%,CYBB;NCF2;CYBA;TAFA4;NOX4
prerank,sulfur compound transport (GO:0072348),-0.39828106213994363,-1.2627110928029812,0.15991471215351813,0.6297531525747526,1.0,11/27,22.32%,SLC25A30;SLC35F3;SLC25A19;RACGAP1;MGST1;SLC26A7;SLC5A6;SLC6A6;SLC26A8;SLC19A2;SLC26A4
prerank,tryptophan catabolic process (GO:0006569),-0.5027876193786418,-1.262442986898353,0.18144329896907216,0.6287626271132024,1.0,3/11,20.17%,KMO;IDO2;KYAT1
prerank,cellular response to hydrogen peroxide (GO:0070301),0.39121517568754377,1.262392045622752,0.15412186379928317,0.7220928883318394,1.0,11/33,19.03%,SIRPA;NFE2L2;RHOB;PRKCD;TRPM2;IMPACT;PAX2;ABL1;MAPK7;ANKZF1;ECT2
prerank,cell cycle checkpoint signaling (GO:0000075),-0.49802418544597704,-1.2622777671966332,0.1900647948164147,0.627528680885966,1.0,4/12,10.35%,ZW10;PLK2;BUB1B;BUB1
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.4893735515533557,1.2621762683503184,0.18673647469458987,0.7212691380784536,1.0,3/15,7.25%,SMOC2;LGMN;MET
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.38408873864125115,-1.2618149125592761,0.12559241706161137,0.6272600548813109,1.0,10/32,12.39%,RIMS2;LRRK2;SYN1;MCTP2;GSK3B;CPLX2;RIMS4;MCTP1;KCNMB4;DTNBP1
prerank,response to leucine (GO:0043201),0.53332682717714,1.2617964278632308,0.20388349514563106,0.719538402637052,1.0,7/10,38.87%,RPTOR;MTOR;SESN1;UBR2;SESN2;SESN3;LARS1
prerank,cellular response to leucine (GO:0071233),0.53332682717714,1.2617964278632308,0.20388349514563106,0.719538402637052,1.0,7/10,38.87%,RPTOR;MTOR;SESN1;UBR2;SESN2;SESN3;LARS1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.4762538071608835,-1.261340612746813,0.17057569296375266,0.6269459957699988,1.0,4/14,7.72%,HTT;PKIA;RAPGEF2;SIRT1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.538585322011802,1.261317025290639,0.19962335216572505,0.7196164228071622,1.0,7/10,29.51%,IVD;ACADM;ETFDH;ETFA;ETFB;ACADVL;ACAD11
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.45677238455019464,1.2606269768990708,0.18714555765595464,0.7206833019769422,1.0,3/18,4.13%,GSAP;PICALM;CLU
prerank,cellular response to organonitrogen compound (GO:0071417),-0.3020904837125359,-1.26036368813667,0.0707070707070707,0.6283196766732991,1.0,38/99,23.91%,AKAP6;CTNNA1;HCN1;GABRB1;SLIT2;HRH1;RYR3;RAPGEF2;CPEB3;GLRA1;RRAGB;GOLPH3;PKD2;GABRG2;ACTB;GABRB3;P2RY1;AHR;GLRA2;CDH1;KCNQ1;PDE2A;HCN2;CRHBP;TSHR;SFRP1;CFTR;NR1H4;LAMTOR3;CPEB4;SLC26A3;EZR;AQP1;HCN4;SLC5A5;CTNNB1;FOLR1;WT1
prerank,adipose tissue development (GO:0060612),0.536911263523907,1.2602127629900146,0.1889908256880734,0.7206184564950969,1.0,2/11,1.99%,LRP5;SOX8
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.3523827200058165,1.2600235514436111,0.1212624584717608,0.7198107541569639,1.0,14/63,10.24%,SASH3;IL18;CCDC88B;MEF2C;AIF1;TNFSF13B;TNFRSF13C;IL6ST;CD86;CD320;PNP;PDCD1LG2;IL12B;NCKAP1L
prerank,snRNA transcription (GO:0009301),0.34054398706409994,1.2600016853339786,0.12091503267973856,0.7183313939951802,1.0,12/70,7.31%,NCBP1;POLR2H;SRRT;POLR2J;CDK9;INTS11;TAF8;POLR2D;ELL2;TAF6;RPAP2;INTS3
prerank,regulation of DNA recombination at telomere (GO:0072695),0.44998812827091966,1.259769135808876,0.18888888888888888,0.7161168185052967,1.0,7/19,21.63%,POLR2H;POLR2J;POLR2D;TERF1;POLR2E;ACD;POLR2I
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.44998812827091966,1.259769135808876,0.18888888888888888,0.7161168185052967,1.0,7/19,21.63%,POLR2H;POLR2J;POLR2D;TERF1;POLR2E;ACD;POLR2I
prerank,excitatory postsynaptic potential (GO:0060079),-0.43455545079387015,-1.2590931160238485,0.17555555555555555,0.6304580421918206,1.0,6/19,8.77%,GRID2;LRRK2;GRIN2A;GRIN2B;GSK3B;GRIN2D
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.3840645177625941,1.2590853336573877,0.12935323383084577,0.7170059476372653,1.0,8/39,10.11%,PI4KB;PIK3R1;TMEM150A;PIK3CG;PIK3C3;SOCS6;PIK3CD;PIK3CB
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.4847750330307186,1.2587360657752082,0.17647058823529413,0.7167325004379931,1.0,6/14,23.79%,DNAJB9;FICD;BFAR;PTPN1;TMEM33;BCL2L11
prerank,indolalkylamine catabolic process (GO:0046218),-0.5170654276954506,-1.25860693942624,0.18126272912423624,0.6301921818344065,1.0,3/10,20.17%,KMO;IDO2;KYAT1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.4742739329219724,-1.2585170658576337,0.1704781704781705,0.6287758219853955,1.0,3/14,3.66%,USP15;ANKRD17;DDX60
prerank,protein destabilization (GO:0031648),-0.382434567281906,-1.2584253240361802,0.14055299539170507,0.6273644661301753,1.0,9/32,8.17%,CCDC88C;HTT;GSN;CUL3;CDC73;PRKN;BTRC;SIRT1;IRGM
prerank,pore complex assembly (GO:0046931),-0.4365066761658457,-1.2582887154634919,0.18140589569160998,0.6261272500163705,1.0,5/19,10.85%,AFDN;NUP98;RTN4;ANO6;NUP205
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.5212725236194182,1.2582159382854146,0.20146520146520147,0.715636196177823,1.0,3/10,9.00%,PRKCD;PLA2G6;SMPD2
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.5212725236194182,1.2582159382854146,0.20146520146520147,0.715636196177823,1.0,3/10,9.00%,PRKCD;PLA2G6;SMPD2
prerank,muscle cell differentiation (GO:0042692),-0.38213708830002846,-1.2579164576761614,0.14390243902439023,0.6256047520936686,1.0,5/32,7.83%,SGCZ;DMD;NEBL;SYNE1;NINJ1
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5346072228088304,-1.2566529279009302,0.21380846325167038,0.6278335715336834,1.0,5/10,25.98%,ZC3H8;BMP4;GLI3;IRF1;CTLA4
prerank,response to cAMP (GO:0051591),-0.366931407706472,-1.2564837246587555,0.11848341232227488,0.6267015647630263,1.0,17/37,25.09%,AKAP6;HCN1;RAPGEF2;PKD2;AHR;KCNQ1;PDE2A;HCN2;CRHBP;CFTR;SLC26A3;EZR;AQP1;HCN4;SLC5A5;WT1;HCN3
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.4206289145305363,-1.2563943493784002,0.18973214285714285,0.6253498083821672,1.0,5/22,4.62%,SORBS1;PPARG;CREBL2;ZBTB20;APOE
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.5121001512287664,-1.2559502238009923,0.2053941908713693,0.6250776923838737,1.0,6/11,38.24%,SIK1;C1QTNF3;CRY1;C1QTNF12;GCK;PGP
prerank,cellular response to alcohol (GO:0097306),-0.35937706852048934,-1.2557225289647462,0.14386792452830188,0.6241132065073915,1.0,15/42,15.51%,CTNNA1;ADCY2;LRP6;GLRA1;KLF9;GOLPH3;ADCY5;ADCY3;ADCY8;GNAI1;AHR;GLRA2;CDH1;SFRP1;CFTR
prerank,organelle disassembly (GO:1903008),0.3929261011139728,1.255608270338702,0.1438721136767318,0.7234382296507418,1.0,12/33,18.38%,ULK2;PLK5;PELO;RB1CC1;KLC1;PLK3;RETREG1;UBA5;ULK1;EIF2D;MTIF2;STX5
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.4128827522767529,1.2555820857847602,0.1590909090909091,0.721993630166257,1.0,9/26,22.27%,NAV3;RAC1;NUMA1;MET;TRPV4;MAPRE1;FES;MAPT;KATNB1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.46590458418293096,1.2553318866938126,0.17562724014336917,0.7214584773404005,1.0,6/17,21.79%,LIPC;LMF1;SORT1;APOH;NR1H2;FURIN
prerank,brain morphogenesis (GO:0048854),-0.49833852895766906,-1.255302323496398,0.20869565217391303,0.6237350352446414,1.0,3/12,5.39%,CTNNA2;SHANK3;VPS51
prerank,nuclear membrane organization (GO:0071763),0.4508397679303635,1.255109541183903,0.17615658362989323,0.7207695576821108,1.0,8/19,19.78%,AKAP8L;GPER1;NEMP1;TOR1AIP1;TARDBP;UBXN2A;CHMP2A;VPS4A
prerank,base conversion or substitution editing (GO:0016553),-0.5011126022257495,-1.254827190859627,0.2059447983014862,0.6236675353735992,1.0,6/11,32.61%,ADARB2;ADAR;AICDA;APOBEC2;ADAD1;APOBEC1
prerank,response to interleukin-6 (GO:0070741),0.5332721556451939,1.2543990862786716,0.17898832684824903,0.7218804816675983,1.0,3/10,2.43%,ST3GAL6;SELPLG;SBNO2
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.4960905090079628,1.2540282533867535,0.1949317738791423,0.7216877158443713,1.0,4/13,14.53%,NCBP1;CSTF2;CPSF1;FIP1L1
prerank,positive regulation of neurogenesis (GO:0050769),-0.32112274340179836,-1.2536511883294366,0.09950248756218906,0.6255303486832974,1.0,17/68,8.02%,ROBO1;PTPRD;CDKL5;SLIT2;PLXNC1;SLITRK1;MME;IL1RAPL1;NTRK2;NPTN;SOX11;SHANK3;PLXND1;PLXNA2;OPRM1;CUL7;LIG4
prerank,heme biosynthetic process (GO:0006783),0.42280962141816497,1.253617279509805,0.18661971830985916,0.7216378773993503,1.0,6/22,14.34%,HMBS;PPOX;FECH;NFE2L1;UROD;TSPO
prerank,regulation of GTPase activity (GO:0043087),0.29746336305546645,1.2535217874231863,0.06880733944954129,0.720460100611454,1.0,41/177,15.49%,SRGAP2;CHN2;DOCK8;FGD2;F11R;VAV2;ITGA6;ARHGAP27;MAP4K4;RAP1GDS1;ASAP3;PICALM;TGM2;RGS10;TBC1D10B;TBC1D7;LRCH1;SNX18;TBC1D15;CCL3;FLCN;FICD;RASA4;SGSM2;RAB3GAP2;RAB3GAP1;DOCK10;LIMS1;WNK1;RASIP1;RAPGEF3;FGD3;PIN1;SEMA4D;GMIP;TBC1D30;SOD1;EZH2;RTN4R;ADAP1;SNX13
prerank,C4-dicarboxylate transport (GO:0015740),-0.47317268304364535,-1.2533916691792735,0.17857142857142858,0.6246121580730782,1.0,6/14,17.38%,SLC25A30;SLC1A6;SLC25A12;SLC25A18;SLC13A5;SLC1A1
prerank,phosphatidic acid metabolic process (GO:0046473),0.36880677451339844,1.2531342986642844,0.14871794871794872,0.7203465517772569,1.0,9/48,9.07%,LIPH;PLD1;LPCAT4;PLA2G4A;PLA2G6;PLD2;DGKD;PLA2G4B;PLA2G5
prerank,positive regulation of leukocyte migration (GO:0002687),0.41012749783620234,1.2529461047945352,0.18197879858657243,0.7195080437499333,1.0,7/27,14.97%,AIF1;MIA3;EDN3;EDN2;IL6R;NCKAP1L;CSF1
prerank,microtubule anchoring (GO:0034453),-0.49874358161408433,-1.2527261843174702,0.1888412017167382,0.6250683474949661,1.0,5/12,28.58%,BICD1;SAXO2;DAG1;PEX14;GCC2
prerank,arachidonate transport (GO:1903963),0.5371947076791102,1.2526136704394122,0.20315581854043394,0.7177625949278224,1.0,4/10,18.00%,PLA2G5;NMUR2;DRD2;BDKRB2
prerank,arachidonic acid secretion (GO:0050482),0.5371947076791102,1.2526136704394122,0.20315581854043394,0.7177625949278224,1.0,4/10,18.00%,PLA2G5;NMUR2;DRD2;BDKRB2
prerank,ERK1 and ERK2 cascade (GO:0070371),0.4468037151469896,1.2524143062619957,0.1797752808988764,0.7170048025172332,1.0,5/21,7.75%,LGALS9;KARS1;ITGAV;ZFP36L1;ZFP36L2
prerank,regulation of protein localization to membrane (GO:1905475),-0.3940743118023267,-1.2520336355678234,0.1547911547911548,0.6255321145014469,1.0,11/28,20.91%,GPC6;SPTBN1;GSN;GPC5;PRKN;ACTB;GPC3;GPC4;MMP14;GPC1;FYN
prerank,carbohydrate catabolic process (GO:0016052),0.3793527986171379,1.2516235414407197,0.13893653516295026,0.7183893797965932,1.0,9/38,14.06%,HK2;MAN2B1;PFKL;NEU3;PGK1;GAPDH;PFKFB2;PGAM4;PGAM1
prerank,cellular response to interleukin-6 (GO:0071354),0.418768533155355,1.251315287640174,0.17657342657342656,0.718120533154745,1.0,7/26,9.01%,ST3GAL6;SELPLG;SBNO2;SRC;CTR9;IL6ST;IL6R
prerank,regulation of neutrophil migration (GO:1902622),0.5241609881042235,1.2509276596114156,0.22476190476190477,0.7180282153360258,1.0,3/10,10.24%,RAC1;RHOH;NCKAP1L
prerank,lipid translocation (GO:0034204),-0.42120862209293436,-1.2507232937530626,0.16741071428571427,0.627829234464216,1.0,10/21,22.43%,ATP8B4;ATP11A;ATP11C;ATP9B;ABCA4;ATP10B;ATP8B2;ABCC1;ATP10A;ABCA7
prerank,membrane organization (GO:0061024),-0.26448300440806893,-1.2503018321471078,0.049019607843137254,0.6274730257492436,1.0,48/227,15.57%,SGCZ;DAB2;HIP1;ANK3;MYOF;DNM3;ANK2;DNAJC6;SPTBN1;TMCC1;EGFR;REEP3;ACTR3;SYT1;CTTN;AP2A2;ITSN1;LDLR;VAPA;SGIP1;PIK3C2A;DNM1L;SH3GL2;DNM1;PLEKHA3;TOR1A;CHRM2;SAR1B;SNX9;ACTB;MYADM;DMPK;CCDC88A;ARPC5;KIF20A;DYSF;REEP4;COX18;EPS15;TOR1AIP2;REPS1;OCRL;AP2B1;HSPA8;NUP155;IGF2R;CFTR;ATP10B
prerank,negative regulation of cyclase activity (GO:0031280),-0.4750224601438623,-1.2498001037023503,0.18541666666666667,0.6274957401074457,1.0,4/14,5.28%,CCR2;GABBR2;PALM;EDNRB
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.410211927835707,1.2497637727354152,0.15817223198594024,0.7205938929663697,1.0,10/29,27.17%,BAG6;STAG3;KASH5;TEX12;PRDM9;SYCE2;MAJIN;SYCP2;ZCWPW1;HORMAD1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.5301108639140115,1.2496325791023288,0.19925512104283055,0.7196212535906055,1.0,2/11,2.55%,RAC1;SIRT2
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.44187328956744315,-1.2494356922060992,0.19426048565121412,0.6270487879730735,1.0,8/17,18.12%,DNM1L;GGCT;FIS1;MFF;BAK1;SOD2;BCL2;BOK
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.33571666980337694,1.2493205581223186,0.12419354838709677,0.7192281515464698,1.0,19/72,19.09%,RNASE1;PCNA;DDB2;RFC2;DXO;REXO4;RPS27A;UBC;GTF2H2;ERCC2;CUL4B;POLD2;ERCC4;RNASE6;DCP1B;ISG20;RFC1;FBH1;CUL4A
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.4433908825193861,-1.2492474943313618,0.1759656652360515,0.6259837330864804,1.0,6/17,16.61%,PRKG1;PPARG;TAFA5;SOD2;CDKN1A;APLN
prerank,vasodilation (GO:0042311),0.4974205335093512,1.2491989924428923,0.18878504672897195,0.718216136274832,1.0,5/13,20.35%,KCNMA1;AGTR2;GPER1;SOD1;NOS1
prerank,generation of neurons (GO:0048699),-0.2698813810727949,-1.2491233102911847,0.040498442367601244,0.6247406582463236,1.0,41/190,15.67%,AUTS2;PTPRD;ADGRL3;SPOCK1;NRCAM;CDKL5;NAV1;GPM6A;MAP1B;FUT9;TAFA1;IL1RAPL1;ASTN2;RAPGEF2;ACSL3;NTRK2;SNPH;MYT1L;SOX11;SH3RF1;RACGAP1;NR4A2;EML1;PER2;WNT4;DCDC2;ERCC6;PLXNB2;DDIT4;ASTN1;EN2;RUNX2;IRX5;CX3CL1;TUBB2A;MDGA1;HEY2;WNT9A;POU3F2;RELN;POMGNT2
prerank,potassium ion export across plasma membrane (GO:0097623),-0.4831824222345804,-1.2481425440767224,0.2021978021978022,0.6261606831163258,1.0,6/13,19.74%,KCNT2;KCND3;KCNQ1;KCNIP2;KCNE3;KCNK5
prerank,positive regulation of lymphocyte migration (GO:2000403),0.5162789062789642,1.2477798444403096,0.2011070110701107,0.7218735549761285,1.0,3/12,2.84%,DOCK8;AIF1;JAM2
prerank,activation of protein kinase activity (GO:0032147),0.31657651967959766,1.2477335959619424,0.11057692307692307,0.7205825981578811,1.0,25/106,14.70%,IL18;TGFBR2;MAP4K4;ADCY9;PRKACA;PHB2;PRKCD;PTK2B;STRADA;PDPK1;CD86;PDGFB;ZFP91;ADCY4;MTOR;MLST8;PRRC1;ADCY6;PINK1;TAOK2;MARK2;ABL1;CHRNA3;GHR;AKT1
prerank,acylglycerol metabolic process (GO:0006639),0.38749582383604597,1.247685711436118,0.15070921985815602,0.719288533478005,1.0,10/37,14.40%,ABHD12;SEL1L;DGAT1;LMF1;DGKK;DGKD;GK5;ABHD6;APOH;PGS1
prerank,cell chemotaxis (GO:0060326),0.34820043944807366,1.247610852891235,0.13367174280879865,0.7181099051482959,1.0,8/60,8.05%,CX3CR1;DOCK4;BIN2;ARRB2;PRKCD;EGR3;PDGFB;CCR7
prerank,protein localization to plasma membrane (GO:0072659),-0.284074085798705,-1.2475366362110318,0.052941176470588235,0.6262326685257377,1.0,26/129,10.78%,KCNIP4;DPP6;ANK3;KCNB2;DPP10;ANK2;SPTBN1;RAB3C;MYO5A;RAPGEF2;EHD1;LRP6;AFDN;RAB40B;RAB3D;ATP1B3;PIGW;ACTN2;RAB8A;MYADM;RAB3A;SPTBN4;CCDC88A;P2RY1;ITGB1BP1;ZDHHC23
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.38446185808989575,1.2475337056348392,0.1486013986013986,0.7169484805536289,1.0,13/39,19.09%,PCNA;DDB2;RFC2;RPS27A;UBC;GTF2H2;ERCC2;CUL4B;POLD2;ERCC4;RFC1;NTHL1;CUL4A
prerank,import into cell (GO:0098657),0.3728038042448737,1.2463947029419336,0.13874788494077833,0.7195050771468569,1.0,13/41,17.80%,SLC7A8;SLC1A3;SLC7A5;SLC36A1;SLC12A6;NEURL1B;SLC22A2;IL10RA;SLC29A1;LRRC8A;SLC5A3;SLC38A1;SLC19A1
prerank,regulation of TOR signaling (GO:0032006),0.34000108105973925,1.2461610600988908,0.11813643926788686,0.7188477638212855,1.0,15/67,12.55%,GNA12;TBC1D7;TBCK;PKHD1;FLCN;RFFL;LAMTOR2;SEC13;RPTOR;ARAF;TNFAIP8L1;MLST8;LAMTOR5;WDR24;PDCD6
prerank,negative regulation of stress fiber assembly (GO:0051497),0.42237343064328714,1.2459720556719949,0.16666666666666666,0.7180445688836774,1.0,6/24,9.80%,F11R;PIK3R1;ARHGAP28;MET;TJP1;INPP5K
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.3702206373084966,-1.24595113670123,0.12926829268292683,0.6294913857378105,1.0,14/35,20.66%,NLGN1;CDH8;CDH22;CDH7;CDH20;CDH10;CDH11;CDH13;CDHR3;CDH5;PCDHB16;PCDHB13;PCDHB6;SELL
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.49803656684816944,-1.2458212818209147,0.2068230277185501,0.6283488491533764,1.0,4/11,19.25%,ATF7IP;SETDB2;PPHLN1;DNMT1
prerank,peptide biosynthetic process (GO:0043043),-0.2786616574974579,-1.245668079748191,0.07492795389048991,0.627277262759187,1.0,63/153,27.76%,DMD;PCSK5;RPL36A;RPS29;RPL30;RPL35A;RPS3;RPL4;RPS7;RPS2;RPLP2;RPL7A;IGHMBP2;RPL41;RPL26;RPS27;RPL18A;RPS25;RPL38;GGT7;EEF1A2;RPS6KB2;MRPL18;RPL37;HBS1L;RPS15A;RPS14;MRPS7;RPL24;RPS9;RPLP0;RPLP1;RPL8;RPL22;MRPS33;RPS12;RPS10;RPL19;RHD;RPS6;RPL13A;RPL18;RPS5;RPS19;RPL23A;PABPC4;YARS2;RPL29;RPS23;RPS11;GGTA1;ZAR1;MRPL55;MRPL24;RPS15;RPL23;MRPL23;RPL17;RSL24D1;AGO2;CARNS1;EEF1A1;MRRF
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.36918385761559225,1.2456414407085201,0.12622950819672132,0.7178045255560316,1.0,15/51,15.14%,CSF1R;LGALS9;AIF1;VEGFB;LGMN;C1QBP;AKIRIN1;EDN3;CCR7;EDN2;IL6R;SERPINE1;IL34;CSF1;CXCL17
prerank,neuron projection regeneration (GO:0031102),0.5305840237751988,1.2454732051732138,0.19144981412639406,0.7169162217522556,1.0,2/10,6.30%,RTN4RL1;NREP
prerank,glycolytic process (GO:0006096),0.40657502214567404,1.2453186045716333,0.16725978647686832,0.7160068522428314,1.0,7/28,14.06%,HK2;PFKL;PGK1;GAPDH;PFKFB2;PGAM4;PGAM1
prerank,copper ion transport (GO:0006825),-0.500168506536232,-1.2452933807507445,0.19117647058823528,0.6267530924736671,1.0,5/11,24.20%,ATP7A;SLC31A2;STEAP4;CUTC;STEAP3
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.4920286928026718,1.2450883888151516,0.19814814814814816,0.7154489730384969,1.0,6/14,19.13%,CSF1R;AKIRIN1;IL34;CSF1;CXCL17;THBS1
prerank,cellular lipid catabolic process (GO:0044242),0.412773489778235,1.2449860782428854,0.16494845360824742,0.7144052073676359,1.0,6/27,4.79%,ABHD12;SIRT2;PPARD;LPIN2;NUDT19;PLA2G15
prerank,cellular response to exogenous dsRNA (GO:0071360),0.49482084191749526,1.2444995742945535,0.1846435100548446,0.7145986963900192,1.0,9/12,33.70%,ZCCHC3;DHX9;CGAS;MAVS;RALB;FLOT1;IFIT1;MUL1;COLEC12
prerank,triglyceride biosynthetic process (GO:0019432),0.45109414574563345,1.2441948095938484,0.18962432915921287,0.7143052496108556,1.0,5/18,8.94%,AGMO;LPIN2;DGAT1;MOGAT1;MOGAT2
prerank,purine nucleotide catabolic process (GO:0006195),-0.4862868594592944,-1.2441366411895702,0.18584070796460178,0.6285216640329733,1.0,3/13,6.56%,XDH;GDA;HINT1
prerank,respiratory electron transport chain (GO:0022904),-0.4683278791081225,-1.244103727756452,0.1885593220338983,0.6270669407385139,1.0,5/14,15.36%,GPD2;SDHA;ETFRF1;SLC25A12;SLC25A18
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.4895555307839575,-1.2436191789791111,0.2068230277185501,0.6269776050712371,1.0,5/12,19.25%,ATF7IP;TET1;SETDB2;PPHLN1;DNMT1
prerank,cilium-dependent cell motility (GO:0060285),-0.4094604457250357,-1.2435471269718739,0.1574074074074074,0.6255959472409933,1.0,10/22,22.07%,RFX3;DNAH8;DNAH2;DNAI3;CFAP44;DNAH3;DNAH17;CCDC65;CCDC39;TEKT5
prerank,lysosome organization (GO:0007040),0.3873843733409035,1.2434440664611617,0.16776315789473684,0.7154848381388598,1.0,17/36,28.03%,HPS4;HOOK2;ARSB;MYO7A;MBTPS1;AKTIP;MTOR;CLN3;ACP4;ACP2;GAA;HOOK3;ABCA1;GNPTAB;VPS18;HPS1;TMEM106B
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.44906668035617636,1.2429978438042122,0.16576576576576577,0.7156061691401276,1.0,8/19,22.96%,CD27;RHOH;NCKAP1L;AXL;ZMIZ1;GATA3;XRCC6;ZBTB1
prerank,positive regulation of lamellipodium organization (GO:1902745),0.3931096866033801,1.242823674185913,0.18165467625899281,0.7147867008370435,1.0,9/32,10.91%,RREB1;TWF2;RAC1;PIK3R1;SRC;FSCN1;AKIRIN1;AVIL;CYFIP1
prerank,double-strand break repair via break-induced replication (GO:0000727),0.49901817622238265,1.2419684419443278,0.20107719928186715,0.7163277434018989,1.0,7/12,29.66%,GINS4;MCM2;MCM3;MCMDC2;CDC7;MCM6;MCM7
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.36729975424732497,-1.24187516171618,0.14153132250580047,0.629329426988163,1.0,12/33,27.05%,PTPN22;RPS3;CD226;PTPN2;TESPA1;UBASH3A;THY1;EZR;LCK;TRAT1;RELA;SLA2
prerank,negative regulation of lyase activity (GO:0051350),-0.45565978658443795,-1.241828350330367,0.19791666666666666,0.6279155576257196,1.0,4/16,5.28%,CCR2;GABBR2;PALM;EDNRB
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.423103771813639,-1.24169564158741,0.20449438202247192,0.6267548785214967,1.0,4/20,4.18%,PDE4D;ADRA1A;RAPGEF2;ZDHHC21
prerank,presynapse organization (GO:0099172),-0.5145953618632432,-1.2416575507234349,0.21535181236673773,0.6253235800409388,1.0,2/10,9.22%,NLGN1;LRRTM3
prerank,protein sumoylation (GO:0016925),0.3541433930089801,1.2416069969037609,0.14502529510961215,0.7161042842217421,1.0,15/49,17.82%,SUMO1;RANBP2;UBA2;TRPM4;STX1A;NUP42;EGR2;NUP50;NUP35;NUP88;PIAS3;PIAS2;NUP62;SEH1L;NUP107
prerank,regulation of synapse maturation (GO:0090128),-0.49947094705207573,-1.2414197697035505,0.22125813449023862,0.6246202172446391,1.0,4/10,23.78%,NRXN1;RELN;NEUROD2;ARHGEF15
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.3195673660241749,1.2413044913639057,0.10832025117739404,0.7157550458642122,1.0,28/96,21.52%,SRRM1;NCBP1;RANBP2;MAGOHB;MAGOH;U2AF2;NUP42;SEC13;DHX38;NUP50;SRSF5;CPSF1;NUP35;RBM8A;NUP88;U2AF1L4;SLU7;FIP1L1;ALYREF;ALKBH5;NUP62;SEH1L;NUP107;THOC6;SRSF9;DDX19B;HNRNPA2B1;DDX39B
prerank,regulation of osteoblast differentiation (GO:0045667),0.32850512731608905,1.2409365248950308,0.13228346456692913,0.7156639922819381,1.0,17/82,13.33%,TMEM119;LRP5;NBR1;GREM1;MEF2C;DDX5;SKI;PRKACA;NPNT;TRPM4;CTNNBIP1;IL6ST;TWIST2;IL6R;WNT7B;DDR2;SEMA4D
prerank,T cell proliferation (GO:0042098),0.4899218335290142,1.2407711730762343,0.19402985074626866,0.7148003172396463,1.0,3/13,3.76%,DOCK8;CADM1;PIK3CG
prerank,protein polymerization (GO:0051258),-0.3277901728755316,-1.2406055303629961,0.11910669975186104,0.6255630737974645,1.0,11/55,9.07%,ARHGAP6;PSTPIP1;GSN;PSTPIP2;TPPP;DIAPH3;JAK2;WASF1;PRKN;MSRB1;UBE2K
prerank,negative regulation of histone modification (GO:0031057),-0.4582042306649945,-1.239344834131628,0.20930232558139536,0.62789862546005,1.0,8/14,23.96%,JARID2;TAF7;SNCA;AASS;FOXP3;THAP7;NOC2L;SPHK2
prerank,proteasomal protein catabolic process (GO:0010498),0.286826791820905,1.2391810411211348,0.07291666666666667,0.7190924887947707,1.0,67/201,24.41%,BAG6;NFE2L2;DDIT3;UCHL1;RNF216;SEL1L;ARRB2;SMURF1;SIRT2;ITCH;MTA1;SPSB1;RNF41;ENC1;RFFL;ZSWIM8;ERLEC1;SPSB2;PCBP2;SOCS6;MAEA;TRIM72;CDC34;CUL4B;ANKRD9;CRBN;PSMD3;BFAR;KCTD2;AREL1;PSMB3;UBE2U;PSMA7;RNF187;WWP2;DCAF11;PSMC1;PSMC2;FBXL22;PSME4;PSMB9;UBXN2A;UBE2A;ARRB1;SPOPL;RNF4;TNFAIP1;KAT5;STUB1;ZFAND2A;CUL4A;PSMD4;PSMB5;TRIM3;PMAIP1;TOPORS;SYVN1;GID8;PSMB7;RNF34;ATE1;GID4;PSMB8;ZNRF1;FBXW5;KCTD5;RAD23B
prerank,rRNA transcription (GO:0009303),0.4576579812034218,1.2391783917651842,0.1783783783783784,0.7177028882324562,1.0,7/17,25.30%,GTF3C2;GTF3A;BRF1;GTF3C6;POLR1E;POLR1G;SPIN1
prerank,RNA 3'-end processing (GO:0031123),0.3358204666139264,1.2391042086763382,0.12436974789915967,0.716591417666269,1.0,15/69,14.84%,SRRM1;NCBP1;CSTF2;MAGOHB;MAGOH;U2AF2;DHX38;PABPN1;SRSF5;CPSF1;RBM8A;U2AF1L4;SLU7;FIP1L1;ALYREF
prerank,calcium ion import (GO:0070509),-0.38499485685568124,-1.2388799307558984,0.1603563474387528,0.6277647862450799,1.0,13/28,24.03%,CACNA1E;MCU;TRPC4;ATP2A2;CACNA1C;MCUB;MICU2;MICU3;CACNA1B;MS4A1;CACNA1G;SMDT1;ATP2A1
prerank,regulation of microtubule polymerization (GO:0031113),0.36865038447114346,1.2388476083591458,0.1542649727767695,0.7160863189826412,1.0,11/40,17.81%,NAV3;RAC1;CAMSAP1;NUMA1;MET;CAMSAP2;CLIP3;ABL1;DYRK1A;MAPRE1;FES
prerank,regulation of protein secretion (GO:0050708),-0.2879594031844124,-1.238620965813497,0.0821917808219178,0.6269620048228275,1.0,26/119,13.89%,STXBP5L;CACNA1E;ITPR1;DISP1;KCNC2;DPP4;RSAD2;RFX3;APOE;PPIA;STXBP5;SLC8B1;DNM1L;CACNA1C;ALOX5;GOLPH3;SNAP25;PER2;P3H1;CLOCK;ADRA2A;FFAR1;UNC13B;HMGCR;ACHE;CCL5
prerank,negative regulation of interleukin-10 production (GO:0032693),0.4713964563541513,1.2386209207440646,0.2026266416510319,0.7154760720024319,1.0,6/16,11.32%,VSIR;AGER;TNFRSF21;PDCD1LG2;IL12B;DLL1
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.38300875939744816,1.2383319654729374,0.17128027681660898,0.7151195586907442,1.0,5/36,3.59%,CX3CR1;TGFBR1;CRADD;CSNK2A2;CSNK2A1
prerank,regulation of store-operated calcium entry (GO:2001256),0.5239132174125806,1.2382384706398468,0.20964749536178107,0.7140729460787466,1.0,2/10,1.30%,SARAF;CD84
prerank,epithelial cell migration (GO:0010631),-0.36113858586094033,-1.2380961380930469,0.15201900237529692,0.6270289126073582,1.0,11/37,15.60%,DPP4;PLXND1;FSTL1;GIPC1;ZEB2;CDH13;KANK1;PLEKHG5;KIT;TNFSF12;STARD13
prerank,regulation of cardiac conduction (GO:1903779),-0.3296594896699402,-1.2371017679500895,0.13513513513513514,0.6284421423151091,1.0,12/54,11.52%,ANK2;ITPR1;SLC8A3;ATP2B1;RYR3;RYR2;ATP2A2;TMEM65;ATP1B3;DMPK;ATP2A3;ATP1A1
prerank,ncRNA 3'-end processing (GO:0043628),0.472571372695591,1.2368510988417207,0.2037735849056604,0.7174531756133534,1.0,3/14,3.61%,INTS6L;TRNT1;SSB
prerank,regulation of mRNA polyadenylation (GO:1900363),0.45522061869541985,1.236236607543422,0.17383512544802868,0.7181970448172676,1.0,5/17,15.23%,NCBP1;CDK9;CTR9;RNF20;NELFE
prerank,regulation of lipid kinase activity (GO:0043550),0.5115264898209525,1.2361111511938558,0.21518987341772153,0.7172526954044343,1.0,5/11,19.19%,PIK3R1;RBL2;PIK3R3;PPP2R5A;WDR81
prerank,canonical glycolysis (GO:0061621),0.4180361764256497,1.2355625045677703,0.17636363636363636,0.7164706006012252,1.0,6/24,14.06%,HK2;PFKL;FOXK2;PGK1;GAPDH;PGAM1
prerank,glucose catabolic process to pyruvate (GO:0061718),0.4180361764256497,1.2355625045677703,0.17636363636363636,0.7164706006012252,1.0,6/24,14.06%,HK2;PFKL;FOXK2;PGK1;GAPDH;PGAM1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.43577917260913457,-1.2351836559167055,0.18421052631578946,0.6327461365818904,1.0,3/17,3.89%,ANK2;RYR2;NEDD4L
prerank,membrane fusion (GO:0061025),-0.3627770861370562,-1.2349815943944715,0.17274939172749393,0.6318697806277698,1.0,5/33,6.54%,MYOF;DNM3;VAPA;DNM1L;DNM1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.5165757438048681,-1.2346046261518016,0.2219873150105708,0.6314286812149128,1.0,4/10,19.99%,PTPN22;NINJ1;LBP;LTF
prerank,regulation of astrocyte differentiation (GO:0048710),0.4975076137776833,1.2339167355336198,0.226,0.7209743690239315,1.0,3/12,15.62%,BIN1;SERPINE2;NOG
prerank,lipid droplet organization (GO:0034389),0.4250380745301746,1.2337677835024599,0.2003577817531306,0.7201547278130298,1.0,5/22,15.29%,RAB3GAP1;PPID;AUP1;BSCL2;CDS1
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.40996775919211237,-1.2335671210828114,0.19506726457399104,0.6329558364580233,1.0,5/21,8.69%,PPARG;PLTP;APOE;SIRT1;NFKBIA
prerank,RNA export from nucleus (GO:0006405),0.3159695245870255,1.2335659971974604,0.10172143974960876,0.7195249769937446,1.0,36/100,26.58%,SRRM1;NCBP1;RANBP2;MAGOHB;MAGOH;U2AF2;NUP42;SEC13;NUP62CL;DHX38;NUP50;SRSF5;CPSF1;NUP35;RBM8A;NUP88;U2AF1L4;SLU7;FIP1L1;ALYREF;ALKBH5;NUP62;SEH1L;NUP107;THOC6;SRSF9;DDX19B;HNRNPA2B1;DDX39B;NUP153;XPO5;HNRNPA1;NUP188;NDC1;THOC3;ZC3H11A
prerank,ribosomal small subunit assembly (GO:0000028),-0.4404382745294365,-1.2334250938135722,0.1873479318734793,0.6318650214825089,1.0,10/16,33.00%,RPS27;RPS14;MRPS7;ABT1;XRCC5;RPS5;RPS19;RPS15;RPSA;PWP2
prerank,lipid droplet formation (GO:0140042),0.5192196320800884,1.2330009573666905,0.21272365805168986,0.7202512283024733,1.0,3/10,15.29%,AUP1;BSCL2;CDS1
prerank,negative regulation of cation channel activity (GO:2001258),-0.38402138464436286,-1.2327706635117008,0.17715617715617715,0.6323539806306309,1.0,11/26,26.95%,GPR35;CALM1;CBARP;PKD2;GNB5;KCNE3;UBQLN1;EPHB2;CASQ2;CALM3;MMP9
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5333132130193243,1.2327119841107355,0.22160148975791433,0.7198601545419804,1.0,2/10,1.07%,MLXIPL;ABCD2
prerank,positive regulation of response to external stimulus (GO:0032103),0.30444302790515,1.232468437046648,0.1078125,0.7193776818719936,1.0,31/128,16.93%,IL18;TLR7;POLR3G;LY86;P2RY12;ETS1;AIF1;TLR4;PRKCA;ZCCHC3;SLC15A4;CCL3;TRADD;AKIRIN2;DHX9;PDGFB;CNTF;IL12B;DDT;CD180;PDGFRB;APOH;SERPINE1;IL33;STX4;OPTN;OSM;PLG;GBP5;GPR4;AGT
prerank,heart contraction (GO:0060047),-0.35117124131054755,-1.2320033726721313,0.13981042654028436,0.6330209895110772,1.0,4/41,3.24%,SGCZ;DMD;RYR2;SGCD
prerank,protein import into nucleus (GO:0006606),0.3336676793677625,1.2316116750638453,0.12307692307692308,0.7209942411103054,1.0,31/66,27.91%,SPRN;RANBP2;PHB2;FAM53A;PTTG1IP;SEC13;NUP62CL;TNPO1;APPL1;NUP50;NUP35;NUP88;IPO4;RPAIN;AKT1;TNPO3;NUP62;CSE1L;NUP107;E2F3;KPNA3;IPO7;NUP153;IPO5;PRICKLE1;NUP188;APPL2;STAT3;IPO9;RANBP17;HIKESHI
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.3884291137928187,1.2313018333111847,0.16869565217391305,0.7206887841636033,1.0,5/34,6.83%,SASH3;SLC7A5;DNAJB9;PHB2;CD86
prerank,thyroid hormone generation (GO:0006590),0.5203238322943264,1.2312395358687507,0.2137546468401487,0.7195744971235766,1.0,3/10,7.92%,TG;FOXE1;DUOX1
prerank,RNA processing (GO:0006396),0.2920129492262794,1.2311070199757983,0.07357357357357357,0.7186602419953871,1.0,53/176,22.48%,IVNS1ABP;SRRM1;SON;NCBP1;PPP1R9B;FUS;PRKACA;AKAP8L;SF3B1;SF3B2;MAGOHB;MAGOH;HNRNPC;U2AF2;CELF2;SNRPF;SNRPA1;HNRNPH1;RBM39;SNRNP48;TSEN2;HNRNPR;DDX17;PABPN1;SRSF5;RBM8A;DDX54;TSEN54;TARDBP;LUC7L3;DDX20;LSM5;SLU7;SF3A1;ALKBH5;DUSP11;PRPF4;PRPF3;SCNM1;ZCCHC8;SNRPN;SNRNP40;GEMIN2;WBP4;SRSF9;HNRNPH3;FASTKD2;HNRNPA2B1;DDX39B;HNRNPUL1;RBPMS;DDX47;MPHOSPH10
prerank,sphingolipid biosynthetic process (GO:0030148),0.3327172946759261,1.2307806393355607,0.15042735042735042,0.7184183406344622,1.0,18/71,14.45%,LARGE1;ST3GAL5;ALOXE3;CERS3;DEGS2;SPTLC3;PPM1L;HACD3;PNPLA1;SMPD2;ACER3;ACER2;PLPP1;ASAH1;PLPP2;PRKD3;CERS2;VAPB
prerank,protein import (GO:0017038),0.31886582022812593,1.2300691764440341,0.1321656050955414,0.7196218013358137,1.0,38/84,27.91%,ABCD2;SPRN;PHB2;CLU;FAM53A;HSPA4;PTTG1IP;SEC13;NUP62CL;TNPO1;APPL1;NUP50;NUP88;IPO4;RPAIN;AKT1;TNPO3;PXMP2;NUP62;CSE1L;NUP107;E2F3;LAMP2;RAB8B;IPO7;NUP153;ABCD1;IPO5;PRICKLE1;NUP188;PEX3;APPL2;STAT3;SNX33;SAMM50;IPO9;RANBP17;HIKESHI
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.4821133241856171,1.2300511624163029,0.20754716981132076,0.718345894986262,1.0,3/13,15.23%,NELFB;RNF8;NELFE
prerank,negative regulation of protein polymerization (GO:0032272),0.40164640489285736,1.2289240177169531,0.17857142857142858,0.721045141038125,1.0,9/27,16.04%,SSH2;TWF2;CYRIB;PRKCD;SSH1;CLIP3;HIP1R;DYRK1A;MAPRE1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3152472163490812,1.2284366577452017,0.1256198347107438,0.7214741355473787,1.0,20/100,13.33%,IL18;PIK3R1;CRNN;LYN;IGF1R;SRC;PIK3CG;PIK3AP1;PDGFB;SELP;GPER1;FSHR;PIK3CD;PIK3CB;FBXL2;CEACAM1;PDGFRB;PPP2R5B;HCST;SEMA4D
prerank,rRNA methylation (GO:0031167),0.4178777081547895,1.2278605653901014,0.18618042226487524,0.7221731149528985,1.0,9/22,21.08%,EMG1;BUD23;NSUN5;METTL5;FTSJ3;NSUN3;TFB1M;NSUN4;FBL
prerank,sodium ion import across plasma membrane (GO:0098719),0.4564103379837274,1.2277782062876965,0.23105360443622922,0.721152125402708,1.0,3/17,5.45%,SLC9A9;TRPM4;SLC8A1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.4736507523720701,1.2276234496660094,0.21601489757914338,0.7190798368569249,1.0,8/15,20.69%,CNOT1;ZFP36L1;ZFP36L2;NANOS2;TOB1;TNRC6C;NANOS1;TNRC6B
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.4736507523720701,1.2276234496660094,0.21601489757914338,0.7190798368569249,1.0,8/15,20.69%,CNOT1;ZFP36L1;ZFP36L2;NANOS2;TOB1;TNRC6C;NANOS1;TNRC6B
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.48599053605131737,-1.2276145247186694,0.21199143468950749,0.6445202689149214,1.0,7/12,23.77%,RIMS2;SYT1;UNC13C;UNC13B;RIMS1;DOC2B;SYT5
prerank,Notch signaling pathway (GO:0007219),0.34036143964657767,1.2272972269714078,0.1653290529695024,0.718863776355395,1.0,19/59,17.58%,MAML3;HEYL;ITCH;DTX4;JAG2;NOTCH4;POFUT1;DTX1;PSENEN;GALNT11;MAML2;DLL1;PSEN2;NLE1;NOTCH3;DTX3;DTX3L;ADAM10;APH1B
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.46438933881045885,1.2269455552434925,0.19662921348314608,0.7188968925106748,1.0,5/15,8.25%,EBI3;SHH;PNP;HSPH1;IL12B
prerank,transferrin transport (GO:0033572),0.39551774577789905,1.2263449243554514,0.17690875232774675,0.7197488193800333,1.0,7/33,11.63%,DNM2;ATP6V0B;MCOLN1;ATP6V1D;TCIRG1;ATP6V0A2;ATP6V0A4
prerank,energy reserve metabolic process (GO:0006112),-0.42687132175644615,-1.2262831572774333,0.21541950113378686,0.6468505740249404,1.0,6/19,13.46%,PID1;PRKAG2;GSK3B;GBE1;GFPT2;PYGM
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.443008536144918,1.2259733837856024,0.20577617328519857,0.719768953620456,1.0,5/18,8.45%,CX3CR1;SELPLG;JAM2;SELE;SELP
prerank,regulation of immunoglobulin production (GO:0002637),0.4253670392117099,1.225660806503841,0.18342151675485008,0.71958502623472,1.0,4/23,6.83%,SASH3;DNAJB9;PHB2;CD86
prerank,regulation of phagocytosis (GO:0050764),0.35263976907827943,1.2255270485944845,0.15449915110356535,0.7187834396471169,1.0,12/53,17.73%,MERTK;SIRPA;TGM2;ITGAV;CAMK1D;GATA2;PLA2G5;PYCARD;RAB27A;SNX3;SCARB1;SLC11A1
prerank,neuromuscular process controlling balance (GO:0050885),-0.47344162626617164,-1.225169375083111,0.22377622377622378,0.6488003592021028,1.0,2/12,0.81%,NRXN1;PCDH15
prerank,protein deacylation (GO:0035601),0.41669440165862665,1.2250369847219051,0.19237749546279492,0.7192751108544103,1.0,5/23,7.03%,ABHD17C;SIRT2;HDAC10;PPT1;SIN3A
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.4506098897431342,1.2244966650242848,0.2037037037037037,0.7198655141066921,1.0,5/17,11.46%,DOCK4;AIF1;ADAMTS1;PDGFB;PDGFRB
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.3765238596430675,1.2243730580365513,0.16440677966101694,0.7190343190066818,1.0,16/38,26.39%,NDUFB2;NDUFB8;NDUFB10;NDUFS4;NDUFS3;NDUFB3;NDUFAF1;NDUFA13;NDUFS5;NDUFV3;NDUFV2;NDUFA9;NDUFB11;NDUFC2;NDUFV1;NDUFB4
prerank,endoderm formation (GO:0001706),0.38684628777991736,1.2242968315252787,0.14774774774774774,0.7179594582861453,1.0,10/35,16.08%,ITGB5;ITGB2;ITGAV;MMP2;SOX17;LAMA3;DUSP5;ITGA7;SETD2;COL11A1
prerank,sterol transport (GO:0015918),-0.42217332560838805,-1.2239198466487442,0.2036613272311213,0.6511865254513769,1.0,3/19,3.27%,CD36;MSR1;LDLR
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.4983466098715097,1.2235029209953685,0.20970873786407768,0.7193950669919561,1.0,4/12,7.08%,DOCK4;MEF2C;ADAMTS1;PDGFB
prerank,leukocyte tethering or rolling (GO:0050901),0.4489904517796775,1.2230780407965463,0.21636363636363637,0.719550446346997,1.0,5/17,8.45%,CX3CR1;SELPLG;JAM2;SELE;SELP
prerank,mRNA destabilization (GO:0061157),0.37310517092835443,1.2227925324425948,0.16455696202531644,0.7192109099734806,1.0,12/38,18.02%,CNOT1;POLR2D;MOV10;DIS3L2;ZFP36L1;ZFP36L2;RBM24;DCPS;TARDBP;METTL14;RIDA;ROCK2
prerank,positive regulation of cell division (GO:0051781),-0.35410111751295675,-1.2226559583673342,0.15454545454545454,0.6534780022751813,1.0,9/38,9.30%,CUL3;KIF23;RACGAP1;HTR2B;CDC42;GIPC1;KIF14;PKP4;AURKB
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.4654852328516666,1.2224832333490383,0.2026266416510319,0.7189996396569296,1.0,5/16,8.73%,ETS1;ITGB2;SELE;SELP;FUT7
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.5180741296155629,-1.2222747525820552,0.2281449893390192,0.6529966283248093,1.0,6/10,28.72%,DSE;PXYLP1;B3GAT2;CSGALNACT2;CSGALNACT1;DSEL
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.49971441001230044,-1.2221599954037694,0.20915032679738563,0.651848238939501,1.0,6/10,30.36%,ZBTB16;SOX5;ACVRL1;SOX6;BMPR1B;GDF6
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.47590195825982706,1.2221149648996388,0.21311475409836064,0.7189857935687698,1.0,7/14,26.44%,U2AF2;SFSWAP;C1QBP;RBMX;SRSF9;PCBP4;SRSF10
prerank,positive regulation of cell killing (GO:0031343),0.49505842750500095,1.2220204161865176,0.23694029850746268,0.7180014097832269,1.0,4/13,14.53%,RAC1;NOS2;MAPK8;NOXO1
prerank,hematopoietic stem cell proliferation (GO:0071425),0.5013813344269282,1.2218587800135488,0.23185840707964603,0.7172531288112818,1.0,4/11,12.07%,WNT2B;WNT10B;CD34;RUNX1
prerank,negative regulation of metabolic process (GO:0009892),0.3435155668722285,1.2217823258183613,0.1546218487394958,0.7162771477462518,1.0,14/54,16.06%,DDIT3;PLCL1;PCTP;TLR4;LAMA4;FLCN;TFE3;ID1;WNT10B;ABHD6;PLCL2;ZDHHC7;NRDC;ACVR2B
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.3982019467272184,1.2216254207694497,0.195578231292517,0.7155236274623554,1.0,6/29,8.25%,ITGAM;CADM1;CYRIB;RAET1E;NOS2;IL12B
prerank,intracellular sterol transport (GO:0032366),0.47934529459141306,1.2214388361248185,0.2202729044834308,0.7149585949151535,1.0,6/13,25.91%,NPC1;NPC2;OSBP;SERAC1;VPS4A;ABCA1
prerank,neuron projection development (GO:0031175),-0.26936581534859433,-1.221267976937453,0.06528189910979229,0.6531004262313173,1.0,29/168,9.57%,CNTNAP2;NLGN1;GRM7;CTNND2;FRY;NYAP2;LRRK2;GPM6A;BDNF;APP;CTTN;RAPGEF2;VAPA;DCLK1;EHD1;MAP2;APOE;SHANK3;STMN4;GSK3B;SH3GL2;CDC42;TOR1A;PAK3;ERCC6;LGI1;ATP7A;RASGRF1;CNTNAP1
prerank,positive regulation of hydrolase activity (GO:0051345),0.3015941450190767,1.2207483208101115,0.11885895404120443,0.7160231612313991,1.0,29/137,15.49%,SRGAP2;DOCK8;F11R;ITGA6;ARHGAP27;MAP4K4;RAP1GDS1;ASAP3;PICALM;TGM2;RGS10;TBC1D7;SNX18;CCL3;FLCN;SGSM2;RAB3GAP1;DOCK10;LIMS1;RAPGEF3;PINK1;PIN1;SEMA4D;TBC1D30;EZH2;MAPK8;RTN4R;NDUFA13;SNX13
prerank,negative regulation of actin filament polymerization (GO:0030837),0.4233243087622584,1.2202614533486376,0.20841683366733466,0.7163124518091344,1.0,7/22,14.18%,SSH2;TWF2;CYRIB;PRKCD;SSH1;HIP1R;PFN4
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.48612601126899885,-1.2200139218969968,0.2112970711297071,0.6553303695100048,1.0,7/12,16.09%,GSN;CIITA;MID2;IFITM3;LY6E;IFITM2;IFITM1
prerank,peptidyl-arginine modification (GO:0018195),0.4630284994484833,1.219975203620876,0.21960072595281308,0.7160262732571646,1.0,6/15,22.68%,ART4;PADI2;PRMT8;PRMT1;NDUFAF5;PARK7
prerank,transition metal ion homeostasis (GO:0055076),-0.3834279528944863,-1.2198908296792208,0.16989247311827957,0.6541912495099208,1.0,9/28,15.46%,FTL;ABCB7;NEO1;B2M;PRKN;TFR2;HMOX1;FBXL5;CYBRD1
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.5037547309691423,-1.2198823451856202,0.23492723492723494,0.6527080687570838,1.0,6/10,22.86%,JARID2;SIRT1;DNMT3B;RIF1;DNMT1;MYB
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.4039098201382762,1.2196618743904482,0.17747440273037543,0.7158803906713859,1.0,14/25,32.25%,SRRM1;SF3B1;TRA2B;SLU7;PRPF4;PRPF3;SNRNP40;GEMIN2;MPHOSPH10;SRSF10;SF3B3;TXNL4A;PRPF8;SF3B4
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.3019392418954611,-1.2196234625957694,0.09264305177111716,0.6519243542394518,1.0,14/80,9.67%,NLGN1;EPS8;AUTS2;GPM6A;ARHGAP35;HTT;ACTR3;TENM2;PALM;RIPOR2;CDC42;FAM98A;ABI2;CCDC88A
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.4279615895682948,-1.219559508597912,0.2229580573951435,0.6505595423938759,1.0,10/19,27.19%,ALDH1L1;SLC46A1;SHMT1;MTHFD1L;MTHFD2L;FPGS;FOLR2;MTHFD2;SLC25A32;DHFR
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.4052670544026573,-1.2195595078390256,0.18625277161862527,0.6475753243095004,1.0,6/23,8.71%,DAB2;SDCBP;ING2;GIPC1;HIPK2;ZEB2
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.4052670544026573,-1.2195595078390256,0.18625277161862527,0.6475753243095004,1.0,6/23,8.71%,DAB2;SDCBP;ING2;GIPC1;HIPK2;ZEB2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.479797786746453,1.219499827474632,0.19642857142857142,0.7151680024340552,1.0,4/13,12.55%,TGFBR2;SHH;NOTCH4;ENG
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.4405233788839494,-1.2194070065444622,0.21171171171171171,0.6465883690011736,1.0,6/17,14.09%,PID1;PFKFB1;HDAC4;FIS1;TIGAR;CBFA2T3
prerank,organelle transport along microtubule (GO:0072384),-0.3697937750127146,-1.219333444223278,0.17592592592592593,0.6453052628842477,1.0,10/31,14.71%,BICD1;BORCS5;HTT;RAB6A;CDC42;KIF5B;COPG2;RHOT2;ARHGAP21;BICDL1
prerank,dorsal/ventral pattern formation (GO:0009953),0.4281397161841104,1.2189870964617293,0.20913884007029876,0.715736171104827,1.0,5/20,15.62%,GREM1;FBXL15;SHH;MDFI;NOG
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.3482278583207641,1.218692663569482,0.16267942583732056,0.715469196554246,1.0,25/52,29.67%,EXTL3;PREB;HYOU1;PDIA5;DNAJB9;GFPT1;KLHDC3;CXXC1;PLA2G4B;PPP2R5B;VAPB;TSPYL2;EDEM1;SYVN1;HDGF;SEC31A;CTDSP2;SERP1;DNAJB11;FKBP14;SRPRB;DDX11;ACADVL;ZBTB17;MYDGF
prerank,retina homeostasis (GO:0001895),-0.39552612472863197,-1.218555754758716,0.18140589569160998,0.6462745123688624,1.0,8/23,20.55%,B2M;PRDX1;SLC28A2;ACTB;POTEF;JCHAIN;LTF;ACTG1
prerank,nucleoside phosphate catabolic process (GO:1901292),0.4801699946296242,1.2181222516764538,0.2222222222222222,0.7162001191621917,1.0,3/13,12.73%,ENTPD1;NUDT15;ENTPD7
prerank,response to axon injury (GO:0048678),0.44485745639030816,1.2175634545248204,0.21575984990619138,0.716881871687311,1.0,3/18,6.30%,RTN4RL1;P2RY12;NREP
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2953112823796211,1.217339283676057,0.1111111111111111,0.716449609633438,1.0,33/148,16.02%,NUAK1;RHNO1;CHEK2;CSNK2A2;CSNK2A1;RFC2;ATM;NBN;TAF12;RAD17;RFFL;MDM4;PDPK1;TAF6;PIP4P1;POU4F1;CHD3;EHMT2;BOP1;MTOR;PRDM1;MLST8;BRCA1;TAF1;EXO1;RAD1;PIN1;PLK3;TAF4;BLM;AKT1;MAPK14;AURKA
prerank,myeloid cell differentiation (GO:0030099),-0.33582144448137013,-1.2169425935015685,0.16169154228855723,0.6497866051278341,1.0,11/47,13.59%,ZBTB16;KMT2E;JAK2;RASGRP4;FLVCR1;HIPK2;PTPN2;RPS14;CEBPA;KIT;KAT6A
prerank,receptor metabolic process (GO:0043112),0.3459659241908493,1.2167416941339033,0.1689419795221843,0.7172965377498443,1.0,11/53,10.45%,DNM2;PHETA1;CD9;ARRB2;PICALM;SMURF1;ITGB2;LGMN;SH3GLB1;LRP1;GRK2
prerank,nucleic acid metabolic process (GO:0090304),0.32841467751870734,1.2166190742725262,0.15728476821192053,0.7164743854133232,1.0,22/69,24.00%,NCBP1;POLR2H;POLR2J;HNRNPA3;DXO;HNRNPC;POLR2D;PCBP2;HNRNPH1;HNRNPR;MMS19;DDX54;DNASE2;POLR2E;DUSP11;METTL14;RBMX;HNRNPA2B1;POLR2I;TOPBP1;LSM8;HNRNPA1
prerank,protein localization to chromatin (GO:0071168),-0.42261936509940545,-1.2165797564571388,0.21179039301310043,0.6494487642014303,1.0,8/18,27.81%,MCM9;SGF29;PPHLN1;PIH1D1;MSH2;FAM47E;PLK1;MCM8
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.29146500195058506,-1.2161719684806165,0.12359550561797752,0.6493147008807777,1.0,28/95,17.44%,GPC6;HS3ST5;B4GALT5;ST3GAL1;ST3GAL4;B4GALT6;UST;CHSY3;HS3ST2;EXT1;DSE;SDC3;GPC5;HS6ST2;HS3ST1;HSPG2;VCAN;B4GALT2;GPC3;PXYLP1;CSPG4;NDST1;GPC4;CSGALNACT2;EXT2;AGRN;LUM;B4GALT7
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.27900753321973604,-1.2158482715715162,0.08010335917312661,0.6488644504894148,1.0,35/125,17.98%,KNL1;CENPF;DYNC1I2;CENPT;CDCA8;CENPP;ZW10;SPDL1;NUP98;EML1;BIRC5;RAN;CENPE;NDC80;PLK2;RPS27;NUSAP1;BUB1B;SPC25;KNTC1;AURKB;KIF11;DLGAP5;BUB1;TTK;GPSM2;ERCC6L;NUP43;DCTN6;MAD1L1;RCC2;CENPS;CCNB1;KIF4A;SPC24
prerank,filopodium assembly (GO:0046847),0.45627176170427275,1.2155027499658928,0.22621184919210055,0.7190474917441634,1.0,5/16,11.31%,SRGAP2;FGD2;PPP1R9B;SPATA13;FGD3
prerank,positive regulation of dendritic spine development (GO:0060999),-0.4066977957096936,-1.2154234419297167,0.2109004739336493,0.6486630295284542,1.0,4/20,4.64%,NLGN1;CPEB3;APOE;SHANK3
prerank,positive regulation of type 2 immune response (GO:0002830),-0.4502309283669617,-1.2153798203416482,0.21841541755888652,0.6473155227812801,1.0,5/14,10.07%,CD74;RSAD2;DENND1B;PRKCZ;RARA
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.26735651090193757,-1.2153689637829619,0.05,0.6458921604841564,1.0,40/186,15.49%,DAB2;CCDC88C;SHISA6;CUL3;LIMD1;HECW1;PSMD14;LATS1;APC2;RBMS3;LRP6;APOE;GSK3B;TRABD2B;PSMD8;MLLT3;IGFBP4;PSMA2;FRZB;PSMF1;PSMD6;PRKN;TLE4;AXIN1;PSME2;SOX13;NXN;NLK;GRB10;TLE1;PSMD5;PSMD12;MCC;NPHP3;IGFBP2;PSMD11;NKD1;SCYL2;SFRP1;PSMD1
prerank,negative regulation of autophagy (GO:0010507),0.3458277873505658,1.2153495080363952,0.1717171717171717,0.7182678204687207,1.0,16/54,14.80%,SNRNP70;SIRT2;CPTP;EIF4G1;FOXK2;MET;TAB2;MTOR;USP36;RASIP1;BMF;PINK1;KDM4A;IL10RA;AKT1;RRAGA
prerank,interstrand cross-link repair (GO:0036297),0.3471992321084358,1.21531360045296,0.1497504159733777,0.7171465548388368,1.0,20/53,22.47%,RAD51AP2;WDR48;RPS27A;UBC;FANCM;POLN;SLX4;FAAP24;RNF8;FANCG;DCLRE1B;ERCC4;DCLRE1C;FANCI;FANCA;DCLRE1A;FAAP100;UBE2T;RPA3;RFWD3
prerank,amino acid import across plasma membrane (GO:0089718),0.4199994724407403,1.215235190648309,0.20577617328519857,0.716177963346922,1.0,4/24,2.37%,SLC7A8;SLC1A3;SLC7A5;SLC36A1
prerank,regulation of mitochondrial fission (GO:0090140),-0.39549864238921056,-1.215218187611155,0.18599562363238512,0.6449783588432917,1.0,7/24,9.46%,LRRK2;MCU;DNM1L;DDHD1;PRKN;FIS1;MFF
prerank,oligodendrocyte development (GO:0014003),-0.4565403938047382,-1.215046534669987,0.19861431870669746,0.6440707822678332,1.0,5/15,9.57%,B4GALT5;B4GALT6;TPPP;MYRF;CNTNAP1
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.4314820655812817,-1.214769308322115,0.2068230277185501,0.6433813298687276,1.0,5/17,13.45%,NLGN1;SYT10;RAB3D;RAB3A;SLC4A8
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.3702121077520437,1.2133369991100242,0.18867924528301888,0.7213619679365646,1.0,7/38,6.66%,POLR3G;LY86;PRKCA;ZCCHC3;SLC15A4;AKIRIN2;DHX9
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.2585897347554051,1.2132127390879974,0.045454545454545456,0.7205289449115199,1.0,92/509,13.33%,CX3CR1;TGFBR1;IL18;TLR7;P2RY12;CFLAR;RAC1;PIM2;DDIT3;LGALS9;PIK3R1;RIPK2;GAB2;AGER;TMEM101;TGM2;ATP2C1;TLR4;LYN;MAP3K3;TRIM5;NEK6;ITGAV;IGF1R;SRC;PIK3CG;ZCCHC3;TRAF5;PHB2;PLCG2;CCL3;FLCN;RYK;CD27;CASP1;LRRC19;NDFIP2;THEM4;KSR1;TRADD;SPRY2;TRIM44;PDPK1;PIK3AP1;CD86;PDGFB;CGAS;NOS1AP;GCNT2;MET;MTDH;C1QBP;LAMTOR2;TMED4;SEC13;RPTOR;EPHA8;CCR7;IL12B;EDA2R;RASD2;SELP;GPER1;CALCR;FSHR;TAB2;AKAP13;GAPDH;LIMS1;PIK3CD;RTKN2;FRS2;PIK3CB;RNF31;TICAM2;CXXC5;MLST8;ZDHHC13;AXL;LAMTOR5;WDR24;MIB2;PRKCB;BMF;PDGFRB;PINK1;HCST;ENG;TRIM62;PTPN11;GJA1;SEMA4D
prerank,ganglion development (GO:0061548),-0.4869557422631864,-1.2130094684226442,0.2336244541484716,0.6472725136170254,1.0,1/11,0.70%,UNC5C
prerank,histone H2A monoubiquitination (GO:0035518),0.44531242298066986,1.212540131205621,0.20107719928186715,0.7216392859235247,1.0,8/17,23.63%,DDB2;BCOR;CUL4B;PCGF2;RNF2;KDM2B;RING1;PCGF3
prerank,protein glycosylation (GO:0006486),0.30221551589845336,1.2125070172349526,0.11764705882352941,0.7205587897781187,1.0,29/125,12.56%,ST3GAL6;LARGE1;MGAT4A;B3GNT2;ST3GAL5;TRAK1;ALG12;GFPT1;POMGNT1;MPI;GALNT10;TET3;ALG6;GCNT2;DPM3;GALNT1;B3GNT4;FUT7;MGAT2;POMT1;MAN1C1;MGAT5;ALG11;POFUT1;MGAT1;NPC1;GALNT7;EOGT;ALG2
prerank,positive regulation of biosynthetic process (GO:0009891),-0.35344419762397694,-1.2122042882062152,0.15085158150851583,0.6482819453945939,1.0,14/40,16.91%,SORBS1;CD36;CREBL2;VIM;ZBTB20;APOE;WNT4;CYBA;RGCC;MMP8;CCL5;SCX;MTPN;BMP4
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.41775233216662744,1.2119654992924014,0.19964028776978418,0.7211769878926526,1.0,9/22,22.83%,GREM1;NBN;PDGFB;TNKS1BP1;TAOK2;GPNMB;DDX3X;RASSF2;CALM2
prerank,negative regulation of protein modification process (GO:0031400),-0.3104888605068187,-1.2110846202213357,0.13333333333333333,0.6501970981304355,1.0,16/79,10.12%,PID1;DMD;LRRK2;XDH;SLIT2;TPPP;LRP6;NTRK3;PPIA;CADM4;GSK3B;SH3GL2;PRKN;SIRT1;MYADM;P3H1
prerank,positive regulation of apoptotic process (GO:0043065),0.2701356099012527,1.210757488943306,0.0584144645340751,0.7241234694831198,1.0,54/293,14.63%,TGFBR1;BIN1;FGD2;ARHGEF2;DNM2;CTSD;PREX1;VAV2;ITGA6;QRICH1;PRMT2;CALHM2;CRADD;DDIT3;KCNMA1;IGFBP3;TGM2;SIRT2;KLF11;RHOB;ATM;CLU;CCL3;FLCN;SUDS3;RPS27A;UBC;TRADD;ARL6IP5;C1QBP;WNT10B;PIP5KL1;GPER1;JUN;AKAP13;SLC27A4;CLIP3;PPID;PRDM11;PSENEN;BMF;FGD3;TRIO;PSEN2;APAF1;HIP1R;MAP3K10;MAP3K11;DDX20;ABL1;SOD1;LATS2;MAPK8;PYCARD
prerank,regulation of microglial cell activation (GO:1903978),-0.4420844855919943,-1.2104747324077794,0.22790697674418606,0.6505823847249148,1.0,5/15,16.01%,STAP1;LDLR;MMP8;CX3CL1;TTBK1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.4356797263368297,1.2100824448629173,0.2323943661971831,0.7250958578754702,1.0,6/19,15.71%,POLR3G;CHD8;BRF2;RPTOR;MTOR;TENM1
prerank,calcium ion transport (GO:0006816),-0.2836828731083048,-1.209471696706836,0.10315186246418338,0.6522426684935364,1.0,23/113,10.26%,ANK2;CACNA1E;ITPR1;SLC8A3;TRPC5;CCR1;RYR3;RYR2;NALCN;TRPC4;TRPM3;ATP2A2;SLC24A2;TPT1;CACNA1C;PKD2;GRIN3A;TMEM165;STIM2;TRPC3;ANO6;CHRNA4;ATP2A3
prerank,second-messenger-mediated signaling (GO:0019932),0.3183695917454387,1.2091495565246184,0.13500784929356358,0.7270435651855641,1.0,18/82,8.15%,CX3CR1;P2RY12;LAT2;PPP1R9B;PPP1R9A;TRPM4;PLCG2;AGTR2;CCL3;PDPK1;DGKD;CAMKK2;SELE;PLA2G4B;EDN3;CCR7;NOS2;EDN2
prerank,cell-cell junction organization (GO:0045216),0.32048741508874634,1.2090431989323833,0.15629984051036683,0.7261863716070328,1.0,23/79,15.64%,CADM1;CSF1R;SMAD3;DSP;CXADR;NECTIN4;TLN2;PKHD1;FLCN;FSCN1;CSK;DSG2;CDH18;CDH24;PKP3;TJP1;LIMS1;GJA4;TRPV4;NECTIN2;TJP2;CDH15;CDH3
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.35793267277693025,1.2089471553363345,0.15834767641996558,0.72524848093846,1.0,16/46,21.93%,SIRPA;CNKSR3;TLR4;LYN;FLCN;SPRY2;GPER1;RGS14;PTPN1;DUSP29;PIN1;DUSP6;TNIP1;SYNJ2BP;WNK2;SPRED2
prerank,myeloid leukocyte differentiation (GO:0002573),0.33229848756822933,1.2088480738452738,0.15609756097560976,0.7243554871702638,1.0,15/65,15.33%,TGFBR2;CSF1R;LGALS9;GAB2;SBNO2;MYH9;MT1G;CCR7;PIK3CD;PDE1B;OSTM1;RUNX1;CSF1;OSCAR;MAPK14
prerank,N-terminal protein amino acid modification (GO:0031365),0.46282319572624725,1.2085956654026389,0.22244094488188976,0.7240469811926536,1.0,6/14,24.07%,NAA11;NAA50;NAA40;METAP2;METAP1D;NAA60
prerank,positive regulation of vasculature development (GO:1904018),0.3115449871608512,1.2084629721936289,0.14580031695721077,0.7233513606766948,1.0,18/94,12.55%,SMOC2;HK2;ANXA3;ETS1;PRKCA;RHOB;VEGFB;PDPK1;MTDH;GATA2;CD34;PIK3CD;BRCA1;PRKCB;RAPGEF3;SERPINE1;RUNX1;PDCD6
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3244987937665344,1.208274948666951,0.16198347107438016,0.7227999313965208,1.0,24/74,24.43%,TGFBR1;ARHGEF2;ITGA6;CFLAR;ITGAV;SRC;TRADD;RFFL;ZMYND11;GDNF;EYA3;BRCA1;SERPINE1;AKT1;MAPK7;THBS1;IL1A;DDX3X;BCL2L1;RNF34;PARK7;EYA4;FADD;FAIM
prerank,transepithelial transport (GO:0070633),0.46635124947332374,1.2082205784468818,0.2303473491773309,0.7217667891111325,1.0,6/15,24.65%,SLC1A3;CXADR;SLC23A2;SLC23A1;SLC26A6;GPLD1
prerank,response to chemokine (GO:1990868),0.47961270982565296,1.2080762190819827,0.22532588454376165,0.721033656486804,1.0,4/13,15.47%,DOCK8;LRCH1;WNK1;STK39
prerank,response to endoplasmic reticulum stress (GO:0034976),0.30540061846795813,1.208006223827258,0.13725490196078433,0.7200344629449013,1.0,18/107,11.01%,BAG6;HYOU1;QRICH1;DDIT3;PIK3R1;SEL1L;DNAJB9;FICD;CREB3L2;EIF2S1;ATF3;ERLEC1;MBTPS1;USP19;OS9;JUN;MBTPS2;SCAMP5
prerank,negative regulation of telomere maintenance (GO:0032205),0.4636893955365164,1.2071785467677503,0.21811460258780038,0.7215594438435318,1.0,5/15,13.61%,ATM;NBN;SLX4;ERCC4;TERF1
prerank,atrial septum development (GO:0003283),-0.45236955008713065,-1.2068669897445237,0.22972972972972974,0.658782062630179,1.0,6/13,26.73%,ANK2;NPHP3;HEY2;GJA5;NOTCH2;ZFPM1
prerank,cell cycle G2/M phase transition (GO:0044839),0.2975463547692131,1.2066893824148122,0.14173228346456693,0.7220500421522578,1.0,40/129,21.89%,DNM2;SDCCAG8;TUBA4A;CSNK1E;AKAP8;CHEK2;PRKACA;AKAP8L;FBXL15;ODF2;TUBB;CEP164;TUBG1;HAUS7;CNTRL;FBXL8;TUBA1A;CEP63;CEP57;OPTN;HAUS6;PLK3;HAUS2;PPP1CB;SFI1;FBXL22;AURKA;MAPRE1;CEP135;MASTL;ACTR1A;KDM8;OFD1;KHDRBS1;CEP43;DCTN2;CCNY;CEP70;FBXL7;CSNK1D
prerank,regulation of TORC1 signaling (GO:1903432),0.37594921842290246,1.2066264421793111,0.20284697508896798,0.7210524324633337,1.0,12/33,23.43%,ATM;FLCN;PIP4P1;GPR137C;LAMTOR5;RRAGA;GPR137;SEH1L;CASTOR1;SESN1;TELO2;DEPDC5
prerank,regulation of macrophage cytokine production (GO:0010935),-0.4686780028138848,-1.206353102678211,0.22637362637362637,0.6588571983714431,1.0,5/13,18.60%,CD74;LILRB1;SIRT1;SEMA7A;IRAK3
prerank,neurotransmitter uptake (GO:0001504),0.48747756129440367,1.206321762682026,0.23247232472324722,0.7209232956571678,1.0,5/12,16.43%,SLC1A3;SLC22A2;SLC29A4;SLC29A1;SLC38A1
prerank,positive regulation of TOR signaling (GO:0032008),0.36360338665927006,1.2060053724697672,0.1916376306620209,0.7207741035968881,1.0,13/40,17.51%,FLCN;PIP4P1;LAMTOR2;SEC13;RPTOR;GPR137C;NCKAP1L;MLST8;LAMTOR5;WDR24;RRAGA;GPR137;SEH1L
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.47121151754846063,-1.2049721117984236,0.23024830699774265,0.6615801093601755,1.0,2/12,2.21%,SORBS1;IRS1
prerank,positive regulation of microtubule polymerization (GO:0031116),0.39191317144226134,1.2044202443395837,0.19884169884169883,0.724959028350345,1.0,4/28,7.25%,NAV3;RAC1;NUMA1;MET
prerank,steroid metabolic process (GO:0008202),0.3225204937765483,1.2041942112061785,0.1527331189710611,0.7244991223613116,1.0,15/72,16.45%,FDXR;HSD3B2;HSD17B1;LGMN;DHRS4;SHH;CYP46A1;AKR1D1;SULT2A1;NPC1;CYP7B1;TSPO;FDX1;HSD17B10;CYP2R1
prerank,response to progesterone (GO:0032570),0.4318709335763511,1.204087522433793,0.22527472527472528,0.7236195028088426,1.0,7/18,24.41%,SRC;UBE3A;THBS1;ACOD1;TGFB1;CATSPER2;WBP2
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.3655909163421412,-1.2037657388685703,0.1975609756097561,0.6637958256703673,1.0,8/29,9.04%,GRIK2;SHISA9;SHISA6;APP;APOE;SLC4A10;NETO1;RAB3A
prerank,clathrin-dependent endocytosis (GO:0072583),-0.3822083914138999,-1.2037437662764083,0.20465116279069767,0.6624124726310189,1.0,6/26,3.88%,DNAJC6;AP2A2;ITSN1;SNAP91;SIGLEC1;SGIP1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.29390005070350617,-1.2033255284908795,0.14058355437665782,0.6622701006440279,1.0,18/90,13.37%,ESRRG;CCR2;KSR2;CD36;FABP4;JAK2;PLAC8;IRF4;CEBPB;ADIPOR2;PER2;ZBTB7B;THRA;G0S2;GRB10;PRDM16;ALMS1;ACHE
prerank,positive regulation of TORC1 signaling (GO:1904263),0.45067636170783065,1.202624609685738,0.2199630314232902,0.7275009592558874,1.0,7/16,17.51%,FLCN;PIP4P1;GPR137C;LAMTOR5;RRAGA;GPR137;SEH1L
prerank,Rac protein signal transduction (GO:0016601),0.44526040565495745,1.2025956739147043,0.23214285714285715,0.7264076801428593,1.0,6/18,10.91%,ELMO1;RAC1;AIF1;RHOH;HACD3;CYFIP1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.33729360760335,-1.2022880627887955,0.1529126213592233,0.6640758194313264,1.0,13/45,13.66%,OAS2;CD44;CIITA;B2M;JAK2;SP100;IRF4;NCAM1;VCAM1;IFNGR1;PTAFR;GBP2;OAS3
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.41978196141903235,-1.2022399715092071,0.21100917431192662,0.6627757438856757,1.0,7/20,21.40%,ITGA4;GSN;CD40;ANO6;RGCC;PRKCI;PLA2R1
prerank,regulation of hemopoiesis (GO:1903706),0.5069106328025892,1.2019774878762883,0.23992673992673993,0.7273850408112471,1.0,3/10,12.07%,MYSM1;PRKCB;RUNX1
prerank,cytoskeleton organization (GO:0007010),0.2997039674651877,1.2014210431318408,0.12883435582822086,0.7279643510496787,1.0,18/114,6.34%,BIN1;FGD2;DST;RAC1;RND1;ARAP3;ZRANB1;CAPZB;RANBP10;FMNL3;RHOB;RHOBTB1;CCL3;CAMSAP1;PLD2;RND2;RHOH;SIPA1
prerank,DNA double-strand break processing (GO:0000729),0.4406641547151947,1.2008911337329924,0.23134328358208955,0.7285232342619243,1.0,8/18,17.86%,ATM;NBN;RNF138;SLX4;BRCA1;UBE2V2;BLM;KAT5
prerank,endothelial cell development (GO:0001885),-0.3860639905210318,-1.2005953467301311,0.21016166281755197,0.6664576530523026,1.0,11/25,28.40%,PDE4D;RAPGEF2;MYADM;PDE2A;PECAM1;MSN;EZR;ICAM1;TNMD;CNMD;PPP1R16B
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.41185459362691956,1.2003277181699594,0.20795660036166366,0.7292938874860104,1.0,8/24,19.87%,NFE2L2;PDPK1;GATA2;SERPINE1;TNIP2;MAPK7;GATA3;KRIT1
prerank,cellular response to organic substance (GO:0071310),0.3008440099030245,1.2000349569427267,0.14125200642054575,0.7291133246866296,1.0,29/116,17.22%,TGFBR1;IL18;TGFBR2;CSF1R;SMAD3;TWF2;IL1RL2;CRNN;CDK9;CCL3;CASP1;PDGFB;ARL6IP5;CCR7;PLK5;POU4F1;INPP5K;DCPS;PTPN11;IL18BP;GHR;LDLRAP1;MAPK8;CIB1;NCOA3;ACVR2B;PTPN5;MAPK7;PTPN23
prerank,cytoplasmic microtubule organization (GO:0031122),0.3382006202141436,1.1999301442291217,0.18076285240464346,0.7282745314194046,1.0,12/54,14.87%,DST;HOOK2;CCDC88B;CAMSAP1;NUMA1;TUBGCP5;WDR73;CAMSAP2;CLIP3;TRPV4;PLK3;CIB1
prerank,positive regulation of heart rate (GO:0010460),-0.42706304257341465,-1.1986901469940918,0.22811059907834103,0.6707576039083326,1.0,4/17,3.96%,PDE4D;ADRA1A;RYR2;ATP2A2
prerank,negative regulation of cell growth (GO:0030308),0.2957141988638566,1.198244604838882,0.13782051282051283,0.7328594423551051,1.0,30/121,18.43%,FGF13;SMAD3;ULK2;CDKL3;DIP2B;PPP1R9B;CCDC85B;OSGIN2;AGTR2;FLCN;SIPA1;NDUFS3;PPT1;APBB2;SEMA3G;SOX17;NME6;PRDM11;SMARCA2;OSGIN1;GJA1;RTN4R;TSPYL2;NDUFA13;DACT3;VGLL4;MAG;ULK1;PTPRJ;NAIF1
prerank,lymphocyte differentiation (GO:0030098),0.3283075280601706,1.1981696893372196,0.1778846153846154,0.7319304021791354,1.0,22/68,22.12%,BLNK;IKZF1;LYL1;GPS2;DNAJB9;PLCG2;CHD7;RHOH;JAG2;PIK3CD;AXL;CEBPG;RELB;HDAC5;TCF3;GATA3;PTPRJ;TPD52;ADAM17;CD79A;GPR89B;GPR89A
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.503646578861624,-1.1977860741969224,0.2515463917525773,0.6721099049310347,1.0,5/10,20.79%,RIC1;RGP1;ANXA2;CDK5RAP3;EPHA4
prerank,regulation of water loss via skin (GO:0033561),0.4542081974917249,1.1975477064701474,0.23574144486692014,0.7317019051276032,1.0,3/15,9.21%,ALOXE3;MET;LSR
prerank,establishment of skin barrier (GO:0061436),0.4542081974917249,1.1975477064701474,0.23574144486692014,0.7317019051276032,1.0,3/15,9.21%,ALOXE3;MET;LSR
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.2866493686472571,-1.1973991838584028,0.125,0.6719073017835622,1.0,20/93,12.24%,DMD;PDE4D;CD44;EGFR;NCK2;BDNF;APP;LATS1;CREBL2;NTRK3;NLRP2B;AXIN1;IRGM;INPP5J;SPTBN4;OPRD1;NSD1;DDIT4;PAQR3;RAF1
prerank,cellular response to calcium ion (GO:0071277),-0.312467665707848,-1.1966281792311484,0.15384615384615385,0.6727902903255985,1.0,26/67,23.77%,NLGN1;IQGAP1;SYT1;RYR3;KCNH1;CARF;SYT10;ALOX5AP;PKD2;CPNE8;CPNE4;RASGRP2;SLC25A24;ADCY8;CHP2;CRHBP;SYT3;HPCA;CPNE2;ALOX15;CPNE6;BRAF;NEUROD2;PRKAA1;PPIF;SYT5
prerank,ventricular septum morphogenesis (GO:0060412),0.4000571661669238,1.1955038981556756,0.2111111111111111,0.7375935649065747,1.0,4/27,1.47%,TGFBR1;TGFBR2;SMAD7;HEYL
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3260361240492476,1.195467930111947,0.18090452261306533,0.7365201090799784,1.0,18/64,23.96%,DAGLB;ALOXE3;ACAD9;ACSL4;PLA2G4A;HPGD;PLA2G4B;SLC27A4;FADS1;GPX4;CPT1A;DAGLA;HACL1;ACOT1;ACOT8;SCP2;ABCD1;ACOT4
prerank,regulation of protein autophosphorylation (GO:0031952),0.3705832534236075,1.1953942147160292,0.19786096256684493,0.7356042567130213,1.0,13/36,22.83%,NBN;IMPACT;PDGFB;TNKS1BP1;PPP2R5B;ENG;TAOK2;GPNMB;PPP2R5A;ERRFI1;DDX3X;RASSF2;CALM2
prerank,DNA damage checkpoint signaling (GO:0000077),0.3897874028518379,1.1953336662868377,0.21880650994575046,0.7346052984619502,1.0,8/28,13.38%,RHNO1;CHEK2;ATM;NBN;RAD17;USP28;RAD1;CEP63
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.4987839131530829,1.1952762330587403,0.24500907441016334,0.7336111993052973,1.0,2/11,2.98%,PJA2;LYN
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.3592381111683227,1.1948349258185147,0.20107719928186715,0.733844228824819,1.0,10/40,16.01%,GNA12;SMURF1;CSNK2A2;CSNK2A1;CLU;PTK2B;ARAF;TAF1;UBE3A;CCDC22
prerank,postreplication repair (GO:0006301),0.3500135319725255,1.1947714397345581,0.21338155515370705,0.7329088755009957,1.0,16/45,24.48%,PCNA;PRIMPOL;RFC2;RPS27A;UBC;POLN;BRCA1;POLD2;UBE2V2;PCLAF;UBE2A;RFC1;RPA3;ZBTB1;SPRTN;POLD4
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.4307042107180633,-1.1947269862447754,0.226215644820296,0.6770892518307525,1.0,6/16,19.58%,VIM;WNT4;RGCC;SCX;BMP4;SUCO
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.4564841041196054,1.1945471441994289,0.2332155477031802,0.7324697849610706,1.0,5/15,12.95%,FAM98B;CSTF2;TSEN2;CPSF1;TSEN54
prerank,protein phosphorylation (GO:0006468),0.25595234861443866,1.1933936034915689,0.05179282868525897,0.7351922245209003,1.0,109/479,18.02%,TGFBR1;MERTK;NUAK1;TGFBR2;TLR7;ABI3;CSF1R;SMAD7;BMP2K;ULK2;CSNK1E;CDKL3;PIM2;MAP4K4;IGFBP3;RPS6KA1;CHEK2;TLR4;PRKCA;PRKACA;LYN;EFEMP1;MAP3K3;CDK9;TBCK;NEK6;CSNK2A2;CSNK2A1;IGF1R;SRC;ATM;MKNK1;PRKCD;MAP4K3;RYK;NEK3;CAMK1D;PTK2B;ULK3;STRADA;RPS6KA5;CSK;PDK1;PDPK1;NRBP1;PKN3;CAMKK2;PDGFB;VRK3;EPHA8;TSSK4;TSSK6;PIK3CD;MTOR;WNK1;NUAK2;PDK2;GRK2;PRKCB;PDGFRB;EEF2K;TAF1;PKDCC;MAP4K2;PINK1;HCST;DDR2;BAZ1B;MUSK;UHMK1;CDK11B;TAOK2;MAP3K10;MAP3K11;MARK2;NEK7;ABL1;PXK;BMX;CCNE1;MORC3;LATS2;MAST3;MAPK8;DYRK1A;AKT1;FAM20B;DYRK4;PICK1;MAPK14;STK39;PASK;STK19;TEC;MAP2K1;AURKA;ACVR2B;MASTL;ULK1;CDC42BPB;ADAM10;RPS6KA4;TRIB1;LIPE;EIF2AK2;EIF2AK1;VRK2;FES;ROCK2
prerank,regulation of ion transport (GO:0043269),-0.2962010756177571,-1.1933647059828814,0.1478494623655914,0.6799229180409125,1.0,18/76,15.29%,NKAIN2;ANK3;KCNJ3;SYT1;B2M;NEDD4L;SYT10;TOR1A;PRKN;SPTBN4;SIK1;CHRNA4;ATP1A1;DTNBP1;NKAIN3;PER1;SYT3;SNCA
prerank,cellular response to nitrogen compound (GO:1901699),0.42879734943459313,1.1931527523438135,0.2068345323741007,0.7347656475573161,1.0,11/20,34.84%,EPG5;SPIDR;BLM;ROCK2;NSMCE3;RTF2;ATP2B4;DDX11;ATRX;PDE12;DDI2
prerank,negative regulation of neuron projection development (GO:0010977),-0.32342681568920384,-1.1929229673888406,0.1630170316301703,0.6797872222132114,1.0,12/56,14.31%,NLGN1;DCC;SPOCK1;BCL11A;LINGO1;APOE;RTN4;KANK1;STMN2;PAQR3;MINAR1;THY1
prerank,epidermal cell differentiation (GO:0009913),0.36238053785608565,1.1925775915589005,0.19310344827586207,0.73550391156451,1.0,7/41,11.12%,DSP;CERS3;ST14;ERCC2;OVOL2;SPRR1A;ASAH1
prerank,negative regulation of locomotion (GO:0040013),-0.4677006640723044,-1.1925504848589008,0.2465753424657534,0.6794949594812454,1.0,3/12,8.09%,FRMD5;SPOCK3;PTPN2
prerank,keratan sulfate metabolic process (GO:0042339),0.3833237444563438,1.192212645584577,0.21317157712305027,0.7355699704140631,1.0,7/31,8.27%,ST3GAL6;HEXB;B3GNT2;PRELP;CHST1;HEXA;B3GNT4
prerank,long-term memory (GO:0007616),-0.40725910028697,-1.1920374225686647,0.2209026128266033,0.6795949423453902,1.0,9/19,24.24%,LDLR;CAMK4;CPEB3;APOE;RASGRF1;EIF2AK4;CALB1;SLC2A4;ARC
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.2699774292756984,1.191657208861613,0.09497206703910614,0.7362556831843657,1.0,63/259,18.78%,SRGAP2;FGD2;OPHN1;ASAP1;EXOC7;P2RY12;RAC1;MAP4K4;RILPL1;AIF1;KIF3B;BBS9;PPP1R9B;EHD4;TTLL3;CEP162;PKHD1;UBXN10;HYLS1;RP2;FSCN1;ATP6V1D;CEP164;ARFIP2;DYNLT2B;CFAP52;TTC36;NME8;AVIL;CFAP221;RAB1A;MKS1;INPP5K;NUDCD3;INPP5E;CCDC28B;CYFIP1;GALNT11;SPATA13;FGD3;IFT52;BBS2;CDC14B;KIF27;ATAT1;IFT20;WDR90;CFAP20;PDE6D;PMP22;TCTN1;KIF3A;ARL3;CD2AP;PTPN23;CCDC66;EXOC6;VSTM5;OFD1;B9D1;CPLANE2;SSX2IP;TMEM17
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3150495844794486,1.1915399009955543,0.16051364365971107,0.73549625256341,1.0,18/75,14.70%,LRP5;PKIG;UCHL1;INCA1;LYN;PRKCD;SLC8A1;SPRY2;CDK5RAP1;INPP5K;PIK3CB;RGS14;RASIP1;PTPN1;ABL1;LATS2;PYCARD;AKT1
prerank,negative regulation of immune effector process (GO:0002698),-0.4546787945461114,-1.191346479093847,0.2317596566523605,0.6803204170668891,1.0,2/13,1.75%,CD47;LILRB1
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.5063133511366823,-1.1912324641269365,0.2742616033755274,0.6792258296288002,1.0,5/10,19.32%,PPARG;RARG;RARA;RARB;SNW1
prerank,negative regulation of synaptic transmission (GO:0050805),-0.38637244669619575,-1.1905713457900835,0.24,0.6797952306360459,1.0,7/23,16.06%,LRRK2;ATAD1;SLC24A2;MTMR2;PLK2;ACHE;GRIK3
prerank,skin development (GO:0043588),0.3282372516926826,1.1902701021470792,0.16887417218543047,0.7387360898577742,1.0,10/65,11.32%,ITGA6;ALOXE3;DSP;CERS3;ST14;MET;SPRR1A;LSR;ASAH1;DLL1
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.45363801310587354,-1.1902679379085053,0.23648648648648649,0.67935052862188,1.0,3/13,9.05%,LRRK2;SCFD1;SMCR8
prerank,cell projection organization (GO:0030030),0.38815669052170765,1.190229530414579,0.22283609576427257,0.7377137590223225,1.0,8/30,12.28%,P2RY12;RAC1;PLEK;RHOQ;RHOH;NCKAP1L;CYFIP1;CSPG5
prerank,regulation of cell cycle (GO:0051726),0.269144906127825,1.190226521118332,0.09142053445850915,0.7365584888463518,1.0,57/271,17.12%,TGFBR1;BIN1;TTC28;MLXIPL;SON;SMAD3;PIM2;SIRT2;PPP1R9B;PRKACA;CDK9;NEK6;CSNK2A2;CSNK2A1;RHOB;ATM;NBN;HBP1;HPGD;AFAP1L2;SIPA1;PES1;MAEA;TAF6;THAP1;APBB2;IL12B;CKS1B;GPER1;POU4F1;INHA;JUN;BOP1;RNF20;PRDM11;FBXL8;BRCA1;CDC14B;UHRF2;LIN9;UHMK1;CDK11B;E4F1;TARDBP;NEK7;PCLAF;ABL1;TSPYL2;FBXL22;PROX1;MAP2K1;XIAP;MED25;MASTL;RPRM;ADAM10;LIN37
prerank,regulation of mitochondrion organization (GO:0010821),-0.32680061687876766,-1.1899356724506212,0.18691588785046728,0.6789600850575179,1.0,11/47,10.07%,PID1;LRRK2;IAPP;DNM1L;GSK3B;PARL;GOLPH3;PRKN;FIS1;MFF;RHOT2
prerank,positive regulation of cartilage development (GO:0061036),-0.423369003471286,-1.1885798957072213,0.22544642857142858,0.6818511070292674,1.0,9/17,32.23%,ZBTB16;SOX5;SCX;ACVRL1;BMP4;SOX6;BMPR1B;GDF6;BMP1
prerank,cellular response to metal ion (GO:0071248),-0.27605115424813337,-1.1884215517955312,0.09550561797752809,0.6808590662930215,1.0,29/123,15.29%,DLG2;NLGN1;ANK3;IQGAP1;LRRK2;EGFR;SYT1;RYR3;B2M;KCNH1;GLRA1;CARF;SYT10;ALOX5AP;PKD2;CPNE8;CPNE4;PRKN;RASGRP2;SLC25A24;ADCY8;TIGAR;TFR2;GLRA2;CDH1;CHP2;CRHBP;SYT3;SNCA
prerank,regulation of cell projection organization (GO:0031344),0.4712342435529784,1.1884187609283818,0.26022304832713755,0.7414920173880905,1.0,5/13,13.33%,SPRY2;MOV10;MACF1;ERMN;SEMA4D
prerank,endodermal cell differentiation (GO:0035987),0.38322039478714554,1.1880013292310232,0.1944954128440367,0.741743468231331,1.0,9/31,16.08%,ITGB5;ITGB2;ITGAV;MMP2;CTR9;LAMA3;ITGA7;SETD2;COL11A1
prerank,lipoxygenase pathway (GO:0019372),0.4605367242333985,1.1879553256061117,0.23844731977818853,0.7407115399816574,1.0,5/14,13.56%,ALOXE3;HPGD;PON2;PON3;GPX4
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.263772376041634,-1.1878759640986505,0.09971509971509972,0.6810907145731172,1.0,58/168,21.08%,SAMD4A;RPL36A;PPP2R2A;RPS29;RPL30;RPL35A;RPS3;RPL4;RPS7;RPS2;RPLP2;RPL7A;SMG7;RPL41;XRN2;EIF3E;RPL26;TUT4;EIF4A3;SMG6;PABPC1;RPS27;RPL18A;RPS25;MRTO4;SMG5;RPL38;RPL37;PPP2R1A;RPS15A;RPS14;LSM1;ERI1;EXOSC7;RPL24;CNOT10;HELZ2;RPS9;TENT2;RPLP0;RPLP1;RPL8;RPL22;RPS12;SMG1;TUT1;RPS10;PATL1;RPL19;RPS6;RPL13A;RPL18;RPS5;POLR2G;RPS19;RPL23A;UPF1;RPL29
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.39995847573265086,-1.1871414526653168,0.23706896551724138,0.6818569684184603,1.0,4/20,4.42%,RSAD2;B2M;DENND1B;PRKCZ
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.3620967671376521,1.1867599324516651,0.2084063047285464,0.7435616408707052,1.0,8/38,8.34%,BIN1;KCNA5;CACNB2;DSP;TRPM4;SCN4B;DSG2;KCNH6
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.32530459535522926,1.1858652951128554,0.19262981574539365,0.7453831855553595,1.0,19/70,16.56%,ELMO1;VAV2;RAC1;PIK3R1;LYN;SRC;PRKCD;PLCG2;PLA2G6;PLD2;PIK3CB;NCKAP1L;CYFIP1;ARPC1A;ABL1;WIPF2;ARPC3;WASL;MYH2
prerank,glycine transport (GO:0015816),0.5021352074383905,1.1856774973140511,0.26811594202898553,0.7448963709348707,1.0,3/10,13.04%,SLC7A8;SLC36A1;SLC6A9
prerank,vasculogenesis (GO:0001570),0.37642960396971303,1.1849034785647654,0.21402877697841727,0.7463125510543326,1.0,8/32,15.90%,TGFBR2;SHH;SOX17;WNT7B;RASIP1;PDGFRB;ENG;CCM2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.3240532122615587,1.1847150748215742,0.18635607321131448,0.745800192848491,1.0,19/71,16.56%,ELMO1;VAV2;RAC1;PIK3R1;LYN;SRC;PRKCD;PLCG2;PLA2G6;PLD2;PIK3CB;NCKAP1L;CYFIP1;ARPC1A;ABL1;WIPF2;ARPC3;WASL;MYH2
prerank,regulation of calcium ion transport (GO:0051924),-0.3179768716689148,-1.184692364025238,0.18160377358490565,0.6877691830039708,1.0,16/54,14.96%,ANK2;LILRB1;ATP2B1;CCR1;PLPP4;SLC8B1;HOMER1;PKD2;STIM2;IL16;ADRA2A;EPB41;FFAR1;LILRA5;CCL5;BCL2
prerank,vesicle transport along actin filament (GO:0030050),0.4308541053458521,1.1846596044504636,0.24907063197026022,0.7448355112101381,1.0,7/19,16.53%,MYO1B;MYO1F;MYO1E;MYO7A;MYO5B;MYO15A;WASL
prerank,positive regulation of interferon-beta production (GO:0032728),0.3709163887787721,1.1845896901528323,0.211340206185567,0.7439169077809689,1.0,8/33,17.11%,TLR7;POLR3G;RIPK2;TLR4;DHX9;PTPN11;MAVS;IRF3
prerank,negative regulation by host of viral process (GO:0044793),-0.4968366651328524,-1.1844892648729712,0.25792811839323465,0.6869482353873068,1.0,6/10,29.80%,VAPA;PRKN;EIF2AK4;LTF;CCL8;CRP
prerank,immunoglobulin mediated immune response (GO:0016064),-0.48868762500407414,-1.1844845493348612,0.2650862068965517,0.6855408368764276,1.0,5/10,22.73%,CD74;FCGR2B;TLR8;GAPT;CD19
prerank,positive regulation of vacuole organization (GO:0044090),0.5015101440583302,1.1843663631648194,0.2558983666061706,0.7435731583190212,1.0,3/10,9.47%,RAB3GAP2;RAB3GAP1;SH3GLB1
prerank,blood circulation (GO:0008015),-0.3198865407950267,-1.1842480980032877,0.19069767441860466,0.6848408379701116,1.0,8/49,10.90%,SGCZ;MYOF;SGCD;GUCY1B1;SERPING1;OLR1;ITGB1BP1;MEOX2
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.372896773460118,-1.1841704363857466,0.21296296296296297,0.6836769515267966,1.0,6/25,9.75%,HIP1;RBPJ;RTN4;DOK1;CCDC88A;PDE6H
prerank,regulation of peptide hormone secretion (GO:0090276),-0.30325284054895546,-1.183571651370497,0.16831683168316833,0.6841541002862065,1.0,17/67,14.82%,CACNA1E;ITPR1;KCNC2;DPP4;HTR2C;RFX3;SLC8B1;CACNA1C;ALOX5;SNAP25;PER2;CLOCK;ADRA2A;TFR2;FFAR1;CCL5;CRHBP
prerank,positive regulation of cytokine production (GO:0001819),0.26720221162367225,1.1833282603336472,0.10495626822157435,0.7459095132685296,1.0,71/292,18.02%,IL18;TLR7;POLR3G;ARHGEF2;CADM1;CSF1R;CCDC88B;DDIT3;SLC7A5;LGALS9;AIF1;RIPK2;AGER;POLR2H;CYRIB;TLR4;PIK3CG;EGR1;PLCG2;EBI3;AFAP1L2;IL6ST;DHX9;CD86;CGAS;PNP;NLRP3;CCR7;NOS2;IL12B;ORM2;IL6R;RAB1A;GAPDH;CD34;PIK3CD;APPL1;IL12RB2;POLR3H;G3BP1;BRCA1;LAMTOR5;LY9;SCAMP5;SERPINE1;HAVCR2;RUNX1;IL33;PTPN11;CEBPG;ARNT;DRD2;SOD1;MAVS;PYCARD;CXCL17;MAPK14;POU2F2;OSM;POLR2E;GBP5;STAT6;AGT;IRF3;RAB7B;POLR1C;EIF2AK2;SLC11A1;GATA3;TICAM1;ROCK2
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.4855467891571365,1.183269388883198,0.23853211009174313,0.7449633251497684,1.0,4/11,15.86%,PRKCD;PDK1;ARL6IP5;PDCD10
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.4864283514896842,-1.1828172328946929,0.27522935779816515,0.6850921789990081,1.0,3/10,7.48%,SH3RF1;IRF4;ZBTB7B
prerank,smooth muscle tissue development (GO:0048745),0.4984678268414131,1.1827246199026555,0.26436781609195403,0.7455996863363983,1.0,5/10,22.80%,SHH;ENG;SMO;PROX1;PTCH1
prerank,protein stabilization (GO:0050821),0.2789793512042289,1.1826294046548471,0.14040561622464898,0.7447487313926274,1.0,35/168,15.86%,HPS4;BAG6;SUMO1;SMAD7;PIM2;COA8;PIK3R1;SEL1L;CHEK2;VHL;PHB2;PRKCD;CLU;STX12;MDM4;TRIM44;SWSAP1;WNT10B;SOX17;USP19;GAPDH;FLOT2;USP36;PEX6;TAF1;PINK1;HIP1R;PIN1;CCT3;MORC3;MFSD1;BAG4;TNIP2;NAPG;PDCD10
prerank,positive regulation of cell motility (GO:2000147),0.27481921759197,1.1825789417055868,0.11739130434782609,0.7437739023540304,1.0,51/205,19.68%,TGFBR1;NUMB;CSF1R;ITGA6;SEMA3B;MAP4K4;VSIR;AIF1;PRKCA;FERMT3;SEMA4C;IGF1R;ATM;CCL3;SEMA4G;PTK2B;TRADD;SPRY2;PDGFB;GCNT2;SUN2;DUOX1;CCR7;GPER1;SEMA3G;TWIST2;TJP1;PIK3CD;MGAT5;PDGFRB;STX4;SEMA4D;SMO;CFAP20;CIB1;CSF1;GPNMB;PIK3R3;PDCD10;MAPRE1;LAMC2;CCAR1;ADAM10;ROCK2;MIEN1;CLDN1;PPM1F;CEP43;THBS1;CCL24;SEMA3D
prerank,sulfate transport (GO:0008272),-0.4466345440249973,-1.1823056040815507,0.2435344827586207,0.6852794559834965,1.0,6/14,22.32%,SLC25A30;RACGAP1;SLC26A7;SLC26A2;SLC26A8;SLC26A4
prerank,potassium ion transport (GO:0006813),-0.2755041083876837,-1.1822778177017754,0.1178082191780822,0.6839692023404979,1.0,20/120,8.15%,KCND2;KCNB2;KCNK10;KCNN2;HCN1;KCNC2;KCNQ5;KCNJ3;NALCN;KCNMB2;KCNH1;SLC24A2;KCND3;KCNA6;KCNQ3;KCNH7;KCNAB2;PKD2;ATP1B3;KCNH5
prerank,positive regulation of angiogenesis (GO:0045766),0.2993715331306074,1.182021519829805,0.16169544740973313,0.7444217892059944,1.0,20/108,12.55%,SMOC2;HK2;ANXA3;ETS1;PRKCA;RHOB;VEGFB;PDPK1;MTDH;GATA2;TJP1;CD34;PIK3CD;BRCA1;PRKCB;RAPGEF3;DLL1;SERPINE1;RUNX1;PDCD6
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.3881761108173132,1.1815176058473837,0.24007561436672967,0.7449762685016367,1.0,5/27,3.43%,SIRPA;CCDC88B;ETS1;CYRIB;ITGB2
prerank,macromolecule catabolic process (GO:0009057),0.40036196062523766,1.1811607521411667,0.22887323943661972,0.7450600441947969,1.0,6/26,10.14%,CAPN3;SMURF1;LGMN;PPT1;SH3GLB1;MTOR
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.3266858060352903,1.1808874322836855,0.189419795221843,0.7448622746517588,1.0,14/63,16.93%,TGFBR1;ITGA6;CFLAR;ITGAV;SRC;AGTR2;TRADD;ZMYND11;GPER1;STX4;PYCARD;BCL2L14;TNFRSF12A;AGT
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.44340916000167174,-1.1807063120594976,0.2478448275862069,0.6872237468820163,1.0,7/15,16.60%,RBPJ;EGFR;PTPN12;MVB12A;CDH13;FER;WDR54
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.32178028913108964,1.1806343011591909,0.1762820512820513,0.7446384341493335,1.0,14/67,12.55%,ELMO1;VAV2;RAC1;PIK3R1;ITGAV;SRC;SHB;VEGFB;PTK2B;PIK3CB;NCKAP1L;AXL;CYFIP1;PDCD6
prerank,regulation of cellular protein localization (GO:1903827),-0.32862791039213446,-1.1804064703796715,0.18932038834951456,0.6867119819233176,1.0,10/45,10.23%,GPC6;BDNF;GPC5;MAP2;VCPIP1;KCNAB2;TOR1A;TRIM67;GPC3;TRIM46
prerank,regulation of lamellipodium assembly (GO:0010591),0.3701066087028606,1.180096085434856,0.22905982905982905,0.7452456078337168,1.0,9/34,10.91%,ABI3;TWF2;RAC1;PIK3R1;CAPZB;FSCN1;AKIRIN1;AVIL;CYFIP1
prerank,glycerolipid catabolic process (GO:0046503),0.4170603910137396,1.179924618499675,0.2560747663551402,0.7447324724583101,1.0,4/19,11.37%,ABHD12;PLA2G4A;PLA2G4B;ABHD6
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.5073253391521397,1.1795748429130823,0.27151051625239003,0.7436110557313703,1.0,3/10,17.13%,CDC42EP2;CCR7;CDC42EP3
prerank,regulation of pseudopodium assembly (GO:0031272),0.5073253391521397,1.1795748429130823,0.27151051625239003,0.7436110557313703,1.0,3/10,17.13%,CDC42EP2;CCR7;CDC42EP3
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.3515351541807017,1.1794606690346492,0.20754716981132076,0.7428816018306293,1.0,8/46,9.07%,LIPH;PLD1;LPCAT4;PLA2G4A;PLD2;DGKD;PLA2G4B;PLA2G5
prerank,positive regulation of ERAD pathway (GO:1904294),0.47112471857937566,1.1789681879601919,0.26247689463955637,0.743404437297375,1.0,2/13,1.23%,BAG6;NFE2L2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.2511824663942594,1.17887245718149,0.07529722589167767,0.7426185009713948,1.0,97/476,17.95%,TGFBR1;ZFHX3;SALL1;MLXIPL;DNM2;LRP5;RREB1;SMAD3;BICRAL;CAPN3;ETS1;QRICH1;PRMT2;PIM2;HIVEP3;DDIT3;YWHAH;MEF2C;LYL1;SOX8;KARS1;FLI1;RPS6KA1;PICALM;TGFB1I1;PPARD;FOXE1;CHEK2;VHL;ZFP90;TNNI2;DEAF1;EGR1;PAX6;ELK1;ATMIN;TFE3;CHD8;CALCOCO1;CREB3L2;NFATC1;FOXK2;TRIM44;AFAP1L2;ILF2;CD86;SHH;JMJD6;FZD2;CXXC1;CAMKK2;PDGFB;EGR2;TRIM45;BICRA;CNBP;SOX17;JUN;RXRB;INPP5K;NOTCH4;MMS19;RNF20;PRDM11;KDM3A;PITHD1;SMARCD3;BRCA1;PAX2;NFYA;SMARCA2;RUNX1;MAP3K2;RLF;MED4;RNF187;ZIC1;ZBTB48;BLM;DYRK1A;AKT1;SNX5;TAL1;TCF3;MAP2K1;ZMIZ1;DTX3L;AGT;FZD1;NUP62;FANK1;RNF4;GATA3;KAT5;KDM8;MITF;HMGB2
prerank,lipid modification (GO:0030258),-0.3467863180036788,-1.178338806468179,0.2009132420091324,0.691837066312744,1.0,8/37,8.42%,PLA2G7;DGKB;PLPP5;PLPPR4;DGKI;PLPP4;ALOX5;PLPPR1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.4801052603926261,1.177857989618087,0.24721189591078066,0.7448034683666733,1.0,4/12,6.31%,BIN1;DSP;TRPM4;DSG2
prerank,regulation of JNK cascade (GO:0046328),0.30048802310131584,1.1778112554484048,0.1853035143769968,0.7438289580925923,1.0,24/101,15.84%,SIRPA;MAP4K4;PJA2;AGER;ITCH;GPS2;IGF1R;TRAF5;CD27;PTK2B;ZMYND11;KLHL31;CCR7;EDA2R;WNT7B;MAP4K2;PINK1;TAOK2;MAP3K10;MAP3K11;MAPK8IP1;PYCARD;TNFRSF19;SLAMF1
prerank,regulation of striated muscle contraction (GO:0006942),-0.370378741180277,-1.1775584830618426,0.22673031026252982,0.6928960797203644,1.0,5/27,5.23%,DMD;ANK2;SLC8A3;RYR2;CALM1
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.4089905060833587,1.1768098172021924,0.23877917414721722,0.7460905487171524,1.0,8/21,16.28%,CHST11;BGN;CHPF;CHPF2;CHST7;BCAN;CSPG5;CHSY1
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.4755458244893452,-1.1767736297770328,0.25427350427350426,0.6938673138437651,1.0,2/10,4.19%,LRP6;SOX11
prerank,regulation of hippo signaling (GO:0035330),-0.41661950859253444,-1.1766149462822544,0.24949290060851928,0.6929935737987275,1.0,4/17,4.19%,MOB3B;LIMD1;MARK3;SOX11
prerank,negative regulation of chemokine production (GO:0032682),0.4646344161614731,1.1765587572333183,0.2675521821631879,0.7458423242312447,1.0,2/14,1.75%,SIRPA;LGALS9
prerank,sphingoid metabolic process (GO:0046519),0.4849403214469551,1.1763193301610477,0.26373626373626374,0.745564025587503,1.0,4/12,11.49%,DEGS2;SPTLC3;PLPP1;PLPP2
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.4817494282867863,-1.1761941686802997,0.25826446280991733,0.692858291234192,1.0,5/10,20.54%,TAF7;SIRT1;SNCA;THAP7;NOC2L
prerank,actin polymerization or depolymerization (GO:0008154),-0.32170206860088335,-1.1758754494619266,0.18796992481203006,0.692513163145389,1.0,12/50,10.11%,ARHGAP6;PSTPIP1;GSN;PSTPIP2;DIAPH3;JAK2;DSTN;WASF1;MICAL3;MSRB1;ABI2;VILL
prerank,positive regulation of actin filament polymerization (GO:0030838),0.34244811396576125,1.17550449077854,0.18214285714285713,0.7471328357353583,1.0,14/44,20.53%,BIN1;BAIAP2L2;CDC42EP2;PTK2B;CCR7;NCKAP1L;SPIRE1;PYCARD;TENM1;FCHSD2;CDC42EP3;VASP;CCL24;FCHSD1
prerank,actin crosslink formation (GO:0051764),-0.4624747225306957,-1.175389886060008,0.24390243902439024,0.6926240262328823,1.0,3/12,3.45%,EPS8;GAS2;GAS2L3
prerank,regulation of interleukin-10 production (GO:0032653),0.3547876085210713,1.175365114351091,0.2306338028169014,0.7464755198572939,1.0,10/44,11.32%,LGALS9;VSIR;AGER;TLR4;PLCG2;TNFRSF21;PDCD1LG2;IL12B;CD34;DLL1
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.42210176269731337,-1.1747478951790653,0.23736263736263735,0.6933169488363358,1.0,4/16,4.62%,CD36;KCNC2;GUCY1B1;APOE
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.3648713514983219,1.1742103863028592,0.2080536912751678,0.7493253032020459,1.0,9/35,13.69%,F11R;ABI3;CSF1R;BAIAP2L2;TRPM2;PTK2B;TJP1;RAPGEF3;ABL1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.2922595554728682,1.174168049924552,0.1523809523809524,0.7483680004145206,1.0,26/119,15.59%,INPP5D;PI4KB;PIK3R1;TMEM150A;PIK3CG;PLCG2;PIGV;PIK3C3;RAB4A;PGAP2;SOCS6;DPM3;INPP4B;PIK3CD;INPP5K;PIK3CB;INPP5E;MTMR14;PLEKHA4;PIGO;MTMR4;BMX;IMPA1;CDS1;PIK3R3;PITPNM1
prerank,establishment of mitotic spindle localization (GO:0040001),-0.36945250585861344,-1.173859250163877,0.2222222222222222,0.6946786204655441,1.0,9/28,19.06%,HTT;ZW10;SPDL1;CDK5RAP2;NDC80;NUSAP1;GPSM2;ITGB1;NSFL1C
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.409159645744668,1.1737870733581437,0.2527075812274368,0.7485713130668146,1.0,5/21,17.61%,CX3CR1;SMARCD3;DRD2;PROX1;KDM1A
prerank,retrograde axonal transport (GO:0008090),-0.42106132589206957,-1.1737493429211174,0.26337448559670784,0.6936011653714897,1.0,4/16,13.59%,DLG2;ACTR10;KIF5B;TMEM108
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.43249908204285736,1.1735653930505712,0.2730696798493409,0.7482059224959117,1.0,8/18,22.68%,EDN3;EDN2;GDNF;ABL1;AGT;NOD2;POR;PARK7
prerank,pharyngeal system development (GO:0060037),0.45804409447955524,1.1735445029362823,0.23198594024604569,0.7471630394563183,1.0,1/15,0.06%,TGFBR1
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.506945961181119,1.1735155958032315,0.27358490566037735,0.746171966097682,1.0,3/10,21.37%,IMPACT;ENG;ERRFI1
prerank,negative regulation of cell adhesion (GO:0007162),-0.2944739222701623,-1.1734261250138078,0.14640198511166252,0.6932121274254684,1.0,23/72,16.15%,SPOCK1;PLXNC1;ADAM22;SEMA5A;RIPOR2;PLXND1;PLXNA2;ERBB3;PLXNB2;CDH13;ITGB1BP1;SPN;PODXL;CBLL1;CX3CL1;CDH1;JAM3;JAG1;PLXNB1;DACT2;ACVRL1;SNAI2;ARHGDIA
prerank,maintenance of protein localization in organelle (GO:0072595),0.4146850923554203,1.1732078964975499,0.2577696526508227,0.7461796714709158,1.0,5/19,14.70%,HK2;TAF8;PINK1;MORC3;AKT1
prerank,tRNA aminoacylation (GO:0043039),0.3604171618116953,1.1725969844041066,0.2255772646536412,0.7471027928904026,1.0,13/37,21.36%,KARS1;NARS1;SARS1;SARS2;RARS1;FARSA;IARS1;DARS2;EPRS1;QARS1;WARS2;IARS2;MARS2
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.4220813155478838,-1.172534732821598,0.26954732510288065,0.6944743565101296,1.0,8/16,27.07%,DPM2;PIGW;PIGX;PIGP;PIGC;PIGA;PIGB;PIGZ
prerank,regulation of T cell activation (GO:0050863),0.3459121521020968,1.17241538649595,0.22482014388489208,0.7465952129807183,1.0,10/42,16.94%,PAG1;SIRPA;CCDC88B;CYRIB;TNFAIP8L2;TNFSF8;ABL1;PYCARD;GPNMB;SPINK5
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.4092823918098645,1.1720445561062103,0.26508226691042047,0.746806608126349,1.0,11/21,31.48%,MYH9;PSENEN;PSEN2;SPPL2B;ADAM10;RBMX;ADAM17;ERAP1;APH1A;ADAM9;SPPL3
prerank,cellular response to ketone (GO:1901655),-0.3482019921160703,-1.1719213817562826,0.20316027088036118,0.6950216118051933,1.0,13/35,17.61%,ADCY2;KLF9;GOLPH3;ADCY5;SPP1;ADCY3;ADCY8;GNAI1;AHR;SFRP1;CFTR;NR3C1;MSN
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.4342398993156386,-1.1716347447566746,0.25,0.6945351907373704,1.0,2/15,2.01%,IQGAP2;ACTR3
prerank,lipoprotein catabolic process (GO:0042159),0.4945040119028917,1.1715150788180988,0.2622641509433962,0.7474541922782334,1.0,3/11,6.74%,CTSD;ABHD17C;PPT1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.2642188461493857,-1.1712789234078895,0.11830985915492957,0.6941852980513578,1.0,23/151,7.48%,CD74;CD44;CD36;EGFR;ADRA1A;FGF10;GAREM1;CCR1;DSTYK;APP;PTPN22;HTR2C;RAPGEF2;ROR1;NTRK2;PDGFD;NTRK3;PRKCZ;APOE;HTR2B;ERBB4;OPRM1;PDE8A
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.3189731232603186,-1.1709929574132505,0.18032786885245902,0.6937478505669541,1.0,8/52,5.90%,RBFOX1;RBFOX2;NOVA1;KHDRBS2;PUF60;MBNL3;CELF6;RBFOX3
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.45307034156585646,-1.1708913283180091,0.275,0.6927040378888917,1.0,5/12,23.51%,TNKS2;PARP12;TIPARP;PARP3;PARP10
prerank,growth hormone receptor signaling pathway (GO:0060396),0.45928624919914046,1.1701854764344015,0.2578397212543554,0.7507199119897028,1.0,8/14,25.89%,PIK3R1;LYN;PTPN1;GHR;STAT6;PXN;STAT5B;STAT3
prerank,central nervous system development (GO:0007417),-0.24778290830412414,-1.1701103774797317,0.07911392405063292,0.6937469749712277,1.0,56/250,16.18%,CNTNAP2;ZBTB16;NFIB;ADGRL3;SPOCK1;NRCAM;GRIN2A;GRIN2B;SLC8A3;GSN;POMK;TPPP;JARID2;ADAM22;WWP1;MYRF;CNTN6;IL1RAPL2;DCLK1;SOX11;VIT;ATP6AP2;NR4A2;POU6F2;COL4A1;SH3GL2;CDK5RAP2;EML1;PKD2;PBX1;PRKN;HSPG2;ECRG4;LIG4;VCAN;GRIN2D;PBX3;PLXNB2;ZFHX2;SERPINI1;DDIT4;GRIK1;MFSD2A;MAL;AHI1;ALDH3A2;MDGA1;ZIC5;AFF2;PKD1;SCYL2;CYP26C1;RELN;PTS;NKX2-2;BTD
prerank,regulation of cell development (GO:0060284),0.36540023941964067,1.1700791518936295,0.22168284789644013,0.7499824477508571,1.0,3/36,2.44%,CX3CR1;HEYL;FBXO22
prerank,sphingolipid catabolic process (GO:0030149),0.43924549674962304,1.1699944737501389,0.25868725868725867,0.7491703938382475,1.0,5/15,11.12%,PPT1;SMPD2;ACER3;ACER2;ASAH1
prerank,nuclear membrane disassembly (GO:0051081),0.4541866737492268,1.1694577577135505,0.25523809523809526,0.7498287772157136,1.0,4/14,11.15%,PRKCA;AKAP8L;NEK6;PRKCB
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.3460837970874918,1.1688396658091076,0.20550161812297735,0.7508153371000287,1.0,10/45,8.53%,LGALS9;RIPK2;AGER;PYDC1;TLR4;EGR1;CCL3;CASP1;NLRP3;ORM2
prerank,heterochromatin assembly (GO:0031507),-0.3989223750539207,-1.168689901752393,0.2567287784679089,0.6968173841235732,1.0,6/20,13.79%,SUV39H1;SIRT1;HELLS;H3-3A;BAHD1;CDKN2A
prerank,chemical homeostasis (GO:0048878),-0.3071712481008139,-1.1684137057350912,0.2025,0.6963406655131131,1.0,21/61,24.26%,PPARG;NEDD4L;USF1;ZBTB20;TLCD3A;AQP4;SLC4A10;CEBPA;AQP11;SLC4A8;ANGPTL3;ABHD5;TLCD3B;RBP1;PNPLA3;EIF5A2;SLC4A1;TM6SF2;FBXW7;ABCB11;WNK4
prerank,regulation of response to biotic stimulus (GO:0002831),-0.36237726216902333,-1.1681632568608382,0.2125,0.695815214611566,1.0,6/28,13.31%,CD36;PTPN22;FOXP1;FCGR2B;SAMHD1;CX3CL1
prerank,cytosolic transport (GO:0016482),0.29482741735770257,1.1678119791696104,0.18138801261829654,0.7531998907902506,1.0,36/108,23.22%,HOOK2;PHETA1;TBC1D17;TBC1D10B;AP2A1;VPS26B;SORT1;PIK3C3;YKT6;AKTIP;VPS54;CLN3;MON2;SNX5;DENND5A;SNX32;RBSN;DOP1B;PTPN23;VPS29;STX5;RAB6B;AP4M1;WDR81;VPS26A;VPS13C;VPS35;CCDC91;PREPL;SNX6;ANKFY1;STX8;RAB9A;HOOK3;VPS52;STX16
prerank,positive regulation of cellular process (GO:0048522),0.24497964114206752,1.1671073314698164,0.052830188679245285,0.7545781348099748,1.0,104/565,16.91%,TGFBR1;ZFHX3;MERTK;TGFBR2;SIRPA;MLXIPL;LRP5;CSF1R;GREM1;ETS1;FAM98B;RAC1;NCBP1;AIF1;RIPK2;RPS6KA1;GAB2;TGM2;SIRT2;KMT2D;TLR4;PRKCA;LYN;VHL;TBC1D8;CSNK2A1;ITGAV;IGF1R;ATM;TRPM4;PKHD1;PRKCD;FLCN;EIF4G1;TFE3;MEIS3;NUMA1;CAMK1D;PTK2B;MTLN;LGMN;IL6ST;CD86;SHH;PDGFB;GCNT2;EGR2;C1QBP;TCIRG1;ZFP36L1;S1PR3;CNBP;RPTOR;GATA2;EDN3;CNTF;CCR7;EDN2;GDNF;IL12B;GPER1;CALCR;CTF1;FUT7;NEUROD4;IL6R;PLA2G5;ACER3;ACER2;TJP1;PRMT1;RTKN2;IL12RB2;LRP1;DLL1;TBX6;PDGFRB;DHPS;STX4;RNF187;IL34;ADGRG1;EZH2;HTR1A;MAPK8;NOXO1;PYCARD;AKT1;CIB1;HPN;CSF1;TAL1;VIP;PROX1;CDH3;SLAMF1;PDCD10;OSM;TSPAN31;LAMC2;RAB27A;CCAR1;ADAM10;UBE2A
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.3420965128689445,-1.1670335040830018,0.2408256880733945,0.6978837523597442,1.0,6/35,3.88%,HIP1;BICD1;MKLN1;B2M;SNAP91;SGIP1
prerank,positive regulation of cell development (GO:0010720),0.3775310531958802,1.1669620163350527,0.23652173913043478,0.7539311270614447,1.0,5/31,10.84%,CX3CR1;NUMB;TGM2;GPER1;RGS14
prerank,histone H3-K4 methylation (GO:0051568),0.38049550125624526,1.1668118060006305,0.25318761384335153,0.753345664223504,1.0,12/26,29.56%,KMT2D;CTR9;TET3;CXXC1;SETD4;PRDM9;DPY30;KMT2B;WDR5;KMT2A;PAXIP1;DYDC2
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.3127485893227558,1.1662319970389927,0.20033112582781457,0.7542187045127311,1.0,14/76,9.69%,TLR7;LGALS9;AGER;TLR4;PHB2;CD27;LRRC19;TRADD;TRIM44;CD86;NLRP3;IL12B;LIMS1;RTKN2
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.44906579490334125,1.1658510987727413,0.24910394265232974,0.7544154172403277,1.0,3/14,5.89%,PYDC1;GPS2;RFFL
prerank,regulation of response to oxidative stress (GO:1902882),-0.4646562345951445,-1.1658301730740597,0.26898047722342733,0.7002354244451506,1.0,5/11,19.71%,ALOX5;PRKN;GGT7;MCTP1;STOX1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.4266804156960199,1.1656500952871396,0.27205882352941174,0.7539654652785152,1.0,3/18,2.04%,BAG6;DDIT3;PIK3R1
prerank,Ras protein signal transduction (GO:0007265),0.2853733558674034,1.1654598335610689,0.1627172195892575,0.7535153268680042,1.0,22/137,11.28%,ELMO1;ARHGAP5;GNA12;RASGRP3;RREB1;RAC1;PLD1;AIF1;USP8;CDC42EP2;RGL2;RHOB;KSR1;RHOH;HACD3;USP28;TAX1BP3;JUN;RRAS2;G3BP1;CYFIP1;RAPGEF3
prerank,diacylglycerol metabolic process (GO:0046339),0.39120542624206844,1.1654208011277976,0.24210526315789474,0.7525599796938935,1.0,9/23,19.87%,DGAT1;DGKK;PLA2G15;DGKD;MOGAT1;MOGAT2;PGS1;LIPE;DAGLA
prerank,mitochondrial transport (GO:0006839),-0.3166998510471148,-1.1652960396524974,0.1884422110552764,0.7005474846966165,1.0,18/53,17.60%,TOMM22;TIMM23;TIMM17B;FLVCR1;SLC25A24;TOMM5;SLC25A16;FIS1;MFF;BAK1;TIMM17A;FBXO7;COX18;MTX2;TIMM10;BCL2;AIP;SPG7
prerank,cartilage development (GO:0051216),-0.3210667612271586,-1.1647168787252615,0.21921182266009853,0.7010461207847339,1.0,13/49,16.91%,ZBTB16;NFIB;CD44;SULF2;SOX5;SNX19;ATP7A;FGFR3;RUNX2;SCX;PKD1;CCN3;BMP4
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.3871493632927207,1.1646004943761208,0.24061433447098976,0.7542530911092394,1.0,9/29,15.14%,LGALS9;AIF1;AGER;JAM2;LGMN;C1QBP;CCR7;SERPINE1;CXCL17
prerank,epidermis development (GO:0008544),0.3281935919626473,1.1644368862683767,0.22003577817531306,0.7538059542607386,1.0,17/56,24.02%,DSP;ATP2C1;CERS3;OVOL2;EDA2R;SPRR1A;FLOT2;DLL1;LAMA3;LAMC2;KRTDAP;SPINK5;TGM5;SVEP1;CRABP2;PTHLH;FGFR2
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.45655965472577564,-1.1642515569664933,0.2537634408602151,0.7010807751137113,1.0,3/12,4.62%,IAPP;LDLR;APOE
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.3338568323843074,-1.164195197127809,0.21686746987951808,0.6998984837702332,1.0,8/40,5.41%,ARHGAP6;EGFR;ADRA1A;BDNF;NTRK2;NTRK3;RASGRP4;HTR2B
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.3382409937345682,-1.164036895383608,0.2384428223844282,0.6990312896461777,1.0,13/38,21.72%,KNL1;CENPT;CENPP;ASF1A;MIS18BP1;CENPW;H3-3A;RBBP7;NASP;NPM1;CENPS;HAT1;OIP5
prerank,regulation of dendrite extension (GO:1903859),-0.4101505853100109,-1.1635968687343436,0.2534246575342466,0.69902902246979,1.0,7/18,21.04%,RIMS2;SYT1;NEDD4L;SYT3;RIMS1;PLAA;CPNE6
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.40922019394234327,1.163556489714065,0.24725274725274726,0.7557903067438373,1.0,4/21,7.10%,SNTA1;KCNA5;SCN4B;NOS1AP
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3546675621464642,1.1630499745211602,0.22638146167557932,0.7563465163824147,1.0,5/37,3.59%,BAG6;FHIT;UCHL5;CSNK2A2;CSNK2A1
prerank,modulation by host of symbiont process (GO:0051851),0.3716937364834274,1.162887239518412,0.23333333333333334,0.7558100795711393,1.0,7/31,14.89%,CX3CR1;CCL3;LRRC19;JUN;INPP5K;TARDBP;HPN
prerank,negative regulation of cell development (GO:0010721),-0.36928168821832885,-1.162719109217516,0.24532710280373832,0.7002513143697657,1.0,9/25,24.42%,LILRB1;B2M;GSK3B;FBN1;LTF;WNT7A;FBXW7;REST;RFLNB
prerank,mRNA transport (GO:0051028),0.29840533508855743,1.162651012570163,0.18412698412698414,0.7555012960679094,1.0,29/101,21.52%,SRRM1;NCBP1;RANBP2;MAGOHB;MAGOH;U2AF2;NUP42;SEC13;ZFP36L1;DHX38;NUP50;SRSF5;CPSF1;NUP35;RBM8A;NUP88;U2AF1L4;SLU7;FIP1L1;ALYREF;ALKBH5;NUP62;SEH1L;NUP107;THOC6;SRSF9;DDX19B;HNRNPA2B1;DDX39B
prerank,primary neural tube formation (GO:0014020),0.37090782117748716,1.1626459312758388,0.23948811700182815,0.7544500094473626,1.0,14/30,25.71%,SKI;SEMA4C;DEAF1;PAX2;MTHFD1;VANGL2;VASP;TGFB1;CELSR1;DVL2;PRICKLE1;IFT122;SCRIB;GRHL3
prerank,regulation of cell aging (GO:0090342),0.4844917360307348,1.1626386614978035,0.2987012987012987,0.7533943929216095,1.0,2/11,3.58%,NUAK1;NEK6
prerank,negative regulation of potassium ion transport (GO:0043267),0.4572904456546722,1.162529347610883,0.2725490196078431,0.7527072935309589,1.0,5/13,20.35%,BIN1;PTK2B;VIP;STK39;NOS1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.3709607061052827,-1.1622326792120363,0.23608017817371937,0.7003753766982558,1.0,5/25,8.82%,DMD;ANK3;ANK2;ATP1B3;ACTN2
prerank,regulation of myelination (GO:0031641),0.3896096276835197,1.1621873271096865,0.2618629173989455,0.7527579828724831,1.0,6/25,7.18%,SIRT2;JAM2;TNFRSF21;NSUN5;KLK8;EGR2
prerank,regulation of defense response to virus by host (GO:0050691),0.3713187514309636,1.1616549773179765,0.23693379790940766,0.7535272886250506,1.0,9/30,16.59%,RNF216;TRIM44;DHX9;SIN3A;CGAS;IL12B;MAVS;AIM2;DTX3L
prerank,regulation of endocytic recycling (GO:2001135),-0.4675833593981141,-1.1616126209211517,0.27702702702702703,0.7008970304804697,1.0,4/11,17.41%,EHD1;ACTN2;INPP5F;EHD2
prerank,positive regulation of metabolic process (GO:0009893),-0.27950470860198406,-1.1614215293319712,0.16847826086956522,0.700157033196892,1.0,22/103,16.16%,ESRRG;CCR2;KSR2;CD36;FABP4;JAK2;PLAC8;IRF4;CEBPB;ADIPOR2;PER2;ZBTB7B;THRA;G0S2;GRB10;PRDM16;ALMS1;JCHAIN;ACHE;TSHR;AGPAT1;FFAR4
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.45209726490728563,1.1613982903998203,0.2695167286245353,0.7533495592003302,1.0,3/14,8.25%,IL18;CD84;IL12B
prerank,lamellipodium assembly (GO:0030032),0.38469411978023466,1.1606044649293161,0.26335174953959484,0.7550404810261196,1.0,6/26,11.26%,SRGAP2;P2RY12;RAC1;ARFIP2;CYFIP1;SPATA13
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.24467257201115677,1.1601212948096127,0.08470290771175727,0.7555115081062188,1.0,122/572,17.98%,ZFHX3;SALL1;ETV5;RREB1;SMAD3;DNMT3A;SUMO1;SMAD7;PHF21A;HOXD9;DDIT3;MEF2C;SOX8;DDX5;SKI;SIRT2;CNOT1;PPARD;FOXE1;MTA1;GPS2;KLF11;VHL;ZFP90;CRY2;HDAC10;DEAF1;ERF;PAX6;SKIL;FLCN;SUDS3;ID1;ZNF568;CUX1;ZBTB21;CHD8;RPS27A;UBC;IMPACT;MLX;CTR9;GTF2IRD1;BCOR;ATF3;MDM4;ZBTB18;SHH;THAP1;SIN3A;PDGFB;MTDH;C1QBP;SARS1;CNBP;BCL6B;LEFTY1;CRYM;TLE6;ZBTB32;HAMP;ANKRD2;POU4F1;TMPRSS6;KLF12;MDFI;CHD3;MOSPD1;JUN;EHMT2;DPF2;NR2F1;IRF8;NOTCH4;PPID;MEF2A;CXXC5;PRDM1;RPL10;TBX6;SMARCA2;IRF2BP2;TAF1;TCF25;PCGF2;RUNX1;IL33;E4F1;MXI1;SEMA4D;BRMS1L;DDX20;WWP2;PLK3;ZNF3;ID3;EZH2;PRDM2;HDAC5;PROX1;EED;MXD1;NOG;TCF3;NRIP1;FST;ACVR2B;ZEB1;MED25;MYPOP;UXT;ZBTB2;KANK2;HDAC8;LIN37;SIN3B;TGIF1;KDM1A;GATA3;KAT5;MITF;CUX2
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.4592584961645575,-1.1598603357491308,0.26021505376344084,0.70351876587174,1.0,3/12,7.78%,DMD;ANK3;ATP1B3
prerank,Golgi to endosome transport (GO:0006895),0.43231422199241615,1.1597583075866722,0.27848101265822783,0.7556840162922195,1.0,8/16,27.32%,AP2A1;SORT1;MON2;DOP1B;AP4M1;VPS13C;SYS1;GBF1
prerank,regulation of dendritic spine development (GO:0060998),-0.3952702181550568,-1.1595048253267315,0.2297872340425532,0.7032727187526809,1.0,6/19,7.14%,NLGN1;PPFIA2;CPEB3;APOE;SHANK3;GRIN3A
prerank,regulation of type I interferon production (GO:0032479),0.3060785227772575,1.1593571946741326,0.20748299319727892,0.7559718534926329,1.0,22/84,17.38%,POLR3G;RNF216;POLR2H;ITCH;OTUD5;UBA7;PCBP2;DHX9;CGAS;DTX4;GAPDH;UFD1;IRF8;POLR3H;G3BP1;PIN1;MAVS;NLRX1;POLR2E;STAT6;IRF3;POLR1C
prerank,synaptic vesicle exocytosis (GO:0016079),-0.330980875818698,-1.1591058359870436,0.21957040572792363,0.7031295518445606,1.0,9/40,9.04%,RIMS2;SYT1;UNC13C;SNPH;SYT10;PCLO;CPLX2;SNAP25;RAB3A
prerank,cell-cell junction maintenance (GO:0045217),0.4724454249260823,1.1584785264712463,0.286231884057971,0.757801385496835,1.0,2/11,9.43%,CSF1R;TJP1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.23647645941653883,1.1584230790635661,0.049596309111880045,0.7569608675582944,1.0,220/1082,18.41%,TGFBR1;MAML3;ZFHX3;SALL1;IL18;ETV5;ARHGEF2;MLXIPL;DNM2;LRP5;RREB1;BRD8;SMAD3;BICRAL;GREM1;SMAD7;CAPN3;ETS1;ITGA6;QRICH1;NFE2L2;PRMT2;HEYL;PIM2;HIVEP3;DDIT3;CEBPZ;YWHAH;MEF2C;LYL1;SOX8;PIK3R1;KARS1;FLI1;RIPK2;FOXJ2;SKI;RPS6KA1;SBNO2;PICALM;TGFB1I1;SIRT2;UBP1;PPARD;MLXIP;FOXE1;CHEK2;KMT2D;TLR4;GPS2;AKAP8L;VHL;ZFP90;CDK9;LPIN2;TNNI2;RHOQ;DEAF1;NKX2-8;EGR1;ATM;MEF2D;PAX6;AATF;ELK1;ATMIN;FLCN;TFE3;MEIS3;CHD8;CALCOCO1;CREB3L2;MYSM1;NFATC1;RPS27A;UBC;ELK3;MLX;FIZ1;AKIRIN2;RPS6KA5;FOXK2;RBM14;ATF3;TRIM44;AFAP1L2;PADI2;ZBTB18;ILF2;DHX9;TET3;TAF6L;TAF6;CD86;SHH;JMJD6;FZD2;CXXC1;SIN3A;CAMKK2;PDGFB;EGR2;TRIM45;NLRP3;MET;MED19;BICRA;CNBP;RPTOR;AKIRIN1;GATA2;ABRA;SPAG8;GDNF;GPER1;CITED4;SOX17;POU4F1;TMPRSS6;MOSPD1;JUN;HMGN1;DPF2;RXRB;DDX17;INPP5K;NR2F1;IRF8;NOTCH4;MTOR;BCL9;FHOD1;MMS19;MEF2A;RNF20;PRDM11;SMARCA5;E2F2;KDM3A;ZSCAN21;PITHD1;SMARCD3;NRF1;BRCA1;CRTC1;MAML2;PAX2;DLL1;NFYA;SMARCA2;SERPINE1;CCDC62;RUNX1;DPF1;MAP3K2;IL33;ENG;RLF;CEBPG;ARNT;MED4;E4F1;PIN1;POGZ;RNF187;ABL1;ZIC1;NFATC2IP;ZBTB48;MAVS;MED10;BLM;DYRK1A;AKT1;CSRNP2;PRDM2;ALYREF;MLLT6;HDAC5;SNX5;TNIP2;TAL1;PROX1;ZMIZ2;NCOA3;TCF3;POU2F2;NRIP1;MAP2K1;OSM;AKNA;MED25;ZMIZ1;WASL;DTX3L;STAT6;AGT;HDAC8;RPS6KA4;IRF3;MAPK7;GLMP;FZD1;POU2F1;NUP62;ARRB1;FANK1;KDM1A;RNF4;SLC11A1;GATA3;KAT5;KDM8;MITF;HMGB2;LPIN1;SSBP4;PPRC1;ARID1A;LMO1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.41473222457457004,1.1583025825377304,0.2574430823117338,0.7562654219847131,1.0,6/19,17.25%,BIN1;PICALM;CLU;FLOT2;PIN1;GGA3
prerank,positive regulation of protein catabolic process (GO:0045732),-0.2820774123285319,-1.1582579421050203,0.17027027027027028,0.7044115031476741,1.0,24/84,17.61%,WWP1;HECW2;HECW1;APC2;FAF1;NEDD4L;APOE;GSK3B;BARD1;PRKN;AXIN1;PLK2;SNX9;ATG7;GPC3;ADRA2A;SH3D19;TIPARP;NKD1;TNFSF12;OAZ1;RILP;FOXO1;MSN
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.23180704451750406,1.157838018251241,0.02753303964757709,0.7567264644474697,1.0,431/1668,23.89%,MAML3;ZFHX3;SALL1;IKZF1;ARID3B;IL18;ETV5;ZSCAN26;ARHGEF2;MLXIPL;LRP5;RREB1;CSF1R;SALL3;BRD8;SMAD3;ZNF697;DNMT3A;SUMO1;GREM1;SMAD7;BACH2;ETS1;ITGA6;NFE2L2;PHF21A;HEYL;TRAK1;HIVEP3;HOXD9;DDIT3;CEBPZ;MEF2C;LYL1;SOX8;PIK3R1;FLI1;RIPK2;DDX5;FOXJ2;SKI;RPS6KA1;SBNO2;SIRT2;UBP1;CNOT1;PPARD;FUS;MLXIP;FOXE1;MTA1;KMT2D;TLR4;GPS2;KLF11;AKAP8L;VHL;ZFP90;CDK9;LPIN2;EPOP;ZNF83;CRY2;HDAC10;RHOQ;DEAF1;NKX2-8;EGR1;ATM;ERF;MEF2D;KLF3;PAX6;AATF;ELK1;ATMIN;SKIL;FLCN;SUDS3;ZXDB;TFE3;MEIS3;HOXB8;ID1;ZNF568;HBP1;CUX1;ZIM3;ZBTB21;CHD8;CALCOCO1;CREB3L2;MYCL;MYSM1;NFATC1;RPS27A;UBC;GTF2H2;ELK3;IMPACT;MLX;FIZ1;CTR9;AKIRIN2;RPS6KA5;GTF2IRD1;FOXK2;PHF14;RBM14;BCOR;MOV10;ATF3;MDM4;EGR3;ZBTB18;ZBTB24;CCNL1;DHX9;TET3;TAF6L;TAF6;KDM5B;SHH;JMJD6;THAP1;SIN3A;RPAP2;TIAL1;EGR2;NLRP3;MET;SLTM;MTDH;C1QBP;MED19;ZFP91;SARS1;CNBP;MIDEAS;AKIRIN1;ZNF319;TAL2;OVOL2;GATA2;ABRA;HOXA6;BCL6B;BARHL1;LEFTY1;SPAG8;GDNF;BHLHE22;CRYM;ALX4;TLE6;GPER1;ZBTB32;PAX1;FOXO6;HAMP;DMRTB1;CITED4;ANKRD2;SOX17;NEUROD6;NEUROD4;TWIST2;POU4F1;HMX2;TMPRSS6;PKNOX1;KLF12;MDFI;ZNF569;CHD3;MOSPD1;PATZ1;JUN;EHMT2;NPAS1;DPF2;RXRB;DDX17;SRCAP;NR2F1;IRF8;NOTCH4;BCL9;PPID;FHOD1;MEF2A;CXXC5;PRDM1;LBX1;ACTL6A;SMARCA5;E2F2;KDM3A;ZSCAN21;SMARCD3;NFE2L1;NRF1;BRCA1;PRKCB;RPL10;CRTC1;MAML2;PAX2;DLL1;MYNN;TBX6;NFYA;SMARCA2;IRF2BP2;ZNF367;TAF1;TCF25;SERPINE1;PCGF2;CCDC62;RUNX1;DPF1;IL33;ETV3;LIN9;TEF;ENG;BAZ1B;RLF;SMAD9;CEBPG;ARNT;MED4;E4F1;MXI1;RELB;PIN1;SEMA4D;POGZ;BRMS1L;DDX20;ABL1;MRGBP;WWP2;PLK3;SP9;ZNF3;ID3;ZIC1;NFATC2IP;PIAS3;ZBTB48;SAFB;EZH2;MAVS;ZNF292;OLIG2;MED10;BRD9;CSRNP2;PRDM2;ZBTB8B;MLLT6;HDAC5;HR;PIAS2;TNIP2;TAL1;PROX1;SP110;MAPK14;ZMIZ2;EED;MXD1;TTC21B;NCOA3;NOG;TCF7L1;TCF3;ZBTB39;POU2F2;NRIP1;OSM;FST;ACVR2B;ZEB1;AKNA;TADA1;MED25;ZMIZ1;WASL;MYPOP;STAT6;MED18;UXT;ZBTB2;KANK2;HDAC8;RPS6KA4;IRF3;LIN37;SIN3B;MAPK7;GLMP;ZFP62;POU2F1;ARRB1;MAFG;HES6;SP140;TGIF1;KDM1A;RNF4;SLC11A1;IRF9;GATA3;KAT5;MITF;HMGB2;CUX2;PROX2;LPIN1;SSBP4;PPRC1;ARID1A;LMO1;ZNF740;IRF2;ZNF260;EID1;ZKSCAN1;TNRC6C;CAMK1;ZSCAN22;KDM7A;E2F3;MIER3;KTI12;NR1H2;DMTF1;REPIN1;RNF2;TOX2;IL4I1;RBMX;XRCC6;ZFP82;ZNF585B;ZNF585A;BHLHA9;KDM2A;MGA;NOD2;BRD3;TNIP1;ZNF394;KCNIP3;NOS1;ZSCAN12;ZNF692;TNRC6B;CEBPD;EPC1;CDK8;EFNA1;GZF1;NLRC5;ZNF513;PLAGL2;SETD3;CBX8;PHF20;KAT6B;THAP3;ZC3H12A;E2F5;HDGF;IRX1;DDX3X;PAXBP1;CASZ1;MED7;DBX2;ZBTB45;CXCL10;DEK;TWIST1;ZNF691;KANSL3;MED12;RFXANK;HIVEP1;ATAD2;ZBTB6;SAFB2;ARF4;NFIA;PARK7;KDM2B;FOXP4;PTCH1;MED20;ZBTB1;HDGFL2;BMP2;MNT;TGFB1;LMO2;SCRT1;TEAD3;ELP3;GLYR1;CNOT2;MSC;KMT5A;BRMS1;SUFU;AGO1;BATF3;JUP;TFAP4;PCGF3;TGIF2;DR1;YY1;DVL2;KLF15;SMARCA4;ACTR2;TP53;STAT5B
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.3845904899249064,1.1576443776775756,0.2521150592216582,0.7562992390812947,1.0,4/25,4.09%,ABI3;TBC1D7;CAPZB;PRKCD
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.45479046808697904,1.1575593931113586,0.27071823204419887,0.7555157500052061,1.0,3/13,12.09%,DNAJB9;BFAR;PTPN1
prerank,carbohydrate biosynthetic process (GO:0016051),-0.3840787463658117,-1.1571707924685777,0.25586854460093894,0.7063560342109185,1.0,3/21,2.03%,B3GALT1;ST3GAL4;FUT9
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.3274222305351113,-1.1570805086942348,0.22142857142857142,0.7053118113804077,1.0,14/39,20.37%,LTV1;RPS7;SNU13;RPS27;RPS25;RIOK3;RPS14;MRPS7;RIOK1;NPM1;NOB1;RPS6;RPS5;RPS19
prerank,regulation of T cell migration (GO:2000404),0.429176986845008,1.1569150035803253,0.2717391304347826,0.7565593709748287,1.0,3/18,2.72%,DOCK8;AIF1;LRCH1
prerank,cardiac cell development (GO:0055006),0.47287517742692875,1.1562425292864016,0.31103074141048825,0.7578176877090378,1.0,2/11,5.45%,CXADR;SLC8A1
prerank,response to hydrogen peroxide (GO:0042542),0.34249245755634433,1.1559245566814085,0.25092250922509224,0.7578688007472574,1.0,14/45,19.03%,SIRPA;NFE2L2;RHOB;PRKCD;TRPM2;IMPACT;APTX;PAX2;ABL1;SOD1;PDCD10;MAPK7;ANKZF1;ECT2
prerank,mitotic spindle organization (GO:0007052),-0.2591054335431633,-1.1556328232110038,0.13256484149855907,0.7085337927370816,1.0,39/153,17.98%,KNL1;CENPF;DYNC1I2;CENPT;KIF23;CDCA8;CENPP;ZW10;SPDL1;NUP98;TOGARAM2;EML1;TPX2;BIRC5;RAN;CENPE;NDC80;PLK2;RPS27;BUB1B;SPC25;KNTC1;AURKB;KIF11;DLGAP5;MAP9;PRC1;BUB1;TTK;GPSM2;ERCC6L;NUP43;DCTN6;MAD1L1;RCC2;CENPS;CCNB1;KIF4A;SPC24
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.2533861975916033,1.155477246978436,0.12125534950071326,0.7582723891058977,1.0,106/341,24.89%,BAG6;MVB12B;NFE2L2;DDIT3;UCHL1;RNF216;ARRB2;FBXO22;SMURF1;TGFB1I1;SIRT2;ITCH;MTA1;ZRANB1;SPSB1;NDFIP2;UBE2H;RFFL;ZSWIM8;FBXW4;SPSB2;PCBP2;MAEA;TRIM72;ARRDC1;CDC34;ANKRD9;OS9;CRBN;RNF8;PSMD3;UFD1;BFAR;RNF20;MYLIP;KCTD2;AREL1;RNF166;ANAPC15;PSMB3;TAF1;PINK1;UBE2U;PSMA7;RNF187;VPS37D;ZNRF3;WWP2;DCAF11;PSMC1;FBXO21;PSMC2;KCTD6;VPS37A;RNF7;FBXL22;RNF144B;PSME4;NTAN1;AURKA;FBXO11;RNF11;ANAPC11;PSMB9;DTX3L;UBXN2A;UBE2A;PTPN23;ARRB1;UBE4A;SPOPL;RNF4;TNFAIP1;KAT5;STUB1;ZFAND2A;UBQLN4;CUL4A;WDR81;VPS37B;VPS4A;PSMD4;PSMB5;TRIM3;TOPORS;SYVN1;GID8;TSG101;UBE2R2;PSMB7;KLHL3;FBXL7;RNF34;ANAPC1;ATE1;GID4;RC3H2;PSMB8;ANAPC2;ZNRF1;FBXW5;KCTD5;RAD23B;FBXO8;NPLOC4;PSMD13
prerank,positive regulation of cell differentiation (GO:0045597),0.26343850000216407,1.155082124137353,0.13439306358381503,0.7585094873012895,1.0,52/237,16.13%,TGFBR1;TMEM119;IL18;TGFBR2;ARHGEF2;LRP5;SMAD3;HEYL;MEF2C;MMD;IGFBP3;RPS6KA1;TGFB1I1;PPARD;NPNT;VHL;TRPM4;CTNNBIP1;IMPACT;IL6ST;SIN3A;GCNT2;ASB4;ZFP36L1;AKIRIN1;EDN3;GDNF;RBM24;NEUROD4;IL6R;PLA2G5;CD34;MTOR;MEF2A;WNT7B;CEACAM1;PAX2;PKDCC;DDR2;BNIP2;GJA1;ABL1;EZH2;LRRC8A;AKT1;CSF1;CDS1;MAPK14;CDH15;TCF3;ACVR2B;ZEB1
prerank,tRNA export from nucleus (GO:0006409),0.36540840218572473,1.1549979462110256,0.25880281690140844,0.7566714820559322,1.0,11/32,17.82%,XPOT;RANBP2;SSB;NUP42;SEC13;NUP50;NUP35;NUP88;NUP62;SEH1L;NUP107
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.36540840218572473,1.1549979462110256,0.25880281690140844,0.7566714820559322,1.0,11/32,17.82%,XPOT;RANBP2;SSB;NUP42;SEC13;NUP50;NUP35;NUP88;NUP62;SEH1L;NUP107
prerank,cellular response to decreased oxygen levels (GO:0036294),-0.2988257562595741,-1.1546814918182795,0.17326732673267325,0.7102576611416874,1.0,21/65,20.32%,KCND2;SLC8A3;SUV39H1;SCN2A;NPEPPS;LMNA;HIPK2;SIRT1;OPRD1;TIGAR;RGCC;HMOX1;AK4;EGLN3;SFRP1;MDM2;SUV39H2;UBQLN1;TERT;CPEB4;TSC1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.35769306353697383,-1.154162433390519,0.23665893271461716,0.7105620348594844,1.0,10/30,18.17%,CD74;CD44;RPS3;TPT1;SIRT1;CCAR2;MDM2;SNAI2;SFRP2;DDIAS
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.31532843832313473,1.1541565897429844,0.2197986577181208,0.7584104547257514,1.0,19/73,16.56%,ELMO1;VAV2;RAC1;PIK3R1;LYN;SRC;PRKCD;PLCG2;PLA2G6;PLD2;PIK3CB;NCKAP1L;CYFIP1;ARPC1A;ABL1;WIPF2;ARPC3;WASL;MYH2
prerank,response to alcohol (GO:0097305),0.38003702048665156,1.1538905026026496,0.23629489603024575,0.7582859434366489,1.0,7/27,14.18%,TGFBR1;TGFBR2;HSD3B2;CCL3;CCR7;CCR5;SOD1
prerank,negative regulation of lipid metabolic process (GO:0045833),0.4026274782990553,1.1538396508829754,0.2710951526032316,0.7574113914086876,1.0,5/22,17.03%,PDE3B;GPER1;CEACAM1;BSCL2;PPP2R5A
prerank,positive regulation of dendrite extension (GO:1903861),-0.41016377985221825,-1.1536690778010985,0.25892857142857145,0.7106927890531961,1.0,7/17,21.04%,RIMS2;SYT1;NEDD4L;SYT3;RIMS1;PLAA;CPNE6
prerank,B cell differentiation (GO:0030183),0.3410343842603196,1.1533850874914804,0.25752508361204013,0.7579064568899713,1.0,14/46,20.91%,BLNK;LYL1;GPS2;DNAJB9;PLCG2;IRF2BP2;CEBPG;HDAC5;TCF3;PTPRJ;TPD52;ADAM17;CD79A;SYVN1
prerank,positive regulation of MAPK cascade (GO:0043410),-0.24472711279148598,-1.1533456841900147,0.10153846153846154,0.7103836889868994,1.0,32/245,7.48%,CD74;IQGAP1;ROBO1;RIT2;LRRK2;CD44;CD36;EGFR;ADRA1A;TMEM106A;FGF10;GAREM1;CCR1;DSTYK;APP;PTPN22;IAPP;HTR2C;CD40;RAPGEF2;ROR1;NTRK2;PDGFD;NTRK3;PRKCZ;APOE;HTR2B;ERBB4;TPD52L1;RET;OPRM1;PDE8A
prerank,multivesicular body organization (GO:0036257),0.3700093572580964,1.1533333711550913,0.24150268336314848,0.7570235292735885,1.0,16/31,31.38%,VPS37D;VPS37A;VPS36;RAB27A;CHMP1A;IST1;VPS37B;CHMP2A;VPS4A;HGS;TSG101;PDCD6IP;VTA1;STAM2;CHMP7;RAB11A
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.338784056029597,1.153282936368096,0.23299319727891157,0.7561176406537378,1.0,8/49,9.01%,IL18;CSF1R;LYN;IL6ST;CNTF;IL12B;CTF1;IL6R
prerank,protein localization to cell periphery (GO:1990778),-0.2613357969112904,-1.153249536375246,0.13271604938271606,0.7093830129993196,1.0,24/133,10.78%,KCNIP4;DPP6;ANK3;KCNB2;DPP10;ANK2;SPTBN1;RAB3C;MYO5A;RAPGEF2;EHD1;LRP6;RAB40B;RAB3D;ATP1B3;PIGW;ACTN2;RAB8A;MYADM;RAB3A;SPTBN4;P2RY1;ITGB1BP1;ZDHHC23
prerank,negative regulation of establishment of protein localization (GO:1904950),0.480118847137511,1.1530762134468389,0.26704545454545453,0.7557281761503412,1.0,8/10,30.44%,NDFIP2;TERF1;WWP2;SNX3;PPM1F;MAPT;DNAJA1;CORO2B
prerank,bile acid metabolic process (GO:0008206),0.378274042442038,1.1530577312381494,0.27256317689530685,0.7547548187668711,1.0,10/27,23.32%,CH25H;OSBPL3;CYP46A1;AKR1D1;NPC1;CYP7B1;HSD17B10;OSBP;ACOT8;SCP2
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.42739790657371607,1.1524224901805746,0.25435540069686413,0.7558595665813342,1.0,7/17,29.91%,COX7A2L;COX8A;COX5A;COX6B1;COX6A2;AFG1L;COX6A1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.48538498216017356,1.152415676707717,0.28733459357277885,0.7548508198827271,1.0,3/11,9.82%,DDIT3;ATF3;MBTPS2
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.286831830985144,-1.152365202311991,0.17771883289124668,0.7109070419683171,1.0,28/83,23.49%,POLA1;CDK14;TFDP2;CDK7;CUL3;LATS1;PLK2;PPP6C;USP29;CACUL1;BCAT1;CDK15;CDKN2A;CDKN1A;DBF4;GPR132;CDK2;NASP;SPDYA;E2F1;NPAT;CDK4;USP26;TFDP1;EIF4EBP1;RPS6KB1;BACH1;CCNH
prerank,regulation of interleukin-4 production (GO:0032673),0.40414018066644364,1.1521626257728477,0.2714285714285714,0.7546458510134747,1.0,6/21,11.93%,DDIT3;SLC7A5;LGALS9;CD86;NLRP3;HAVCR2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.31370767589933385,-1.1520307347202063,0.23173803526448364,0.710622448368714,1.0,14/51,14.84%,CNTNAP2;NYAP2;LRRK2;GPM6A;BDNF;CTTN;DCLK1;WASF1;ATP7A;CNTNAP1;DTNBP1;PLXNB1;MYO16;PAK1
prerank,regulation of neurogenesis (GO:0050767),0.3281852930326962,1.1519973522747693,0.21371610845295055,0.7541561442045607,1.0,8/55,11.32%,CX3CR1;NUMB;HEYL;TGM2;PAX6;GPER1;RGS14;DLL1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.35403348252481104,-1.1518822133834001,0.24093816631130063,0.7097781936409632,1.0,13/31,23.96%,DCUN1D2;RPS2;UBE2N;BTRC;AXIN1;ARRDC3;UBE2C;DCUN1D3;FZR1;TRIB3;FBXW7;PLK1;MAGEC2
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.4967839935120828,1.1518155706408444,0.30939226519337015,0.7537571491597084,1.0,5/10,17.02%,ATP5PO;ATP5PD;ATP5MC1;VPS9D1;ATP5F1D
prerank,dendritic cell migration (GO:0036336),-0.42101461222679554,-1.1518025383836987,0.2725274725274725,0.7087362863608279,1.0,4/16,5.83%,EPS8;CCR2;CCR1;ALOX5
prerank,proton transmembrane transport (GO:1902600),0.36232418863825694,1.151572987028142,0.26992753623188404,0.7535391535761038,1.0,9/36,17.24%,SLC36A1;ATP1A4;HVCN1;ATP6V0A4;SLC25A27;ATP5PO;NNT;ATP6V0E2;SLC25A14
prerank,B cell mediated immunity (GO:0019724),-0.47215297093340913,-1.1515086813567326,0.27510917030567683,0.7082763781529854,1.0,6/10,27.05%,CD74;FCGR2B;TLR8;CD19;MSH2;SLA2
prerank,histone monoubiquitination (GO:0010390),0.3959320255823162,1.1510172947455553,0.25573192239858905,0.7543984034129521,1.0,11/24,27.41%,DDB2;CTR9;BCOR;CUL4B;RNF20;DTX3L;RNF2;KDM2B;RING1;ATXN7L3;PCGF1
prerank,regulation of establishment of protein localization (GO:0070201),0.46496918761012607,1.1504288876011093,0.2896678966789668,0.7552845407985183,1.0,5/13,19.86%,CTSD;SPIDR;CEP295;CEP135;PTP4A3
prerank,substrate-dependent cell migration (GO:0006929),0.4453129557968343,1.1501693450932218,0.2772808586762075,0.7551626012844534,1.0,3/14,7.99%,OPHN1;P2RY12;EPHA8
prerank,keratinocyte differentiation (GO:0030216),0.37816964134595976,1.1500430667128407,0.2608695652173913,0.7545818286221784,1.0,5/29,11.12%,DSP;CERS3;ST14;SPRR1A;ASAH1
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.4340677940829436,1.1499505746742882,0.2833333333333333,0.753872398368008,1.0,5/15,19.28%,PRKCD;PLA2G6;SMPD2;ORMDL2;SMPD3
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.4471360387592413,-1.1496824873683567,0.2984409799554566,0.7124525832740534,1.0,2/12,7.46%,GSS;GGCT
prerank,aorta development (GO:0035904),-0.4296337463140849,-1.1485810525323932,0.2760084925690021,0.7144948501440204,1.0,8/14,29.04%,ROBO1;PKD2;PDE2A;JAG1;APLNR;ROBO2;TBX1;ADAMTS9
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.46941013506336376,-1.1481771904006983,0.30128205128205127,0.7144466721264076,1.0,4/10,20.54%,EMC3;MMGT1;EMC2;EMC7
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.323977148883341,-1.1478972897064128,0.24819277108433735,0.7140113633973771,1.0,22/46,22.59%,ATRNL1;ITGA4;TMEFF2;ITGB7;FN1;KIF14;LAMB2;MEGF9;ITGA8;SRCIN1;FER;NTNG1;NTNG2;LAMA5;TEK;LAMC3;PARVG;RADIL;PARVB;NTN4;PEAK1;MICALL2
prerank,regulation of MAPK cascade (GO:0043408),-0.2569602471139427,-1.1477534031914545,0.15405405405405406,0.7131277854841743,1.0,31/157,15.40%,CD74;IQGAP1;RIT2;LBH;EGFR;PAK5;ADRA1A;TMEM106A;FGF10;IAPP;PHLPP1;ROR1;NTRK2;NTRK3;FN1;ATP6AP2;PAK3;RET;STYX;ZDHHC17;FGFR3;ADRA2A;KIT;LILRA5;FAM83D;MMP8;CX3CL1;WWC1;PAK1;DAG1;TEK
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.25285239737753856,1.147163334102128,0.14125874125874127,0.7620190628854226,1.0,108/314,27.51%,BAG6;FBXL18;NFE2L2;DDIT3;UCHL1;RNF216;SEL1L;ARRB2;SMURF1;SIRT2;ITCH;MTA1;DNAJB9;FBXL20;SPSB1;FBXL15;RPS27A;UBC;RFFL;ZSWIM8;FBXW4;SPSB2;PCBP2;MAEA;TRIM72;CDC34;CUL4B;ANKRD9;USP19;OS9;CRBN;RNF103;PSMD3;UFD1;BFAR;KCTD2;AREL1;FBXL8;FBXL2;ANAPC15;PSMB3;AUP1;TAF1;UBE2U;PSMA7;RNF187;WWP2;DCAF11;PSMC1;PSMC2;FBXL22;PSME4;FBXO38;AURKA;EDEM1;NEMF;ANAPC11;PSMB9;UBXN2A;UBE2A;ARRB1;UBE4A;SPOPL;ANKZF1;RNF4;TNFAIP1;KAT5;MAN1B1;STUB1;ZFAND2A;CUL4A;DCAF12;PSMD4;PSMB5;TRIM3;TOPORS;RNF121;SYVN1;GID8;PSMB7;FBXL7;RNF34;ANAPC1;GID4;LTN1;PSMB8;ANAPC2;ZNRF1;FBXW5;FBXL3;KCTD5;RAD23B;NPLOC4;PSMD13;FBXL14;UBXN1;DNAJB14;UBE2G2;CUL1;FBXO2;FBXL12;TBL1X;ECPAS;SGTA;PSMD2;RHBDD2;ANAPC16;UBE2D1
prerank,embryonic heart tube morphogenesis (GO:0003143),0.33571985740655885,1.1468042572749215,0.2469982847341338,0.7621470994906258,1.0,10/43,14.72%,TGFBR2;MEF2C;SHH;SOX17;DLL1;TBX6;ENG;NDRG4;CCDC40;SMO
prerank,response to muramyl dipeptide (GO:0032495),0.4686995669742442,1.1467662808766486,0.2801418439716312,0.7612689493965435,1.0,2/12,2.14%,ARHGEF2;RIPK2
prerank,vascular transport (GO:0010232),0.3032874758714192,1.1467046071785219,0.19540229885057472,0.7604248423875398,1.0,19/81,17.85%,SLCO2B1;SLC7A8;SLC1A3;SLC7A5;AGER;SLC24A3;ABCC9;SLC22A2;SLC29A4;ATP1A4;SLC27A4;LRP1;SLC16A7;SLC6A9;SLC29A1;SLC5A3;SLC38A1;SLC19A1;SLC15A2
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.37930663194157266,-1.1454712656272885,0.24882629107981222,0.7187725432487003,1.0,6/23,9.67%,KIF5C;CCDC88C;KIF1B;DYNC1I2;KIF5B;CCDC88A
prerank,bone development (GO:0060348),0.3530509856866097,1.145358831229241,0.25125628140703515,0.7639602665973982,1.0,17/39,26.04%,LRP5;SKI;TGM2;DYM;AKAP13;MBTPS2;GJA1;GNAS;SBDS;SFRP4;STC1;SH3PXD2B;TP53;FGFR2;PTPRC;SULF1;SLC10A7
prerank,lysosome localization (GO:0032418),0.3556880680805734,1.1450603474254835,0.2549019607843137,0.7639077518508737,1.0,8/37,10.04%,KXD1;PIK3CG;MYH9;FLCN;PIP4P1;PIK3CD;RAB34;PLEKHM2
prerank,T cell differentiation in thymus (GO:0033077),0.4373090210771321,1.1450087026007283,0.29084380610412924,0.7630566408711653,1.0,6/14,24.23%,SHH;ZFP36L1;ZFP36L2;ADAM17;PTPRC;FADD
prerank,regulation of ERAD pathway (GO:1904292),0.47645657554618104,1.144499210050493,0.31238095238095237,0.7637318721898176,1.0,3/11,8.93%,BAG6;USP25;USP19
prerank,response to laminar fluid shear stress (GO:0034616),0.4845620332061192,1.1440675454753721,0.30490018148820325,0.7642082078106611,1.0,2/10,1.23%,SMAD7;NFE2L2
prerank,regulation of cellular biosynthetic process (GO:0031326),0.3785141561463088,1.143528256707462,0.26654740608228983,0.765026378037267,1.0,5/28,8.36%,CX3CR1;SIRPA;RAC1;NOS1AP;AVIL
prerank,regulation of transforming growth factor beta production (GO:0071634),0.4183980626524274,1.14329604778914,0.27624309392265195,0.7648417462185272,1.0,4/18,9.52%,SMAD3;LGALS9;ITGAV;CD34
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.3611942306141559,1.1432415903441173,0.2815699658703072,0.7640291174156889,1.0,11/34,20.07%,P2RY12;PIK3R1;ATG14;PTK2B;PDGFB;EPHA8;CCR7;PDGFRB;PIK3R3;WDR81;NOD2
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.46134968127492904,-1.1431913078583973,0.2938856015779093,0.7245963360784116,1.0,3/11,21.77%,LMNA;FOXO1;MLIP
prerank,blood vessel morphogenesis (GO:0048514),0.32212594673213135,1.1431434919243226,0.23924268502581755,0.7632907982974781,1.0,11/54,15.90%,TGFBR1;TGFBR2;LRP5;SMAD7;ID1;SHH;SOX17;RASIP1;ENG;PROX1;CCM2
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.43046730078916073,1.1431372273988076,0.29313543599257885,0.7623110420061012,1.0,6/16,18.50%,ULBP1;TUBB;RAET1E;PLEKHM2;CEBPG;VAMP7
prerank,regulation of actomyosin structure organization (GO:0110020),0.4479666009019728,1.1429430224093151,0.27735849056603773,0.7618933316679203,1.0,4/13,10.25%,RAC1;ASAP3;AKAP13;FHOD1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.4527945727291225,-1.1426660957871382,0.2683982683982684,0.7249444307352862,1.0,3/12,4.44%,TMEFF2;PF4;TAF7
prerank,integrin-mediated signaling pathway (GO:0007229),0.30779138701892805,1.14260576406444,0.21512605042016808,0.7619825568595505,1.0,20/73,16.79%,ITGB5;DST;FYB1;FERMT3;FYB2;ITGB2;PLEK;ITGAV;SRC;MYH9;ADAMTS1;PTK2B;CEACAM1;LAMA3;ZYX;PTPRA;ABL1;TEC;CCM2;ADAM10
prerank,limb development (GO:0060173),0.37446645243804383,1.1425740473787487,0.2859504132231405,0.7610733977756521,1.0,7/28,15.62%,SALL1;GREM1;CHD7;LRP4;IQCE;ZNRF3;NOG
prerank,endochondral bone morphogenesis (GO:0060350),0.46931045722063847,1.1425234109662135,0.29444444444444445,0.760216672848149,1.0,2/11,1.74%,TMEM119;MEF2C
prerank,epithelial structure maintenance (GO:0010669),0.4840955098333119,1.1423324818317813,0.3094812164579606,0.7598917048542283,1.0,4/11,26.92%,CXADR;MUC6;NOD2;TLR9
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.31349284026329666,1.1417882124579743,0.24877250409165302,0.7606414055299023,1.0,16/67,15.79%,ABI3;CSF1R;LYN;EFEMP1;IGF1R;SRC;PTK2B;PDGFB;PDGFRB;PKDCC;DDR2;ABL1;BMX;GHR;DYRK1A;TEC
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.34431778793262496,-1.141749693806291,0.2619047619047619,0.7264810189612,1.0,6/32,5.80%,SORBS1;PRKAG2;CREBL2;ZBTB20;APOE;ADIPOR2
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.4325459554550987,-1.141717110525273,0.270509977827051,0.72525548043601,1.0,6/14,26.65%,RPS3;CD226;TESPA1;LCK;TRAT1;RELA
prerank,cardiac ventricle development (GO:0003231),0.4060737227918124,1.1415681174689554,0.27079646017699116,0.7603719695718928,1.0,3/20,6.10%,SALL1;HEYL;MDM4
prerank,cilium organization (GO:0044782),0.26404892838074107,1.1415328887185692,0.14884393063583815,0.7594843129401638,1.0,68/209,25.75%,ASAP1;EXOC7;RILPL1;KIF3B;BBS9;EHD4;TTLL3;CEP162;ODF2;PKHD1;UBXN10;HYLS1;RP2;ATP6V1D;CEP164;DYNLT2B;CFAP52;TTC36;NME8;AVIL;CFAP221;RAB1A;MKS1;NUDCD3;INPP5E;CCDC28B;GALNT11;IFT52;BBS2;CDC14B;KIF27;ATAT1;IFT20;MNS1;WDR90;IQCG;CFAP20;PDE6D;TCTN1;KIF3A;ARL3;PTPN23;CCDC66;EXOC6;OFD1;B9D1;CPLANE2;SSX2IP;TMEM17;MARK4;TTC17;EXOC1;RAB8B;TTBK2;ARF4;EXOC8;PLA2G3;ACTR2;TRAPPC14;EXOC4;DYNLL1;DYNC2H1;IFT122;CCP110;CATIP;HDAC6;TCTN2;IFT140
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.38460159211842815,1.1408407973190748,0.2573913043478261,0.7608188205255414,1.0,7/27,16.43%,SLC7A8;SLC1A3;SLC7A5;ARL6IP5;SLC22A2;SLC6A9;SLC38A1
prerank,regulation of postsynapse organization (GO:0099175),0.36904430980589215,1.140673515305558,0.2921146953405018,0.7603945373338036,1.0,4/28,0.97%,TANC2;ARHGAP22;ABI3;ABHD17C
prerank,rRNA metabolic process (GO:0016072),-0.2517204058659095,-1.1406679330015015,0.12612612612612611,0.727157924253596,1.0,46/160,20.46%,RPL36A;RPL30;DEDD2;RPL35A;DDX10;RPL4;RPS7;UTP20;RPS2;SNU13;RPLP2;RPL7A;LAS1L;RPL41;EXOSC1;POP4;XRN2;RPL26;DCAF13;RPS27;RPL18A;RPS25;MRTO4;RPL38;NOC4L;RPL37;UTP14A;RPS14;EXOSC7;RPL24;WDR18;RPS9;RPLP0;RPLP1;RPL8;RPL22;NOB1;ESF1;RPL19;RPS6;PIH1D1;RRP9;RPL13A;RPL18;RPS19;RPL23A
prerank,regulation of pH (GO:0006885),0.47570840834339606,1.140590495122288,0.3,0.7596430018411855,1.0,3/11,11.63%,ATP1A4;PDK2;ATP6V0A4
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.3789130758207811,1.1403667511403717,0.2638146167557932,0.759443540589926,1.0,8/27,13.09%,P2RY12;ATG14;PTK2B;PDGFB;EPHA8;CCR7;PDGFRB;AGAP2
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.35415154101800334,1.140324329750158,0.24083769633507854,0.7586042930375063,1.0,15/33,28.55%,KLK2;PRMT2;DDX5;RUNX1;KCTD6;UBA5;KDM1A;CARM1;SAFB2;PARK7;KLK3;PKN1;HDAC6;AR;CALR
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.2612578266022371,-1.1402120196484873,0.1590909090909091,0.7272750583988764,1.0,44/138,21.92%,NEDD9;MTSS1;PTPRG;PTPRD;STAP1;PTPRT;EGFR;SHC3;BDNF;ROR1;NTRK2;JAK2;NTRK3;RASGRP4;ERBB4;GFRA2;RET;EPHA5;ALK;FRK;ERBB3;BCAR1;FGFR3;CLNK;LIFR;KIT;AHI1;FER;TEK;MPZL1;CD3E;STYK1;LMTK2;GUCY2F;GUCY2D;BLK;EPHB2;EFS;EPHA4;FYN;EPHA7;FLT3;TIE1;LTK
prerank,spermatid development (GO:0007286),0.36586671552279576,1.139838810668067,0.26595744680851063,0.7592557682310982,1.0,8/32,14.87%,JAM2;PIWIL1;RIMBP3;RNF8;IQCG;CEP57;NECTIN2;CIB1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.3085916745599966,-1.139123596775471,0.24615384615384617,0.7293956236021982,1.0,17/50,26.17%,CDK7;CCND2;CCNF;ACTB;CCNJ;CDKN1A;CDC25C;TTBK1;PKMYT1;CCNB1;CDK5RAP3;STOX1;CDKN1C;CCNH;GTF2H1;HSP90AB1;SERTAD1
prerank,positive regulation of secretion (GO:0051047),-0.46975497046973536,-1.1389539050067807,0.30184804928131415,0.7285782045701977,1.0,6/11,33.71%,ACSL3;AQP1;ABCB11;XBP1;SCIN;TRH
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.3128210303091774,1.1388134429291157,0.2508038585209003,0.7617068294755451,1.0,16/69,11.60%,CSF1R;PI4KB;NYAP1;PLCL1;PIK3R1;GAB2;SIRT2;IGF1R;PIK3CG;PIK3C3;C1QBP;ZFP36L1;PIK3CD;PIK3CB;PDGFRB;PLCL2
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.3610381718372694,1.138647409281038,0.2615658362989324,0.7612553963551593,1.0,10/30,17.33%,F11R;RAC1;ABRA;GPR55;AKAP13;GPR18;ADGRG1;RTN4R;GPR4;ARRB1
prerank,regulation of cilium assembly (GO:1902017),0.31801040439573636,1.137429557734596,0.2508361204013378,0.7642347976186824,1.0,9/62,6.09%,TBC1D16;SDCCAG8;TBC1D17;TBC1D9B;TBC1D10B;TBC1D7;TBC1D8;TBC1D15;DYNLT2B
prerank,wound healing (GO:0042060),0.3232100966402449,1.137055897152111,0.24006622516556292,0.7644878317711564,1.0,9/62,7.60%,TGFBR1;DST;SMAD3;CFLAR;DSP;MYH9;TRIM72;MACF1;MIA3
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.3022372947952976,1.1369800163608623,0.23166666666666666,0.7637361163698568,1.0,29/82,25.08%,SDCCAG8;TUBA4A;CSNK1E;PRKACA;ODF2;TUBB;CEP164;TUBG1;HAUS7;CNTRL;TUBA1A;CEP63;CEP57;HAUS6;HAUS2;SFI1;AURKA;MAPRE1;CEP135;ACTR1A;OFD1;CEP43;DCTN2;CEP70;CSNK1D;TP53;DYNLL1;NDE1;CCP110
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.43616302451483674,1.1369154132736083,0.28142589118198874,0.7629386463421399,1.0,4/15,11.76%,SEL1L;OS9;UFD1;AUP1
prerank,protein O-linked mannosylation (GO:0035269),-0.405056529688498,-1.1366610694242474,0.2992874109263658,0.734607925995343,1.0,8/18,16.23%,DPM2;TMTC1;CRPPA;POMT2;TMTC4;FKTN;POMGNT2;TMTC2
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.38443793717538977,-1.1364549205991537,0.2829736211031175,0.7339649716009837,1.0,3/20,2.03%,B3GALT1;ST3GAL4;FUT9
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.2985409928826983,1.1351647272927574,0.2370486656200942,0.7675622623758218,1.0,28/88,24.86%,SMAD3;SUMO1;CDC42EP2;PRKCA;PLEK;CLU;SPIDR;MTLN;SLX4;SH3GLB1;BMF;GNL3L;TAL1;SLF2;SMPD3;CHMP2A;VPS4A;HGS;TSG101;STX18;PARK7;PDCD6IP;TGFB1;BCL2L11;CHGA;BRK1;RHOC;AJUBA
prerank,receptor internalization (GO:0031623),0.3347861241911033,1.1350199852994867,0.26465364120781526,0.7670777208867282,1.0,9/44,11.23%,DNM2;CD9;ARRB2;PICALM;ITGB2;GTF2H2;LRP1;GRK2;CEACAM1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.37873592462039324,1.134909926247793,0.29642857142857143,0.7664822545780929,1.0,6/25,14.06%,HK2;PFKL;FOXK2;PGK1;GAPDH;PGAM1
prerank,regulation of biosynthetic process (GO:0009889),-0.4573529104846811,-1.1348160027674683,0.29850746268656714,0.7377830994596898,1.0,4/11,23.96%,ALOX5;SNCA;GSTP1;SPHK2
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.4395186839887224,1.1347375318927184,0.29304029304029305,0.7660833660313183,1.0,7/15,21.59%,POP1;KHNYN;ZC3H12C;ZC3H12B;NUDT16;RNASEH1;ZC3H12A
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.39042878379819773,-1.1345318767795314,0.2828054298642534,0.7372792388064207,1.0,6/20,18.12%,DCC;GSK3B;ERBB3;BAK1;BCL2;BOK
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.23335433186260648,1.1341929911244801,0.08795180722891566,0.7669214465878698,1.0,170/807,18.10%,ZFHX3;SALL1;IKZF1;ETV5;BASP1;MLXIPL;RREB1;SMAD3;DNMT3A;SUMO1;SMAD7;CAPN3;PRMT2;PHF21A;HEYL;HOXD9;DDIT3;MEF2C;SOX8;DDX5;PBXIP1;SKI;SBNO2;SIRT2;CNOT1;PPARD;FOXE1;MTA1;CCDC85B;GPS2;KLF11;VHL;ZFP90;CRY2;HDAC10;DEAF1;PHB2;SAMD1;ERF;PAX6;SKIL;FLCN;SUDS3;ID1;ZNF568;CUX1;ZBTB21;CHD8;LOXL3;RPS27A;UBC;ELK3;IMPACT;MLX;CTR9;RPS6KA5;GTF2IRD1;FOXK2;BCOR;ATF3;MDM4;ZBTB18;EID2;SHH;THAP1;SIN3A;PDGFB;MTDH;C1QBP;ZMYND11;BCL7A;SARS1;FOXN3;CNBP;MIDEAS;SAMD11;BCL6B;LEFTY1;CRYM;TLE6;ZBTB32;SAMD13;HAMP;ANKRD2;TWIST2;POU4F1;TMPRSS6;KLF12;MDFI;CHD3;MOSPD1;PATZ1;JUN;LIMS1;EHMT2;NPAS1;DPF2;INPP5K;NR2F1;EID2B;IRF8;MBD1;NOTCH4;PPID;MEF2A;CXXC5;PRDM1;PRDM11;BRCA1;RPL10;PAX2;TBX6;SMARCA2;IRF2BP2;TAF1;TCF25;PCGF2;RUNX1;DPF1;IL33;KDM4A;E4F1;MAP3K10;MXI1;SEMA4D;PRMT6;BRMS1L;GCLC;DDX20;WWP2;PLK3;ZNF3;ID3;EZH2;NDUFA13;PRDM2;HDAC5;PROX1;EED;MXD1;NOG;TCF3;NRIP1;FST;ACVR2B;ZEB1;MED25;VGLL4;COMMD7;MYPOP;TSC22D4;UXT;ZBTB2;QARS1;KANK2;SCMH1;HDAC8;LIN37;SIN3B;POU2F1;TGIF1;KDM1A;GATA3;KAT5;KDM8;MITF;HMGB2;CHMP1A;CUX2;DKK3
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.43595160619661694,-1.1341814608100433,0.3039832285115304,0.7371095770288155,1.0,4/13,5.23%,ANK2;KCNN2;KCNJ3;CACNA1C
prerank,positive regulation of cilium assembly (GO:0045724),-0.39929430274913735,-1.133836808100802,0.28921568627450983,0.7368857872990842,1.0,4/18,9.67%,ARHGAP35;HTT;SEPTIN9;CCDC88A
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.2345719739116226,1.1337841187947377,0.08820023837902265,0.7672775725939723,1.0,164/834,18.23%,MAML3;ZFHX3;SALL1;IL18;ETV5;ARHGEF2;MLXIPL;LRP5;RREB1;BRD8;SMAD3;GREM1;SMAD7;ETS1;ITGA6;NFE2L2;HEYL;DDIT3;CEBPZ;MEF2C;SOX8;PIK3R1;RIPK2;FOXJ2;SKI;RPS6KA1;SBNO2;SIRT2;UBP1;PPARD;MLXIP;KMT2D;TLR4;GPS2;AKAP8L;CDK9;LPIN2;RHOQ;NKX2-8;EGR1;ATM;MEF2D;PAX6;AATF;ELK1;ATMIN;FLCN;TFE3;MEIS3;CHD8;CALCOCO1;MYSM1;NFATC1;RPS27A;UBC;ELK3;MLX;FIZ1;AKIRIN2;RPS6KA5;FOXK2;RBM14;ATF3;ZBTB18;DHX9;TET3;TAF6L;TAF6;SHH;JMJD6;SIN3A;PDGFB;EGR2;NLRP3;MET;MED19;CNBP;AKIRIN1;GATA2;ABRA;SPAG8;GDNF;GPER1;CITED4;SOX17;POU4F1;TMPRSS6;MOSPD1;JUN;DPF2;RXRB;DDX17;NR2F1;IRF8;NOTCH4;BCL9;FHOD1;MEF2A;SMARCA5;E2F2;ZSCAN21;SMARCD3;NRF1;BRCA1;CRTC1;MAML2;PAX2;DLL1;SMARCA2;SERPINE1;CCDC62;RUNX1;DPF1;IL33;ENG;RLF;SMAD9;CEBPG;ARNT;MED4;E4F1;PIN1;POGZ;ABL1;GCN1;NFATC2IP;MAVS;MED10;CSRNP2;PRDM2;NOTCH3;MLLT6;HDAC5;TNIP2;TAL1;PROX1;ZMIZ2;NCOA3;TCF3;POU2F2;NRIP1;OSM;AKNA;MED25;ZMIZ1;WASL;STAT6;HDAC8;RPS6KA4;IRF3;MAPK7;GLMP;POU2F1;ARRB1;KDM1A;RNF4;SLC11A1;GATA3;KAT5;MITF;HMGB2;LPIN1;SSBP4;PPRC1
prerank,signal transduction in response to DNA damage (GO:0042770),0.32944377756157767,1.1336264702785892,0.2521440823327616,0.7668214291716031,1.0,12/49,15.33%,RHNO1;CHEK2;ATM;NBN;RAD17;MDM4;USP28;ACER2;RAD1;CEP63;ABL1;MAPK14
prerank,regulation of hydrolase activity (GO:0051336),-0.2899812665827652,-1.1334753681857643,0.23399014778325122,0.7367942568642439,1.0,18/71,14.19%,ARHGAP15;VAV3;PRKG1;PLXNC1;FGD6;NTRK2;PLXND1;FGD5;PLXNA2;CHN1;EPHA5;PLXNB2;FGD4;ITGB1BP1;EFNA5;RALBP1;OCRL;PLXNB1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.22670333684585853,1.1334512069405096,0.0462046204620462,0.7664333195736632,1.0,350/1646,19.86%,TGFBR1;ZFHX3;SALL1;IKZF1;ARID3B;ETV5;POLR3G;BASP1;ZSCAN26;MLXIPL;DNM2;LRP5;RREB1;SALL3;SMAD3;ZNF697;BICRAL;DENND4A;SUMO1;SMAD7;BACH2;CAPN3;ETS1;QRICH1;NFE2L2;PRMT2;HEYL;TRAK1;PIM2;HIVEP3;HOXD9;DDIT3;YWHAH;MEF2C;LYL1;SOX8;KARS1;FLI1;DDX5;PBXIP1;FOXJ2;RPS6KA1;SBNO2;PICALM;TGFB1I1;SIRT2;SRRT;PCNA;UBP1;PPARD;FUS;MLXIP;FOXE1;CHEK2;KMT2D;CCDC85B;KLF11;EFEMP1;VHL;ZFP90;EPOP;ZNF83;CRY2;TNNI2;HDAC10;DEAF1;NKX2-8;EGR1;PHB2;SAMD1;ERF;MEF2D;KLF3;PAX6;AATF;ELK1;ATMIN;REXO4;CHD7;SUDS3;ZXDB;TFE3;MEIS3;HOXB8;ID1;ZNF568;HBP1;CUX1;ZIM3;ZBTB21;CHD8;CALCOCO1;CREB3L2;MYCL;LOXL3;NFATC1;GTF2H2;ELK3;MLX;CTR9;RPS6KA5;GTF2IRD1;RHOH;FOXK2;PHF14;BCOR;ATF3;MDM4;TRIM44;EGR3;AFAP1L2;ZBTB18;ZBTB24;ILF2;EID2;CCNL1;DHX9;TAF6L;KDM5B;CD86;SHH;JMJD6;FZD2;THAP1;CXXC1;SIN3A;CAMKK2;PDGFB;TIAL1;EGR2;TRIM45;SLTM;MTDH;ZFP91;BICRA;ZMYND11;BCL7A;APBB2;FOXN3;CNBP;BRF2;MIDEAS;ZNF319;TAL2;OVOL2;SAMD11;GATA2;HOXA6;BCL6B;BARHL1;BHLHE22;ALX4;ZBTB32;SAMD13;PAX1;FOXO6;DMRTB1;ANKRD2;SOX17;NEUROD6;NEUROD4;TWIST2;POU4F1;HMX2;TMPRSS6;PKNOX1;KLF12;ZNF569;CHD3;PATZ1;JUN;LIMS1;NPAS1;DPF2;RXRB;DDX17;SRCAP;INPP5K;NR2F1;EID2B;IRF8;MBD1;NOTCH4;MMS19;MEF2A;RNF20;PRDM1;LBX1;POFUT1;ACTL6A;PRDM11;SMARCA5;E2F2;KDM3A;ZSCAN21;NUP35;PITHD1;SMARCD3;NFE2L1;NRF1;RGS14;BRCA1;PRKCB;PAX2;MYNN;TBX6;NFYA;SMARCA2;IRF2BP2;ZNF367;RUNX1;DPF1;MAP3K2;ETV3;LIN9;TEF;KDM4A;ENG;BAZ1B;FADS1;RLF;SMAD9;CDK11B;CEBPG;ARNT;MED4;E4F1;MAP3K10;MXI1;RELB;RNF187;PRMT6;GCLC;ABL1;MRGBP;TRAPPC2;WWP2;SP9;ZNF3;ID3;ZIC1;CCNE1;PIAS3;ZBTB48;HP1BP3;SAFB;EZH2;ZNF292;OLIG2;BLM;DYRK1A;AKT1;BRD9;CSRNP2;NDUFA13;PRDM2;ZBTB8B;MLLT6;HDAC5;HR;SNX5;PIAS2;TAL1;PROX1;SP110;MAPK14;ZMIZ2;EED;MXD1;TTC21B;TCF7L1;TCF3;ZBTB39;POU2F2;TENM1;MAP2K1;TAF5L;ACVR2B;SPTY2D1;ZEB1;TADA1;ZMIZ1;VGLL4;COMMD7;MYPOP;DTX3L;STAT6;TSC22D4;MED18;CCAR1;UXT;ZBTB2;QARS1;AGT;SCMH1;RPS6KA4;IRF3;FZD1;ZFP62;POU2F1;NUP62;ARRB1;FANK1;MAFG;HES6;SP140;TGIF1;KDM1A;RNF4;IRF9;NUP107;GATA3;KAT5;CARM1;KDM8;MITF;HMGB2;CHMP1A;CUX2;PROX2;DKK3;ARID1A;ZNF740;IRF2;ZNF260;EID1;KHDRBS1;EDRF1;WTIP;ZKSCAN1;ZSCAN22;KDM7A;PPM1F;E2F3;ZBTB11;KTI12;NR1H2;DMTF1;REPIN1;TP53INP2;TOX2;XRCC6;TYMS;ZFP82;ZNF585B;ZNF585A;BHLHA9;KDM2A;MGA;PTP4A3
prerank,positive regulation of protein processing (GO:0010954),-0.3949680488249094,-1.133449029942528,0.2979214780600462,0.7355782120454717,1.0,3/19,1.93%,NLRC4;CCBE1;GSN
prerank,sodium ion transport (GO:0006814),-0.2790477292578325,-1.133412982151742,0.2099737532808399,0.7343511602452033,1.0,37/85,32.35%,HCN1;SLC8A3;SCN2A;NALCN;NEDD4L;SLC24A2;SCN3A;PKD2;ATP1B3;SLC6A15;ANO6;SLC4A8;HCN2;ASIC3;SCN9A;SLC12A1;SLC6A16;SLC5A6;SLC6A1;SLC6A6;SLC6A7;SCN1A;HCN4;SLC5A5;SLC12A3;HCN3;SLC6A17;SLC6A12;SLC5A1;SLC6A13;CATSPER4;SLC6A19;SLC6A14;SLC5A10;SLC4A11;SLC5A12;SCN4A
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.4755642705113911,1.1332029841685178,0.3203125,0.7662622718167359,1.0,3/11,10.66%,MERTK;CCR7;AXL
prerank,regulation of cholesterol storage (GO:0010885),-0.4155327860245066,-1.1331713268399288,0.2762557077625571,0.7337585058957071,1.0,3/15,3.85%,PPARG;MSR1;EHD1
prerank,skeletal system morphogenesis (GO:0048705),0.3433712573845152,1.1328975417963445,0.2664359861591695,0.7662616827728268,1.0,4/42,2.27%,TGFBR1;LRP5;HOXD9;SKI
prerank,neuromuscular process (GO:0050905),-0.40184451489110695,-1.1328941615197403,0.2696629213483146,0.733313736460578,1.0,1/16,0.11%,NRXN1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.4365575691943167,1.1328600482250015,0.30978260869565216,0.7654133601239058,1.0,3/15,7.25%,SMOC2;LGMN;MET
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.2604959177869175,-1.1327027106847416,0.1783783783783784,0.7325997652219628,1.0,29/129,15.49%,LRRK2;EGFR;FGF10;CSNK1G1;SEMA5A;PPM1A;PSMD14;GPC5;UBR5;ATP6AP2;PSMD8;PSMA2;PSMF1;PSMD6;AXIN1;PSME2;ZEB2;CCAR2;GPC3;LGR5;KANK1;PSMD5;TNKS2;PSMD12;LGR4;PSMD11;COL1A1;SFRP1;PSMD1
prerank,negative regulation of lymphocyte migration (GO:2000402),0.48746024415390476,1.1326740644336375,0.311284046692607,0.7650172616965074,1.0,5/10,16.53%,LRCH1;PADI2;MIA3;AKT1;WASL
prerank,actin filament-based transport (GO:0099515),0.40664734952513426,1.1325629849734609,0.30206378986866794,0.7644123974542936,1.0,8/21,16.53%,MYO1B;MYO1F;MYO1E;MYO7A;SUN2;MYO5B;MYO15A;WASL
prerank,positive regulation of B cell proliferation (GO:0030890),-0.35389834379980867,-1.132495570636499,0.28708133971291866,0.7318967501741714,1.0,4/29,3.27%,VAV3;CD38;CD74;CD40
prerank,phospholipid metabolic process (GO:0006644),0.3053283780287027,1.1323851792653854,0.233278955954323,0.7640172647161547,1.0,24/71,24.09%,ABHD12;LPCAT4;PLA2G4A;PLA2G15;PIP4P1;PLA2G4B;PLB1;SMPD2;PLA2G5;PLPP1;PLPP2;MBOAT1;FADS1;PLBD2;GPX4;PLPPR2;SMPD3;LCAT;LPCAT1;ACP6;GDE1;PLCB2;PLA2G3;GNPAT
prerank,phosphorylation (GO:0016310),0.2468270491895116,1.1323591980742957,0.14037433155080214,0.7631149782296087,1.0,87/385,17.63%,TGFBR1;MERTK;NUAK1;TGFBR2;BMP2K;CSNK1E;CDKL3;PIM2;MAP4K4;IGFBP3;CHEK2;PRKCA;PRKACA;LYN;CDK9;TBCK;NEK6;CSNK2A1;PIK3CG;ATM;MKNK1;DGKK;PRKCD;MAP4K3;RYK;NEK3;PTK2B;STRADA;RPS6KA5;CSK;PDK1;PDPK1;DGKD;NRBP1;PKN3;CAMKK2;PDGFB;PGK1;GK5;TSSK4;TSSK6;PIK3CD;PIK3CB;MTOR;WNK1;NUAK2;PDK2;GRK2;CERK;PANK2;PRKCB;XYLB;TAF1;MAP4K2;PINK1;HCST;CDK11B;TAOK2;MAP3K11;MARK2;NEK7;ABL1;PXK;BMX;CCNE1;MORC3;LATS2;MAPK8;DYRK1A;AKT1;FAM20B;PICK1;STK39;PASK;STK19;TEC;MAP2K1;AURKA;ACVR2B;ULK1;CDC42BPB;ADAM10;RPS6KA4;TRIB1;LIPE;EIF2AK2;VRK2
prerank,positive regulation of cholesterol transport (GO:0032376),-0.3565068950710679,-1.132221415463111,0.27654867256637167,0.7314660196761098,1.0,6/27,10.26%,PPARG;PLTP;APOE;SIRT1;NFKBIA;ABCA5
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3132691269687606,1.1319316965970534,0.23164763458401305,0.7635713580263238,1.0,9/62,6.77%,NCBP1;NELFB;POLR2H;POLR2J;CDK9;GTF2H2;CTR9;POLR2D;ERCC2
prerank,positive regulation of interleukin-1 production (GO:0032732),0.32689673528718216,1.1318507447429969,0.24324324324324326,0.7628948775381967,1.0,10/51,8.53%,LGALS9;RIPK2;AGER;PYDC1;TLR4;EGR1;CCL3;CASP1;NLRP3;ORM2
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.3797875594114097,-1.1318414216323536,0.26824034334763946,0.7313162436095162,1.0,7/21,11.82%,DMD;PDE4D;NCK2;NLRP2B;INPP5J;DDIT4;PAQR3
prerank,snRNA processing (GO:0016180),0.4150253615730313,1.1307080549777242,0.2846441947565543,0.7656588649186731,1.0,3/16,7.31%,INTS6L;INTS11;INTS3
prerank,bile acid biosynthetic process (GO:0006699),0.38144604224830736,1.1300540266198957,0.3021978021978022,0.7668939411500463,1.0,9/24,23.32%,CH25H;OSBPL3;CYP46A1;AKR1D1;CYP7B1;HSD17B10;OSBP;ACOT8;SCP2
prerank,endodermal cell fate commitment (GO:0001711),0.48831518451157147,1.1300470689605806,0.3193916349809886,0.7659497959170893,1.0,2/10,8.74%,CTR9;SOX17
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.3801743434489041,1.1298556151539147,0.27124773960216997,0.7655755504226944,1.0,5/25,7.10%,SMAD3;TLR4;CLU;AGTR2;NOS1AP
prerank,aminoglycan catabolic process (GO:0006026),-0.35124598736647134,-1.12982620459736,0.21939953810623555,0.7362588003990158,1.0,13/28,25.19%,GPC6;HGSNAT;SDC3;GPC5;HSPG2;GPC3;GPC4;AGRN;FUCA1;GPC1;SGSH;IDUA;SDC2
prerank,regulation of cell migration (GO:0030334),0.2464843762868426,1.1292821049053745,0.15193370165745856,0.7664672879363932,1.0,76/382,16.79%,TGFBR1;SRGAP3;SRGAP2;LDLRAD4;NUMB;NAV3;GNA12;ABI3;CSF1R;KIF2A;SMAD7;ARSB;SLURP1;ITGA6;RAC1;SEMA3B;MAP4K4;VSIR;AIF1;CYRIB;PRKCA;FERMT3;SEMA4C;IGF1R;SRC;RNF41;RHOB;ATM;CCL3;FLCN;SEMA4G;PTK2B;TRADD;SPRY2;RFFL;SHH;PDGFB;MACF1;GCNT2;MIA3;SUN2;PIP5KL1;GPER1;SEMA3G;TWIST2;DOCK10;TJP1;PIK3CD;APPL1;DPEP1;MGAT5;RNF20;CLN3;CEACAM1;SPATA13;PDGFRB;SERPINE1;ENG;OSGIN1;STX4;SERPINE2;SEMA4D;DRD2;AKT1;SMO;CIB1;CSF1;GPNMB;PIK3R3;NOG;PDCD10;MAPRE1;LAMC2;ARHGAP4;CCAR1;ADAM10
prerank,activation of phospholipase C activity (GO:0007202),-0.3469494606418633,-1.1292155661057761,0.26303317535545023,0.7369332387782969,1.0,7/29,5.41%,ARHGAP6;EGFR;ADRA1A;BDNF;NTRK2;RASGRP4;HTR2B
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.46963341347210386,-1.1288555120028134,0.32962138084632514,0.7367830937904475,1.0,2/10,9.33%,PID1;GRB10
prerank,skeletal muscle contraction (GO:0003009),0.4036796269630799,1.1287172201285685,0.2820976491862568,0.7673619426029089,1.0,4/19,19.12%,TNNI2;CCDC78;RCSD1;MYH14
prerank,cellular response to unfolded protein (GO:0034620),-0.36159763525762123,-1.1278349144329662,0.2876404494382023,0.7386595683271137,1.0,8/26,14.52%,ERN1;BAG3;PRKN;BAK1;HSPA2;HSPA1B;HSPA5;HSPA8
prerank,respiratory system development (GO:0060541),0.35684833891975526,1.1277573249969042,0.2746858168761221,0.7694584251767079,1.0,8/32,15.27%,BAG6;BASP1;CHD7;LOXL3;SHH;WNT7B;CCDC40;PROX1
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.34849982292319504,-1.1274649764361095,0.2600896860986547,0.7385136227568133,1.0,9/31,14.52%,ERN1;UBE2W;BAG3;PRKN;BAK1;HSPA2;HSPA1B;HSPA5;HSPA8
prerank,ether lipid biosynthetic process (GO:0008611),0.4861774784534249,1.1272701723186285,0.31992337164750956,0.7701148209610078,1.0,2/10,4.75%,LPCAT2;PLA2G4A
prerank,cGMP metabolic process (GO:0046068),-0.4411339154930128,-1.1271635503091288,0.32819383259911894,0.7381516156761136,1.0,5/12,18.67%,PDE9A;GUCY1B1;PDE2A;GUCY2F;GUCY2D
prerank,negative regulation of MAPK cascade (GO:0043409),0.2964744484670844,1.1269159308160572,0.22632423756019263,0.7703171003672078,1.0,23/87,20.24%,SIRPA;UCHL1;CNKSR3;TLR4;LYN;PRKCD;FLCN;SPRY2;GPER1;INPP5K;PIK3CB;RGS14;PEBP1;PTPN1;DUSP29;PIN1;DUSP6;QARS1;AGT;PTPRJ;TNIP1;SYNJ2BP;WNK2
prerank,long-chain fatty acid import into cell (GO:0044539),-0.47100987000718186,-1.1267213291252098,0.3171247357293869,0.7383895487017714,1.0,6/10,30.93%,CD36;ACSL3;RPS6KB1;ACSL1;SPX;SLC27A5
prerank,pulmonary valve morphogenesis (GO:0003184),-0.4040411843839135,-1.126227284215501,0.3169642857142857,0.7386764643087039,1.0,8/17,22.46%,ROBO1;SLIT2;JAG1;HEY2;BMP4;ROBO2;GJA5;NOTCH2
prerank,metal ion transport (GO:0030001),-0.272480998828281,-1.1261508190535299,0.20918367346938777,0.7376465052753891,1.0,24/86,17.17%,CACNA1E;ITPR1;SLC8A3;TRPC5;CCR1;RYR3;RYR2;TRPC4;TPT1;CACNA1C;PKD2;GRIN3A;TRPC3;CHRNA4;NDFIP1;ATP2A3;PANX1;MMGT1;CCL5;CACNB3;SELENOK;CACNA1B;MAGT1;TRPV6
prerank,cardiac muscle cell differentiation (GO:0055007),0.39715010724484023,1.1261181827850835,0.3079922027290448,0.7719207208142695,1.0,4/21,9.35%,MEF2C;CXADR;SLC8A1;AKAP13
prerank,protein neddylation (GO:0045116),-0.4469072970109115,-1.1256621230097805,0.2967741935483871,0.7377451066756034,1.0,4/13,16.79%,DCUN1D2;UBA3;DCUN1D3;UBE2M
prerank,regulation of protein export from nucleus (GO:0046825),-0.35897529645527,-1.1253823343232185,0.2692307692307692,0.7373825753224361,1.0,5/23,6.69%,YWHAE;SP100;GSK3B;BARD1;BAG3
prerank,membrane protein proteolysis (GO:0033619),0.34299187036060824,1.1251094165214355,0.2705061082024433,0.7742913726268121,1.0,14/37,23.10%,MYH9;MBTPS1;TMPRSS6;MBTPS2;PSENEN;PSEN2;SPPL2B;ADAM10;APH1B;AFG3L2;RBMX;ADAM17;ERAP1;TGFB1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.3228917373124436,1.125083550803438,0.2569558101472995,0.7734354311524113,1.0,10/53,14.52%,GNA12;OPHN1;UCHL5;PRKACA;USP19;NUDT15;ECSCR;ARAF;PINK1;PSMC2
prerank,regulation of translation (GO:0006417),0.26709921316394825,1.1247901587086768,0.2175226586102719,0.7734859148341453,1.0,52/173,22.99%,PLD1;NCBP1;EIF4A2;RPS6KA1;CNOT1;ETF1;CTIF;EIF4G1;ENC1;IMPACT;EIF2A;NSUN5;METTL5;DHX9;NANOS2;PKP3;GAPDH;EIF4H;MTOR;EIF2B4;MIF4GD;CYFIP1;RPL10;TOB1;RPS27L;MRPL13;IGF2BP2;SHFL;PASK;NEMF;METTL14;RIDA;EPRS1;EIF3D;EIF2AK2;FXR2;MTIF2;EIF1B;THBS1;EIF5;NSUN3;EIF1;TYMS;EIF2AK3;CAPRIN1;PCIF1;NANOS1;DDX3X;LARP1;ELAVL1;EIF4G2;LTN1
prerank,lung epithelium development (GO:0060428),-0.4635276843495882,-1.1247133736502815,0.3176229508196721,0.7382726951049888,1.0,5/10,22.81%,FGF10;RCN3;PKD1;BMP4;GRHL2
prerank,negative regulation of JNK cascade (GO:0046329),0.355955089626085,1.1241673449465892,0.2872727272727273,0.7745299040881881,1.0,7/31,13.62%,SIRPA;ITCH;GPS2;ZMYND11;KLHL31;PINK1;MAPK8IP1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.31949829087004733,1.1241024922017693,0.2676767676767677,0.7728080955571509,1.0,23/56,27.34%,NDUFB2;NDUFB8;ACAD9;NDUFB10;NDUFS4;NDUFS3;NDUFAF6;NDUFB3;NDUFAF1;NDUFA13;TMEM126A;BCS1L;NDUFS5;NDUFAF5;NDUFV3;NDUFV2;NDUFA9;NDUFB11;NDUFC2;NDUFV1;NDUFAF7;NDUFB4;NDUFAF3
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.31949829087004733,1.1241024922017693,0.2676767676767677,0.7728080955571509,1.0,23/56,27.34%,NDUFB2;NDUFB8;ACAD9;NDUFB10;NDUFS4;NDUFS3;NDUFAF6;NDUFB3;NDUFAF1;NDUFA13;TMEM126A;BCS1L;NDUFS5;NDUFAF5;NDUFV3;NDUFV2;NDUFA9;NDUFB11;NDUFC2;NDUFV1;NDUFAF7;NDUFB4;NDUFAF3
prerank,positive regulation of lymphocyte activation (GO:0051251),0.3636338432244426,1.123827288157607,0.2786885245901639,0.7727728000121178,1.0,10/28,20.07%,SIRPA;CCDC88B;CYRIB;IL12B;NCKAP1L;PYCARD;TNIP2;TICAM1;XRCC6;NOD2
prerank,regulation of nervous system development (GO:0051960),0.3482122647900436,1.1237888967305938,0.27597955706984667,0.7719427999317373,1.0,4/37,5.67%,CX3CR1;HEYL;SIRT2;NSUN5
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.3664762064632429,-1.1237129875833831,0.28211009174311924,0.7400913657230429,1.0,3/26,2.97%,NCK2;APP;CBLB
prerank,regulation of lymphocyte activation (GO:0051249),0.4522397662696407,1.1237037063338382,0.3162705667276051,0.771242712805238,1.0,1/12,0.03%,PAG1
prerank,ncRNA transcription (GO:0098781),0.4456186350238696,1.1230437469243888,0.31985940246045697,0.7723475163481717,1.0,6/13,25.72%,GTF3A;RPAP2;BRF1;POLR1G;SPIN1;SNAPC2
prerank,cation transmembrane transport (GO:0098655),0.3386229281350181,1.121993592021518,0.2773972602739726,0.7747100267800822,1.0,7/44,8.74%,SLC7A8;SLC7A5;TRPM4;TRPM2;TRPM6;ABCC9;SLC29A4
prerank,T cell migration (GO:0072678),0.4443645075841862,1.1218032307365746,0.3408662900188324,0.7743787113880952,1.0,3/13,9.62%,PIK3CG;CCL3;PIK3CD
prerank,glutathione biosynthetic process (GO:0006750),-0.4471407160234774,-1.1216574021563048,0.3252747252747253,0.7451095485195534,1.0,2/11,7.46%,GSS;GGCT
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.28729792577392604,-1.1216260237771385,0.2458628841607565,0.7439397301999969,1.0,13/67,9.90%,NEDD9;UTRN;DOCK5;CD36;VIT;JAK2;FN1;GSK3B;CDC42;SKAP1;CARMIL1;MYADM;CDH13
prerank,regulation of amyloid-beta formation (GO:1902003),0.35172490579732363,1.1216162594161638,0.2808586762075134,0.7740217501516271,1.0,4/34,4.13%,BIN1;GSAP;PICALM;CLU
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.39666420970637045,1.1216032522207606,0.3145009416195857,0.7731182959055839,1.0,3/20,3.82%,TGFBR1;ITCH;EGR1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.3574208113596864,1.1214334175057212,0.2801418439716312,0.7726795413644749,1.0,3/31,1.65%,TGFBR1;TGFBR2;HOXD9
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.2757864464340209,-1.1213379978007765,0.21621621621621623,0.7435942966722916,1.0,15/91,9.90%,RIMS2;HIP1;RIT2;STXBP5L;LRRK2;RAB3C;SYT1;STXBP5;RAB5C;CPLX2;SCFD1;RAB3D;RAB8A;RAB3A;CDH13
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.4033637161257579,1.121264041528502,0.3113207547169811,0.7722883009501115,1.0,7/20,23.24%,DIP2B;RPS6KA5;BRCA1;RPS6KA4;ARRB1;NOS1;GLYR1
prerank,histone acetylation (GO:0016573),0.3048574959785932,1.1210852656090409,0.2623762376237624,0.7719155656165178,1.0,25/69,24.66%,BRD8;TAF12;TAF6L;TAF6;CPA4;ACTL6A;MORF4L1;MRGBP;NAA50;TAF5L;TADA1;JADE2;KAT5;MBIP;NAA40;EPC1;TAF10;MORF4L2;PHF20;KAT6B;DR1;TAF5;NAA60;BRD1;WDR5
prerank,reverse cholesterol transport (GO:0043691),0.4511880723605406,1.1207962382800905,0.3272058823529412,0.7719669770480205,1.0,5/13,20.26%,LIPC;CLU;APOM;SCARB1;LCAT
prerank,myeloid cell activation involved in immune response (GO:0002275),0.4183185759045169,1.1203401852849568,0.3216168717047452,0.7725610532208623,1.0,5/18,15.84%,KARS1;SBNO2;PLCG2;PYCARD;SLAMF1
prerank,endoplasmic reticulum organization (GO:0007029),-0.281493965805841,-1.1202990753377735,0.2262210796915167,0.7455386714702585,1.0,15/72,14.73%,LRRK2;TMCC1;REEP3;APP;UBE2J2;VAPA;ATL2;DNM1L;VCPIP1;RTN4;REEP4;TOR1AIP2;ALDH3A2;HMOX1;LMAN1
prerank,ATP synthesis coupled proton transport (GO:0015986),0.41958266410623646,1.1201803705296625,0.30927835051546393,0.772110647494738,1.0,7/17,23.62%,ATP5PO;ATP5PD;ATP5MC1;VPS9D1;ATP5F1D;STOML2;ATP5PF
prerank,regulation of humoral immune response (GO:0002920),0.3346195681929648,1.1188607431571143,0.2956989247311828,0.7754441646176162,1.0,7/44,8.05%,C1QB;PROS1;PHB2;CLU;C1QA;C1QBP;CCR7
prerank,positive regulation of programmed cell death (GO:0043068),0.25079942612064454,1.1186100644530041,0.17837078651685392,0.7753639504130513,1.0,50/272,14.63%,BIN1;FGD2;ARHGEF2;DNM2;CTSD;PREX1;VAV2;ITGA6;QRICH1;PRMT2;CALHM2;CRADD;KCNMA1;IGFBP3;TGM2;KLF11;RHOB;ATM;CLU;FLCN;SUDS3;RPS27A;UBC;TRADD;ARL6IP5;C1QBP;WNT10B;NOS2;PIP5KL1;GPER1;JUN;AKAP13;SLC27A4;CLIP3;PPID;PSENEN;BMF;FGD3;TRIO;PSEN2;APAF1;HIP1R;MAP3K10;MAP3K11;DDX20;ABL1;SOD1;LATS2;MAPK8;PYCARD
prerank,negative regulation of axon extension (GO:0030517),0.36022512786317024,1.1182206505594705,0.29464285714285715,0.7756710064829779,1.0,9/30,16.66%,SEMA3B;CDKL3;DIP2B;SEMA4C;SEMA4G;SEMA3G;SEMA4D;RTN4R;MAG
prerank,regulation of neuron differentiation (GO:0045664),0.29865528004211583,1.1181422957998366,0.25967741935483873,0.7749865581200869,1.0,13/76,11.32%,BIN1;ZFHX3;ARHGEF2;HEYL;YWHAH;MEF2C;MMD;IMPACT;NREP;SIN3A;CDK5RAP1;DTX1;DLL1
prerank,peptidyl-lysine acetylation (GO:0018394),0.4718604502787043,1.1179835189654306,0.3432282003710575,0.7745471176745581,1.0,1/10,0.46%,BAG6
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.35620018797979275,1.1179182934655043,0.307032590051458,0.773804906804248,1.0,11/30,24.23%,CSF1R;PLEK;ARMC6;SHH;TNFRSF13B;PLD4;FST;SBDS;TGFB1;TP53;PTPRC
prerank,positive regulation of proteolysis (GO:0045862),-0.2997724146202161,-1.1177929016545685,0.2665094339622642,0.7520263559372241,1.0,11/55,11.62%,NLRC4;CCBE1;CTSC;CYFIP2;APOE;RCN3;BTRC;SNX9;BAK1;ADRA2A;SH3D19
prerank,neural tube closure (GO:0001843),0.34731101937311404,1.117735168982877,0.2958257713248639,0.7734583657360774,1.0,15/34,25.71%,SKI;SEMA4C;DEAF1;PAX2;MTHFD1;VANGL2;VASP;KDM2B;TGFB1;CELSR1;DVL2;PRICKLE1;IFT122;SCRIB;GRHL3
prerank,myotube differentiation (GO:0014902),0.41345693054856764,1.117555514451173,0.3321678321678322,0.7731126576993205,1.0,5/17,8.04%,MEF2C;SKI;JAM2;SORT1;KLHL40
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.27597827060739094,1.1174052071519147,0.21800947867298578,0.7726738700319936,1.0,49/128,27.65%,DNM2;SDCCAG8;TUBA4A;CSNK1E;CHEK2;PRKACA;FBXL15;ODF2;TUBB;CEP164;TUBG1;HAUS7;CNTRL;FBXL8;TUBA1A;CEP63;CEP57;OPTN;HAUS6;PLK3;HAUS2;PPP1CB;SFI1;FBXL22;AURKA;MAPRE1;CEP135;MASTL;ACTR1A;KDM8;OFD1;KHDRBS1;CEP43;DCTN2;CCNY;CEP70;FBXL7;CSNK1D;FBXL3;DYNLL1;AJUBA;NDE1;CCP110;CUL1;HAUS5;FBXL12;CDC25A;ENSA;HAUS8
prerank,anterograde axonal transport (GO:0008089),-0.32515429145499275,-1.1172807320023297,0.2577777777777778,0.7523450893133767,1.0,10/37,18.94%,DLG2;KIF5C;KIF1B;AP3M1;AP3S2;KIF5B;DTNBP1;RAB27B;KIF4A;BLOC1S3
prerank,rRNA processing (GO:0006364),-0.2449594563451013,-1.1170707795256742,0.15451895043731778,0.7517812136036367,1.0,49/172,20.46%,RPL36A;RPL30;RPL35A;DDX10;NSA2;RPL4;RPS7;UTP20;RPS2;SNU13;RPLP2;RPL7A;LAS1L;RPL41;EXOSC1;POP4;XRN2;RPL26;DCAF13;RPS27;RPL18A;RPS25;MRTO4;RIOK3;RPL38;NOC4L;RPL37;UTP14A;RPS14;ERI1;EXOSC7;RPL24;WDR18;RPS9;RIOK1;RPLP0;RPLP1;RPL8;RPL22;NOB1;ESF1;RPL19;RPS6;PIH1D1;RRP9;RPL13A;RPL18;RPS19;RPL23A
prerank,protein deacetylation (GO:0006476),0.33139366573198725,1.1170410307832408,0.2534246575342466,0.7729568909718082,1.0,17/41,26.97%,SIRT2;MTA1;HDAC10;SUDS3;RBM14;SIN3A;MIDEAS;MORF4L1;BRMS1L;HDAC5;SIN3B;MIER3;MORF4L2;BRMS1;HDAC6;HDAC11;TBL1X
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.2488062790989268,1.1166708430150403,0.20055325034578148,0.773265120586887,1.0,86/327,24.26%,TGFBR1;ZFHX3;ZSCAN26;MLXIPL;DNM2;RREB1;DENND4A;DDIT3;MEF2C;LYL1;SBNO2;SRRT;FUS;CHEK2;KMT2D;EFEMP1;VHL;HDAC10;REXO4;CHD7;MLX;CTR9;RPS6KA5;GTF2IRD1;RHOH;FOXK2;TAF6L;THAP1;CXXC1;APBB2;FOXN3;CNBP;SOX17;CHD3;PATZ1;RNF20;POFUT1;ZSCAN21;NUP35;NFYA;SMARCA2;ENG;FADS1;CDK11B;ABL1;TRAPPC2;HP1BP3;EZH2;PRDM2;MLLT6;TCF7L1;TCF3;TAF5L;ACVR2B;SPTY2D1;ZMIZ1;CCAR1;RPS6KA4;HES6;NUP107;CARM1;MITF;IRF2;WTIP;ZBTB11;DMTF1;PTP4A3;SAP30L;GZF1;CRABP2;KAT6B;CASZ1;ZFPL1;BNC2;NFIA;BMP2;SCRT1;MSC;LIN54;SUFU;TGIF2;DVL2;TP53;TAF5;ZNF628;ACVR1B
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.37067227755423326,1.1165030130306037,0.30996309963099633,0.7728437309952508,1.0,11/27,21.59%,RNASE1;POP1;KHNYN;RNASE6;ZC3H12C;ZC3H12B;NHP2;PCF11;NUDT16;RNASEH1;ZC3H12A
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.3080415146203451,1.1162718314676956,0.2620578778135048,0.7727086499119536,1.0,9/70,4.06%,SRGAP2;OPHN1;RAC1;MEF2C;RILPL1;PIK3R1;FERMT3;ITGAV;PKHD1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.33977617582442776,1.1160158838943537,0.276707530647986,0.7726414466625224,1.0,8/36,13.38%,RHNO1;CHEK2;ATM;NBN;RAD17;USP28;RAD1;CEP63
prerank,actomyosin structure organization (GO:0031032),0.296117062207352,1.1158088591986253,0.2571884984025559,0.7724161442404901,1.0,7/75,3.78%,EPB41L2;ITGB5;F11R;CAPN3;FLII;SRC;MYH9
prerank,inflammatory response (GO:0006954),0.26300868989949294,1.1153189762222722,0.2183406113537118,0.7731263251353494,1.0,28/195,9.62%,BLNK;IL18;F11R;CSF1R;RAC1;LGALS9;AIF1;RIPK2;PJA2;ITCH;TLR4;ITGB2;PIK3CG;AGTR2;CCL3;ADORA1;LOXL3;AFAP1L2;TAC4;NLRP3;SELE;PLA2G4B;CCR7;NOS2;VNN1;FUT7;CXCL1;PIK3CD
prerank,striated muscle cell development (GO:0055002),0.4296609883577548,1.1151181389298626,0.32629558541266795,0.7728605932826431,1.0,2/14,2.08%,CAPN3;FLII
prerank,positive regulation of T cell migration (GO:2000406),0.39905126628916576,1.1148332990943488,0.3141831238779174,0.7727886390502502,1.0,9/20,22.03%,DOCK8;AIF1;WNK1;PYCARD;STK39;ADAM10;ADAM17;TNFRSF14;CXCL10
prerank,regulation of acute inflammatory response (GO:0002673),0.40494007859868497,1.114772304601231,0.3196428571428571,0.7720465289242053,1.0,4/18,15.89%,F12;IL6ST;NLRP3;OSM
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.42487088809781115,-1.1145947723582827,0.32112068965517243,0.7581264312078092,1.0,4/14,13.05%,ITGA4;CD40;ANO6;RGCC
prerank,tube closure (GO:0060606),0.353626373933986,1.1144846017288204,0.29508196721311475,0.7721147383118727,1.0,14/31,25.71%,SKI;SEMA4C;DEAF1;PAX2;MTHFD1;VANGL2;VASP;TGFB1;CELSR1;DVL2;PRICKLE1;IFT122;SCRIB;GRHL3
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.3580823797070122,-1.1144441529012348,0.3157894736842105,0.7573650562824675,1.0,6/24,6.54%,ITPR1;RYR3;RYR2;HTR2C;HTR2B;PKD2
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.28330065962277956,1.114426650529553,0.250386398763524,0.771372745963757,1.0,20/107,8.98%,SLC30A5;ATP13A1;ATP2C1;SLC24A3;SLC30A10;PKHD1;CCL3;MT1B;MT1G;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A;SLC8A1;EDN3;SLC30A8;EDN2;MT2A
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.38109172220797183,-1.113913313694284,0.3057471264367816,0.7576564733386658,1.0,8/19,22.16%,TMEM106A;APP;KLF2;KLF4;MTPN;SLCO1C1;MAP2K5;PAX8
prerank,regulation of execution phase of apoptosis (GO:1900117),0.45757412606556974,1.1138357293953562,0.3088235294117647,0.772302989964801,1.0,6/11,28.58%,SIRT2;ZC3H12A;BCL2L1;TP53;FZD3;FAP
prerank,response to ATP (GO:0033198),0.4050630691922586,1.113560376002635,0.3351449275362319,0.7722467015722222,1.0,4/18,11.77%,P2RY12;ABCC9;SSH1;TAF1
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.4220131673698675,1.1128044501170427,0.33579335793357934,0.7737636260284868,1.0,9/15,34.69%,ENTPD1;CMPK1;ENTPD7;ENTPD6;AK8;ENTPD3;AK1;AK7;CMPK2
prerank,B cell activation (GO:0042113),0.3062166649518716,1.1127313058282837,0.2640901771336554,0.773095929370466,1.0,15/68,15.68%,BLNK;MEF2C;LYL1;FCRL1;LAT2;GPS2;DNAJB9;PHB2;PLCG2;CD86;PIK3CD;PRKCB;CEBPG;HDAC5;TCF3
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.3687105667348678,-1.1126877436929692,0.3131991051454139,0.7602037726070768,1.0,8/23,19.06%,HTT;ZW10;SPDL1;CDK5RAP2;NDC80;GPSM2;ITGB1;NSFL1C
prerank,organophosphate ester transport (GO:0015748),0.3747726503001561,1.1123330204207587,0.29874776386404295,0.7734348842761122,1.0,11/24,24.85%,PCTP;PITPNC1;EPG5;NPC2;OSBPL5;PITPNM1;SCARB1;MTTP;SCP2;PRELID2;PITPNB
prerank,response to UV-B (GO:0010224),-0.435944483107642,-1.112134663697277,0.340080971659919,0.7606845970425048,1.0,7/12,29.32%,MME;CRIP1;CDKN1A;MFAP4;MSH2;RELA;IL12A
prerank,protein O-linked glycosylation (GO:0006493),0.2871612637664581,1.1119711421666254,0.2667660208643815,0.7736448337319853,1.0,22/96,13.57%,LARGE1;XXYLT1;B3GNT2;TRAK1;GALNT12;GALNT5;POMGNT1;GALNT10;TET3;DPM3;GALNT1;MUC6;B3GNT4;POMT1;POFUT1;GALNT11;GALNT7;GALNT15;GXYLT2;EOGT;GALNT3;ST3GAL3
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.46271579527331813,-1.1119143981563304,0.3391304347826087,0.7601365708081986,1.0,3/11,6.25%,ATL2;VCPIP1;RTN4
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.42086114805121555,-1.1118429192821233,0.3295194508009153,0.759084046005447,1.0,2/13,2.21%,SORBS1;IRS1
prerank,glucose transmembrane transport (GO:1904659),0.41081584340618593,1.1114844333503062,0.31746031746031744,0.7742928298478775,1.0,4/18,16.40%,PPARD;SORT1;RAB4B;SLC5A3
prerank,aerobic electron transport chain (GO:0019646),0.3054834051234184,1.111332486959776,0.25833333333333336,0.7738665667751095,1.0,24/68,26.53%,NDUFB2;NDUFB8;NDUFB10;COX7A2L;COX8A;NDUFS4;UQCRC2;UQCRB;NDUFS3;NDUFB3;NDUFAF1;COX5A;NDUFA13;NDUFS5;NDUFV3;NDUFV2;COX6B1;NDUFA9;NDUFB11;NDUFC2;COX6A2;NDUFV1;NDUFB4;AFG1L
prerank,peptidyl-lysine trimethylation (GO:0018023),0.3699126467221218,1.1113280838989328,0.3147482014388489,0.7729736577888653,1.0,10/26,21.28%,KMT2D;CTR9;TET3;EEF2KMT;KMT5C;ANTKMT;SETD2;SETD4;PRDM9;SETD3
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.46025282243541404,1.111244853915708,0.327683615819209,0.772318793814013,1.0,3/11,3.39%,ABCD2;COA8;SLC30A10
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.48347351995462273,1.1112021096914677,0.34099616858237547,0.771558441624731,1.0,3/10,9.90%,SEC14L1;C1QBP;UFD1
prerank,heart morphogenesis (GO:0003007),0.31823598227999245,1.1111439723482046,0.28689883913764513,0.7708419006146637,1.0,6/50,8.74%,TGFBR1;HEYL;CHD7;MDM4;LEFTY1;SOX17
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.45649377525151247,1.1104669106799099,0.34210526315789475,0.7720740610950083,1.0,4/11,24.23%,UNC93B1;TNIP2;TICAM1;FADD
prerank,negative regulation of B cell activation (GO:0050869),0.3838246895408598,1.1104172252663143,0.3193430656934307,0.7713214423010323,1.0,5/21,9.19%,LYN;ATM;TNFRSF21;TNFRSF13B;INHA
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.4761032102657656,1.1103762520348233,0.3382899628252788,0.7705753612220201,1.0,7/10,31.67%,DCLRE1B;DCLRE1C;DCLRE1A;ACD;RTEL1;TFIP11;TERF2
prerank,positive regulation of defense response (GO:0031349),0.28909512825420963,1.1100785237572655,0.2794348508634223,0.7706355642367142,1.0,20/89,16.93%,IL18;TLR7;POLR3G;ETS1;MEF2C;TLR4;SLC15A4;CCL3;TRADD;AKIRIN2;DHX9;IL12B;DDT;SERPINE1;IL33;OPTN;OSM;GBP5;GPR4;AGT
prerank,modulation by symbiont of host process (GO:0044003),-0.4656508882954096,-1.1096816749190286,0.3367768595041322,0.7646753581336901,1.0,2/10,2.87%,MRC1;B2M
prerank,positive regulation of interleukin-6 production (GO:0032755),0.3073551734269153,1.1095596028977697,0.2946859903381642,0.7714216298740045,1.0,22/68,23.52%,TLR7;ARHGEF2;LGALS9;AIF1;AGER;TLR4;PLCG2;DHX9;NOS2;IL6R;IL33;PTPN11;MAVS;PYCARD;POU2F2;RAB7B;SETD4;NOD2;IL1A;TWIST1;MYD88;TYROBP
prerank,epithelial to mesenchymal transition (GO:0001837),0.3253974709628374,1.1092389660934803,0.2937062937062937,0.7715296134187665,1.0,17/47,24.68%,TGFBR1;HEYL;DDX5;LOXL3;LIMS1;DDX17;NOTCH4;ENG;NOG;AKNA;ROCK2;TASOR;DLG5;BMP2;TGFB1;SOX9;HIF1A
prerank,regulation of gene expression (GO:0010468),0.22772597061289737,1.1091411787444838,0.1255980861244019,0.770951147454791,1.0,173/903,16.37%,TGFBR1;ZFHX3;TMEM119;SNRNP70;SIRPA;ZSCAN26;MLXIPL;DNM2;RREB1;SON;SMAD3;DENND4A;ETS1;FAM98B;NFE2L2;DDIT3;SLC7A5;MEF2C;LGALS9;VSIR;LYL1;AIF1;CLK1;COQ7;SBNO2;PICALM;CRNN;SRRT;FUS;TRIM11;CHEK2;MTA1;KMT2D;TLR4;LYN;EFEMP1;VHL;SLC24A3;TRIM5;ATG14;HDAC10;HNRNPDL;CIAO3;EGR1;ATM;PLCG2;CLU;CCL3;PAX6;FLCN;REXO4;CHD7;RBL2;LRRC19;CALCOCO1;NDFIP2;SLC8A1;MLX;CTR9;RPS6KA5;LGMN;GTF2IRD1;SPRY2;RHOH;SORT1;FOXK2;MOV10;TRIM44;SART3;PCBP2;TAF6L;SHH;HNRNPH1;THAP1;CXXC1;ADNP;PDGFB;NOS1AP;GCNT2;CLK4;APBB2;FOXN3;ZFP36L1;CNBP;OVOL2;GATA2;EDN3;CNTF;BCL6B;NOS2;GDNF;PKP3;IL12B;GPER1;CALCR;SLC22A2;SOX17;UTY;POU4F1;ZUP1;CHD3;PATZ1;FLOT2;LIMS1;CD34;PIK3CD;PIK3CB;MTOR;USP36;C1D;PABPN1;RNF20;PRDM1;ESRP1;POFUT1;PRDM11;ZSCAN21;NUP35;BRCA1;LAMTOR5;TOB1;NFYA;SMARCA2;TAF1;TCEAL1;ANKRA2;HAVCR2;TRA2B;PINK1;RUNX1;IL33;NFKBID;KDM4A;ENG;MUSK;FADS1;CDK11B;TARDBP;GJA1;PIN1;POGZ;RNF187;NWD1;ABL1;TRAPPC2;WWP2;HP1BP3;EZH2;IGF2BP2;MAPK8;AKT1;SMO;PRDM2;HPN;MLLT6;HDAC5;CSF1;PROX1;MAPK14;PIK3R3;NOG;CDH3;TCF7L1;TCF3;MAP2K1;TAF5L;PDCD10;AURKA;ACVR2B;SPTY2D1;ANXA7;LGALS7;RAB27A
prerank,glycogen metabolic process (GO:0005977),-0.3476788732990804,-1.1090766801721899,0.29504504504504503,0.7653794227619475,1.0,11/27,22.19%,PRKAG2;CALM1;GSK3B;GBE1;PER2;GYG1;PYGM;PHKG1;STBD1;UGP2;PGM2L1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.43775654499615413,-1.1089579692298772,0.3125,0.7644609747648556,1.0,3/12,15.34%,BICD1;CEP19;CCDC120
prerank,positive regulation of cell death (GO:0010942),0.3094753322752622,1.1089234917749413,0.2658450704225352,0.7707571801186143,1.0,12/59,10.19%,ITGAM;RIPK2;PICALM;ITGB2;EGR1;CLU;EIF4G1;EIF2S1;C1QA;CALCR;ACER2;LRP1
prerank,global genome nucleotide-excision repair (GO:0070911),0.3736620671180438,1.108838693237815,0.2998236331569665,0.770152416442794,1.0,6/26,7.30%,DDB2;RPS27A;UBC;GTF2H2;ERCC2;CUL4B
prerank,regulation of cytokine production (GO:0001817),0.2743323136591447,1.1084221810805843,0.2648401826484018,0.7706377069815225,1.0,30/126,17.85%,SIRPA;CADM1;CCDC88B;LGALS9;LYN;PIK3CG;LRRC19;RPS6KA5;AFAP1L2;DTX4;CCR7;BCL6B;NOS2;IL12B;GAPDH;PIK3CD;PLD4;IRF8;SCAMP5;IL33;SOD1;IGF2BP2;MAPK14;GPNMB;AGT;RPS6KA4;IRF3;EIF2AK2;SLC11A1;GATA3
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.2839428119337231,1.1083612296236864,0.26582278481012656,0.7699265639996499,1.0,24/102,18.08%,PDE3B;PIK3R1;ADCY9;PRKACA;LPIN2;SLC30A10;RHOQ;SRC;PRKCD;PDPK1;ZFP36L1;TRARG1;GPER1;LHCGR;ADCY4;INPP5K;CEACAM1;ADCY6;AKT1;HDAC5;EPRS1;RAB13;ADCY7;LPIN1
prerank,organic substance transport (GO:0071702),0.2738064851354441,1.1081251605891302,0.2559241706161137,0.7697642801339056,1.0,26/121,17.96%,SLCO2B1;ABCD2;ABCA9;PCTP;MYH9;TAP2;NME4;PPT1;ARRDC1;CD320;ARL6IP5;MIA3;RD3;SLC22A2;SLC22A6;SLC29A4;SCAMP2;SCAMP5;ARRDC2;TOM1;PICK1;KIF3A;MFSD2B;SLC23A1;SLC19A1;CHMP1A
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.4726862335413155,1.1077861683111978,0.31985940246045697,0.7699099760279254,1.0,6/10,25.89%,LYN;PTPN1;GHR;STAT6;STAT5B;STAT3
prerank,regulation of mitochondrial translation (GO:0070129),0.3906094135987576,1.107725012563003,0.3333333333333333,0.7692411155230531,1.0,14/21,35.22%,C1QBP;RMND1;MPV17L2;FASTKD3;UQCC2;NSUN3;FASTKD2;NGRN;MTG1;TSFM;MTG2;MRPS27;RCC1L;ALKBH1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.37723896799438367,1.1066145985771996,0.3041144901610018,0.7717750044189914,1.0,7/24,10.91%,TWF2;RAC1;PIK3R1;FSCN1;AKIRIN1;AVIL;CYFIP1
prerank,modified amino acid transport (GO:0072337),-0.4026618655721013,-1.1065678942376473,0.33820459290187893,0.7708521732211728,1.0,8/15,29.48%,MGST1;SLC46A1;SLC1A4;SLC5A6;FOLR2;FOLR1;SLC25A32;SLC6A13
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.3521276436999552,1.1064290691000287,0.3094405594405594,0.7715064124839943,1.0,8/32,14.63%,BAG6;FHIT;DDX5;USP28;POU4F1;PDK2;RPS27L;PYCARD
prerank,regulation of chromosome organization (GO:0033044),-0.3808432268244273,-1.106418085959588,0.2981651376146789,0.7700026170457885,1.0,9/22,20.98%,SMG6;LIG4;SMG5;BUB1;XRCC5;SMG1;PIF1;SETMAR;UPF1
prerank,nucleocytoplasmic transport (GO:0006913),0.33045453135480674,1.1062589344985938,0.2914572864321608,0.7711477531991245,1.0,10/40,16.30%,BACH2;NCBP1;SNRPF;ANP32A;RGS14;SMN1;GEMIN6;SNUPN;DDX20;NEMF
prerank,purine nucleotide biosynthetic process (GO:0006164),0.4497781864871673,1.1061971365665146,0.3345656192236599,0.7704687723189905,1.0,8/12,25.96%,GART;PRPS1L1;PRPS1;MTHFD1;PRPSAP1;PRPSAP2;ADSL;AMPD2
prerank,cellular modified amino acid catabolic process (GO:0042219),0.41881061771990835,1.106055812427073,0.30952380952380953,0.7700157664753019,1.0,4/15,20.73%,ABHD12;DPEP1;ALDH4A1;GGT5
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.43235387433295885,1.1059840282707916,0.32592592592592595,0.7693396247610561,1.0,7/14,17.17%,MEF2C;AIF1;IGFBP3;LRP1;SERPINE1;NDRG4;TRIB1
prerank,cellular response to type I interferon (GO:0071357),-0.31325102957634343,-1.1058967551919616,0.28756476683937826,0.7690856772717894,1.0,18/41,26.95%,OAS2;RSAD2;SP100;IFITM3;IRF4;GBP2;RNASEL;IFIT3;SAMHD1;IFITM2;OAS3;IFITM1;IRF7;BST2;IRF1;ADAR;OASL;IP6K2
prerank,type I interferon signaling pathway (GO:0060337),-0.31325102957634343,-1.1058967551919616,0.28756476683937826,0.7690856772717894,1.0,18/41,26.95%,OAS2;RSAD2;SP100;IFITM3;IRF4;GBP2;RNASEL;IFIT3;SAMHD1;IFITM2;OAS3;IFITM1;IRF7;BST2;IRF1;ADAR;OASL;IP6K2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.35410947924100233,-1.10586093725421,0.31385281385281383,0.767913316067115,1.0,6/26,11.45%,CUL3;HECW2;CDK5RAP2;CENPE;DLGAP5;UBE2C
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.4607188149163287,-1.1055580000881893,0.31910112359550563,0.7676189474252462,1.0,6/10,31.21%,PRKN;SNCA;HP;ETFBKMT;GZMA;AOC3
prerank,sodium ion transmembrane transport (GO:0035725),-0.27253136467744526,-1.1055222271048133,0.2398989898989899,0.7664686646950111,1.0,25/84,23.14%,HCN1;SLC8A3;SCN2A;NALCN;SLC24A2;SCN3A;PKD2;ATP1B3;SLC6A15;ANO6;ATP1A1;SLC4A8;HCN2;SLC9A4;ASIC3;SCN9A;SLC12A1;SLC6A16;SLC6A1;SLC6A6;SLC6A7;SLC9A2;SCN1A;HCN4;SLC12A3
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.2894923061019234,1.105376991600901,0.26161790017211706,0.7704704001727802,1.0,35/76,31.25%,SENP2;SMAD7;RIPK2;TBC1D7;UBA2;WDR48;NDFIP2;PTTG1IP;KLHL40;RASD2;BRCA1;PINK1;PIAS3;UBE3A;FANCI;XIAP;PHF23;STUB1;TNIP1;DCUN1D1;ZC3H12A;NSMCE3;SPRTN;PRICKLE1;DCUN1D4;UBE2D1;TSPYL5;TRAF6;SAE1;PAXIP1;LAPTM5;BIRC2;DCUN1D5;PIAS4;UBE2L3
prerank,regulation of cellular metabolic process (GO:0031323),0.3261501768703621,1.1053348942162176,0.31413612565445026,0.7697308752811939,1.0,16/45,22.58%,TBC1D16;COQ7;BCO2;RNF41;SSH1;PDK2;PANK2;PINK1;NPC2;PM20D2;STUB1;RSPO1;VPS35;ARF1;RNF34;ARF4
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.3386875081271079,1.1053173524987752,0.3005366726296959,0.768909985387387,1.0,4/40,2.53%,TGFBR1;TGFBR2;SMAD3;TGFB1I1
prerank,positive regulation of reproductive process (GO:2000243),0.3555742622092823,1.1049535798681065,0.31896551724137934,0.7691868532031998,1.0,6/31,15.26%,LHFPL2;SIRT2;TAC4;C1QBP;PGAM4;VIP
prerank,positive regulation of cell migration (GO:0030335),0.25133632729502237,1.104498068087906,0.21968616262482168,0.7697501766847132,1.0,59/253,19.83%,TGFBR1;NUMB;ARHGEF2;RREB1;CSF1R;ITGA6;SEMA3B;MAP4K4;VSIR;AIF1;PRKCA;FERMT3;SEMA4C;IGF1R;SRC;ATM;PLCG2;CCL3;SEMA4G;PTK2B;TRADD;SPRY2;PDGFB;GCNT2;C1QBP;MIA3;SUN2;GPER1;SEMA3G;TWIST2;TJP1;PIK3CD;MGAT5;MTOR;NCKAP1L;PDGFRB;DDR2;INSL3;STX4;SEMA4D;SMO;CIB1;CSF1;GPNMB;PIK3R3;PDCD10;MAPRE1;LAMC2;CCAR1;ADAM10;ROCK2;MIEN1;CLDN1;PPM1F;CEP43;THBS1;CCL24;SEMA3D;CRKL
prerank,cellular response to insulin stimulus (GO:0032869),0.27582771676677936,1.1040578045704237,0.2450532724505327,0.7703273781324782,1.0,27/124,18.08%,PDE3B;PIK3R1;ATP6V0B;LPIN2;IRS4;RHOQ;IGF1R;ATP6V1D;PDPK1;TCIRG1;ATP6V0A2;ZFP36L1;TRARG1;SLC27A4;APPL1;INPP5K;PDK2;CEACAM1;ATP6V0A4;ZDHHC7;AKT1;HDAC5;PIK3R3;ATP6V0E2;EPRS1;RAB13;LPIN1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.29390696051075704,1.1038608336135427,0.282793867120954,0.7700404786761763,1.0,10/71,7.30%,BAG6;ZRANB1;RNF41;RPS27A;UBC;CTSS;LGMN;YME1L1;SOCS6;CUL4B
prerank,RNA transport (GO:0050658),0.2980623869870298,1.1036361186766297,0.2973421926910299,0.7698763478385616,1.0,25/71,26.58%,SRRM1;TGFBR2;NCBP1;MAGOHB;MAGOH;U2AF2;ZFP36L1;NUP62CL;DHX38;SRSF5;RBM8A;U2AF1L4;SLU7;ALYREF;NUP62;THOC6;SRSF9;HNRNPA2B1;DDX39B;NUP153;XPO5;HNRNPA1;NUP188;THOC3;ZC3H11A
prerank,chordate embryonic development (GO:0043009),0.3128618664772621,1.1030824863383906,0.2980132450331126,0.7708127527999815,1.0,20/55,28.40%,TGFBR1;SOX8;DEAF1;FLCN;CHD7;ZNF568;WNT7B;BRCA1;PROX1;NOG;ADAM10;GATA3;PTCH1;BMP2;TGFB1;FGFR2;SULF1;PTPRR;WNT5A;MBNL1
prerank,negative regulation of proteolysis (GO:0045861),0.3416995425419455,1.1030601585794728,0.32075471698113206,0.7700017631869174,1.0,10/34,20.94%,BAG6;CST3;CLN3;SERPINE2;AKT1;DNAJC1;ACP4;TMEM59;GAS1;EFNA1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.2957470381124663,1.102859853987775,0.29093799682034976,0.7697489781379777,1.0,29/78,23.10%,NUMB;MRAP;ABI3;PIK3R1;PICALM;AKAP5;RHOQ;PDPK1;GPER1;ZDHHC5;APPL1;CLIP3;LRP1;CLN3;ZDHHC7;STX4;LDLRAP1;AKT1;CIB1;PPP2R5A;MRAP2;TMEM59;VPS4A;WNK3;EPHA2;PRKCH;BCL2L1;STX8;TGFB1
prerank,positive regulation of telomerase activity (GO:0051973),-0.33198381008594624,-1.1028516570883806,0.30158730158730157,0.7735517695433948,1.0,14/33,25.47%,PARM1;CCT2;MAPKAPK5;AURKB;KLF4;WRAP53;PRKCQ;XRCC5;TCP1;MAPK1;GRHL2;CTNNB1;MAPK15;HSP90AB1
prerank,detection of mechanical stimulus (GO:0050982),-0.38325029055390747,-1.102817552383556,0.33406593406593404,0.772406562756577,1.0,9/19,34.85%,PKD2;PKD1;PIEZO2;CTNNB1;LHFPL5;PTK2;TTN;PKD1L1;PKD2L1
prerank,regulation of interleukin-13 production (GO:0032656),0.4455885628340441,1.1027645908325814,0.33868092691622104,0.7691992028132175,1.0,3/13,4.55%,IL18;LGALS9;TNFRSF21
prerank,cellular protein localization (GO:0034613),0.2488583149558718,1.102703184086742,0.20709219858156028,0.7685014723629947,1.0,82/285,20.14%,TBC1D16;UNC93B1;ARHGEF2;HERC2;CAPN3;TBC1D17;YWHAH;TBC1D9B;ARFIP1;COPA;ARFGAP3;SMURF1;TBC1D10B;ATG9A;AP2A1;VPS26B;ARL5C;TBCK;TBC1D8;VIPAS39;TBC1D15;FAM91A1;AP3D1;STXBP1;ID1;STX1A;STX12;ARFIP2;TMED9;MYO7A;SGSM2;RAB3GAP2;LAMTOR2;TMED4;CPE;SEC13;STX19;RAB1A;PIGK;MESD;TICAM2;TM9SF1;SAR1A;TBC1D9;SNX31;RUNDC1;BBS2;SEC31B;PDCD6;STX4;GJA1;TBC1D30;RAB20;SLU7;CROCC;SCG5;RRAGA;TRAPPC8;RAB32;PICK1;ATG9B;NAPG;SNX13;USP4;ADPRH;SGSM3;GGA3;EIF2D;CTSA;VPS29;ARL11;STX5;RAB6B;CPLANE2;GRTP1;AP4M1;ACD;PIGU;VPS26A;CEP68;PACS2;VPS35
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.286938232631052,1.1023765634741551,0.26411960132890366,0.768605874224588,1.0,32/87,26.39%,NDUFB2;NDUFB8;COA8;ACAD9;NDUFB10;NDUFS4;NDUFS3;NDUFAF6;UQCC1;NDUFB3;COX19;NDUFAF1;NDUFA13;TMEM126A;SURF1;BCS1L;NDUFS5;NDUFAF5;FASTKD3;UQCC2;NDUFV3;COX16;NDUFV2;LYRM7;NDUFA9;NDUFB11;NDUFC2;NDUFV1;COX17;NDUFAF7;SAMM50;NDUFB4
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.34555132935054894,1.1021654609933673,0.31022530329289427,0.768375404329911,1.0,9/33,19.87%,NFE2L2;PKHD1;PDPK1;GATA2;SERPINE1;TNIP2;MAPK7;GATA3;KRIT1
prerank,modification-dependent protein catabolic process (GO:0019941),0.25614072181284203,1.1020292174853477,0.2465331278890601,0.7679183823341158,1.0,52/193,22.29%,BAG6;PCYOX1;FBXO22;SMURF1;ITCH;SPSB1;RPS27A;UBC;NDFIP2;UBE2H;RFFL;FBXW4;SPSB2;ARRDC1;CDC34;OS9;RNF8;PSMD3;UFD1;BFAR;RNF20;MYLIP;AREL1;RNF166;ANAPC15;TAF1;PINK1;ZNRF3;FBXO21;PSMC2;KCTD6;RNF7;RNF144B;NTAN1;AURKA;FBXO11;RNF11;ANAPC11;DTX3L;UBE2A;ARRB1;UBE4A;STUB1;UBQLN4;WDR81;TOPORS;SYVN1;UBE2R2;KLHL3;FBXL7;RNF34;ANAPC1
prerank,ceramide biosynthetic process (GO:0046513),0.33161830172761814,1.1020277685152764,0.2945205479452055,0.7670628672509241,1.0,10/40,13.47%,ST3GAL5;ALOXE3;CERS3;DEGS2;SPTLC3;PNPLA1;SMPD2;ASAH1;B4GALNT1;CERS2
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.4315657203102873,-1.1019716706264122,0.34182590233545646,0.7737900927556478,1.0,5/13,16.13%,CD74;CD44;SIRT1;MDM2;SNAI2
prerank,intracellular pH reduction (GO:0051452),0.35179350995526404,1.101743652518198,0.31316725978647686,0.7671569093409683,1.0,12/33,22.51%,ATP6V0B;ATP6V1D;TCIRG1;ATP6V0A2;RAB39A;ATP6V0A4;RAB20;ATP6V0E2;SLC11A1;GPR89B;GPR89A;ATP6V0C
prerank,cellular response to glucose starvation (GO:0042149),0.33742194600197034,1.1016893625949118,0.3128390596745027,0.7664557915941955,1.0,14/41,24.83%,NUAK1;ATG14;IMPACT;PIK3C3;SH3GLB1;NUAK2;PICK1;EIF2AK3;PMAIP1;ZC3H12A;SESN1;TP53;HNRNPA1;RRP8
prerank,metanephros development (GO:0001656),0.3681669306479789,1.10164116279697,0.3345656192236599,0.7657447621888848,1.0,6/26,11.24%,BASP1;SHH;GDNF;SOX17;WNT7B;PAX2
prerank,positive regulation of catalytic activity (GO:0043085),0.3395521862775178,1.1015072016718217,0.3099315068493151,0.7653482325310534,1.0,12/37,20.41%,PSENEN;PSEN2;SSBP1;STX4;ABL1;SOD1;MAPK8;CIB1;MAPK14;SLC5A3;NOD2;FGFR4
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.40044825863048916,1.1013170560814551,0.3333333333333333,0.7650796731556055,1.0,5/17,9.80%,SMAD7;SIRT2;EIF4G1;SPRY2;INPP5K
prerank,regulation of B cell proliferation (GO:0030888),0.3278080541059164,1.1008153520968667,0.30808080808080807,0.7658158492489616,1.0,9/44,7.21%,SASH3;MEF2C;LYN;ATM;TNFSF13B;TNFRSF21;TNFRSF13C;CD320;TNFRSF13B
prerank,cellular response to amyloid-beta (GO:1904646),-0.3263762132543913,-1.1005936392256093,0.29107981220657275,0.7769659029953091,1.0,8/35,11.45%,ITGA4;GRM5;CD36;GRIN2A;APP;GSK3B;VCAM1;FCGR2B
prerank,DNA duplex unwinding (GO:0032508),0.3169432643042421,1.1004531772491792,0.30564784053156147,0.7661105685271347,1.0,9/50,7.30%,DDB2;NBN;RPS27A;UBC;GTF2H2;MCM2;DHX9;ERCC2;CUL4B
prerank,sensory perception of chemical stimulus (GO:0007606),-0.40494458043406945,-1.1002498954261444,0.3269230769230769,0.7767553001155317,1.0,3/15,10.29%,CD36;SYT10;ADCY3
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.2713900136156374,-1.0997281487520945,0.2631578947368421,0.7770839202923466,1.0,23/85,26.10%,MTSS1;EGFR;FGF10;B2M;CDC73;DUSP10;FGF7;FGF9;MCC;AQP11;ACVRL1;SFRP1;NME2;SFRP2;BMP4;CDKN1C;TIE1;TGFBR3;MARVELD3;ZFP36;FGF16;NLRC3;ANGPT1
prerank,regulation of endocytosis (GO:0030100),-0.2927708334480652,-1.0997121410408026,0.2641975308641975,0.7758672582766022,1.0,17/61,15.68%,DAB2;HIP1;RIT2;LILRB1;NEDD4L;APOE;MTMR2;RAB5C;RUBCN;CDH13;GPC3;CD151;TFR2;MCTP1;CBLL1;SNCA;SNX12
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.30106974329124725,1.0997066709786403,0.27229299363057324,0.7675411998722754,1.0,9/64,6.77%,NCBP1;NELFB;POLR2H;POLR2J;CDK9;GTF2H2;CTR9;POLR2D;ERCC2
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.38799367060766266,-1.0996658906007049,0.3340857787810384,0.7747653371236396,1.0,4/18,9.13%,ACSL3;ELOVL7;HACD1;ELOVL5
prerank,atrial septum morphogenesis (GO:0060413),-0.43908770431056887,-1.0996309775525097,0.34,0.7736031138239561,1.0,4/10,27.81%,HEY2;NOTCH2;ZFPM1;SOX4
prerank,autophagy of nucleus (GO:0044804),0.4035561453496322,1.099418817045504,0.3192660550458716,0.7675711864452044,1.0,6/16,17.41%,ULK2;ATG9A;RB1CC1;ATG9B;ULK1;ATG5
prerank,positive regulation of catabolic process (GO:0009896),-0.28273604013997,-1.0993727174070227,0.27979274611398963,0.7732223427196714,1.0,19/65,17.10%,WWP1;HECW2;HECW1;APC2;NEDD4L;GSK3B;BARD1;PRKN;AXIN1;PLK2;ATG7;GPC3;TIPARP;NKD1;TNFSF12;OAZ1;RILP;ANGPTL3;FOXO1
prerank,connective tissue development (GO:0061448),-0.3199607436569245,-1.0992516844296507,0.3052391799544419,0.7723427780187264,1.0,15/35,26.78%,ZBTB16;CD44;SULF2;SOX5;PGRMC2;ATP7A;SCX;PKD1;SLC39A13;SOX6;GHRL;ITGB8;RORC;HES5;XBP1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.3906360347965543,1.0992409455815868,0.3413793103448276,0.7672845743630743,1.0,4/20,7.25%,IL18;ENTPD1;CASP1;NLRP3
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.2553976606195567,-1.0992341955727567,0.23711340206185566,0.7711621791716852,1.0,21/108,10.91%,CTNND2;MDFIC;LRRK2;CDK14;SULF2;APP;ATP6AP2;TRABD2B;FRZB;CDC73;PRKN;BTRC;AXIN1;DCDC2;NXN;NLK;GRB10;TLE1;GPC3;KANK1;PPP2R1A
prerank,response to glucose (GO:0009749),0.32655083984859995,1.0986767378923268,0.2793103448275862,0.7681177454359529,1.0,16/46,24.65%,PRKACA;PFKL;IGF1R;EIF2B3;SLC30A8;GPER1;EIF2B4;PAX2;TRA2B;KHK;SELENOT;THBS1;PCK2;KCNB1;EIF2B2;GPLD1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.388872570409096,1.0976162527910436,0.3302919708029197,0.7706282212032822,1.0,6/19,18.93%,RAC1;MAP4K4;LIMS1;ABL1;PTPRJ;PPM1F
prerank,protein localization to vacuole (GO:0072665),0.4376100115253234,1.097273116512509,0.3458498023715415,0.7708112798143266,1.0,4/13,17.16%,SH3GLB1;LAMTOR5;MFSD1;GLMP
prerank,manganese ion transport (GO:0006828),-0.4121525292225607,-1.0972395281770808,0.33114035087719296,0.7761087483343981,1.0,4/14,8.56%,TRPC5;TRPC4;TMEM165;TRPC3
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.3187694266444292,1.0970325203489248,0.3083475298126065,0.770723007307794,1.0,7/49,5.34%,LDLRAD4;PMEPA1;PYDC1;CPTP;SRC;CLU;IMPACT
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.4195212493407498,1.0969973980009824,0.36396396396396397,0.7699713763230995,1.0,4/14,12.40%,IL18;CD86;NLRP3;NFKBID
prerank,negative regulation of RNA splicing (GO:0033119),0.39499029551734766,1.096308914376501,0.3333333333333333,0.7711578373144757,1.0,11/19,28.65%,U2AF2;SFSWAP;C1QBP;TMBIM6;RBMX;SRSF9;PCBP4;PTBP3;SRSF10;RPS26;RPS13
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.3087692648727238,1.0962914421444772,0.31596638655462184,0.7703644445930014,1.0,23/62,22.68%,ARHGEF2;HYOU1;NFE2L2;SRC;CLU;NDUFS3;PTTG1IP;VNN1;RTKN2;PINK1;TMBIM6;AKT1;NDUFA13;ARMC10;MAPK7;TMEM161A;HTRA2;SYVN1;DDX3X;BCL2L1;TXNDC12;OPA1;PARK7
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.29631727242457023,1.0955053167021067,0.28225806451612906,0.7718774290616343,1.0,14/69,14.35%,CX3CR1;MEF2C;SLC30A10;PTK2B;LGMN;PPT1;CNTF;GDNF;POU4F1;CLN3;PINK1;AGAP2;SOD1;RETREG1
prerank,regulation of interleukin-6 production (GO:0032675),0.285879247897707,1.095413077779283,0.3097913322632424,0.7713025708007323,1.0,29/96,23.52%,TLR7;SIRPA;ARHGEF2;LGALS9;AIF1;AGER;TLR4;PLCG2;AFAP1L2;DHX9;NOS2;IL6R;NCKAP1L;IL33;PTPN11;MAVS;PYCARD;POU2F2;SLAMF1;RAB7B;ARRB1;SETD4;NOD2;SYT11;IL1A;ZC3H12A;TWIST1;MYD88;TYROBP
prerank,regulation of macromolecule metabolic process (GO:0060255),0.2610132607690939,1.0952642571906592,0.26822157434402333,0.7709406862692915,1.0,35/170,15.27%,TBC1D16;SIRPA;AIF1;COQ7;CRNN;TRIM11;TRIM5;HNRNPDL;CIAO3;SLC8A1;SORT1;TRIM44;SART3;PCBP2;SHH;ADNP;ZFP36L1;EDN3;GDNF;UTY;ZUP1;C1D;PRDM1;PRDM11;TOB1;ANKRA2;MTMR4;NFKBID;TARDBP;PIN1;POGZ;RNF187;IGF2BP2;PRDM2;PROX1
prerank,regulation of mRNA catabolic process (GO:0061013),0.2701951946590309,1.095182485416279,0.3011093502377179,0.7703534843670244,1.0,45/121,27.57%,CNOT1;PRKCA;PRKCD;EIF4G1;RPS27A;UBC;MOV10;ZFP36L1;ZFP36L2;PKP3;RBM24;TNPO1;PSMD3;ANP32A;PSMB3;CSDC2;PSMA7;PSMC1;IGF2BP2;EXOSC5;PSMC2;AKT1;DIS3;PSME4;PSMB9;FXR2;EXOSC8;PSMD4;PSMB5;PSMB7;ZC3H12A;ELAVL1;RC3H2;PSMB8;PCID2;XPO1;PSMD13;GTPBP1;PCBP4;SAMD4B;YTHDF3;PARN;ZC3H14;PSMD2;PUM1
prerank,nucleotide catabolic process (GO:0009166),-0.39887859807333026,-1.0950217634580268,0.32207207207207206,0.7817827396473451,1.0,4/16,13.22%,XDH;GDA;NUDT3;SAMHD1
prerank,positive regulation of interleukin-4 production (GO:0032753),0.40160454777448945,1.094801322862365,0.3309608540925267,0.7706755054500853,1.0,5/17,11.93%,SLC7A5;LGALS9;CD86;NLRP3;HAVCR2
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.4082110042925963,1.0947600460023843,0.3540489642184557,0.7699843618341007,1.0,5/16,13.18%,MOV10;ZFP36L1;ZFP36L2;RBM24;TARDBP
prerank,positive regulation of wound healing (GO:0090303),0.33676754756167976,1.0939459600658243,0.3178694158075601,0.7716919374271686,1.0,8/36,12.75%,RREB1;SMOC2;F12;DUOX1;MTOR;APOH;SERPINE1;INSL3
prerank,protein autoprocessing (GO:0016540),0.40127507235647886,1.0935203566356129,0.3371647509578544,0.7721368932300964,1.0,7/17,23.44%,FAM111A;CASP1;F12;HTRA2;AFG3L2;PIDD1;SPRTN
prerank,positive regulation of lipid kinase activity (GO:0090218),0.35677694989571246,1.0933470782599382,0.32051282051282054,0.7718335209270161,1.0,7/29,11.46%,P2RY12;ATG14;PTK2B;PDGFB;EPHA8;CCR7;PDGFRB
prerank,peptidyl-tyrosine modification (GO:0018212),0.30864197254658304,1.0932557347715204,0.32274247491638797,0.7712782323353703,1.0,14/56,15.79%,ABI3;CSF1R;LYN;EFEMP1;SRC;TPST2;PTK2B;PDGFB;PDGFRB;PKDCC;DDR2;ABL1;DYRK1A;TEC
prerank,endothelial cell migration (GO:0043542),-0.3197279832932273,-1.0931209723532969,0.3080357142857143,0.7865436345326707,1.0,11/37,16.38%,DPP4;PLXND1;FSTL1;GIPC1;CDH13;PLEKHG5;CDH5;TNFSF12;STARD13;CCN3;CORO1B
prerank,positive regulation of cellular catabolic process (GO:0031331),0.2677972680543448,1.0930448800009673,0.242152466367713,0.771100367223231,1.0,42/132,25.22%,DAGLB;MLXIPL;ABCD2;PIM2;CNOT1;ITCH;TRIM5;PRKCD;DXO;FLCN;MTLN;MOV10;ZSWIM8;MTDH;PTTG1IP;SH3GLB1;PIK3CB;TPCN1;PHKG2;PTPN1;PFKFB2;ARNT;OPTN;NRDC;VGLL4;DTX3L;ULK1;TMEM59;KAT5;TICAM1;VPS35;SLC4A4;ZC3H12A;FURIN;TWIST1;ABCD1;GPLD1;HIF1A;TRIM14;MEFV;GTPBP1;TRIM65
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.4025507319660017,-1.0929909023124182,0.3282608695652174,0.7857052247490705,1.0,4/14,14.73%,ANK2;ATP1B3;ACTN2;KCNIP2
prerank,lymphocyte migration (GO:0072676),-0.3347317136051042,-1.092922289464108,0.30045871559633025,0.7846757147110823,1.0,13/32,32.76%,MYO1G;RET;CX3CL1;CCL5;CCL14;MSN;CCL7;TBX21;CRTAM;CCL19;CCL8;MSMP;CCL4
prerank,positive regulation of mitochondrial translation (GO:0070131),0.42375027183979996,1.0928048295280324,0.34398496240601506,0.7710299435682615,1.0,7/14,23.20%,C1QBP;RMND1;MPV17L2;FASTKD3;UQCC2;FASTKD2;NGRN
prerank,regulation of epithelial cell differentiation (GO:0030856),0.4027480962097798,1.0926795373227771,0.3430127041742287,0.7705720141598995,1.0,6/17,17.85%,DSPP;CEACAM1;DLL1;MAFG;AJAP1;GATA3
prerank,regulation of protein phosphorylation (GO:0001932),-0.22870182230972536,-1.0923499938243453,0.18181818181818182,0.7852111022493492,1.0,52/256,15.76%,PID1;DAB2;CD74;LRRK2;XDH;CCDC88C;GRM5;SLIT2;EGFR;FGF10;KDM4D;APP;CD40;NTRK2;LRP6;NPTN;NTRK3;FN1;PPIA;CCND2;CADM4;CEBPB;SH3GL2;ERBB4;SLCO3A1;VEGFD;PDE8A;PRKN;SIRT1;AXIN1;IRGM;MOB1B;MYADM;PLXNB2;SPTBN4;LIMCH1;CCDC88A;FGF7;NSD1;P2RY1;FGF9;PAQR3;CDH5;EFNA5;PTPN13;PECAM1;RALBP1;FER;PAK1;TEK;PRR5L;PLPP3
prerank,calcium-mediated signaling (GO:0019722),0.2850238225000769,1.0923398018375798,0.29555895865237364,0.7708561703797518,1.0,18/93,8.45%,CX3CR1;P2RY12;LAT2;PPP1R9B;PRKACA;PPP1R9A;TRPM4;PLCG2;TRPM2;CCL3;SLC8A1;PDPK1;CAMKK2;SELE;PLA2G4B;CCR7;EDN2;SELP
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.29083091291104923,-1.0921097945099771,0.2956730769230769,0.7847682254335223,1.0,18/56,19.75%,PLCB1;EGFR;FGF10;KMT2E;CUL3;ANKRD17;CCND2;UBE2E2;DLGAP5;UBE2C;RGCC;CDC25C;RCC2;CCNB1;CDK4;DTL;STOX1;TFDP1
prerank,dendritic spine organization (GO:0097061),-0.34076655419360513,-1.0920906503683052,0.3054892601431981,0.7835798190885845,1.0,5/26,6.93%,CTNND2;SHANK3;MTMR2;CDC42;PAK3
prerank,skeletal system development (GO:0001501),-0.2447056315862266,-1.0919604083315189,0.24848484848484848,0.7827573704217139,1.0,48/148,24.42%,TRPS1;ZBTB16;CD44;MMP16;SULF2;PCSK5;EXT1;SOX5;PRDX1;SOX11;PAPSS2;FBN1;FRZB;TLL1;COL13A1;ATP7A;VCAN;CDH11;P3H1;FGFR3;EBP;RBP4;GDF11;TEAD4;COL1A1;PKD1;PHEX;MMP14;EXTL1;COL19A1;GDF10;SPEF2;CHRD;TNFRSF11B;SOX6;ACAN;BGLAP;ALPL;NOTUM;EVC;GHRL;NPR3;PPIB;ITGB8;SHOX2;HAPLN4;BPNT2;RFLNB
prerank,regulation of heart contraction (GO:0008016),-0.26388946453888423,-1.0916432694834413,0.26345609065155806,0.7824623926251956,1.0,20/90,16.86%,ANK2;ITPR1;PDE4D;SLC8A3;ATP2B1;RYR3;RYR2;ATP2A2;TMEM65;CALM1;ATP1B3;DMPK;ATP2A3;ATP1A1;KCNQ1;FXYD4;KCNIP2;S100A1;APLN;DES
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.4028788357424828,1.0915405681142134,0.326605504587156,0.7725291557981605,1.0,3/17,3.17%,LY86;PRKCA;TRIM5
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.44865512661046797,1.0913437162455688,0.36745886654478976,0.7722798378765309,1.0,5/11,20.33%,PADI2;ZMIZ2;ZMIZ1;ARID1A;ELOF1
prerank,regulation of integrin activation (GO:0033623),0.41739214200278896,1.0912871352414935,0.32737030411449014,0.771618450222911,1.0,6/15,19.70%,PLEK;SRC;SELP;RASIP1;FBLIM1;PIEZO1
prerank,positive regulation of signal transduction (GO:0009967),-0.23150096022820246,-1.091194158990238,0.2,0.7826634344993512,1.0,40/238,10.88%,NRXN1;NLGN1;RIMS2;RBPJ;CD74;SORBS1;ROBO1;LRRK2;CCBE1;HTT;BDNF;SULF2;IRS1;DSTYK;ERN1;RPS3;LMO3;NPTN;JAK2;NTRK3;CD226;PRKCZ;SHANK3;ATP6AP2;VWF;KLF2;HOMER1;PKD2;TPD52L1;CDC73;ZBTB7B;SIRT1;DCDC2;F7;GRB10;PDE6H;BAK1;KANK1;ITGB1BP1;MN1
prerank,positive regulation of interleukin-13 production (GO:0032736),0.4705543428954351,1.091188995518917,0.3591549295774648,0.7710925501829151,1.0,2/10,1.75%,IL18;LGALS9
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.2931518508811853,-1.090847931186419,0.30260047281323876,0.7825246733888888,1.0,13/53,14.98%,CCR1;HRH1;HTR2C;HTR2B;CHRM2;OPRM1;CHRM3;HTR1D;OPRD1;HTR4;HTR6;CNR2;TSHR
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.40279373545077723,1.0907913790491415,0.32123411978221417,0.771494150498965,1.0,4/17,11.76%,SEL1L;OS9;UFD1;AUP1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.46087612921853693,-1.0903446834170931,0.355119825708061,0.7828601303519794,1.0,2/10,11.96%,DPYD;UPP2
prerank,metanephric mesenchyme development (GO:0072075),0.4536477453835731,1.0901783582855253,0.37377690802348335,0.7725029596501399,1.0,3/10,11.24%,BASP1;SHH;PAX2
prerank,regulation of axon extension (GO:0030516),0.33998220166861637,1.0895152550448108,0.3204903677758319,0.7737271704620288,1.0,9/37,9.05%,DNM2;TWF2;CDKL3;DIP2B;DBN1;SIN3A;MACF1;SEMA3G;GOLGA4
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.4453105643915926,-1.089489184547019,0.3466666666666667,0.784408948716246,1.0,6/11,28.70%,STK26;PRKN;UBQLN1;FYN;REST;LANCL1
prerank,positive regulation of cell cycle (GO:0045787),-0.2845570437521168,-1.0893236505841015,0.2627551020408163,0.7837413121948311,1.0,21/62,22.22%,EGFR;APP;ANKRD17;LRP6;CCND2;CCNYL1;PKD2;TTL;RARA;RPS15A;RGCC;CHEK1;PKD1;MDM2;SRPK2;CCNB1;SPDYA;CDK4;EIF4EBP1;TGM1;RPS6KB1
prerank,transport across blood-brain barrier (GO:0150104),0.28675796673927384,1.08923828173951,0.28078817733990147,0.7737440465693856,1.0,19/83,17.85%,SLCO2B1;SLC7A8;SLC1A3;SLC7A5;AGER;SLC24A3;ABCC9;SLC22A2;SLC29A4;ATP1A4;SLC27A4;LRP1;SLC16A7;SLC6A9;SLC29A1;SLC5A3;SLC38A1;SLC19A1;SLC15A2
prerank,purine nucleotide metabolic process (GO:0006163),0.3664431258511093,1.0892202109057072,0.35168738898756663,0.7729773406971845,1.0,8/24,15.51%,FHIT;GUK1;PNP;NUDT15;GART;PRPS1L1;PRPS1;MTHFD1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.29923624275898447,1.0890818857659643,0.29850746268656714,0.7726063808874336,1.0,24/69,26.53%,NDUFB2;NDUFB8;NDUFB10;COX7A2L;COX8A;NDUFS4;UQCRC2;UQCRB;NDUFS3;NDUFB3;NDUFAF1;COX5A;NDUFA13;NDUFS5;NDUFV3;NDUFV2;COX6B1;NDUFA9;NDUFB11;NDUFC2;COX6A2;NDUFV1;NDUFB4;AFG1L
prerank,mitotic metaphase plate congression (GO:0007080),-0.2951670779701986,-1.089005962988449,0.30392156862745096,0.7835186041278108,1.0,17/51,25.05%,CUL3;CDCA8;ZW10;SPDL1;KIF22;KIF14;CENPE;NDC80;BECN1;MAD1L1;CCNB1;RRS1;KIFC1;KIF2C;NUF2;CHMP1B;BOD1
prerank,phospholipid biosynthetic process (GO:0008654),-0.3154154999659286,-1.0886526455940344,0.3140096618357488,0.7833856256547191,1.0,14/36,26.03%,SGMS1;SGMS2;AGPAT4;MVD;DPAGT1;SRD5A3;HDHD5;AGPAT3;CPNE6;GPAT2;SPHK2;SAMD8;FAR1;FDPS
prerank,negative regulation of TORC1 signaling (GO:1904262),0.42792659520592813,1.0885004895057828,0.35110294117647056,0.7735855195665259,1.0,4/13,23.43%,ATM;CASTOR1;SESN1;DEPDC5
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.3539002373617416,-1.0883206813892914,0.3192488262910798,0.7819731623193948,1.0,7/23,19.75%,YWHAQ;TFDP2;YWHAE;PPP3CC;BCL2;E2F1;TFDP1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.3539002373617416,-1.0883206813892914,0.3192488262910798,0.7819731623193948,1.0,7/23,19.75%,YWHAQ;TFDP2;YWHAE;PPP3CC;BCL2;E2F1;TFDP1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.42676198455196057,-1.087884420368585,0.3435448577680525,0.7821556203923236,1.0,2/12,0.58%,MAGI2;IQGAP1
prerank,protein autophosphorylation (GO:0046777),0.26044571015267626,1.0877397712188666,0.28593272171253825,0.7750525015961727,1.0,41/157,17.81%,CSF1R;ULK2;PIM2;CHEK2;LYN;MAP3K3;NEK6;IGF1R;SRC;ATM;MKNK1;PTK2B;ULK3;PDPK1;CAMKK2;EPHA8;MTOR;PDGFRB;EEF2K;TAF1;PINK1;DDR2;MUSK;UHMK1;TAOK2;MAP3K10;MAP3K11;MARK2;ABL1;BMX;DYRK1A;AKT1;STK39;PASK;TEC;AURKA;ULK1;EIF2AK2;EIF2AK1;VRK2;FES
prerank,regulation of activated T cell proliferation (GO:0046006),0.35241849192511976,1.0875881164908658,0.3175438596491228,0.7746903919062649,1.0,5/30,8.25%,IL18;LGALS9;AGER;PDCD1LG2;IL12B
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.37140869154638106,-1.0874078827916762,0.3477272727272727,0.7823929933585531,1.0,9/20,19.71%,EGFR;CCND2;CCNYL1;PKD2;RGCC;PKD1;TTBK1;SPDYA;STOX1
prerank,positive regulation of exocytosis (GO:0045921),-0.3204177203569336,-1.0873383099334193,0.3163972286374134,0.7814048871494718,1.0,8/35,16.22%,CADPS;STXBP5;SDCBP;RAB3D;RAB3A;SNCA;CFTR;RAB27B
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.38693811650335946,1.087319682696759,0.3475177304964539,0.7746546146098519,1.0,7/20,19.16%,MRAP;PLEK;MET;GRK2;RGS14;MRAP2;MGRN1
prerank,negative regulation of double-strand break repair (GO:2000780),-0.33649861767800565,-1.087127603632791,0.3219954648526077,0.7808533777651329,1.0,10/30,19.40%,UBR5;TRIP12;PARPBP;OGG1;RNF169;ERCC6;CYREN;SHLD3;RIF1;FANCB
prerank,positive regulation of T cell differentiation (GO:0045582),0.334104924567897,1.0870677117059757,0.3137931034482759,0.7746254834310072,1.0,10/36,19.40%,VSIR;RHOH;SHH;PNP;IL12B;VNN1;NCKAP1L;ZMIZ1;GATA3;IL4I1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.3107674078661516,1.0869391760258489,0.298372513562387,0.7741479415625327,1.0,11/54,14.63%,CFLAR;PYDC1;OTULIN;GPS2;CASP1;TRADD;RFFL;CLIP3;RNF31;SPPL2B;PYCARD
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.39480109005138453,-1.0860748480032427,0.34451901565995524,0.7829887451343871,1.0,9/15,31.92%,BDNF;NTRK2;BCAR1;DDIT4;NGFR;HAP1;NTRK1;NGF;NTF4
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.3529854179870988,1.085822568951274,0.34024179620034545,0.7768609302668019,1.0,6/29,7.30%,DDB2;RPS27A;UBC;GTF2H2;ERCC2;CUL4B
prerank,regulation of cellular localization (GO:0060341),-0.3021972451143472,-1.085712960431603,0.31494252873563217,0.7829998134189822,1.0,15/46,16.59%,LRRK2;GSN;MAP2;ADCY5;TTL;PRKN;EPHA5;TRIM67;TRIM46;SPAG5;EFNA5;WWC1;FER;MAD1L1;NR1H4
prerank,coenzyme A metabolic process (GO:0015936),0.4161521182299093,1.085350533063439,0.33707865168539325,0.7775052003150088,1.0,5/14,16.75%,PPCDC;PANK4;PANK2;CROT;DCAKD
prerank,multivesicular body assembly (GO:0036258),0.35180684972798826,1.084978881290156,0.3327272727272727,0.7778591601302066,1.0,15/30,31.38%,VPS37D;VPS37A;VPS36;CHMP1A;IST1;VPS37B;CHMP2A;VPS4A;HGS;TSG101;PDCD6IP;VTA1;STAM2;CHMP7;RAB11A
prerank,positive regulation of organelle assembly (GO:1902117),0.3164982548342251,1.0849391760191247,0.33222591362126247,0.777154752157483,1.0,16/44,23.33%,ASAP1;CNOT1;FSCN1;NUMA1;RAB3GAP2;RAB3GAP1;SH3GLB1;G3BP1;CROCC;ENTR1;NUP62;MARK4;STX18;PDCD6IP;RALB;CNOT2
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.4213321989035409,-1.0849385456682132,0.3456521739130435,0.7843083537672692,1.0,4/13,9.90%,PPARG;CD36;LDLR;CDH13
prerank,visual system development (GO:0150063),0.3350810742578467,1.0847418266613966,0.3426086956521739,0.7769229609095061,1.0,5/37,6.19%,ITGAM;FREM2;PAX6;MEIS3;C1QA
prerank,regulation of gluconeogenesis (GO:0006111),-0.3415982104660277,-1.0846156882463074,0.3389423076923077,0.7841286686518923,1.0,12/27,34.06%,SIRT1;PTPN2;SIK1;GNMT;C1QTNF3;CRY1;PPARGC1A;C1QTNF12;GCK;SDHAF3;DDB1;ARPP19
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.37297357444084395,1.0843709139912785,0.34265734265734266,0.7772579368509085,1.0,4/23,5.78%,CADM1;LGALS9;ARRB2;RAET1E
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.39417476332478035,1.084342314140107,0.3525305410122164,0.7765314197672479,1.0,7/18,21.10%,PCNA;GINS4;LIG1;POLD2;GINS3;MCM3;MCMDC2
prerank,regulation of lipase activity (GO:0060191),0.42976717009257276,1.0841866406534724,0.3546617915904936,0.7762153335349035,1.0,2/13,3.63%,LIPC;LMF1
prerank,tRNA wobble uridine modification (GO:0002098),0.4144507383000354,1.0836225380827473,0.3537037037037037,0.7771242372018625,1.0,9/14,28.43%,TRMU;CTU2;MTO1;KTI12;ELP3;ELP1;MOCS3;ALKBH8;TRMT9B
prerank,protein targeting to lysosome (GO:0006622),0.3867376809326579,1.0834747336763793,0.3467153284671533,0.7767757223422022,1.0,8/20,21.29%,CLU;GGA3;ZFYVE16;NCOA4;AP4M1;VPS4A;LAMP2;HGS
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.3575547656663403,1.083308578492832,0.31161971830985913,0.7764733499207451,1.0,5/26,4.12%,ABCD2;COA8;TLR4;SLC30A10;PLCG2
prerank,negative regulation of developmental growth (GO:0048640),0.34730582039079566,1.0822882606909743,0.31970260223048325,0.7787745620812682,1.0,9/30,16.73%,FGF13;ULK2;CDKL3;DIP2B;SEMA3G;BBS2;RTN4R;MAG;ULK1
prerank,regulation of lamellipodium organization (GO:1902743),0.4184582515154063,1.0822494675470382,0.3591682419659735,0.7780866292269993,1.0,3/14,3.33%,TWF2;RAC1;CAPZB
prerank,cellular glucan metabolic process (GO:0006073),-0.4301982069392174,-1.0821959570084616,0.3782608695652174,0.7907878899005267,1.0,5/11,19.49%,PRKAG2;GSK3B;GBE1;PYGM;UGP2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.3783025910587282,-1.0818447415256667,0.3606194690265487,0.7906624614153055,1.0,3/18,4.62%,CTSC;FAF1;APOE
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.3111553200958608,-1.081549510293932,0.29638009049773756,0.7903791862728485,1.0,8/43,12.95%,EGFR;CBLB;SH3GL2;CDC42;PTPN3;PTPN2;RNF126;EPS15
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.38536097634083344,-1.0815036202294115,0.35477178423236516,0.7880785491764691,1.0,5/16,18.64%,ARHGAP6;ITGB1BP1;ACVRL1;RCC2;BCAS3
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.38536097634083344,-1.0815036202294115,0.35477178423236516,0.7880785491764691,1.0,5/16,18.64%,ARHGAP6;ITGB1BP1;ACVRL1;RCC2;BCAS3
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.29779026023321464,-1.0812748319347125,0.3200992555831266,0.7875973943201727,1.0,4/48,1.22%,DMD;AKAP6;ANK2;PDE4D
prerank,regulation of coagulation (GO:0050818),-0.4492934729557937,-1.0812312290927872,0.37117903930131,0.7865592003537742,1.0,1/11,0.67%,HS3ST5
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.32556736637441697,-1.0809994506493827,0.33410672853828305,0.7860921069336266,1.0,5/31,4.64%,NLGN1;PDLIM5;LRRK2;PPFIA2;SHANK3
prerank,mRNA stabilization (GO:0048255),0.3281025870735196,1.0808796640009957,0.33962264150943394,0.7813448862971236,1.0,15/40,23.35%,FUS;TENT5C;HNRNPC;DHX9;GDNF;RBM24;TARDBP;VIP;MAPK14;SLC11A1;BOLL;LARP1;ELAVL1;AXIN2;MYD88
prerank,cellular response to superoxide (GO:0071451),-0.448907184332361,-1.0807297974246688,0.34408602150537637,0.7857363338463509,1.0,3/10,14.04%,PRDX1;ATP7A;SOD2
prerank,glycine metabolic process (GO:0006544),-0.4287284616289679,-1.0805638135196964,0.34838709677419355,0.7850729395351607,1.0,6/12,23.45%,GCSH;SHMT1;AMT;GLDC;GLYAT;GCAT
prerank,cellular response to organic cyclic compound (GO:0071407),-0.24418653603280754,-1.0805344806116253,0.2724795640326976,0.7839937642920746,1.0,39/141,17.75%,AKAP6;LRRK2;CTNNA1;HCN1;GABRB1;EGFR;HRH1;ADCY2;RYR3;RAPGEF2;GOLPH3;ADCY5;PKD2;GABRG2;SPP1;ACTB;GABRB3;RIOK3;ADCY3;ADCY8;P2RY1;GNAI1;ATP1A1;AHR;LCOR;CDH1;KCNQ1;PDE2A;HCN2;CCL5;TIPARP;CRHBP;SFRP1;CFTR;NR3C1;NR1H4;SLC1A1;MSN;ADTRP
prerank,amide biosynthetic process (GO:0043604),-0.30153207682068034,-1.0802638657410044,0.3047404063205418,0.783667591362991,1.0,7/47,7.51%,DMD;PAM;PCSK5;SGMS1;SGMS2;SPTSSA;ASL
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.33809139544856776,-1.0801971273030235,0.34606741573033706,0.7826739178316863,1.0,6/26,9.89%,RSAD2;PTPN22;RTN4;NINJ1;CYBA;LBP
prerank,positive regulation of telomere capping (GO:1904355),-0.3850846229690928,-1.0801561032773657,0.3420479302832244,0.7816090866907391,1.0,7/17,23.99%,MAPKAPK5;AURKB;TNKS2;PRKCQ;MAPK1;NABP2;MAPK15
prerank,cellular protein modification process (GO:0006464),0.22227220144730747,1.0799695109368896,0.19591346153846154,0.7832601758248202,1.0,195/983,17.42%,TGFBR1;GOLM1;MERTK;ST3GAL6;NUAK1;PTPRM;SSH2;TGFBR2;PPM1H;LARGE1;CST3;CTTNBP2NL;FBXL18;MGAT4A;BMP2K;B3GNT2;ST3GAL5;CSNK1E;CDKL3;PIM2;PRKCSH;MAN2B1;MAP4K4;MACROD1;DSP;DAPP1;IGFBP3;FBXO22;TGM2;SIRT2;CHEK2;ASB8;PRKCA;PRKACA;LYN;VHL;CDK9;TBCK;ART4;FBXL20;DDB2;SPSB1;NEK6;CSNK2A1;FBXL15;UBA7;ATM;MKNK1;PRKCD;COPS4;MAP4K3;DCAF8;RYK;PPM1L;MPI;NEK3;PTK2B;STRADA;RPS6KA5;DCAF10;CSK;GAD1;PIK3C3;PDK1;PDPK1;FBXW4;PORCN;SPSB2;SOCS6;SSH1;MBTPS1;USP25;NRBP1;PKN3;CAMKK2;PDGFB;GCNT2;MAN2A2;CDC34;CUL4B;ASB4;MIA3;CPE;PTPRE;AMBN;B3GNT4;TSSK4;TSSK6;ASB15;SPRR1A;FUT7;ANKRD9;PP2D1;RCE1;RAB1A;PIGK;ASB11;ARAF;PIK3CD;RABGGTA;PSMD3;MTOR;ASB3;WNK1;KBTBD8;NUAK2;PDK2;ASB5;GRK2;FBXL8;ILKAP;MGAT1;FBXL2;NPC1;PRKCB;PSMB3;MSLN;CDC14B;WSB1;PPP2R5B;TAF1;JMJD7;MAP4K2;PINK1;PTPN1;SLC35A1;HCST;MTMR4;PTPRA;DUSP29;CDK11B;TAOK2;DUSP5;PSMA7;MAP3K11;MARK2;PPP4R2;NEK7;ST3GAL3;ABL1;PXK;BMX;TIMM50;WWP2;GPS1;CCNE1;MORC3;LATS2;PPP1CB;DCAF11;PTPRH;PSMC1;MAPK8;FBXO21;PSMC2;PTPN21;DYRK1A;AKT1;KCTD6;CSF1;FAM20B;RNF7;PICK1;KCTD7;FBXL22;WDTC1;STK39;PASK;STK19;TEC;PSME4;MAP2K1;CCDC22;AURKA;ACVR2B;FBXO11;COPS6;ADPRH;PARP8;DUSP11;PSMB9;DUSP6;PTPN5;ULK1;CDC42BPB;ADAM10;RPS6KA4;PPP2R5A;TULP4;TRIB1;LIPE;WSB2;RAB13;ATG5;EIF2AK2
prerank,platelet degranulation (GO:0002576),0.2689041592724111,1.079832155015634,0.2908805031446541,0.7828783945794634,1.0,21/118,12.00%,LHFPL2;TUBA4A;CD9;CYRIB;FERMT3;LYN;PROS1;PLEK;SPARC;CLU;STXBP1;VEGFB;CYB5R1;PDGFB;SELENOP;SELP;ORM2;F8;APOH;SERPINE1;ENDOD1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.3068951660455701,1.079825815190077,0.3167495854063018,0.7820869799543135,1.0,20/54,26.02%,ETS1;MEF2C;PRKCA;AGTR2;PDPK1;PDGFB;GATA2;AKT1;MAPK14;PRCP;THBS1;EPHA2;ADAM17;ANGPT2;TGFB1;JUP;HIF1A;PLCG1;ATP2B4;SH3BP1
prerank,negative regulation of axonogenesis (GO:0050771),0.3579283046082032,1.0796817739187923,0.3632887189292543,0.7817072182692917,1.0,9/27,16.73%,FGF13;ULK2;CDKL3;DIP2B;SEMA3G;LRP4;RTN4R;MAG;ULK1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.2865021038427074,1.0796736361300097,0.304857621440536,0.7809165280263501,1.0,21/76,20.53%,BIN1;BAIAP2L2;CDC42EP2;PLEK;NUMA1;PTK2B;CCR7;NCKAP1L;SORBS3;ABL1;WDR1;PYCARD;PROX1;TENM1;FCHSD2;CDC42EP3;NUP62;FES;VASP;CCL24;FCHSD1
prerank,external encapsulating structure organization (GO:0045229),-0.22969509039725255,-1.0796243494258881,0.23030303030303031,0.7821780719895126,1.0,63/205,19.24%,ITGA4;CD44;CD47;MMP16;APP;ADAMTS17;ITGB7;VIT;FN1;ITGAL;VWF;THSD4;COL4A1;ADAMTS19;FBN1;COL13A1;POSTN;HSPG2;ATP7A;VCAN;SPP1;TNC;LAMB2;FBN2;COL14A1;MMP12;MMP15;ADAM12;VCAM1;ST7;LOX;ADAMTSL1;ITGA8;ADAMTSL5;TNR;MMP19;ITGA2B;ITGB6;MMP8;CDH1;JAM3;SMOC1;PECAM1;COL1A1;DAG1;LAMA5;COL23A1;COL5A1;MMP14;ELN;AGRN;LUM;LAMC3;ITGA11;ITGB1;COL6A3;COL19A1;ADAMTS10;ADAMTSL4;BSG;ADAMTS12;ITGAD;LAMA1
prerank,negative regulation of ion transport (GO:0043271),0.3619937381254374,1.0794894448205525,0.3435804701627486,0.7806919378065651,1.0,12/24,22.43%,PTK2B;INPP5K;WNK1;CD33;PXK;VIP;WNK3;WNK2;NOS1;SYT11;PLN;STC1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.3459158216607199,-1.0794792123462447,0.34651162790697676,0.7814477582554369,1.0,10/24,20.64%,B2M;SEC23A;TAP1;SAR1B;SEC24D;SEC24B;SEC24C;BCAP31;ABCB9;ACE
prerank,regulation of cellular component movement (GO:0051270),0.31307422268111706,1.0793499526423496,0.32593856655290104,0.7803255101344385,1.0,6/49,6.20%,TGFBR1;ETS1;CD9;LYN;PKHD1;ZSWIM8
prerank,neural crest cell development (GO:0014032),0.3231924764372799,1.0792626340384455,0.3076923076923077,0.779756762612362,1.0,10/44,13.33%,SEMA3B;SOX8;SEMA4C;SEMA4G;SHH;GDNF;SEMA3G;KBTBD8;PDCD6;SEMA4D
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2607197655440981,1.0791888562515333,0.2895148669796557,0.7791667725688324,1.0,38/158,18.16%,CFLAR;PIM2;LGALS9;RIPK2;TMEM101;ATP2C1;MAP3K3;TRIM5;NEK6;TRAF5;CASP1;NDFIP2;TRADD;MTDH;TMED4;CCR7;EDA2R;TAB2;AKAP13;GAPDH;RNF31;TICAM2;CXXC5;ZDHHC13;LAMTOR5;MIB2;PRKCB;PINK1;TRIM62;GJA1;MAVS;TNIP2;TNFRSF19;CCDC22;PELI2;NUP62;TICAM1;MAP3K14
prerank,regulation of cytokinesis (GO:0032465),-0.27079168371168016,-1.0790916584843968,0.30670103092783507,0.7814564877017953,1.0,17/78,11.32%,CUL3;KIF23;RACGAP1;CALM1;CDC42;KLHL13;GIPC1;UVRAG;KIF14;PKP4;PLK2;AURKB;MAP9;PRC1;BECN1;E2F7;KIF20A
prerank,positive regulation of behavior (GO:0048520),-0.45551982783671335,-1.0777500657452903,0.36942675159235666,0.7845020869373077,1.0,2/10,3.88%,NLGN1;SGIP1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.3876497638644546,-1.0775082197850445,0.34831460674157305,0.7840905387839286,1.0,9/15,37.77%,PTPN2;TTLL12;SAMHD1;OAS3;DCST1;CACTIN;STAT2;USP18;YTHDF2
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.3738514274320445,-1.0772844852458483,0.3595238095238095,0.7836139332083193,1.0,4/19,5.14%,CD74;MCU;RIPOR2;DNM1L
prerank,microtubule polymerization (GO:0046785),0.346568137953896,1.0769969689931185,0.3278084714548803,0.7850236589732936,1.0,9/28,26.82%,FGF13;TUBGCP5;TUBG1;TRPV4;PIN1;MAPT;CSNK1D;NDE1;TPPP3
prerank,positive regulation of interleukin-10 production (GO:0032733),0.34881313454692486,1.0766226163953931,0.35060449050086356,0.7853436605451822,1.0,5/30,9.52%,LGALS9;TLR4;PLCG2;IL12B;CD34
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.4306928822866762,1.0761890833298897,0.3710801393728223,0.7858556612626966,1.0,3/12,12.31%,IL18;CCL3;IL33
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.3443943513470305,-1.075738287160467,0.354978354978355,0.7872182093374135,1.0,5/26,7.48%,IQGAP1;EGFR;GAREM1;PTPN12;PDE8A
prerank,macroautophagy (GO:0016236),0.267919681875743,1.0756963577640923,0.3203125,0.7865356729207928,1.0,36/118,21.70%,NBR1;ATG14;VIPAS39;CSNK2A2;CSNK2A1;HDAC10;SRC;EPG5;ULK3;PIK3C3;TCIRG1;LIX1;CLN3;MTMR14;RB1CC1;PINK1;ATG101;VPS37D;GABARAPL1;VDAC1;VPS37A;VPS36;ULK1;TOMM20;ATG5;TOMM7;VAMP7;VPS37B;CHMP2A;VPS4A;LAMP2;VPS39;EI24;HGS;TSG101;KLHL3
prerank,negative regulation of viral release from host cell (GO:1902187),0.42404794761790315,1.075551963962118,0.3507751937984496,0.7861446170465877,1.0,2/13,3.17%,TRIM11;TRIM5
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.42014293163856553,-1.0754397005924607,0.3537832310838446,0.7869337596352876,1.0,6/12,23.64%,DAB2;FOXP1;SIRT1;SFRP1;NCOR1;HDAC1
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.2938529703626209,1.0752753403920887,0.33446519524617996,0.786204288000765,1.0,16/72,14.63%,SUMO1;CFLAR;IRAK2;OTULIN;TRADD;TRIM44;ABCE1;CLIP3;RNF31;AXL;RUNX1;PTPN1;PTPN11;SPPL2B;IFNGR2;PYCARD
prerank,regulation of interleukin-2 production (GO:0032663),-0.30048942978839266,-1.0752002288471645,0.2975609756097561,0.7864564791669851,1.0,7/43,7.07%,PDE4B;SPTBN1;CCR2;PDE4D;RPS3;IRF4;VSIG4
prerank,regulation of ossification (GO:0030278),-0.3131719420670238,-1.0749116073754954,0.3354978354978355,0.7861697149365636,1.0,5/36,4.19%,RBPJ;ZBTB16;SGMS2;LRP6;SOX11
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.2721179534621938,-1.0748810415078303,0.30845771144278605,0.7850942256544271,1.0,19/72,16.15%,EPS8;ARHGEF3;ROBO1;RIT2;ARHGAP35;CUL3;STARD8;RIPOR2;APOE;GPR35;HEG1;KANK1;RAF1;RALBP1;SCAI;GPR174;LPAR4;STARD13;ARHGDIA
prerank,bicarbonate transport (GO:0015701),-0.33921403721712984,-1.0748507086336647,0.3348314606741573,0.784040499993135,1.0,14/25,31.66%,SLC4A10;SLC26A7;SLC4A8;CFTR;CYB5R2;CA4;SLC4A1;AQP1;CYB5R4;RHAG;CYB5RL;CA1;SLC4A11;CA3
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.4042225105467022,1.0742335103858724,0.36313868613138683,0.7886213661087124,1.0,9/15,24.90%,PYDC1;TLR4;CPTP;GBP5;EIF2AK2;USP50;DDX3X;MYD88;MEFV
prerank,response to ionizing radiation (GO:0010212),0.2910843462390805,1.0737445166381359,0.3149078726968174,0.7892724370913728,1.0,20/70,19.73%,RHNO1;MTA1;RHOB;ATM;SPIDR;USP28;INTS3;EYA3;RNF8;BRCA1;TNKS1BP1;RAD1;ABRAXAS1;BLM;MAPK14;NABP1;KAT5;BABAM1;ECT2;RAD9A
prerank,regulation of protein localization to centrosome (GO:1904779),-0.44872374200018794,-1.0732536975212807,0.36942675159235666,0.7878744695408916,1.0,2/10,5.38%,BICD1;GSK3B
prerank,regulation of synapse organization (GO:0050807),-0.341748315503013,-1.0731681747882542,0.3532110091743119,0.786953606773445,1.0,4/26,2.81%,PDLIM5;CTNNA2;CDKL5;IL1RAPL1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.2716355793781499,1.0730475615828508,0.3005008347245409,0.7905642917795027,1.0,10/100,4.13%,GNA12;BAG6;SUMO1;SMAD7;FHIT;UCHL5;CSNK1E;FBXO22;SIRT2;CLU
prerank,regulation of mRNA stability (GO:0043488),0.2597381230464043,1.0729638325887478,0.3089430894308943,0.7900041366937103,1.0,48/145,25.83%,FUS;PRKCA;TENT5C;PRKCD;EIF4G1;RPS27A;UBC;ZFP36L1;ZFP36L2;GDNF;RBM24;TNPO1;PSMD3;ANP32A;PSMB3;CSDC2;PSMA7;PSMC1;IGF2BP2;EXOSC5;PSMC2;AKT1;VIP;DIS3;PSME4;PSMB9;METTL14;RIDA;SLC11A1;ROCK2;FASTKD3;FXR2;EXOSC8;PSMD4;PSMB5;PSMB7;LARP1;ELAVL1;AXIN2;RC3H2;PSMB8;PCID2;XPO1;PSMD13;PCBP4;SAMD4B;YTHDF3;PARN
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.4461501873918379,1.072831773659119,0.37962962962962965,0.7896150969932826,1.0,1/10,0.96%,DNMT3A
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.41004435716556764,1.0727437448090116,0.3562152133580705,0.7890792091110587,1.0,4/15,12.17%,CST3;FSCN1;LRP1;DDR2
prerank,cellular response to osmotic stress (GO:0071470),0.3793009180933025,1.0723880011461813,0.3582089552238806,0.7892976925591703,1.0,9/21,21.70%,ARHGEF2;CAPN3;ZFP36L1;RCSD1;TRPV4;STK39;LRRC8D;WNK3;DDX3X
prerank,cellular response to tumor necrosis factor (GO:0071356),0.25549732261293684,1.0723225264970595,0.3068702290076336,0.7886863960162314,1.0,49/175,21.75%,ARHGEF2;NFE2L2;PYDC1;NPNT;TRAF5;CCL3;TNFSF13B;TNFRSF21;CD27;PTK2B;TRADD;TNFRSF25;TNFRSF13C;DHX9;TNFRSF13B;ZFP36L1;ZFP36L2;EDA2R;GPER1;LIMS1;INPP5K;PSMD3;TNFRSF17;BRCA1;ASAH1;PSMB3;TNFSF8;PSMA7;PSMC1;PSMC2;BAG4;PYCARD;AKT1;CIB1;PSME4;AIM2;PSMB9;TNFRSF12A;COMMD7;GATA3;MAP3K14;CCL24;PSMD4;PSMB5;ADAM17;TNFRSF14;PSMB7;ZC3H12A;ACOD1
prerank,regulation of peptidase activity (GO:0052547),0.3861143267275181,1.0717634745632723,0.34962406015037595,0.7895682540478685,1.0,6/19,23.38%,CST3;PINK1;NRDC;NDUFA13;FURIN;PSMB8
prerank,positive regulation of developmental growth (GO:0048639),-0.2885840366478723,-1.0715840505242107,0.3176470588235294,0.7907676580905257,1.0,6/49,3.89%,RIMS2;PLCB1;CDKL5;BDNF;SYT1;NEDD4L
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.35525099471141874,1.0715393866206442,0.3321554770318021,0.7894683774041492,1.0,6/27,9.80%,F11R;PIK3R1;ARHGAP28;MET;TJP1;INPP5K
prerank,regulation of protein kinase C signaling (GO:0090036),-0.40208424301229007,-1.0712178964038426,0.3632286995515695,0.7907368964718864,1.0,3/14,9.00%,ADRA1A;CD40;MYADM
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2347159068370011,1.0710722115330857,0.2832214765100671,0.7900674947467384,1.0,94/366,24.26%,TGFBR1;ZFHX3;ZSCAN26;MLXIPL;DNM2;RREB1;DENND4A;DDIT3;MEF2C;LYL1;SBNO2;SRRT;FUS;CHEK2;KMT2D;EFEMP1;VHL;HDAC10;REXO4;CHD7;MLX;CTR9;EIF2A;RPS6KA5;GTF2IRD1;RHOH;FOXK2;TAF6L;THAP1;CXXC1;APBB2;FOXN3;CNBP;PKP3;SOX17;CHD3;PATZ1;EHMT2;EIF2B4;RNF20;POFUT1;ZSCAN21;NUP35;CYFIP1;RPL10;NFYA;SMARCA2;ENG;FADS1;CDK11B;ABL1;TRAPPC2;HP1BP3;EZH2;PRDM2;MLLT6;TCF7L1;TCF3;TAF5L;ACVR2B;SPTY2D1;CCAR1;RPS6KA4;HES6;ORC3;NUP107;CARM1;MITF;IRF2;WTIP;ZBTB11;DMTF1;PTP4A3;SAP30L;PCIF1;DSCC1;GZF1;CRABP2;KAT6B;CASZ1;ZFPL1;BNC2;NFIA;BMP2;SCRT1;MSC;LIN54;SUFU;TGIF2;DVL2;TP53;TAF5;ZNF628;ACVR1B
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.3937263468895028,1.0708754781185865,0.362453531598513,0.7898415331683546,1.0,8/16,29.66%,MCM2;SSBP1;BLM;MCMDC2;MCM6;RPA1;RECQL;MCM7
prerank,protein acylation (GO:0043543),-0.3111674263617718,-1.0705661059393483,0.3701149425287356,0.7916107421160757,1.0,11/38,17.10%,ZDHHC21;ZDHHC16;GTF2B;ZDHHC17;CLOCK;ZDHHC23;ZDHHC15;KAT6A;ZDHHC18;SELENOK;FOXO1
prerank,regulation of feeding behavior (GO:0060259),-0.43046448809353327,-1.070016566607083,0.3738532110091743,0.7921450892564016,1.0,6/11,32.03%,SGIP1;EIF2AK4;AGRP;LEPR;GNB3;NR4A3
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4474026872398953,-1.0697672713483342,0.39433551198257083,0.791783076447993,1.0,4/10,6.50%,APP;NPTN;SHANK3;NETO1
prerank,N-glycan processing (GO:0006491),0.39071282768243515,1.0694022579562548,0.36279926335174956,0.793627471507575,1.0,5/18,10.04%,MGAT4A;PRKCSH;GANAB;MAN2A2;MAN1C1
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.33737952915011676,1.0691512349299137,0.3724832214765101,0.7935782695119936,1.0,5/31,3.93%,LRP5;NBR1;GREM1;SKI;TRPM4
prerank,small GTPase mediated signal transduction (GO:0007264),0.27195515629585354,1.0689252494083614,0.3135048231511254,0.7934863234878449,1.0,17/103,10.49%,RAPGEF5;RASGRP3;RREB1;RAC1;PLD1;USP8;RGL2;ARHGAP30;KSR1;PLD2;ARFIP2;HACD3;RGS19;USP28;JUN;RRAS2;G3BP1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.33475983109526186,-1.0688589473872356,0.3438914027149321,0.7935181923705438,1.0,9/28,16.59%,ITPR1;TMEM117;ERN1;CEBPB;BAK1;ATP2A3;ERO1A;BCL2;SELENOK
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.34269986659280705,-1.068688107956039,0.3372365339578454,0.7928606585713096,1.0,3/26,2.18%,CCR2;CCBE1;SULF2
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.3493966576971882,-1.068221640788401,0.3333333333333333,0.7931310922522588,1.0,6/25,5.23%,CTNNA3;ANK2;RYR2;ATP2A2;CALM1;CACNA1C
prerank,regulation of programmed necrotic cell death (GO:0062098),0.37676434958911253,1.0681933243619541,0.3870967741935484,0.7948602193883093,1.0,12/20,33.52%,CFLAR;FLOT2;ASAH1;STUB1;PDCD6IP;CDC37;FLOT1;BIRC2;CYLD;BIRC3;PELI1;OGT
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.4342713131209395,-1.0681423955129363,0.36904761904761907,0.7922315245936417,1.0,5/10,16.53%,DPP4;SKAP1;PODXL;CCL5;CD3E
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.24800497860342657,-1.0678911828735584,0.3,0.7919000930248111,1.0,44/110,31.95%,ADGRB3;ADGRL3;ADGRE5;ADRA1A;ADCY2;ADGRG6;IAPP;RAPGEF2;PF4;ADCY5;LGR5;ADCY3;ADCY8;GPR161;ADRA2A;LGR4;ADGRG5;CNR2;TSHR;LPAR2;RXFP2;ADGRL4;S1PR2;ADM;GNAQ;ADRA1B;MC4R;GNA13;PTGIR;S1PR5;PTH1R;GPR65;PTGER1;PTGFR;S1PR4;ADGRG4;CXCL9;ADGRD1;DRD1;GPR12;GPR3;ADRA2C;GHRH;CALCB
prerank,positive regulation of ion transport (GO:0043270),-0.29773827684468945,-1.0674621828231867,0.3341645885286783,0.7920810672293805,1.0,12/48,13.89%,ANK3;ANK2;ATP2B1;CCR1;STIM2;KIF5B;ACTN2;ANO6;ADRA2A;FFAR1;LILRA5;CCL5
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.36608629014177496,-1.0668401529267777,0.36629213483146067,0.7928701511434516,1.0,4/19,5.04%,ROBO1;XDH;CCBE1;CADM4
prerank,positive regulation of macrophage differentiation (GO:0045651),0.44677857933024195,1.0666326247242865,0.36174242424242425,0.7988238724501936,1.0,5/11,24.23%,PRKCA;IL34;CSF1;TGFB1;FADD
prerank,lymphocyte chemotaxis (GO:0048247),0.3375357537651172,1.0664597386566776,0.3612565445026178,0.7985383303310756,1.0,9/34,24.27%,PIK3CG;CH25H;CCL3;PIK3CD;CYP7B1;CCL24;CXCL10;CCL25;CKLF
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.2715964508385755,-1.0655545126817192,0.3458823529411765,0.7957931542686162,1.0,14/67,11.76%,CYBB;CD36;B2M;PSMD14;NCF2;PSMD8;PSMA2;PSMF1;TAP1;PSMD6;PSME2;CYBA;PSMD5;PSMD12
prerank,heart development (GO:0007507),-0.23986255421107328,-1.0655542017742674,0.29411764705882354,0.7946381569474715,1.0,34/150,16.92%,SGCZ;PDLIM5;ZFPM2;FGF12;PCSK5;FLRT2;SGCD;CACYBP;NTRK3;FN1;ZDHHC16;CACNA1C;HTR2B;PDLIM1;RBM20;PKD2;ERBB4;FBN1;HEG1;ERBB3;GPC3;RBP4;PDLIM4;CRIP1;MYBPC3;CDKN1A;ACVRL1;PKD1;TEK;SRF;FOXC2;APLN;BMP4;APLNR
prerank,barbed-end actin filament capping (GO:0051016),-0.376701804893115,-1.0652149615164603,0.3731958762886598,0.7934329595004274,1.0,3/18,1.93%,EPS8;ADD3;GSN
prerank,actin filament capping (GO:0051693),-0.376701804893115,-1.0652149615164603,0.3731958762886598,0.7934329595004274,1.0,3/18,1.93%,EPS8;ADD3;GSN
prerank,protein K48-linked deubiquitination (GO:0071108),0.3680750445655854,1.064735495602444,0.35514018691588783,0.8031094936846461,1.0,6/23,12.53%,USP8;OTUD5;USP25;USP5;MINDY2;OTUB2
prerank,retinoic acid metabolic process (GO:0042573),0.416757761744862,1.064592690963089,0.3622641509433962,0.802758857427255,1.0,2/14,3.55%,BCO2;ALDH8A1
prerank,mesenchymal cell development (GO:0014031),0.3854752467496887,1.0640293267181955,0.3643122676579926,0.803701005858962,1.0,4/18,12.55%,HEYL;SOX8;KBTBD8;PDCD6
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.3198956395948775,1.0630530475995712,0.37217391304347824,0.8058365701374992,1.0,8/43,9.34%,SMAD3;ETS1;DDX5;PPARD;EGR1;PDGFB;GATA2;JUN
prerank,protein polyglutamylation (GO:0018095),-0.4344651249853045,-1.0626956271265053,0.38392857142857145,0.8002831693840236,1.0,3/11,6.94%,TTLL11;TTLL7;TTLL5
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.43602922032042385,-1.0625460920303402,0.3788187372708758,0.7995916344942703,1.0,5/10,25.05%,IRS1;SLC45A3;SNCA;PRKCE;PTH1R
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.3258258879589699,-1.062253418375621,0.3724137931034483,0.7993868606663171,1.0,11/30,26.03%,LBR;EBP;LSS;HMGCR;HMGCS1;MVD;DHCR7;MSMO1;ACLY;CYP51A1;FDPS
prerank,regulation of sprouting angiogenesis (GO:1903670),0.332584210349828,1.0622198481771583,0.3572679509632224,0.8075615035377969,1.0,7/33,11.32%,EPN1;PDPK1;TJP1;PIK3CB;E2F2;CEACAM1;DLL1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.34320578242156535,-1.062083136260287,0.3747276688453159,0.7987553108777584,1.0,4/23,14.31%,SH3BP5;CBLB;SRCIN1;THY1
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.43779630550639037,-1.061927801939454,0.401673640167364,0.7980855248032626,1.0,4/10,23.11%,HSPA2;HSPA1B;DNAJB2;SACS
prerank,negative regulation of receptor internalization (GO:0002091),-0.41194373102661197,-1.0617862236759406,0.3648068669527897,0.7974038697358627,1.0,7/12,27.44%,MTMR2;SDCBP;UBQLN2;WDR54;ATXN2;ANKRD13A;RIN3
prerank,vesicle transport along microtubule (GO:0047496),0.36072506242735514,1.061718436675946,0.3763440860215054,0.8082826612739548,1.0,10/23,26.80%,TRAK1;KIF3B;BICDL2;RAB1A;CLN3;KIF3A;FYCO1;KIF13A;NDE1;KIF1A
prerank,positive regulation of acute inflammatory response (GO:0002675),0.4062811910524736,1.0616985067024447,0.3867403314917127,0.8075189370596608,1.0,3/14,22.68%,IL6ST;OSM;PARK7
prerank,histone H2B ubiquitination (GO:0033523),0.456877100701516,1.0615112315105912,0.396709323583181,0.8072465936949886,1.0,4/10,16.59%,CTR9;RNF8;RNF20;DTX3L
prerank,protein-containing complex assembly (GO:0065003),-0.22288022407517669,-1.0614032060565541,0.2534246575342466,0.7974168564999141,1.0,60/259,18.12%,DMD;CD74;LRRK2;GRIA1;MCU;HGSNAT;CUL3;CTSC;CD40;GOSR2;FN1;ZW10;SEC23A;AFDN;DNM1L;GSK3B;RAB1B;WASF1;ST13;SCFD1;CDC73;TLE4;AXIN1;GEMIN5;SAR1B;PPP6C;SNX9;TCF7;ANO6;KNTC1;CDC123;TLE1;PPIH;BCL9L;ADCY8;ITGB1BP1;TRAPPC1;PPP2R1A;SEC24D;IL2RB;JCHAIN;CX3CL1;PARD3;PYGO2;IL1RAP;TMED2;GPAA1;LMAN1;SEC24B;TIAM1;MDM2;REPS2;CD3E;TRAF1;ADD2;RIMS1;WDR19;SPG7;CARD10;BOK
prerank,regulation of cellular component size (GO:0032535),-0.32221089975648126,-1.0611546371059624,0.36768149882903983,0.7970048864487933,1.0,5/30,5.68%,VAV3;EPS8;PEX11A;RAB22A;RARG
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.34355551651744154,1.0610149369839204,0.3706293706293706,0.8080113227518337,1.0,12/30,25.05%,SRC;CTC1;HNRNPC;ERCC4;GNL3L;TERF1;EXOSC10;TEN1;ACD;TP53;HNRNPA1;STN1
prerank,xenobiotic transport (GO:0042908),0.3866306322435769,1.0609137627322125,0.3700361010830325,0.8075141948673463,1.0,5/17,17.85%,SLC7A5;SLC22A2;SLC29A4;GJA1;SLC15A2
prerank,embryonic digit morphogenesis (GO:0042733),0.38951869619431057,1.0599903364763772,0.3833922261484099,0.8095042476790689,1.0,2/18,6.86%,SALL1;SHH
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.3429587249035002,1.059982752452288,0.3720508166969147,0.8087153294177946,1.0,8/30,18.17%,DPM3;MGAT2;MGAT5;MGAT1;NUDT14;OSTC;ALG8;ALG5
prerank,protein localization to lysosome (GO:0061462),0.34289477723375944,1.0598158559827373,0.34,0.808445207754527,1.0,9/28,21.29%,LAMTOR5;MFSD1;GLMP;GGA3;ZFYVE16;NCOA4;AP4M1;VPS4A;HGS
prerank,iron ion transport (GO:0006826),0.30944609261337697,1.059472054352756,0.33687943262411346,0.8087046563440049,1.0,7/47,7.47%,DNM2;ATP6V0B;MCOLN1;ATP6V1D;SLC40A1;TCIRG1;ATP6V0A2
prerank,autophagosome organization (GO:1905037),0.3012091645611144,1.059213723408045,0.35845896147403683,0.8086495640669096,1.0,16/50,20.09%,ULK2;ATG9A;ATG14;ULK3;PIK3C3;STX12;RAB1A;RB1CC1;ATG101;GABARAPL1;ATG9B;UBXN2A;ULK1;ATG5;TP53INP2;PACS2
prerank,lipid homeostasis (GO:0055088),-0.2824899682857599,-1.0589969038392166,0.34739454094292804,0.8025523216008809,1.0,21/57,27.55%,PPARG;USF1;ZBTB20;TLCD3A;APOE;RCN3;SIRT1;CEBPA;ANGPTL3;ABHD5;TLCD3B;RBP1;PNPLA3;POLD1;TM6SF2;FBXW7;PRKAA1;ABCB11;ADCK1;XBP1;DGAT2
prerank,regulation of cell-cell adhesion (GO:0022407),-0.30480019750425347,-1.0589819276558015,0.36613272311212813,0.8014527041073993,1.0,11/39,14.22%,PTPRG;TENM3;CD47;DPP4;FUT9;AFDN;PODXL;EFNA5;CDH1;JAG1;MDGA1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.41736906610902996,-1.0587949258019573,0.368763557483731,0.8009272041145703,1.0,6/11,38.06%,NECAB1;ITM2A;ABCA7;AGO2;SOAT1;BACE2
prerank,melanosome organization (GO:0032438),0.3471548328650922,1.0584815797985478,0.35804701627486435,0.8100575398321848,1.0,13/26,33.41%,HPS4;AP3D1;SHROOM2;RAB32;KIF13A;TRAPPC6A;BLOC1S6;HPS1;RAB29;LYST;BLOC1S5;AP1G1;AP3B1
prerank,neutrophil activation (GO:0042119),0.43466445176955226,1.0580123207813235,0.3905109489051095,0.8106146939171702,1.0,2/12,4.09%,PREX1;PRKCD
prerank,positive regulation of interferon-gamma production (GO:0032729),0.3122600393530282,1.0577225047248213,0.31560283687943264,0.8107072486977425,1.0,9/48,10.06%,IL18;TLR7;SLC7A5;LGALS9;CYRIB;TLR4;EBI3;IL12B;IL12RB2
prerank,outflow tract septum morphogenesis (GO:0003148),-0.3409775050589038,-1.057551496657237,0.3584474885844749,0.8035986261835621,1.0,2/24,0.73%,ROBO1;ZFPM2
prerank,amino sugar metabolic process (GO:0006040),-0.43410608797725136,-1.0571698622986774,0.37339055793991416,0.8036682410327598,1.0,3/10,11.20%,ST3GAL1;EXTL2;GFPT2
prerank,female gonad development (GO:0008585),0.383236617497618,1.0571674614884892,0.38120567375886527,0.8116142686706402,1.0,6/19,17.82%,FSHR;LHCGR;INHA;EIF2B4;SOD1;NUP107
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.40060675121283684,-1.0571037275127817,0.394919168591224,0.802732802255475,1.0,7/14,23.57%,AUTS2;KMT2E;DNMT3B;DNMT1;SNW1;MYB;CTNNB1
prerank,coenzyme A biosynthetic process (GO:0015937),0.4291485678457079,1.0568559754218139,0.3800738007380074,0.8101319408238372,1.0,7/11,29.60%,PPCDC;PANK4;PANK2;DCAKD;PANK1;ACAT1;ACOT7
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.4291485678457079,1.0568559754218139,0.3800738007380074,0.8101319408238372,1.0,7/11,29.60%,PPCDC;PANK4;PANK2;DCAKD;PANK1;ACAT1;ACOT7
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.4291485678457079,1.0568559754218139,0.3800738007380074,0.8101319408238372,1.0,7/11,29.60%,PPCDC;PANK4;PANK2;DCAKD;PANK1;ACAT1;ACOT7
prerank,actin nucleation (GO:0045010),-0.35716392551221443,-1.0567040117547615,0.34368530020703936,0.8028429300633397,1.0,2/21,2.01%,IQGAP2;ACTR3
prerank,positive regulation of immune effector process (GO:0002699),-0.3291159880181019,-1.0561857747902097,0.38588235294117645,0.8032504952726655,1.0,4/27,3.66%,CCR2;LILRB1;ANKRD17;DDX60
prerank,regulation of complement activation (GO:0030449),0.32317692898796047,1.0561756147447607,0.36213235294117646,0.8114268917234959,1.0,6/40,7.28%,C1QB;PROS1;PHB2;CLU;C1QA;C1QBP
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3105818653487988,1.0560176510782746,0.38155515370705245,0.8111315994011217,1.0,11/42,18.40%,CHD8;HNRNPC;CHD3;RNF8;SRCAP;ACTL6A;SMARCA5;SMARCA2;INO80B;SPTY2D1;ARID1A
prerank,negative regulation by host of viral transcription (GO:0043922),0.42796795086539585,1.0559313176473937,0.3619047619047619,0.8106042054403557,1.0,4/12,13.18%,CCL3;JUN;INPP5K;TARDBP
prerank,negative regulation of anoikis (GO:2000811),-0.3870296213391094,-1.055740791942499,0.3739669421487603,0.8034328946292081,1.0,8/14,26.15%,TLE1;PTRH2;BCL2;SNAI2;ITGB1;PDK4;MCL1;PTK2
prerank,protein secretion (GO:0009306),-0.2819813666240315,-1.0554393099075698,0.3248730964467005,0.8032365254972024,1.0,12/56,11.05%,RIMS2;OLFM2;RAB3C;PCSK5;SNX19;RCN3;GOLPH3;RAB3D;COPG2;RAB8A;RAB3A;ARL4D
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.30983411837029196,1.0554304988083332,0.35571687840290384,0.8113233647871428,1.0,14/43,22.97%,ATM;NBN;RAD17;INTS3;FOXN3;BRCA1;CDC14B;TAOK2;ABRAXAS1;BLM;NABP1;BABAM1;TOPBP1;DONSON
prerank,regulation of RNA splicing (GO:0043484),0.2878679925180316,1.0553956535729205,0.3460207612456747,0.8106294965748454,1.0,11/69,7.38%,SNRNP70;SON;PIK3R1;QKI;CLK1;FUS;U2AF2;HNRNPH1;JMJD6;RBM39;CLK4
prerank,striated muscle tissue development (GO:0014706),-0.3299491194178481,-1.0553751468246437,0.36384976525821594,0.8022879747750125,1.0,2/29,3.24%,SGCZ;SGCD
prerank,response to purine-containing compound (GO:0014074),0.38452947336474824,1.0547397413268298,0.36363636363636365,0.8118983362566559,1.0,4/17,7.92%,TRPM2;NDUFS4;ABCC9;DUOX1
prerank,oligosaccharide metabolic process (GO:0009311),-0.28636096987772847,-1.054448522937536,0.34523809523809523,0.8040865209904912,1.0,13/46,16.79%,B3GALT1;ST3GAL4;FUT9;ST8SIA4;ST8SIA1;ST8SIA2;GLA;B3GALT4;B3GALT2;MANBA;NAGA;ST8SIA3;FUT4
prerank,carboxylic acid metabolic process (GO:0019752),0.32919961060430286,1.0543453017460913,0.39019963702359345,0.8123114856667576,1.0,9/33,17.87%,TBXAS1;PLA2G4A;HAO1;PON3;CARNMT1;AGXT;SLC23A2;SLC23A1;GNE
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.353735742209037,-1.0542364296956013,0.39909297052154197,0.8036403044810649,1.0,10/23,21.27%,ZW10;PLK2;BUB1B;PABIR1;AURKB;BUB1;CHEK1;CDK5RAP3;SETMAR;NABP2
prerank,peptidyl-asparagine modification (GO:0018196),0.33690679343131424,1.054072406130657,0.370304114490161,0.8123729718519631,1.0,8/31,18.17%,DPM3;MGAT2;MGAT5;MGAT1;NUDT14;OSTC;ALG8;ALG5
prerank,protein targeting (GO:0006605),-0.2451268146195562,-1.0539822045163694,0.3118279569892473,0.8032964503623012,1.0,35/118,20.76%,NLGN1;AKAP6;CHM;ZDHHC21;SPCS2;AP4S1;TOMM22;TIMM23;SDCBP;TIMM17B;GIPC1;PEX12;TOMM5;FIS1;MFF;ZFAND6;ZDHHC23;TIMM17A;FBXO7;AQP11;ZDHHC15;PARD3;TIMM10;ZDHHC18;AIP;VPS37C;RASSF9;AP4E1;ZDHHC24;ATG3;PRKCI;BCAP31;AP1S3;PEX19;NACA
prerank,cellular response to ATP (GO:0071318),0.40866674230196337,1.0539318129873814,0.397459165154265,0.8119858497245505,1.0,3/14,11.77%,P2RY12;SSH1;TAF1
prerank,cholesterol homeostasis (GO:0042632),0.29371336986298013,1.0538931036815864,0.37520391517128876,0.8113058336187693,1.0,15/64,21.72%,IL18;LIPC;LRP5;CNBP;APOM;NPC1;CYP7B1;TTC39B;NPC2;LDLRAP1;SCARB1;NR1H2;LCAT;FGFR4;MTTP
prerank,negative regulation of apoptotic process (GO:0043066),0.22703571037254644,1.0538861483436086,0.28515625,0.8105394423820875,1.0,84/444,17.34%,CX3CR1;MERTK;SON;GREM1;CAPN3;CFLAR;PIM2;MAP4K4;MEF2C;SOX8;PIK3R1;RIPK2;RPS6KA1;ITCH;PRKCA;VHL;SLC30A10;CSNK2A2;CSNK2A1;IGF1R;SRC;PHB2;PKHD1;PRKCD;AATF;CD27;RPS27A;UBC;PTK2B;LGMN;ATAD3A;SPRY2;YME1L1;EGR3;IL6ST;MAEA;PPT1;MGMT;SHH;MTDH;WDR73;CIAPIN1;CNTF;GDNF;POU4F1;TJP1;ARAF;DPEP1;NCKAP1L;BFAR;NUAK2;AXL;AREL1;LAMTOR5;CLN3;RPL10;PAX2;DLL1;PSEN2;APOH;PINK1;BNIP2;AGAP2;SEMA4D;GCLC;PLK3;SOD1;RETREG1;TMBIM6;MAPK8;BAG4;AKT1;VDAC1;CIB1;HPN;VIP;RNF144B;PDCD10;XIAP;MAG;ADAM10;QARS1;NUP62;FANK1
prerank,regulation of B cell apoptotic process (GO:0002902),-0.4247067154439005,-1.053773686009948,0.38461538461538464,0.8028391277512559,1.0,6/12,23.08%,FOXP1;BTK;AURKB;BLK;NOC2L;IL2
prerank,natural killer cell mediated immunity (GO:0002228),0.40414650896859283,1.0537420694296566,0.4022140221402214,0.8101592792499127,1.0,5/15,12.91%,ULBP1;TUBB;RAET1E;PLEKHM2;CEBPG
prerank,endocytic recycling (GO:0032456),0.3019629646233787,1.0534327216683945,0.35973597359735976,0.8102718704616898,1.0,17/50,20.59%,CCDC93;EHD4;ACAP2;TRARG1;SNX31;RAB35;DENND1C;ENTR1;CCDC22;SNX3;PTPN23;RAB13;VPS29;VPS26A;CMTM6;VPS35;VPS39
prerank,negative regulation of protein binding (GO:0032091),-0.26807014582048844,-1.053408646294311,0.33962264150943394,0.8028401708634676,1.0,12/71,10.64%,DAB2;ITGA4;LRRK2;B2M;ATP2A2;MAP2;GSK3B;STYX;ACTB;AURKB;ATP2A3;ITGB1BP1
prerank,histone deacetylation (GO:0016575),0.3139960119758474,1.0532802853537575,0.3647260273972603,0.8098947214865708,1.0,18/43,26.97%,SIRT2;MTA1;HDAC10;SUDS3;RBM14;SIN3A;MIDEAS;MORF4L1;BRMS1L;HDAC5;HDAC8;SIN3B;MIER3;MORF4L2;BRMS1;HDAC6;HDAC11;TBL1X
prerank,protein insertion into membrane (GO:0051205),-0.3197015693802583,-1.0531122108870856,0.3694690265486726,0.8027109891011056,1.0,7/32,13.56%,EGFR;APP;UBE2J2;VAPA;COX18;ALDH3A2;HMOX1
prerank,RNA methylation (GO:0001510),0.2969453812961833,1.0529133280686884,0.36689419795221845,0.8102493619778779,1.0,22/60,24.42%,TRMT6;BUD23;NSUN5;METTL5;NSUN6;METTL6;TGS1;BCDIN3D;FTSJ3;METTL14;MTO1;NSUN3;TRMT61A;PCIF1;WDR6;TFB1M;NSUN4;FBL;THUMPD3;TRDMT1;METTL8;FTSJ1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.30329332275834053,1.0528660134696255,0.37043478260869567,0.8088228045030977,1.0,14/50,17.82%,POLR2H;POLR2J;RANBP2;EIF4G1;POLR2D;NUP42;SEC13;NUP50;NUP35;NUP88;POLR2E;NUP62;SEH1L;NUP107
prerank,regulation of gene silencing by RNA (GO:0060966),0.30329332275834053,1.0528660134696255,0.37043478260869567,0.8088228045030977,1.0,14/50,17.82%,POLR2H;POLR2J;RANBP2;EIF4G1;POLR2D;NUP42;SEC13;NUP50;NUP35;NUP88;POLR2E;NUP62;SEH1L;NUP107
prerank,regulation of translational initiation (GO:0006446),0.2934229913332615,1.0524904266833162,0.3818770226537217,0.8091814578278586,1.0,21/63,22.64%,NCBP1;EIF4A2;CTIF;EIF4G1;IMPACT;POLR2D;ATF3;EIF4H;MIF4GD;UHMK1;EIF4EBP2;MTIF2;EIF1B;KHDRBS1;EIF5;EIF1;EIF2AK3;BOLL;DDX3X;LARP1;EIF4G2
prerank,protein mannosylation (GO:0035268),-0.35382004557675734,-1.0521614987997678,0.38694638694638694,0.8046065069959251,1.0,9/22,16.23%,DPY19L1;DPM2;TMTC1;CRPPA;POMT2;TMTC4;FKTN;POMGNT2;TMTC2
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.3403055465308945,1.0520236930531361,0.36666666666666664,0.8097794838739105,1.0,9/27,19.56%,GUK1;NME4;CMPK1;DUT;DCTD;AK2;NME1;NUDT13;TYMS
prerank,ncRNA export from nucleus (GO:0097064),0.3240532517330051,1.0518815943647137,0.37217391304347824,0.8094359888399236,1.0,11/36,17.82%,XPOT;RANBP2;SSB;NUP42;SEC13;NUP50;NUP35;NUP88;NUP62;SEH1L;NUP107
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.44577755222748894,1.0516741042010045,0.3840155945419103,0.8092479044603551,1.0,4/10,23.08%,SMAD7;NFKBID;ZC3H12A;RC3H2
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.3750052019946294,-1.051608927404111,0.3837471783295711,0.8052891879741526,1.0,2/17,0.59%,ANK3;AKAP6
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.4133309075861208,1.0515683243108263,0.38330170777988615,0.8088038571384001,1.0,3/13,11.77%,DDIT3;SIN3A;TAF1
prerank,zymogen activation (GO:0031638),0.3162693255177025,1.0513762389236152,0.36923076923076925,0.8086008061676765,1.0,7/39,7.51%,KLK2;VSIR;RIPK2;ASPH;F12;LGMN;PGK1
prerank,cardiac ventricle morphogenesis (GO:0003208),0.3173360091648959,1.051274555303861,0.3647260273972603,0.8081562526506498,1.0,6/41,8.39%,TGFBR2;SMAD7;HEYL;MEF2C;CPE;MYL3
prerank,mitotic nuclear division (GO:0140014),-0.2672492364401818,-1.0509768707851488,0.3490566037735849,0.8061290602381395,1.0,14/71,12.73%,EPS8;SMC4;CDCA8;ZW10;TOGARAM2;TPX2;RAN;NDC80;NUSAP1;KIF11;MAP9;SPAG5;UBE2C;KIF18B
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.373857855541576,-1.0508778393867717,0.39775280898876403,0.8052844539880651,1.0,4/17,5.14%,CD74;MCU;RIPOR2;DNM1L
prerank,autophagosome assembly (GO:0000045),0.29748516947163955,1.0507348312989608,0.3536379018612521,0.8090690453943427,1.0,17/52,20.09%,ULK2;SMURF1;ATG9A;ATG14;PIK3C3;STX12;RAB1A;RB1CC1;ATG101;GABARAPL1;TRAPPC8;ATG9B;UBXN2A;ULK1;ATG5;TP53INP2;PACS2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.2839157531509503,1.050680162262607,0.365,0.8084410946703302,1.0,17/76,17.33%,PRMT2;DDIT3;IRAK2;ARRB2;PYDC1;OTULIN;ITCH;PKHD1;NLRP3;COMMD6;HAVCR2;NWD1;PYCARD;CCDC22;AIM2;COMMD7;ARRB1
prerank,positive regulation of neutrophil migration (GO:1902624),-0.36991214115609394,-1.0506660972542967,0.3900226757369615,0.8048394795917412,1.0,4/18,5.14%,CD74;MCU;RIPOR2;DNM1L
prerank,myeloid dendritic cell activation (GO:0001773),0.4311350388888113,1.050642678553843,0.409009009009009,0.8077567857407958,1.0,5/12,24.68%,TGFBR2;PYCARD;SLAMF1;BATF3;DOCK2
prerank,regulation of insulin secretion (GO:0050796),-0.24963003437728268,-1.0505843609388534,0.31754874651810583,0.8039856857141648,1.0,24/101,16.59%,CACNA1E;ITPR1;KCNC2;DPP4;MCU;IRS1;RFX3;SLC8B1;CACNA1C;ALOX5;ADCY5;SNAP25;PER2;PRKN;EPHA5;CLOCK;ADRA2A;FFAR1;RBP4;EFNA5;CCL5;SFRP1;CCN3;NR1H4
prerank,histone exchange (GO:0043486),-0.3086070182308026,-1.050478106468351,0.3552036199095023,0.8032060464601736,1.0,12/37,21.72%,KNL1;CENPT;CENPP;MIS18BP1;ACTR6;CENPW;RBBP7;NASP;NPM1;CENPS;ANP32E;OIP5
prerank,DNA alkylation (GO:0006305),-0.3666648547756951,-1.0504632364426902,0.3952483801295896,0.8010194738802101,1.0,9/19,25.56%,KMT2E;ATF7IP;GATAD2A;DNMT3B;HELLS;SPOCD1;DNMT1;EHMT1;FOS
prerank,DNA methylation or demethylation (GO:0044728),-0.3666648547756951,-1.0504632364426902,0.3952483801295896,0.8010194738802101,1.0,9/19,25.56%,KMT2E;ATF7IP;GATAD2A;DNMT3B;HELLS;SPOCD1;DNMT1;EHMT1;FOS
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.3079222559235334,1.0504512370285253,0.3647260273972603,0.807576545571591,1.0,14/42,24.48%,PCNA;PRIMPOL;RFC2;RPS27A;UBC;POLN;POLD2;PCLAF;RFC1;RPA3;ZBTB1;SPRTN;WRNIP1;POLD4
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.42691980160866777,1.050420722881535,0.39552238805970147,0.8068785353695196,1.0,2/12,8.25%,IL18;IL12B
prerank,embryonic organ morphogenesis (GO:0048562),-0.29783018031758934,-1.0502713626845042,0.3526570048309179,0.8004510383958118,1.0,11/42,15.65%,HOXC4;RYR2;HOXC9;SOX11;RARG;FBN1;FBN2;HOXB3;RBP4;RBPMS2;HOXB4
prerank,negative regulation of response to wounding (GO:1903035),0.3728152309997366,1.049782799079349,0.3731060606060606,0.8079890795704929,1.0,6/19,17.59%,RTN4RL1;KLK8;SERPINE1;CERS2;RTN4R;AJAP1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.40132691017641464,-1.0493029846741846,0.3900862068965517,0.8023288804664751,1.0,1/13,0.15%,PID1
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.34157880032394417,-1.0488796850193107,0.39955357142857145,0.8025643105188265,1.0,4/24,5.76%,CTNNA2;CTNNA1;OLFM2;CDC42
prerank,negative regulation of cell migration (GO:0030336),0.25593281117693806,1.0486598509737117,0.34520123839009287,0.8106063381559888,1.0,23/137,13.89%,SRGAP3;SRGAP2;LDLRAD4;NAV3;SMAD7;SLURP1;RAC1;IGFBP3;RNF41;RHOB;FLCN;SHH;MIA3;PIP5KL1;DPEP1;LRP1;RNF20;SERPINE1;ENG;NDRG4;GJA1;DRD2;ADGRG1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.36356839400662677,-1.0483091948150223,0.378076062639821,0.8031669712976017,1.0,6/18,13.96%,ARHGAP35;CUL3;RIPOR2;HEG1;KANK1;SCAI
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.3828469084243542,-1.048233750635503,0.3834745762711864,0.8022984902130507,1.0,7/17,25.59%,ANXA4;PTPN22;KLF4;MAP2K5;SSC5D;ANXA1;MAPKBP1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.4442067242634336,1.048228337841388,0.3894927536231884,0.8111649136282842,1.0,6/10,20.67%,DGKD;CHRM1;PLPP1;PRKD3;PICK1;GAP43
prerank,embryonic eye morphogenesis (GO:0048048),-0.41595634362119843,-1.0480585130984075,0.40979955456570155,0.8017571771027632,1.0,4/11,8.95%,LRP6;RARG;FBN1;FBN2
prerank,regulation of cholesterol efflux (GO:0010874),-0.3202603968172847,-1.047982498782568,0.3471882640586797,0.8008929948657039,1.0,7/30,12.93%,PPARG;PLTP;APOE;SIRT1;NFKBIA;ABCA5;YJEFN3
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.312053549185036,-1.0477931577401618,0.38717339667458434,0.8004167100562659,1.0,8/32,16.92%,AKAP6;HTT;CALM1;PKD2;CX3CL1;THY1;SNCA;APLNR
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.3651688769423964,1.047780143293149,0.40293040293040294,0.8117036675876083,1.0,8/22,21.31%,MVB12B;VPS37D;VPS37A;VPS36;PTPN23;VPS37B;VPS4A;TSG101
prerank,regulation of angiogenesis (GO:0045765),0.24516168685850054,1.0477626148196038,0.329803328290469,0.8109892724620411,1.0,30/192,12.55%,PDE3B;PTPRM;SMOC2;HK2;ANXA3;ETS1;FOXJ2;PRKCA;ADAMTS1;RHOB;SPARC;VEGFB;SPRY2;PDPK1;EGLN1;MTDH;PGK1;SARS1;GATA2;ECSCR;CD34;PIK3CD;BRCA1;PRKCB;CEACAM1;RAPGEF3;APOH;SERPINE1;RUNX1;PDCD6
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.3664523818478569,-1.0476271230485277,0.38372093023255816,0.7998120753743589,1.0,5/17,13.89%,PLA2G7;CCR2;CCR1;ANO6;CCL5
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.42138175957934765,1.047030709331618,0.41929499072356213,0.8124530402914851,1.0,4/12,13.15%,TRPM4;PLA2G6;C2CD2L;STX4
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.31742113027075636,-1.0468856825836543,0.37772397094430993,0.8009889888326038,1.0,8/33,7.34%,PLCB1;EGFR;FGF10;KMT2E;ANKRD17;CCND2;UBE2E2;CDC73
prerank,cholesterol biosynthetic process (GO:0006695),-0.32000738923134453,-1.0467367711246038,0.39622641509433965,0.8003721594908929,1.0,11/31,26.03%,LBR;EBP;LSS;HMGCR;HMGCS1;MVD;DHCR7;MSMO1;ACLY;CYP51A1;FDPS
prerank,sodium-independent organic anion transport (GO:0043252),0.4386220276190699,1.0464249768814158,0.4107806691449814,0.8134820185059719,1.0,1/10,0.06%,SLCO2B1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.2716498797211939,1.046402039950327,0.3519163763066202,0.8127738704008248,1.0,35/80,31.25%,SENP2;SMAD7;RIPK2;TBC1D7;MTA1;NDFIP2;FANCM;PTTG1IP;KLHL40;BRCA1;PINK1;PDCD6;PIN1;UBE3A;FANCI;XIAP;PHF23;KDM1A;STUB1;TOPORS;DCUN1D1;NSMCE3;SPRTN;ARRDC4;PRICKLE1;DCUN1D4;UBE2D1;TSPYL5;TRAF6;PAXIP1;RBX1;LAPTM5;BIRC2;DCUN1D5;UBE2L3
prerank,cognition (GO:0050890),-0.29612865911914277,-1.0462639764972768,0.38498789346246975,0.8007247512696117,1.0,13/42,20.19%,GRM5;ST3GAL4;APP;JAKMIP1;MGAT3;CHRNA4;SETD5;MFSD2A;RP9;MAGT1;PTCHD1;SLC1A4;METTL23
prerank,muscle tissue development (GO:0060537),0.4068710670225211,1.0462228357143015,0.392226148409894,0.812520829721405,1.0,7/13,30.23%,SHH;ENG;SMO;PTCH1;PGM5;CSRP2;POGLUT1
prerank,metal ion export (GO:0070839),-0.3215494719144164,-1.0461167040726607,0.4,0.8000656674720142,1.0,9/31,19.74%,KCNT2;KCND3;ATP1B3;ATP7A;ATP1A1;KCNQ1;KCNIP2;KCNE3;KCNK5
prerank,spinal cord development (GO:0021510),-0.41174298339589294,-1.045881201701804,0.37093275488069416,0.7997179368008445,1.0,5/12,15.39%,SOX11;VIT;PKD2;PKD1;RELN
prerank,protein export from nucleus (GO:0006611),0.3424315100193996,1.04577899700786,0.4044750430292599,0.8130954395742286,1.0,5/27,7.19%,SMURF1;STRADA;NUP42;EGR2;RANBP3
prerank,artery development (GO:0060840),0.35376062672339825,1.0455695545932484,0.3953488372093023,0.8129788342449985,1.0,2/23,1.04%,TGFBR1;SMAD7
prerank,fatty acid metabolic process (GO:0006631),0.26169621079385347,1.0454890994719364,0.3312883435582822,0.8124521021750232,1.0,18/115,13.56%,LIPC;LIPH;ABCD2;ALOXE3;ACAD9;ACSL4;PPARD;LPIN2;NUDT19;PLA2G15;THEM4;HPGD;ACADM;SLC27A4;PON2;CROT;PON3;GPX4
prerank,positive regulation of protein phosphorylation (GO:0001934),0.22996444541597863,1.0449780657024184,0.3361462728551336,0.8132423482893313,1.0,100/348,24.54%,CX3CR1;TGFBR1;TMEM119;ARHGEF2;CSF1R;RAC1;MMD;RIPK2;AGER;CAMKK1;LYN;CDK9;ATG14;SRC;NBN;PLCG2;FLCN;EIF4G1;VEGFB;LCP2;PTK2B;RPS6KA5;SPRY2;AKTIP;CAMKK2;PDGFB;RPTOR;CCR7;LEFTY1;GPER1;CALCR;TAB2;IL6R;INHA;ARAF;CLIP3;TNKS1BP1;RAPGEF3;RB1CC1;PINK1;DDR2;CCND3;ENG;MUSK;PTPN11;TAOK2;AGAP2;PIN1;SEMA4D;IL34;ABL1;GHR;MAVS;AKT1;CIB1;CSF1;CDK2AP1;GPNMB;PIK3R3;TENM1;TEC;PDCD10;OSM;PELI2;AGT;RPS6KA4;ARRB1;ROCK2;FXR2;PTPRJ;FBH1;CAMK1;XRCC6;RSPO1;CRKL;WNK3;NOS1;ADAM17;TNFRSF14;EFNA1;TNK2;FGF20;DDX3X;CSNK1D;RBPMS;RASSF2;PARK7;AXIN2;CALM2;JTB;BMP2;TGFB1;RALB;DVL2;TP53;SOX9;PTPRC;ITGB3;DUSP19;FGF1
prerank,transcription by RNA polymerase II (GO:0006366),0.2331390578461872,1.0449734296419293,0.34081346423562414,0.8124807907814806,1.0,62/305,17.76%,MAML3;RREB1;NCBP1;ARRB2;DDX5;NELFB;POLR2H;SRRT;PPARD;TTF2;POLR2J;CDK9;HDAC10;DEAF1;NKX2-8;CSTF2;INTS11;GTF2H2;CTR9;TAF8;TAF12;POLR2D;ELL2;SNRPF;TAF6;ERCC2;NRBP1;RPAP2;RNMT;INTS3;PAX1;PKNOX1;RXRB;NR2F1;MBD1;NOTCH4;PABPN1;E2F2;CPSF1;DTX1;MAML2;NFYA;TAF1;HSF2BP;MED4;SETD2;TAF4;FIP1L1;NOTCH3;HDAC5;GTF2I;NELFE;RPAP1;POU2F2;TAF5L;POLR2E;INTS8;NABP1;MED18;POU2F1;PCF11;IRF9
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.27759618641945516,1.044918139714494,0.37458745874587457,0.8118788818551244,1.0,25/80,23.22%,PHETA1;TBC1D17;TBC1D10B;VPS26B;TMED9;YKT6;SGSM2;VPS54;SNX5;DENND5A;SNX32;RBSN;SNX3;RAB7B;VPS29;STX5;RAB6B;VPS26A;VPS35;PREPL;SNX6;ANKFY1;RAB9A;VPS52;STX16
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.37505455301912444,1.0448487431811233,0.40892193308550184,0.8113054318849949,1.0,2/20,1.47%,TGFBR1;HEYL
prerank,cAMP metabolic process (GO:0046058),-0.4083786229328973,-1.0440621300922035,0.3755186721991701,0.8042630070132502,1.0,5/13,10.29%,PDE4D;ADCY2;ADCY5;ADCY3;ADCY8
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.3911351329211519,-1.0436748986409343,0.38396624472573837,0.8044333225067062,1.0,6/15,24.78%,LDLR;SIK1;MFSD2A;CNEP1R1;FBXW7;CTDNEP1
prerank,apoptotic cell clearance (GO:0043277),0.33788927740127683,1.0436563926996925,0.37865748709122204,0.8141348242705342,1.0,11/30,24.33%,RAC1;TGM2;ITGAV;RHOBTB1;RHOH;LRP1;SCARB1;THBS1;MEGF10;TYROBP;ITGB3
prerank,negative regulation of T cell activation (GO:0050868),0.32250202642940673,1.0435886757232318,0.372972972972973,0.8135749319610752,1.0,8/35,11.93%,PAG1;TNFRSF21;CD86;PDCD1LG2;NCKAP1L;TNFAIP8L2;CEACAM1;HAVCR2
prerank,mRNA 3'-end processing (GO:0031124),0.2748757602292765,1.0435651211327306,0.38499184339314846,0.8128935160885428,1.0,16/78,14.84%,SRRM1;NCBP1;CSTF2;MAGOHB;MAGOH;U2AF2;POLR2D;DHX38;PABPN1;SRSF5;CPSF1;RBM8A;U2AF1L4;SLU7;FIP1L1;ALYREF
prerank,regulation of DNA repair (GO:0006282),-0.29067307946942783,-1.0433248592655588,0.36980306345733044,0.8043894292072529,1.0,12/44,13.13%,EGFR;FGF10;RPS3;UBR5;TRIP12;UBE2N;SIRT1;ERCC6;BABAM2;TIGAR;WRAP53;EYA2
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.24934816530885406,-1.043308484901916,0.336986301369863,0.803343029340983,1.0,27/98,21.73%,ANK3;SORBS1;DPP10;SPTBN1;YWHAQ;EGFR;TFDP2;YWHAE;PRKN;KIF5B;PLS1;MTCL1;FIS1;MFF;ITGB1BP1;PPP3CC;BCL2;ITGB1;E2F1;PRKCE;PRKCI;TFDP1;EPHB2;TCAF1;FYN;CNPY4;RANGRF
prerank,negative regulation of protein kinase activity (GO:0006469),-0.25291016504553754,-1.0432713562883988,0.36772486772486773,0.8023640409004501,1.0,26/88,20.51%,SH3BP5;PTPRT;SLC8A3;PPM1E;PRKAG2;LRP6;TAF7;PPIA;DBNDD1;DUSP10;SMCR8;DUSP26;ITGB1BP1;SRCIN1;DTNBP1;CDKN1A;THY1;SNCA;TAB1;NPM1;GSTP1;CDK5RAP3;GNAQ;CDKN1C;CAMK2N2;DEPTOR
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.4291049877296589,1.0431439070117499,0.4074766355140187,0.8133739002350042,1.0,3/11,11.76%,BAG6;UFD1;AUP1
prerank,extracellular structure organization (GO:0043062),-0.22283605968842637,-1.0430429861054713,0.3170731707317073,0.8019708674103375,1.0,64/204,19.24%,ITGA4;CD44;CD47;MMP16;APP;ADAMTS17;ITGB7;VIT;FN1;ITGAL;VWF;THSD4;COL4A1;ADAMTS19;FBN1;COL13A1;POSTN;HSPG2;ATP7A;VCAN;SPP1;TNC;LAMB2;FBN2;COL14A1;MMP12;MMP15;ADAM12;VCAM1;ST7;LOX;ADAMTSL1;ITGA8;ADAMTSL5;TNR;MMP19;ITGA2B;ITGB6;MMP8;CDH1;JAM3;SMOC1;PECAM1;COL1A1;TEX14;DAG1;LAMA5;COL23A1;COL5A1;MMP14;ELN;AGRN;LUM;LAMC3;ITGA11;ITGB1;COL6A3;COL19A1;ADAMTS10;ADAMTSL4;BSG;ADAMTS12;ITGAD;LAMA1
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.40783402575226935,1.0427818671298354,0.4275491949910555,0.8137213169514224,1.0,8/14,25.54%,MIA3;SEC13;RAB1A;SAR1A;SEC31B;SCAP;SEC31A;SEC24A
prerank,positive regulation of viral process (GO:0048524),0.2910131125302164,1.0427623652722466,0.3719298245614035,0.8130242276338973,1.0,16/60,21.91%,NELFB;POLR2H;POLR2J;CDK9;POLR2D;HACD3;DHX9;PPID;AXL;VAPB;NELFE;POLR2E;VPS4A;POLR2I;DDX3X;LARP1
prerank,negative regulation of MAP kinase activity (GO:0043407),0.31253949252306557,1.042600191832417,0.3618881118881119,0.812756841214849,1.0,11/44,18.35%,UCHL1;LYN;PRKCD;SPRY2;INPP5K;PIK3CB;RGS14;PTPN1;MAPK8IP1;AGT;PTPRJ
prerank,positive regulation of transferase activity (GO:0051347),-0.23876515523525627,-1.0420460801889,0.33773087071240104,0.8039818130554344,1.0,48/142,23.99%,CD74;DCUN1D2;EGFR;DSTYK;PARM1;ROR1;NTRK2;CCT2;NTRK3;RPS2;UBE2N;ERBB4;RET;MAPKAPK5;LMO4;EPHA5;AXIN1;ALK;ERBB3;ARRDC3;AURKB;FGFR3;KLF4;WRAP53;KIT;DCUN1D3;PRKCQ;SERINC5;TEK;XRCC5;LMTK2;MRE11;TCP1;MAPK1;EPHB2;EPHA4;EPHA7;FLT3;TIE1;LTK;TRIB3;GRHL2;DDR1;FBXW7;CTNNB1;PLK1;MAGEC2;MAPK15
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.39781554184125834,1.0420279051794463,0.4029574861367837,0.8137535849799533,1.0,6/15,15.79%,IGF1R;PTK2B;ABL1;BMX;DYRK1A;TEC
prerank,sensory perception of smell (GO:0007608),-0.42304380720773327,-1.0420154980150915,0.39323467230443976,0.8030033275995956,1.0,5/11,33.21%,SYT10;ADCY3;MKKS;BBS4;SLC24A4
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.3254366088358853,1.0417676966294878,0.3912280701754386,0.8137530143765808,1.0,15/34,31.17%,TLR4;GPS2;LYN;GPR108;TICAM2;RAB7B;TICAM1;ACOD1;GRAMD4;OTUD4;TLR9;TYRO3;TLR6;TREM2;TNFAIP3
prerank,negative regulation of biosynthetic process (GO:0009890),0.38930479173632426,1.041502892966833,0.40429338103756707,0.813836528451206,1.0,5/16,11.23%,ABCD2;COA8;SLC30A10;GPER1;CEACAM1
prerank,positive regulation of protein import (GO:1904591),0.33273189753315946,1.0413473880495505,0.3718861209964413,0.8135442784885673,1.0,11/30,24.22%,SMAD3;PIK3R1;PRKCD;ZIC1;MAVS;ECT2;ARHGEF5;ZC3H12A;TGFB1;JUP;IPO5
prerank,mesonephric tubule development (GO:0072164),0.3916880516061505,1.0412151412092663,0.38649155722326456,0.8131715443244524,1.0,2/15,2.97%,SALL1;NPNT
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.41562503124721106,-1.0411465050970314,0.3922018348623853,0.8046682598478444,1.0,4/11,14.25%,PARP14;PARP12;TIPARP;PARP3
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.4062364324315693,-1.0409358123085213,0.3890063424947146,0.8042587095389991,1.0,4/13,17.39%,CDK5RAP2;NDC80;GEN1;CCNB1
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.24202968619969478,-1.0406430846765782,0.3542234332425068,0.8040732558010237,1.0,22/110,12.40%,CD36;GSN;TPPP;NAPB;IAPP;LATS1;ATF7IP;RPS3;FAF1;PRKCZ;APOE;GSK3B;TRABD2B;CDC42;SAR1B;IRGM;RIOK3;OPRD1;BAK1;RAF1;CDH5;SLF1
prerank,cell proliferation in forebrain (GO:0021846),0.4541510408978018,1.0405512084589283,0.4011406844106464,0.8144485073562763,1.0,1/10,0.19%,NUMB
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.3590378739559118,-1.0403959977278123,0.4014084507042254,0.8037846217698799,1.0,8/19,19.57%,AMPD3;POLL;ADK;APRT;CDA;POLD1;POLD3;TERT
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.3796339099851264,-1.0402744308545642,0.4022727272727273,0.8030711060941851,1.0,7/16,18.17%,RPS3;TPT1;CCAR2;NACC2;SNAI2;SFRP2;DDIAS
prerank,negative regulation of lipid catabolic process (GO:0050995),0.3843624609654855,1.0402388571794197,0.38761061946902653,0.8146302331060249,1.0,3/17,14.70%,PDE3B;BSCL2;AKT1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.3315367634462553,1.0398316384091748,0.39215686274509803,0.8151079034717875,1.0,9/33,10.11%,NYAP1;PIK3R1;SIRT2;IGF1R;PIK3CG;C1QBP;ZFP36L1;PIK3CD;PIK3CB
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.42542618315433367,1.0393043566284288,0.42775665399239543,0.8158922222425419,1.0,1/11,0.12%,BIN1
prerank,negative regulation of platelet activation (GO:0010544),0.385958152787682,1.0389884025681049,0.4087719298245614,0.8160279249877506,1.0,5/16,13.17%,CD9;PRKCD;PDGFB;CEACAM1;SERPINE2
prerank,positive regulation of insulin secretion (GO:0032024),0.32280868086595915,1.0388294221455583,0.40476190476190477,0.8157173131109622,1.0,9/36,14.33%,ACSL4;TRPM4;PLA2G6;C2CD2L;SLC30A8;GPER1;TM7SF3;STX4;LRRC8A
prerank,cytokine-mediated signaling pathway (GO:0019221),0.22203061760157908,1.0387727156583046,0.3411458333333333,0.8151303080500056,1.0,115/532,18.67%,INPP5D;IL18;ITGAM;CSF3R;CSF1R;IL1RL2;PIK3R1;IRAK2;RIPK2;GAB2;PYDC1;PRKACA;MAP3K3;TRIM5;ITGB2;HNRNPDL;SRC;EGR1;TRAF5;PRKCD;CCL3;TNFSF13B;FSCN1;CD27;CASP1;STX1A;EBI3;RPS27A;UBC;MMP2;PTK2B;CTR9;TRADD;TNFRSF25;RPS6KA5;CSK;TNFRSF13C;IL6ST;SOCS6;SNRPA1;CD86;MID1;PDGFB;TNFRSF13B;DUOX1;CNTF;NOS2;EDN2;IL12B;EDA2R;CTF1;CXCL1;TAB2;LMNB1;MT2A;IL6R;LIMS1;MAP3K8;PIK3CD;APPL1;PSMD3;IRF8;IL12RB2;PIK3CB;TNFRSF17;CEACAM1;PSMB3;IL10RB;IL33;TRIM62;PTPN11;TNFSF8;PSMA7;STX4;IL10RA;IL34;IL18BP;CCR5;IFNGR2;SOD1;GHR;PSMC1;PSMC2;BAG4;PYCARD;IL4R;AKT1;CSF1;IL1RL1;TNIP2;IL1R2;TEC;PSME4;OSM;ZEB1;AIM2;PSMB9;TNFRSF12A;COMMD7;TXLNA;ISG20;PELI2;STAT6;RPS6KA4;CSF2RA;IRF3;POU2F1;IRF9;IL7R;GATA3;IL20RA;MAP3K14;PTPRJ;TYK2;IRF2
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.3815650907808982,-1.0387224009120537,0.38556701030927837,0.8066460685161884,1.0,5/14,14.74%,FAF1;PKD2;NFKBIA;G3BP2;PKD1
prerank,neutrophil chemotaxis (GO:0030593),0.3016672052302333,1.038720455809469,0.3852739726027397,0.8145223728734735,1.0,9/53,10.24%,CXADR;ITGB2;PIK3CG;CCL3;EDN3;EDN2;CXCL1;PIK3CD;NCKAP1L
prerank,hepaticobiliary system development (GO:0061008),0.37125954340949197,1.0386630231989253,0.38786764705882354,0.8139547882011078,1.0,6/20,15.27%,PRKCSH;NKX2-8;MET;LSR;CEBPG;PROX1
prerank,protein complex oligomerization (GO:0051259),-0.2570306570171203,-1.0385776691370077,0.36666666666666664,0.8059918425402018,1.0,19/85,15.63%,LRRC8C;NLRC4;KCNC2;MCU;HGSNAT;EHD1;LETM1;ATL2;DNM1L;TRMT61B;HOMER1;PKD2;NINJ1;ADCY8;AQP11;G3BP2;MPP2;SNCA;NACC2
prerank,negative regulation of cellular protein localization (GO:1903828),-0.31402807783265524,-1.0384059909549679,0.4068181818181818,0.8054437476709939,1.0,7/34,8.82%,CTNNA1;LATS1;NEDD4L;RIPOR2;GSK3B;ILRUN;ACTN2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.3894037177623555,-1.0380012152351377,0.39819004524886875,0.8056027647475701,1.0,4/15,11.62%,APOE;SNX9;ADRA2A;SH3D19
prerank,regulation of B cell differentiation (GO:0045577),0.3731746372239136,1.0379902313584002,0.4033457249070632,0.8152002830835463,1.0,5/17,10.24%,CD27;ZFP36L1;ZFP36L2;INHA;NCKAP1L
prerank,blood vessel endothelial cell migration (GO:0043534),0.36255129434234185,1.0377510346942675,0.40966010733452596,0.8151420433061934,1.0,7/22,15.54%,GREM1;MYH9;ID1;EGR3;MIA3;AKT1;PIK3R3
prerank,positive regulation of type I interferon production (GO:0032481),0.28183282312524555,1.037663548857103,0.38054607508532423,0.8146479617218007,1.0,17/73,17.38%,TLR7;POLR3G;RIPK2;POLR2H;TLR4;DHX9;CGAS;GAPDH;POLR3H;G3BP1;PTPN11;SETD2;MAVS;POLR2E;STAT6;IRF3;POLR1C
prerank,organelle organization (GO:0006996),0.22598829323821412,1.0376613650431539,0.3682758620689655,0.8138984233281705,1.0,135/388,26.68%,BIN1;FGD2;DST;ABCD2;TMEM135;ARAP3;DYM;CXADR;GOLGA8B;GOLGA5;ZRANB1;CAPZB;RANBP10;FMNL3;IRAG2;PHB2;ODF2;CCL3;MCOLN1;PEX10;CAMSAP1;NUMA1;PLD2;ATAD3A;SORT1;YME1L1;SIPA1;TMED9;WDR73;RAB3GAP1;TMED4;MIA3;LMAN1L;RAB1A;RAB34;PLEKHM2;PPID;TICAM2;SAR1A;NRF1;TJAP1;FANCG;FGD3;PEX6;AUP1;SEC31B;PINK1;CSPG5;FMNL2;BSCL2;SSBP1;MNS1;STX4;IQCG;MIEF2;LYSMD3;REEP6;OPTN;NECTIN2;TRAPPC11;MAST3;COG2;VAPB;TRAPPC8;SPRYD3;RAB32;KIF3A;HSD17B10;TMEM11;POLG2;ATXN7;TANGO2;WASL;ARHGAP4;UBXN2A;CDC42BPB;DOP1B;GORASP1;MTX1;ZFYVE16;SEC61A1;BCS1L;CHMP1A;PPRC1;PACSIN2;PEX1;WTIP;WDR81;CHMP2A;CCL24;VPS4A;EIF2AK3;MARK4;TTC17;VPS13C;NCKIPSD;MYO18A;TFB1M;AGTPBP1;STOML2;DMTN;CSNK1D;OPA1;SEC31A;PYROXD2;PARK7;PDCD6IP;REEP5;ABCD1;VPS13D;MICAL1;CHGA;DYNC2H1;NPLOC4;PITPNB;AJUBA;PEX3;MAST2;CATIP;GAK;LONP1;ARHGEF7;SPTBN5;COG7;YTHDF3;BNIP1;LMAN2L;ARMC2;GORASP2;BAG5;ZMYM4;AFG1L;VPS18;PACSIN3;PTCD2
prerank,cellular response to mechanical stimulus (GO:0071260),0.3083158571822302,1.03762834638092,0.3983606557377049,0.813246441186281,1.0,5/46,4.84%,F11R;TLR7;CRADD;TLR4;CASP1
prerank,nuclear pore complex assembly (GO:0051292),-0.42974888398849237,-1.0374571851447454,0.41814159292035397,0.806209595233681,1.0,3/10,10.85%,NUP98;RTN4;NUP205
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.3005502535793135,-1.0372617906111414,0.39149888143176736,0.8057432731496894,1.0,8/39,12.95%,EGFR;PTPN12;SH3GL2;CDC42;PTPN3;PTPN2;RNF126;EPS15
prerank,negative regulation of cellular component organization (GO:0051129),-0.26216141260444487,-1.037171450461737,0.3902439024390244,0.804959037609899,1.0,19/74,16.59%,LILRB1;IAPP;TMEFF2;PRKCZ;MTMR2;GSK3B;CDC42;CARMIL1;RUBCN;RIOK3;OPRD1;MCTP1;RAF1;HSPA2;HSPA1B;HSPA5;HSPA8;XRCC5;NR1H4
prerank,cell junction maintenance (GO:0034331),0.400163069131505,1.0367539354924475,0.4462962962962963,0.815097565492193,1.0,4/14,19.05%,CSF1R;CBLN1;CLDN1;CBLN2
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.33832553015286676,-1.0366589337799206,0.41123595505617977,0.8054542846379994,1.0,11/23,23.69%,APP;PRKAG2;CALM1;AXIN1;IRGM;UBE2K;S1PR2;MAPK1;STOX1;PLK1;CAB39
prerank,positive regulation of neuron differentiation (GO:0045666),0.3118523503234073,1.0365249857620245,0.3893653516295026,0.8150520448354691,1.0,13/40,23.06%,ARHGEF2;HEYL;MEF2C;MMD;IMPACT;SIN3A;PROX1;TCF3;ZEB1;ECT2;PCP4;FGF20;BMP2
prerank,histone mRNA metabolic process (GO:0008334),0.3418471233245899,1.036352603659142,0.4092526690391459,0.8148261959227189,1.0,4/27,6.55%,NCBP1;SSB;ATM;SNRPF
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.33326389891799746,1.0361103700812861,0.39679715302491103,0.8148018798705373,1.0,9/30,18.48%,HPS4;CSNK2A2;SH3GLB1;RNF31;USP36;LEPROT;PINK1;TOMM7;HTRA2
prerank,negative regulation of blood pressure (GO:0045776),0.40541359588423215,1.0361033624309741,0.4127906976744186,0.8140734010533136,1.0,4/13,20.35%,NOS2;DRD2;PRCP;NOS1
prerank,mitotic recombination (GO:0006312),-0.38554036355454935,-1.0359236574866404,0.40301724137931033,0.806747778153357,1.0,9/15,33.76%,SMC5;GEN1;RAD51D;DMC1;TPRKB;ERCC1;RAD51;NSMCE2;RAD52
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.2817796411139367,1.0357614678694118,0.40923566878980894,0.8143443136263105,1.0,11/70,9.63%,SMAD3;CRADD;ITGAV;RNF41;CD27;TRADD;SORT1;PDPK1;IL6R;SIVA1;APPL1
prerank,positive regulation of innate immune response (GO:0045089),0.33551322964076713,1.0355753607309537,0.3799654576856649,0.8141237297173666,1.0,8/30,16.40%,POLR3G;SLC15A4;AKIRIN2;DHX9;PLA2G5;TRIM62;MAVS;GBP5
prerank,peptide cross-linking (GO:0018149),-0.33824806483970987,-1.0355735819494252,0.39957716701902746,0.806734797303865,1.0,14/25,31.16%,F13A1;FN1;TGM4;EVPL;CD247;TGM1;ABCA7;KRT10;ANXA1;NDNF;TGM6;EPB42;TGM7;CD3G
prerank,protein hydroxylation (GO:0018126),0.3951590196725893,1.0355108432879676,0.40625,0.8135689577537413,1.0,4/15,11.85%,ASPH;VIPAS39;P3H2;JMJD7
prerank,regulation of T cell mediated immunity (GO:0002709),0.44102709565766246,1.035492697130159,0.4351005484460695,0.8128792228926961,1.0,3/10,8.73%,AGER;TRPM4;FUT7
prerank,regulation of oxidative phosphorylation (GO:0002082),0.39263257720566996,1.0353145333613527,0.43042671614100186,0.8126426629575155,1.0,5/16,23.42%,MLXIPL;COX7A2L;PINK1;UQCC2;ABCD1
prerank,peptidyl-proline hydroxylation (GO:0019511),0.43415632590952025,1.0353106479506953,0.41904761904761906,0.81191073825807,1.0,3/11,9.63%,EGLN1;P4HA1;P3H2
prerank,endothelial cell differentiation (GO:0045446),-0.4039593736082907,-1.0351257943585654,0.4282700421940928,0.8071375838834723,1.0,4/12,21.57%,FSTL1;JAG1;ACVRL1;TIE1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.4455855374639356,1.0348031145204115,0.41505791505791506,0.8126643026511231,1.0,4/10,10.66%,LGALS9;LYN;CCR7;AXL
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.4515087471966326,1.0346274623688754,0.4056795131845842,0.8124144749922162,1.0,3/10,18.93%,NOTCH4;PLG;PPM1F
prerank,regulation of osteoclast differentiation (GO:0045670),0.32870870078230885,1.0346032520930957,0.3854166666666667,0.8117458639164049,1.0,10/33,16.79%,TLR4;CCL3;UBASH3B;GPR55;IL12B;POU4F1;MTOR;CSF1;GPR137;CARTPT
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.3651775788855407,-1.0344588682907983,0.3927765237020316,0.808096676161823,1.0,3/17,5.80%,PPARG;PRKAG2;ADIPOR2
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.20771428165871608,-1.0342043704485897,0.3037037037037037,0.8078269125181039,1.0,58/390,10.97%,VAV3;NEDD9;MTSS1;SORBS1;PTPRG;PLCB1;CYBB;STAP1;PTPRT;EGFR;GRIN2B;RBFOX2;FGF10;ACTR3;NCK2;SHC3;BDNF;SULF2;IRS1;AP2A2;ITSN1;FLRT2;RAPGEF2;ROR1;NTRK2;CYFIP2;PDGFD;JAK2;NTRK3;ATP6V0D2;RASGRP4;PIK3C2A;GSK3B;CDC42;NCF2;SDCBP;CHN1;DNM1;ERBB4;GFRA2;PAK3;VEGFD;RET;EPHA5;PTPN2;ALK;FRK;ACTB;ERBB3;CYBA;GRB10;BCAR1;FGF7;FGFR3;DDIT4;ARPC5;FGF9;CLNK
prerank,regulation of cell division (GO:0051302),0.28424167790760246,1.0341406536908615,0.400974025974026,0.8124026627527225,1.0,18/72,16.02%,ZFYVE26;SIRT2;FLCN;PIK3C3;SHH;TLE6;PLK5;SH3GLB1;DLL1;PIN1;SETD2;PLK3;ENTR1;BLM;CIB1;TAL1;NCOA3;AURKA
prerank,response to organophosphorus (GO:0046683),0.3861745662944769,1.0339881077462558,0.42783505154639173,0.8120871385314984,1.0,3/16,7.92%,NDUFS4;ABCC9;DUOX1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.36930928957791365,-1.033631318460144,0.4144736842105263,0.8084663749396525,1.0,7/17,17.84%,EGFR;CCND2;CCNYL1;PKD2;RGCC;PKD1;SPDYA
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.326096391459089,-1.0334590848057779,0.40326340326340326,0.8079173628291529,1.0,4/24,2.38%,PLA2G7;CCR2;SLIT2;CCR1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.31236912359752594,-1.0333945631666541,0.4,0.8070493717642534,1.0,10/31,18.74%,PKD2;CDC73;E2F7;KLF4;DCUN1D3;CDKN2A;CDKN1A;MYO16;RBL1;CDK4
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.3281321123760173,-1.0333753666436842,0.375,0.8060498914899338,1.0,3/24,5.38%,SORBS1;IRS1;GSK3B
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.4311656108198389,1.0332149406685833,0.41064638783269963,0.8136798612730571,1.0,4/10,13.17%,CD9;PRKCD;CEACAM1;SERPINE2
prerank,negative regulation of angiogenesis (GO:0016525),0.271169577064534,1.033205743168823,0.3912310286677909,0.812967576576364,1.0,27/84,23.51%,PDE3B;PTPRM;EPN1;FOXJ2;ADAMTS1;SPARC;SPRY2;PGK1;SARS1;ECSCR;PIK3CB;E2F2;APOH;SERPINE1;GTF2I;SERPINF1;SPINK5;ROCK2;THBS1;KRIT1;SYNJ2BP;NAXE;HGS;CXCL10;EFNA3;KLK3;AGO1
prerank,sterol homeostasis (GO:0055092),0.28651013763164235,1.0328250488171158,0.4025974025974026,0.8133635515753437,1.0,15/65,21.72%,IL18;LIPC;LRP5;CNBP;APOM;NPC1;CYP7B1;TTC39B;NPC2;LDLRAP1;SCARB1;NR1H2;LCAT;FGFR4;MTTP
prerank,positive regulation of myoblast differentiation (GO:0045663),0.38742645413202736,1.0326047796948206,0.4073394495412844,0.8132820201226233,1.0,6/16,15.33%,MEF2C;IGFBP3;AKIRIN1;RBM24;LRRC8A;MAPK14
prerank,neural crest cell migration (GO:0001755),0.3215341979304716,1.0323911063960773,0.3979933110367893,0.8131782199577612,1.0,7/36,8.57%,SEMA3B;SOX8;SEMA4C;SEMA4G;SHH;GDNF;SEMA3G
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.2823674244816514,-1.0320447618628463,0.3617021276595745,0.8090314843159911,1.0,9/48,9.00%,NEDD9;PTPRD;CDKL5;DOCK5;IL1RAPL1;CDC42;CARMIL1;CUL7;MYADM
prerank,cardiac muscle cell contraction (GO:0086003),-0.35355415554914726,-1.0320008413382753,0.39828693790149894,0.8081168032860014,1.0,4/19,11.52%,FGF12;GSN;CACNA1C;ATP1A1
prerank,regulation of viral release from host cell (GO:1902186),0.35536545798798297,1.0317921246672521,0.41889483065953653,0.8142298868452922,1.0,7/21,21.31%,TRIM11;TRIM5;TRIM62;VPS37B;CHMP2A;VPS4A;TSG101
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.28985553307813594,-1.031718147350471,0.4024390243902439,0.807927901634072,1.0,25/47,28.15%,ZBTB16;PPARG;CREBL2;LMO3;CEBPB;FRZB;ZBTB7B;NAPEPLD;SOX13;FNDC5;PIM1;SFRP1;SFRP2;VSTM2A;SYAP1;AAMDC;ASXL2;NOCT;ZFP36;RARRES2;CREB1;XBP1;ID2;CCDC71L;METRNL
prerank,activation of protein kinase B activity (GO:0032148),0.33547282676967805,1.0313523410697845,0.3954305799648506,0.8148274654138988,1.0,7/29,14.70%,IL18;PDPK1;PDGFB;MTOR;MLST8;PINK1;AKT1
prerank,mRNA splice site selection (GO:0006376),0.3313524386145746,1.0312563294654036,0.3944636678200692,0.8143890741165088,1.0,9/30,17.11%,SNRPC;SFSWAP;CELF2;PRPF39;SRSF5;LUC7L3;SLU7;SF3A1;LUC7L
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.3826968807280015,1.0311558263454073,0.4076782449725777,0.8139617127242881,1.0,7/16,18.74%,DDX5;PADI2;DDX17;DDX54;SAFB;ARID1A;NCOA4
prerank,positive regulation of heart contraction (GO:0045823),-0.3574515472459494,-1.0308715325661728,0.41025641025641024,0.8095015291853628,1.0,6/19,18.49%,ADRA1A;RYR2;ATP2A2;KCNQ1;APLN;ADM
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.3968746114362955,1.0306090795836005,0.4110320284697509,0.8148535935713519,1.0,5/14,27.20%,PES1;BOP1;FTSJ3;RPL7;WDR12
prerank,regulation of keratinocyte migration (GO:0051547),-0.40640847250378087,-1.0304346601274739,0.423728813559322,0.8097261192236006,1.0,3/12,9.79%,IQSEC1;FGF10;FGF7
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.312744875602869,-1.0303867037456282,0.3873239436619718,0.8088351074910785,1.0,14/32,31.27%,POLA1;CDK14;TFDP2;E2F7;CDK15;ESRRB;E2F1;NPAT;TFDP1;BACH1;ID2;DHFR;GFI1;RRM2
prerank,RNA biosynthetic process (GO:0032774),0.3279966029587829,1.0303709825504581,0.40854700854700854,0.8148371893116915,1.0,8/31,14.09%,TTF2;TAF12;TAF6;BRF1;BRF2;SMARCA5;SMN1;TAF4
prerank,sterol biosynthetic process (GO:0016126),-0.3090914080592975,-1.0301833092944628,0.40669856459330145,0.8083749800710485,1.0,11/33,22.69%,PRKAG2;LBR;EBP;LSS;HMGCR;HMGCS1;MVD;DHCR7;MSMO1;ACLY;CYP51A1
prerank,folic acid metabolic process (GO:0046655),-0.3686950031776891,-1.0298225127202314,0.3961038961038961,0.8084084024720287,1.0,10/18,27.19%,ALDH1L1;SLC46A1;SHMT1;MTHFD1L;MTHFD2L;FPGS;FOLR2;MTHFD2;SLC25A32;DHFR
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.26665770665382915,-1.0298159307795731,0.38313253012048193,0.8073853787391136,1.0,15/65,14.57%,HIP1;EGFR;PTPN12;SH3GL2;CDC42;PTPN3;DOK1;PTPN2;CCDC88A;PDE6H;MVB12A;CDH13;RNF126;EPS15;FER
prerank,receptor catabolic process (GO:0032801),0.35075200574741217,1.0297521107288774,0.4014336917562724,0.8159559210999804,1.0,7/24,13.72%,SMURF1;AP2A1;LGMN;SH3GLB1;MYLIP;CLTA;ZNRF3
prerank,sensory perception of light stimulus (GO:0050953),0.27088302830867983,1.0296425870004207,0.4016393442622951,0.8155861805694178,1.0,14/87,11.58%,CDH23;CRYBB1;EFEMP1;WHRN;PAX6;RP2;TULP2;MYO7A;RD3;EYA3;DRAM2;RABGGTA;PAX2;BBS2
prerank,negative regulation of cell motility (GO:2000146),0.259260691880168,1.029529004422255,0.42443729903536975,0.8151948705495439,1.0,25/108,18.35%,SRGAP3;SRGAP2;LDLRAD4;NAV3;SMAD7;SLURP1;RNF41;RHOB;FLCN;SHH;MIA3;PIP5KL1;DPEP1;RNF20;CCDC125;SERPINE1;ENG;PIN1;DRD2;SPINT2;NOG;ARHGAP4;GATA3;MITF;PTPRJ
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.43843184524277046,-1.0291952209315285,0.4279475982532751,0.8082800300138924,1.0,3/10,7.48%,LRRK2;STK26;PDE8A
prerank,positive regulation of sodium ion transport (GO:0010765),0.40627507281568853,1.0290495556198689,0.42418772563176893,0.8159511185133214,1.0,5/12,20.35%,CNKSR3;SCN4B;SCN1B;WNK3;NOS1
prerank,positive regulation of kinase activity (GO:0033674),-0.24346778202389927,-1.0290412156609339,0.3638814016172507,0.807739174667934,1.0,35/107,21.92%,CD74;IQGAP1;EGFR;DSTYK;RAPGEF2;PRKAG2;ROR1;NTRK2;NTRK3;ERBB4;RET;CENPE;LMO4;EPHA5;SNX9;ALK;ERBB3;CACUL1;EEF1A2;FGFR3;TIGAR;KIT;CDKN1A;RELN;TEK;XRCC5;LMTK2;MRE11;SPDYA;EPHB2;EPHA4;EPHA7;FLT3;TIE1;LTK
prerank,autophagy of mitochondrion (GO:0000422),0.3074652931848051,1.028357690898176,0.3956228956228956,0.8173274712814789,1.0,11/38,17.41%,ULK2;ATG9A;ATG14;PHB2;RB1CC1;PINK1;MARK2;GABARAPL1;ATG9B;ULK1;ATG5
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.26230611700151907,-1.0280619542951153,0.41262135922330095,0.8097166149970517,1.0,14/70,11.76%,CYBB;CD36;B2M;PSMD14;NCF2;PSMD8;PSMA2;PSMF1;TAP1;PSMD6;PSME2;CYBA;PSMD5;PSMD12
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.3869949595090049,-1.0279716259012992,0.4083333333333333,0.8089601977229013,1.0,5/13,10.71%,ZBTB7B;NAPEPLD;SOX13;FNDC5;PIM1
prerank,ribosome biogenesis (GO:0042254),-0.22242218834996316,-1.027824342058988,0.40836012861736337,0.8084144078536061,1.0,53/187,20.54%,RPL36A;RPL30;RPL35A;DDX10;LTV1;RPL4;RPS7;UTP20;RPS2;SNU13;RPLP2;RPL7A;LAS1L;RPL41;EXOSC1;POP4;XRN2;RAN;RPL26;DCAF13;RPS27;RPL18A;RPS25;MRTO4;RPL38;NOC4L;RPL37;UTP14A;RPS14;EXOSC7;RPL24;WDR18;RPS9;RIOK1;RPLP0;RPLP1;RPL8;RPL22;NPM1;NOB1;ESF1;NOP16;RPL19;RPS6;RRS1;PIH1D1;RRP9;RPL13A;RPL18;TSC1;RPS19;RPL23A;NOC2L
prerank,regulation of membrane depolarization (GO:0003254),-0.35999434621893545,-1.0276556529648222,0.4029535864978903,0.8078528455550432,1.0,3/18,6.07%,LRRK2;NEDD4L;PTPN3
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.39096825754552744,-1.027559463253508,0.40772532188841204,0.8071114892100991,1.0,2/13,2.60%,RBPJ;RYR2
prerank,ameboidal-type cell migration (GO:0001667),0.3022289962989117,1.0274182790808601,0.3916083916083916,0.8193860126409859,1.0,9/51,8.57%,SRGAP2;SEMA3B;SOX8;SEMA4C;SEMA4G;SHH;PKN3;GDNF;SEMA3G
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.31723719760569336,1.0271955337562753,0.4117647058823529,0.8192964110375853,1.0,10/37,14.29%,MEF2C;FOXJ2;ADAMTS1;MEF2D;MMP2;PDGFB;GPER1;JUN;GJA1;LDLRAP1
prerank,regulation of fat cell differentiation (GO:0045598),0.2799438628575764,1.027095799106817,0.3932038834951456,0.8188463463239627,1.0,21/74,17.88%,LRP5;SMAD3;SIRT2;PPARD;CCDC85B;GPS2;TRPM4;TAF8;ZFP36L1;ZFP36L2;GATA2;WNT10B;GPER1;TRIO;BBS12;AKT1;CDS1;ANKRD26;MEDAG;GATA3;CARM1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.32207725100011697,1.0270393256097443,0.41074523396880414,0.8182690009692598,1.0,6/33,9.34%,SMAD3;ETS1;EGR1;PDGFB;GATA2;JUN
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.35293176731820225,-1.026925627368055,0.3893805309734513,0.8080229799899818,1.0,2/18,1.28%,ITGA4;PPARG
prerank,apoptotic mitochondrial changes (GO:0008637),-0.3100804478396972,-1.0264372036864278,0.41445783132530123,0.8085107783193334,1.0,12/32,18.58%,DNM1L;NDUFS1;ERBB4;GGCT;FIS1;MFF;CCAR2;BAK1;SOD2;BCL2;BOK;ATG3
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.3959651715282001,1.0263196960513077,0.41603053435114506,0.8196012192832259,1.0,4/14,14.53%,NCBP1;CSTF2;CPSF1;FIP1L1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.33031261586767274,1.026112235638021,0.4137323943661972,0.8194795513023122,1.0,8/29,24.02%,SMAD7;MYL3;ENG;PROX1;NOG;BMP2;TGFB1;FGFR2
prerank,mesenchymal cell differentiation (GO:0048762),0.2953776884602894,1.0259466877543235,0.40336134453781514,0.819250575567375,1.0,18/51,24.68%,TGFBR1;HEYL;MEF2C;DDX5;LOXL3;LIMS1;DDX17;NOTCH4;ENG;NOG;AKNA;ROCK2;DLG5;BMP2;TGFB1;FGFR2;SOX9;HIF1A
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.3281339330918213,1.0256811692865668,0.4273356401384083,0.8193727597716013,1.0,10/29,22.79%,FUS;TENT5C;GDNF;PKP3;RBM24;VIP;SLC11A1;LARP1;ELAVL1;AXIN2
prerank,entry into host (GO:0044409),0.40132827189251674,1.025596665558068,0.4203703703703704,0.8189011819182472,1.0,4/13,13.93%,ITGAV;SRC;MET;CCR5
prerank,ERBB signaling pathway (GO:0038127),-0.2703822020718974,-1.0255091973623434,0.39036144578313253,0.8103074359750286,1.0,11/64,9.50%,IQGAP1;EGFR;GAREM1;NCK2;SHC3;PTPN12;PIK3C2A;ERBB4;ERBB3;BCAR1;NRG2
prerank,positive chemotaxis (GO:0050918),-0.36803462244123514,-1.0250763711984403,0.4078091106290672,0.8106339437983419,1.0,4/17,13.31%,FGF10;SEMA5A;FGF7;CX3CL1
prerank,regulation of macrophage differentiation (GO:0045649),0.38684925186037833,1.0250013841518373,0.4233576642335766,0.8199638524339691,1.0,4/15,14.97%,PRKCA;INHA;IL34;CSF1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.3083954407072124,-1.0249730771290013,0.39325842696629215,0.8099314782003738,1.0,5/31,9.37%,DLG2;LRRC7;DLG3;CDC42;MTCL1
prerank,endothelial tube morphogenesis (GO:0061154),-0.4276553923166081,-1.0246521573133676,0.4247422680412371,0.8098833530627151,1.0,4/10,16.91%,RBPJ;ACVRL1;STARD13;BMP4
prerank,protein heterooligomerization (GO:0051291),-0.36420131743732403,-1.024561901719323,0.4168466522678186,0.8091180709455988,1.0,7/17,26.67%,KCNC2;GRIN2B;PKD2;PKD1;CBR4;KRT10;CPSF7
prerank,acute-phase response (GO:0006953),-0.4004536000668881,-1.0245515821997364,0.4308390022675737,0.8081183518679188,1.0,6/12,33.96%,CEBPB;LBP;SIGIRR;PLSCR1;CRP;IL22
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.36020130766820874,-1.0243804709525086,0.4170403587443946,0.8076199231662147,1.0,7/17,26.32%,RFX3;VEZF1;AHI1;SULT2B1;BMP4;FOXN1;KDF1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.3734858717192764,1.0243701281367144,0.42513863216266173,0.8210942288280777,1.0,4/17,5.70%,CACNB2;TRPM4;SLC8A1;SCN4B
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.319619003569081,-1.0243213483008968,0.41092636579572445,0.8068011306104222,1.0,7/29,14.74%,CCR2;JAK2;PKD2;STAT4;PIAS1;FER;PKD1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.27132016201725273,-1.0242350663114745,0.4176334106728538,0.8060508116931083,1.0,12/56,11.72%,ANK3;SPTBN1;SEPTIN9;KIF23;RACGAP1;CUL7;SNX9;NUSAP1;AURKB;UNC119;KIF20A;ALKBH4
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.42641598135610137,-1.0241291838519009,0.4219409282700422,0.8053578541745007,1.0,3/10,8.82%,SEMA5A;CARMIL1;ACTN2
prerank,negative regulation of defense response to virus (GO:0050687),0.4414203592958543,1.0236813263739704,0.436,0.8223881984881203,1.0,3/10,7.28%,ITCH;PCBP2;C1QBP
prerank,regulation of wound healing (GO:0061041),-0.2890265079495275,-1.0236765953980844,0.4117647058823529,0.8056712229917069,1.0,18/42,32.45%,CADM4;ALOX5;CASK;CD109;KANK1;ADRA2A;ITGB1;PRKCE;EPHB2;ACTG1;ANXA1;OCLN;PTK2;PLAU;VTN;HRG;FOXA2;CLDN19
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.4325110453683541,-1.023629787728591,0.43157894736842106,0.804798816630385,1.0,6/10,20.67%,RACGAP1;CDC42;SPAG5;RCC2;CCNB1;KNSTRN
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.28974005078060977,1.0236176042670408,0.41,0.8218461447238945,1.0,8/57,9.01%,IL18;CSF1R;LYN;IL6ST;CNTF;IL12B;CTF1;IL6R
prerank,negative regulation of cellular catabolic process (GO:0031330),0.28469852837996174,1.023520766638236,0.41118421052631576,0.8214036902800901,1.0,14/63,14.80%,CST3;SIRT2;CPTP;EIF4G1;FOXK2;MET;TAB2;MTOR;RASIP1;BMF;KDM4A;IL10RA;AKT1;RRAGA
prerank,bone morphogenesis (GO:0060349),0.40724044788249036,1.023429061448956,0.4397810218978102,0.8209474203396221,1.0,2/14,2.27%,LRP5;SKI
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.25838678721373737,-1.0233162492287506,0.36,0.8047504395323352,1.0,20/78,18.31%,EGFR;CDK7;LATS1;CCND2;CCNF;CCNYL1;PKD2;ACTB;CCNJ;CEBPA;RGCC;CDKN2A;CDKN1A;PKD1;CDC25C;HEXIM2;PKMYT1;CCNB1;SPDYA;CDK5RAP3
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.2386980812836988,1.0232212525955033,0.3918918918918919,0.8208301960924143,1.0,41/208,15.29%,CAPN3;CFLAR;PIM2;LGALS9;RIPK2;TMEM101;ATP2C1;MAP3K3;TRIM5;NEK6;TRAF5;PLCG2;CASP1;NDFIP2;TRADD;RHOH;PDPK1;MTDH;TMED4;ZMYND11;CCR7;EDA2R;TAB2;AKAP13;GAPDH;RNF31;TICAM2;CXXC5;ZDHHC13;LAMTOR5;MIB2;PRKCB;PINK1;TRIM62;GJA1;OPTN;MAVS;PYCARD;NLRX1;TNIP2;TNFRSF19
prerank,motile cilium assembly (GO:0044458),-0.40483382418496944,-1.0229732127887987,0.44123711340206184,0.8047237838107668,1.0,5/12,25.57%,SPATA6;DNAAF3;DNAAF1;CCDC39;BBOF1
prerank,neural tube development (GO:0021915),-0.37655889561580075,-1.022889499950531,0.4051724137931034,0.8039768743151764,1.0,7/15,27.81%,SOX11;PKD2;PKD1;GRHL2;HES5;STIL;SOX4
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.2778002527433568,1.0227028849203759,0.408130081300813,0.8216140439480508,1.0,25/69,29.71%,BAG6;SEL1L;DNAJB9;USP19;OS9;RNF103;UFD1;AUP1;EDEM1;UBE4A;ANKZF1;MAN1B1;STUB1;RNF121;SYVN1;NPLOC4;DNAJB14;UBE2G2;FBXO2;ECPAS;SGTA;RHBDD2;ERLIN2;FBXO17;RNF5
prerank,pulmonary valve development (GO:0003177),-0.36093704470421206,-1.022511779476412,0.425764192139738,0.8041044699102463,1.0,7/18,22.46%,ROBO1;SLIT2;JAG1;HEY2;BMP4;ROBO2;NOTCH2
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.34098430704107624,1.0224976818557199,0.4117647058823529,0.821499167820071,1.0,7/24,18.93%,RAC1;MAP4K4;PIK3R1;LIMS1;ABL1;PTPRJ;PPM1F
prerank,negative regulation of cell population proliferation (GO:0008285),-0.20840790689574323,-1.0219048398947403,0.37943262411347517,0.8048139832673845,1.0,92/351,20.91%,MAGI2;MTSS1;PPARG;ADRA1A;NCK2;APP;B2M;ST18;RAPGEF2;LMNA;ZBTB7C;SOX11;JAK2;UTP20;ACVR1C;DLG3;S100A11;RARG;PKD2;ERBB4;FRZB;OPRM1;PER2;CDC73;TNS2;PTPN2;FRK;DUSP10;SLC16A2;CDH13;P3H1;RERG;ITGB1BP1;MN1;E2F7;CTCF;KLF4;TESC;CEBPA;MCC;AQP11;RAF1;MINAR1;RBP4;IFIT3;RGCC;SMYD2;HMOX1;CDKN2A;SOD2;CDKN1A;CBFA2T3;PLXNB1;SULT2B1;HSPA1B;FKTN;ACVRL1;MYO16;PAK1;CGREF1;WNT9A;SFRP1;NACC2;CCN3;IFITM1;NIBAN2;NPM1;SFRP2;BMP4;BNIPL;SPEG;COPS8;B4GALT7;TNN;TNFRSF8;E2F1;GSTP1;PBRM1;FOXP3;KLF10;IGFBP7;DNAJA3;RPS6KA2;TPTE;TFDP1;CDKN1C;AVPR2;TSC1;BTG2;PTPRK;DNAJB2;NOX4
prerank,establishment of endothelial barrier (GO:0061028),-0.3142766917087602,-1.0218353349275573,0.3893129770992366,0.8040458638446188,1.0,11/29,22.16%,PDE4D;RAPGEF2;AFDN;RAB1B;MYADM;PDE2A;PECAM1;MSN;RAPGEF6;EZR;ICAM1
prerank,regulation of cellular response to stress (GO:0080135),0.25645102172659934,1.021753444646406,0.39375,0.8230266453357428,1.0,43/115,27.91%,NUAK1;RANBP2;NEK6;ATM;EIF4G1;ATF3;NUP42;HSPH1;SEC13;RPTOR;USP19;MBTPS2;NUP50;MTOR;MLST8;NUP35;CLN3;HSPB8;PINK1;NUP88;ABL1;BAG4;ARMT1;NUP62;SEH1L;NUP107;ROCK2;DNAJC7;MAPT;RPA3;NUP153;ABCD1;FKBP4;AJUBA;NUP188;CRYAB;NDC1;IER3;BAG5;CHORDC1;RPA1;CAMK2D;HIKESHI
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.3933884786130734,-1.0217381238385785,0.4021505376344086,0.8033297391261939,1.0,4/12,11.75%,UST;DSE;VCAN;CSPG4
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.23108679207665667,-1.0216125665451887,0.37267080745341613,0.8026987669119311,1.0,29/151,13.61%,DMD;GPHN;B4GALT5;PAM;ST3GAL4;PCSK5;SGMS1;SGMS2;SLC44A5;VAPA;ELOVL7;SLC44A1;APOE;MGST1;GOLPH3;CHAT;SPTSSA;ASL;HACD1;SGPL1;SLC44A2;ELOVL5;MFSD2A;CHKA;CERS1;CEPT1;ALDH3A2;ACHE;NMRAL1
prerank,protein K48-linked ubiquitination (GO:0070936),0.28947794472936633,1.0215959493383444,0.39655172413793105,0.8227617357235163,1.0,19/54,22.17%,RNF216;ITCH;UBE2H;RFFL;CDC34;RNF8;BFAR;RNF187;UBE3A;FBXO38;DTX3L;UBE2A;RNF4;UBE2T;TOPORS;SYVN1;UBE2R2;KLHL3;RNF34
prerank,positive regulation of actin nucleation (GO:0051127),-0.4123519067888154,-1.0215440569295131,0.44377510040160645,0.801923031261938,1.0,3/11,9.48%,GSN;WASF1;ABI2
prerank,MAPK cascade (GO:0000165),-0.21380971659536233,-1.0213897742015747,0.36728395061728397,0.8013951636681934,1.0,50/295,12.24%,DLG2;RIT2;LRRC7;SPTBN1;LRRK2;RASAL2;EGFR;GRIN2B;FGF10;SHC3;IRS1;RGL1;CUL3;PSMD14;RAPGEF2;YWHAE;MARK3;JAK2;RASGRP4;DLG3;SHANK3;CALM1;HTR2B;PSMD8;PTPN3;NCAM1;ERBB4;PSMA2;GFRA2;PSMF1;RET;PSMD6;BTRC;PSME2;SPTBN2;ACTN2;ERBB3;RASGRF1;NRG2;SPTBN4;FGF7;IL3RA;FGFR3;PSMD5;FGF9;PSMD12;IL2RB;PAQR3;KIT;RAF1
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.27773457667516216,-1.0210937152530302,0.4146341463414634,0.8002769605996005,1.0,14/51,17.39%,REEP3;PPP2R2A;LMNA;LBR;NUP98;RAN;NUP205;PPP2R1A;REEP4;NUP43;BANF1;NUP155;VRK1;CCNB1
prerank,mitotic nuclear membrane organization (GO:0101024),-0.27773457667516216,-1.0210937152530302,0.4146341463414634,0.8002769605996005,1.0,14/51,17.39%,REEP3;PPP2R2A;LMNA;LBR;NUP98;RAN;NUP205;PPP2R1A;REEP4;NUP43;BANF1;NUP155;VRK1;CCNB1
prerank,cardiac conduction system development (GO:0003161),-0.32701760644158934,-1.0208871194211764,0.4264069264069264,0.7998797344561233,1.0,11/24,32.25%,HEY2;BMP4;SMAD1;GJA5;MSX1;NOTCH2;CACNA1G;HCN4;SHOX2;NPPA;TBX18
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.3844871390567881,-1.0206181627694497,0.43683083511777304,0.7996915737884915,1.0,4/15,11.45%,HECW2;CENPE;PTTG1;UBE2C
prerank,nucleotide-excision repair (GO:0006289),0.2604028606879417,1.0204672062552766,0.44019138755980863,0.8253292279617136,1.0,21/101,16.27%,POLR2H;PCNA;POLR2J;DDB2;RFC2;COPS4;RPS27A;UBC;GTF2H2;POLR2D;ERCC2;SLX4;CUL4B;HMGN1;LIG1;MMS19;POLD2;ERCC4;GPS1;COPS6;POLR2E
prerank,pyruvate metabolic process (GO:0006090),0.29090418987557043,1.0195543345216034,0.4227504244482173,0.8272519446011729,1.0,16/52,26.83%,HK2;PFKL;PGK1;GAPDH;PFKFB2;PGAM4;PGAM1;VDAC1;LDHAL6B;SDS;PCK2;LDHA;HK3;ME2;PDHB;SLC16A1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.3619074950312089,1.019422152322142,0.42700729927007297,0.8268897834927016,1.0,8/21,26.14%,UCHL5;ULK3;SHH;RAB34;SMO;TUBD1;DLG5;KIF7
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.2946342807101357,1.0191597614378138,0.4378029079159935,0.8269528340846795,1.0,19/48,27.46%,POLR2H;SF3B1;PADI2;SMARCA5;BAZ1B;ZMIZ2;POLR2E;ZMIZ1;POLR1C;ARID1A;ELOF1;TBP;DEK;ATAD2;POLR1E;POLR1G;WBP2;MYO1C;POLR1A
prerank,regulation of muscle contraction (GO:0006937),-0.3198265045915872,-1.0189934890760988,0.4149184149184149,0.8035341756867908,1.0,5/26,13.99%,KCNB2;CHRM2;TNNI1;MYL9;MYBPC3
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.3287487812819599,1.018929789792393,0.418018018018018,0.8268819106866928,1.0,3/30,1.26%,BAG6;FHIT;UCHL5
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.25008261994882547,-1.0184419080734897,0.39800995024875624,0.8042926040406042,1.0,20/84,17.39%,CUL3;PSMD14;PSMD8;PSMA2;PSMF1;PSMD6;ECRG4;PSME2;BUB1B;PTTG1;AURKB;PSMD5;UBE2C;ANAPC10;PSMD12;PSMD11;PSMD1;CDK2;SKP2;CCNB1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.42103596563189044,1.0183025411286202,0.4293785310734463,0.8279786752329983,1.0,5/11,17.98%,ITGAM;ITGB2;STX4;MAVS;TICAM1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.20569198513673861,-1.0183000101056485,0.38489208633093525,0.8037062842083076,1.0,83/348,19.77%,MAGI2;PID1;RIMS2;RBPJ;CD74;ANK3;ROBO1;ANK2;ATF2;CD36;STAP1;LILRB1;FGF10;GSN;APP;PTPN22;ATF7IP;NTRK2;RBMS3;ATAD1;PF4;RPS3;UBR5;SOX11;RPS7;NTRK3;FN1;AFDN;AGO4;GSK3B;KLF2;FAM98A;ZBTB7B;PRKN;TNRC6A;DNMT3B;FGF7;TLE1;IFNGR1;FGF9;CTCF;KLF4;TESC;CDH5;DTNBP1;AHI1;SETDB2;RGCC;MMP8;PDE2A;INPP5F;HSPA1B;SCX;CD46;ANXA2;SCYL2;HEY2;SNCA;POU3F1;PPHLN1;TTBK1;HMGN5;MTPN;CD3E;SRPK2;BMP4;RIMS1;VSTM2A;TFRC;MSN;ADTRP;E2F1;FGF5;TADA3;MAPK1;DNMT1;LEF1;CD63;SMAD1;ACTA1;MAP2K5;STOX1;EPHB2
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.38455850417687115,1.017997810088996,0.427536231884058,0.8281408259837749,1.0,7/16,20.85%,DDX5;DHX9;DDX17;RBM17;SLU7;SCNM1;SRSF9
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.2422907745573279,-1.0179438700832222,0.4297520661157025,0.8037720214493257,1.0,17/108,10.26%,HIP1;ROBO1;XDH;NLRC4;PPARG;GSN;DAP;ST18;RPS3;JAK2;ACVR1C;DIABLO;DAPK1;SIRT1;BEX3;FIS1;ATP2A3
prerank,response to amyloid-beta (GO:1904645),-0.28515171287588054,-1.0179207621411488,0.4174757281553398,0.8028681462927386,1.0,9/44,11.45%,ITGA4;GRM5;CD36;GRIN2A;APP;GSK3B;MMP12;VCAM1;FCGR2B
prerank,termination of RNA polymerase II transcription (GO:0006369),0.3230749234391082,1.0178641268792339,0.4388111888111888,0.827836305349743,1.0,9/33,17.65%,NCBP1;TTF2;CSTF2;SNRPF;PABPN1;CPSF1;FIP1L1;MED18;PCF11
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.41861814770261635,-1.0176961592014417,0.43792325056433407,0.8025392235759885,1.0,2/10,7.70%,ATF7IP;THRA
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.37189911028441336,-1.017404975946706,0.4272930648769575,0.8023998316332679,1.0,6/15,22.91%,YWHAE;GSK3B;BAG3;GTSE1;XPO4;EMD
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.4067591609997855,1.0169915071031865,0.45925925925925926,0.8297125939074222,1.0,5/11,20.18%,EPN1;PIK3CB;E2F2;THBS1;SYNJ2BP
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.31981512614347707,1.0166272474973068,0.44912280701754387,0.8300484043226962,1.0,14/33,27.61%,PPP6R3;CTC1;TNKS1BP1;DCLRE1B;TERF1;ZBTB48;NHP2;RFC1;ACD;SHQ1;TELO2;STN1;RPA1;RTEL1
prerank,response to interferon-gamma (GO:0034341),-0.26294864663975126,-1.0165657129276842,0.4254742547425474,0.8038448703718756,1.0,21/67,20.38%,CD74;CD47;CIITA;CD40;SP100;IFITM3;GBP3;AQP4;DAPK1;GBP4;GBP2;CX3CL1;IFITM2;CCL5;CCL14;SNCA;IFITM1;CCL7;NUB1;RPL13A;SYNCRIP
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.4217979633191671,-1.0162923045767067,0.4336283185840708,0.8036422523440124,1.0,3/10,3.27%,BTLA;LILRB1;CD40
prerank,regulation of gene silencing by miRNA (GO:0060964),0.28023580392243685,1.0162905677791079,0.41903171953255425,0.8302522660302902,1.0,25/62,26.23%,POLR2H;POLR2J;RANBP2;EIF4G1;POLR2D;NUP42;DHX9;SEC13;NUP50;NUP35;NUP88;POLR2E;NUP62;SEH1L;NUP107;WTIP;POLR2I;ELAVL1;NUP153;TGFB1;AGO1;AJUBA;NUP188;STAT3;NDC1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.3262630087225247,1.0159664888179833,0.41843971631205673,0.8304737506749933,1.0,4/30,2.18%,KLK2;PRMT2;HEYL;DDX5
prerank,cell cycle G1/S phase transition (GO:0044843),-0.26519785979166405,-1.015716211776031,0.42462311557788945,0.8044293836178039,1.0,21/61,23.49%,CDK7;CUL3;LATS1;PLK2;PPP6C;USP29;CACUL1;BCAT1;CDKN2A;CDKN1A;DBF4;GPR132;CDK2;NASP;SPDYA;E2F1;CDK4;USP26;EIF4EBP1;RPS6KB1;CCNH
prerank,cellular biogenic amine catabolic process (GO:0042402),0.4322409839605379,1.0156042085561432,0.47435897435897434,0.8307819709783124,1.0,3/10,11.96%,CHDH;COMT;SMOX
prerank,hippo signaling (GO:0035329),-0.32348202785929897,-1.0155187140496813,0.4217687074829932,0.8040072391712402,1.0,6/26,13.55%,LATS1;YWHAE;FAT4;MOB1B;WWC1;TEAD4
prerank,endomembrane system organization (GO:0010256),-0.22168269116455822,-1.0154167368970077,0.3691860465116279,0.8033402772684423,1.0,34/178,14.88%,ATP8B4;ANK3;MYOF;SPTBN1;LRRK2;TMCC1;HTT;REEP3;SYNE1;VAPA;RAB22A;ZW10;STX17;ATL2;DNM1L;VPS51;CDC42;GOLPH3;DNM1;TOR1A;CUL7;TMED1;VMP1;DMPK;FAM174B;DYSF;ARHGAP21;REEP4;ALS2CL;TOR1AIP2;OBSL1;TMED2;LMAN1;NUP155
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.3402273685838072,1.0149588326267978,0.44727272727272727,0.8319313999318325,1.0,5/26,7.10%,SMAD3;TLR4;CLU;AGTR2;NOS1AP
prerank,positive regulation of vasculogenesis (GO:2001214),0.4387846259172018,1.014934584655632,0.4312617702448211,0.8312596205415559,1.0,3/10,11.23%,ASB4;CD34;CEACAM1
prerank,negative regulation of dephosphorylation (GO:0035305),0.36828578553242675,1.0148428227197392,0.43151969981238275,0.8307977369740792,1.0,4/18,11.54%,ZCCHC9;GPATCH2;INPP5K;SH2D4A
prerank,protein insertion into ER membrane (GO:0045048),-0.29364496347329133,-1.0147674216386418,0.441527446300716,0.8043029632182173,1.0,13/37,22.91%,APP;UBE2J2;VAPA;GET3;ALDH3A2;EMC3;HMOX1;MMGT1;EMC2;GET4;EMC7;TRAM2;EMD
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.2573686452724458,-1.0147098650561484,0.42455242966751916,0.8034931309082122,1.0,8/73,4.86%,HIP1;ROBO1;XDH;NLRC4;PPARG;DAP;JAK2;DIABLO
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.3796311180706537,1.014677750111217,0.4257602862254025,0.8305398314177589,1.0,4/17,15.15%,ALG12;ALG6;ALG2;ALG8
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.3593213930805463,1.0146277991051353,0.4166666666666667,0.8299765352824549,1.0,5/20,13.33%,SEMA3B;SEMA4C;SEMA4G;SEMA3G;SEMA4D
prerank,stem cell development (GO:0048864),0.3779022462635667,1.0142573708829186,0.4207650273224044,0.8302817949042914,1.0,4/16,12.55%,SOX8;SHH;KBTBD8;PDCD6
prerank,natural killer cell activation (GO:0030101),0.34128322591631066,1.0140258462506666,0.4261992619926199,0.8302428301050206,1.0,5/23,10.66%,BAG6;ULBP1;IL12B;PIK3CD;AXL
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.32019728880927334,1.0139489376753081,0.4432234432234432,0.8297597464739627,1.0,11/32,22.97%,ATM;NBN;FOXN3;BRCA1;CDC14B;TAOK2;ABRAXAS1;BLM;BABAM1;TOPBP1;DONSON
prerank,hyaluronan catabolic process (GO:0030214),0.37496431152655985,1.013922883205399,0.44802867383512546,0.829109068553499,1.0,3/18,6.12%,HEXB;GUSB;HEXA
prerank,cellular response to hypoxia (GO:0071456),-0.23574247222335581,-1.0132814866563689,0.4254742547425474,0.8067658216972705,1.0,27/126,16.06%,KCND2;SLC8A3;SUV39H1;SCN2A;NPEPPS;LIMD1;PSMD14;LMNA;PSMD8;PSMA2;PSMF1;HIPK2;PSMD6;SIRT1;PSME2;OPRD1;PSMD5;TIGAR;PSMD12;RGCC;HMOX1;PSMD11;AK4;EGLN3;SFRP1;PSMD1;MDM2
prerank,response to reactive oxygen species (GO:0000302),-0.2762923186282065,-1.013016178859215,0.43765281173594134,0.8065509555882092,1.0,18/54,20.91%,EGFR;RPS3;ROMO1;APOE;STK26;PKD2;SIRT1;AGAP3;HMOX1;SOD2;FER;ERCC6L2;HP;GSTP1;MAPK1;CAT;PTPRK;FYN
prerank,nucleoside catabolic process (GO:0009164),-0.4135894525729013,-1.0130085551108543,0.45052631578947366,0.8056023695217251,1.0,3/11,20.36%,DPYD;UPP2;DERA
prerank,BMP signaling pathway (GO:0030509),0.27894002161121434,1.0128869573962473,0.4052718286655684,0.8313533077148939,1.0,20/62,28.03%,SMAD3;SMAD7;DDX5;SMURF1;LEFTY1;ENG;SMAD9;USP9Y;NOG;ACVR2B;ZFYVE16;HIVEP1;TMEM100;BMP2;TGFB1;PDCD4;AMH;ACVR1;SMAD5;SMAD6
prerank,positive regulation of histone acetylation (GO:0035066),0.35003757563983523,1.0127236572502953,0.43097014925373134,0.8310804690387716,1.0,10/23,31.36%,RPS6KA5;BRCA1;RPS6KA4;ARRB1;NOS1;GLYR1;WBP2;PAXIP1;MUC1;BRD7
prerank,response to exogenous dsRNA (GO:0043330),0.3651137579279336,1.0125868728749807,0.4523364485981308,0.8307787692225667,1.0,10/18,33.70%,ZCCHC3;DHX9;CGAS;MAVS;TICAM1;RALB;FLOT1;IFIT1;MUL1;COLEC12
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.26077445698207863,-1.0124270586106356,0.42890995260663506,0.8062824007316485,1.0,8/66,7.02%,ROBO1;LRRK2;EGFR;CD40;RPS3;PDGFD;HTR2B;TPD52L1
prerank,cellular response to reactive oxygen species (GO:0034614),0.28174299192926666,1.0123358623540384,0.4189655172413793,0.8308088485660533,1.0,16/59,19.03%,SIRPA;NFE2L2;RHOB;PRKCD;TRPM2;IMPACT;CAMKK2;JUN;PDK2;PAX2;ABL1;MAPK8;AKT1;MAPK7;ANKZF1;ECT2
prerank,regulation of nuclear division (GO:0051783),-0.34934274695253276,-1.0121925347594742,0.432967032967033,0.8060122797479449,1.0,9/20,32.43%,MKI67;CUL7;OBSL1;CDC25C;PKMYT1;CAV2;BORA;CCDC8;NEK2
prerank,positive regulation of histone modification (GO:0031058),0.31690187918460383,1.012002167040692,0.43447037701974867,0.8310944262246635,1.0,10/33,20.35%,AKAP8;AKAP8L;CDK9;RPS6KA5;SART3;BRCA1;RPS6KA4;ARRB1;KDM1A;NOS1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.2976499532808038,-1.0118339500105575,0.397196261682243,0.806106296145233,1.0,9/36,15.05%,CD74;CD300LF;PARP14;PRKN;IRGM;UBE2K;TXK;HSPA1B;AGPAT1
prerank,regulation of Golgi organization (GO:1903358),0.3753395978057651,1.0116626419979864,0.4358523725834798,0.8313635538030997,1.0,7/17,21.45%,CAMSAP2;ARMH3;RBSN;MAP2K1;PDCD10;STX5;STX18
prerank,regulation of cell size (GO:0008361),0.35423975179299405,1.0115909057924573,0.44,0.8308509427794615,1.0,6/23,10.88%,VAV2;RAC1;PLEK;RPTOR;MTOR;LAMTOR5
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.2835231889218019,-1.011540434037407,0.4268867924528302,0.8060444929435561,1.0,11/41,16.53%,ANK3;CD44;CD47;AFDN;SKAP1;PODXL;CX3CL1;CCL5;THY1;PLPP3;CD3E
prerank,proteoglycan biosynthetic process (GO:0030166),0.31570591991797176,1.0113110088063033,0.4230769230769231,0.8309463494305726,1.0,3/31,2.36%,EXTL3;CHST11;GAL3ST4
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.3125634625089554,-1.011234369012655,0.3933649289099526,0.805994349462366,1.0,5/30,5.23%,ANK2;FGF12;RYR2;NEDD4L;CACNA1C
prerank,dendritic cell chemotaxis (GO:0002407),0.3930829791004409,1.011227621922458,0.437847866419295,0.8304968770485468,1.0,5/14,13.93%,PIK3CG;TRPM4;TRPM2;CCR7;CCR5
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.3042954417411996,1.0108670423108899,0.4432809773123909,0.8307867979510587,1.0,8/41,15.84%,SIRPA;LGALS9;VSIR;TLR4;CD34;HAVCR2;CD33;SLAMF1
prerank,negative regulation of interleukin-2 production (GO:0032703),0.3654028684293567,1.0106184241577834,0.4229390681003584,0.8307857931947674,1.0,4/18,17.86%,NAV3;CD34;HAVCR2;KAT5
prerank,basement membrane organization (GO:0071711),-0.3866717365273679,-1.0105860303761711,0.4391304347826087,0.8069170498808748,1.0,8/14,25.94%,FLRT2;COL4A1;LAMB2;NTNG1;NTNG2;NTN4;NID2;NID1
prerank,regulation of receptor internalization (GO:0002090),-0.2977574998007958,-1.0104909819214005,0.44768856447688565,0.8062309084794832,1.0,5/35,6.20%,MAGI2;MKLN1;ATAD1;MTMR2;SDCBP
prerank,protein N-linked glycosylation (GO:0006487),0.277605277476927,1.0103968253412339,0.43906510851419034,0.8307256958549767,1.0,13/66,12.56%,MGAT4A;ALG12;GFPT1;ALG6;DPM3;MGAT2;MAN1C1;MGAT5;ALG11;MGAT1;NUDT14;OSTC;ALG2
prerank,lymphocyte proliferation (GO:0046651),-0.33484156462765846,-1.010175711681146,0.418013856812933,0.8062116923460926,1.0,10/22,25.12%,CD40;HELLS;CR2;CTPS1;BCL2;TNFRSF4;MSN;MS4A1;FLT3;RASGRP1
prerank,regulation of apoptotic process (GO:0042981),0.2117026805769246,1.0101251162242928,0.4338689740420272,0.830838426307521,1.0,113/676,14.89%,BIN1;FGD2;ARHGEF2;DNM2;CTSD;SON;PREX1;VAV2;GREM1;CAPN3;ITGA6;QRICH1;PRMT2;CALHM2;CFLAR;PIM2;CRADD;MAP4K4;MEF2C;KCNMA1;SOX8;PIK3R1;RIPK2;IGFBP3;RPS6KA1;TGM2;ITCH;KLF11;VHL;IGF1R;SRC;RHOB;ATM;PHB2;PKHD1;CLU;AATF;FLCN;SUDS3;CD27;CASP1;PLSCR3;RPS27A;UBC;PTK2B;TRADD;TNFRSF25;ATAD3A;SPRY2;YME1L1;EGR3;IL6ST;PPT1;MGMT;SHH;ARL6IP5;MTDH;WDR73;C1QBP;CIAPIN1;WNT10B;GDNF;PIP5KL1;GPER1;PLK5;ACER2;JUN;AKAP13;TJP1;ARAF;SLC27A4;CLIP3;RABGGTA;DPEP1;USP36;PPID;NCKAP1L;BFAR;NUAK2;ANP32A;AXL;AREL1;PSENEN;CLN3;BMF;RPL10;PAX2;FGD3;TRIO;PSEN2;PINK1;APAF1;HIP1R;BNIP2;OSGIN1;MAP3K10;MAP3K11;TARDBP;SEMA4D;GCLC;DDX20;ABL1;PLK3;SOD1;LATS2;TMBIM6;MAPK8;BAG4;PYCARD;AKT1;VDAC1;CIB1;HPN
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.28136407145409575,-1.0099430741154858,0.41244239631336405,0.8059393266081459,1.0,17/45,24.61%,BRINP3;ZW10;PTPN3;BRINP2;PLK2;BUB1B;BUB1;TRIM35;RGCC;CHEK1;BMP4;FOXC1;CDKN1C;BTG2;NABP2;CTNNB1;TOM1L2
prerank,histone lysine demethylation (GO:0070076),0.34046267641483086,1.009941766736001,0.4283185840707965,0.8306507149045409,1.0,12/25,24.83%,KDM5B;UTY;KDM3A;KDM4A;HR;KDM1A;KDM8;KDM7A;KDM2A;KDM5A;KDM2B;PHF8
prerank,regulation of organelle organization (GO:0033043),0.2682620486141063,1.0091391896873982,0.44264943457189015,0.8322923100909538,1.0,24/80,21.45%,F11R;PREB;TMED9;PISD;CAMSAP2;TJP1;ARMH3;SAR1A;CLN3;PINK1;MARK2;MIEF2;PRMT6;MAVS;RBSN;PDCD10;STX5;CPLANE2;TMEM33;VPS35;SYT11;ARHGEF5;MAPT;STX18
prerank,negative regulation of programmed cell death (GO:0043069),0.22170120431329574,1.0090592205176347,0.4336870026525199,0.8318522860777549,1.0,69/355,17.34%,SON;GREM1;CAPN3;CFLAR;PIM2;MAP4K4;SOX8;PIK3R1;RIPK2;RPS6KA1;ITCH;VHL;IGF1R;SRC;PHB2;PKHD1;AATF;CD27;RPS27A;UBC;PTK2B;ATAD3A;SPRY2;YME1L1;EGR3;IL6ST;PPT1;MGMT;SHH;MET;MTDH;WDR73;CIAPIN1;GDNF;POU4F1;TM7SF3;TJP1;ARAF;DPEP1;NCKAP1L;BFAR;NUAK2;AXL;AREL1;CLN3;RPL10;PAX2;PSEN2;DCPS;BNIP2;SEMA4D;GCLC;GPX4;PLK3;TMBIM6;MAPK8;BAG4;AKT1;VDAC1;CIB1;HPN;VIP;RNF144B;PDCD10;XIAP;ADAM10;KANK2;NUP62;FANK1
prerank,regulation of cell morphogenesis (GO:0022604),0.3308363575957658,1.0089740582725764,0.4547008547008547,0.8314059870248495,1.0,6/30,7.12%,ZRANB1;CAPZB;SPARC;CAMSAP1;MOV10;MACF1
prerank,membrane depolarization (GO:0051899),-0.30814924716639036,-1.008737335604732,0.45539906103286387,0.8085123806535054,1.0,10/32,22.68%,CACNA1E;SCN2A;CACNG2;SCN3A;CHRNA4;CACNB3;CACNA1B;SCN9A;CACNA1G;SCN1A
prerank,apoptotic nuclear changes (GO:0030262),-0.3241453031848354,-1.0083609785381338,0.4178743961352657,0.8086711073113586,1.0,3/24,4.34%,DEDD2;TOP2A;ACVR1C
prerank,establishment of spindle localization (GO:0051293),0.39186085653089664,1.0080985703650829,0.46828358208955223,0.8332375433292625,1.0,3/14,11.92%,TLE6;MAP4;LLGL1
prerank,cell junction organization (GO:0034330),0.2735843124142403,1.0080771339697674,0.42289348171701113,0.8325970638599012,1.0,23/71,21.90%,OPHN1;SMAD3;PPFIA4;CXADR;PKHD1;C1QA;APBB2;TJP1;LIMS1;WNT7B;FLNC;LRP4;PIN1;FBLIM1;TJP2;CBLN1;CLDN1;VASP;CBLN2;RAB8B;PPFIBP2;MAPT;SLC8A2
prerank,peptidyl-lysine modification (GO:0018205),0.2557738918770626,1.0080375876591354,0.4483870967741935,0.8320093585342277,1.0,21/99,17.86%,SUMO1;SENP2;SIRT2;RANBP2;UBA2;VIPAS39;HDAC10;TRPM4;STX1A;LOXL3;NUP42;EGR2;NUP50;NUP35;NUP88;PIAS3;PIAS2;NUP62;SEH1L;NUP107;KAT5
prerank,positive regulation of protein import into nucleus (GO:0042307),0.33068025564191283,1.0078357915878198,0.4223826714801444,0.8318769098053714,1.0,10/28,24.22%,SMAD3;PIK3R1;PRKCD;ZIC1;MAVS;ECT2;ZC3H12A;TGFB1;JUP;IPO5
prerank,inorganic anion transport (GO:0015698),-0.2748912220961841,-1.0078316914398993,0.4492753623188406,0.809255273223679,1.0,9/53,13.84%,SLC25A30;GLRA1;RACGAP1;SLC4A10;ANO6;SLC26A7;ANO5;XPR1;ANO10
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.22358798960725995,-1.0074238065184358,0.4099722991689751,0.8094982603864402,1.0,33/152,18.49%,ADGRB3;ADGRL3;GRM8;ADGRE5;GRK5;ADCY2;ADGRG6;IAPP;GABBR1;PF4;GNAO1;ADCY5;CHRM2;HTR1D;LGR5;ADCY3;ADCY8;GPR161;ADRA2A;GNAI1;RGS1;LGR4;PDE2A;ADGRG5;CNR2;TSHR;LPAR2;HTR1F;RXFP2;ADCYAP1R1;ADGRL4;S1PR2;ADM
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.38192475617920507,1.0068673809028363,0.43462246777163904,0.8339318378797298,1.0,5/15,14.26%,CRNN;PHB2;PLCG2;KLHL18;EZH2
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.3075928299725195,-1.0068544109499382,0.416289592760181,0.8101643400909451,1.0,8/32,21.16%,RPL30;PF4;ROMO1;CAMP;RNASE3;LTF;RPS19;CXCL14
prerank,histone H4-K16 acetylation (GO:0043984),0.3642051962955302,1.0066939076959374,0.46715328467153283,0.8337394395444694,1.0,9/19,28.32%,KANSL2;MSL2;JADE2;PHF20;KANSL3;WDR5;KANSL1;MCRS1;KMT2A
prerank,neutrophil mediated immunity (GO:0002446),-0.19994188905158264,-1.0061594240346357,0.3911290322580645,0.8112463225055638,1.0,79/432,15.01%,IQGAP2;ATP8B4;IQGAP1;ARMC8;LRRC7;ADGRE5;PTPRN2;CYBB;ACTR10;AMPD3;CD44;CD47;CD36;LILRB3;FTL;CD93;GSN;CYSTM1;CLEC12A;MME;AP2A2;HGSNAT;KMT2E;B2M;CTSC;PSMD14;VAPA;CCT2;STOM;RAB6A;ITGAL;PPIA;PLAC8;ATP6AP2;S100A11;MGST1;ALOX5;RAB5C;ATP11A;SDCBP;KCNAB2;SNAP25;PSMA2;CNN2;CFP;PSMD6;RAB3D;TBC1D10C;CAMP;FRK;ANO6;RAB3A;SLC44A2;ATG7;GPI;CYBA;DNAJC3;OLR1;ANPEP;PTAFR;TRAPPC1;ARPC5;AP1M1;APRT;PSMD12;RNASE3;GYG1;LAMP1;MMP8;GLA;ALDOC;MCEMP1;PECAM1;PSMD11;MANBA;HSPA1B;HSPA8;ANXA2;IGF2R
prerank,DNA metabolic process (GO:0006259),0.2258122210464074,1.0059073628783042,0.4314868804664723,0.8353501691930691,1.0,64/270,20.71%,SUMO1;CSNK1E;PCNA;EID3;PRIMPOL;DDB2;RFC2;ATM;NBN;REXO4;CTC1;MPG;RPS27A;UBC;RAD17;MCM2;RAD51B;MGMT;SLX4;CDC34;INTS3;CNBP;NUDT15;LIG1;MMS19;TOP3B;BRCA1;FANCG;POLD2;TOP2B;KMT5C;DCLRE1B;UHRF2;EXO1;ERCC4;RAD1;UBE2U;UBE2V2;PARG;TERF1;RPAIN;BLM;PSME4;DNASE2;NABP1;UBE2A;ORC3;RFC1;KAT5;HMGB2;NTHL1;FANCA;TOP3A;MCM3;ACD;XRCC6;TYMS;RAD9A;TSN;LTO1;PWWP3A;UBE2T;PARP4;RNASEH1
prerank,microvillus organization (GO:0032528),-0.3907433284957691,-1.005820625004254,0.4295774647887324,0.8112940765617019,1.0,3/13,4.72%,RAPGEF2;FXYD5;STK26
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.3809222835699951,-1.0057124541022113,0.46485260770975056,0.8106710158762603,1.0,3/14,16.74%,LDLR;CX3CL1;CD200R1
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.38964730120894,1.0056744133851905,0.46368715083798884,0.835311289879029,1.0,3/15,8.46%,ZFP36L1;ZFP36L2;GPER1
prerank,respiratory tube development (GO:0030323),0.32804100980415785,1.0056448413952763,0.44646098003629764,0.834693767897747,1.0,7/28,15.27%,BAG6;LOXL3;HECA;SHH;WNT7B;CCDC40;PROX1
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.30682989287061213,1.0056192751772612,0.43238434163701067,0.8340520372562921,1.0,13/38,14.87%,DDIT3;ARRB2;PKHD1;FLCN;THEM4;GPER1;INPP5K;PIK3CB;PPP2R5B;PDCD6;DRD2;AKT1;CIB1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.23890050032379292,1.005552883150629,0.4307458143074581,0.8335401627100854,1.0,65/184,27.65%,SDCCAG8;TUBA4A;CSNK1E;SIRT2;PPP1R9B;PRKACA;NEK6;ODF2;TUBB;RPS27A;UBC;CEP164;TUBG1;ERCC2;HAUS7;ZFP36L1;ZFP36L2;PLK5;APPL1;PSMD3;CNTRL;ANAPC15;PSMB3;CDC14B;TUBA1A;PSMA7;CEP63;CEP57;HAUS6;HAUS2;KLHL18;PSMC1;PSMC2;SFI1;PSME4;AURKA;MAPRE1;ANAPC11;PSMB9;CEP135;ACTR1A;OFD1;CEP43;DCTN2;PSMD4;PSMB5;CEP70;PSMB7;CSNK1D;ANAPC1;PSMB8;TFAP4;ANAPC2;DYNLL1;NDE1;PSMD13;CCP110;APPL2;CUL1;HAUS5;ANLN;PSMD2;ANAPC16;UBE2D1;HAUS8
prerank,negative regulation of cell cycle (GO:0045786),0.26630011981244694,1.0051788745917023,0.4370748299319728,0.8338958854369986,1.0,28/73,25.91%,SMAD3;INCA1;RHOB;HECA;HPGD;SIPA1;TAF6;GPER1;INHA;CDK5RAP1;LATS2;TSPYL2;GATA3;CHMP1A;HTRA2;GAS1;NUDT6;IPO7;CDKN1B;BMP2;TGFB1;TFAP4;PDCD4;IPO5;NPPC;SCRIB;BTG1;GMNN
prerank,nitrogen compound transport (GO:0071705),0.24512332001883583,1.0050158799430875,0.44301765650080255,0.833670778297772,1.0,33/141,19.92%,SLC7A8;SLC7A5;SLC36A1;SEC14L1;MYH9;SLC15A4;SLC25A45;PPT1;ARRDC1;CD320;ARL6IP5;MIA3;RD3;SLC52A3;SLC22A2;SLC29A4;SCAMP2;SCAMP5;SLC52A2;SLC52A1;ARRDC2;TOM1;PICK1;KIF3A;SLC38A1;SLC23A1;SLC11A1;SLC15A2;CHMP1A;CHMP2A;SLC6A8;CMTM6;LRRC8D
prerank,positive regulation of lipid storage (GO:0010884),-0.3325239951738551,-1.0049679496398154,0.4149184149184149,0.811880061492916,1.0,6/21,20.18%,MSR1;EHD1;PLIN2;IKBKE;VSTM2A;PLIN3
prerank,ESCRT complex disassembly (GO:1904896),0.4303676015743052,1.004958558822188,0.4696132596685083,0.8324213284424459,1.0,6/10,30.24%,CHMP1A;IST1;CHMP2A;VPS4A;VTA1;CHMP7
prerank,ESCRT III complex disassembly (GO:1904903),0.4303676015743052,1.004958558822188,0.4696132596685083,0.8324213284424459,1.0,6/10,30.24%,CHMP1A;IST1;CHMP2A;VPS4A;VTA1;CHMP7
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.38192071070663525,1.004802261678294,0.4495726495726496,0.832154710286721,1.0,6/16,23.62%,ATP5PO;ATP5PD;ATP5MC1;ATP5F1D;STOML2;ATP5PF
prerank,renal filtration (GO:0097205),-0.41004601893896436,-1.00474124358306,0.4788135593220339,0.8116381928914145,1.0,4/10,13.19%,TMEM63C;SULF2;XPNPEP3;JCHAIN
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.3387647388577609,1.0044957868036863,0.4542190305206463,0.8323456222213238,1.0,5/27,8.92%,IRAK2;TLR4;RPS27A;UBC;TAB2
prerank,organonitrogen compound catabolic process (GO:1901565),0.28509074967298087,1.0044506248321288,0.4606164383561644,0.8317689960711163,1.0,16/57,19.40%,LIPC;CAPN3;PLA2G4A;PLA2G15;PLA2G6;PPT1;MPST;SMPD2;PLA2G5;MTOR;AMDHD2;GADL1;RIDA;NPL;TXN2;IL4I1
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.24806876066933586,1.0041623934220698,0.4346456692913386,0.8319115143268045,1.0,26/124,13.28%,PTPRM;OPHN1;CSF1R;RAC1;AGER;PPP1R9B;LYN;PPP1R9A;PLEK;ODF2;NPY;CAMSAP1;RYK;ARFIP2;EPHA8;CCR7;GDNF;POU4F1;PRMT1;MAP4;CYFIP1;RAB35;UHMK1;MNS1;GPRIN2;IQCG
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.42505440926193394,1.0039719015329813,0.4550561797752809,0.8310457452192228,1.0,3/10,12.16%,AP2A1;MYLIP;CLTA
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.42505440926193394,1.0039719015329813,0.4550561797752809,0.8310457452192228,1.0,3/10,12.16%,AP2A1;MYLIP;CLTA
prerank,regulation of chondrocyte differentiation (GO:0032330),0.34407277144748644,1.0038621411399322,0.458029197080292,0.8306488617342185,1.0,4/24,3.07%,TGFBR1;GREM1;EFEMP1;MBOAT2
prerank,protein K63-linked ubiquitination (GO:0070534),0.3000726198099518,1.0037668105501885,0.4584070796460177,0.8302414450908935,1.0,11/41,20.48%,ITCH;TRIM5;TRAF5;ZFP91;RNF8;BFAR;UBE2V2;WWP2;RNF4;STUB1;UBE2T
prerank,granulocyte chemotaxis (GO:0071621),0.29051976333289947,1.0037248249786197,0.44482758620689655,0.8296591436415127,1.0,9/55,10.24%,CXADR;ITGB2;PIK3CG;CCL3;EDN3;EDN2;CXCL1;PIK3CD;NCKAP1L
prerank,cholesterol transport (GO:0030301),0.3002953789883564,1.0036355935835208,0.43824027072758037,0.8292454954672749,1.0,13/45,20.26%,LIPC;CLU;STX12;APOM;NPC1;NPC2;OSBPL5;LDLRAP1;SCARB1;OSBP;SERAC1;VPS4A;LCAT
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.3597796479657363,-1.0031933144126928,0.43537414965986393,0.8151999558705247,1.0,6/16,18.66%,KDM4D;WRAP53;PARP3;SHLD3;RIF1;SETMAR
prerank,cellular response to glucose stimulus (GO:0071333),0.32830885027750917,1.0028786702570334,0.45195729537366547,0.8307046941337353,1.0,7/30,11.94%,MLXIPL;AGER;PRKACA;IGF1R;GPER1;PAX2;TRA2B
prerank,neutrophil degranulation (GO:0043312),-0.1993181445864443,-1.002771957576512,0.42231075697211157,0.8154901495210262,1.0,78/425,15.01%,IQGAP2;ATP8B4;IQGAP1;ARMC8;LRRC7;ADGRE5;PTPRN2;CYBB;ACTR10;AMPD3;CD44;CD47;CD36;LILRB3;FTL;CD93;GSN;CYSTM1;CLEC12A;MME;AP2A2;HGSNAT;B2M;CTSC;PSMD14;VAPA;CCT2;STOM;RAB6A;ITGAL;PPIA;PLAC8;ATP6AP2;S100A11;MGST1;ALOX5;RAB5C;ATP11A;SDCBP;KCNAB2;SNAP25;PSMA2;CNN2;CFP;PSMD6;RAB3D;TBC1D10C;CAMP;FRK;ANO6;RAB3A;SLC44A2;ATG7;GPI;CYBA;DNAJC3;OLR1;ANPEP;PTAFR;TRAPPC1;ARPC5;AP1M1;APRT;PSMD12;RNASE3;GYG1;LAMP1;MMP8;GLA;ALDOC;MCEMP1;PECAM1;PSMD11;MANBA;HSPA1B;HSPA8;ANXA2;IGF2R
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.37185839834235573,1.002615707584338,0.42830882352941174,0.830730397917646,1.0,3/17,7.10%,SNTA1;SCN4B;NOS1AP
prerank,regulation of dephosphorylation (GO:0035303),-0.3634961202803275,-1.0025094937721866,0.4593406593406593,0.8153306385431403,1.0,8/15,22.56%,MTMR2;SMG7;SMG6;SMG5;MTMR1;CDK5RAP3;PPP1R17;MTMR3
prerank,aggrephagy (GO:0035973),-0.3122790811117663,-1.0021252121564668,0.4663677130044843,0.8154667433205627,1.0,5/27,7.58%,DYNC1I2;VIM;ACBD5;UBE2N;PRKN
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.28894280498614283,1.0019087226400265,0.464041095890411,0.8321087297186021,1.0,13/46,19.55%,IL18;AIF1;IGFBP3;PDGFB;IL12B;IL6R;PDGFRB;NDRG4;AKT1;VIP;TRIB1;THBS1;XRCC6
prerank,digestive tract development (GO:0048565),0.31699454366554947,1.0017639569033663,0.444636678200692,0.8318358304156881,1.0,6/32,14.72%,SALL1;NPY;CHD8;PKDCC;CCDC40;SMO
prerank,regulation of inflammatory response (GO:0050727),0.23562481088106646,1.001437307868287,0.44511278195488724,0.8320489198924605,1.0,42/190,20.14%,IL18;TLR7;SIRPA;DAGLB;ETS1;IL1RL2;SBNO2;OTULIN;PPARD;TLR4;GPS2;PRKCD;CCL3;CASP1;LRRC19;TRADD;PIK3AP1;DHX9;NLRP3;SELE;BCL6B;IL12B;GPER1;DDT;AREL1;TNFAIP8L2;SERPINE1;IL33;NLRP6;CXCL17;OSM;XIAP;AKNA;GPR4;AGT;MAPK7;GATA3;SETD4;DAGLA;NOD2;TNIP1;VPS35
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.36174208821267295,1.0006270790706395,0.45993031358885017,0.8336314873681975,1.0,5/18,12.81%,SRC;CTR9;IL6ST;IL6R;PTPN11
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.37162486172545584,1.0005191382832512,0.447841726618705,0.8332434467291927,1.0,4/16,11.23%,AGER;CYRIB;IL12B;CEACAM1
prerank,phospholipid transport (GO:0015914),-0.27177917297554405,-1.000197230728572,0.4835443037974684,0.820276969237107,1.0,13/52,15.82%,ATP8B4;LDLR;PLTP;APOE;ATP11A;ATP11C;MFSD2A;OSBPL8;ATP9B;ABCA4;ATP10B;ATP8B2;ABCC1
prerank,response to tumor necrosis factor (GO:0034612),0.26074284074865023,0.9998230767051307,0.4287949921752739,0.8345148877177301,1.0,19/91,14.87%,ARHGEF2;NFE2L2;NPNT;CCL3;MAP4K3;TNFRSF21;TRADD;DHX9;ZFP36L1;ZFP36L2;SELE;GPER1;INPP5K;BRCA1;ASAH1;BAG4;PYCARD;AKT1;CIB1
prerank,negative regulation of catabolic process (GO:0009895),0.29215880940484884,0.9995391673367895,0.4537521815008726,0.8346627448018102,1.0,8/47,13.32%,PDE3B;CST3;SIRT2;MDM4;BSCL2;ZDHHC7;AGAP2;PIN1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.3794144364696731,-0.9993439811322008,0.44967880085653106,0.8217830413930275,1.0,9/14,37.39%,TNKS2;XRCC5;TERT;NABP2;BRCA2;ATR;TINF2;TERF2IP;PINX1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.2742194784562882,0.9992294187981703,0.4449760765550239,0.8348564067318929,1.0,29/73,26.06%,ARHGEF2;LGALS9;AGER;TLR4;PLCG2;CLU;CCL3;DHX9;CD86;IL12B;ORM2;DDT;HAVCR2;IL33;PTPN11;MAVS;PYCARD;PTPRJ;SETD4;THBS1;NOD2;IL1A;TWIST1;TYROBP;PTPRC;FADD;FZD5;STAT3;MIF
prerank,regulation of lipid catabolic process (GO:0050994),0.3579293428014334,0.9991085575604477,0.48194945848375453,0.8345035718174926,1.0,1/19,0.09%,PDE3B
prerank,myotube cell development (GO:0014904),0.4276392985290771,0.998734745126096,0.4602888086642599,0.8348843451616177,1.0,2/10,8.04%,SKI;KLHL40
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.29494404513574324,-0.9986562016237068,0.45260663507109006,0.8228824636825876,1.0,8/34,13.82%,PTPRT;PTPN22;PTPN12;TNS2;PTPN2;DUSP10;DUSP16;PTPN13
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.3228401160950836,0.9977933773170363,0.45936395759717313,0.8369521997492738,1.0,3/25,3.59%,OPHN1;CSNK2A2;CSNK2A1
prerank,neutrophil activation involved in immune response (GO:0002283),-0.1983149088048964,-0.9976957591237561,0.41015625,0.8247151011702186,1.0,78/428,15.01%,IQGAP2;ATP8B4;IQGAP1;ARMC8;LRRC7;ADGRE5;PTPRN2;CYBB;ACTR10;AMPD3;CD44;CD47;CD36;LILRB3;FTL;CD93;GSN;CYSTM1;CLEC12A;MME;AP2A2;HGSNAT;B2M;CTSC;PSMD14;VAPA;CCT2;STOM;RAB6A;ITGAL;PPIA;PLAC8;ATP6AP2;S100A11;MGST1;ALOX5;RAB5C;ATP11A;SDCBP;KCNAB2;SNAP25;PSMA2;CNN2;CFP;PSMD6;RAB3D;TBC1D10C;CAMP;FRK;ANO6;RAB3A;SLC44A2;ATG7;GPI;CYBA;DNAJC3;OLR1;ANPEP;PTAFR;TRAPPC1;ARPC5;AP1M1;APRT;PSMD12;RNASE3;GYG1;LAMP1;MMP8;GLA;ALDOC;MCEMP1;PECAM1;PSMD11;MANBA;HSPA1B;HSPA8;ANXA2;IGF2R
prerank,response to molecule of bacterial origin (GO:0002237),0.27386396518494566,0.9975122745765727,0.434991974317817,0.8370540858483959,1.0,10/69,8.92%,LGALS9;SIRT2;CYRIB;TLR4;OTUD5;SLPI;SELE;NOS2;SELP;TAB2
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.24566444843707344,-0.9973623977083326,0.46835443037974683,0.8247532113205102,1.0,21/87,15.84%,PSMD14;PSMD8;PKD2;PSMA2;PSMF1;PSMD6;CDC73;PSME2;PSMD5;E2F7;KLF4;PSMD12;RGCC;DCUN1D3;CDKN2A;PSMD11;CDKN1A;GPR132;MYO16;PSMD1;RBL1
prerank,muscle cell migration (GO:0014812),-0.4118452787801465,-0.9972196081298261,0.47649572649572647,0.8242283727996506,1.0,6/10,31.03%,ITGB1BP1;PLAT;CCN3;DDR1;ROCK1;THBS4
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.41730887466410926,-0.9969322150553099,0.47568710359408034,0.8241060108117383,1.0,3/10,9.79%,IQSEC1;FGF10;FGF7
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.3087309289241965,-0.996505541076661,0.4533029612756264,0.8243590456493793,1.0,8/28,18.66%,KDM4D;ERCC6;WRAP53;PARP3;CYREN;SHLD3;RIF1;SETMAR
prerank,negative regulation of mRNA processing (GO:0050686),0.3825501555665739,0.9964918898149046,0.46126126126126127,0.8392432771925324,1.0,7/15,26.44%,U2AF2;SFSWAP;C1QBP;RBMX;SRSF9;PCBP4;SRSF10
prerank,heterochromatin organization (GO:0070828),-0.37586118713596905,-0.9963921220665072,0.4606986899563319,0.8237439367358838,1.0,4/14,12.92%,SIRT1;PRDM16;BAHD1;SETDB2
prerank,cation transport (GO:0006812),0.2377566055122886,0.9955547205980038,0.47604790419161674,0.8412786644456786,1.0,22/167,8.88%,FGF13;SLC7A8;KCNA5;KCNMA1;SLC36A1;KCNK6;TRPM4;TRPM2;MCOLN1;KCNH4;KCNN1;CNGB3;TRPM6;NDFIP2;SLC8A1;SCN4B;ABCC9;KCNG2;SLC22A2;SLC29A4;ATP1A4;KCNS2
prerank,ribonucleoprotein complex assembly (GO:0022618),0.24269379852142917,0.9954697608120072,0.4691358024691358,0.8408120616895491,1.0,33/132,21.52%,NCBP1;SF3B1;SNRPC;POLR2D;COIL;SART3;CELF2;SNRPF;DHX9;EIF4H;BOP1;SRSF5;SMN1;GEMIN6;RPL10;NLE1;SNUPN;TGS1;RPS27L;LUC7L3;DDX20;EIF2S2;MRPS11;BRIX1;LUC7L;EIF2D;EIF5;GEMIN2;DHX29;TRAF7;SRSF9;SHQ1;DDX39B
prerank,cellular response to interleukin-15 (GO:0071350),-0.39070637870515185,-0.9950808531948947,0.46405228758169936,0.8257276398835308,1.0,2/13,11.77%,PLCB1;IL2RB
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.39070637870515185,-0.9950808531948947,0.46405228758169936,0.8257276398835308,1.0,2/13,11.77%,PLCB1;IL2RB
prerank,catecholamine biosynthetic process (GO:0042423),-0.40547052440621933,-0.9950697093046953,0.45161290322580644,0.824801933798727,1.0,3/11,18.07%,DAO;SNCA;MOXD1
prerank,cellular response to peptide (GO:1901653),-0.26448421791058185,-0.9948589018272878,0.4578005115089514,0.824448885435183,1.0,8/56,5.38%,ITGA4;GRM5;CD36;GRIN2A;APP;PTPN22;VIM;GSK3B
prerank,vesicle organization (GO:0016050),0.29685375148958176,0.994679873641011,0.4567901234567901,0.8423751750465827,1.0,21/46,30.15%,HOOK2;PHETA1;USP8;SORT1;AKTIP;CD34;SAR1A;LAPTM4B;WASL;ZFYVE16;USP50;WASHC4;HOOK3;EXOC8;DNAJC13;SNX33;VPS18;SNX11;SRGN;SQSTM1;ARFGEF2
prerank,protein localization to organelle (GO:0033365),-0.2274014504735527,-0.9946431737642031,0.46647230320699706,0.8241243684986691,1.0,22/133,14.08%,ANK2;CNTLN;LRRK2;BICD1;APP;WDR35;YWHAE;LMNA;UBE2J2;VAPA;EHD1;RAB6A;XPA;TOR1A;MTCH2;PAQR3;GBP2;LAMP1;ALDH3A2;OBSL1;HMOX1;COL1A1
prerank,neutral amino acid transport (GO:0015804),0.3249262258389709,0.9946088297983497,0.4720720720720721,0.841875425926491,1.0,3/28,2.37%,SLC7A8;SLC7A5;SLC36A1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.39719383514897155,-0.9945718916198443,0.4703196347031963,0.8224024179511572,1.0,2/11,6.54%,CALM1;PKD2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.39719383514897155,-0.9945718916198443,0.4703196347031963,0.8224024179511572,1.0,2/11,6.54%,CALM1;PKD2
prerank,histone ubiquitination (GO:0016574),0.345325659079542,0.9941280749516495,0.4626334519572954,0.8425445033137904,1.0,6/21,16.91%,CTR9;RNF8;RNF20;UBE2U;DTX3L;UBE2A
prerank,cellular glucose homeostasis (GO:0001678),0.3054741994142239,0.994064752319272,0.47676419965576594,0.8420124779182337,1.0,14/41,22.85%,HK2;PIK3R1;PRKACA;IGF1R;FOXK2;GPER1;PAX2;TRA2B;LRRC8A;CARTPT;LRRC8D;PCK2;KCNB1;HK3
prerank,protein K63-linked deubiquitination (GO:0070536),0.3178328645317367,0.9938433651698025,0.4490161001788909,0.8419643108179764,1.0,7/31,13.05%,USP8;OTUD5;ZRANB1;USP25;STAMBPL1;OTUB2;ABRAXAS1
prerank,bile acid and bile salt transport (GO:0015721),0.3296927355636355,0.9937896456018744,0.4608208955223881,0.8414294147229817,1.0,1/24,0.06%,SLCO2B1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.3662067259115629,0.9935604687972999,0.46935201401050786,0.8414441858267323,1.0,9/18,28.14%,PSENEN;CLN3;PSEN2;LDLRAP1;ADAM10;APH1B;ADAM17;TMCC2;APH1A
prerank,regulation of cell growth (GO:0001558),0.22982638568033895,0.993457119373929,0.44525547445255476,0.841026829194401,1.0,37/204,14.89%,TGFBR1;SMAD3;NCBP1;RPS6KA1;PPP1R9B;ITCH;CCDC85B;OSGIN2;LTBP4;CSNK2A1;AGTR2;FLCN;EIF4G1;ATAD3A;SIPA1;NDUFS3;PPT1;LAMTOR2;APBB2;RPTOR;PAPPA2;SOX17;NME6;MTOR;PRDM11;CEACAM1;SMARCA2;CDK11B;OSGIN1;TAOK2;GJA1;TSPYL2;AKT1;NDUFA13;DACT3;CIB1;HPN
prerank,positive regulation of developmental process (GO:0051094),-0.2200522803561422,-0.9932037091716388,0.48295454545454547,0.8253384921941604,1.0,36/164,17.43%,NRXN1;NLGN1;ZBTB16;PLCB1;B4GALT5;MCU;SOX5;LMNA;CPEB3;GRIP1;APOE;SHANK3;DNM1L;CEBPB;RTN4;DDHD1;PRKN;SIRT1;ALK;FIS1;MFF;MAP3K13;ENPP2;ZDHHC15;RALBP1;SCX;ESRRB;DAG1;RELN;SHLD3;SRF;CORO1B;NIBAN2;RIF1;BMP4;TFRC
prerank,muscle organ development (GO:0007517),0.2784251266098268,0.9930653774130116,0.4513422818791946,0.8414803885149688,1.0,10/54,10.31%,LARGE1;CAPN3;MEF2C;MEF2D;SGCE;EGR3;TRIM72;CTF1;ANKRD2;MEF2A
prerank,ureteric bud development (GO:0001657),0.36523650515643535,0.9929932163187825,0.44090056285178236,0.8410325698203234,1.0,2/17,2.97%,SALL1;NPNT
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.3006967320738612,0.9927258744585814,0.4565972222222222,0.8410862678867014,1.0,10/37,22.30%,NCBP1;ENTPD1;NUDT15;RNASE6;ENTPD7;ISG20;NUDT16;SND1;RNASEH1;ENTPD6
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.3903334118034516,-0.9926470662712029,0.4671201814058957,0.826040781985407,1.0,3/12,7.21%,LRRK2;ATP6AP2;TMEM165
prerank,ether lipid metabolic process (GO:0046485),0.38658887297849887,0.9922492763472959,0.4635514018691589,0.8417645102419274,1.0,3/14,5.28%,AGMO;TMEM86B;PLA2G6
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.28003150063863064,0.9914573038546324,0.46779661016949153,0.84339628653499,1.0,14/59,23.32%,LIPC;LIPH;CH25H;OSBPL3;CYP46A1;AKR1D1;CYP7B1;HSD17B10;GAMT;OSBP;SDS;PARK7;ACOT8;SCP2
prerank,regulation of phospholipase C activity (GO:1900274),-0.37012771126254707,-0.9912726335502826,0.48903508771929827,0.8291500376881259,1.0,3/15,12.19%,BICD1;NTRK3;KIT
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.3237639019957472,-0.9910615485759242,0.452914798206278,0.8287706161999642,1.0,9/22,29.83%,LRRK2;TAFA1;SLC16A2;SHCBP1;DLL4;NES;ID2;TOX;RASSF10
prerank,regulation of cellular pH (GO:0030641),0.3231547653518808,0.9909486145503819,0.47750865051903113,0.8441453040016349,1.0,9/29,24.65%,SLC9A9;SLC9A8;ATP1A4;CLN3;SLC4A4;SLC4A5;SLC4A3;SLC26A6;SLC9A3
prerank,regulation of protein transport (GO:0051223),-0.31515074472329513,-0.9909029269985948,0.5069444444444444,0.828269985049012,1.0,8/27,15.68%,STXBP5L;DISP1;STXBP5;SCFD1;P3H1;NDFIP1;HSPA8;SNX12
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.35921218628859275,-0.9905420149742692,0.45493562231759654,0.8284263289796936,1.0,6/17,16.13%,CD74;CD44;PRKN;SIRT1;MDM2;SNAI2
prerank,inner dynein arm assembly (GO:0036159),-0.42130300098084916,-0.9904825881117063,0.4591194968553459,0.8276573005097062,1.0,5/10,22.28%,DNAAF5;DNAI3;DNAAF1;CCDC39;CFAP100
prerank,regulation of protein catabolic process (GO:0042176),-0.23690770940588918,-0.9904715419808738,0.4650537634408602,0.8267475407675396,1.0,28/99,19.04%,EGFR;WWP1;HECW2;HECW1;APC2;FAF1;NEDD4L;GSK3B;BARD1;PRKN;AXIN1;PLK2;ATG7;GPC3;EEF1A2;FAM83D;HMGCR;TIPARP;NKD1;TNFSF12;OAZ1;RILP;SNX12;MDM2;FOXO1;AZIN1;IRAK3;DTL
prerank,positive regulation of cell population proliferation (GO:0008284),0.2131861065745451,0.9900405500667089,0.49732620320855614,0.8460095028832106,1.0,74/423,16.93%,TGFBR1;TMEM119;IL18;TGFBR2;MLXIPL;LRP5;CSF1R;GREM1;FAM98B;MEF2C;AIF1;SOX8;GAB2;KMT2D;LYN;MAP3K3;TBC1D8;CSNK2A1;ITGAV;IGF1R;TRPM4;PKHD1;MEIS3;PTK2B;LGMN;NDUFS4;IL6ST;DHX9;CD86;SHH;PDGFB;GCNT2;TCIRG1;S1PR3;CNBP;EDN3;CNTF;EDN2;GDNF;GPER1;CTF1;IL6R;ACER3;ACER2;TJP1;PRMT1;RTKN2;IL12RB2;PAX2;DLL1;TBX6;PDGFRB;DDR2;DHPS;STX4;GJA1;RNF187;IL34;EZH2;HTR1A;AKT1;CIB1;CSF1;VIP;PROX1;SLAMF1;PDCD10;OSM;TSPAN31;LAMC2;CCAR1;ADAM10;UBE2A;AGT
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.4119232522756231,0.9899377163329482,0.4720720720720721,0.8449368449212619,1.0,3/10,15.84%,MPG;MGMT;ALKBH5
prerank,DNA dealkylation (GO:0035510),0.4119232522756231,0.9899377163329482,0.4720720720720721,0.8449368449212619,1.0,3/10,15.84%,MPG;MGMT;ALKBH5
prerank,positive regulation of DNA recombination (GO:0045911),0.3248137716738013,0.9896787064637876,0.4595959595959596,0.8449879043007524,1.0,6/27,12.90%,FUS;WDR48;ERCC2;MMS19;KMT5C;SHLD2
prerank,positive regulation of binding (GO:0051099),-0.24146294449768718,-0.9892093410842822,0.47435897435897434,0.8295588565498515,1.0,23/84,19.57%,LRRK2;PPARG;KDM4D;APP;B2M;RAPGEF2;MARK3;APOE;GSK3B;HIPK2;RAN;PRKN;RARA;EPB41;MMP8;PKD1;TIAM1;ADD2;BMP4;CLN5;FOXC1;USP33;TERT
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.3637968388657009,0.9891789957623579,0.4633699633699634,0.8457292543688736,1.0,13/16,38.06%,NAA11;NAA25;NAA50;NAA20;NAA40;NAA60;KAT2B;NAA10;EP300;CREBBP;NAA80;AANAT;NAA35
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.27658199098497216,0.9888238689117118,0.49642857142857144,0.8460698612647645,1.0,16/60,20.45%,SMOC2;GREM1;PCNA;RFC2;ATM;PDGFB;CHTF18;PDGFRB;NEK7;CCT3;NVL;POLG2;CCT8;ACD;FGFR4;DSCC1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.3240384584992185,0.9884760879511832,0.46785714285714286,0.8463807461444607,1.0,8/27,16.28%,CHST11;BGN;CHPF;CHPF2;CHST7;BCAN;CSPG5;CHSY1
prerank,mitochondrion localization (GO:0051646),0.3570450306948456,0.988225946941111,0.450261780104712,0.8463821716248289,1.0,5/19,13.74%,TRAK1;TLE6;MEF2A;MARK2;NECTIN2
prerank,regulation of protein kinase A signaling (GO:0010738),-0.3303528356172838,-0.9882232460454629,0.4646924829157175,0.8316125103213321,1.0,3/20,2.85%,AKAP6;LRRK2;IAPP
prerank,male meiosis I (GO:0007141),0.36857406112169844,0.9880588559199164,0.4767025089605735,0.8462005342907961,1.0,3/16,12.14%,FOXJ2;ZSCAN21;HSF2BP
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.3970656889192611,0.9880316403765514,0.4564393939393939,0.8455935027909347,1.0,3/13,8.73%,ETS1;ITGB2;FUT7
prerank,UV protection (GO:0009650),-0.41214807336976617,-0.987944263971471,0.4838709677419355,0.831472522897071,1.0,5/10,22.09%,XPA;MFAP4;CAT;FEN1;SCARA3
prerank,regulation of tumor necrosis factor production (GO:0032680),0.25092514504825586,0.9879020147156573,0.472809667673716,0.8453072899361846,1.0,21/112,14.63%,CX3CR1;SIRPA;ARHGEF2;LGALS9;VSIR;AGER;TLR4;PLCG2;CLU;CCL3;DHX9;IL12B;ORM2;DDT;CD34;HAVCR2;IL33;PTPN11;CD33;MAVS;PYCARD
prerank,extracellular matrix assembly (GO:0085029),-0.3229510284811573,-0.9875906289021932,0.47157894736842104,0.8315805244415497,1.0,15/23,41.98%,ATP7A;LAMB2;NTNG1;NTNG2;MFAP4;NTN4;TNXB;LAMB3;QSOX1;HAS1;EMILIN1;HAS2;RAMP2;MYH11;EFEMP2
prerank,regulation of brown fat cell differentiation (GO:0090335),0.36840998915959944,0.9875422054589147,0.4746376811594203,0.8456714914309984,1.0,3/16,4.59%,RREB1;FLCN;TFE3
prerank,positive regulation of calcium ion transport (GO:0051928),-0.285816131827344,-0.9874463173754265,0.4575,0.8310670805952485,1.0,8/36,13.89%,ANK2;ATP2B1;CCR1;STIM2;TRPC3;FFAR1;LILRA5;CCL5
prerank,regulation of protein acetylation (GO:1901983),0.4030182662742442,0.9874401910262867,0.4896030245746692,0.845263753545623,1.0,6/12,22.68%,CEP295;RAPGEF3;KAT5;CAMK1;DDX3X;PARK7
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.23584187245019425,0.9871907345232843,0.4946070878274268,0.8452768451539138,1.0,43/163,21.59%,PAG1;INPP5D;BLNK;FYB1;MEF2C;PIK3R1;RIPK2;LAT2;FYB2;PLCG2;TNFRSF21;EIF2B3;LCP2;CSK;PDPK1;TAB2;PIK3CD;PSMD3;PIK3CB;RNF31;NCKAP1L;WNK1;EIF2B4;PRKCB;PSMB3;NFKBID;PSMA7;BMX;PSMC1;PSMC2;TEC;PSME4;PSMB9;GATA3;PTPRJ;KHDRBS1;PSMD4;PSMB5;CD79A;SH2B2;PSMB7;STOML2;ZC3H12A
prerank,regulation of stress fiber assembly (GO:0051492),0.2627418963018699,0.9871743445917947,0.49335548172757476,0.8446423597295046,1.0,13/74,13.69%,TGFBR1;F11R;RAC1;ASAP3;PIK3R1;ARHGAP28;MET;TJP1;INPP5K;FHOD1;RAPGEF3;SORBS3;ABL1
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.2274903844987695,-0.9869660150432071,0.5157894736842106,0.8315867841497971,1.0,27/124,16.84%,PLCB1;CCDC88C;PRICKLE2;AP2A2;PSMD14;GNAO1;AGO4;CALM1;CDC42;PSMD8;PSMA2;FRZB;PSMF1;PSMD6;WNT4;PSME2;TNRC6A;NLK;PSMD5;PSMD12;PSMD11;AP2B1;SFRP1;PSMD1;TIAM1;DAAM1;SFRP2
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.2588917180497322,-0.9869651676181377,0.47715736040609136,0.8306504245569596,1.0,21/57,26.95%,HTT;MCU;DNM1L;GSK3B;DDHD1;PRKN;ZNF205;FIS1;MFF;BAK1;FBXO7;RALBP1;BOK;CHCHD10;CIDEB;PPIF;HRK;PPARGC1A;ADCK1;BID;MMP9
prerank,glycoprotein metabolic process (GO:0009100),0.2830428182541764,0.9862329160868313,0.4774624373956594,0.8466102746537213,1.0,8/53,10.04%,LARGE1;MGAT4A;PRKCSH;MAN2B1;GAL3ST4;GANAB;MAN2A2;MAN1C1
prerank,positive regulation of ossification (GO:0045778),-0.28403500004360493,-0.9860295598922529,0.4699074074074074,0.8325564138480849,1.0,7/39,8.95%,ZBTB16;ATP2B1;SOX11;ALOX5;WNT4;ANO6;FBN2
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.3330985589762543,-0.9857511324250248,0.4630071599045346,0.8324087147295536,1.0,10/21,27.92%,CDC25C;RCC2;NPM1;CCNB1;CDK4;DTL;STOX1;ATAD5;CDC25B;MECP2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.2577552306641301,0.9855504420548288,0.47440273037542663,0.847904536904392,1.0,21/93,15.86%,PJA2;AGER;SEMA4C;TRAF5;CD27;PTK2B;MID1;ARL6IP5;CCR7;EDA2R;PRMT1;WNT7B;MAP4K2;TAOK2;MAP3K10;MAP3K11;MAPK8IP1;PYCARD;TNFRSF19;SLAMF1;PDCD10
prerank,regulation of organelle assembly (GO:1902115),0.26442377651196836,0.9853261926897781,0.4927536231884058,0.8478452500279217,1.0,9/72,6.09%,TBC1D16;SDCCAG8;TBC1D17;TBC1D9B;TBC1D10B;TBC1D8;TBC1D15;ATXN2L;DYNLT2B
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.3707618074387148,-0.9853007541853496,0.47835497835497837,0.8327988549619953,1.0,7/14,21.60%,ITGB1BP1;MEOX2;KLF4;STARD13;CARD10;MAP2K5;DLL4
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.3997233042098459,-0.9852756577833419,0.4682713347921225,0.8319422030437088,1.0,2/10,8.83%,STAP1;ANO6
prerank,response to iron ion (GO:0010039),-0.3958663808539479,-0.985160861606593,0.46956521739130436,0.8313513019159658,1.0,4/12,15.29%,B2M;TFR2;BCL2;SNCA
prerank,steroid hormone biosynthetic process (GO:0120178),0.31756397449360707,0.9848263839178624,0.47619047619047616,0.8486362413179327,1.0,5/29,15.51%,FDXR;HSD3B2;HSD17B1;TSPO;FDX1
prerank,regulation of cell motility (GO:2000145),-0.22625770717291685,-0.9844612077209935,0.509641873278237,0.8324746550247103,1.0,24/121,14.19%,FRMD5;EGFR;SPOCK3;FGF10;PLXNC1;SLK;LMNA;PLXND1;CADM4;PLXNA2;ERBB4;MGAT3;KIF14;LMO4;ERBB3;NRG2;PLXNB2;FGF7;FGF9;SRCIN1;RAF1;ENPP2;INPP5F;PLXNB1
prerank,regulation of spindle organization (GO:0090224),-0.3491571478933053,-0.9843503342115282,0.4831223628691983,0.8318780097826606,1.0,10/18,30.71%,TPX2;MAP9;GNAI1;GPSM2;PARP3;BORA;SENP6;FSD1;DYNC1H1;PSRC1
prerank,protein targeting to membrane (GO:0006612),-0.2445912694497397,-0.9840853019254168,0.48812664907651715,0.8317159005839408,1.0,23/83,20.78%,CHM;ATAD1;ZDHHC21;ACBD5;SDCBP;PEX12;GET3;SEC62;FIS1;ZDHHC23;AQP11;ZDHHC15;ALDH3A2;PARD3;ZDHHC18;SRP19;VPS37C;ZDHHC24;ATG3;PRKCI;PEX19;NACA;SSR2
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.3697939668279044,0.9840545688166015,0.4934823091247672,0.8501195873721615,1.0,5/15,18.02%,PRKCA;IL6ST;MEF2A;AGT;ROCK2
prerank,establishment of apical/basal cell polarity (GO:0035089),0.38526215440479367,0.9837255156827031,0.4814159292035398,0.8503693546621389,1.0,2/14,4.60%,OPHN1;FSCN1
prerank,regulation of viral genome replication (GO:0045069),-0.26445292760726136,-0.9836842629801213,0.4806763285024155,0.8318975263447708,1.0,23/56,26.51%,OAS2;RSAD2;IFITM3;PPIA;PABPC1;PPIH;RNASEL;IFITM2;OAS3;CCL5;BANF1;IFITM1;SRPK2;IFIH1;LTF;ZC3HAV1;PARP10;BST2;NR5A2;ADAR;OASL;PPARA;PLSCR1
prerank,regulation of phosphorylation (GO:0042325),-0.22600821198035198,-0.9836671820344696,0.4666666666666667,0.8310250528310708,1.0,25/120,14.88%,CCDC88C;GRM5;STAP1;EGFR;KDM4D;APP;PRKAG2;FN1;CADM4;NUP98;BARD1;SDCBP;SIRT1;PLXNB2;CCDC88A;NUP205;CDH5;NUP210;CDKN2A;NUP54;NUP43;CCL5;CDKN1A;FER;NUP155
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.2872730922997862,-0.9836422551602982,0.4792176039119804,0.8301717129077085,1.0,7/37,13.00%,BICD1;TPPP;STMN4;GSK3B;STMN2;SKA3;EFNA5
prerank,recombinational repair (GO:0000725),0.2613522897297843,0.9835982479742219,0.4869281045751634,0.8500349037500106,1.0,19/77,19.11%,ZFYVE26;RHNO1;RAD51AP2;NBN;RNF138;SPIDR;RAD54B;POLN;RAD51B;SWSAP1;SLX4;BRCA1;MORF4L1;ERCC4;BLM;AP5Z1;NABP1;FBH1;PALB2
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.3799445801350947,0.9834441711289506,0.479646017699115,0.8497931390294821,1.0,3/14,10.29%,FUS;WDR48;MMS19
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.25481908333571635,0.9831638124771576,0.48292682926829267,0.8498871871301197,1.0,25/94,21.92%,BAG6;FHIT;QRICH1;DDIT3;DDX5;CHEK2;ATM;PRKCD;PDK1;ARL6IP5;C1QBP;POU4F1;PDK2;BRCA1;APAF1;ABL1;PYCARD;HTRA2;PPM1F;CUL4A;EPHA2;PMAIP1;TOPORS;DDX3X;BCL2L1
prerank,regulation of endothelial cell proliferation (GO:0001936),0.25597622576938805,0.9830625367323316,0.5,0.8494923116938495,1.0,27/88,25.37%,TGFBR1;PTPRM;PRKCA;SPARC;VEGFB;EGR3;PDGFB;PIK3CD;APOH;PDCD6;ARNT;AKT1;VIP;PROX1;HMGB2;THBS1;CCL24;KRIT1;AGGF1;SYNJ2BP;BMP2;NRAS;ITGB3;AIMP1;HIF1A;ATP5IF1;SULF1
prerank,ncRNA catabolic process (GO:0034661),0.3235119134311919,0.982957563304567,0.4823321554770318,0.8491202279900507,1.0,11/28,25.83%,POP1;DIS3L2;EXOSC10;EXOSC5;DIS3;ZCCHC8;EXOSC8;NUDT16;SND1;RBM7;PARN
prerank,regulation of protein neddylation (GO:2000434),-0.4197689461459827,-0.9828218733802447,0.47863247863247865,0.8316117719343888,1.0,2/10,13.11%,DCUN1D2;DCUN1D3
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.32694186072400355,0.9824971993041777,0.5027522935779817,0.849777216409751,1.0,5/27,9.65%,LPIN2;PLA2G15;PLA2G6;PISD;CHKB
prerank,dermatan sulfate metabolic process (GO:0030205),-0.36797848506345354,-0.9823988471470817,0.47547974413646055,0.8319502291897475,1.0,4/13,11.75%,UST;DSE;VCAN;CSPG4
prerank,positive regulation of glucose import (GO:0046326),-0.3249235569457655,-0.982183597296726,0.5,0.831658532976893,1.0,3/21,3.46%,SORBS1;IRS1;CREBL2
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.3705827498328993,-0.9819173091899768,0.4681724845995893,0.8315022070320977,1.0,4/13,10.05%,NLRC4;GRIN2A;CYFIP2;BAK1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.42443164606080963,0.9819079438582606,0.49633699633699635,0.8507642390241478,1.0,4/10,26.92%,TLR4;IL33;NOD2;TLR9
prerank,phospholipid dephosphorylation (GO:0046839),-0.2851766482189321,-0.9816894933423063,0.48048780487804876,0.8312554460208166,1.0,14/37,22.56%,PLPP5;PLPPR4;PLPP4;MTMR2;PLPPR1;INPP5J;MTMR1;INPP5F;OCRL;PLPP3;PLPPR3;TPTE;SACM1L;MTMR3
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.30651466645432296,-0.9816562797836893,0.45813953488372094,0.8304267361914791,1.0,6/27,10.26%,PPARG;CD36;MSR1;PF4;NFKBIA;ABCA5
prerank,V(D)J recombination (GO:0033151),0.40764760612954165,0.9814106135037693,0.4896907216494845,0.8514983030573645,1.0,3/11,17.95%,LIG1;TCF3;HMGB2
prerank,selective autophagy (GO:0061912),0.2749064871679882,0.9807529311037091,0.48281786941580757,0.8526959393368697,1.0,13/56,17.41%,NBR1;ULK2;ATG14;ATM;PHB2;RPS27A;UBC;RB1CC1;AUP1;RETREG1;UBA5;ULK1;ATG5
prerank,protein monoubiquitination (GO:0006513),-0.2816493883253535,-0.9807269858888296,0.48009367681498827,0.8322469652248015,1.0,7/36,11.19%,CUL3;UBE2W;WAC;CDC73;PEX12;PRKN;RNF126
prerank,substantia nigra development (GO:0021762),0.3046892646503078,0.9806839972352187,0.48903878583473864,0.8522320403561282,1.0,8/37,12.63%,BASP1;YWHAH;SIRT2;SUDS3;PADI2;NDUFS3;CKB;RAD1
prerank,lipid phosphorylation (GO:0046834),-0.4093123231003548,-0.9798794879129656,0.4853273137697517,0.8337033682858837,1.0,3/10,12.01%,DGKB;DGKI;DGKH
prerank,double-strand break repair via homologous recombination (GO:0000724),0.2524236884251102,0.9797882721814671,0.4920886075949367,0.8541182942666394,1.0,33/95,27.93%,ZFYVE26;RAD51AP2;GINS4;NBN;RNF138;SPIDR;RAD54B;FANCM;POLN;MCM2;RAD51B;SWSAP1;SLX4;BRCA1;MORF4L1;ERCC4;BLM;AP5Z1;NABP1;FBH1;MCM3;PALB2;MCMDC2;RPA3;RFWD3;YY1;RAD51C;CDC7;MCM6;SWI5;HELQ;RPA1;RECQL
prerank,negative regulation of protein phosphorylation (GO:0001933),0.23659235767143508,0.9797079181387408,0.4961832061068702,0.8536621656556316,1.0,19/150,6.24%,LDLRAD4;SIRPA;MLXIPL;GREM1;SMAD7;PMEPA1;CNKSR3;IGFBP3;PYDC1;SIRT2;LYN;ATG14;PRKCD;EIF4G1;PRKRIP1;UBASH3B;IMPACT;SPRY2;PDPK1
prerank,dicarboxylic acid transport (GO:0006835),-0.30607112554512356,-0.9795344519762748,0.5044843049327354,0.8337349129451049,1.0,14/28,24.56%,SLC1A6;GIPC1;SLC13A3;SLC26A7;SLC46A1;SLC25A12;SLC25A18;SLC13A5;SLC1A1;ABCC2;SLC26A8;FOLR2;FOLR1;SLC25A32
prerank,negative regulation of cellular process (GO:0048523),0.20886094151837448,0.9793436864874205,0.5199468085106383,0.8540297100013166,1.0,111/521,20.86%,SRGAP2;PDE3B;SIRPA;CTTNBP2NL;SMAD3;SLURP1;ETS1;ATP8A2;PIM2;CD9;RND1;IGFBP3;SKI;INCA1;TGFB1I1;SIRT2;PPP1R9B;JAM2;CCDC85B;KLF11;LYN;VHL;OSGIN2;MYH9;ADAMTS1;RNF41;RHOB;PKHD1;CLU;AGTR2;FLCN;TNFRSF21;IMPACT;PTK2B;HPGD;MDM4;SIPA1;GNRH1;DIS3L2;KLK8;NDUFS3;PPT1;TAF6;SHH;APBB2;MIA3;PIWIL1;GPER1;SOX17;CXCL1;LPXN;INHA;CD34;P3H2;NME6;NOTCH4;PLPP1;PRDM11;TOB1;DLL1;SMARCA2;CLMN;CD33;OSGIN1;GJA1;SEMA4D;DRD2;ADGRG1;TMBIM6;TSPYL2;BLM;NDUFA13;DACT3;CIB1;PROX1;GPNMB;TENM1;MAP2K1;OSM;PLG;TMEM98;SNX3;VGLL4;ADAM10;KANK2;NUP62;ATG5;EIF2AK2;NME1;GATA3;CHMP1A;CD164;PTPRJ;NAIF1;HTRA2;NR1H2;NUDT6;CHMP2A;EIF2AK3;VPS13C;VPS35;PLXNA4;WNK2;NOS1;WDR6;PTPN14;EI24;SYT11;ADAM15;PLXNA3;SFRP4
prerank,response to glucocorticoid (GO:0051384),0.3299297097990377,0.9793207546426902,0.48,0.8534219755855597,1.0,4/26,8.49%,HSD3B2;ZFP36L1;ZFP36L2;CALCR
prerank,negative regulation of signal transduction (GO:0009968),0.22306439116286617,0.9788326808868492,0.5014084507042254,0.8540993839679466,1.0,59/249,19.16%,CX3CR1;IGFBP3;CNOT1;GPS2;LYN;SHISA2;PLEK;CSNK2A2;CSNK2A1;PRKCD;AGTR2;UBASH3B;NFATC1;CTNNBIP1;ULK3;LGMN;SPRY2;TAX1BP3;ARRDC1;PTPRE;GATA2;IL12B;MDFI;GPR108;SLC27A4;APPL1;INPP5K;PIK3CB;LRP1;LEPROT;RGS14;PRKCB;DLL1;PTPN1;PDCD6;NDRG4;DRD2;WWP2;MOSMO;EZH2;TMBIM6;AKT1;KCTD6;DACT3;NOTCH3;NOG;SLAMF1;CBLN1;VGLL4;QARS1;AGT;KANK2;TRIB1;ARRB1;GATA3;DKK3;PTPRJ;THBS1;MGRN1
prerank,COPII vesicle coating (GO:0048208),-0.25263351269600065,-0.9788033123323587,0.4767726161369193,0.8331105945769209,1.0,14/61,14.86%,GRIA1;CUL3;CTSC;GOSR2;SEC23A;RAB1B;SCFD1;SAR1B;PPP6C;TRAPPC1;SEC24D;TMED2;LMAN1;SEC24B
prerank,vesicle coating (GO:0006901),-0.25263351269600065,-0.9788033123323587,0.4767726161369193,0.8331105945769209,1.0,14/61,14.86%,GRIA1;CUL3;CTSC;GOSR2;SEC23A;RAB1B;SCFD1;SAR1B;PPP6C;TRAPPC1;SEC24D;TMED2;LMAN1;SEC24B
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.25263351269600065,-0.9788033123323587,0.4767726161369193,0.8331105945769209,1.0,14/61,14.86%,GRIA1;CUL3;CTSC;GOSR2;SEC23A;RAB1B;SCFD1;SAR1B;PPP6C;TRAPPC1;SEC24D;TMED2;LMAN1;SEC24B
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.3494537908569133,-0.9785825778624754,0.4857142857142857,0.8327975433247431,1.0,3/17,5.76%,STAP1;NTRK3;CDC42
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.23183900827871612,-0.9779782529439968,0.5300261096605744,0.8336526104762301,1.0,14/101,8.17%,ROBO1;LRRK2;EGFR;CD40;RAPGEF2;PDGFD;CCND2;CALM1;HTR2B;CCNYL1;PKD2;TPD52L1;SIRT1;IRGM
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.22330498435502044,-0.9779262274291954,0.5102040816326531,0.832872770417048,1.0,25/121,13.89%,NEDD9;CD74;BANK1;GRM5;CD44;FGF10;CD40;JAK2;DLG3;PARP14;ERBB4;ERBB3;FGF7;FGFR3;UNC119;SRCIN1;CSPG4;KIT;CD80;LILRA5;ENPP2;CLEC6A;EFNA5;PECAM1;CCL5
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.3208562322411958,0.9777796667669988,0.4708097928436911,0.8565031541211711,1.0,7/27,15.90%,RPS27A;UBC;MAP3K8;TAOK2;MAPK8;TNIP2;CCM2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.2749957732791119,0.9775067808932378,0.5159128978224455,0.8566258224289727,1.0,18/58,19.83%,HERC2;SUMO1;IFFO1;ATM;NBN;RNF8;BRCA1;DCLRE1B;ERCC4;UBE2V2;ABRAXAS1;DCLRE1C;KAT5;HMGB2;BABAM1;DCLRE1A;XRCC6;KDM2A
prerank,circulatory system development (GO:0072359),0.2432157073684395,0.9773661904137622,0.49921011058451814,0.8563412892402813,1.0,16/118,10.31%,TGFBR1;ADAP2;SALL1;TGFBR2;MEF2C;CXADR;BCOR;SHH;PDGFB;SOX17;UTY;POU4F1;TAB2;AKAP13;NOTCH4;MEF2A
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.34220325067981305,-0.9772270563065852,0.5,0.834018149584157,1.0,3/18,3.66%,USP15;ANKRD17;DDX60
prerank,regulation of interleukin-12 production (GO:0032655),0.28383935253449244,0.9768104621150198,0.4873524451939292,0.8571879729439201,1.0,8/47,8.25%,LGALS9;RIPK2;AGER;TLR4;PLCG2;C1QBP;CCR7;IL12B
prerank,peptidyl-lysine dimethylation (GO:0018027),0.35335558482694096,0.9765759036757349,0.5185840707964602,0.857205178339147,1.0,9/18,22.54%,KMT2D;ASH1L;EHMT2;SETD2;SETD4;PRDM9;SETD7;SETD3;KMT2B
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.22680933169788917,-0.9765575212596183,0.5126050420168067,0.8349133326184721,1.0,16/122,7.91%,SORBS1;SAMD4A;EGFR;TMEM106A;CIITA;IRS1;EIF3C;VIM;FAF1;CPEB3;JAK2;EIF3E;RPL26;SIRT1;EIF4A3;PRR16
prerank,microvillus assembly (GO:0030033),-0.3656111089565874,-0.9765354377530346,0.4813953488372093,0.8340662407594159,1.0,3/14,4.72%,RAPGEF2;FXYD5;STK26
prerank,regulation of phosphate metabolic process (GO:0019220),-0.34768712351920533,-0.9763604573474544,0.4624413145539906,0.8336584970493409,1.0,5/16,11.10%,BARD1;SMG7;SMG6;SMG5;TIGAR
prerank,protein methylation (GO:0006479),0.2940582699664873,0.9762865754768449,0.47909407665505227,0.8573471693127416,1.0,9/40,14.26%,FAM98B;PRMT2;ETF1;EEF2KMT;PRMT8;PRMT1;EHMT2;PRMT6;EZH2
prerank,renal system development (GO:0072001),0.27894203376109716,0.9759966955326101,0.4911660777385159,0.857496225362603,1.0,3/52,0.46%,TGFBR1;SALL1;BAG6
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.3381333245986173,0.9758082686994333,0.47442680776014107,0.8573658738829176,1.0,11/23,26.21%,HSPA4;TIMM8B;BMF;TIMM29;NDUFA13;TIMM10B;MAIP1;PMAIP1;BCL2L11;TIMM13;SAMM50
prerank,lipid transport (GO:0006869),0.24951753420955256,0.9753790752121616,0.4845528455284553,0.8578696397402545,1.0,25/97,25.03%,SLCO2B1;ABCD2;ABCA9;PCTP;PITPNC1;PPARD;CPTP;NME4;SLC27A4;CLN3;CEACAM1;NPC2;OSBPL5;PITPNM1;MFSD2B;SCARB1;OSBP;MTTP;ATP8A1;SCP2;ABCD1;PRELID2;SLCO1B1;PITPNB;PEX3
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.39650280337387334,0.9750319284180275,0.48828125,0.8582029500332544,1.0,1/11,1.04%,SMAD7
prerank,cellular response to fluid shear stress (GO:0071498),-0.37639103126946494,-0.9749653587203541,0.5130434782608696,0.8368097566378718,1.0,4/12,11.49%,MTSS1;KLF2;PKD2;KLF4
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.28627472983586594,0.9749125139599208,0.504424778761062,0.8578487306461661,1.0,14/44,21.59%,CNOT1;MOV10;ZFP36L1;ZFP36L2;NANOS2;RBM24;TOB1;METTL14;RIDA;ROCK2;TNRC6C;NANOS1;TNRC6B;ZC3H12A
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3451990384052961,-0.9747675338900796,0.4801762114537445,0.8364513273890818,1.0,2/17,5.23%,MAGI2;CALM1
prerank,visual perception (GO:0007601),0.2571459382332882,0.9743548272189377,0.5260586319218241,0.8587792706294539,1.0,21/84,23.02%,CRYBB1;EFEMP1;PAX6;RP2;TULP2;MYO7A;RD3;EYA3;DRAM2;RABGGTA;PAX2;BBS2;REEP6;COL11A1;ATXN7;CRYBA1;OPA3;OPA1;CACNA2D4;OAT;EYA4
prerank,myeloid cell development (GO:0061515),-0.3393736809090043,-0.9739091433648612,0.46320346320346323,0.8379385629758977,1.0,5/18,14.77%,APP;FOXP1;NRROS;KIT;ANXA2
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.24161136030741887,0.9737673471282136,0.4968847352024922,0.8597615511571187,1.0,32/113,24.68%,TGFBR1;RREB1;CRNN;PRKCA;PKHD1;VEGFB;EGR3;PDGFB;PIK3CD;PAX2;PDCD6;ARNT;AKT1;HPN;VIP;PROX1;CDH3;NME1;HMGB2;CLDN1;C5AR1;CCL24;AGGF1;NOD2;BMP2;STXBP4;NRAS;FGFR2;SOX9;ITGB3;FGF1;HIF1A
prerank,tRNA modification (GO:0006400),0.2727440088664113,0.9736141740353502,0.5016666666666667,0.8595293642846739,1.0,27/62,29.76%,QTRT1;SSB;TRMT6;AARS2;ANKRD16;THUMPD1;CTU2;NSUN6;METTL6;BCDIN3D;CDKAL1;MTO1;TYW5;QTRT2;TRMT61A;OSGEP;WDR6;THUMPD3;TRDMT1;FTSJ1;MOCS3;ALKBH8;TRMT9B;PUS7;TRUB1;METTL2A;METTL2B
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.3265262063549667,0.973316631239403,0.4929078014184397,0.859711191661134,1.0,5/25,8.49%,CAPN3;CACNB2;PDPK1;GPER1;CALCR
prerank,neutrophil migration (GO:1990266),0.27703996566967914,0.9729530384720528,0.5008403361344538,0.8600543670912001,1.0,9/58,10.24%,CXADR;ITGB2;PIK3CG;CCL3;EDN3;EDN2;CXCL1;PIK3CD;NCKAP1L
prerank,brain development (GO:0007420),-0.22213836290316855,-0.9728148062032309,0.5119363395225465,0.8401052592316366,1.0,22/136,11.28%,CNTNAP2;CTNNA2;NFIB;ADGRL3;GRIN2A;GRIN2B;POMK;CENPF;RAPGEF2;SHANK3;VPS51;COL4A1;CDK5RAP2;EML1;PBX1;HSPG2;GRIN2D;PBX3;PLXNB2;ZFHX2;DDIT4;MFSD2A
prerank,maturation of LSU-rRNA (GO:0000470),-0.30905166824060026,-0.9727879411326426,0.4750593824228028,0.8392883808427983,1.0,4/26,5.83%,NSA2;SNU13;RPL7A;LAS1L
prerank,anion transport (GO:0006820),0.3016950679818502,0.972656349678059,0.4918625678119349,0.860196932153116,1.0,9/33,21.65%,SLCO2B1;SLC22A6;SLC17A8;LRRC8A;TSPO;VDAC1;SLC19A1;LRRC8D;VDAC2
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.2699852690299081,0.9725568097708754,0.5,0.8598093703183988,1.0,28/69,26.06%,ARHGEF2;LGALS9;AGER;TLR4;PLCG2;CLU;CCL3;DHX9;IL12B;ORM2;DDT;HAVCR2;IL33;PTPN11;MAVS;PYCARD;PTPRJ;SETD4;THBS1;NOD2;IL1A;TWIST1;TYROBP;PTPRC;FADD;FZD5;STAT3;MIF
prerank,regulation of response to stress (GO:0080134),-0.4015766170815448,-0.9725374287345718,0.5020408163265306,0.8390761341610242,1.0,4/10,19.71%,OPRM1;ADCY8;CRHBP;STOX1
prerank,protein modification process (GO:0036211),0.2627985219890777,0.9724627799721915,0.5169628432956381,0.8594167968144902,1.0,21/76,20.56%,ST3GAL6;CDKL3;MAN2B1;FBXO22;UBA7;USP25;CDC34;CPE;ARAF;RABGGTA;FBXL2;SLC35A1;PPP4R2;ABL1;WWP2;FBXO11;ADPRH;PHKA2;TGM5;DUSP12;PARP4
prerank,regulation of stem cell differentiation (GO:2000736),0.25401857022737584,0.9724614867394182,0.5296,0.8587522789010222,1.0,26/89,23.38%,NELFB;ITCH;ZFP36L2;GATA2;GDNF;RBM24;PSMD3;PSMB3;RUNX1;PSMA7;ABL1;PSMC1;PSMC2;TAL1;TCF3;PSME4;OSM;PSMB9;EIF2AK2;GATA3;LMO1;PSMD4;PSMB5;PSMB7;LMO2;PSMB8
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.3284952928383219,0.9723613471472692,0.5,0.8583611390456936,1.0,7/26,16.79%,TLR4;CCL3;GPR55;INHA;CEACAM1;GPR137;CARTPT
prerank,regulation of protein modification process (GO:0031399),-0.2652807097420874,-0.9723070669116246,0.49476439790575916,0.8388393001490392,1.0,12/50,14.57%,CCDC88C;GRM5;KDM4D;FN1;CADM4;ATG7;PLXNB2;CCDC88A;CCAR2;CDH5;FKTN;FER
prerank,contractile actin filament bundle assembly (GO:0030038),0.36900338649371817,0.9720299107471685,0.49725776965265084,0.8579981608768381,1.0,6/15,17.76%,ITGB5;SRC;ZYX;PDCD10;ARRB1;TNFAIP1
prerank,stress fiber assembly (GO:0043149),0.36900338649371817,0.9720299107471685,0.49725776965265084,0.8579981608768381,1.0,6/15,17.76%,ITGB5;SRC;ZYX;PDCD10;ARRB1;TNFAIP1
prerank,cellular protein catabolic process (GO:0044257),0.2674629027929105,0.9718787904180479,0.5102040816326531,0.8577627526258548,1.0,10/59,12.16%,CHEK2;AP2A1;CTSS;LGMN;YME1L1;PISD;TCIRG1;MYLIP;CTSF;CLTA
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.23720071075071153,-0.9717700663199527,0.493368700265252,0.8394881001492787,1.0,18/86,15.39%,CD74;BANK1;CD44;EGFR;FGF10;APP;JAK2;PRKCZ;CADM4;FGF7;CSPG4;CD80;ENPP2;CLEC6A;EFNA5;PECAM1;SFRP1;RELN
prerank,inorganic ion transmembrane transport (GO:0098660),0.4040949807825256,0.9715864896916622,0.49080882352941174,0.8579149944810158,1.0,2/12,6.35%,TRPM4;ABCC9
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.39322656228940567,0.9715577424716113,0.4971537001897533,0.8573393096200748,1.0,4/12,18.08%,PRKCA;NEK6;PRKCB;LPIN1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.37241378700278116,-0.9703290275679259,0.5152838427947598,0.8426598841941999,1.0,5/13,23.42%,ELOVL7;HACD1;ELOVL5;HACD4;TECRL
prerank,positive regulation of glycolytic process (GO:0045821),-0.31938356881088226,-0.9703087945124222,0.5034168564920274,0.84089714918314,1.0,3/20,4.29%,APP;PFKFB1;ZBTB20
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.31938356881088226,-0.9703087945124222,0.5034168564920274,0.84089714918314,1.0,3/20,4.29%,APP;PFKFB1;ZBTB20
prerank,T cell receptor signaling pathway (GO:0050852),0.23667632316908604,0.9702735249411677,0.5133437990580848,0.8603036797957546,1.0,40/138,24.23%,PAG1;INPP5D;FYB1;PIK3R1;RIPK2;FYB2;PLCG2;TNFRSF21;EIF2B3;LCP2;CSK;PDPK1;TAB2;PIK3CD;PSMD3;PIK3CB;RNF31;WNK1;EIF2B4;PSMB3;NFKBID;PSMA7;PSMC1;PSMC2;TEC;PSME4;PSMB9;GATA3;PTPRJ;KHDRBS1;PSMD4;PSMB5;PSMB7;STOML2;ZC3H12A;PIK3CA;RC3H2;PSMB8;EIF2B2;PTPRC
prerank,regulation of immune effector process (GO:0002697),0.29389430391508137,0.9701329900373686,0.48473967684021546,0.860045705780405,1.0,6/41,7.28%,C1QB;PROS1;PHB2;CLU;C1QA;C1QBP
prerank,defense response to virus (GO:0051607),0.24799409336139266,0.9700246189813392,0.5166402535657686,0.8596790712400421,1.0,32/100,24.23%,TLR7;RNASE1;SERINC3;TRIM5;PHB2;ATAD3A;MOV10;ABCC9;CGAS;ZMYND11;ABCE1;G3BP1;RNASE6;SETD2;MAVS;EXOSC5;PYCARD;SHFL;TTC4;ISG20;IRF3;EIF2AK2;MAP3K14;IRF2;PMAIP1;NLRC5;ACOD1;BCL2L1;CXCL10;MYD88;PTPRC;FADD
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.3508678185230687,0.969957051040094,0.5018050541516246,0.8592040280924202,1.0,5/18,17.01%,CAMK1D;RPS6KA5;TSSK4;CRTC1;RPS6KA4
prerank,sensory perception (GO:0007600),-0.26374364399087635,-0.9699339858763348,0.4891041162227603,0.8410727677749594,1.0,11/45,17.09%,PCDH15;CCR2;TMEM150C;MME;OPRM1;NIPSNAP1;CHRNA4;CLRN1;PTGES;ASIC3;SCN9A
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.3742689577288574,-0.9696311125133722,0.5333333333333333,0.841004330970924,1.0,8/13,29.52%,NFIB;PPARG;SRF;BMP4;REST;PPARA;RELA;NFATC4
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.35450668010235525,-0.9696106006398741,0.4617067833698031,0.8401550455184956,1.0,5/15,15.58%,UST;DSE;VCAN;CSPG4;CSGALNACT2
prerank,proteasome assembly (GO:0043248),0.40254281629233074,0.9694767338368385,0.5157699443413729,0.859834526366754,1.0,2/11,4.82%,OTUD6B;PSMG1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.3857620865021176,0.9694444846651258,0.49454545454545457,0.8592671735051662,1.0,3/11,19.13%,LGALS9;CD34;THBS1
prerank,neuron differentiation (GO:0030182),0.2309759292050855,0.9690965994885351,0.5225225225225225,0.8595688940144874,1.0,22/165,10.51%,TGFBR1;OPHN1;ATP8A2;MEF2C;ACSL4;EPOP;PAX6;RYK;MYO7A;PPT1;ERCC2;SHH;FZD2;WNT2B;MET;WNT10B;BHLHE22;CTF1;NEUROD6;NEUROD4;WNK1;WNT7B
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.34985921391709063,0.9687139981365904,0.4791288566243194,0.8599890979267496,1.0,3/18,8.25%,IL18;AGER;IL12B
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.339681247312026,-0.9686930792634432,0.47874720357941836,0.8418663741878563,1.0,6/18,21.74%,RIC1;FAF1;RGP1;MSN;CDK5RAP3;EZR
prerank,positive regulation of DNA repair (GO:0045739),0.2852218252135056,0.968682562026482,0.5024875621890548,0.8594205592214853,1.0,14/46,19.09%,PCNA;HDAC10;SPIDR;DHX9;MGMT;EYA3;RNF8;SPIRE1;BRCA1;CEBPG;ABRAXAS1;TMEM161A;BABAM1;SLF2
prerank,regulation of T cell proliferation (GO:0042129),0.2733992979356954,0.9684826215802236,0.5128644939965694,0.8593137045791378,1.0,10/61,10.24%,CCDC88B;AIF1;TNFRSF21;TNFRSF13C;IL6ST;CD86;PNP;PDCD1LG2;IL12B;NCKAP1L
prerank,nuclear membrane reassembly (GO:0031468),-0.25963345246593744,-0.9681076905488325,0.5145631067961165,0.8426407031220743,1.0,15/54,19.06%,REEP3;PPP2R2A;LMNA;LBR;NUP98;RAN;NUP205;PPP2R1A;REEP4;NUP43;BANF1;NUP155;VRK1;CCNB1;NSFL1C
prerank,ovarian follicle development (GO:0001541),0.38367155891644583,0.9676448948038835,0.5284090909090909,0.8610116504431373,1.0,4/13,14.18%,LHCGR;INHA;EIF2B4;SOD1
prerank,myelination (GO:0042552),-0.2706296948457507,-0.9676386454847403,0.504739336492891,0.84303548599689,1.0,7/46,3.18%,B4GALT5;B4GALT6;SLC8A3;SCN2A;TPPP;ADGRG6;MYRF
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.37453883135246635,0.9675722902269767,0.4911591355599214,0.8605535231580826,1.0,3/14,9.65%,LPIN2;PISD;CHKB
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.256432149620789,0.9675418355860429,0.5121555915721232,0.8599602283914385,1.0,19/86,17.14%,NFE2L2;DDIT3;VHL;RPS27A;UBC;IMPACT;ATF3;EGLN1;ANKRD2;PSMD3;PSMB3;ARNT;PSMA7;GCN1;PSMC1;PSMC2;PSME4;PSMB9;MAPK7
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.2754779937713949,0.967514387582904,0.5157545605306799,0.8593828410455135,1.0,18/55,26.06%,TGFBR1;CRADD;DDIT3;AGTR2;GPER1;BMF;PYCARD;TNFRSF12A;AGT;PMAIP1;TRAF7;BCL2L1;BCL2L11;TP53;FADD;TRIM39;S100A8;S100A9
prerank,regulation of epidermal cell differentiation (GO:0045604),0.33843621517699585,0.967513136804585,0.4934086629001883,0.8587266763381688,1.0,7/21,21.37%,ZFP36L1;DLL1;RUNX1;MAFG;ROCK2;SFRP4;ERRFI1
prerank,myofibril assembly (GO:0030239),0.2873917800081757,0.9673914206203443,0.5034722222222222,0.8584048959661053,1.0,3/42,2.08%,CAPN3;CFLAR;FLII
prerank,metal ion homeostasis (GO:0055065),0.2928366007875687,0.9673501005628026,0.4742268041237113,0.857862312573197,1.0,5/40,5.62%,SLC7A8;SLC12A6;CNNM2;SLC8A1;SLC12A9
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.28458853892547775,0.9668514233724604,0.4965034965034965,0.8585615412558303,1.0,8/45,6.82%,PIK3R1;EFEMP1;SLC30A10;SRC;PTK2B;RPS6KA5;PDPK1;DGKD
prerank,regulation of lymphocyte differentiation (GO:0045619),0.35302186863397755,0.9666209106384978,0.5046382189239332,0.8585386416466164,1.0,8/18,19.55%,ZFP36L1;ZFP36L2;NCKAP1L;PRDM1;ABL1;SPINK5;IL4I1;XRCC6
prerank,positive regulation of hemostasis (GO:1900048),0.40721466599316014,0.9666137357381037,0.48659003831417624,0.8572438128165566,1.0,5/10,21.85%,F12;APOH;SERPINE1;THBS1;DMTN
prerank,positive regulation of coagulation (GO:0050820),0.40721466599316014,0.9666137357381037,0.48659003831417624,0.8572438128165566,1.0,5/10,21.85%,F12;APOH;SERPINE1;THBS1;DMTN
prerank,positive regulation of histone deacetylation (GO:0031065),0.3901124839432479,0.9664035503711067,0.4849624060150376,0.8572102020316289,1.0,2/12,3.00%,AKAP8;AKAP8L
prerank,cellular response to starvation (GO:0009267),0.23675445883099022,0.9663856253897295,0.5303030303030303,0.856605941830428,1.0,41/147,24.00%,NUAK1;ATP6V0B;ATG14;FLCN;ATP6V1D;IMPACT;EIF2S1;PIK3C3;LAMTOR2;TCIRG1;SEC13;RPTOR;SH3GLB1;EHMT2;MTOR;NUAK2;MLST8;LAMTOR5;WDR24;FADS1;GCN1;GABARAPL1;MAPK8;RRAGA;PICK1;CARTPT;ATP6V0E2;ATG5;EIF2AK2;SEH1L;CASTOR1;EIF2AK3;LAMP2;PMAIP1;ZC3H12A;SESN1;ATP6V0C;RALB;DEPDC5;TP53;HNRNPA1
prerank,negative regulation of signaling (GO:0023057),0.3226926075169877,0.9660605346138311,0.5187165775401069,0.856857217457832,1.0,5/25,15.89%,IGFBP3;UBASH3B;PTPN1;OPTN;OSM
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.33913368579320013,-0.9656722611443107,0.48578199052132703,0.8477270921130147,1.0,4/17,14.31%,PTPN22;PTPN2;UBASH3A;THY1
prerank,hyaluronan metabolic process (GO:0030212),0.3373207421753219,0.9655025667375271,0.5046210720887245,0.8577264732462528,1.0,3/23,6.12%,HEXB;GUSB;HEXA
prerank,cellular senescence (GO:0090398),-0.3085365543037267,-0.9653147593296041,0.5077262693156733,0.8478641953482837,1.0,8/27,15.75%,MAPKAPK5;SIRT1;ECRG4;SMC5;KAT6A;CDKN2A;CDKN1A;SRF
prerank,negative regulation of centrosome duplication (GO:0010826),-0.3965093853834985,-0.9647565386810243,0.5,0.8485701249034275,1.0,5/11,16.75%,CCNF;CDK5RAP2;TRIM37;MDM1;NPM1
prerank,engulfment of apoptotic cell (GO:0043652),0.3675545070345931,0.9647114184635689,0.5249110320284698,0.8592287254154785,1.0,3/15,5.85%,RAC1;RHOBTB1;RHOH
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.29812351917766944,0.9641731991090616,0.49730700179533216,0.8600909527178431,1.0,10/35,19.99%,RASAL3;FLCN;SPRY2;MET;RASIP1;CCDC125;SYNGAP1;TNFAIP1;LZTR1;ARHGAP24
prerank,plasma membrane repair (GO:0001778),-0.37219696806817304,-0.9638731124106341,0.49209932279909707,0.8501463301870381,1.0,4/13,11.68%,MYOF;RAB3A;AHNAK2;DYSF
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.2955472328489995,0.9634791832368459,0.53156146179402,0.8613899876560583,1.0,7/35,11.46%,NUAK1;PPP6R3;CRY2;AGTR2;PPP6R1;MTOR;PDGFRB
prerank,negative regulation of protein processing (GO:0010955),0.39035497152520815,0.9634166636935474,0.4981132075471698,0.8608929974182967,1.0,6/12,19.13%,SERPINE1;SERPINE2;ACP4;TMEM59;GAS1;THBS1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.2752552186508392,0.9634044067370174,0.5094017094017094,0.8602829134530503,1.0,14/54,19.31%,CRADD;PCNA;CNOT1;CHEK2;ATM;RBL2;MDM4;PRMT1;TNKS1BP1;PLK3;CNOT3;AURKA;CARM1;PIDD1
prerank,regulation of interleukin-8 production (GO:0032677),0.2633194847539521,0.9631328120641688,0.5303030303030303,0.8603461871572208,1.0,12/69,14.63%,TLR7;DDIT3;LGALS9;TLR4;AFAP1L2;NOS2;RAB1A;LAMTOR5;SERPINE1;CD33;MAVS;PYCARD
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.3156351277502252,-0.9627363119791096,0.5033112582781457,0.8524164671557192,1.0,8/24,19.25%,MTF2;JARID2;DNMT3B;H3-3A;AEBP2;RBBP7;PPHLN1;DNMT1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.2484038777999963,0.9624721524992693,0.5115511551155115,0.8615484460036803,1.0,18/85,18.34%,BAG6;SUMO1;SMAD7;CSNK1E;FBXO22;SIRT2;CLU;KLHL40;ECSCR;USP5;TAF1;ZYG11B;PSMC2;RNF144B;DET1;TRIB1;ZER1;STUB1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.41876862686426103,0.9620151429182178,0.5177304964539007,0.8621140360950297,1.0,1/10,0.53%,OPHN1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.2882757505399947,-0.961733406137871,0.5234899328859061,0.8543678469886974,1.0,11/33,18.74%,PKD2;CDC73;E2F7;KLF4;DCUN1D3;CDKN2A;CDKN1A;MYO16;NACC2;RBL1;CDK4
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.21097098202374984,-0.9616857077146701,0.565597667638484,0.8535892012633584,1.0,65/182,25.47%,ROBO1;XDH;MSR1;CCR1;APP;PTPN22;LDLR;RBMS3;FOXP1;SOX11;APOE;MTMR2;AGO4;SH3GL2;PARP14;SDCBP;WNT4;PRKN;SIRT1;TET1;TNRC6A;MYADM;SMCR8;REL;OPRD1;NDFIP1;PTRH2;KLF4;SETDB2;MMP8;TIPARP;ACVRL1;CD46;HEY2;SFRP1;SNX12;RBL1;TTBK1;CD3E;WDR54;APLN;SFRP2;BMP4;APLNR;ATXN2;ABCC2;DNMT1;TERT;STOX1;DLL4;NOTCH2;NR0B2;PGR;TRAT1;FBXW7;PRKAA1;NOCT;PARP10;HDAC1;ITGB8;REST;OCLN;RACK1;ANKRD13A;HSP90AB1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.278850318153646,-0.9614255369862958,0.5450236966824644,0.8534704337302585,1.0,14/38,25.59%,OTUD7A;PPM1A;SIRT1;USP10;RIOK3;TLE1;PER1;NR1H4;TRIM59;GSTP1;CARD19;TNIP3;NLRC3;MAPKBP1
prerank,negative regulation of phosphatase activity (GO:0010923),0.3276175620720948,0.9613664746930972,0.525089605734767,0.8631957537300186,1.0,6/25,16.65%,CRY2;ZCCHC9;GPATCH2;SH2D4A;SEMA4D;MASTL
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.3322949319904751,0.9612768221329085,0.5072992700729927,0.8627905402438198,1.0,6/20,14.87%,HOXB8;PTK2B;CTR9;ZFP36L1;PRMT1;CIB1
prerank,receptor recycling (GO:0001881),0.4064820644511462,0.9608893977989834,0.49070631970260226,0.8632219525456102,1.0,1/10,1.00%,PHETA1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.2700853199655525,-0.9606087489680903,0.5022421524663677,0.8548643160047233,1.0,10/39,16.42%,SPOCK1;CASK;KANK1;SPRY4;ITGB1BP1;EFNA5;CX3CL1;JAG1;CDKN2A;RCC2
prerank,cellular response to oxygen-containing compound (GO:1901701),0.21402790606302197,0.9603813889716207,0.5482014388489208,0.8639536702819526,1.0,64/291,18.48%,CX3CR1;SIRPA;TWF2;P2RY12;MEF2C;SBNO2;TGM2;TLR4;LYN;EGR1;ATM;PRKCD;CASP1;IMPACT;PTK2B;CTR9;SSH1;CD86;CAMKK2;PDGFB;NLRP3;LAMTOR2;ZFP36L1;RPTOR;WNT10B;PDCD1LG2;GPER1;CXCL1;POU4F1;JUN;INPP5K;DPEP1;MTOR;TICAM2;PABPN1;PDK2;WNT7B;AXL;LAMTOR5;CD180;PAX2;RAPGEF3;TAF1;SERPINE1;ADCY6;CCDC62;CCR5;MAPK8;PYCARD;AKT1;NDUFA13;RRAGA;TNIP2;MAPK14;NCOA3;NRIP1;ABCB4;FES;KAT5;HMGB2;TICAM1;ROCK2;GNB1;HTRA2
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.3456584254580526,0.9600779507354943,0.4972170686456401,0.8641432838307934,1.0,2/18,8.58%,BIN1;HAMP
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.20636326632234617,0.9593330432590471,0.6075268817204301,0.8655679261145393,1.0,83/417,18.10%,SALL1;IKZF1;BASP1;MLXIPL;SUMO1;CAPN3;PRMT2;HEYL;DDIT3;SOX8;EIF4A2;PBXIP1;SBNO2;SIRT2;PPARD;FOXE1;CCDC85B;CRY2;HDAC10;DEAF1;PHB2;SAMD1;SUDS3;ID1;ZNF568;ZBTB21;CHD8;LOXL3;ELK3;MLX;RPS6KA5;FOXK2;BCOR;ZBTB18;EID2;SIN3A;PDGFB;ZMYND11;BCL7A;FOXN3;MIDEAS;SAMD11;SAMD13;TWIST2;TMPRSS6;PATZ1;JUN;LIMS1;NPAS1;DPF2;INPP5K;EID2B;MBD1;PRDM11;BRCA1;PAX2;SMARCA2;DPF1;KDM4A;MAP3K10;PRMT6;GCLC;WWP2;ID3;EZH2;NDUFA13;HDAC5;PROX1;EED;ZEB1;VGLL4;COMMD7;TSC22D4;QARS1;SCMH1;POU2F1;KDM1A;GATA3;KAT5;KDM8;HMGB2;CHMP1A;DKK3
prerank,lamellipodium organization (GO:0097581),-0.2998071842222642,-0.9590728405609134,0.5375854214123007,0.8582910736181231,1.0,12/29,21.12%,CTTN;ABLIM1;GOLPH3;WASF1;CARMIL1;CCDC88A;CDH13;KIT;ABLIM2;ITGB1;PARVB;SNX2
prerank,Golgi to plasma membrane transport (GO:0006893),-0.265949037067531,-0.9590488082546363,0.5144927536231884,0.8574564673313984,1.0,6/47,6.34%,ANK3;EXOC6B;SPTBN1;EXOC2;GOLPH3;STXBP6
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.20975239901106685,-0.9590322108380419,0.6038781163434903,0.8565838773731798,1.0,25/166,9.55%,SORBS1;SAMD4A;CD36;EGFR;IRS1;EIF3C;LDLR;VIM;FAF1;CPEB3;KLF2;PKD2;GIPC1;EIF3E;RPL26;SLC45A3;SIRT1;EIF4A3;PRR16;PTPN2;ZNF205;ATP7A;ZEB2;ELOVL5;PLXNB2
prerank,axonal transport of mitochondrion (GO:0019896),-0.3847036924760776,-0.9589512835362289,0.5010845986984815,0.8559361324132295,1.0,2/11,3.29%,ACTR10;SYBU
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.2745407890933061,0.9587253665930178,0.5591216216216216,0.8666057931751817,1.0,12/52,14.87%,EPB41L2;PIK3R1;AKAP5;NUMA1;PDPK1;GPER1;ZDHHC5;CLIP3;LRP1;STX4;AKT1;CIB1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.2869452476623473,0.9584756218055285,0.5193661971830986,0.86664218784274,1.0,7/43,12.86%,SIRPA;LGALS9;VSIR;TLR4;CD34;HAVCR2;CD33
prerank,regulation of transmembrane transport (GO:0034762),-0.295902901501917,-0.9584097330207181,0.5342789598108747,0.8566069939995511,1.0,16/31,33.01%,KCNJ3;NEDD4L;ACTB;PIM1;BCL2;SNCA;FFAR4;KCNJ10;ACE2;TRIB3;OCLN;KCNJ8;KCNJ16;CLTRN;KCNJ14;KCNJ6
prerank,cell-cell junction assembly (GO:0007043),-0.24997017199086258,-0.9579015625765057,0.5586034912718204,0.8571118298581099,1.0,16/63,14.03%,CTNND2;CTNNA1;CDH8;CDH22;PATJ;CDH7;CDH20;PKP4;CDH10;ACTB;CDH11;CNTNAP1;CDHR3;CDH5;JAM3;GJB2
prerank,negative regulation of hemostasis (GO:1900047),0.38114515609637123,0.9578909517252739,0.5119266055045871,0.8675973243289419,1.0,4/12,13.17%,CD34;APOH;SERPINE1;SERPINE2
prerank,response to light stimulus (GO:0009416),0.2705658359643203,0.9573308320949206,0.5299145299145299,0.8684668614911537,1.0,11/55,14.46%,PRIMPOL;CRY2;DDB2;MAP4K3;FECH;GTF2H2;ERCC2;ERCC4;DRD2;PCLAF;MAPK8
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.3760426683693209,-0.9569499867287375,0.5374449339207048,0.858899602616331,1.0,1/13,0.63%,PLCB1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.2541757306907531,0.9569221382242562,0.5642633228840125,0.8682999443204376,1.0,26/78,22.49%,DNM2;CTSD;KIF2A;KIF3B;AP2A1;CAPZB;CTSS;LGMN;ACTR1B;SEC13;AP1M2;CTSF;CLTA;AP1S2;KLC1;CTSE;KIF3A;DCTN5;ACTR1A;AP1S1;DCTN4;DCTN2;AP1B1;ARF1;SEC31A;CAPZA2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.2541757306907531,0.9569221382242562,0.5642633228840125,0.8682999443204376,1.0,26/78,22.49%,DNM2;CTSD;KIF2A;KIF3B;AP2A1;CAPZB;CTSS;LGMN;ACTR1B;SEC13;AP1M2;CTSF;CLTA;AP1S2;KLC1;CTSE;KIF3A;DCTN5;ACTR1A;AP1S1;DCTN4;DCTN2;AP1B1;ARF1;SEC31A;CAPZA2
prerank,cellular response to interferon-gamma (GO:0071346),-0.2355363002952045,-0.9569125033789055,0.5647382920110193,0.8580970134301029,1.0,21/88,14.94%,OAS2;CD44;CD47;CIITA;B2M;JAK2;SP100;GBP3;AQP4;IRF4;NCAM1;DAPK1;GBP4;VCAM1;IFNGR1;PTAFR;GBP2;CX3CL1;OAS3;CCL5;CCL14
prerank,stem cell differentiation (GO:0048863),-0.2749245711253099,-0.9567991528847247,0.5406698564593302,0.8575199628412002,1.0,14/39,23.17%,GPM6A;MTF2;JARID2;LRP6;HTR2B;MLLT3;KIT;PSMD11;SFRP1;HOXB4;ACE;WNT7A;SP7;FBXL17
prerank,regulation of neuroinflammatory response (GO:0150077),0.34104395066680265,0.9567797195080613,0.5257352941176471,0.8680591194661922,1.0,1/19,0.37%,IL18
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.34916000706136474,-0.9566337619258038,0.5150862068965517,0.8570695923867154,1.0,5/15,20.18%,PPARG;PLIN2;OSBPL8;ABHD5;PLIN3
prerank,regulation of histone acetylation (GO:0035065),0.3013961958407378,0.9563135585865051,0.5283363802559415,0.8686169969640785,1.0,15/33,28.89%,FLCN;RPS6KA5;BRCA1;RAPGEF3;HDAC5;RPS6KA4;ARRB1;CAMK1;NOS1;PARK7;GLYR1;IWS1;KMT2A;PAXIP1;SPI1
prerank,positive regulation of inflammatory response (GO:0050729),0.2504346324477281,0.9563033054855546,0.5359477124183006,0.8679924234074892,1.0,18/86,18.56%,IL18;TLR7;ETS1;KARS1;TLR4;CCL3;TRADD;IL6ST;DHX9;IL12B;DDT;SERPINE1;IL33;OSM;GPR4;AGT;VAMP7;SETD4
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.39606309654579397,0.955928312545679,0.5482041587901701,0.8683573405700523,1.0,3/11,10.23%,PICALM;TAX1BP3;LEPROT
prerank,protein dephosphorylation (GO:0006470),0.2335079072442671,0.9558992742936842,0.552099533437014,0.8677899667551681,1.0,31/135,17.03%,PTPRM;SSH2;PPM1H;CTTNBP2NL;DAPP1;UBASH3B;PPM1L;SSH1;RPAP2;PTPRE;PP2D1;EYA3;ILKAP;CDC14B;PPP2R5B;PTPN1;MTMR4;PTPRA;DUSP29;PTPN11;DUSP18;DUSP5;PPP4R2;TIMM50;PPP1CB;PTPRH;PTPN21;DUSP11;DUSP6;PTPN5;PPP2R5A
prerank,negative regulation of histone methylation (GO:0031061),-0.39674065788562207,-0.9557588076666403,0.5207877461706784,0.8585739544644874,1.0,5/10,19.25%,MTF2;JARID2;DNMT3B;AASS;DNMT1
prerank,positive regulation of transport (GO:0051050),-0.23406980585488252,-0.9557545101227979,0.544973544973545,0.8576831976701165,1.0,29/85,23.76%,DAB2;CD47;ACSL3;NEDD4L;APOE;GSK3B;SGK2;ZNF205;ACTB;CYBA;GPC3;BAK1;SPAG5;CD151;FCGR2B;TFR2;IL2RB;CBLL1;ANXA2;SNCA;BOK;PLAA;SYNGR3;CHCHD10;FPR2;LYAR;ABCA7;DOC2B;ANXA1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.3065747749740095,0.9554727627352978,0.5171790235081374,0.8682949543114163,1.0,7/31,15.62%,TGFBR1;SMAD7;DSP;MYL3;ENG;PROX1;NOG
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.3505431099232711,0.9550655039953032,0.5210237659963437,0.8686856748970917,1.0,6/17,18.48%,NFE2L2;VNN1;SOD1;AKT1;MAPK7;HTRA2
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.4017503441260633,0.9548385103691145,0.5281306715063521,0.8686642471758858,1.0,4/11,14.60%,F11R;RAB1A;TJP1;TJP2
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.3940266128980384,0.9547817246079225,0.5443786982248521,0.8681772159343936,1.0,2/11,3.75%,RREB1;SRC
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.2810743003222125,-0.9545401769270359,0.5187793427230047,0.8601883559564866,1.0,6/36,5.41%,NOSTRIN;EGFR;ZDHHC21;APOE;CALM1;HTR2B
prerank,extracellular transport (GO:0006858),0.38486668785182104,0.9544084798007512,0.5074906367041199,0.8685227664204751,1.0,4/12,21.31%,ARRDC1;WWP2;CCDC40;TSG101
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.34212206523983935,0.954286223552499,0.5267034990791897,0.8681826235247516,1.0,3/20,8.75%,KCNMA1;SLC8A1;ATP1A4
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.3579623123117577,0.9542734192253879,0.5207207207207207,0.8675785925228571,1.0,5/16,25.84%,KLK2;DRD2;PRCP;KLK3;DDAH1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.31840646523121485,-0.9540167736757849,0.5192743764172335,0.8607537194047269,1.0,5/23,19.59%,CALM1;CAMKMT;GUCY2F;GUCY2D;PDE6A
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.38661207471108183,0.9537046247513066,0.5320754716981132,0.8684483941995615,1.0,8/12,31.19%,FADS1;ACOT8;SCP2;ABCD1;FADS2;ELOVL1;ACOX1;HSD17B4
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.3020340606109026,-0.9531824054530644,0.5,0.8622710727109157,1.0,5/27,6.07%,FGF12;UTRN;NEDD4L;FXYD5;PTPN3
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.3835029154320949,0.9527764901939998,0.532967032967033,0.8703324714818174,1.0,5/13,19.81%,CLU;USP19;MBTPS2;NR1H2;EIF2AK3
prerank,somite development (GO:0061053),0.39952029833994707,0.9524817163539113,0.5245283018867924,0.870493684007754,1.0,4/11,15.51%,LOXL3;SHH;SMO;MTHFD1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.3837607825430105,0.9524799040021021,0.515748031496063,0.8698516367938034,1.0,2/12,5.86%,CHEK2;RAD17
prerank,secretion (GO:0046903),0.3628790656981873,0.952339134051185,0.4972170686456401,0.8695980492310595,1.0,4/14,20.19%,SLC22A2;SLC22A6;VIP;TPD52
prerank,ephrin receptor signaling pathway (GO:0048013),-0.2366963466754117,-0.9523358021724608,0.5729166666666666,0.8637349783103806,1.0,13/82,8.79%,VAV3;GRIN2B;ACTR3;NCK2;AP2A2;ITSN1;CDC42;SDCBP;CHN1;DNM1;PAK3;EPHA5;ACTB
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3064885181213114,0.9514890437404062,0.5229357798165137,0.8712520452388797,1.0,8/29,17.88%,CNOT1;KMT2D;BRCA1;RUNX1;KCTD6;UBA5;KANK2;CARM1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.27995263239751694,0.9513480536739316,0.5357766143106457,0.8709810737630154,1.0,14/48,25.29%,ETS1;PRKCA;MAP3K3;PDPK1;PDGFB;GATA2;AKT1;CIB1;MAPK14;THBS1;ADAM17;TGFB1;HIF1A;PLCG1
prerank,regulation of neuron death (GO:1901214),0.2514939490659118,0.9511458051824199,0.5596774193548387,0.8709087658041512,1.0,12/82,9.85%,ITGAM;MEF2C;RILPL1;PICALM;ITGB2;EGR1;CLU;EIF4G1;EIF2S1;C1QA;CD34;RRAS2
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.286298509231482,0.9510483135803387,0.538860103626943,0.8705306591652429,1.0,11/42,18.96%,FUS;WDR48;SPIDR;CGAS;MMS19;SHLD2;PPP4R2;SETD2;KDM1A;FBH1;UBQLN4
prerank,cellular response to oxygen levels (GO:0071453),0.3988095379346378,0.9507519559922853,0.5540796963946869,0.8706855844615502,1.0,3/10,15.13%,ATP6V0A2;TMEM199;PICK1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.2388713253603765,0.9506311410040472,0.5798045602605864,0.8703855101682125,1.0,31/114,21.34%,PYDC1;TRAF5;TNFSF13B;CD27;PTK2B;TRADD;TNFRSF25;TNFRSF13C;TNFRSF13B;EDA2R;LIMS1;PSMD3;TNFRSF17;PSMB3;TNFSF8;PSMA7;PSMC1;PSMC2;BAG4;PYCARD;PSME4;AIM2;PSMB9;TNFRSF12A;COMMD7;MAP3K14;PSMD4;PSMB5;ADAM17;TNFRSF14;PSMB7
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.401229015753079,0.9506257872977335,0.5421686746987951,0.8697586829994093,1.0,2/11,4.17%,PLCG2;CCL3
prerank,mitotic sister chromatid cohesion (GO:0007064),0.35374654318228804,0.9504521442825471,0.5121951219512195,0.8695921781406976,1.0,5/16,21.25%,MAU2;POGZ;NAA50;DSCC1;CDCA5
prerank,regulation of phospholipase activity (GO:0010517),0.40962994207302694,0.9500628141785357,0.524904214559387,0.8699984231682024,1.0,3/10,10.19%,PDPK1;PLA2G5;LRP1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.3417933646305489,-0.9498668906224529,0.5138592750533049,0.8697608948305658,1.0,2/16,1.79%,AMPD3;PPAT
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.26450860037791646,-0.9495560477620298,0.5413333333333333,0.8696807806050216,1.0,13/46,18.91%,PLCB1;JAK2;PPIA;CDC42;CNN2;STAT4;PSME2;SOD2;ANXA2;RPLP0;AIP;MSN;TCP1
prerank,regulation of smooth muscle cell migration (GO:0014910),0.33768258635659704,0.9494792477807587,0.5277777777777778,0.8709315686622815,1.0,7/20,17.17%,IGFBP3;PDGFB;LRP1;PDGFRB;SERPINE1;NDRG4;TRIB1
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.1970157168880182,-0.948862764312455,0.6319702602230484,0.8707164169415847,1.0,108/306,27.99%,B4GALT5;THRB;POLA1;ST3GAL4;FUT9;RPL36A;EXT1;RPS29;RPL30;RPL35A;RBMS1;CREBL2;RPS3;MCM9;RPL4;POLL;RPS7;APOE;RPS2;NR4A2;RPLP2;RPL7A;GOLPH3;POLE2;BARD1;IGHMBP2;RPL41;RBBP8;RPL26;RPS27;RPL18A;RPS25;RPL38;EEF1A2;RPS6KB2;MRPL18;RPL37;HBS1L;HUS1;RPS15A;RPS14;MRPS7;RPL24;DBF4;CHEK1;SCX;RPS9;EXT2;CDK2;RPLP0;RPLP1;TOP1;RPL8;RPL22;POLR2K;MRPS33;RPS12;MRE11;E2F1;RPS10;POLR2F;PIF1;MCM5;RPL19;POLD1;POLD3;RPS6;TERT;RPL13A;RPL18;RPS5;POLR2G;RPS19;CLSPN;RPL23A;PABPC4;YARS2;UPF1;FEN1;RPL29;PTMS;RPS23;PAX8;TIPIN;ING4;BRIP1;RPS11;ZAR1;RNPS1;MRPL55;MRPL24;RAD9B;PTMA;RFC4;RPS15;EEF1G;KIN;RPL23;MRPL23;RPL17;RECQL4;RSL24D1;AGO2;EEF1A1;B3GNT6;MRRF;MCM8;GRWD1
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.3087737342354864,-0.9485996456831585,0.5521064301552107,0.8705343452975908,1.0,10/25,19.10%,CTNNA3;ITGA4;ITGB7;NINJ1;CD2;VCAM1;JAM3;CD200R1;ITGB1;ITGAD
prerank,sulfur amino acid catabolic process (GO:0000098),0.4031659857701459,0.948172473663171,0.5189393939393939,0.8737905436312473,1.0,3/10,18.05%,MPST;GADL1;TXN2
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.2518725183778678,0.9480927307089334,0.5781990521327014,0.8733657555535037,1.0,26/79,22.49%,DNM2;CTSD;KIF2A;KIF3B;AP2A1;CAPZB;CTSS;LGMN;ACTR1B;SEC13;AP1M2;CTSF;CLTA;AP1S2;KLC1;CTSE;KIF3A;DCTN5;ACTR1A;AP1S1;DCTN4;DCTN2;AP1B1;ARF1;SEC31A;CAPZA2
prerank,regulation of transferase activity (GO:0051338),0.34714071331230034,0.9480280823359747,0.5146520146520146,0.8728955918842738,1.0,9/17,32.85%,ATM;PPP1R3F;PARP4;NLRC5;JMJD8;BAG5;HMBOX1;EMP2;FEM1A
prerank,cellular response to dsRNA (GO:0071359),0.35655884824174416,0.9479413567716638,0.5454545454545454,0.8724826301011028,1.0,4/15,14.28%,ZCCHC3;DHX9;CGAS;MAVS
prerank,modulation by symbiont of entry into host (GO:0052372),0.34976507964380743,0.9476296219163979,0.5268817204301075,0.8726553241302175,1.0,4/16,13.74%,EXOC7;TRIM5;TRIM62;NECTIN2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.27673447798235495,-0.9474477143195666,0.543640897755611,0.8728052292676434,1.0,14/37,26.47%,RPS3;RPS7;DNM1L;FIS1;BECN1;EIF5A;BCL2;NACC2;BOK;BCAP31;MSX1;LCK;RACK1;BID
prerank,potassium ion homeostasis (GO:0055075),0.322246616830586,0.9474325193768384,0.5064220183486239,0.8725651739701343,1.0,4/23,8.75%,KCNMA1;SLC12A6;SLC12A9;ATP1A4
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.31733619874536545,0.9470150547437658,0.5497382198952879,0.8730728859429312,1.0,4/25,15.23%,NELFB;ZMYND11;RNF8;NELFE
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.32905166041007955,0.9468274121770927,0.5283363802559415,0.8729164470225024,1.0,10/21,23.79%,DDIT3;TMBIM6;EIF2AK3;PMAIP1;SYVN1;BCL2L1;TXNDC12;OPA1;PARK7;BCL2L11
prerank,regulation of dopamine secretion (GO:0014059),-0.30142786338435207,-0.9467739106755981,0.5218390804597701,0.8737544524656436,1.0,7/25,15.29%,SYT1;SYT10;PRKN;CHRNA4;DTNBP1;SYT3;SNCA
prerank,regulation of cell population proliferation (GO:0042127),0.19632296026489618,0.946713263285864,0.6724351050679852,0.8725875602787215,1.0,122/691,17.95%,TGFBR1;NUAK1;TGFBR2;ARHGEF2;MLXIPL;LRP5;CSF1R;GREM1;SLURP1;ETS1;FAM98B;ATP8A2;PIM2;AIF1;IGFBP3;SKI;GAB2;INCA1;TGFB1I1;SIRT2;PPP1R9B;KMT2D;KLF11;LYN;VHL;TBC1D8;CSNK2A1;ITGAV;IGF1R;ADAMTS1;RNF41;TRPM4;PKHD1;CLU;MEIS3;KSR1;PTK2B;LGMN;MDM4;IL6ST;GNRH1;DIS3L2;EID2;CD86;SHH;PDGFB;GCNT2;TCIRG1;ZFP36L1;S1PR3;CNBP;EDN3;CNTF;BCL6B;AMBN;EDN2;GDNF;CHRM1;GPER1;CTF1;CXCL1;IL6R;ACER3;INHA;ACER2;JUN;TJP1;JAG2;PRMT1;LIMS1;P3H2;RTKN2;IL12RB2;PLPP1;TOB1;DLL1;TBX6;PDGFRB;SMARCA2;RUNX1;CLMN;DHPS;ENG;CD33;OSGIN1;STX4;RNF187;DRD2;IL34;ADGRG1;HP1BP3;EZH2;TSPO;HTR1A;AKT1;CIB1;CSF1;VIP;PROX1;GPNMB;TENM1;MAP2K1;SLAMF1;PDCD10;OSM;PLG;TSPAN31;XIAP;LAMC2;STAT6;CCAR1;ADAM10;UBE2A;AGT;KANK2;NUP62;EIF2AK2;NME1;FES;IL7R;GATA3;HMGB2
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.3716310737533438,-0.9466348056088403,0.5087336244541485,0.8732364085356923,1.0,3/12,9.05%,UVRAG;IRGM;SMCR8
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.3212938258661802,0.9465116327881058,0.5362318840579711,0.8725307319368473,1.0,5/24,13.33%,SEMA3B;SEMA4C;SEMA4G;SEMA3G;SEMA4D
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.36822506938331784,0.9464635834268912,0.539568345323741,0.8720211846344902,1.0,6/14,20.70%,CCL3;PTK2B;WNK1;STK39;ADAM10;ADAM17
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.259323708704575,0.9463273979520923,0.5682967959527825,0.8717610889106814,1.0,15/62,17.33%,F11R;RAC1;MAP4K4;LYN;PIK3CG;ABRA;GPR55;AKAP13;PIK3CB;GPR18;ADGRG1;RTN4R;STK19;GPR4;ARRB1
prerank,positive regulation of peptidase activity (GO:0010952),0.3469555282552133,0.9462347246801904,0.5252707581227437,0.8713808499147917,1.0,5/20,17.58%,VSIR;PSENEN;PINK1;NDUFA13;APH1B
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.37459946794886634,0.9458087288035589,0.5183752417794971,0.8719115249819297,1.0,2/13,6.00%,CNOT1;MOV10
prerank,negative regulation of reproductive process (GO:2000242),-0.33770686954349494,-0.9456328401689055,0.5258426966292135,0.8751195130691811,1.0,2/17,4.34%,PAEP;ACVR1C
prerank,UV-damage excision repair (GO:0070914),-0.3769743973900349,-0.9455389559155235,0.5479744136460555,0.8744696444683231,1.0,3/12,7.72%,POLA1;XPA;SIRT1
prerank,insulin receptor signaling pathway (GO:0008286),0.2583687338194545,0.9453935975561244,0.5593495934959349,0.872428721880166,1.0,14/69,16.86%,PIK3R1;ATP6V0B;IRS4;RHOQ;IGF1R;ATP6V1D;TCIRG1;ATP6V0A2;APPL1;PDK2;ATP6V0A4;AKT1;PIK3R3;ATP6V0E2
prerank,neuron remodeling (GO:0016322),-0.402295921259892,-0.9453480038719762,0.5143487858719646,0.8741285942706521,1.0,4/10,13.31%,ADGRB3;APP;SCARF1;CX3CL1
prerank,epithelial tube morphogenesis (GO:0060562),-0.28794896947721077,-0.94516986702797,0.5113122171945701,0.8737395420309955,1.0,11/32,16.91%,MTSS1;SLIT2;FGF10;RYR2;COL4A1;PKD2;PODXL;ACVRL1;PKD1;PAK1;BMP4
prerank,regulation of cell-substrate adhesion (GO:0010810),0.281562093457701,0.9451490330067267,0.5342706502636204,0.8724544209212207,1.0,7/42,10.11%,RAC1;NPNT;PKHD1;PDGFB;GCNT2;LIMS1;PIK3CB
prerank,glycoprotein biosynthetic process (GO:0009101),0.25262266961526303,0.944932726036185,0.5548281505728314,0.872408427335136,1.0,12/79,11.05%,ST3GAL6;LARGE1;B3GNT2;ST3GAL5;CHST11;GAL3ST4;MPI;GCNT2;B3GNT4;FUT7;MGAT1;NPC1
prerank,embryonic limb morphogenesis (GO:0030326),0.2947351259859571,0.9449191346939847,0.5508885298869144,0.8718165242452505,1.0,4/34,6.86%,SALL1;SKI;FBXW4;SHH
prerank,glucose metabolic process (GO:0006006),0.2671664853245209,0.9449029560518964,0.56,0.8712232423778263,1.0,13/58,21.15%,LRP5;PPARD;GALM;PGK1;GAPDH;GDPGP1;SORD;PGAM1;SLC25A11;MDH1;SLC25A10;PCK2;GAA
prerank,fatty acid elongation (GO:0030497),-0.36856463433416287,-0.9447528246467921,0.5472527472527473,0.8739788709373285,1.0,3/13,9.13%,ELOVL7;HACD1;ELOVL5
prerank,glycogen catabolic process (GO:0005980),0.36450585250574286,0.9445800617927022,0.5183044315992292,0.8714627491532715,1.0,7/15,21.15%,PYGB;PHKB;AGL;RB1CC1;PHKG2;PHKA2;GAA
prerank,nucleus organization (GO:0006997),0.27429327161378897,0.9442390631926686,0.5307820299500832,0.8717629381635026,1.0,12/47,19.78%,BIN1;IRAG2;NUMA1;WDR73;SUN2;USP36;NUP35;ATXN7;SEH1L;CHMP1A;CHMP2A;VPS4A
prerank,negative regulation of histone acetylation (GO:0035067),-0.38151430707709777,-0.9440861650732181,0.5330578512396694,0.87496863270183,1.0,5/11,20.54%,TAF7;SIRT1;SNCA;THAP7;NOC2L
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.3284482183203315,0.9440701973404887,0.5547576301615799,0.8715986162244188,1.0,3/22,7.94%,LGMN;CBR1;RLBP1
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.3415296660469709,-0.9439915628090582,0.5407098121085595,0.8743391157151131,1.0,3/16,9.06%,AUTS2;CADM4;RASGRF1
prerank,protein polyubiquitination (GO:0000209),0.21049148697393938,0.9437594753729173,0.6137339055793991,0.8717845676598568,1.0,63/297,17.68%,FBXL18;TRIM69;RNF216;FBXO22;SMURF1;ITCH;TRIM5;FBXL20;DDB2;SPSB1;FBXL15;RNF41;TRAF5;UNKL;TRIM36;RPS27A;UBC;UBE2H;RFFL;FBXW4;AKTIP;CDC34;ZFP91;HECTD2;RNF8;PSMD3;RNF31;BFAR;RNF20;MYLIP;AREL1;RNF166;FBXL8;BRCA1;MIB2;PSMB3;WSB1;TAF1;TRIM62;UBE2U;UBE2V2;PSMA7;RNF187;WWP2;PSMC1;FBXO21;PSMC2;UBE3A;MKRN3;FBXL22;ANKRD39;RNF144B;PSME4;FBXO38;FBXO11;ANAPC13;ANAPC11;PSMB9;DTX3L;PELI2;UBE2A;UBE4A;RNF4
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.2637817923179524,0.9437269246112004,0.5581787521079258,0.8712380075277405,1.0,22/57,25.96%,CTSD;RIPK2;ASPH;CASP1;LGMN;ARL6IP5;NLRP3;GPER1;PDCD6;PYCARD;NDUFA13;AIM2;HTRA2;PPM1F;USP50;PMAIP1;DDX3X;GRAMD4;FADD;MEFV;PERP;CARD9
prerank,Golgi localization (GO:0051645),-0.37712238699469314,-0.9437207514856142,0.5389473684210526,0.874192003342038,1.0,3/11,12.29%,CDC42;UVRAG;ARHGAP21
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.3704600468543878,-0.943627076158141,0.5390070921985816,0.8735596360808681,1.0,2/12,2.60%,ANK2;RYR2
prerank,histone H3-K36 demethylation (GO:0070544),0.4045221614899269,0.9430847392063161,0.5510204081632653,0.8722855344618282,1.0,6/10,24.83%,KDM4A;KDM8;KDM7A;KDM2A;KDM2B;PHF8
prerank,regulation of keratinocyte differentiation (GO:0045616),0.3190921303226206,0.9430675559853414,0.5412844036697247,0.871706771868164,1.0,7/24,21.37%,NUMA1;ZFP36L1;RUNX1;NCOA3;ROCK2;PRKCH;ERRFI1
prerank,keratan sulfate biosynthetic process (GO:0018146),0.31090231274785746,0.943003314073301,0.5445205479452054,0.8712444442774846,1.0,5/26,8.27%,ST3GAL6;B3GNT2;PRELP;CHST1;B3GNT4
prerank,positive regulation of JNK cascade (GO:0046330),0.2579229531604014,0.9429797434063949,0.5547945205479452,0.8706835544898759,1.0,16/70,15.84%,PJA2;AGER;TRAF5;CD27;PTK2B;CCR7;EDA2R;WNT7B;MAP4K2;TAOK2;MAP3K10;MAP3K11;MAPK8IP1;PYCARD;TNFRSF19;SLAMF1
prerank,actin filament depolymerization (GO:0030042),-0.38733487538012673,-0.9427211319538011,0.5286343612334802,0.8752461804108383,1.0,3/11,6.20%,GSN;DSTN;MICAL3
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.36660017788249744,-0.9421330124098392,0.5419354838709678,0.8760351437725697,1.0,2/12,1.59%,PLCB1;SLIT2
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.33780282530015515,0.9421021893419543,0.5622568093385214,0.8723574428671751,1.0,6/18,19.51%,COA8;COX19;SURF1;BCS1L;FASTKD3;COX16
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.34271198964089417,-0.941774801462985,0.5101123595505618,0.8761304060132922,1.0,3/15,3.66%,CD36;MSR1;PF4
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.24949807388849365,0.941745602185488,0.5694682675814752,0.8726676187262844,1.0,22/80,22.16%,GSAP;PLD1;PICALM;PRKCD;CLU;PLA2G6;NSUN5;METTL5;SMPD2;MTOR;RPS27L;PASK;METTL14;EIF3D;ROCK2;FXR2;THBS1;SMPD3;PCIF1;EFNA1;DDX3X;ELAVL1
prerank,cellular response to leucine starvation (GO:1990253),0.3943000516768415,0.941634202131758,0.5337186897880539,0.8723322822678845,1.0,4/10,22.23%,IMPACT;MTOR;GCN1;SESN1
prerank,cellular response to UV (GO:0034644),0.2537962521380912,0.9415317699246606,0.5707236842105263,0.8719804442230796,1.0,13/76,12.61%,RHNO1;PCNA;DDB2;PRKCD;IMPACT;MMP2;EIF2S1;USP28;CUL4B;PPID;BMF;TAF1;ERCC4
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.3856553073984569,0.9415176523269263,0.5336976320582878,0.8713900475376518,1.0,1/11,0.66%,ARHGEF2
prerank,regulation of anoikis (GO:2000209),-0.3245382270704324,-0.9413494312426341,0.5406593406593406,0.8764450974323429,1.0,9/19,26.15%,SIK1;TLE1;PTRH2;BCL2;SNAI2;ITGB1;PDK4;MCL1;PTK2
prerank,regulation of receptor recycling (GO:0001919),0.34960594476296925,0.9412751718844926,0.5353356890459364,0.871422057815215,1.0,1/16,0.31%,TBC1D16
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.31825849052283167,0.941246731044669,0.5593803786574871,0.8708667985302954,1.0,11/26,25.39%,LARGE1;GAL3ST4;ALG6;GK5;ALG11;ALG2;ALG8;TNIP1;GBGT1;GCNT1;TKT
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.34598822702908044,0.9409532235931919,0.5514834205933682,0.8709985331545572,1.0,2/17,4.13%,BIN1;CLU
prerank,telomere maintenance (GO:0000723),0.27357520890499704,0.9407779235617829,0.5432098765432098,0.8708269548487344,1.0,19/50,27.61%,PCNA;ATM;NBN;CTC1;POLD2;DCLRE1B;ERCC4;TERF1;ZBTB48;BLM;TEN1;ACD;XRCC6;LTO1;RPA3;POLD4;STN1;RPA1;RTEL1
prerank,regulation of fibrinolysis (GO:0051917),0.37026818672477146,0.9407588396285942,0.5204991087344029,0.8702644879130851,1.0,5/13,19.13%,F12;APOH;SERPINE1;PLG;THBS1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.25134318173421744,0.9406336028187083,0.5637254901960784,0.8699856792016789,1.0,22/75,25.29%,TGFBR1;PRKCA;VEGFB;EGR3;PDPK1;PDGFB;GATA2;PIK3CD;PDCD6;ARNT;AKT1;VIP;PROX1;HMGB2;CCL24;AGGF1;ADAM17;BMP2;NRAS;ITGB3;HIF1A;PLCG1
prerank,nucleic acid-templated transcription (GO:0097659),0.2801706748484547,0.9402162418609881,0.5684575389948007,0.870528064682465,1.0,8/42,10.63%,POLR2H;POLR2J;NKX2-8;POLR2D;THAP1;MMS19;MEF2A;DTX1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.3151066970779336,0.940013954864912,0.5467625899280576,0.8704541515883082,1.0,14/27,30.60%,DDX5;EIF4G1;DHX9;MAP2K1;WTIP;TNRC6B;TGFB1;TP53;AJUBA;STAT3;EIF4E2;PUM1;DDX6;FXR1
prerank,regulation of transport (GO:0051049),-0.2767900217148968,-0.9395500823206261,0.5671641791044776,0.8805469851619073,1.0,9/36,15.88%,LRRK2;SCFD1;PRKN;ACTB;EPB41;WWC1;MYO6;SNCA;ICA1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.3770751099154315,0.9394593374914137,0.5355191256830601,0.8712637523880834,1.0,2/12,5.61%,ABCD2;MTLN
prerank,mitochondrial gene expression (GO:0140053),0.2825980260253114,0.9393269907033917,0.5714285714285714,0.8709872240100089,1.0,12/42,23.29%,MRPS24;MRPL2;MRPS34;MRPS21;MRPS16;MRPS18B;MRPS11;MRPS28;MRPS18A;IARS2;FASTKD2;MRPL47
prerank,embryonic hemopoiesis (GO:0035162),0.3788092484783753,0.9386941921928762,0.5431654676258992,0.8720010074804575,1.0,1/12,0.47%,TGFBR2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.3622544865409436,-0.938556725257463,0.5282167042889391,0.8823877953720243,1.0,5/13,14.67%,FSTL1;FBN1;FBN2;NRROS;CD46
prerank,protein depolymerization (GO:0051261),-0.29375725503124195,-0.9385053934229802,0.5379464285714286,0.8816259019088093,1.0,8/27,15.79%,GSN;DSTN;STMN4;MICAL3;KIF14;STMN2;KIF18B;NCKAP5
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.2875619938821228,-0.9384651575154073,0.5441860465116279,0.880837118886755,1.0,3/30,5.85%,ANK3;SPTBN1;GOLPH3
prerank,negative regulation of cellular component movement (GO:0051271),-0.3428837743589681,-0.9382895767373456,0.5416666666666666,0.8804144455951808,1.0,3/15,4.59%,FRMD5;SPOCK3;SP100
prerank,protein import into mitochondrial matrix (GO:0030150),-0.33075038685885627,-0.9382502364506069,0.5454545454545454,0.8796490584680187,1.0,5/18,11.12%,ROMO1;TIMM23;DNAJC15;TIMM17B;TIMM17A
prerank,nuclear transport (GO:0051169),-0.33818671275860324,-0.9381852173674924,0.5477272727272727,0.878918475469997,1.0,8/16,29.77%,NUP98;RSRC1;NUP205;BANF1;NPM1;NXT2;AAAS;CITED1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.32271411307887865,0.9378350612821712,0.5330882352941176,0.8737485636942627,1.0,4/23,13.56%,ALOXE3;HPGD;FADS1;GPX4
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.30036031202905145,-0.9377900045381868,0.5328798185941043,0.8791125060443261,1.0,6/24,8.10%,CTSC;PSMD14;LATS1;USP14;APOE;PSME2
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.36021921705067417,0.9377892984072239,0.5595463137996219,0.8732486246489115,1.0,4/16,15.00%,IGF1R;ETF1;CLN3;SHFL
prerank,regulation of microtubule nucleation (GO:0010968),-0.40001715551856337,-0.9374583541282743,0.5289256198347108,0.8790875491164226,1.0,4/10,27.92%,HSPA1B;PAK1;RANGRF;MECP2
prerank,Notch signaling involved in heart development (GO:0061314),-0.3818743317838891,-0.9373269866629484,0.5503355704697986,0.8784933162432779,1.0,6/11,22.46%,RBPJ;JAG1;HEY2;SNAI2;DLL4;NOTCH2
prerank,cellular response to interleukin-12 (GO:0071349),-0.25874007129506993,-0.9372292182660433,0.5518134715025906,0.8778584103679782,1.0,14/48,18.91%,PLCB1;CD47;JAK2;PPIA;CDC42;CNN2;STAT4;PSME2;SOD2;ANXA2;RPLP0;AIP;MSN;TCP1
prerank,myoblast fusion (GO:0007520),-0.36522153115173084,-0.9371509396538129,0.5305676855895196,0.8771703072807483,1.0,3/12,10.02%,ADGRB3;KCNH1;ADAM12
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.37080842934373276,0.9371467140231462,0.5401459854014599,0.8742929789618024,1.0,2/13,3.68%,UBA2;UBA7
prerank,regulation of filopodium assembly (GO:0051489),0.28817975779081484,0.936896508224102,0.5680272108843537,0.8743671425608014,1.0,8/38,8.05%,PIK3R1;CAPZB;RHOQ;PRKCD;TRPM2;FSCN1;ABITRAM;CCR7
prerank,carboxylic acid transport (GO:0046942),0.2711029097082751,0.9366693528432005,0.5675675675675675,0.874336155607488,1.0,11/55,17.70%,SLC7A8;SLC16A6;SLC7A5;SLC36A1;SLC15A4;CLN3;SLC16A7;SLC6A9;SLC38A1;SLC23A2;SLC23A1
prerank,Golgi organization (GO:0007030),-0.2185398765967309,-0.9360338716372559,0.6314363143631436,0.8793779648554698,1.0,15/112,8.29%,ATP8B4;LRRK2;HTT;SYNE1;GOSR2;ZW10;STX17;ATL2;VCPIP1;VPS51;CDC42;GOLPH3;CUL7;TMED1;VMP1
prerank,DNA strand elongation (GO:0022616),0.33805600202669434,0.9356433434368064,0.5526315789473685,0.8764410815310986,1.0,7/18,21.10%,GINS4;NBN;POLD2;DCLRE1B;GINS3;MCM3;MCMDC2
prerank,B cell activation involved in immune response (GO:0002312),-0.35858186316081353,-0.935448337851162,0.5320088300220751,0.880073299879992,1.0,6/13,23.15%,LIG4;FCGR2B;MSH6;GAPT;CD19;MSH2
prerank,protein localization to cell junction (GO:1902414),-0.3100706543163393,-0.9351888245348677,0.5435779816513762,0.8799253101258244,1.0,6/22,14.85%,NLGN1;PCLO;NECTIN1;HEG1;JAM3;MPP4
prerank,regulation of defense response (GO:0031347),0.2508185977339015,0.9350377667147909,0.5971337579617835,0.877383336280135,1.0,22/76,25.98%,DAGLB;IL1RL2;SBNO2;CASP1;LRRC19;PIK3AP1;SELE;BCL6B;APPL1;AREL1;NLRP6;XIAP;AKNA;NOD2;CASP12;SHPK;PARK7;ERAP1;MYD88;APPL2;HCK;NR1D2
prerank,odontogenesis (GO:0042476),-0.27533198782074964,-0.9350290184856258,0.567741935483871,0.8794888633408651,1.0,12/35,31.06%,LRP6;EDA;TUFT1;BMP4;FOXC1;WNT6;MSX1;AQP1;HDAC1;TBX1;AMELX;PITX2
prerank,DNA recombination (GO:0006310),0.2820339207968696,0.9349314313076913,0.5714285714285714,0.8770227114718226,1.0,13/37,27.93%,RHNO1;HDAC10;RAD54B;RAD51B;EXO1;RPAIN;BLM;FBH1;TSN;RAD51C;RPA1;RTEL1;RECQL
prerank,negative regulation of interleukin-6 production (GO:0032715),0.3053326170433058,0.9348539897391005,0.5594149908592322,0.8766044027794095,1.0,7/27,21.59%,SIRPA;TLR4;NCKAP1L;SLAMF1;ARRB1;SYT11;ZC3H12A
prerank,regulation of neuron migration (GO:2001222),0.31429921974157315,0.934617929575758,0.5604982206405694,0.8766155596352503,1.0,2/26,0.66%,SRGAP2;ARHGEF2
prerank,kidney development (GO:0001822),0.2579640084123677,0.9345983503827721,0.5769911504424778,0.8760419541294068,1.0,14/65,17.85%,TGFBR1;SALL1;BAG6;SHH;GDNF;SOX17;PAX2;LRP4;PROX1;ARL3;AGT;KANK2;VANGL2;GATA3
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.23628862449573018,0.9342961541883904,0.594855305466238,0.8761972163451536,1.0,22/109,16.50%,VAV2;RAC1;PIK3R1;GAB2;LAT2;LYN;PLCG2;LCP2;NFATC1;PDPK1;TAB2;JUN;PSMD3;PIK3CB;PSMB3;PSMA7;PSMC1;MAPK8;PSMC2;TEC;PSME4;PSMB9
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.3693700174752093,0.9341570553896624,0.5545112781954887,0.875945327438217,1.0,5/13,20.33%,PADI2;ZMIZ2;ZMIZ1;ARID1A;ELOF1
prerank,clathrin coat assembly (GO:0048268),-0.3523375916124838,-0.933813046154349,0.5521064301552107,0.8818943815742262,1.0,3/15,4.37%,HIP1;SGIP1;PIK3C2A
prerank,cellular response to oxidative stress (GO:0034599),-0.2161544751536401,-0.9336487697328789,0.6073298429319371,0.8814500627972941,1.0,34/118,21.40%,LRRK2;CYBB;EGFR;MSRA;RPS3;PRDX1;ROMO1;PPIA;NCF2;PKD2;DAPK1;MGAT3;SLC25A24;AGAP3;CYBA;ERO1A;HMOX1;PYROXD1;SOD2;HSPA1B;FER;ERCC6L2;SNCA;PRR5L;ZFAND1;FOXO1;GSTP1;TXNRD1;MAPK1;CYCS;CAT;PTPRK;NOX4;PLA2R1
prerank,regulation of biomineral tissue development (GO:0070167),0.3084944791321596,0.9332981059614994,0.5616942909760589,0.8775385586353863,1.0,7/26,24.06%,NBR1;BMP2K;DDR2;ROCK2;TWIST1;TGFB1;SOX9
prerank,regulation of mast cell activation (GO:0033003),0.3921562655165203,0.9329054389997221,0.5539033457249071,0.8779561027381245,1.0,2/10,2.98%,CD84;LYN
prerank,collagen fibril organization (GO:0030199),0.2436032413980174,0.9327582225450498,0.5901639344262295,0.8777360810954206,1.0,5/88,1.17%,TGFBR1;DST;COL27A1;GREM1;ITGA6
prerank,B cell proliferation (GO:0042100),-0.3299992845145022,-0.9324871202086311,0.5452488687782805,0.88377149025925,1.0,8/17,25.12%,CD40;CR2;CTPS1;BCL2;MS4A1;GAPT;CD19;RASGRP1
prerank,telomere organization (GO:0032200),0.2796462139849624,0.9324549759919873,0.5659050966608085,0.8779192637848742,1.0,17/43,27.61%,PCNA;ATM;NBN;CTC1;POLD2;DCLRE1B;ERCC4;TERF1;BLM;ACD;XRCC6;LTO1;RPA3;POLD4;STN1;RPA1;RTEL1
prerank,intestinal absorption (GO:0050892),-0.3614118441642362,-0.932210009049024,0.5407925407925408,0.883648517887593,1.0,5/13,13.54%,CD36;ADRA2A;SLC46A1;UGCG;KCNQ1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.24450431463397596,0.9316796277130226,0.5879478827361564,0.8792601509305423,1.0,24/88,21.91%,BAG6;CST3;CNOT1;ENC1;NANOS2;GAPDH;CLN3;TOB1;SERPINE2;MRPL13;IGF2BP2;AKT1;DNAJC1;RIDA;EPRS1;EIF2AK2;FXR2;TYMS;EIF2AK3;CAPRIN1;PCIF1;NANOS1;DDX3X;LARP1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.39103369186855913,0.9315664844655213,0.5447470817120622,0.8789457763791394,1.0,8/10,31.11%,TLR4;MIA3;AKT1;TICAM1;MYD88;CD68;TLR6;TREM2
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.3624028606977417,0.9315357501541924,0.5653923541247485,0.878418187346889,1.0,4/13,22.38%,GPRC5A;TSG101;ERRFI1;SNX6
prerank,negative regulation of cell activation (GO:0050866),-0.34830804239299096,-0.9315050993271798,0.5547945205479452,0.884681770132887,1.0,2/14,4.62%,LDLR;APOE
prerank,cellular defense response (GO:0006968),0.28408153154740406,0.9315030428455534,0.5734265734265734,0.8778855673290059,1.0,5/40,7.54%,CX3CR1;IL1RL2;PTK2B;TCIRG1;ADORA2B
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.3494826015200352,0.931474868165522,0.5614678899082569,0.8773464852991013,1.0,4/16,12.33%,SNRPC;SFSWAP;PRPF39;DCPS
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.3673728906505656,0.9311415320987642,0.5553470919324578,0.8775536614640961,1.0,1/13,0.06%,TGFBR1
prerank,negative regulation of nuclear division (GO:0051784),0.383091195893951,0.9311381122133949,0.5483271375464684,0.876949344841508,1.0,2/11,10.02%,NANOS2;NME6
prerank,modulation by host of viral genome replication (GO:0044827),-0.34955653102213224,-0.93098650620285,0.5635964912280702,0.8852670122059403,1.0,4/13,14.63%,VAPA;PRKN;NUCKS1;EIF2AK4
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.3501321657872765,-0.9309678086851133,0.5553047404063205,0.8844357037684547,1.0,5/15,18.49%,PPARG;IRS1;SLC45A3;PRKCE;ADM
prerank,regulation of protein metabolic process (GO:0051246),-0.2578890334671919,-0.9308763424442492,0.5703703703703704,0.8838136827682321,1.0,8/44,6.26%,APP;LDLR;FAF1;NEDD4L;APOE;KLF2;PARL;SPOP
prerank,regulated exocytosis (GO:0045055),0.22007733384799127,0.9307425945067483,0.6210045662100456,0.8773025241861926,1.0,22/173,8.53%,LHFPL2;TUBA4A;CD9;SYNGR1;CYRIB;FERMT3;LYN;PROS1;PLEK;MYH9;SPARC;CLU;STXBP1;VEGFB;STX1A;RIMS3;ARHGAP17;CYB5R1;PDGFB;SELENOP;SELP;ORM2
prerank,nuclear envelope organization (GO:0006998),-0.3143211492901091,-0.9301709803184746,0.5384615384615384,0.884921382925418,1.0,9/20,29.20%,REEP3;TOR1A;DMPK;REEP4;NUP155;EMD;CTDNEP1;NUP93;SUN3
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.3013930455006244,-0.9300932292778935,0.5802197802197803,0.8842128218004398,1.0,6/23,15.29%,PDE4B;LRRK2;RYR2;PRKN;KCNQ1;SNCA
prerank,gene expression (GO:0010467),0.20351740511837352,0.9299461804792394,0.6926229508196722,0.8787916084656635,1.0,95/348,22.88%,SRRM1;TSPAN14;NCBP1;POLR2H;POLR2J;RANBP2;LMF1;NKX2-8;EIF4G1;MRPL37;RPS27A;MAGOHB;MAGOH;U2AF2;RRBP1;POLR2D;CELF2;NUP42;MRPL43;HNRNPH1;THAP1;RBM39;MRPL34;SARS1;SEC13;DHX38;MRPL9;DDX17;NUP50;RPL15;MMS19;MEF2A;PABPN1;SRSF5;MRPS5;CPSF1;NUP35;DTX1;ASMT;RPL10;RBM8A;NUP88;RPS8;DHPS;DDX54;GSPT2;DDX20;MRPS21;ABCF1;U2AF1L4;SLU7;RPS24;MRPL13;FIP1L1;ALYREF;MRPS16;MRPS18B;MRPS11;ALKBH5;POLR2E;DUSP11;NUP62;EIF4EBP2;SEH1L;PRPF4;NUP107;STUB1;RPL9;MRPS18A;RPL39;SNRNP40;THOC6;TNIP1;MRPL11;MRPL41;MRPL27;GALNT2;TOPORS;SRSF9;EPC1;HNRNPH3;FASTKD2;DDX19B;HNRNPA2B1;ANGPT2;DDX39B;RPL28;POLR2I;HNRNPUL1;RBPMS;MPHOSPH10;LMF2;RPL34;MED20;NUP153
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.21046533401635342,-0.9297485275344953,0.6532951289398281,0.8843011048620127,1.0,31/152,15.49%,LRRK2;EGFR;FGF10;CSNK1G1;SULF2;SEMA5A;PPM1A;PSMD14;GPC5;UBR5;ATP6AP2;PSMD8;PSMA2;PSMF1;PSMD6;CDC73;AXIN1;PSME2;ZEB2;CCAR2;GPC3;LGR5;KANK1;PSMD5;TNKS2;PSMD12;LGR4;PSMD11;COL1A1;SFRP1;PSMD1
prerank,autonomic nervous system development (GO:0048483),-0.3293211040135421,-0.9294132958127976,0.5437352245862884,0.8842934724174555,1.0,3/17,5.28%,SOX11;FN1;EDNRB
prerank,defense response to Gram-negative bacterium (GO:0050829),0.2775528010713684,0.9293803305892194,0.5818505338078291,0.879654426675456,1.0,11/42,17.95%,TLR4;NOS2;IL12B;SELP;IL6R;SERPINE1;RNASE6;OPTN;PYCARD;SLC11A1;HMGB2
prerank,defense response to bacterium (GO:0042742),0.23703569671788874,0.9286182768419862,0.5920398009950248,0.8810285378268337,1.0,26/105,20.83%,ANXA3;LYZL4;TLR4;PRKCD;SLPI;PLA2G6;NOS2;IL12B;SELP;HAMP;IL6R;RAB1A;GBP6;SERPINE1;RNASE6;OPTN;MAVS;PYCARD;SLC11A1;HMGB2;GBP7;RPL39;LPO;NOD2;ADAM17;TNFRSF14
prerank,L-serine metabolic process (GO:0006563),-0.39266685230541537,-0.9285596493710403,0.5558139534883721,0.8857865154860944,1.0,4/10,15.21%,PSAT1;SRR;SHMT1;SERINC5
prerank,positive regulation of phosphorylation (GO:0042327),0.2107148389955846,0.9283527440121057,0.6451149425287356,0.8811060402706571,1.0,68/240,24.68%,MERTK;TMEM119;MLXIPL;CSF1R;ITGA6;RAC1;AGER;LYN;ATG14;IGF1R;NBN;FLCN;VEGFB;RYK;AKTIP;CAMKK2;MET;KCTD20;EPHA8;GPER1;CLIP3;NCKAP1L;AXL;PDGFRB;RB1CC1;PINK1;DDR2;PFKFB2;CCND3;ENG;MUSK;ARNT;PIN1;SEMA4D;IL34;ABL1;MAVS;AKT1;CIB1;CDK2AP1;GPNMB;PIK3R3;PELI2;ARRB1;ROCK2;FXR2;FBH1;THBS1;RSPO1;CRKL;EPHA2;FGFR4;SLC4A4;ADAM17;EFNA1;FGF20;VAC14;CSNK1D;AXIN2;BMP2;TGFB1;RALB;DVL2;FGFR2;SOX9;ITGB3;FGF1;HIF1A
prerank,catecholamine metabolic process (GO:0006584),0.36341979423936027,0.9279763329602576,0.5714285714285714,0.8814135218766742,1.0,3/14,13.47%,SNCAIP;COMT;DRD2
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.23133487161289534,-0.9279375164417065,0.6146095717884131,0.886546593578931,1.0,14/76,10.59%,GRM5;ADRA1A;GRM1;HRH1;HTR2C;GPR35;HTR2B;HOMER1;CHRM2;OPRM1;ACTN2;OPRD1;ADRA2A;P2RY1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.3452449193384579,0.9278793307509706,0.5577617328519856,0.8810336597030642,1.0,2/18,2.98%,BAG6;LYN
prerank,Fc receptor signaling pathway (GO:0038093),0.23383281849888934,0.9278353310633867,0.5926517571884984,0.8805347896976508,1.0,22/110,16.50%,VAV2;RAC1;PIK3R1;GAB2;LAT2;LYN;PLCG2;LCP2;NFATC1;PDPK1;TAB2;JUN;PSMD3;PIK3CB;PSMB3;PSMA7;PSMC1;MAPK8;PSMC2;TEC;PSME4;PSMB9
prerank,regulation of necroptotic process (GO:0060544),0.3149317227936011,0.9276643105012033,0.5514184397163121,0.8803413257036576,1.0,13/23,33.52%,ARHGEF2;CFLAR;FLOT2;STUB1;PDCD6IP;FZD9;CDC37;FLOT1;BIRC2;CYLD;BIRC3;PELI1;OGT
prerank,innate immune response (GO:0045087),0.21318598686477103,0.9276320430415352,0.6285289747399703,0.8798178968777455,1.0,20/217,5.75%,CX3CR1;RIPK2;PJA2;COLEC11;AGER;PYDC1;SERINC3;OTULIN;TRIM11;TLR4;LYN;TRIM5;SRC;PIK3CG;PHB2;PLCG2;SLPI;F12;PTK2B;ATAD3A
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.36365538599697883,-0.9273552267702768,0.5655172413793104,0.8872163894710972,1.0,6/13,19.77%,APP;SHANK3;ADCY8;EIF2AK4;RELN;EPHB2
prerank,positive regulation of viral life cycle (GO:1903902),0.3220757373803987,0.9272668383616691,0.5642361111111112,0.8801516344242288,1.0,7/22,21.31%,LGALS9;TRIM11;AXL;VPS37B;CHMP2A;VPS4A;TSG101
prerank,positive regulation of macrophage activation (GO:0043032),0.34648987744990234,0.927260687836652,0.5493716337522442,0.8795541141422178,1.0,6/17,19.13%,KARS1;TLR4;CCL3;IL33;TNIP2;THBS1
prerank,inner mitochondrial membrane organization (GO:0007007),0.2734583759847088,0.9269107987610212,0.5875420875420876,0.8798012620074076,1.0,19/47,26.21%,TIMM8B;MICOS13;TIMM29;DNAJC11;ATP5PO;ATP5PD;NDUFA13;ATP5MC1;TMEM11;TIMM10B;ATP5F1D;MTX1;AFG3L2;MAIP1;OPA1;ATP5PF;CHCHD6;TIMM13;SAMM50
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.24713060684769209,-0.9268782543716353,0.6035353535353535,0.8876960441491696,1.0,21/55,25.19%,GPC6;LYVE1;CD44;HGSNAT;SDC3;GPC5;HMMR;HSPG2;VCAN;GPC3;CSPG4;GPC4;AGRN;LUM;FUCA1;GPC1;ACAN;SGSH;OGN;IDUA;SDC2
prerank,regulation of exit from mitosis (GO:0007096),0.27869144741489715,0.9267195163317767,0.568760611205433,0.8797216000496048,1.0,7/38,11.68%,SIRT2;PPP1R9B;PHB2;RPS27A;UBC;ANAPC15;CDC14B
prerank,negative regulation of cellular senescence (GO:2000773),0.368524327389422,0.9265451059362,0.5658627087198516,0.8795765151066485,1.0,2/13,3.39%,MAP3K3;SLC30A10
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.382596562333453,0.9262220785163949,0.5806451612903226,0.8798288293273029,1.0,8/12,34.87%,UHMK1;KHDRBS1;PTPN14;TGFB1;RBM4;NUP214;SIRT7;NEDD4
prerank,carbohydrate derivative transport (GO:1901264),0.33578498795753586,0.9261339400464862,0.5906642728904847,0.8794605121480314,1.0,8/18,21.47%,CPTP;SLC15A4;CLN3;NPC2;SLC29A1;SCARB1;SLC15A2;SLC28A1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.25465913517194894,-0.9260200495776754,0.6100478468899522,0.8891931332240306,1.0,13/47,19.33%,NEDD9;DOCK5;CDC42;CARMIL1;MYADM;KANK1;SPRY4;ITGB1BP1;EFNA5;RCC2;S100A10;DOCK1;OLFM4
prerank,positive regulation of double-strand break repair (GO:2000781),0.2820855570749738,0.9257507241051146,0.57166392092257,0.8798355336593761,1.0,8/39,12.90%,FUS;WDR48;SPIDR;MGMT;MMS19;SPIRE1;KMT5C;SHLD2
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.33455340186324445,0.9255652402940515,0.5574614065180102,0.879719184657739,1.0,4/17,13.74%,CADM1;RAET1E;IL12B;NECTIN2
prerank,positive regulation of protein kinase activity (GO:0045860),0.2245014394964209,0.925086176865388,0.6377473363774734,0.880348350817659,1.0,47/148,24.78%,TGFBR2;CSF1R;MAP4K4;MMD;CAMKK1;SRC;EGR1;PRKCD;CLU;LCP2;PTK2B;STRADA;PDGFB;RPTOR;CCR7;IL12B;TAB2;IL6R;DLG4;PTPN1;DDR2;TAOK2;AGAP2;MARK2;IL34;EZH2;CIB1;CSF1;MAP2K1;PDCD10;AGT;SLC11A1;CAMK1;ECT2;XRCC6;EFNA1;DDX3X;SLC8A2;RASSF2;CALM2;JTB;RALB;TELO2;PTPRC;ITGB3;DUSP19;MINK1
prerank,post-translational protein modification (GO:0043687),0.20562851465126986,0.9250007092428761,0.7081005586592178,0.8799686316113601,1.0,88/332,25.44%,GOLM1;CST3;FBXL18;MGAT4A;PRKCSH;IGFBP3;FBXO22;ASB8;VHL;FBXL20;DDB2;SPSB1;FBXL15;COPS4;DCAF8;DCAF10;FBXW4;SPSB2;SOCS6;MBTPS1;CUL4B;ASB4;MIA3;AMBN;ASB15;ANKRD9;RAB1A;ASB11;RABGGTA;PSMD3;ASB3;KBTBD8;ASB5;FBXL8;PSMB3;MSLN;WSB1;PSMA7;GPS1;DCAF11;PSMC1;FBXO21;PSMC2;KCTD6;CSF1;RNF7;KCTD7;FBXL22;WDTC1;PSME4;CCDC22;FBXO11;COPS6;PSMB9;ADAM10;TULP4;WSB2;RAB13;ATG5;EVA1A;CUL4A;DMP1;PENK;PSMD4;PSMB5;DSCC1;SUMF2;DCAF5;PSMB7;DCUN1D1;KLHL3;FBXL7;UBXN7;RCN1;MXRA8;PSMB8;CAND1;FBXW5;KLHL41;FBXL3;WDR5;HIF1A;KLHL9;PSMD13;CHGB;ICMT;APLP2;FBXL14
prerank,response to UV-A (GO:0070141),-0.34878477788340695,-0.9249700412083757,0.5631929046563193,0.8911278990011252,1.0,2/14,2.55%,EGFR;MME
prerank,cellular potassium ion homeostasis (GO:0030007),0.36980077334360667,0.9248933376661357,0.555765595463138,0.8796589060495487,1.0,3/13,18.76%,KCNMA1;ATP1A4;KCNJ2
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.3684515097875799,0.924473995760146,0.5749063670411985,0.8801890560180958,1.0,2/13,8.60%,TPST2;SULT2A1
prerank,retinal metabolic process (GO:0042574),0.3724937094298413,0.9244616788442857,0.5831775700934579,0.8796105995656548,1.0,2/12,3.55%,BCO2;ALDH8A1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.402050496965478,0.924315205105172,0.553639846743295,0.8793916013044636,1.0,4/10,18.86%,BRCA1;RAPGEF3;HDAC5;CAMK1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.3532299015983378,0.924269428809028,0.5524752475247525,0.8789056819261503,1.0,5/15,26.32%,SMAD7;ABL1;DTX3L;PARK7;BAG5
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.2976651761500701,0.9240365714751805,0.5847750865051903,0.878879622806529,1.0,4/30,3.75%,TGM2;LYN;ITGAV;SRC
prerank,regulation of cellular amide metabolic process (GO:0034248),0.293300061715217,0.9238738192822872,0.589041095890411,0.8787074643446231,1.0,8/32,14.06%,PICALM;PRKCD;EIF2A;PKP3;EIF2B4;CYFIP1;RPL10;PGAM1
prerank,negative regulation of myotube differentiation (GO:0010832),0.3590702425605092,0.9238516305224221,0.5656192236598891,0.8781588140937622,1.0,1/12,0.28%,TMEM119
prerank,negative regulation of cell junction assembly (GO:1901889),-0.29520107406268414,-0.9237860257898847,0.5881057268722467,0.893548482650532,1.0,7/25,21.18%,ARHGAP6;ITGB1BP1;ACVRL1;RCC2;BCAS3;ACE;ROBO2
prerank,mitotic cytokinesis (GO:0000281),-0.2527994018758091,-0.9237771229595939,0.6115107913669064,0.892684526166101,1.0,10/47,11.32%,ANK3;SPTBN1;KIF23;RACGAP1;CUL7;SNX9;NUSAP1;CNTROB;UNC119;KIF20A
prerank,cell-substrate junction assembly (GO:0007044),-0.2753841799923449,-0.9231829362680049,0.5813953488372093,0.8933898424344122,1.0,7/33,10.58%,SORBS1;CTTN;FN1;TRIP6;THSD1;ACTN2;CD151
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.2446231305864778,0.9231550433136176,0.599009900990099,0.8793438042741735,1.0,19/80,19.13%,CTSD;RPS6KA1;CSNK2A1;SRC;CASP1;ARL6IP5;NLRP3;GPER1;DPEP1;LAMTOR5;PAX2;PDCD6;PYCARD;AKT1;NDUFA13;XIAP;HTRA2;PPM1F;THBS1
prerank,plasma membrane organization (GO:0007009),-0.24586253452403725,-0.9231278261088536,0.5909090909090909,0.8926481366972836,1.0,11/61,11.68%,ANK3;MYOF;ANK2;SPTBN1;SNX9;ANO6;RAB3A;AHNAK2;PLSCR4;PLSCR2;DYSF
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.3259763881383749,0.9224370400042671,0.5529197080291971,0.8800213493328729,1.0,5/21,12.61%,DDB2;GTF2H2;ERCC2;CUL4B;ERCC4
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.3259763881383749,0.9224370400042671,0.5529197080291971,0.8800213493328729,1.0,5/21,12.61%,DDB2;GTF2H2;ERCC2;CUL4B;ERCC4
prerank,carbohydrate homeostasis (GO:0033500),-0.23666992501864292,-0.9223717727812186,0.6207792207792208,0.8938417087384369,1.0,12/67,12.65%,PPARG;MCU;IRS1;USF1;SLC8B1;ADIPOR2;ALOX5;PTPN2;ADCY8;ADRA2A;CEBPA;RBP4
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),-0.2074622174264883,-0.9219365569074874,0.6685714285714286,0.8941048183091074,1.0,21/142,10.59%,CCR2;CD36;ADRA1A;TRPC5;ATP2B1;CCR1;RYR2;IAPP;TRPC4;YWHAE;NPTN;GPR35;SLC8B1;CACNA1C;ADCY5;TRPC3;HCRTR2;FIS1;CD52;ADCY8;P2RY1
prerank,muscle tissue morphogenesis (GO:0060415),-0.3322058544471888,-0.9216711133829094,0.5720620842572062,0.893952485950516,1.0,6/16,28.64%,HEY2;BMP4;TGFBR3;ZFPM1;TTN;TBX1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.34533446786764777,0.9211440792188693,0.5816135084427767,0.8826772854254151,1.0,5/17,14.89%,MAML3;HEYL;NOTCH4;MAML2;NOTCH3
prerank,regulation of RNA metabolic process (GO:0051252),-0.2407327680921959,-0.9202888838506351,0.6120481927710844,0.8967228443557652,1.0,11/59,10.84%,AHNAK;OAS2;PTBP2;NOVA1;MBNL3;RBM20;GRSF1;PCBP3;PRX;SRRM4;AHNAK2
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.32179550364205156,-0.9199233991943484,0.5607675906183369,0.8968116140108262,1.0,7/18,26.47%,GSK3B;ZNF205;BAK1;BOK;CHCHD10;MPV17L;BID
prerank,regulation of DNA metabolic process (GO:0051052),-0.2566304977822386,-0.9196653991761945,0.5925925925925926,0.8966306893706713,1.0,15/44,22.81%,UBE2N;KDM1B;SMG6;SMG5;WDR18;NUCKS1;WDR70;XRCC5;SMG1;PIF1;USP1;STOX1;UPF1;POLH;GRHL2
prerank,regulation of centriole replication (GO:0046599),-0.33508848381375533,-0.9194093208884913,0.5644444444444444,0.8965066064645997,1.0,7/17,16.75%,CDK5RAP2;TRIM37;PLK2;CEP76;ALMS1;MDM1;NPM1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.38272072788226247,-0.9193761460179981,0.5557894736842105,0.8957234518614362,1.0,2/10,4.41%,LILRB1;FN1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.2682224484161871,-0.9193260290452516,0.6022222222222222,0.8949841110218312,1.0,6/36,9.26%,PLCB1;GNAO1;AGO4;CALM1;TNRC6A;NLK
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.1957816984926225,0.9193117241270247,0.7683089214380826,0.8868215147456683,1.0,102/497,19.08%,SALL1;IKZF1;BASP1;MLXIPL;SUMO1;CAPN3;PRMT2;HEYL;DDIT3;SOX8;PBXIP1;SBNO2;SIRT2;CNOT1;PPARD;FOXE1;CCDC85B;CRY2;HDAC10;DEAF1;PHB2;SAMD1;SUDS3;ID1;ZNF568;ZBTB21;ENC1;CHD8;LOXL3;ELK3;MLX;RPS6KA5;RAD17;FOXK2;BCOR;ZBTB18;EID2;SIN3A;PDGFB;ZMYND11;BCL7A;FOXN3;MIDEAS;SAMD11;NANOS2;SAMD13;TWIST2;TMPRSS6;PATZ1;JUN;GAPDH;LIMS1;NPAS1;DPF2;INPP5K;EID2B;MBD1;PRDM11;BRCA1;PAX2;TOB1;SMARCA2;DPF1;KDM4A;MAP3K10;PRMT6;GCLC;TERF1;WWP2;ID3;EZH2;MRPL13;IGF2BP2;TSPYL2;NDUFA13;HDAC5;PROX1;EED;PASK;ZEB1;VGLL4;COMMD7;RIDA;TSC22D4;EPRS1;QARS1;SCMH1;POU2F1;EIF2AK2;EIF2AK1;KDM1A;GATA3;KAT5;KDM8;HMGB2;CHMP1A;DKK3;FXR2;EID1;KHDRBS1;PPM1F;NR1H2
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.25034173502228935,0.9192604394414601,0.6078431372549019,0.8863531815393213,1.0,22/70,23.38%,ITCH;GATA2;PSMD3;PSMB3;RUNX1;PSMA7;ABL1;PSMC1;PSMC2;TAL1;TCF3;PSME4;OSM;PSMB9;EIF2AK2;GATA3;LMO1;PSMD4;PSMB5;PSMB7;LMO2;PSMB8
prerank,camera-type eye morphogenesis (GO:0048593),-0.3818187994163533,-0.9190857003139254,0.5860566448801743,0.8947531107414538,1.0,2/10,3.94%,TENM3;LRP6
prerank,cellular response to heat (GO:0034605),0.2829256956238853,0.9190684263392176,0.5817555938037866,0.8862217999297061,1.0,11/35,21.24%,SUMO1;PRKACA;POLR2D;PDCD6;TRPV4;SLU7;STUB1;HTRA2;THBS1;MAPT;IL1A
prerank,mammary gland epithelium development (GO:0061180),-0.34395689942440055,-0.9188830975847128,0.5611353711790393,0.8944616053969203,1.0,4/14,7.41%,LATS1;JAK2;ERBB4;WNT4
prerank,protein-containing complex subunit organization (GO:0043933),-0.21654975577302332,-0.9185234078166887,0.6713881019830028,0.8946100591305708,1.0,28/109,17.83%,CD74;CD40;ZW10;NUP98;DNM1L;WASF1;ST13;GEMIN5;SNX9;KNTC1;PPIH;NUP205;PPP2R1A;IL2RB;JCHAIN;PARD3;NUP54;IL1RAP;GPAA1;MDM2;REPS2;CD3E;TRAF1;ADD2;RIMS1;WDR19;SPG7;CARD10
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.23979801190396247,0.9182941805899032,0.6296928327645052,0.8876208645236816,1.0,15/84,11.94%,SON;NCBP1;DDX5;QKI;MAGOH;U2AF2;SFSWAP;CELF2;JMJD6;RBM39;C1QBP;RBM24;DDX17;RBM8A;TRA2B
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.30553358697155475,0.9180270614629941,0.5459183673469388,0.8877096629999731,1.0,9/24,25.37%,IL6ST;BRCA1;ARNT;CXCL17;EIF2AK3;IL1A;TGFB1;HIF1A;SULF1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.2882708610120311,0.9179758786936474,0.6060606060606061,0.8872405990828913,1.0,9/33,17.81%,PRKCA;CTNNBIP1;ZFP36L1;IL12B;POU4F1;RUNX1;IL34;CSF1;FES
prerank,phospholipid homeostasis (GO:0055091),-0.3704291931790864,-0.9179599638478955,0.5565217391304348,0.8952496002577924,1.0,4/11,31.54%,RCN3;ANGPTL3;ABCB11;LIPG
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.20094132868172618,-0.9179176039717591,0.7003257328990228,0.8944806547674777,1.0,24/173,10.98%,ANK3;ANK2;SPTBN1;ACTR10;GRIA1;CUL3;CTSC;DYNC1I2;VAPA;GOSR2;ZW10;SEC23A;STX17;ATL2;RAB1B;SCFD1;SAR1B;F7;SPTBN2;TMED1;COPG2;SPTBN4;TRAPPC1;SEC24D
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.3051732006222744,0.9177980018654995,0.5646630236794171,0.8870543554065523,1.0,4/25,6.49%,RAC1;PICALM;ITGAV;NEU3
prerank,positive regulation of DNA metabolic process (GO:0051054),0.2537441749170996,0.9177320358276866,0.5840266222961731,0.8866136640992032,1.0,12/61,13.05%,SMOC2;PCNA;NBN;DHX9;PDGFB;STPG4;EYA3;RNF8;BRCA1;PDGFRB;CEBPG;ABRAXAS1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.34702928823630264,-0.917649771472792,0.5944798301486199,0.8943717697585062,1.0,4/13,14.11%,LRRK2;AK3;RAN;AK4
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.30388257229984206,-0.9175914009793626,0.5662921348314607,0.8936751618147967,1.0,9/20,23.65%,CWC27;PPIA;PPIH;PPIC;PPIL3;PPWD1;PPIG;PPIF;PPIB
prerank,negative regulation of blood coagulation (GO:0030195),0.2788824666208176,0.9174875753955327,0.5916955017301038,0.8866448675774914,1.0,8/38,15.98%,F12;PDGFB;CD34;F8;APOH;SERPINE1;SERPINE2;PLG
prerank,positive regulation of phagocytosis (GO:0050766),0.27189890734507716,0.9172032586114983,0.5996649916247906,0.8867696648792392,1.0,10/47,18.35%,MERTK;SIRPA;CAMK1D;GATA2;PLA2G5;NCKAP1L;PYCARD;RAB27A;SLC11A1;PTPRJ
prerank,negative regulation of vascular permeability (GO:0043116),-0.3641544258446547,-0.9169327107759553,0.5764462809917356,0.8944874730667571,1.0,3/12,13.67%,SLIT2;SH3GL2;PDE2A
prerank,regulation of cellular response to heat (GO:1900034),0.24359052426555466,0.9168475213739326,0.6081504702194357,0.887033953544247,1.0,30/77,27.91%,RANBP2;ATM;NUP42;HSPH1;SEC13;RPTOR;CD34;NUP50;MTOR;MLST8;NUP35;HSPB8;NUP88;BAG4;NUP62;SEH1L;NUP107;DNAJC7;MAPT;RPA3;NUP153;FKBP4;NUP188;CRYAB;NDC1;BAG5;CHORDC1;RPA1;CAMK2D;HIKESHI
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.25690023753347624,0.9168467640279326,0.6153846153846154,0.8864339702527868,1.0,25/57,28.45%,EMG1;GTF3A;PES1;CUL4B;SDAD1;BOP1;NIP7;NOP14;TGS1;RPS24;NOM1;NVL;CUL4A;LTO1;SHQ1;BYSL;MRPL36;XPO1;DDX31;RRP36;RPL7;URB2;WDR12;PAK1IP1;RBIS
prerank,positive regulation of multicellular organismal process (GO:0051240),0.20416776027314187,0.9168206521611725,0.6923076923076923,0.8858926805996483,1.0,58/308,18.12%,TGFBR1;TMEM119;IL18;TGFBR2;CADM1;RREB1;SMAD3;CCDC88B;SOX8;TGFB1I1;TRPV2;IGF1R;PIK3CG;TRPM4;RBM19;NUMA1;HCRT;SHH;PDGFB;GCNT2;C1QBP;GDNF;IL12B;TLE6;GAPDH;PIK3CD;INPP5K;MTOR;LRP1;KDM3A;SCAMP5;PAX2;KMT5C;SERPINE1;IL33;BSCL2;PTPN11;SHLD2;GJA1;TBXA2R;SOD1;GHR;CNOT3;EZH2;IL4R;SMO;VIP;NCOA3;NOG;FST;GNAS;STAT6;AGT;EIF2AK2;KDM1A;SLC11A1;LPIN1;SCD
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.24070426679106025,0.9167221540804598,0.61,0.8855674614064026,1.0,17/78,18.34%,SUMO1;SMAD7;NFE2L2;CSNK1E;FBXO22;SIRT2;CLU;KLHL40;USP5;TAF1;ZYG11B;PLK3;RNF144B;DET1;TRIB1;ZER1;STUB1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.2118554651648156,0.9166934792378746,0.6816208393632417,0.8850490793087988,1.0,54/214,21.12%,SIRPA;CSF1R;LGALS9;CNKSR3;ARRB2;AGER;TLR4;PRKCA;NPNT;LYN;SLC30A10;PHB2;PKHD1;CCL3;FLCN;PTK2B;SPRY2;PDGFB;GCNT2;GPR55;CCR7;ARHGAP8;GPER1;CALCR;FSHR;DDT;PLA2G5;RGS14;CEACAM1;PDGFRB;PTPN1;DUSP29;NDRG4;PTPN11;PIN1;PYCARD;CIB1;GPNMB;MAP2K1;SLAMF1;DUSP6;ARRB1;C5AR1;CCL24;CRKL;NOD2;TNIP1;EPHA2;SYNJ2BP;WNK2;FGFR4;TRAF7;P2RY6;ARHGEF5
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.2979028080254097,-0.9166665299432781,0.5736961451247166,0.894354681042475,1.0,10/23,28.70%,ACSL3;ELOVL7;HACD1;ELOVL5;FAR2;ACSL1;FAR1;ACSL6;DGAT2;ACSBG1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.24335533206117788,0.9166339372764234,0.6264855687606112,0.8845989046474756,1.0,21/72,25.15%,NCBP1;POLR2H;POLR2J;POLR2D;HNRNPH1;TIAL1;FRS2;ESRP1;PTPN11;GALNT3;CEP57;NOG;POLR2E;FGFR4;FGF20;POLR2I;SPRED2;HNRNPA1;FGFR2;FGF1;FIBP
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.3195478990256878,-0.9166195253731936,0.5835140997830802,0.8936107952028028,1.0,6/18,21.74%,DAB2;MTMR2;SNX12;MSN;MAPK1;EZR
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.3365153185343377,0.9165740384647129,0.573076923076923,0.8841340379349882,1.0,4/18,10.45%,GNA15;RGS10;CHRM1;GRK2
prerank,presynaptic endocytosis (GO:0140238),-0.29302928858398786,-0.9165657036998802,0.5594713656387665,0.8928990256400648,1.0,2/24,2.48%,NLGN1;SYT1
prerank,positive regulation of vascular permeability (GO:0043117),0.37249854503854185,0.9164392085294634,0.5529197080291971,0.8838713498425518,1.0,4/12,23.10%,TJP1;TRPV4;TJP2;TGFB1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.2411105194002765,0.9162470469710033,0.5996563573883161,0.8837277815611453,1.0,17/76,18.34%,SUMO1;SMAD7;CSNK1E;FBXO22;SMURF1;SIRT2;CLU;KLHL40;USP5;TAF1;ZYG11B;RNF144B;CCDC22;DET1;TRIB1;ZER1;STUB1
prerank,DNA methylation (GO:0006306),-0.30401085845341447,-0.9162228115306438,0.5650319829424307,0.8929269645075442,1.0,8/23,21.99%,KMT2E;ATF7IP;GATAD2A;DNMT3B;HELLS;SPOCD1;DNMT1;EHMT1
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.2730445249790682,-0.9161450107653689,0.5745192307692307,0.8922645481271002,1.0,11/36,24.24%,CCR2;JAK2;SHANK3;ADRA2A;BUD31;RELN;ITGB1;EPHB2;FBXW7;HDAC1;ARC
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.2282715887968309,-0.9160169872022685,0.6205128205128205,0.8917276178792338,1.0,19/80,17.95%,HTT;KIF23;RAB6A;RACGAP1;ZW10;RAB1B;GOLPH3;KIF22;UVRAG;SCFD1;CENPE;COPG2;KIF11;ARF3;ATP9B;TMED2;PLPP3;KIF4A;RER1
prerank,anion transmembrane transport (GO:0098656),0.2462398405293625,0.915903401736572,0.6082644628099173,0.8839557320072453,1.0,18/67,20.12%,SLC7A8;SLC1A3;SLC25A42;SLC7A5;ARL6IP5;SLC35A1;SLC16A7;SLC6A9;LRRC8A;SLC25A11;SLC25A14;SLC35B4;SLC23A2;SLC23A1;SLC19A1;SLC6A8;LRRC8D;SLC25A10
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.24790046302883645,0.9158852172136382,0.6033057851239669,0.8834003031855248,1.0,29/73,29.16%,ITCH;GATA2;PSMD3;PSMB3;RUNX1;PSMA7;ABL1;PSMC1;PSMC2;TAL1;TCF3;PSME4;OSM;PSMB9;METTL14;EIF2AK2;GATA3;LMO1;PSMD4;PSMB5;PSMB7;LMO2;PSMB8;PSMD13;PSMD2;KMT2A;SPI1;PUS7;PDCD2
prerank,amyloid fibril formation (GO:1990000),0.264931489068722,0.9149614288431722,0.608318890814558,0.8851412718091148,1.0,6/51,5.24%,TSPAN14;CST3;SERF1A;SNCAIP;RPS27A;UBC
prerank,glucan catabolic process (GO:0009251),0.35151184444317235,0.9147891500420564,0.5470249520153551,0.8849653728294767,1.0,7/15,21.15%,PYGB;PHKB;AGL;PHKG2;PHKA2;MGAM;GAA
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.23944487718333318,-0.9146774688257064,0.6222222222222222,0.8944291462320557,1.0,15/61,17.75%,PSMD14;PRKAG2;PSMD8;PSMA2;PSMF1;PSMD6;SIRT1;PSME2;PSMD5;PSMD12;PSMD11;OAZ1;PSMD1;NR1H4;AZIN1
prerank,negative chemotaxis (GO:0050919),-0.2755377914634535,-0.9145796856657935,0.5925925925925926,0.8938356574675117,1.0,4/33,4.79%,ROBO1;UNC5C;SLIT2;SEMA4A
prerank,regulation of cholesterol transport (GO:0032374),0.3280395705923629,0.9144257496183865,0.5807622504537205,0.8853102437804247,1.0,6/20,21.18%,LRP1;TTC39B;TSPO;ABCB4;NR1H2;NAXE
prerank,regulation of sodium ion transport (GO:0002028),-0.27213703415338913,-0.9144192395351245,0.5955882352941176,0.8934059790463371,1.0,8/34,14.90%,NKAIN2;ANK3;FGF12;SPTBN4;SIK1;ATP1A1;NKAIN3;PER1
prerank,actin filament bundle assembly (GO:0051017),-0.27718865680479526,-0.9144185492788689,0.5938242280285035,0.8925496067821626,1.0,5/33,8.75%,EPS8;NEDD9;PAWR;SHROOM1;PLS1
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.2823785362022823,0.9143671325518709,0.6039783001808319,0.8848480900342593,1.0,7/34,17.31%,LRP5;PDGFB;EDN3;PDGFRB;AURKA;ANAPC11;NUP62
prerank,"base-excision repair, gap-filling (GO:0006287)",0.28469745697917526,0.9139179720419512,0.6163194444444444,0.8854096349458852,1.0,8/35,18.28%,PCNA;RFC2;MPG;LIG1;POLD2;PARG;RFC1;NTHL1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.36983197887710817,0.913745595076079,0.5695238095238095,0.8852430085326531,1.0,2/12,8.25%,IL18;IL12B
prerank,regulation of intracellular transport (GO:0032386),-0.26306296856114963,-0.9136987070507879,0.6167076167076168,0.8936200977127329,1.0,9/38,13.99%,LRRK2;MAP2;SCFD1;SPAG5;NEFH;LAMP1;WWC1;INPP5F;MYBPC3
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.33506442063702313,0.913405957231574,0.5559701492537313,0.885512211176362,1.0,8/18,25.92%,EXOSC10;CCT3;NHP2;CCT8;SHQ1;CCT7;PARN;CCT5
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.3519917782259152,0.9133726824547722,0.5608365019011406,0.884984932706903,1.0,6/15,18.62%,RAB3GAP2;RAB3GAP1;EDEM1;SEC61A1;SRP14;ZFAND2A
prerank,negative regulation of DNA binding (GO:0043392),-0.28937629104503104,-0.91321003498944,0.5903614457831325,0.8940461825857576,1.0,9/28,19.30%,SOX11;JAK2;SP100;ILRUN;PER2;NFKBIA;HEY2;E2F1;LEF1
prerank,positive regulation of defense response to virus by host (GO:0002230),0.31014831635242956,0.9132068294892605,0.585278276481149,0.884789970064621,1.0,7/24,16.59%,TRIM44;SIN3A;CGAS;IL12B;MAVS;AIM2;DTX3L
prerank,RNA metabolic process (GO:0016070),0.224051030588743,0.9131857047961845,0.6573208722741433,0.8842514796877229,1.0,40/127,24.00%,RNASE1;NCBP1;POLR2H;POLR2J;HNRNPA3;HNRNPC;POLR2D;CELF2;PCBP2;DHX9;HNRNPH1;RBM39;HNRNPR;DDX17;PABPN1;DDX54;RNASE6;DDX20;POLR2E;DUSP11;METTL14;ISG20;PRPF4;SNRNP40;RBMX;SND1;RNASEH1;HNRNPH3;FASTKD2;HNRNPA2B1;DDX39B;ZC3H12A;POLR2I;DDX3X;HNRNPUL1;RBPMS;MPHOSPH10;AGO1;LSM8;HNRNPA1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.29625756137140724,0.9131572245549424,0.5827586206896552,0.8837247256117462,1.0,13/27,30.61%,MTA1;CRY2;FBXL8;CRTC1;PPP1CB;FBXL22;TP53;FBXL3;RBM4;PPP1CC;FBXL12;PPP1CA;PDE6B
prerank,purine-containing compound salvage (GO:0043101),-0.3527710191598572,-0.9130997493654209,0.5754310344827587,0.8934936523215028,1.0,3/12,11.28%,AMPD3;ADK;APRT
prerank,cellular response to lipid (GO:0071396),0.21479513064334335,0.9129989513704118,0.6727549467275494,0.8835344364932768,1.0,43/191,18.74%,CX3CR1;SIRPA;TWF2;MEF2C;SBNO2;TLR4;LYN;ATM;CASP1;PTK2B;CTR9;CD86;NLRP3;WNT10B;PDCD1LG2;GPER1;CXCL1;POU4F1;TICAM2;PABPN1;WNT7B;AXL;CD180;PAX2;SERPINE1;ADCY6;CCDC62;CCR5;MAPK8;PYCARD;NDUFA13;TNIP2;MAPK14;NCOA3;NRIP1;ABCB4;FES;KAT5;HMGB2;TICAM1;ROCK2;HTRA2;NCOA4
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.35534679511875306,-0.9126996082440026,0.5796178343949044,0.8937433545206185,1.0,7/12,26.91%,EXTL2;GMDS;GFPT2;UGP2;SLC35A3;FUT8;CSGALNACT1
prerank,regulation of cellular component organization (GO:0051128),0.2233701362496348,0.9125195177480406,0.6630265210608425,0.8841247988822966,1.0,27/135,13.69%,OPHN1;PICALM;SNCAIP;ITCH;LTBP4;GFAP;ATAD3A;RAB4A;KLK8;LAMTOR2;CAMSAP2;RPTOR;PAPPA2;TJP1;MTOR;CEACAM1;ERMN;ANKRA2;PINK1;PTPN1;HIP1R;CDK11B;PTPN11;TAOK2;SEMA4D;RAB4B;ABL1
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.3947646587250284,0.9124986464751317,0.5568627450980392,0.8835923131306396,1.0,2/10,8.20%,LGALS9;PDCD1LG2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.339446870216686,0.9124164014954151,0.5865921787709497,0.8832150357302557,1.0,7/16,28.89%,BRCA1;CEACAM1;WDTC1;SOX9;APPL2;ERLIN2;ACADVL
prerank,regulation of lymphocyte migration (GO:2000401),0.3944554713574954,0.912231635218815,0.5623836126629422,0.8830743140105143,1.0,4/10,16.53%,JAM2;MIA3;AKT1;WASL
prerank,positive regulation of lipid transport (GO:0032370),-0.3522073685906657,-0.9119876176980248,0.5756880733944955,0.8947709334260514,1.0,2/12,8.56%,APOE;SPP1
prerank,mesoderm development (GO:0007498),0.3265761459989055,0.9117729918514805,0.5740402193784278,0.8836469518753776,1.0,4/18,13.76%,IKZF1;MESD;TBX6;BMX
prerank,RNA stabilization (GO:0043489),0.2829990980340152,0.9117408026473313,0.6098418277680141,0.88314566962624,1.0,11/33,25.83%,FUS;TENT5C;GDNF;RBM24;VIP;SLC11A1;LARP1;ELAVL1;AXIN2;TRDMT1;PARN
prerank,regulation of Ras protein signal transduction (GO:0046578),0.24145402538439545,0.9117145961140057,0.627677100494234,0.8826388909503666,1.0,17/86,17.78%,RASAL3;OPHN1;ARHGEF2;DENND4A;LYN;FLCN;SPRY2;ARHGAP17;RALGPS1;AKAP13;STK19;PDCD10;SYNGAP1;KANK2;SGSM3;NUP62;LZTR1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.28961363073532315,0.9115304529267225,0.5884413309982487,0.8825454640347711,1.0,6/35,8.57%,RAC1;SEMA3B;SEMA4C;SEMA4G;MET;SEMA3G
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.38592787092704817,0.9114878663870223,0.6011560693641619,0.882068482258827,1.0,2/10,9.08%,ERLEC1;OS9
prerank,epithelial cell morphogenesis (GO:0003382),0.34042710549620175,0.9111824788943463,0.5833333333333334,0.8822544121727013,1.0,3/17,7.25%,RILPL1;PKHD1;MET
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.24787264493865355,0.9111131113651716,0.6308724832214765,0.8818445087308497,1.0,17/72,17.88%,CRADD;PCNA;CNOT1;CHEK2;ATM;NBN;RBL2;MDM4;ACER2;PRMT1;TNKS1BP1;RPS27L;PLK3;CNOT3;AURKA;KAT5;CARM1
prerank,mitotic chromosome condensation (GO:0007076),0.3050356487515673,0.9103788779387594,0.5966542750929368,0.8830555445417427,1.0,10/26,24.83%,AKAP8L;CSNK2A2;CSNK2A1;NCAPH2;CHMP1A;NCAPH;CDCA5;KMT5A;MCPH1;PHF8
prerank,regulation of calcium ion import (GO:0090279),0.31843714504980736,0.9098605139003489,0.594306049822064,0.8837199718513133,1.0,7/21,22.43%,CCL3;PDGFB;PSEN2;PDGFRB;WNK3;PLN;STC1
prerank,lung development (GO:0030324),-0.27567033782386124,-0.9092055061552584,0.6501128668171557,0.901195756904223,1.0,12/33,20.79%,FGF10;SOX11;RCN3;FGF7;FGF9;CEBPA;NPHP3;RBP4;PKD1;BMP4;DNAAF1;CCDC39
prerank,histone H3 deacetylation (GO:0070932),-0.3357340909535333,-0.9091814113116711,0.5869074492099323,0.9003917865133212,1.0,4/15,14.90%,HDAC4;PER2;SIRT1;PER1
prerank,regulation of embryonic development (GO:0045995),-0.27165321933156333,-0.9087830773046621,0.5932203389830508,0.9005899769946454,1.0,8/34,16.40%,PLCB1;B4GALT5;TRIP12;RACGAP1;CCSAP;NPHP3;DAG1;NIBAN2
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.37331175393182464,0.9085667294510401,0.5845588235294118,0.8863303263158464,1.0,3/11,16.93%,LIPC;PLA2G5;AGT
prerank,establishment of spindle orientation (GO:0051294),-0.28756168751455025,-0.9081948739057448,0.6072234762979684,0.9012034057924077,1.0,8/28,19.06%,HTT;ZW10;SPDL1;CDK5RAP2;NDC80;GPSM2;ITGB1;NSFL1C
prerank,positive regulation of protein modification process (GO:0031401),0.2093394700159505,0.9081829499246059,0.6828908554572272,0.8866878898708033,1.0,59/203,24.54%,TMEM119;CSF1R;RAC1;AGER;LYN;ATG14;PRKCD;FLCN;VEGFB;AKTIP;CAMKK2;NOS1AP;RAB3GAP2;RAB3GAP1;GPER1;CLIP3;CEP295;RAPGEF3;RB1CC1;PINK1;CCND3;ENG;MUSK;PIN1;SEMA4D;IL34;ABL1;MAVS;DYRK1A;AKT1;CIB1;CDK2AP1;GPNMB;PIK3R3;PELI2;PPP2R5A;ARRB1;KAT5;ROCK2;FXR2;FBH1;CAMK1;RSPO1;CRKL;ADAM17;EFNA1;FGF20;DDX3X;CSNK1D;AXIN2;CALM2;BMP2;TGFB1;RALB;BRMS1;DVL2;SOX9;ITGB3;FGF1
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.3602559314091926,-0.9081690118528706,0.5488069414316703,0.9004108688196673,1.0,3/11,7.34%,PAPOLA;BARD1;CDC73
prerank,oligodendrocyte differentiation (GO:0048709),0.32692743240273375,0.908097264485659,0.5672913117546848,0.8863288277564448,1.0,5/19,10.34%,SOX8;EIF2B3;NSUN5;SHH;EIF2B4
prerank,response to UV (GO:0009411),0.23431719289976494,0.9080474454171651,0.6483870967741936,0.8858532280618796,1.0,20/95,17.61%,RHNO1;PCNA;PRIMPOL;DDB2;PRKCD;MAP4K3;GTF2H2;EIF2S1;USP28;ERCC2;IL12B;BMF;TAF1;ERCC4;PCLAF;MAPK8;AKT1;UBE2A;TMEM161A;KDM1A
prerank,Rho protein signal transduction (GO:0007266),-0.2466967833542631,-0.9079697794751923,0.6472019464720195,0.9001004515813666,1.0,8/53,12.08%,EPS8;ARHGEF3;ARHGAP6;CDC42;CDH13;ADRA2A;RHOU;PLEKHG5
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.35429031173102515,-0.9074847376202548,0.5745614035087719,0.9005236386439105,1.0,3/12,10.26%,PPARG;NFKBIA;ABCA5
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.26613210123494657,0.9074183743465037,0.6084033613445378,0.886808669958582,1.0,15/46,24.22%,SMAD3;PIK3R1;PRKCD;DHX9;RAPGEF3;ZIC1;MAVS;KHDRBS1;CAMK1;ECT2;ZC3H12A;TGFB1;JUP;TP53;IPO5
prerank,limb morphogenesis (GO:0035108),0.3217392700733961,0.907212010079626,0.5682210708117443,0.886758009823316,1.0,4/20,13.39%,SKI;FBXW4;SHH;IQCE
prerank,glycerophospholipid metabolic process (GO:0006650),0.24161744460677453,0.9071656828357498,0.6217105263157895,0.88628578401681,1.0,11/75,11.46%,ABHD12;CSF1R;PLEK;PIGV;PLA2G4A;PLA2G15;PLA2G6;PLA2G4B;CLN3;ABHD6;PDGFRB
prerank,regulation of MAP kinase activity (GO:0043405),0.23557519222996773,0.9071009722011208,0.6331168831168831,0.8858718541192252,1.0,24/92,21.31%,UCHL1;LYN;PIK3CG;PRKCD;KSR1;SPRY2;PDGFB;EDN3;INPP5K;PIK3CB;RGS14;PDGFRB;PTPN1;IL34;DIRAS2;EZH2;TENM1;PDCD10;AGT;TRIB1;PTPRJ;NOD2;HGS;TSG101
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.29547801729064993,-0.9070063152367736,0.6008676789587852,0.9009177513414118,1.0,4/24,6.94%,AGBL4;TTLL11;TTLL7;TTLL5
prerank,regulation of vasculogenesis (GO:2001212),-0.3443631151455203,-0.9067342625206561,0.5625,0.9007762925703637,1.0,2/14,3.31%,XDH;RAPGEF2
prerank,regulation of ATP metabolic process (GO:1903578),0.25581570299808165,0.906669747326902,0.6370967741935484,0.8863989426781436,1.0,20/54,26.23%,RANBP2;COX7A2L;NUP42;SEC13;NUP50;NUP35;PINK1;NUP88;PGAM1;NUP62;SEH1L;NUP107;UQCC2;NUP153;ABCD1;HIF1A;NUP188;ATP5IF1;JMJD8;NDC1
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.26203826655736334,-0.9065897186268893,0.6196172248803827,0.900306500772998,1.0,9/39,11.05%,OLFM2;RAB3C;RCN3;GOLPH3;RAB3D;COPG2;RAB8A;RAB3A;ARL4D
prerank,cellular response to growth factor stimulus (GO:0071363),0.2159573102180774,0.906516266210826,0.6791862284820032,0.8862124847841236,1.0,21/151,9.80%,TGFBR1;TGFBR2;SMAD3;TWF2;SMAD7;MEF2C;SIRT2;MT1G;LGMN;SPRY2;ACAP2;EGR3;PDPK1;PDGFB;ZFP36L1;ZFP36L2;OVOL2;PLK5;LIMS1;APPL1;INPP5K
prerank,apoptotic process (GO:0006915),0.21037641637493804,0.906488505944111,0.698956780923994,0.8857012303388351,1.0,37/203,15.60%,ELMO1;BAG6;TGFBR2;HK2;CAPN3;CFLAR;PPARD;ITGB2;RHOB;PRKCD;TNFRSF21;CASP1;PLSCR3;PTK2B;TRADD;TNFRSF25;MCM2;ERCC2;NLRP3;GAPDH;DPF2;MTOR;PDE1B;BMF;APAF1;DPF1;BNIP2;CDK11B;TAOK2;MAP3K10;PLK3;PYCARD;AKT1;VDAC1;CIB1;TNFRSF19;ADORA2A
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.3529703387649569,0.9063464127359835,0.6118299445471349,0.8854538943317222,1.0,5/15,15.94%,LARGE1;CHST1;CHST7;AMDHD2;CHST2
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.22475623478215292,0.9061234119898626,0.6740506329113924,0.885423969463776,1.0,24/117,18.44%,KARS1;ADCY9;PRKACA;LYN;SRC;MYH9;PLCG2;HRH2;ADORA2B;MC2R;CALCR;FSHR;LHCGR;NPS;ADCY4;DPEP1;ADCY6;INSL3;VIP;MAPK14;ADORA2A;ADCY7;GPR84;GNB1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.27734669413889845,0.9060574230758621,0.5958904109589042,0.8849973677401198,1.0,5/36,7.86%,SIRPA;ITCH;GPS2;ZMYND11;KLHL31
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.22823973238712475,-0.9060071368869139,0.6859296482412061,0.9010052556110896,1.0,15/73,17.43%,CD44;EGFR;BDNF;APP;LATS1;CREBL2;NTRK3;AXIN1;IRGM;OPRD1;RAF1;PAK1;SNCA;SFRP2;TFRC
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.2616243377830799,0.9059044303819966,0.627287853577371,0.8847779961971997,1.0,5/51,4.35%,GREM1;SMAD7;SKI;SMURF1;SKIL
prerank,regulation of hormone secretion (GO:0046883),0.346643480177666,0.9058695192627797,0.572972972972973,0.8842734083464915,1.0,5/15,22.38%,EDN3;SCG5;NMB;OSM;SNX6
prerank,Rap protein signal transduction (GO:0032486),-0.3696869327736766,-0.9055485036564933,0.5854700854700855,0.9013138381936323,1.0,2/10,7.85%,RAPGEF2;PLK2
prerank,regulation of actin filament depolymerization (GO:0030834),0.37097936246102836,0.9054366674515335,0.5893536121673004,0.8847691027816945,1.0,6/12,27.37%,PLEK;PLEKHH2;WDR1;PIK3CA;SH3BP1;LIMA1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.35428751805732234,0.9053351261217798,0.5776965265082267,0.8844384166955043,1.0,6/14,25.51%,ABCD2;MTLN;AKT1;TWIST1;ABCD1;TYSND1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.23863647282940953,0.9052350552288551,0.64171974522293,0.8841054689436671,1.0,23/84,21.91%,BIN1;CNOT1;CLU;ENC1;NANOS2;GAPDH;TOB1;PIN1;MRPL13;IGF2BP2;RIDA;EPRS1;GGA3;EIF2AK2;FXR2;ORMDL2;TYMS;EIF2AK3;CAPRIN1;PCIF1;NANOS1;DDX3X;LARP1
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.2802683322065504,-0.9050557045152792,0.6277915632754343,0.9018160800804076,1.0,7/33,14.65%,PTPRG;SLIT2;SP100;APOE;DUSP10;MCC;ACVRL1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.323187685809416,-0.9050394291453739,0.5605095541401274,0.9010179055795564,1.0,7/17,16.84%,SKAP1;RET;PODXL;CCL5;FOXC2;CD3E;SFRP2
prerank,glial cell development (GO:0021782),-0.28880744795022373,-0.9048267446009934,0.5981524249422633,0.9007023016402402,1.0,4/25,4.19%,TPPP;APP;MYRF;SOX11
prerank,bicellular tight junction assembly (GO:0070830),-0.2433292287163494,-0.9048179132830387,0.6517412935323383,0.8998740951155761,1.0,19/46,30.15%,AFDN;PATJ;FRMPD2;CDH5;PARD3;PECAM1;PRKCI;MICALL2;GRHL2;PARD6G;DLG1;MARVELD3;OCLN;STRN;CLDN5;CLDN18;POF1B;CLDN16;PARD6B
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.3089381593693796,-0.9045982069672336,0.583732057416268,0.8995963313071679,1.0,7/19,18.56%,PTPRD;CDKL5;IL1RAPL1;CUL7;OBSL1;RELN;SS18L1
prerank,regulation of actin filament bundle assembly (GO:0032231),0.3010344305799137,0.9044582746302859,0.6082089552238806,0.8854417814340699,1.0,3/26,3.44%,RAC1;ASAP3;PLEK
prerank,cellular response to BMP stimulus (GO:0071773),0.24680976133996596,0.9038503747485095,0.6445578231292517,0.88633906308582,1.0,20/66,28.03%,SMAD3;SMAD7;DDX5;SMURF1;LEFTY1;ENG;SMAD9;USP9Y;ACVR2B;ZFYVE16;HIVEP1;TMEM100;BMP2;TGFB1;SOX9;PDCD4;AMH;ACVR1;SMAD5;SMAD6
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.3501640247248105,0.9038382435984845,0.5856873822975518,0.8857937501550074,1.0,6/14,23.42%,ACOX3;CROT;CRAT;ACOT8;SCP2;ABCD1
prerank,heterocycle biosynthetic process (GO:0018130),-0.33866395983632824,-0.9034775220756425,0.5835051546391753,0.9016417513576364,1.0,2/14,5.83%,GPHN;ALOX5
prerank,hexose transmembrane transport (GO:0008645),-0.3001026573592688,-0.903071026363162,0.5899772209567198,0.9018339855341848,1.0,11/21,35.73%,SLC45A3;SLC2A12;SLC2A8;SLC2A2;SLC2A4;SLC50A1;SLC2A3;SLC5A1;SLC5A10;SLC2A6;SLC45A1
prerank,chondrocyte differentiation (GO:0002062),-0.26980108847895395,-0.9029115044845614,0.6026785714285714,0.901382937702443,1.0,11/32,20.70%,NFIB;SULF2;SOX5;SNX19;FGFR3;RUNX2;SCX;CCN3;BMP4;WNT7A;SOX6
prerank,COPII-coated vesicle budding (GO:0090114),-0.2294535689765779,-0.9028070664212692,0.6932989690721649,0.9008102172904773,1.0,15/68,14.86%,GRIA1;CUL3;CTSC;VAPA;GOSR2;SEC23A;RAB1B;SCFD1;SAR1B;PPP6C;TRAPPC1;SEC24D;TMED2;LMAN1;SEC24B
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.29682081331017907,-0.9027846079025892,0.559322033898305,0.9000243635901117,1.0,3/22,7.88%,SCAF8;CDC73;ERCC6
prerank,muscle contraction (GO:0006936),-0.2095517286979211,-0.9027409147751425,0.7063492063492064,0.8992939310951903,1.0,11/126,5.23%,DMD;SORBS1;MYOF;UTRN;DTNA;ADRA1A;TMOD3;VIM;GNAO1;GLRA1;CALM1
prerank,dephosphorylation (GO:0016311),0.2166348447287203,0.9026281079412474,0.6977099236641221,0.8881039094419308,1.0,35/147,18.93%,PTPRM;SSH2;PPM1H;CTTNBP2NL;DAPP1;PPM1L;SSH1;PTPRE;PP2D1;INPP5K;PLPP1;ILKAP;PLPP2;CDC14B;PPP2R5B;PTPN1;MTMR4;PTPRA;DUSP29;DUSP18;DUSP5;PPP4R2;TIMM50;PLPPR2;PPP1CB;PTPRH;PTPN21;ACP4;DUSP11;DUSP6;PTPN5;PPP2R5A;ACP2;PTPRJ;PPM1F
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.19433800294339834,-0.9025879978533973,0.7795031055900621,0.8988280781226443,1.0,48/198,19.77%,PLCB1;PTPRD;LRRK2;PLBD1;GPD2;PLPPR4;LIMD1;PPM1A;PPA1;PFKFB1;CERKL;ACYP2;LGALS13;CALM1;HTR2B;PLCH1;PLCB4;ALK;PLPPR1;DUSP10;INPP5J;GPI;NUDT3;TIGAR;PXYLP1;GFPT2;DUSP16;PLCH2;PFKP;ALDOC;OCRL;PAK1;AGPAT1;GK;PLPP3;PLCD1;ANGPTL3;TOP1;ISYNA1;PLA2G2D;DUSP28;ITPKC;PLPPR3;PLAA;IPMK;ITPK1;TPTE;EPHB2
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.31199054533064785,-0.9024793751883855,0.6159420289855072,0.8982607797155785,1.0,4/19,13.37%,SLC5A7;APOE;CHRNA4;ACHE
prerank,mitotic cell cycle phase transition (GO:0044772),0.21029732843445284,0.902328341712228,0.7007518796992481,0.8883135133505043,1.0,66/203,27.20%,DNM2;SDCCAG8;TUBA4A;CSNK1E;PIM2;CHEK2;PRKACA;FBXL15;ODF2;TUBB;CEP164;TUBG1;CCNG2;CDC34;CUL4B;HAUS7;CNTRL;FBXL8;CCND3;TUBA1A;CEP63;CEP57;OPTN;HAUS6;PLK3;HAUS2;CCNE1;LATS2;PPP1CB;SFI1;FBXL22;AURKA;MAPRE1;CEP135;MASTL;ACTR1A;KDM8;OFD1;KHDRBS1;CEP43;E2F3;CUL4A;DCTN2;CHMP2A;RCC1;CCNY;CEP70;FBXL7;CSNK1D;ANAPC1;CDKN1B;FBXL3;ACVR1B;DYNLL1;PHF8;AJUBA;NDE1;CCP110;CDC7;CUL1;HAUS5;ACVR1;FBXL12;CRLF3;CDC25A;ENSA
prerank,positive regulation of cellular component organization (GO:0051130),0.2316123822827937,0.9021479037091256,0.6595419847328244,0.8881819808428452,1.0,19/107,13.27%,TGFBR1;ASAP1;SUMO1;CDC42EP2;IGF1R;CLU;SPIDR;MTLN;TMED9;SH3GLB1;CLIP3;PLEKHM2;LRP1;BMF;RAPGEF3;DLL1;RUNX1;GNL3L;LRP4
prerank,regulation of DNA replication (GO:0006275),-0.2448275136689433,-0.9018821479536242,0.6256281407035176,0.8989561488527257,1.0,12/49,16.12%,EGFR;ANKRD17;FAF1;S100A11;CCDC88A;PPP2R1A;NPM2;NUCKS1;ACVRL1;ESCO2;GMNC;PDS5A
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.2099733312501119,0.9017973036159284,0.7034795763993948,0.8884563044614155,1.0,50/190,22.17%,PDE3B;DDIT3;ARRB2;TBC1D7;CYRIB;ARHGAP25;LYN;PLEK;SRC;PKHD1;FLCN;THEM4;RHOH;RFFL;NDUFS3;DGKD;CDC34;NLRP3;ZMYND11;GPER1;TNFAIP8L1;RTKN2;INPP5K;PIK3CB;PPP2R5B;PEBP1;PINK1;PDCD6;DRD2;PYCARD;AKT1;NDUFA13;CIB1;NLRX1;MAPK14;CD2AP;CCDC22;VGLL4;PTPRJ;WTIP;THBS1;MGRN1;TNIP1;EPHA2;PPM1B;ZC3H12A;DDX3X;BCL2L1;TWIST1;RNF34
prerank,epithelium development (GO:0060429),0.22818000693698615,0.9016076601108691,0.6764252696456087,0.8883201594398651,1.0,28/107,24.06%,SALL1;SOX8;PCNA;LOXL3;CBR1;SHH;PGK1;SOX17;CD34;WNT7B;PAX2;DLL1;NDRG4;SMO;VDAC1;PROX1;MTHFD1;ANXA7;SPINK5;KANK2;CPT1A;HNRNPH3;ERRFI1;PTCH1;BMP2;TGFB1;FGFR2;SOX9
prerank,negative regulation of transport (GO:0051051),0.2575631826969739,0.9012708503653727,0.6267123287671232,0.8885545250325874,1.0,13/51,20.62%,SIRPA;CTTNBP2NL;ITGAV;NDFIP2;ARL6IP5;HAMP;SCAMP5;PXK;WWP2;SNX3;PPM1F;NR1H2;SYT11
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.27954559955304714,-0.9012066605444731,0.6357308584686775,0.8998616378431067,1.0,3/27,4.81%,RIMS2;SYT1;SYT10
prerank,inorganic cation transmembrane transport (GO:0098662),0.20418996215653898,0.9003153182540337,0.7285714285714285,0.8902789952124319,1.0,43/268,13.80%,SLC30A5;SLC1A3;KCNA5;SLC9A9;SLC36A1;ATP2C1;KCNK6;SLC9A8;SLC24A3;TRPV2;SLC30A10;ITGAV;TRPM4;TRPM2;MCOLN1;KCNH4;KCNH8;KCNN1;SLC40A1;TRPM6;SLC8A1;SCN4B;ABCC9;ABCB8;LRRC55;KCNG2;SLC30A8;KCNH6;LRRC38;ATP1A4;KCNS2;KCNK13;HVCN1;ATP6V0A4;SLC25A27;KCNA2;SLC39A2;SLC6A9;ATP5PO;NNT;KCND1;TRPV4;KCNAB3
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.21968425262753313,0.9002886351957885,0.6846986089644513,0.8897593716549069,1.0,44/145,25.22%,SDCCAG8;TUBA4A;CSNK1E;PRKACA;ODF2;TUBB;CEP164;TUBG1;RAD51B;HAUS7;PSMD3;CNTRL;PSMB3;TUBA1A;PSMA7;CEP63;CEP57;HAUS6;HAUS2;PSMC1;PSMC2;SFI1;PSME4;AURKA;MAPRE1;PSMB9;CEP135;ACTR1A;OFD1;CEP43;DCTN2;PSMD4;PSMB5;CEP70;PSMB7;FBXL7;CSNK1D;PSMB8;RAD51C;DYNLL1;NDE1;PSMD13;CCP110;CDC7
prerank,pancreas development (GO:0031016),0.36532837100789334,0.9002767586031608,0.5866666666666667,0.8892136878858918,1.0,4/12,18.02%,MET;CCDC40;PROX1;SELENOT
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.29019859339485377,0.9001379873971129,0.6042031523642732,0.8889606031892219,1.0,6/29,15.41%,UTP6;WDR46;TBL3;NOP14;RPS8;MRPS11
prerank,mitochondrial transcription (GO:0006390),-0.3869139936220656,-0.9000464140499626,0.5851063829787234,0.9019710006429685,1.0,3/10,18.74%,POLRMT;MRPL12;TWNK
prerank,regulation of lipid metabolic process (GO:0019216),0.23415174874157316,0.8999670437056092,0.6607142857142857,0.8887959579735282,1.0,19/88,20.42%,CHD9;PPARD;GPS2;SIN3A;C1QTNF2;PLPP1;SMARCD3;GGPS1;PANK2;NFYA;TGS1;NPC2;CERS2;IDI1;SIN3B;CARM1;SCD;FGFR4;OPA3
prerank,cell projection assembly (GO:0030031),0.3141666724456351,0.8998563391066116,0.5800376647834274,0.8884947754472586,1.0,5/22,10.91%,RAC1;RHOQ;RHOH;NCKAP1L;CYFIP1
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.2962300416003043,-0.8996043239526067,0.5991189427312775,0.9022451917077576,1.0,3/22,8.12%,CCR2;LILRB1;BTK
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.25035605152752416,0.8995727298191049,0.634315424610052,0.88860263621656,1.0,20/63,24.93%,CRADD;PCNA;CNOT1;CHEK2;ATM;RBL2;MDM4;PRMT1;TNKS1BP1;RPS27L;PLK3;CNOT3;AURKA;CARM1;PIDD1;RFWD3;CDKN1B;CNOT2;TP53;PCBP4
prerank,receptor signaling pathway via STAT (GO:0097696),-0.2917799983282601,-0.8994706290271672,0.620137299771167,0.9017783002883738,1.0,6/25,14.74%,CCR2;JAK2;PKD2;STAT4;PIAS1;PKD1
prerank,myelin maintenance (GO:0043217),0.3953208051441454,0.8994481557549135,0.5970425138632163,0.8883332807160904,1.0,3/10,14.18%,ABCD2;CLU;SOD1
prerank,organic cation transport (GO:0015695),-0.31290998160508576,-0.8994316131698404,0.6065934065934065,0.9010222123288196,1.0,8/20,20.23%,SLC25A19;SLC44A1;SLC5A7;SLC44A2;SLC47A1;RALBP1;SLC22A18;SLC22A5
prerank,protein localization to cilium (GO:0061512),0.2889093002639185,0.8991499361375604,0.6132404181184669,0.888477724432226,1.0,12/32,25.75%,BBS9;ATP6V1D;TULP2;IFT20;TCTN1;INVS;TTC21B;ARL3;CSNK1D;IFT122;TCTN2;IFT140
prerank,response to unfolded protein (GO:0006986),0.2639546449592558,0.899064839801529,0.6156462585034014,0.8880950227384948,1.0,10/48,16.10%,HSPB3;DDIT3;HSPA4;HSPH1;TM7SF3;HSPB8;PTPN1;OPTN;TMBIM6;HSPA13
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.2896787259305685,-0.898672756825132,0.615979381443299,0.9020927865580431,1.0,7/25,19.22%,SCAF8;ERCC6;CCAR2;SETD5;TCEA2;SUPT4H1;ZNF326
prerank,mitotic DNA replication (GO:1902969),0.3808930917215955,0.8985155142116422,0.5912408759124088,0.8889043557897645,1.0,6/10,26.26%,MCM2;LIG1;GINS3;MCM3;MCMDC2;MCM6
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.3478726370394267,-0.8984495193538683,0.6065934065934065,0.9018340114649994,1.0,2/13,4.22%,PTPRT;JAK2
prerank,negative regulation of defense response (GO:0031348),0.2421585427060931,0.8981742063365137,0.6574675324675324,0.8891783916689378,1.0,11/77,8.46%,SIRPA;SIRT2;OTULIN;ITCH;PPARD;GPS2;PRKCD;PCBP2;NLRP3;C1QBP;GPER1
prerank,synaptic vesicle transport (GO:0048489),-0.3543790507897851,-0.8979267395627216,0.6181015452538632,0.9022948550521406,1.0,3/11,8.62%,KIF5C;TOR1A;KIF5B
prerank,protein import into peroxisome membrane (GO:0045046),-0.29172731457477136,-0.8978160263329743,0.5945945945945946,0.9017411571496126,1.0,5/22,13.20%,ATAD1;ACBD5;PEX12;FIS1;ALDH3A2
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.35646628412550163,-0.8976770038699604,0.5854700854700855,0.9012595530339884,1.0,6/12,25.05%,CENPE;NDC80;MAD1L1;KIF2C;NUF2;BOD1
prerank,glutamine family amino acid metabolic process (GO:0009064),0.276649915961382,0.8976748087348779,0.6224677716390423,0.8898193013883275,1.0,9/33,22.37%,ART4;DGLUCY;NIT2;GCLC;ALDH4A1;RIMKLA;PYCR1;PYCR2;OAT
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.2900462832710379,-0.8975615727586742,0.6165919282511211,0.9007149340843558,1.0,7/25,23.89%,ANK3;PRKN;SNCA;TMTC2;TRPV6;TRPM7;KCNA1
prerank,establishment of protein localization to membrane (GO:0090150),-0.2315925156710521,-0.8973815101876496,0.6794258373205742,0.9003584220795438,1.0,20/66,23.45%,CHM;EGFR;FRMPD1;ZDHHC21;AFDN;SDCBP;ZDHHC23;AQP11;COX18;ZDHHC15;PARD3;ZDHHC18;VPS37C;ZDHHC24;ATG3;PRKCI;NACA;BRAF;ZDHHC19;RFTN1
prerank,macrophage migration (GO:1905517),0.3638614710870738,0.8973284013613969,0.6108108108108108,0.8901103121638837,1.0,4/13,15.14%,P2RY12;CCL3;EDN2;CXCL17
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.3458122252802772,0.8969451031620094,0.6025641025641025,0.8904268130502246,1.0,2/15,2.71%,MLXIPL;PPARD
prerank,early endosome to late endosome transport (GO:0045022),0.31400394080390653,0.8962510115766054,0.5914742451154529,0.8914746168649461,1.0,7/20,22.84%,HOOK2;PIK3C3;AKTIP;PTPN23;WDR81;STX8;HOOK3
prerank,iron ion homeostasis (GO:0055072),-0.2399076750868544,-0.8961372083298083,0.6776470588235294,0.9026328714372411,1.0,13/58,15.46%,FTL;ABCB7;NEO1;B2M;FLVCR1;NDFIP1;SCARA5;TFR2;SLC46A1;HMOX1;FBXL5;ATP6V1A;CYBRD1
prerank,negative regulation of viral transcription (GO:0032897),0.3517785874566231,0.8957172918949108,0.6072727272727273,0.892201817153293,1.0,3/13,12.58%,UBP1;TRIM11;TRIM62
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.3405968892284737,0.8953797451956903,0.5876106194690266,0.8924409025218489,1.0,3/15,11.32%,PDPK1;TJP1;DLL1
prerank,negative regulation of gene expression (GO:0010629),-0.18575438584863896,-0.8953461959507388,0.8220640569395018,0.903775506017226,1.0,64/302,16.92%,ROBO1;SAMD4A;XDH;MSR1;PTBP2;ATP2B1;MTF2;JARID2;CCR1;APP;ERN1;PTPN22;RBMS3;RPS3;CPEB3;NPTN;FOXP1;SOX11;APOE;AGO4;SH3GL2;PARP14;DAPK1;WNT4;PRKN;SIRT1;ZC3H12D;EIF4A3;TNRC6A;MYADM;SMCR8;DNMT3B;REL;OPRD1;NDFIP1;HELLS;PTRH2;FCGR2B;KLF4;H3-3A;SETDB2;RGCC;SHMT1;AEBP2;MMP8;LGR4;RBBP7;CNOT10;TIPARP;HSPA1B;ACVRL1;CD46;HEY2;SFRP1;SNX12;PPHLN1;RBL1;TTBK1;FFAR4;CD3E;APLN;SFRP2;BMP4;APLNR
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.2175563606569721,-0.8953002761383057,0.6961038961038961,0.9030705196463774,1.0,19/86,19.98%,DAB2;RBPJ;SOX11;JAK2;SDCBP;ING2;GIPC1;HIPK2;ZEB2;TTK;CDH5;GDF1;GDF11;ACVRL1;SH2B1;BMP4;GDF10;SNW1;CDKN1C
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.28551545334897765,-0.8950194595566874,0.6387665198237885,0.9029366736761212,1.0,7/26,14.04%,LRRK2;PPIA;PDE8A;PRKN;SIRT1;FBXO7;SOD2
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.27259405127674585,-0.8946238036302436,0.6529126213592233,0.9030952368010574,1.0,6/32,15.22%,MAGI2;PPIA;CALM1;DUSP26;CDH5;PPP1R7
prerank,regulation of neuroblast proliferation (GO:1902692),0.34660775956140777,0.8944180244985908,0.6128440366972477,0.8942302445972884,1.0,4/15,17.61%,CX3CR1;SMARCD3;DRD2;KDM1A
prerank,ncRNA processing (GO:0034470),-0.19199195482074932,-0.8941485249455462,0.7961165048543689,0.9035004294300653,1.0,54/200,20.46%,RPL36A;RPL30;RPL35A;DDX10;RPL4;RPS7;UTP20;RPS2;AGO4;SNU13;RPLP2;RPL7A;LAS1L;RPL41;EXOSC1;POP4;XRN2;RPL26;TUT4;DCAF13;RPS27;RPL18A;RPS25;MRTO4;RPL38;NOC4L;RPL37;UTP14A;RPS14;EXOSC7;INTS9;RPL24;WDR18;POP7;RPS9;DROSHA;RPLP0;RPLP1;RPL8;RPL22;NOB1;ESF1;INTS7;TUT1;AARS1;RPL19;RPS6;SMAD1;PIH1D1;RRP9;RPL13A;RPL18;RPS19;RPL23A
prerank,cholesterol efflux (GO:0033344),0.3188315582616048,0.8937715178278851,0.5918727915194346,0.8952874574924461,1.0,5/20,17.21%,STX12;APOM;NPC1;NPC2;SCARB1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.23396680083813318,0.8936277680275136,0.6672077922077922,0.8950689111998391,1.0,30/88,21.82%,DNM2;CCDC93;MYO1B;AP2A1;RP2;SORT1;AP1M2;SCAMP2;ACBD3;LLGL1;CLTA;MON2;STX4;OSBPL5;AP1S2;ARL3;CCDC22;DOP1B;AP1S1;ARRB1;EXOC6;VAMP7;AP4M1;CHMP2A;VPS13C;EXOC1;CLINT1;HGS;AP1B1;ARF1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.32499636674671684,-0.8934345288028177,0.5857461024498887,0.9044379147786259,1.0,3/15,11.52%,NEDD4L;ATP1B3;ATP1A1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.3865374311309928,0.893033494857262,0.6123595505617978,0.8959585120220183,1.0,2/10,7.24%,PDE3B;CDC34
prerank,myelin assembly (GO:0032288),-0.36564652532683917,-0.8927237441373114,0.6,0.9053719226338369,1.0,3/10,9.57%,TPPP;TENM4;CNTNAP1
prerank,regulation of response to cytokine stimulus (GO:0060759),0.32572671921765706,0.8924812155425575,0.6247755834829444,0.8966708037928199,1.0,5/19,17.14%,IRAK2;DHX9;RUNX1;MAVS;MAPK7
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.37769514049957587,0.8923267769176901,0.6127886323268206,0.8964761885491725,1.0,2/10,4.36%,DIP2B;FLCN
prerank,response to insulin (GO:0032868),0.23673517239865266,0.8920263722206848,0.6736334405144695,0.8966251419203357,1.0,16/80,18.08%,PDE3B;PIK3R1;LPIN2;RHOQ;SORT1;PDPK1;ZFP36L1;TRARG1;INPP5K;CEACAM1;AKT1;HDAC5;EPRS1;KHK;RAB13;LPIN1
prerank,dopamine metabolic process (GO:0042417),-0.3117631692882964,-0.8916461821011048,0.6116071428571429,0.9072812773260642,1.0,7/18,18.87%,PRKN;ATP7A;DAO;SNCA;MAOA;MOXD1;MAOB
prerank,"DNA-templated transcription, termination (GO:0006353)",0.24209053031829258,0.8914001206876675,0.6693037974683544,0.8975562512004595,1.0,20/68,23.72%,NCBP1;POLR2H;TTF2;CSTF2;GTF2H2;SNRPF;ERCC2;PABPN1;CPSF1;SMN1;FIP1L1;POLR2E;MED18;POLR1C;PCF11;UBTF;TBP;POLR1E;POLR1G;MTERF2
prerank,regulation of protein kinase activity (GO:0045859),0.22744404084564723,0.8909702897936975,0.7217806041335453,0.8980064004914419,1.0,28/106,19.55%,MMD;PYDC1;CAMKK1;PRKRIP1;UBASH3B;LCP2;PTK2B;PDPK1;CAMKK2;CCR7;TAB2;SMG8;INPP5K;CEACAM1;DDR2;AGAP2;SOD1;TSPYL2;CEP85;AKT1;CSF1;QARS1;TRIB1;PPM1F;C5AR1;CEP43;ECT2;XRCC6
prerank,neurogenesis (GO:0022008),0.2642731011795575,0.8909663917721566,0.6527777777777778,0.8974444330711691,1.0,3/43,4.77%,DAGLB;TRAK1;RYK
prerank,cellular response to estrogen stimulus (GO:0071391),-0.3302939142132667,-0.890819920130537,0.5995975855130785,0.9084262440448212,1.0,4/14,18.64%,RARA;CRHBP;SFRP1;BCAS3
prerank,response to ketone (GO:1901654),0.29592527193857043,0.8908080103384108,0.6214285714285714,0.8972506024675347,1.0,8/24,24.41%,HSD3B2;CCR7;UBE3A;ABCB4;THBS1;TGFB1;CATSPER2;WBP2
prerank,positive regulation of response to stimulus (GO:0048584),-0.25476022305923374,-0.8904471690067276,0.6487179487179487,0.9085244994415584,1.0,9/40,13.79%,RSAD2;B2M;HOMER1;NSMCE4A;SIRT1;FCGR2B;CD80;IER5;CDKN2A
prerank,positive regulation of protein deacetylation (GO:0090312),0.34356151683851976,0.8904307355088457,0.6075268817204301,0.8976061540546661,1.0,2/14,3.00%,AKAP8;AKAP8L
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.2605539082869374,0.8903726939516682,0.6327212020033389,0.8971774617058641,1.0,13/46,17.60%,HK2;TOMM20L;PITRM1;TIMM8B;TIMM44;PINK1;TIMM50;TSPO;AKT1;TOMM20;TIMM10B;GRPEL1;TOMM7
prerank,regulation of cellular catabolic process (GO:0031329),-0.2311755194982355,-0.8901521785617136,0.672289156626506,0.9084866357288595,1.0,10/62,9.05%,LRRK2;ITPR1;DRAM1;RRAGB;DAPK1;PRKN;USP10;USP13;RAB8A;SMCR8
prerank,cellular response to DNA damage stimulus (GO:0006974),0.1952864308152667,0.8896981673392743,0.8178025034770514,0.8981827249972324,1.0,88/336,23.99%,HERC2;SUMO1;CSNK1E;DDIT3;MACROD1;EID3;CHEK2;LYN;HPF1;DDB2;FAM111A;UBA7;RFC2;ATM;NBN;AATF;REXO4;WDR48;SPIDR;RAD17;USP28;RAD51B;MGMT;AKTIP;CGAS;SLX4;CUL4B;INTS3;RBM24;PLK5;ACER2;RNF8;LIG1;MMS19;BRCA1;FANCG;APTX;KMT5C;TAF1;EXO1;BAZ1B;ERCC4;RAD1;UBE2U;TAOK2;CEP63;PCLAF;ABL1;RPAIN;PLK3;BLM;CIB1;MAPK14;PSME4;XIAP;DTX3L;MASTL;NABP1;UBE2A;IRF3;GNL1;FANCA;HTRA2;FBH1;UBQLN4;CUL4A;SLF2;PIDD1;RAD9A;EPHA2;PWWP3A;UBE2T;TOPORS;PARP4;SETD7;ZC3H12A;TOPBP1;BCL2L1;NSMCE3;RFWD3;PARK7;ZBTB1;SPRTN;STXBP4;YY1;BCL2L11;TP53;RAD51C
prerank,apical junction assembly (GO:0043297),-0.23423239072239097,-0.889028591970709,0.7088607594936709,0.9104554113178421,1.0,20/53,30.15%,CTNNA1;AFDN;PATJ;FRMPD2;CDH5;PARD3;PECAM1;PRKCI;MICALL2;GRHL2;PARD6G;DLG1;MARVELD3;OCLN;STRN;CLDN5;CLDN18;POF1B;CLDN16;PARD6B
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.23148725003251358,-0.8889907694463571,0.6923076923076923,0.909721639209369,1.0,16/65,18.31%,PSMD14;PSMD8;PSMA2;PSMF1;PSMD6;PSME2;PABIR1;AURKB;PSMD5;PSMD12;PSMD11;CHEK1;GPR132;PSMD1;USP47;CDK5RAP3
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.3731496251516843,-0.8889776973647138,0.5953389830508474,0.9089367242282826,1.0,1/10,0.46%,ANK3
prerank,regulation of chromosome segregation (GO:0051983),0.33619877866414316,0.8885044681905298,0.620754716981132,0.9003930202775579,1.0,3/16,4.87%,CSNK2A2;CSNK2A1;NUMA1
prerank,positive regulation of protein metabolic process (GO:0051247),0.22689739939090525,0.8881587149385858,0.6948356807511737,0.9006860442629703,1.0,28/110,19.08%,IL18;SMURF1;ITCH;CSNK2A1;RNF41;CLU;EIF4G1;CD86;SLC25A37;IL12B;RAB1A;ASB11;PRMT1;ASB5;AREL1;SLC6A9;WWP2;MAPK8;AKT1;NDUFA13;CSF1;VIP;OAZ2;AGT;MAPK7;ROCK2;STX5;NR1H2
prerank,defense response to symbiont (GO:0140546),0.22898708239041654,0.8881234311001033,0.7041139240506329,0.9002021375602285,1.0,29/92,24.23%,TLR7;RNASE1;SERINC3;TRIM5;MOV10;ABCC9;CGAS;ZMYND11;ABCE1;G3BP1;RNASE6;SETD2;MAVS;EXOSC5;PYCARD;SHFL;TTC4;ISG20;IRF3;EIF2AK2;MAP3K14;IRF2;PMAIP1;NLRC5;ACOD1;BCL2L1;MYD88;PTPRC;FADD
prerank,regulation of neurotransmitter transport (GO:0051588),-0.32324561873532537,-0.8876371309015563,0.6087912087912087,0.9114773307119576,1.0,5/16,12.32%,SYN1;MCTP2;CPLX2;MCTP1;KCNMB4
prerank,Golgi inheritance (GO:0048313),0.3639207471401965,0.887580157349735,0.5776173285198556,0.9008986469336485,1.0,4/11,18.38%,PLK5;PLK3;PDCD10;STX5
prerank,neural crest cell differentiation (GO:0014033),0.3265097621623842,0.8875242203863593,0.6044776119402985,0.9004564181647758,1.0,4/18,12.55%,MEF2C;SOX8;KBTBD8;PDCD6
prerank,microtubule depolymerization (GO:0007019),-0.3152459210592742,-0.8874512580753232,0.6177105831533477,0.9110912299268232,1.0,9/17,25.40%,STMN4;KIF14;CCSAP;STMN2;KIF18B;NCKAP5;KIF24;KIF2C;STMN3
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.30193371351815856,0.8872357095659223,0.628158844765343,0.9005454119391253,1.0,6/24,17.14%,NFE2L2;DDIT3;ATF3;MBTPS2;GCN1;MAPK7
prerank,respiratory chain complex IV assembly (GO:0008535),0.30424561147771073,0.8867022797332347,0.5902255639097744,0.9012651957869551,1.0,6/21,19.51%,COA8;COX19;SURF1;BCS1L;FASTKD3;COX16
prerank,mitotic sister chromatid segregation (GO:0000070),-0.21469600957097934,-0.8860589989463533,0.7396593673965937,0.9136575438915199,1.0,30/98,25.15%,CUL3;SMC4;KIF23;CDCA8;ZW10;SPDL1;KIF22;KIF14;RAN;CENPE;NDC80;NUSAP1;DLGAP5;PRC1;SPAG5;BECN1;KIF18B;TEX14;NCAPD3;PDS5A;CCNB1;NCAPG2;RRS1;KIFC1;KNSTRN;KIF2C;PLK1;CHMP1B;BOD1;NCAPG
prerank,regulation of myeloid cell differentiation (GO:0045637),0.2424654849934764,0.8860073095787119,0.6678082191780822,0.9023750308238335,1.0,20/62,24.66%,MEF2C;KMT2D;LYN;HOXB8;PTK2B;CTR9;MOV10;SIN3A;PRMT1;PRKCB;RUNX1;PRMT6;FES;TNRC6C;THBS1;TNRC6B;DPY30;KMT2B;AGO1;WDR5
prerank,negative regulation of developmental process (GO:0051093),-0.23034401534150634,-0.8859743095256251,0.6839506172839506,0.913048814438417,1.0,25/69,28.64%,NFIB;DCC;BCL11A;GRIN3A;PRKN;HOPX;KANK1;FGFR3;PARP3;THY1;HEY2;SFRP1;BMP4;TFRC;FOXC1;NEUROD2;VAT1;ARHGEF15;ADCK1;KLF7;FUZ;RPS6KA6;ROCK1;BNIP3;TBX1
prerank,regulation of B cell activation (GO:0050864),-0.2817411561632725,-0.885754825737747,0.6235294117647059,0.9127946821077361,1.0,4/25,11.70%,BANK1;IKZF3;FCGR2B;AHR
prerank,cellular protein metabolic process (GO:0044267),0.1923760281547333,0.88548877175181,0.8273572377158035,0.9029720709702533,1.0,84/396,20.70%,GOLM1;ST3GAL6;CST3;CCDC59;MGAT4A;CDKL3;PRKCSH;MAN2B1;IGFBP3;FBXO22;CHEK2;FDXR;UBA7;EIF4G1;MRPL37;RPS27A;MMP2;LGMN;RRBP1;YME1L1;MRPL43;MBTPS1;USP25;CDC34;ADORA2B;MRPL34;MIA3;CPE;SARS1;AMBN;PAPPA2;MRPL9;ARAF;RABGGTA;RPL15;MRPS5;ASMT;PSENEN;FBXL2;GALNT11;RPL10;PSEN2;MSLN;SLC35A1;RPS8;DHPS;PPP4R2;GSPT2;MRPS21;ABL1;ABCF1;WWP2;RPS24;MRPL13;MRPS16;CSF1;MRPS18B;MRPS11;FDX1;ADORA2A;PLG;FBXO11;ADPRH;ADAM10;CSF2RA;EIF4EBP2;APH1B;EVA1A;HTRA2;RPL9;PHKA2;AFG3L2;MRPS18A;DMP1;RPL39;PENK;TGM5;TNIP1;DUSP12;MRPL11;MRPL41;MRPL27;PARP4;ADAM17
prerank,mitotic spindle assembly (GO:0090307),-0.24889794865355178,-0.8851667558227689,0.6415094339622641,0.9134717896923472,1.0,8/42,9.74%,KIF23;RACGAP1;TOGARAM2;TPX2;AURKB;KIF11;MAP9;PRC1
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.22838338614563597,-0.884447518144625,0.7017994858611826,0.9144570729081181,1.0,15/64,16.53%,UTRN;CD36;SLK;GSK3B;SKAP1;CASK;LIMCH1;CDH13;EFNA5;CX3CL1;JAG1;CDKN2A;THY1;SFRP1;CD3E
prerank,positive regulation of B cell activation (GO:0050871),-0.2442882520635903,-0.8844171519256698,0.6658227848101266,0.9136996020704459,1.0,4/50,3.27%,VAV3;CD38;CD74;CD40
prerank,cellular response to arsenic-containing substance (GO:0071243),0.3359920554600731,0.884080673921447,0.6044776119402985,0.9057371191965675,1.0,8/15,33.02%,ATF3;ZC3H12A;DDX3X;HNRNPA1;CPEB2;GSTO2;VCP;GSTO1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.26843059435439387,0.8840133575583934,0.6593959731543624,0.905325428761266,1.0,12/40,23.86%,CLU;PLSCR3;GPER1;BMF;PINK1;PYCARD;AKT1;PMAIP1;BCL2L1;OPA1;BCL2L11;TP53
prerank,alpha-amino acid metabolic process (GO:1901605),-0.24753071434376286,-0.8838201626683314,0.6705336426914154,0.9143306829910385,1.0,13/45,20.91%,GLS;ASPA;THAP4;KMO;ATP7A;SRR;GNMT;SLC25A12;GPT;PYCR3;DDAH2;KYAT1;NOX4
prerank,activation of protein kinase A activity (GO:0034199),0.33700993860454964,0.8837123514026826,0.6186915887850467,0.9055015001018842,1.0,5/16,11.91%,ADCY9;PRKACA;ADCY4;PRRC1;ADCY6
prerank,regulation of response to external stimulus (GO:0032101),0.219605666804824,0.8837044194533706,0.7251552795031055,0.9049466894707494,1.0,13/121,10.68%,DAGLB;P2RY12;IL1RL2;SBNO2;CYRIB;TRIM5;CASP1;LRRC19;PIK3AP1;SELE;BCL6B;APPL1;AREL1
prerank,histone H4-K5 acetylation (GO:0043981),0.340502965247314,0.8834201106831931,0.6125461254612546,0.9045078244359521,1.0,7/15,26.70%,KANSL2;JADE2;PHF20;KANSL3;WDR5;KANSL1;MCRS1
prerank,histone H4-K8 acetylation (GO:0043982),0.340502965247314,0.8834201106831931,0.6125461254612546,0.9045078244359521,1.0,7/15,26.70%,KANSL2;JADE2;PHF20;KANSL3;WDR5;KANSL1;MCRS1
prerank,response to metal ion (GO:0010038),0.2417220913498488,0.8831673955967392,0.6984667802385008,0.9045294100230973,1.0,18/67,22.83%,SLC30A5;CAPN3;KCNMA1;MT1X;MT1A;SLC30A8;HAMP;MT2A;HVCN1;PDCD6;ALG2;KHK;ATP5F1D;THBS1;MAPT;IL1A;SEC31A;CALM2
prerank,positive regulation of gene expression (GO:0010628),0.18999554996389154,0.8831012905701793,0.8300132802124834,0.9041258794526552,1.0,118/442,24.15%,TGFBR1;TMEM119;CADM1;SMAD3;CCDC88B;ETS1;FAM98B;NFE2L2;PLD1;MEF2C;LGALS9;VSIR;PIK3R1;DDX5;POLR2H;TLR4;SLC24A3;PIK3CG;EGR1;ATM;PLCG2;CLU;CCL3;PAX6;SF3B1;CALCOCO1;NSUN5;U2AF2;SPRY2;METTL5;MOV10;PDGFB;NOS1AP;OVOL2;GATA2;CNTF;PKP3;GPER1;CALCR;SLC22A2;RBM24;POU4F1;GAPDH;LIMS1;CD34;PIK3CD;PIK3CB;MTOR;SMARCA5;BRCA1;LAMTOR5;SCAMP5;IL33;BAZ1B;RPS27L;MUSK;GJA1;NWD1;SOD1;MAPK8;DYRK1A;AKT1;SMO;HPN;CSF1;MAPK14;PASK;PIK3R3;NOG;CDH3;MAP2K1;PDCD10;POLR2E;LGALS7;RAB27A;METTL14;AGT;EIF3D;POLR1C;EIF2AK2;SLC11A1;MITF;CUX2;TICAM1;ROCK2;FXR2;MBIP;TNRC6C;PPM1F;THBS1;EIF2AK3;VPS35;PCIF1;FGFR4;TNRC6B;SFRP4;IL1A;HGS;FGF20;ZC3H12A;DDX3X;TBP;DEK;TWIST1;ELAVL1;PARK7;POLR1E;BMP2;IL36G;TGFB1;POLR1G;MYD88;AGO1;TYROBP;TP53;SOX9;DNAJA4;HNRNPLL
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.3255756665928166,-0.8830698509693441,0.654945054945055,0.9153298614074048,1.0,1/15,0.06%,MAGI2
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.26993790339453894,0.882906886129012,0.6344827586206897,0.9040679029461768,1.0,11/39,19.87%,NFE2L2;PDPK1;GATA2;GPER1;ECSCR;SERPINE1;TNIP2;MAPK7;GATA3;THBS1;KRIT1
prerank,defense response to tumor cell (GO:0002357),0.37733603149284,0.8828277599404362,0.5817120622568094,0.9036865609436101,1.0,2/10,8.69%,ABI3;PLK5
prerank,negative regulation of cell aging (GO:0090344),0.3336030198021921,0.8827042819733252,0.6062846580406654,0.903424887763529,1.0,2/16,3.39%,MAP3K3;SLC30A10
prerank,regulation of monooxygenase activity (GO:0032768),-0.29357280954781406,-0.8825289370121151,0.6598173515981736,0.9157634934309266,1.0,4/23,5.23%,NOSTRIN;EGFR;ZDHHC21;CALM1
prerank,chemokine-mediated signaling pathway (GO:0070098),-0.25235884545505033,-0.8825138952864537,0.6807511737089202,0.914978157407059,1.0,9/42,18.50%,CCR2;CCR1;PF4;GPR35;CX3CL1;CCL5;CCL14;CCL7;FOXC1
prerank,L-glutamate transmembrane transport (GO:0015813),0.3827606242388289,0.8824017912071463,0.5981132075471698,0.9035668478053795,1.0,2/10,7.21%,SLC1A3;ARL6IP5
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.23606818243008182,0.8823398220484531,0.6695205479452054,0.9031470757730289,1.0,23/75,23.51%,PDE3B;PTPRM;FOXJ2;ADAMTS1;SPARC;SPRY2;PGK1;SARS1;ECSCR;APOH;GTF2I;SERPINF1;SPINK5;ROCK2;THBS1;KRIT1;SYNJ2BP;NAXE;HGS;CXCL10;EFNA3;KLK3;AGO1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.3349483190557588,-0.8819681200503313,0.6247379454926625,0.9154934449268787,1.0,1/14,0.40%,DPYD
prerank,epithelial cell differentiation (GO:0030855),-0.21498046621038253,-0.881947660104744,0.7253333333333334,0.9147253081742757,1.0,33/88,32.47%,DAB2;PPARG;ANXA4;LATS1;FSTL1;ERBB4;TST;E2F7;TAGLN;ALDOC;JAG1;DHRS9;BMP4;CNN3;PIH1D1;GRHL2;DEUP1;CTSB;HDAC1;ANXA1;WT1;GSTK1;CASP6;TBX1;CITED1;AKR1C1;CDHR2;IRF6;OVOL1;PTER;GLI1;GSTA2;CCNO
prerank,ion transport (GO:0006811),0.22369384020952038,0.8819411748726457,0.719551282051282,0.9034765299698901,1.0,16/111,10.29%,SLC1A3;SLC9A9;SLC36A1;SLC12A6;SLC9A8;SLC24A3;SLC20A2;SLC15A4;MCOLN1;KCNN1;CNGB3;SLC8A1;ATP1A4;SLC32A1;SLC17A8;WNK1
prerank,positive regulation of axon extension (GO:0045773),0.30814651245602037,0.8818072131483161,0.6252220248667851,0.9032531217516849,1.0,4/22,9.05%,TWF2;DBN1;MACF1;GOLGA4
prerank,maturation of 5.8S rRNA (GO:0000460),0.31893407458575834,0.8818060420819163,0.6286764705882353,0.902691629451064,1.0,5/17,19.02%,PES1;C1D;EXOSC10;FTSJ3;MPHOSPH6
prerank,purine-containing compound biosynthetic process (GO:0072522),0.2970034523915601,0.8816563541462145,0.6366782006920415,0.902471574784104,1.0,12/25,25.96%,GMPR2;PNP;GART;PRPS1L1;PRPS1;MTHFD1;PAICS;DGUOK;PRPSAP1;PRPSAP2;ADSL;AMPD2
prerank,positive regulation of cell cycle process (GO:0090068),-0.2164389823093116,-0.8813026261301117,0.7331606217616581,0.9154832240710449,1.0,23/91,19.06%,CUL3;KIF23;RACGAP1;CDC42;GIPC1;KIF14;PKP4;NDC80;NUSAP1;AURKB;SPAG5;E2F7;WIZ;GPSM2;GEN1;RGCC;DBF4;NPM2;RCC2;CCNB1;CEP120;PRKCE;NSFL1C
prerank,inositol phosphate-mediated signaling (GO:0048016),0.31065638085585423,0.8807988604724164,0.6389891696750902,0.9039311789763199,1.0,5/19,17.29%,NFATC1;EDN3;EDN2;NMUR2;GPR62
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.2266857762598372,0.880630299348538,0.7163009404388715,0.9037699196113456,1.0,28/94,23.38%,IRAK2;RIPK2;MAP3K3;EGR1;RPS27A;UBC;RPS6KA5;TAB2;MAP3K8;PSMD3;PSMB3;PSMA7;PSMC1;PSMC2;TNIP2;IL1R2;PSME4;PSMB9;PELI2;RPS6KA4;PSMD4;NOD2;PSMB5;IL1A;PSMB7;IRAK4;MYD88;PSMB8
prerank,positive regulation of neuron migration (GO:2001224),0.3646851157221418,0.8804450937956986,0.6177536231884058,0.9036487973406045,1.0,1/11,0.66%,ARHGEF2
prerank,carboxylic acid catabolic process (GO:0046395),0.35415903420573946,0.8804292265127374,0.6367041198501873,0.9031203553543089,1.0,6/12,23.96%,AMDHD2;PON3;NPL;IL4I1;ACOT8;ACOT4
prerank,Wnt signaling pathway (GO:0016055),0.22877358798300673,0.8803642571116188,0.7304625199362041,0.902698077100821,1.0,33/92,26.49%,LRP5;CSNK1E;ZRANB1;PLCG2;RYK;RPS27A;UBC;PORCN;FZD2;WNT2B;CPE;WNT10B;BCL9;WNT7B;FZD6;TCF7L1;SNX3;FZD1;VPS29;VPS26A;CSNK1G2;VPS35;RAC3;SFRP4;DDX3X;DVL2;WLS;FZD5;FZD9;FZD3;CUL1;FZD10;WNT5B
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.37345344246181517,-0.8799946561225004,0.6350210970464135,0.9178820545300606,1.0,4/10,22.50%,KLF4;IRAK3;MAP2K5;SIGIRR
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.35030800967248427,-0.8795773946441143,0.6203090507726269,0.9181009077594782,1.0,4/11,34.85%,RTP4;RTP2;TAS1R3;PKD2L1
prerank,response to interleukin-4 (GO:0070670),-0.36632187161175656,-0.8794429947332605,0.6063829787234043,0.9175913501387213,1.0,7/10,37.00%,TCF7;LEF1;DCSTAMP;XBP1;CITED1;RUFY4;JAK3
prerank,telomere maintenance via recombination (GO:0000722),-0.35911904480326734,-0.8794126273021123,0.5903083700440529,0.9168419676785666,1.0,6/11,33.63%,SMC5;RAD51D;TPRKB;ERCC1;RAD51;NSMCE2
prerank,negative regulation of DNA recombination (GO:0045910),0.2596675745401085,0.8789766257633855,0.6791808873720137,0.9053288642620847,1.0,11/43,19.08%,POLR2H;POLR2J;POLR2D;CGAS;SHLD2;TERF1;BLM;POLR2E;FBH1;UBQLN4;ACD
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.3134915728281817,-0.8786992794944537,0.6277056277056277,0.9177621113098964,1.0,6/17,19.58%,VIM;WNT4;RGCC;SCX;BMP4;SUCO
prerank,extracellular matrix organization (GO:0030198),0.19659247703413782,0.8786009358969743,0.8162983425414365,0.9056401223198551,1.0,34/276,12.17%,TGFBR1;ITGB5;ITGAM;F11R;DST;COL27A1;SMOC2;KLK2;GREM1;ITGA6;DSPP;JAM2;NPNT;ITGB2;ITGAV;ADAMTS1;SPARC;LAMA4;LOXL3;SH3PXD2A;CTSS;MMP2;MATN4;PDGFB;TMPRSS6;P4HA1;P3H2;BGN;ADAMTS4;MFAP5;BCAN;LAMA3;SERPINE1;DDR2
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.3103397302629941,0.8780933831877605,0.6486988847583643,0.9062675513375534,1.0,9/19,25.56%,CSNK2A2;CAMKK2;USP36;PINK1;VDAC1;HTRA2;PARK7;FZD5;HDAC6
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.3662258086697651,-0.8780732709091037,0.6058091286307054,0.9175867019807402,1.0,3/10,19.63%,MYADM;KLF4;MAP2K5
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.3662258086697651,-0.8780732709091037,0.6058091286307054,0.9175867019807402,1.0,3/10,19.63%,MYADM;KLF4;MAP2K5
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.35548601695542614,-0.8774283670615945,0.6167800453514739,0.9183092489348795,1.0,4/11,15.32%,DAB2;MLLT3;NKD1;SFRP1
prerank,steroid biosynthetic process (GO:0006694),0.2456948615859733,0.8773683944379423,0.6768707482993197,0.9073369764106953,1.0,8/56,11.69%,FDXR;HSD3B2;CH25H;HSD17B1;OSBPL3;CYP46A1;AKR1D1;CYP7B1
prerank,embryonic organ development (GO:0048568),0.24566353914007846,0.8768578561315133,0.6903973509933775,0.9079548706595654,1.0,9/61,12.76%,SALL1;TGFBR2;FOXE1;GDNF;SOX17;WNT7B;RPL10;PKDCC;NDRG4
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.3695710114216807,0.8768436750676013,0.6170634920634921,0.9074196416417522,1.0,2/11,6.08%,UQCRC2;UQCRB
prerank,mitochondrion disassembly (GO:0061726),0.26899104795905626,0.876559507824941,0.6711635750421585,0.9075121378837726,1.0,9/34,17.41%,ULK2;ATG9A;RB1CC1;PINK1;MARK2;GABARAPL1;ATG9B;ULK1;ATG5
prerank,myoblast differentiation (GO:0045445),0.3409928759306422,0.8764699499547831,0.603082851637765,0.9071513201262809,1.0,2/14,9.74%,DDX5;DDX17
prerank,negative regulation of response to stimulus (GO:0048585),-0.22739368605934746,-0.8764615734200413,0.7076167076167076,0.9197905880636676,1.0,18/60,19.63%,SLIT2;ALOX5;CASK;SIRT1;ERBB3;GGT7;ADRA2A;PIM3;FCGR2B;KLF4;MCTP1;AQP11;THY1;RBL1;FOXP3;FCRLB;TERT;MAP2K5
prerank,cellular protein-containing complex assembly (GO:0034622),0.21118137122742733,0.8760539562746225,0.7503692762186115,0.9075554087225519,1.0,27/159,14.27%,BIN1;SMAD3;PICALM;DRC1;OTUD6B;TMEM35A;SRC;CLU;STXBP1;COX7A2L;PSMG1;VAMP1;CLTB;EID2;DHX9;MIS12;HSPA4;EIF4H;TTC12;CLTA;HIP1R;NDUFAF1;POGZ;GPX4;CCDC40;CHRNA3;BBS12
prerank,secondary alcohol metabolic process (GO:1902652),0.2664443946795053,0.8759872309243107,0.6818950930626058,0.9071547353796571,1.0,10/42,22.21%,PPARD;CH25H;PIP4P1;SULT2A1;OSBPL5;LDLRAP1;FDX1;LCAT;SCAP;NSDHL
prerank,mucosal immune response (GO:0002385),-0.3244888337634859,-0.8758870723780339,0.6152173913043478,0.9203747696341762,1.0,3/15,19.99%,CAMP;RNASE3;LTF
prerank,hexose metabolic process (GO:0019318),0.26308870679662194,0.8753283271617337,0.671353251318102,0.9081269585523217,1.0,12/39,29.36%,PPARD;CHST1;GALM;GDPGP1;SORD;KHK;GAA;CHST15;PMM1;HECTD4;OMA1;GALK1
prerank,positive regulation of autophagy (GO:0010508),0.2303488651815057,0.8752474199748874,0.7023411371237458,0.9077506916430653,1.0,24/81,25.22%,SCOC;PIM2;TRIM5;PHB2;FLCN;CAMKK2;MTDH;SH3GLB1;PIK3CB;TPCN1;PINK1;OPTN;PLK3;ULK1;TMEM59;KAT5;TICAM1;ZC3H12A;LARP1;SESN1;PARK7;TRIM14;MEFV;TRIM65
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.3133434844014051,0.8752329672067991,0.6382978723404256,0.9072198263450919,1.0,2/19,1.74%,TGFBR1;MEF2C
prerank,cAMP biosynthetic process (GO:0006171),-0.36934211928045013,-0.8747555224652867,0.654320987654321,0.9222301486990021,1.0,4/10,10.29%,ADCY2;ADCY5;ADCY3;ADCY8
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.26785834060594205,0.8746086783537053,0.6827094474153298,0.9080843385836527,1.0,8/37,11.13%,SMAD7;RIPK2;SIRT2;EIF4G1;SPRY2;RPTOR;INPP5K;TNKS1BP1
prerank,androgen metabolic process (GO:0008209),0.315222778181809,0.8745957330722591,0.6329588014981273,0.9075494627521894,1.0,4/18,15.83%,HSD3B2;SHH;AKR1D1;HSD17B10
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.34208904641830123,-0.8745576885172376,0.6400862068965517,0.9218703879976079,1.0,3/12,13.72%,CCR2;CLEC6A;PRKCQ
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.25188401972028057,0.8743160105419765,0.663023679417122,0.9076362679782132,1.0,18/49,24.66%,MEF2C;KMT2D;MOV10;SIN3A;PRMT1;PITHD1;RUNX1;PRMT6;CIB1;RAB7B;HMGB2;TNRC6C;THBS1;TNRC6B;DPY30;KMT2B;AGO1;WDR5
prerank,protein targeting to mitochondrion (GO:0006626),0.24913190334017954,0.8739047653043774,0.6688632619439868,0.9080495153445168,1.0,15/52,17.60%,TOMM20L;PITRM1;HSPA4;TIMM8B;PMPCA;TIMM44;TIMM29;TIMM50;MIPEP;TSPO;NDUFA13;TOMM20;TIMM10B;GRPEL1;TOMM7
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.3117743010093847,-0.8738310404520158,0.6473118279569893,0.9228273010058389,1.0,8/16,27.69%,APOE;IFNGR1;HMGCR;SRF;ABCA7;CYP51A1;HDAC1;ROCK1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.339676247628178,-0.8735295882341513,0.6412556053811659,0.9227301112116723,1.0,3/12,14.44%,GET3;SEC62;HSPA5
prerank,membrane raft organization (GO:0031579),0.33659360708237307,0.8732575731349417,0.6495412844036698,0.9089826269563244,1.0,4/15,11.05%,PPT1;FLOT2;CLN3;NPC1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.28306702211292006,0.8731600366234501,0.6721611721611722,0.9086341604000086,1.0,14/29,33.22%,TLR4;RPS27A;UBC;TICAM2;IRF3;TICAM1;FADD;UBE2D1;TLR6;IKBKB;BIRC2;BIRC3;TBK1;CD14
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.33047827714421896,0.8727482575588074,0.6229205175600739,0.9090301422616659,1.0,6/15,16.53%,BMP2K;NEU3;DGKD;PIK3CB;HIP1R;WASL
prerank,B cell receptor signaling pathway (GO:0050853),0.2742337119168781,0.8726020507392283,0.6537785588752196,0.9088116118430041,1.0,9/32,15.79%,BLNK;MEF2C;LAT2;PLCG2;PIK3CD;NCKAP1L;PRKCB;BMX;TEC
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.2908089427282497,-0.8725797376046002,0.6473029045643154,0.9241894453720872,1.0,9/22,24.66%,FGF10;KLF9;CASK;FGF7;SNAI2;PTPRK;TGM1;NOTCH2;ZFP36
prerank,glycolipid biosynthetic process (GO:0009247),0.26551362997405864,0.8724783046660761,0.6544117647058824,0.9085349689233403,1.0,5/38,7.17%,LARGE1;ST3GAL5;PIGV;PGAP2;DPM3
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.2971229372822043,0.8724658291293856,0.6660649819494585,0.9080011835279037,1.0,8/23,23.10%,GREM1;MEF2C;RBM24;PROX1;MAPK14;PIEZO1;SMYD1;TGFB1
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.36553992551423975,-0.872302987207765,0.6260869565217392,0.924074209307846,1.0,3/10,15.91%,ST3GAL1;RENBP;GNPDA2
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.3545581151283486,0.8715433030860661,0.6118299445471349,0.9095570767841356,1.0,4/11,25.83%,EXOSC10;EXOSC5;FBL;PARN
prerank,positive regulation of exosomal secretion (GO:1903543),0.3390079390066935,0.8713662339928081,0.64349376114082,0.9094014681007698,1.0,6/15,22.68%,SMPD3;CHMP2A;VPS4A;HGS;TSG101;PDCD6IP
prerank,regulation of muscle cell differentiation (GO:0051147),0.277652308524055,0.8713381340102807,0.6666666666666666,0.9089035840699967,1.0,10/31,19.92%,MEF2C;CDK9;MEF2A;BNIP2;ABL1;MAPK14;CDH15;TCF3;CAMK1;MEGF10
prerank,sulfur compound biosynthetic process (GO:0044272),0.219609612629532,0.8713177980205747,0.7413010590015129,0.9083936593395655,1.0,20/104,16.28%,ST3GAL6;HPGDS;B3GNT2;CHST11;PRELP;CHST1;B3GNT4;MPST;BGN;CHPF;CHPF2;CHST7;BCAN;CSPG5;GCLC;ST3GAL3;PAPSS1;GSTA3;CHST2;CHSY1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.3597528456045316,0.8713114875906685,0.6278659611992945,0.9078521164175674,1.0,3/11,8.85%,GREM1;PADI2;DDT
prerank,male gonad development (GO:0008584),0.2722695018419189,0.8709414913731469,0.6481802426343154,0.9081206505459523,1.0,5/34,8.62%,SOX8;WNT2B;ADAM29;FSHR;LHCGR
prerank,inorganic cation import across plasma membrane (GO:0098659),0.23394018920537063,0.8708531324454157,0.7173553719008264,0.907783905031976,1.0,9/75,8.75%,SLC9A9;SLC12A6;TRPV2;TRPM4;TRPM2;SLC8A1;SLC12A9;ABCC9;ATP1A4
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.35110346046859875,0.8702923991927466,0.6356877323420075,0.9085267274693437,1.0,4/13,15.94%,LARGE1;CHST1;CHST7;CHST2
prerank,cardiac muscle contraction (GO:0060048),-0.25946485902314176,-0.8696047905772202,0.6864988558352403,0.9297681777714354,1.0,3/34,2.60%,DMD;GSN;RYR2
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.31599404265740216,-0.8691326424202297,0.6347438752783965,0.9300812782885454,1.0,7/16,20.42%,B4GALT6;ST8SIA4;ST8SIA1;ST8SIA2;B3GALT4;ST8SIA3;ST8SIA5
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.2591735617375318,-0.8687383530717063,0.6725274725274726,0.9301588220460248,1.0,9/32,18.64%,ARHGAP6;CASK;MMP12;ITGB1BP1;JAG1;CDKN2A;ACVRL1;RCC2;BCAS3
prerank,smooth muscle cell differentiation (GO:0051145),-0.33980134047384847,-0.8682197459281322,0.6204545454545455,0.9305498565795194,1.0,7/12,32.25%,EDNRB;HEY2;BMP4;APLNR;MRTFB;MYOCD;TBX18
prerank,aortic valve morphogenesis (GO:0003180),-0.2715329127900114,-0.8672005710165839,0.6898148148148148,0.932143640104908,1.0,10/30,21.60%,ROBO1;SLIT2;JAG1;HEY2;SNAI2;ELN;BMP4;ROBO2;TIE1;DLL4
prerank,positive regulation of DNA replication (GO:0045740),0.32754014051618785,0.8671639393247864,0.6389891696750902,0.9152432428085382,1.0,3/16,6.66%,PCNA;CTC1;DHX9
prerank,actin filament bundle organization (GO:0061572),-0.26444662992080725,-0.8669800392648268,0.6889952153110048,0.9318967805993342,1.0,5/33,8.75%,EPS8;NEDD9;PAWR;SHROOM1;PLS1
prerank,positive regulation of intracellular protein transport (GO:0090316),0.21047223229711312,0.8668330681174864,0.7704918032786885,0.9154114159692189,1.0,29/144,19.03%,ITGAM;HPS4;SMAD3;YWHAH;PIK3R1;ITGB2;CSNK2A2;AKAP5;PRKCD;SH3GLB1;RNF31;USP36;LEPROT;SAR1A;RAPGEF3;PINK1;MIEF2;PLK3;ZIC1;MAVS;MAPK8;CIB1;TENM1;PDCD10;OAZ2;TOMM7;HTRA2;CAMK1;ECT2
prerank,regulation of cell killing (GO:0031341),0.3307282541629656,0.8666152388476347,0.655367231638418,0.9153544996539827,1.0,5/16,23.74%,RAC1;MAPK8;NOXO1;CFH;DVL2
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.2858473299965826,0.8664447455933401,0.6709323583180987,0.9151528585613613,1.0,7/25,18.34%,BAG6;YME1L1;UFD1;AUP1;ZYG11B;ZER1;STUB1
prerank,RNA destabilization (GO:0050779),0.3111399485776317,0.8662408529509176,0.644808743169399,0.9150389166666,1.0,5/18,18.02%,DXO;RBM24;METTL14;RIDA;ROCK2
prerank,mitochondrial protein processing (GO:0034982),0.36774223862075134,0.8659201676021181,0.6411764705882353,0.9151967433669111,1.0,5/11,21.49%,YME1L1;PMPCA;MIPEP;AFG3L2;STOML2
prerank,negative regulation of cell communication (GO:0010648),0.3048307278578347,0.8655436610653361,0.6535714285714286,0.9154875955876687,1.0,4/21,15.89%,IGFBP3;UBASH3B;PTPN1;OSM
prerank,regulation of leukocyte activation (GO:0002694),0.33810972549352375,0.8654686594558376,0.6678383128295254,0.9150923120170008,1.0,8/14,28.47%,PJA2;LYN;GPER1;CD33;MYO18A;SHPK;MIF;GPR137B
prerank,positive regulation of receptor internalization (GO:0002092),-0.2860865036745094,-0.8654016086656925,0.6801801801801802,0.9347775101598585,1.0,6/22,19.37%,MAGI2;ATAD1;AHI1;SCYL2;APLN;CD63
prerank,response to nitric oxide (GO:0071731),-0.32924023872040753,-0.8653483894530963,0.6495901639344263,0.934086166835578,1.0,6/13,25.54%,KCNC2;GUCY1B1;CDK2;FOXO1;AQP1;CCL19
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.28693322595322057,0.8647275517473596,0.6648648648648648,0.9162489909382722,1.0,7/29,19.28%,COPA;GOLGA5;COG2;NAPG;COG6;RAB6B;COG5
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.2730214630333776,0.8641714708862219,0.6636528028933092,0.9169589203926243,1.0,8/33,17.17%,MEF2C;AIF1;IGFBP3;IL12B;GPER1;NDRG4;VIP;TRIB1
prerank,negative regulation of lymphocyte activation (GO:0051250),0.302179427545576,0.8635830123163252,0.6849056603773584,0.9177438348401801,1.0,1/21,0.03%,PAG1
prerank,protein ADP-ribosylation (GO:0006471),0.28102615254823166,0.8628041035631554,0.6841216216216216,0.9188798730790209,1.0,3/28,3.29%,SIRT2;ART4;HPF1
prerank,negative regulation of cell death (GO:0060548),0.22682542682651086,0.862724139380577,0.7443729903536977,0.9185018850196965,1.0,23/88,24.24%,SRGAP2;CLU;EIF4G1;IMPACT;POU4F1;TM7SF3;CD34;PAX2;PINK1;DCPS;AKT1;CSF1;GPNMB;KANK2;NUP62;ATG5;HTRA2;CHMP2A;VPS35;TXNDC12;PARK7;LRPAP1;CHGA
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.271181362476966,0.8626946593156531,0.6728499156829679,0.9180161080203825,1.0,12/33,25.66%,CRNN;PHB2;PLCG2;PLK5;APPL1;TAF1;EZH2;CDKN1B;STXBP4;APPL2;TRIM39;ATP2B4
prerank,glutamine family amino acid catabolic process (GO:0009065),0.3393007765738963,0.8625409661425419,0.6486486486486487,0.9177910601044339,1.0,5/13,25.84%,GAD1;NOS2;ALDH4A1;NOS1;DDAH1
prerank,calcium ion import across plasma membrane (GO:0098703),0.33594612186312905,0.8625108546203138,0.6451612903225806,0.9172925555968434,1.0,4/14,13.29%,TRPV2;TRPM2;SLC8A1;TRPV4
prerank,organophosphate catabolic process (GO:0046434),0.3556526900580471,0.8618974246233297,0.625,0.9180481777547512,1.0,3/11,13.08%,ABHD12;NUDT15;PLBD2
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.3381729701159746,-0.8617541556907634,0.6477987421383647,0.9399973310189734,1.0,2/12,9.53%,CUL3;DLGAP5
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.3381729701159746,-0.8617541556907634,0.6477987421383647,0.9399973310189734,1.0,2/12,9.53%,CUL3;DLGAP5
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.3381729701159746,-0.8617541556907634,0.6477987421383647,0.9399973310189734,1.0,2/12,9.53%,CUL3;DLGAP5
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.26075586872974355,0.8612917946773013,0.6998284734133791,0.9188422078040233,1.0,15/41,26.23%,RANBP2;NUP42;SEC13;NUP50;NUP35;NUP88;PGAM1;NUP62;SEH1L;NUP107;NUP153;HIF1A;NUP188;JMJD8;NDC1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.27160318515357484,-0.8611477801999212,0.6916299559471366,0.9405748115503079,1.0,11/26,23.64%,DAB2;FOXP1;STRN3;SIRT1;CLOCK;PER1;SFRP1;CRY1;NCOR1;CNOT9;HDAC1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.26005950437398023,0.861049877364832,0.6945392491467577,0.9188317981050707,1.0,15/41,26.23%,RANBP2;NUP42;SEC13;NUP50;NUP35;NUP88;PGAM1;NUP62;SEH1L;NUP107;NUP153;HIF1A;NUP188;JMJD8;NDC1
prerank,cellular component assembly (GO:0022607),-0.1803947972603795,-0.860946005887687,0.8972602739726028,0.9402312630114004,1.0,49/253,17.83%,NLGN1;EPS8;NEDD9;CD74;ANK3;SPTBN1;GSN;CD40;ZW10;DNM1L;PCLO;VCPIP1;CDC42;WASF1;RTN4;ST13;PAWR;GEMIN5;VMP1;SNX9;SHROOM1;PLS1;ACTB;KNTC1;LRRTM3;PPIH;PPP2R1A;DNAJB13;CFAP206;IL2RB;RHOU;NEFH;JCHAIN;PARD3;IL1RAP;GPAA1;MDM2;REPS2;CORO1B;CD3E;TRAF1;ADD2;RSPH1;PARVG;RIMS1;WDR19;SPG7;TRIP13;CARD10
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.3439530690867589,-0.8606967830686708,0.6558891454965358,0.9399731785678858,1.0,2/11,5.43%,LRP6;NR4A2
prerank,positive regulation of leukocyte activation (GO:0002696),0.3105987216621796,0.8606421369063771,0.65,0.9191786320947292,1.0,6/18,19.13%,KARS1;TLR4;IL33;NECTIN2;TNIP2;THBS1
prerank,negative regulation of viral genome replication (GO:0045071),-0.249721875475375,-0.8605498425507473,0.714622641509434,0.9394947567667683,1.0,17/40,26.51%,OAS2;RSAD2;IFITM3;RNASEL;IFITM2;OAS3;CCL5;BANF1;IFITM1;SRPK2;IFIH1;LTF;ZC3HAV1;PARP10;BST2;OASL;PLSCR1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.35719762969490504,0.8604044360453531,0.6666666666666666,0.9191786234148754,1.0,3/11,12.42%,SLC19A3;DCTD;ERH
prerank,acute inflammatory response (GO:0002526),-0.28108090109180167,-0.8602714333374619,0.6643835616438356,0.9392981565715909,1.0,10/23,33.96%,CEBPB;ANO6;LBP;HPR;HP;SIGIRR;PLSCR1;CRP;CD6;IL22
prerank,cellular response to chemokine (GO:1990869),0.25313961955556036,0.8600941620981545,0.6921708185053381,0.9192938115841474,1.0,6/46,10.29%,DOCK8;LRCH1;CCL3;PTK2B;CXCL1;WNK1
prerank,regulation of isotype switching (GO:0045191),0.331091596923706,0.8600776176118021,0.6401446654611211,0.9187778389994504,1.0,3/14,12.90%,SLC15A4;KMT5C;SHLD2
prerank,positive regulation of cell aging (GO:0090343),-0.3450037431804784,-0.8594921648406496,0.6468085106382979,0.9402365984268893,1.0,4/11,13.79%,B2M;LMNA;SIRT1;CDKN2A
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.34990278161254934,0.8592619531289248,0.6790352504638218,0.9200269142194042,1.0,2/13,3.90%,DDX5;ATM
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.2830021644645571,-0.8591717918389086,0.691566265060241,0.9401870601988771,1.0,4/24,11.20%,PID1;NDUFS1;SDHAF4;GFPT2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.3414746592758021,0.858887230450679,0.6386861313868614,0.9203017433121725,1.0,7/13,30.40%,PLEK;SOD1;DKK3;SCAP;BMP2;ERLIN2;NFKB1
prerank,negative regulation of protein transport (GO:0051224),0.2903554237962044,0.8584716182865009,0.6823956442831216,0.9206358742012943,1.0,8/25,18.93%,NDFIP2;CSK;IL12B;PKDCC;DRD2;WWP2;SNX3;PPM1F
prerank,replication fork processing (GO:0031297),0.2620023366853881,0.8579639536735454,0.7185314685314685,0.9211738478012615,1.0,5/38,5.95%,PCNA;CDK9;PRIMPOL;FAM111A;FANCM
prerank,protein import into peroxisome matrix (GO:0016558),0.3453575215620483,0.8576283116335424,0.6360078277886497,0.9213314674945449,1.0,3/12,18.70%,PEX10;PEX6;PEX1
prerank,negative regulation of leukocyte activation (GO:0002695),-0.32029462104766315,-0.8575742760451512,0.6788008565310493,0.9430154302270328,1.0,3/15,11.45%,LRFN5;CD300LF;FCGR2B
prerank,regulation of telomerase activity (GO:0051972),-0.24293645377129652,-0.8575048967142405,0.710955710955711,0.9423350035445679,1.0,18/45,25.47%,PARM1;CCT2;MAPKAPK5;SMG6;AURKB;KLF4;WRAP53;CERS1;PRKCQ;XRCC5;PIF1;TCP1;MAPK1;NABP2;GRHL2;CTNNB1;MAPK15;HSP90AB1
prerank,vacuolar acidification (GO:0007035),0.29950219227263414,0.857360179572751,0.6803571428571429,0.9213580646601428,1.0,8/21,17.73%,PPT1;TCIRG1;ATP6V0A2;CLN3;TMEM199;ATP6V0A4;ATP6V0E2;SLC11A1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.234507999438591,-0.8567696785662491,0.740990990990991,0.9431932197437395,1.0,14/48,18.67%,AMPD3;ADCY2;GUCY1B1;PAPSS2;ADCY5;SLC25A16;ADCY3;ADCY8;SLC26A2;ADSS2;SLC35B3;PPCS;GUCY2F;GUCY2D
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.30712016931307073,-0.856769292671378,0.7017937219730942,0.9423744756293786,1.0,5/16,21.97%,SOX5;HOXB4;FOXC1;SOX6;SP7
prerank,superoxide metabolic process (GO:0006801),-0.2669568007852817,-0.8565970748022653,0.701123595505618,0.9419489784515107,1.0,8/29,16.33%,CYBB;PRDX1;NCF2;ATP7A;CYBA;NRROS;SOD2;TAFA4
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.23391986265977316,-0.8564324438461018,0.7348484848484849,0.9414717427598438,1.0,6/52,3.76%,YWHAQ;NPEPPS;TFDP2;ATG13;YWHAE;UBE2J2
prerank,gliogenesis (GO:0042063),0.32582539699653296,0.855924628062081,0.6741154562383612,0.9239439351540187,1.0,5/15,22.10%,CD9;PAX2;METRN;METTL14;MMP24
prerank,negative regulation of response to external stimulus (GO:0032102),0.218633102623086,0.8559151169962363,0.7649918962722853,0.9234090688734738,1.0,23/105,17.85%,SIRPA;RTN4RL1;SIRT2;OTULIN;ITCH;PPARD;GPS2;PRKCD;KLK8;PCBP2;NLRP3;C1QBP;GPER1;TNFAIP8L2;SERPINE1;CERS2;DRD2;RTN4R;CXCL17;MAPK7;TRIB1;AJAP1;GATA3
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.2337761957804022,-0.8558265816898663,0.7336561743341404,0.9419990032169927,1.0,12/50,17.75%,PSMD14;PSMD8;PSMA2;PSMF1;PSMD6;PSME2;PSMD5;PSMD12;PSMD11;OAZ1;PSMD1;AZIN1
prerank,regulation of DNA binding (GO:0051101),0.25292010504055273,0.8557985455914514,0.7077922077922078,0.9231075677624853,1.0,11/44,17.95%,SUMO1;SKI;SIRT2;MDFI;JUN;CEBPG;MAPK8;SMO;KDM1A;NME1;HMGB2
prerank,regulation of stem cell proliferation (GO:0072091),0.31946802371234717,0.8553529004172411,0.6785046728971963,0.9235691249832758,1.0,5/17,17.95%,ZFP36L1;GJA1;EIF2AK2;KDM1A;HMGB2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.299235403264096,0.8551819293491623,0.6742957746478874,0.9233921476617653,1.0,5/22,18.02%,CRY2;MGAT5;NCKAP1L;MASTL;ROCK2
prerank,negative regulation of cellular metabolic process (GO:0031324),0.26063153168641096,0.8547844381423242,0.7104795737122558,0.9237182937504109,1.0,8/37,13.52%,SIRT2;ITGAV;AATF;BRCA1;PAX2;DLG4;PINK1;OPTN
prerank,regulation of macrophage activation (GO:0043030),-0.26086844251802166,-0.8544071782625481,0.6975169300225733,0.9444303417810842,1.0,6/30,13.27%,CD74;LRFN5;LBP;FCGR2B;CEBPA;MMP8
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.2327717317987436,-0.8543307913945779,0.7202970297029703,0.9438043179408689,1.0,5/52,3.58%,SORBS1;DPP10;SPTBN1;EGFR;ACSL3
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.2717975058801865,-0.8542724492671867,0.6897374701670644,0.9430938776650647,1.0,3/26,3.46%,SORBS1;IRS1;CREBL2
prerank,maintenance of blood-brain barrier (GO:0035633),0.27952318916890023,0.8542431949866092,0.6683168316831684,0.9243416623826554,1.0,10/30,20.50%,F11R;JAM2;LSR;TJP1;GJA1;TJP2;CLDN12;CLDN1;WNK3;LAMA2
prerank,cellular response to purine-containing compound (GO:0071415),-0.35476353061254556,-0.8537923601050545,0.6535947712418301,0.943379063686852,1.0,3/10,10.59%,RYR3;RYR2;P2RY1
prerank,histone methylation (GO:0016571),0.2874633854268634,0.8536300323510034,0.6794871794871795,0.9250877007551781,1.0,9/26,22.56%,PRMT2;PRMT8;PRMT1;EHMT2;PRMT6;EZH2;CARM1;FBL;SMYD1
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.2593490414454942,-0.8534638305689526,0.7189695550351288,0.9433248429721286,1.0,10/28,20.79%,APP;APOE;SHANK3;GSK3B;ADCY8;EIF2AK4;RELN;CALB1;EPHB2;EPHA4
prerank,regulation of cell junction assembly (GO:1901888),0.28746733561112964,0.8533803285139795,0.6703499079189686,0.9251082036106071,1.0,5/27,12.07%,F11R;MEF2C;PRKACA;TJP1;RUNX1
prerank,positive regulation of RNA splicing (GO:0033120),0.2787470827273189,0.8533158300267233,0.6605166051660517,0.924706484286349,1.0,9/29,24.15%,NCBP1;PIK3R1;U2AF2;TRA2B;DYRK1A;TRA2A;RBMX;DAZAP1;HNRNPLL
prerank,leukocyte cell-cell adhesion (GO:0007159),0.2901237618531761,0.8532128287230993,0.6809269162210339,0.9243717714044817,1.0,5/24,8.45%,F11R;FERMT3;ITGB2;SELE;SELP
prerank,positive regulation of macroautophagy (GO:0016239),0.24824018528052694,0.8531210034377519,0.7235099337748344,0.92402083743656,1.0,13/48,23.50%,SCOC;RAB3GAP2;RAB3GAP1;SH3GLB1;HSPB8;PINK1;OPTN;VDAC1;FYCO1;LARP1;SESN1;RALB;VPS13D
prerank,ERBB2 signaling pathway (GO:0038128),-0.26924401865940295,-0.8524898237277361,0.6936936936936937,0.9447493975491457,1.0,5/31,9.50%,EGFR;PTPN12;ERBB4;ERBB3;NRG2
prerank,DNA-dependent DNA replication (GO:0006261),0.20781406037232794,0.8523489801116544,0.8024691358024691,0.9251167561702675,1.0,41/128,27.93%,PRIMPOL;GINS4;RFC2;RPS27A;UBC;MCM2;CDC34;PSMD3;POLD2;PSMB3;GINS3;SSBP1;PSMA7;RPAIN;PSMC1;PSMC2;BLM;CDK2AP1;PSME4;POLG2;PSMB9;ORC3;RFC1;MCM3;PSMD4;PSMB5;MCMDC2;PSMB7;TOPBP1;RPA3;PSMB8;WRNIP1;POLD4;PSMD13;CDC7;GMNN;MCM6;ORC2;PSMD2;RPA1;RECQL
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.33488685867220935,-0.8519927823079142,0.6506550218340611,0.9442297590229737,1.0,1/12,0.59%,AKAP6
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.33488685867220935,-0.8519927823079142,0.6506550218340611,0.9442297590229737,1.0,1/12,0.59%,AKAP6
prerank,liver development (GO:0001889),0.26873860700546426,0.8519381368330308,0.6879432624113475,0.9254464621250929,1.0,8/32,16.02%,PRKCSH;NKX2-8;MET;LSR;CEBPG;CCDC40;PROX1;AURKA
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.2693772403393112,0.8510388942601187,0.704225352112676,0.9267847949885318,1.0,4/32,3.59%,PCTP;LPIN2;CSNK2A2;CSNK2A1
prerank,inhibitory synapse assembly (GO:1904862),-0.34170218100433825,-0.8509655173694283,0.6613636363636364,0.9457448311365495,1.0,5/11,18.80%,GABRA2;GABRG2;GABRB3;PLXNB1;CBLN4
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.32665231725855626,0.8507790878147291,0.6280373831775701,0.9267796340092167,1.0,5/15,23.69%,LIPC;APOM;SCARB1;LCAT;PLA2G3
prerank,protein deneddylation (GO:0000338),0.35914091688915806,0.8506328350200493,0.6598130841121496,0.9265492240563951,1.0,3/10,16.18%,COPS4;GPS1;COPS6
prerank,innate immune response in mucosa (GO:0002227),-0.3555062633894325,-0.8505546780197282,0.6379310344827587,0.945833202601808,1.0,3/10,19.99%,CAMP;RNASE3;LTF
prerank,negative regulation of protein catabolic process (GO:0042177),0.25329232986511074,0.8502696820277535,0.734982332155477,0.9267503148437616,1.0,8/40,17.64%,SNRNP70;CST3;SIRT2;MDM4;AGAP2;PIN1;SNX3;CTSA
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.2787192187461333,0.849633258062754,0.7018518518518518,0.9275850526326503,1.0,4/26,7.28%,SIRT2;ITCH;PCBP2;C1QBP
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.25069514687362304,-0.8491530000159556,0.720763723150358,0.948092012633582,1.0,6/35,12.13%,PAM;ALOX5;ALOX5AP;HMGCLL1;GGT7;FAR2
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.31682166362485303,0.8483435794550362,0.6771799628942486,0.9297862943543983,1.0,5/16,22.16%,NCBP1;TRA2B;TRA2A;RBMX;DAZAP1
prerank,macrophage chemotaxis (GO:0048246),0.3699629440977796,0.8479709689689583,0.6697761194029851,0.9300028576805078,1.0,3/10,15.14%,CCL3;EDN2;CXCL17
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.2637869613682678,-0.847488130324845,0.710955710955711,0.95088892815062,1.0,5/28,11.79%,MAP1B;MAP2;STMN4;STMN2;SKA3
prerank,TOR signaling (GO:0031929),0.2846638407434068,0.8474737745582738,0.6601769911504425,0.9305098395859652,1.0,8/26,17.85%,FLCN;RPTOR;MTOR;MLST8;PINK1;AKT1;EIF4EBP2;GATA3
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.25890465388443706,-0.8473422533307068,0.7020833333333333,0.9503949452685581,1.0,12/29,27.20%,CDC73;TLE4;TCF7;TLE1;BCL9L;PYGO2;LEF1;TERT;CTNNB1;HDAC1;RBBP5;ASH2L
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.2815606801538755,-0.8471431925682849,0.6975717439293598,0.9500111685682463,1.0,7/21,25.82%,LRP6;GSK3B;AXIN1;WNT8B;FRAT1;CTNNB1;CSNK1A1
prerank,regulation of lipid storage (GO:0010883),-0.2869822214955166,-0.8467535183071457,0.7099767981438515,0.9500716906750885,1.0,9/22,29.80%,SIRT1;PTPN2;NFKBIA;IKBKE;VSTM2A;FBXW7;ALKBH7;PLA2G10;CRP
prerank,positive regulation of phosphatase activity (GO:0010922),0.29205447970542564,0.8465265886088116,0.6631944444444444,0.9319654005652223,1.0,5/21,11.46%,MEF2C;PLEK;AGTR2;MTOR;PDGFRB
prerank,phasic smooth muscle contraction (GO:0014821),0.36126981750266374,0.8465039154618439,0.6720430107526881,0.9314523176403832,1.0,4/10,13.47%,EDN3;EDN2;GDNF;DRD2
prerank,cellular response to light stimulus (GO:0071482),0.2328466591710611,0.8464341845568021,0.775206611570248,0.931061404882059,1.0,16/66,23.86%,RHNO1;PCNA;PRKCD;EIF2S1;USP28;BMF;TAF1;ERCC4;TMEM161A;KDM1A;GNB1;GPR52;NSMCE3;ZBTB1;YY1;TP53
prerank,ear morphogenesis (GO:0042471),0.29635191010438955,0.8462891030431942,0.6824817518248175,0.9308278537790249,1.0,6/20,24.02%,CHD7;PAX2;ZIC1;NOG;TWIST1;FGFR2
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.3469341360981285,0.8459883851575246,0.6666666666666666,0.9309081894292869,1.0,6/12,31.50%,NBN;BLM;WRNIP1;GMNN;METTL4;TICRR
prerank,regulation of phosphatase activity (GO:0010921),0.2884762034996533,0.84583087030394,0.7084078711985689,0.9306963479197761,1.0,5/24,11.54%,PPP6R3;ZCCHC9;GPATCH2;PPP6R1;SH2D4A
prerank,regulation of telomere maintenance (GO:0032204),-0.26810382553042394,-0.8455901465437841,0.7225950782997763,0.9517877822428702,1.0,14/26,34.86%,SMG6;SMG5;XRCC5;SMG1;MRE11;PIF1;UPF1;PPP1R10;PML;ERCC1;GNL3;TINF2;TERF2IP;DHX36
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.2697044024460623,0.8454910298139061,0.701048951048951,0.9308388264742556,1.0,6/31,8.20%,LYN;ATM;TNFRSF21;CD86;TNFRSF13B;PDCD1LG2
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.34120333229944366,0.8451870088628979,0.6764705882352942,0.9309427660853716,1.0,3/12,18.94%,MBTPS1;MBTPS2;CLCN2
prerank,negative regulation of neuron death (GO:1901215),0.22062499493255788,0.8450789429877636,0.7761674718196457,0.9306229326591662,1.0,27/93,24.24%,MEF2C;SLC30A10;EIF4G1;PTK2B;LGMN;PPT1;CNTF;GDNF;POU4F1;CD34;CLN3;PINK1;AGAP2;SOD1;RETREG1;AKT1;CSF1;GPNMB;MAG;HTRA2;VPS35;FGF20;SNX6;PARK7;KDM2B;PLA2G3;CHGA
prerank,aorta morphogenesis (GO:0035909),-0.2973687618023567,-0.8446704729341433,0.6870748299319728,0.9530391959671602,1.0,4/17,14.99%,RBPJ;JAG1;ACVRL1;HEY2
prerank,intracellular cholesterol transport (GO:0032367),-0.30903695868579395,-0.8445763477317366,0.6746724890829694,0.9524315807149109,1.0,3/15,8.81%,LDLR;LRP6;RELCH
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.34130498375008417,-0.844512532625184,0.6754385964912281,0.9517545870919266,1.0,2/11,2.21%,PLCB1;IRS1
prerank,mitochondrion organization (GO:0007005),0.20127586921779866,0.8440017276542902,0.8338235294117647,0.9323736342528407,1.0,45/165,22.68%,DNM2;HK2;TRAK1;CXADR;PHB2;COX7A2L;MIGA2;ATAD3A;YME1L1;PITRM1;PISD;TIMM8B;MEF2A;NRF1;FANCG;TIMM44;PINK1;SSBP1;MIEF2;TIMM50;TSPO;RAB32;HSD17B10;TMEM11;POLG2;TOMM20;TIMM10B;ATP5F1D;MTX1;BCS1L;TOMM7;PPRC1;AFG3L2;MYH14;WDR81;ATCAY;VPS13C;TFB1M;MTFR1L;AGTPBP1;STOML2;BCL2L1;OPA1;PYROXD2;PARK7
prerank,negative regulation of neuron differentiation (GO:0045665),-0.2760308957527011,-0.8434390702853,0.7022222222222222,0.9533136985538313,1.0,10/22,34.17%,B2M;GSK3B;EIF2AK4;REST;CNTN4;HES5;MED1;SOX3;POU4F2;HES1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.2104522499433153,-0.8432913675612403,0.8239795918367347,0.9528087536839706,1.0,17/85,16.84%,MAGI2;PRICKLE2;AP2A2;PSMD14;CDC42;PSMD8;PSMA2;PSMF1;PSMD6;PSME2;PSMD5;PSMD12;PSMD11;AP2B1;PSMD1;TIAM1;DAAM1
prerank,regulation of kinase activity (GO:0043549),0.21873979409149008,0.8432181792953899,0.7768456375838926,0.9335386130168519,1.0,16/89,14.62%,MERTK;CSF1R;IGF1R;NBN;RYK;RBL2;CAMKK2;MET;EPHA8;SMG8;AXL;PDGFRB;DDR2;MUSK;SOD1;TSPYL2
prerank,regulation of mitotic spindle organization (GO:0060236),-0.24838216279631015,-0.8431797667107747,0.7095343680709535,0.9522221826982967,1.0,14/35,32.91%,TPX2;CCSAP;MAP9;GNAI1;GPSM2;PARP3;HSPA1B;PLK1;CHMP1B;BORA;FSD1;DYNC1H1;PSRC1;DRG1
prerank,iron ion transmembrane transport (GO:0034755),-0.35445319411639437,-0.8429117751861546,0.6652977412731006,0.9519825836774655,1.0,3/10,10.27%,ABCB7;SLC25A28;SCARA5
prerank,response to cytokine (GO:0034097),0.20523242818971474,0.8427510534142105,0.8101851851851852,0.933993129995591,1.0,29/141,17.73%,CSF1R;SMAD3;IL1RL2;LGALS9;IRAK2;CRNN;PRKCA;CDK9;SRC;MAP4K3;CASP1;IL6ST;SELE;CCR7;SELP;POU4F1;IL6R;PTPN11;RELB;IL18BP;SETD2;LDLRAP1;MAPK8;SHFL;PTPN5;ADAM10;PTPN23;EIF2AK2;SLC11A1
prerank,dopaminergic neuron differentiation (GO:0071542),-0.2852074753712382,-0.8423520302202838,0.6750572082379863,0.9524037753898794,1.0,8/19,31.32%,LRP6;NR4A2;CTNNB1;PHOX2A;FOXA2;EN1;WNT2;CDNF
prerank,regulation of establishment of planar polarity (GO:0090175),0.22095324523696477,0.8421991641533934,0.7774140752864157,0.9346444689478534,1.0,26/88,24.89%,RAC1;ARRB2;SMURF1;AP2A1;PKHD1;FZD2;PSMD3;PSMB3;FZD6;PSMA7;PSMC1;PSMC2;PSME4;PSMB9;VANGL1;FZD1;VANGL2;PSMD4;PSMB5;PSMB7;PSMB8;CELSR1;DVL2;PRICKLE1;FZD5;PSMD13
prerank,autophagosome maturation (GO:0097352),-0.25014237371492015,-0.8421324271975643,0.722488038277512,0.9520992607111879,1.0,6/32,8.29%,ATP2A2;SNX14;STX17;CALM1;UVRAG;VMP1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2551234354903279,0.8417751203233792,0.7225130890052356,0.9349885562287551,1.0,5/40,5.95%,PCNA;CDK9;PRIMPOL;FAM111A;FANCM
prerank,chromatin organization (GO:0006325),-0.19020028003159628,-0.8416593708660143,0.8756756756756757,0.9523397665548906,1.0,29/132,20.02%,SUV39H1;MTF2;JARID2;KDM4D;BAZ2B;HDAC4;SIRT1;SMARCE1;MPND;MTA2;MCM3AP;PADI4;SETD5;PRDM16;KDM4C;SETDB2;HMG20A;NPM2;NUCKS1;PAK1;CBX3;TOP1;NPM1;SUV39H2;PBRM1;FOXP3;SUPT4H1;PIH1D1;KDM6A
prerank,negative regulation of interferon-beta production (GO:0032688),0.3619473285224783,0.8416228371356561,0.6750972762645915,0.9347505655941154,1.0,5/10,23.70%,SIRPA;RELB;PYCARD;PPM1B;YY1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.2969483224658343,0.8414989460552226,0.6979742173112339,0.9344552678604452,1.0,9/22,30.67%,CYRIB;IL12B;FBXO38;ZBTB1;FADD;FZD5;TRAF6;IL12RB1;STX7
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.32610465498261065,-0.8413864628861005,0.6795698924731183,0.9521090110809542,1.0,1/12,1.28%,PPARG
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.35383794000639235,0.8413095619681559,0.6797274275979557,0.9342960228891066,1.0,3/11,10.06%,EBI3;IL6ST;IL12RB2
prerank,regulation of cell cycle process (GO:0010564),-0.20229176726417972,-0.8412308923268415,0.8360215053763441,0.9516218854367124,1.0,26/104,17.11%,MKI67;RACGAP1;CALM1;CDC42;KLHL13;UVRAG;TTL;CUL7;PLK2;AURKB;KIF11;MAP9;PRC1;BUB1;SPAG5;BECN1;KIF20A;DCUN1D3;OBSL1;DBF4;CHEK1;IHO1;SFRP1;CDC25C;MAD1L1;PKMYT1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.31238422103176156,0.8408777149827799,0.6588447653429603,0.9347218494667662,1.0,4/16,13.61%,ATM;SLX4;ERCC4;TERF1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.2804419865031301,-0.8404109800323301,0.7065217391304348,0.9526236969094677,1.0,4/20,9.12%,LIMD1;AGO4;TNRC6A;HELZ
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.29947312300408924,0.8401711618814591,0.6799276672694394,0.935656681555589,1.0,5/20,18.12%,ACSL4;DGAT1;PPT1;SCD5;SCD
prerank,vasoconstriction (GO:0042310),-0.3436022477621231,-0.8399882356131337,0.6458797327394209,0.9526853040544178,1.0,3/11,5.41%,PIK3C2A;EDNRB;HTR2B
prerank,positive regulation of cellular senescence (GO:2000774),0.36512424811303956,0.8399433754494973,0.6866791744840526,0.9356010298887749,1.0,2/10,7.09%,ABI3;CGAS
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.3198777639307142,-0.8395878873513654,0.6744186046511628,0.9527589644675084,1.0,1/13,0.58%,ITGA4
prerank,ribosome assembly (GO:0042255),0.24693289217742123,0.8391742904885515,0.7667785234899329,0.9366188643617636,1.0,14/47,21.70%,EIF2A;C1QBP;BOP1;MPV17L2;RPL10;NLE1;RPS27L;MRPS11;BRIX1;SBDS;DHX29;TRAF7;EFL1;DDX3X
prerank,organelle fusion (GO:0048284),-0.28000278982510163,-0.838858255039933,0.7053763440860215,0.9534997714011659,1.0,6/22,17.60%,EEA1;MIGA1;FIS1;MFF;CYP26C1;SPG7
prerank,positive regulation of monooxygenase activity (GO:0032770),0.28322116444183304,0.8387572507381235,0.7137931034482758,0.9369499086954204,1.0,10/26,24.68%,AGTR2;NOS1AP;GDNF;PIK3CB;AKT1;CDH3;SCARB1;POR;PARK7;HIF1A
prerank,regulation of metal ion transport (GO:0010959),-0.3026151709949147,-0.8384748225281761,0.6757894736842105,0.9535127478801858,1.0,4/16,14.96%,ANK2;IL16;EPB41;BCL2
prerank,regulation of T cell cytokine production (GO:0002724),0.3204869522968954,0.8381637209234065,0.6774193548387096,0.9376367445307053,1.0,2/15,3.93%,SMAD7;TRPM4
prerank,fat cell differentiation (GO:0045444),0.23664686383293576,0.8380646342656884,0.7696245733788396,0.9373103693864845,1.0,10/57,12.70%,SENP2;ALOXE3;SOX8;BBS9;OSBPL11;EGR2;TMEM120B;CLIP3;BBS2;BSCL2
prerank,response to interleukin-1 (GO:0070555),0.22692133593983,0.8380374602546873,0.8050847457627118,0.9368149372072899,1.0,6/73,4.17%,SIRPA;LGALS9;IRAK2;PRKCA;SRC;CCL3
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.22583174602601405,-0.8373095822652603,0.7832512315270936,0.9551458008871718,1.0,12/53,17.75%,PSMD14;PSMD8;PSMA2;PSMF1;PSMD6;PSME2;PSMD5;PSMD12;PSMD11;OAZ1;PSMD1;AZIN1
prerank,histone H3 acetylation (GO:0043966),0.2514540758038643,0.8370034762301789,0.731239092495637,0.9383292677904177,1.0,18/40,30.60%,TAF12;PHF14;TAF6L;TAF5L;TADA1;JADE2;MBIP;TAF10;KAT6B;DR1;TAF5;NAA60;BRD1;WDR5;YEATS2;SPI1;KAT2B;SUPT7L
prerank,peripheral nervous system development (GO:0007422),0.2824841419635985,0.8368817220478679,0.6920353982300885,0.9380325721481656,1.0,4/23,8.18%,SOX8;ARTN;EGR2;GDNF
prerank,regulation of urine volume (GO:0035809),0.3598287968337192,0.8367272851327476,0.6672897196261682,0.9378120666261679,1.0,2/10,11.91%,INPP5K;ADCY6
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.329975992479678,-0.8366830459502153,0.6733333333333333,0.9557139141271601,1.0,4/12,13.27%,CD36;ZNF205;CYBA;MMP8
prerank,regulation of programmed cell death (GO:0043067),-0.18603692742768632,-0.8363087743650249,0.9098591549295775,0.9556894875691884,1.0,20/161,9.48%,HIP1;LRRK2;CHM;NLRC4;SLK;PHLPP1;RPS3;JAK2;STK26;TPT1;RARG;IKZF3;RTN4;BIRC5;DAPK1;PRKN;SIRT1;ALK;ACTN2;BCAR1
prerank,regulation of double-strand break repair (GO:2000779),0.2555771551180284,0.8358732858676412,0.7399650959860384,0.9389874789498781,1.0,20/39,32.89%,SPIDR;MGMT;SPIRE1;OTUB2;SHLD2;PPP4R2;SETD2;KDM1A;SLF2;DEK;TWIST1;ACTR2;ZCWPW1;RTEL1;DDX11;FOXM1;USP51;MRNIP;RPA2;SIRT7
prerank,cellular response to alkaloid (GO:0071312),0.30759586234037806,0.8358455553990256,0.7018181818181818,0.9384877042804795,1.0,3/17,5.57%,TGM2;SLC8A1;SPIDR
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.24179261899476062,0.8351907836720547,0.7425742574257426,0.9393044299383837,1.0,12/48,17.82%,RANBP2;NUP42;SEC13;NOS2;NUP50;NUP35;NUP88;PGAM1;KHK;NUP62;SEH1L;NUP107
prerank,regulation of fibroblast proliferation (GO:0048145),-0.23280552292464898,-0.8349035739720457,0.7475961538461539,0.9578125389853885,1.0,15/45,25.35%,CD74;FN1;CDC73;LIG4;CDKN1A;SFRP1;B4GALT7;E2F1;GSTP1;CDK4;AQP1;EMD;PARP10;CTNNB1;NLRC3
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.29974085832925573,0.8348859117147125,0.6833333333333333,0.9394037766345814,1.0,3/18,14.92%,TMEM119;FRS2;HDAC5
prerank,cellular response to estradiol stimulus (GO:0071392),0.30403188374294426,0.8348563233401202,0.7071823204419889,0.9389166369580273,1.0,6/18,17.86%,GPER1;POU4F1;CCDC62;NCOA3;NRIP1;KAT5
prerank,GTP metabolic process (GO:0046039),-0.30284517359177315,-0.8346745676260781,0.7060085836909872,0.9575108374310299,1.0,3/15,7.38%,LRRK2;AK3;RAN
prerank,regulation of BMP signaling pathway (GO:0030510),0.2244240112685333,0.8343861600508439,0.7693548387096775,0.9393699904715508,1.0,7/73,4.87%,GREM1;SMAD7;SKI;SMURF1;FBXL15;SKIL;NUMA1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.2943152376971874,-0.834224595660109,0.7024070021881839,0.9576025041354836,1.0,3/17,10.54%,ADRA1A;RAPGEF2;ADRA2A
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.28067809687721845,-0.8334461973595695,0.7053364269141531,0.9584066921123973,1.0,8/21,27.69%,SLK;LIMCH1;EFNA5;ACTG1;PEAK1;PTK2;EPHA3;ROCK1
prerank,ubiquinone metabolic process (GO:0006743),0.3150205764893812,0.8333627292150014,0.6716697936210131,0.9409618192334338,1.0,2/15,3.31%,COQ7;FDXR
prerank,potassium ion import across plasma membrane (GO:1990573),-0.2358337848900087,-0.832969179037908,0.7755610972568578,0.9585681821460292,1.0,17/41,34.04%,KCNJ3;SLC12A8;SLC12A4;ATP1B3;SLC12A5;ATP1A1;HCN2;SLC12A1;KCNJ10;HCN4;SLC12A3;KCNJ8;KCNJ16;KCNE2;KCNJ14;KCNJ6;KCNH2
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.34463317343498373,-0.8324699053383723,0.6811594202898551,0.9588233567780822,1.0,2/10,5.04%,XDH;CADM4
prerank,protein maturation (GO:0051604),0.2158676795470444,0.8318986127176041,0.807131280388979,0.9434414977235102,1.0,31/95,28.14%,TSPAN14;LMF1;F12;CTSS;PITRM1;CPE;NAA11;MMS19;PSENEN;CLN3;PSEN2;NAA50;CCS;ADAM10;APH1B;STUB1;NAA40;AFG3L2;METAP2;GALNT2;ADAM17;FURIN;LMF2;PTCH1;NAA60;TYSND1;DNAJB11;PCSK7;ISCA1;CASP2;APH1A
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.30238307920067414,-0.8318331298407505,0.7152317880794702,0.9593878159632044,1.0,7/16,23.57%,AUTS2;DNMT3B;DNMT1;SNW1;PIH1D1;MYB;CTNNB1
prerank,regulation of protein polymerization (GO:0032271),0.2598559356457272,0.8317120801434851,0.711864406779661,0.9432734889218525,1.0,16/35,30.06%,DBN1;CAMSAP1;ARHGAP28;ABITRAM;CAMSAP2;ABL1;FCHSD2;DBNL;FCHSD1;MAPT;ESAM;TPPP3;COTL1;PLEKHG2;RASA1;MAPRE3
prerank,activation of adenylate cyclase activity (GO:0007190),0.26107218313372726,0.8316782311815097,0.7247706422018348,0.9427920982444951,1.0,7/35,11.91%,ADCY9;ADORA2B;CALCR;FSHR;LHCGR;ADCY4;ADCY6
prerank,photoreceptor cell development (GO:0042461),-0.3138730780953907,-0.831389603521938,0.6948051948051948,0.9595144126800685,1.0,3/14,12.91%,RORB;MFSD2A;AHI1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.2068469922743141,0.8313336334879774,0.8193343898573693,0.942951214861742,1.0,23/116,18.44%,ADCY9;PRKACA;LYN;SRC;MYH9;PLCG2;HRH2;ADORA2B;MC2R;CALCR;FSHR;LHCGR;NPS;ADCY4;DPEP1;ADCY6;INSL3;VIP;MAPK14;ADORA2A;ADCY7;GPR84;GNB1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.22151752086304152,0.8311552323882038,0.7870967741935484,0.942795738171392,1.0,8/79,5.79%,GREM1;SMAD7;SKI;SMURF1;SHISA2;AGTR2;SKIL;SPRY2
prerank,glycerolipid metabolic process (GO:0046486),-0.3259281038094596,-0.8311313618909327,0.6752136752136753,0.9592322773437709,1.0,1/11,1.15%,DGKB
prerank,endoderm development (GO:0007492),0.3369194936510814,0.8311107707404656,0.6840148698884758,0.9423220342121456,1.0,2/13,13.01%,SOX17;DUSP5
prerank,polarized epithelial cell differentiation (GO:0030859),0.33911601743554504,0.8308229938931773,0.6924460431654677,0.9423629324122073,1.0,1/13,0.53%,OPHN1
prerank,regulation of myotube differentiation (GO:0010830),0.2781910306328445,0.830748367906983,0.7124773960216998,0.9419741626082256,1.0,5/24,15.33%,TMEM119;FBXO22;RBM24;HDAC5;MAPK14
prerank,regulation of DNA recombination (GO:0000018),0.2636770908388211,0.8305935866856058,0.7280701754385965,0.9417307562309108,1.0,8/32,17.83%,SPIDR;SHLD2;PPP4R2;SETD2;BLM;ALYREF;KDM1A;IL7R
prerank,negative regulation of peptidase activity (GO:0010466),0.24371519625641302,0.8304200597246552,0.7653061224489796,0.9415251800041055,1.0,9/47,16.94%,CST3;GAPDH;LRP1;SERPINE1;SERPINE2;AKT1;SERPINF1;AGT;SPINK5
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.29684541844043805,-0.8303880491697226,0.7155756207674944,0.9599758662395258,1.0,1/16,0.15%,PID1
prerank,mitochondrion distribution (GO:0048311),-0.3147112062302373,-0.8299508873957605,0.6939655172413793,0.9601008580758182,1.0,2/12,5.14%,LRRK2;DNM1L
prerank,regulation of neuron projection arborization (GO:0150011),-0.31118077610749023,-0.8299262911968515,0.7065217391304348,0.959353906793378,1.0,5/15,14.58%,GRIP1;MFSD2A;MAP3K13;NTNG1;NTNG2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.2835455789699264,0.8294375452408906,0.7271028037383177,0.9429662440976725,1.0,5/22,18.02%,PRKCA;IL6ST;MEF2A;AGT;ROCK2
prerank,sprouting angiogenesis (GO:0002040),0.24025542482341966,0.8294150076681869,0.7763371150729336,0.9424601524325703,1.0,12/51,15.54%,GREM1;OTULIN;VEGFB;PTK2B;EGR3;JMJD6;MIA3;DLL1;ENG;RSPO3;AKT1;PIK3R3
prerank,SNARE complex assembly (GO:0035493),0.3540952852492999,0.8286008499095292,0.6820702402957486,0.943553927100498,1.0,2/10,5.10%,STXBP1;VAMP1
prerank,eye morphogenesis (GO:0048592),-0.2815513014042439,-0.8284632562370357,0.6899766899766899,0.9615533481118547,1.0,6/19,15.47%,TENM3;RARG;FBN1;FBN2;NKD1;COL5A1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.27436495949186823,0.8283083612343364,0.748653500897666,0.9435951375006472,1.0,4/26,6.97%,LRP5;TRPM4;PLA2G6;C2CD2L
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.2619486503294063,-0.8281637812324665,0.7489177489177489,0.9613464727035069,1.0,5/25,16.91%,RBPJ;SOX11;CDH5;ACVRL1;BMP4
prerank,regulation of endopeptidase activity (GO:0052548),0.23161962139866524,0.8280974792298261,0.782392026578073,0.9434752494385645,1.0,12/59,17.58%,VSIR;PICALM;GAPDH;PSENEN;SERPINE1;SERPINE2;NRDC;AKT1;SERPINF1;PSMB9;AGT;APH1B
prerank,homocysteine metabolic process (GO:0050667),0.33914639038433214,0.8280035511787299,0.7072243346007605,0.943103668857348,1.0,3/11,20.67%,MPST;DPEP1;MMUT
prerank,cellular response to misfolded protein (GO:0071218),-0.2823721799033685,-0.8278821408718168,0.688034188034188,0.9611311729706096,1.0,5/20,11.19%,CUL3;UBE2W;TOR1A;POMT2;RNF126
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.27713460011956625,-0.8278400794890192,0.728310502283105,0.9604304405343769,1.0,5/21,11.45%,STAP1;PTPN22;FOXP1;PAX5;FCGR2B
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.2514241628409898,0.8275678836706624,0.7704347826086957,0.9434234651907363,1.0,16/36,28.83%,RILPL1;MACF1;TRARG1;GOLGA4;RAB34;BBS2;OPTN;GORASP1;GGA3;PREPL;KIF13A;SYS1;GORASP2;NECTIN3;RAB26;GOLPH3L
prerank,negative regulation of stem cell differentiation (GO:2000737),0.3327367773608455,0.8275629861672844,0.6780952380952381,0.942889197365914,1.0,2/12,7.75%,NELFB;ZFP36L2
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.35477226734149725,0.827327457945212,0.6942909760589319,0.9428055670524472,1.0,1/10,0.12%,BIN1
prerank,nucleotide biosynthetic process (GO:0009165),0.2990600588926757,0.8270566908177305,0.7075812274368231,0.942800252669262,1.0,8/18,25.27%,PNP;GART;PRPS1L1;PRPS1;MTHFD1;PRPSAP1;PRPSAP2;ADSL
prerank,chromatin remodeling (GO:0006338),-0.1969196786541261,-0.8270334126398087,0.8759493670886076,0.9612650104425468,1.0,23/100,20.02%,JARID2;KDM4D;BAZ2B;HDAC4;SIRT1;SMARCE1;ERCC6;MPND;MTA2;ACTB;PADI4;KDM4C;BAHD1;NPM2;PAK1;CBX3;TOP1;NPM1;SUV39H2;PBRM1;FOXP3;PIH1D1;KDM6A
prerank,renal absorption (GO:0070293),-0.34756034519654466,-0.8268800568544069,0.6708595387840671,0.9607871478880909,1.0,2/10,13.54%,GSN;KCNQ1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.24460892527496583,-0.8264591437887469,0.7417840375586855,0.9608748947762403,1.0,11/33,21.60%,PPARG;APOE;ITGB1BP1;MEOX2;KLF4;RGCC;ACVRL1;STARD13;CARD10;MAP2K5;DLL4
prerank,glutathione metabolic process (GO:0006749),0.25325346433290824,0.8262420757435357,0.7422680412371134,0.9438840591598928,1.0,9/38,22.69%,HPGDS;DPEP1;GCLC;SOD1;GSTA3;GGT5;CTNS;PARK7;GSTM5
prerank,cochlea morphogenesis (GO:0090103),0.34594319084692754,0.8262367412152448,0.6734317343173432,0.9433537148393437,1.0,4/10,24.17%,PAX2;HPN;SOX9;POU3F4
prerank,vitamin transport (GO:0051180),-0.25911232002974416,-0.8260513082659313,0.7225950782997763,0.9608989970934554,1.0,11/29,24.56%,SLC35F3;SLC46A1;TCN2;SLC5A6;SLC2A8;SLC19A2;SLC2A2;FOLR2;FOLR1;CUBN;SLC25A32
prerank,neurotransmitter biosynthetic process (GO:0042136),0.31685947312789053,0.8259103465049061,0.7073170731707317,0.943443925907447,1.0,4/14,20.35%,DAGLB;SLC22A2;DAGLA;NOS1
prerank,secretory granule organization (GO:0033363),-0.3443496041200852,-0.8256122570893896,0.68389662027833,0.9609968170800225,1.0,5/10,35.94%,DTNBP1;BLOC1S3;VPS33B;BLOC1S2;F2R
prerank,positive regulation of bone mineralization (GO:0030501),0.2559772381510551,0.8255709328142287,0.7266313932980599,0.9435819214803196,1.0,3/35,5.45%,TMEM119;MEF2C;SLC8A1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.2852121165390335,0.825567441698966,0.6977152899824253,0.9430455734736616,1.0,4/23,12.93%,MLXIPL;PDGFB;PFKFB2;ARNT
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.31341431903820305,-0.8254272049500911,0.7006960556844548,0.9605825615108633,1.0,1/13,0.24%,B3GALT1
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.20594114178155298,-0.8252588702993099,0.8384615384615385,0.9601032703168707,1.0,15/72,17.83%,PSMD14;PSMD8;PSMA2;PSMF1;PSMD6;BTRC;PSME2;NFKB2;REL;PSMD5;PSMD12;PSMD11;PSMD1;COPS8;CARD10
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.33093933322802793,0.8250184776983462,0.6988636363636364,0.9436147284642423,1.0,2/12,5.30%,BRD8;CTSS
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.22305073131949027,-0.82497173961663,0.8181818181818182,0.9599032467290827,1.0,15/54,20.54%,RPL35A;NSA2;SNU13;RPL7A;LAS1L;RPL26;MRTO4;PPAN;RPL24;RPLP0;NPM1;NOP16;RRS1;RPL23A;NOC2L
prerank,negative regulation of translation (GO:0017148),0.21610575247463482,0.824941638554607,0.8223684210526315,0.9432383292566066,1.0,36/87,30.60%,CNOT1;ENC1;NANOS2;RBM24;GAPDH;TOB1;MRPL13;IGF2BP2;METTL14;RIDA;EPRS1;EIF4EBP2;EIF2AK2;ROCK2;FXR2;TYMS;EIF2AK3;CAPRIN1;PCIF1;NANOS1;DDX3X;CPEB1;LARP1;SAMD4B;YTHDF3;CPEB2;RBM4;EIF4E2;PUM1;UNK;CALR;PUS7;ILF3;DDX6;CNOT8;FXR1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.317048716695143,-0.8248977997324102,0.7077922077922078,0.9592569298400595,1.0,2/13,4.81%,SYT1;SYT10
prerank,proteolysis (GO:0006508),0.18681045320406672,0.8246449072790617,0.9226277372262773,0.9432917768704905,1.0,58/252,23.47%,CTSD;CAPN3;VHL;FAM111A;ST14;CAPN9;NAALAD2;CASP1;F12;CTSS;MMP2;LGMN;YME1L1;CAPN5;PITRM1;MBTPS1;USP25;CPE;CPA4;PRSS38;PAPPA2;CPB1;TMPRSS6;PSENEN;FBXL2;CLN3;DPP7;PSEN2;CTSF;RNPEP;SPPL2B;PM20D2;MIPEP;UBE3A;HPN;ATG4C;CTSE;PLG;ADAM10;PRCP;APH1B;CTSA;CPA6;HTRA2;AFG3L2;METAP2;RNF123;PSMB5;ADAM17;GGT5;FURIN;MMP24;MMP25;ERAP1;PTCH1;KLK3;SPRTN;SUFU
prerank,peptidyl-proline modification (GO:0018208),-0.2576040010133511,-0.8246190653491728,0.7227272727272728,0.9590310760985834,1.0,10/25,23.65%,CWC27;PPIA;PPIH;PPIC;PPIL3;PPWD1;PPIG;NTMT1;PPIF;PPIB
prerank,histone H4 acetylation (GO:0043967),0.24122084956085435,0.8244900565568704,0.7809364548494984,0.943059246783604,1.0,15/47,26.70%,BRD8;KANSL2;MSL2;ACTL6A;MORF4L1;JADE2;NAA40;EPC1;MORF4L2;PHF20;KANSL3;NAA60;WDR5;KANSL1;MCRS1
prerank,glycerol metabolic process (GO:0006071),-0.34172268067747225,-0.824348251295069,0.7136929460580913,0.958785074435067,1.0,8/10,42.40%,COQ2;GK;ANGPTL3;GOT1;TPI1;PGP;COQ3;PDXP
prerank,antibacterial humoral response (GO:0019731),0.3090577638511115,0.823820558669848,0.7132216014897579,0.9438350717036482,1.0,4/16,19.39%,SLPI;PLA2G6;RNASE6;RPL39
prerank,calcium ion import into cytosol (GO:1902656),0.31562542854244546,0.8236771360318073,0.6916058394160584,0.9435653996877944,1.0,3/15,5.45%,TRPV2;TRPM2;SLC8A1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.27420671080100856,-0.8234871785930177,0.7152317880794702,0.9597782672598529,1.0,5/21,10.29%,ADCY2;GUCY1B1;ADCY5;ADCY3;ADCY8
prerank,positive regulation of RNA metabolic process (GO:0051254),0.24501476110092107,0.8234338326762797,0.7592920353982301,0.9434902434636567,1.0,5/45,5.76%,PIK3R1;DDX5;DXO;BUD23;U2AF2
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.2917525978262807,0.8232895793388726,0.7168141592920354,0.9432093132682984,1.0,3/20,5.79%,SMOC2;SHISA2;SPRY2
prerank,urogenital system development (GO:0001655),0.34306065356712206,0.8231359992527076,0.7213740458015268,0.9430068860255287,1.0,5/11,30.31%,SHH;PAX2;SOX9;AMH;OSR1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.3134144609107,-0.8230370367346669,0.7136363636363636,0.9598913343483276,1.0,1/12,0.24%,B3GALT1
prerank,phospholipid catabolic process (GO:0009395),0.276409542284221,0.8229481662386926,0.7262569832402235,0.942838764841583,1.0,4/24,13.08%,ABHD12;PLA2G4A;PLA2G4B;PLBD2
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.2687223213640626,-0.8225466678342054,0.735357917570499,0.9601049835796551,1.0,5/24,10.64%,ANK3;MTCL1;FIS1;MFF;ITGB1BP1
prerank,"phototransduction, visible light (GO:0007603)",-0.31068243407182866,-0.8223986716554516,0.7357723577235772,0.9596056229313855,1.0,3/14,19.65%,ABCA4;PDE6A;GNAQ
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.2734879130637184,0.8220671692710587,0.723404255319149,0.943977863583038,1.0,5/26,15.25%,SMOC2;PRKCA;LGMN;KLHL18;TAL1
prerank,positive regulation of cellular metabolic process (GO:0031325),0.21241680040894406,0.822050807064918,0.8095975232198143,0.9434666719668168,1.0,23/98,19.13%,TGFBR2;GREM1;ARRB2;PPARD;RNF41;EIF4G1;CBR1;DHRS4;PDGFB;SELE;RAB1A;PDGFRB;IL10RB;AKT1;HPN;CSF1;PICK1;MAPK14;AGT;ARRB1;GATA3;NR1H2;THBS1
prerank,carnitine metabolic process (GO:0009437),0.3338485551934689,0.8216012845756422,0.710431654676259,0.9437970972215131,1.0,5/12,24.69%,ACADM;CROT;CRAT;CPT1A;CPT1C
prerank,photoperiodism (GO:0009648),0.2650821790676378,0.8213188266178572,0.7417102966841187,0.9438539949512991,1.0,13/28,30.61%,MTA1;CRY2;FBXL8;CRTC1;PPP1CB;FBXL22;TP53;FBXL3;RBM4;PPP1CC;FBXL12;PPP1CA;PDE6B
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.19535628095365998,0.8210815185214205,0.8796992481203008,0.9437520685995567,1.0,23/166,11.77%,MAML3;POLR2H;PPARD;POLR2J;CDK9;HDAC10;GTF2H2;TAF8;TAF12;POLR2D;TAF6;ERCC2;NRBP1;BRF1;BRF2;RXRB;NR2F1;NOTCH4;POLR3H;SMARCA5;E2F2;MAML2;TAF1
prerank,tyrosine metabolic process (GO:0006570),-0.33015600571052334,-0.8209584520765751,0.6911764705882353,0.9617038824731527,1.0,5/11,31.39%,THAP4;DCT;GSTZ1;TAT;TH
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.29158887459537564,0.8206440380665192,0.716390423572744,0.9440964050093207,1.0,7/20,23.10%,PAX6;POU4F1;LAMTOR5;GATA3;TWIST1;PARK7;TGFB1
prerank,eye development (GO:0001654),0.23388689787703154,0.8204623045159737,0.7857142857142857,0.9439078528151962,1.0,8/54,11.24%,SKI;FREM2;EFEMP1;PAX6;MEIS3;RAB3GAP1;SHROOM2;PAX2
prerank,nuclear pore organization (GO:0006999),-0.30961944342929826,-0.8204267758355936,0.7276887871853547,0.961978352444518,1.0,4/14,13.80%,NUP98;RTN4;NUP205;NUP54
prerank,regulation of monocyte differentiation (GO:0045655),-0.309357069195665,-0.8202637123975937,0.7266811279826464,0.9615061490401596,1.0,2/14,4.09%,CD74;FOXP1
prerank,quinone biosynthetic process (GO:1901663),0.31532450786163424,0.82008760020267,0.702247191011236,0.9440938055468348,1.0,2/14,3.31%,COQ7;FDXR
prerank,establishment of vesicle localization (GO:0051650),-0.28205177440159057,-0.820071382038401,0.7023255813953488,0.961113903413012,1.0,3/18,8.62%,KIF5C;TOR1A;KIF5B
prerank,negative regulation of hormone secretion (GO:0046888),0.35208524733774044,0.8199082386924901,0.6753246753246753,0.9439124829357276,1.0,2/10,15.89%,GJA1;OSM
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.22190604763134078,-0.8198421497095224,0.8197115384615384,0.9607967196955497,1.0,11/55,15.49%,PSMD14;PSMD8;PSMA2;PSMF1;PSMD6;PSME2;PSMD5;PSMD12;PSMD11;GPR132;PSMD1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.24070324682188435,0.819480070565092,0.7434094903339191,0.9442150550365291,1.0,14/48,23.86%,BAG6;CHEK2;ATM;USP28;BRCA1;RPS27L;ABL1;PYCARD;HTRA2;EPHA2;TOPORS;BCL2L1;BCL2L11;TP53
prerank,motor neuron axon guidance (GO:0008045),-0.2992385913560427,-0.8190086304990528,0.7346491228070176,0.9616283575898432,1.0,3/15,9.60%,SLIT2;CHN1;TMEFF1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.2694383673612764,-0.8189506925158483,0.7697516930022573,0.9609741775326762,1.0,5/23,13.89%,JAK2;ERBB4;OCIAD2;KIT;CCL5
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.2641333349210678,0.8187018303933702,0.7622504537205081,0.945177016296532,1.0,14/30,33.22%,TLR4;RPS27A;UBC;TICAM2;IRF3;TICAM1;FADD;UBE2D1;TLR6;IKBKB;BIRC2;BIRC3;TBK1;CD14
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.27687281513375916,0.8187014118161567,0.7328646748681898,0.9446423686674751,1.0,4/24,8.41%,PDE3B;CGAS;CDC34;RASD2
prerank,negative regulation of cell projection organization (GO:0031345),0.24042337802224933,0.8184202802969948,0.7687074829931972,0.9446407632903387,1.0,12/48,17.04%,RTN4RL1;YWHAH;SPRY2;MYLIP;ADCY6;TRPV4;RTN4R;CIB1;ACP4;DENND5A;MAG;GORASP1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.2943598995976805,0.8182788843612191,0.7234782608695652,0.9443891204287009,1.0,4/18,11.15%,APPL1;CLIP3;INPP5K;PRKCB
prerank,cardiac muscle cell development (GO:0055013),-0.27830806937034724,-0.8181585560341386,0.7289293849658315,0.9617339852843241,1.0,8/20,30.27%,PDLIM5;OBSL1;HEY2;FHOD3;SORBS2;TTN;MYH6;ALPK3
prerank,regulation of cell cycle phase transition (GO:1901987),-0.19832541069298365,-0.818123415002739,0.8628428927680798,0.9610089440886932,1.0,19/91,17.39%,PSMD14;PSMD8;PSMA2;PSMF1;PSMD6;BTRC;PSME2;BUB1B;PSMD5;MN1;UBE2C;ANAPC10;PSMD12;PSMD11;CDKN1A;DBF4;PSMD1;GTSE1;CCNB1
prerank,regulation of response to interferon-gamma (GO:0060330),-0.30694966907657384,-0.8179919500107928,0.7272727272727273,0.9604645295708735,1.0,4/14,12.63%,JAK2;PTPN2;IFNGR1;PIAS1
prerank,membrane lipid biosynthetic process (GO:0046467),0.23127452600477055,0.8172342233621578,0.7885615251299827,0.9458998622470042,1.0,12/58,14.45%,CERS3;DEGS2;SPTLC3;PPM1L;HACD3;ACER3;ACER2;PLPP1;PLPP2;PRKD3;CERS2;VAPB
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.28335139108852825,-0.8171963944229755,0.7296137339055794,0.9612525261412391,1.0,2/20,4.27%,RBPJ;CARF
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.2831682181417494,0.8170940080827654,0.7708333333333334,0.9456326551344841,1.0,4/23,11.44%,UBASH3B;PTK2B;NOS1AP;PSEN2
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.3194690769365045,-0.8170149442709932,0.7039473684210527,0.960824081394886,1.0,3/12,14.31%,CD44;SKAP1;THY1
prerank,steroid catabolic process (GO:0006706),-0.3411601506618166,-0.816921325414274,0.6792035398230089,0.9602305481846993,1.0,6/10,31.36%,SPP1;HSD17B11;HSD11B1;HSD17B14;FGF23;CYP19A1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.276525565061094,0.8169006940848724,0.7353463587921847,0.9454582648711125,1.0,5/23,23.25%,REXO4;DNASE2;HMGB2;FBH1;EXOG
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.33880302253565614,-0.8168001054297634,0.7184265010351967,0.9596854145324898,1.0,2/10,5.23%,PDE4B;CALM1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.1980062333389591,-0.8166993875866557,0.9025641025641026,0.9590945385246502,1.0,15/101,10.05%,SAMD4A;EIF3C;CYFIP2;VIM;FAF1;CPEB3;EIF3E;RPL26;BTRC;EIF4A3;PRR16;NFKBIA;ATG7;PLXNB2;BAK1
prerank,cellular response to chemical stress (GO:0062197),-0.1943971454267196,-0.816579018437876,0.871859296482412,0.9585535324613139,1.0,25/96,20.91%,LRRK2;CYBB;MSRA;PRDX1;PPIA;NCF2;PKD2;MGAT3;SLC25A24;ATG7;CYBA;ERO1A;PYROXD1;SOD2;HSPA1B;SNCA;PRR5L;ZFAND1;FOXO1;GSTP1;TXNRD1;STOX1;CYCS;CAT;NOX4
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.3344205236623916,-0.8164341741150362,0.716024340770791,0.9580506384731206,1.0,3/10,17.97%,PTPN22;DUSP10;GSTP1
prerank,response to prostaglandin E (GO:0034695),0.34327690713440595,0.8163121534646254,0.6947565543071161,0.9460935545141272,1.0,3/10,18.44%,CCR7;ADCY6;GNB1
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.32156808880929494,-0.8162133424179071,0.7214428857715431,0.9576795614086445,1.0,4/12,15.29%,MAP2;STMN2;CDH5;SNCA
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.28542014887288786,0.8161030952485431,0.7353463587921847,0.9459458359898173,1.0,1/21,0.06%,TGFBR1
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.3102592253409356,-0.815842194348007,0.7081447963800905,0.9576189054257597,1.0,5/13,19.48%,LTV1;NOP9;RAN;NPM1;RRS1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.33392289998186403,-0.8154383373065157,0.7031578947368421,0.9576411580549032,1.0,5/10,33.09%,DLGAP1;DLGAP2;NPTX1;NPTXR;CACNG5
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.27545861603582833,0.8153297281405538,0.7317073170731707,0.9469118094711243,1.0,3/23,8.39%,SMAD7;DSG2;MYL3
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.28320456310296943,0.8149217506865141,0.7292817679558011,0.9471382450605469,1.0,5/19,21.30%,TJP1;NOTCH4;PLG;PPM1F;DENND6A
prerank,nitric oxide metabolic process (GO:0046209),0.3215496711344771,0.814747761186197,0.7288461538461538,0.9469542141952962,1.0,5/14,24.47%,NOS2;AKT1;NQO1;NOS1;SPR
prerank,alanine transport (GO:0032328),-0.34577435675890905,-0.8147343288337116,0.6936170212765957,0.9582263455493165,1.0,7/10,31.55%,SLC36A2;SLC1A4;SLC6A6;SLC36A3;SLC6A17;SLC6A14;SLC38A3
prerank,eye photoreceptor cell development (GO:0042462),-0.3011817269805104,-0.8146593972965039,0.7239915074309978,0.9576075143229761,1.0,3/15,14.53%,RORB;THY1;RPGRIP1
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.27116466234521935,-0.8145242023456915,0.7400881057268722,0.9571101199814721,1.0,5/22,14.52%,MAP1B;MAP2;APOE;AEBP1;HSPA8
prerank,nitric oxide biosynthetic process (GO:0006809),0.3215650268192762,0.814471229530645,0.716390423572744,0.9469333389191831,1.0,5/13,24.47%,NOS2;AKT1;NQO1;NOS1;SPR
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.3374561178759641,-0.814372483603846,0.715203426124197,0.9566189241719307,1.0,4/11,24.78%,LDLR;MFSD2A;CNEP1R1;CTDNEP1
prerank,regulation of cellular protein metabolic process (GO:0032268),0.2398813162909969,0.8142294329041336,0.8034188034188035,0.9468354056143311,1.0,14/47,20.22%,EIF4G1;EIF2A;SSH1;PKP3;EIF2B4;CYFIP1;RPL10;PM20D2;AKT1;CSF1;AGT;NR1H2;VPS35;PCIF1
prerank,negative regulation of organelle assembly (GO:1902116),-0.24674580126371737,-0.8138946915811334,0.7875894988066826,0.9567737015545481,1.0,5/35,9.05%,LRRK2;CDK5RAP2;TRIM37;SCFD1;SMCR8
prerank,mesoderm formation (GO:0001707),-0.28978358528960246,-0.8127377785723826,0.7288503253796096,0.9582714826428247,1.0,7/17,34.57%,ITGA8;SCX;ITGB1;EOMES;SNAI1;SMAD2;ITGA3
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.31579077947453366,-0.8121578300830242,0.707983193277311,0.9585655252363959,1.0,4/13,16.91%,CAMK4;TESPA1;ZC3H8;BMP4
prerank,embryonic digestive tract development (GO:0048566),0.29895817351854165,0.8120355056779819,0.7254901960784313,0.9503659060790951,1.0,1/18,0.18%,SALL1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.1896079711669466,0.811644953878869,0.9220389805097451,0.9505521331587478,1.0,50/199,24.36%,LDLRAD4;SMAD7;DDIT3;MEF2C;PLCL1;PCTP;AGER;TLR4;LAMA4;FLCN;TFE3;ID1;RPS6KA5;SPRY2;SHH;OVOL2;WNT10B;APOM;ABHD6;BBS2;PLCL2;GJA1;LRP4;NRDC;HPN;GPNMB;ACVR2B;PROCR;CHSY1;RPS6KA4;PTPN23;SLC11A1;GATA3;ROCK2;NR1H2;SYT11;ADAM17;EFNA1;SPRED2;IP6K1;STC1;PTCH1;EVL;BMP2;TGFB1;NOVA2;ADIPOR1;SOX9;LRPAP1;WDR77
prerank,inositol phosphate metabolic process (GO:0043647),-0.22219850355284237,-0.8111835805226622,0.8137254901960784,0.9596188504082739,1.0,13/46,19.40%,PLCB1;CALM1;PLCH1;PLCB4;INPP5J;NUDT3;PLCH2;OCRL;PLCD1;ISYNA1;ITPKC;IPMK;ITPK1
prerank,canonical Wnt signaling pathway (GO:0060070),-0.2067560601415888,-0.8111553727351589,0.8457583547557841,0.9589078597200842,1.0,21/68,21.84%,LRRK2;LRP6;GSK3B;NR4A2;RARG;FRZB;WNT4;AXIN1;TCF7;BCL9L;SCYL2;WNT9A;SFRP1;PLPP3;SFRP2;LEF1;RAB5A;WNT7A;WNT6;WNT8B;FRAT1
prerank,regulation of vasculature development (GO:1901342),-0.2609391983158722,-0.8110120241315374,0.7478260869565218,0.9583899429028649,1.0,6/26,15.32%,SP100;PLXND1;HTATIP2;VASH2;HMOX1;SFRP1
prerank,response to peptide (GO:1901652),0.2563248901102778,0.8101487448566622,0.7807308970099668,0.9528233643395776,1.0,12/33,27.32%,AGER;EIF2B3;MMP2;CALCR;EIF2B4;CACNA1A;STAT6;NOD2;STAT5B;EIF2B2;STAT3;IRF5
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.24572411107920294,-0.8101008459501771,0.7902439024390244,0.9593649394480922,1.0,14/32,29.43%,PIK3C2A;ITGB1BP1;MEOX2;KLF4;HMOX1;STARD13;FOXC2;CARD10;MAP2K5;DLL4;ANXA1;RHOJ;AKT3;SRPX2
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.28664853694592024,0.8100191655714263,0.7407407407407407,0.9525297821775112,1.0,8/22,30.57%,MTOR;EIF2AK3;UBTF;SMARCA4;PHF8;IPPK;DDX11;HEATR1
prerank,axonal transport (GO:0098930),0.2437690070624827,0.8092717872419766,0.7805309734513274,0.9533380706884969,1.0,4/36,6.81%,DST;KIF3B;AP3D1;AP3B2
prerank,heart trabecula morphogenesis (GO:0061384),0.29206615759360605,0.8091819291135396,0.7190388170055453,0.9529590430486411,1.0,1/18,0.06%,TGFBR1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.297879650427748,0.8091692571971743,0.7455516014234875,0.9524442012841093,1.0,9/18,26.32%,NFE2L2;VNN1;PINK1;AKT1;MAPK7;HTRA2;PARK7;HIF1A;BAG5
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.3113938031568949,0.8085302295412857,0.7156488549618321,0.9530832827396969,1.0,3/13,10.17%,CALCOCO1;GPER1;PLPP1
prerank,regulation of G0 to G1 transition (GO:0070316),0.2443218622842998,0.8084755412100052,0.775,0.9526554439678118,1.0,14/38,25.22%,RHNO1;EHMT2;BRCA1;PCGF2;APAF1;EZH2;EED;UXT;RNF2;MGA;EPC1;RING1;PHC1;CDC7
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.2790185384117668,-0.8083585745419393,0.7448275862068966,0.9618354100161132,1.0,5/20,16.20%,AMPD3;PPAT;AK3;AK4;ADSS2
prerank,glucose homeostasis (GO:0042593),0.21476236952814762,0.8083157403832257,0.8489326765188834,0.9524269131147548,1.0,11/83,10.36%,MLXIPL;HK2;PIK3R1;CRY2;IGF1R;PAX6;FOXK2;SLC30A8;MTNR1B;INPP5K;PDK2
prerank,metallo-sulfur cluster assembly (GO:0031163),0.2806448814299405,0.8074180047191153,0.7476808905380334,0.9535850529530966,1.0,4/22,10.29%,CIAO3;ISCU;CIAPIN1;MMS19
prerank,negative regulation of inflammatory response (GO:0050728),0.1900156736736394,0.8073154867976037,0.8974358974358975,0.9532514857333936,1.0,34/182,18.44%,SIRPA;OTULIN;PPARD;ADCY9;PRKACA;GPS2;LYN;SRC;MYH9;PRKCD;PLCG2;HRH2;NLRP3;ADORA2B;MC2R;GPER1;CALCR;FSHR;LHCGR;NPS;ADCY4;DPEP1;TNFAIP8L2;ADCY6;INSL3;CXCL17;VIP;MAPK14;ADORA2A;MAPK7;ADCY7;GPR84;GATA3;GNB1
prerank,sodium ion homeostasis (GO:0055078),-0.2671255396216939,-0.807203267676894,0.7391304347826086,0.9632051502237947,1.0,5/21,23.14%,NEDD4L;ATP1B3;ATP1A1;SLC12A1;SLC12A3
prerank,protein processing (GO:0016485),0.2059503157526592,0.8070450208872566,0.8668730650154799,0.9532427882459744,1.0,26/102,23.44%,KLK2;VSIR;FAM111A;CASP1;F12;CTSS;LGMN;YME1L1;PITRM1;CPE;RCE1;PSENEN;CLN3;PSEN2;ADAM10;APH1B;HTRA2;AFG3L2;METAP2;PIDD1;ADAM17;STOML2;FURIN;PTCH1;KLK3;SPRTN
prerank,positive regulation of chromatin organization (GO:1905269),0.32493631427518865,0.8070372600129363,0.7031539888682746,0.9527275012020422,1.0,4/12,19.08%,SIN3A;TERF1;TAL1;ACD
prerank,phosphate ion transport (GO:0006817),-0.29368992645311526,-0.806769572109351,0.7303609341825902,0.9631966867173517,1.0,3/16,10.95%,SLC25A30;SLC37A4;XPR1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.2819676011949414,-0.8064312678182585,0.75,0.9630926493640303,1.0,8/18,27.92%,CDC25C;RCC2;CCNB1;CDK4;DTL;STOX1;CDC25B;MECP2
prerank,rRNA catabolic process (GO:0016075),0.30544146792102,0.8063654445033711,0.7476808905380334,0.9534070296586972,1.0,5/16,18.97%,PELO;EXOSC10;EXOSC5;DIS3;EXOSC8
prerank,cellular response to hexose stimulus (GO:0071331),0.2811028449580162,0.8061681598798958,0.7308377896613191,0.9532207747262904,1.0,5/23,11.94%,PRKACA;IGF1R;GPER1;PAX2;TRA2B
prerank,regulation of myoblast fusion (GO:1901739),-0.31680124463090703,-0.8060151166850126,0.7261146496815286,0.9631133241856035,1.0,2/11,4.60%,EHD1;RIPOR2
prerank,regulation of neuron apoptotic process (GO:0043523),0.20739842075156273,0.8059322605863778,0.8571428571428571,0.953101319141911,1.0,15/96,14.35%,DDIT3;MEF2C;SLC30A10;CCL3;PTK2B;LGMN;PPT1;CNTF;GDNF;POU4F1;CLN3;PINK1;AGAP2;SOD1;RETREG1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.21194713397604256,0.8057399555257502,0.837248322147651,0.9529148685133288,1.0,30/88,27.41%,FBXL18;FBXL20;FBXL15;FBXW4;CUL4B;PSMD3;FBXL8;FBXL2;PSMB3;PSMA7;PSMC1;PSMC2;FBXL22;PSME4;FBXO38;PSMB9;CUL4A;PSMD4;PSMB5;PSMB7;FBXL7;PSMB8;FBXW5;FBXL3;PSMD13;FBXL14;CUL1;FBXO2;FBXL12;PSMD2
prerank,aortic valve development (GO:0003176),-0.24572496993285012,-0.80571294319423,0.8066037735849056,0.9628949957553886,1.0,10/34,21.60%,ROBO1;SLIT2;JAG1;HEY2;SNAI2;ELN;BMP4;ROBO2;TIE1;DLL4
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.29490715403775025,0.8056030200396369,0.7372400756143668,0.9526213950036169,1.0,1/17,0.46%,BAG6
prerank,nucleosome assembly (GO:0006334),0.26008149972044214,0.8054423750855721,0.7741379310344828,0.9523861320609227,1.0,10/31,24.07%,UBN1;SART3;SMARCA5;IPO4;SPTY2D1;HMGB2;CHAF1B;KAT6B;SOX9;NAA60
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.34118907890534206,0.8053764121184278,0.734225621414914,0.9519884592790168,1.0,3/11,8.61%,NOS1AP;LRRC55;LRRC38
prerank,regulation of smoothened signaling pathway (GO:0008589),0.23344443093016237,0.805002311410639,0.8098360655737705,0.9521276323306097,1.0,17/50,26.14%,UCHL5;ULK3;SHH;RAB34;ZIC1;MOSMO;SMO;KCTD6;GAS1;MGRN1;TUBD1;PTCH1;DLG5;SUFU;FGFR2;IFT122;KIF7
prerank,tRNA 5'-leader removal (GO:0001682),0.3175747379477728,0.8047064844445666,0.6937394247038917,0.9521362002731873,1.0,3/13,12.29%,POP1;SSB;RPP21
prerank,gluconeogenesis (GO:0006094),-0.23170959855024495,-0.8040948357193368,0.837772397094431,0.9650556668396183,1.0,7/39,15.15%,PFKFB1;SLC37A4;PER2;GPI;RBP4;ALDOC;SLC25A12
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.2423244288834672,0.8039767638687273,0.786096256684492,0.9528938598677829,1.0,11/39,23.10%,MIA3;NOTCH4;WNK1;AKT1;SPINT2;PLG;AKNA;MAPK7;PPM1F;BMP2;TGFB1
prerank,protein localization to nucleus (GO:0034504),0.20182383587170494,0.8036423584851082,0.8863636363636364,0.9529762898582278,1.0,34/102,28.55%,SPRN;PHB2;FAM53A;TAF8;PTTG1IP;SEC13;NUP62CL;TNPO1;APPL1;NUP50;TOR1AIP1;NUP88;IPO4;RPAIN;MORC3;AKT1;TNPO3;NUP62;CSE1L;NUP107;E2F3;TOPORS;IPO7;NUP153;IPO5;PRICKLE1;NUP188;APPL2;STAT3;IPO9;BANP;RANBP17;HIKESHI;CALR
prerank,negative regulation of heart contraction (GO:0045822),0.3338827118635797,0.8036353641492854,0.7095588235294118,0.9524622973457241,1.0,5/11,21.59%,PIK3CG;AGTR2;GRK2;PLN;ZC3H12A
prerank,regulation of chromatin binding (GO:0035561),0.3404899353874692,0.8033491317265631,0.7527272727272727,0.9524386913012141,1.0,7/10,28.45%,MED25;DTX3L;GMNN;HMBOX1;BTAF1;WAPL;DDX11
prerank,negative regulation of hippo signaling (GO:0035331),-0.31388599311300736,-0.8029826685377468,0.723404255319149,0.9663256254497685,1.0,3/12,13.37%,LIMD1;MARK3;WWC1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.28522469903320974,-0.8027924046786689,0.7775330396475771,0.9659407501603132,1.0,7/17,22.46%,RBPJ;JAG1;HEY2;SNAI2;BMP4;DLL4;NOTCH2
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.3303146892839788,0.802754308905617,0.7267857142857143,0.9530010817167804,1.0,3/12,11.32%,PTK2B;DOCK10;DLL1
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.2998604634122198,0.8024507498496374,0.7346221441124781,0.9530114182689091,1.0,5/17,15.54%,GREM1;EGR3;MIA3;AKT1;PIK3R3
prerank,glutamate metabolic process (GO:0006536),0.2853362646536906,0.8023705456435282,0.7229601518026565,0.9526353286791613,1.0,3/19,13.55%,DGLUCY;GAD1;GCLC
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.31769258695083324,-0.8023275583732035,0.7077625570776256,0.9660702037024421,1.0,4/11,32.62%,PRDX1;CAT;GPX3;PRDX4
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.22448974903207428,0.8020572850220805,0.8242530755711776,0.9526680712929515,1.0,17/57,23.86%,CHEK2;ATM;NBN;RAD17;FOXN3;BRCA1;CDC14B;RPS27L;TAOK2;ABRAXAS1;BLM;BABAM1;RAD9A;TOPBP1;RFWD3;DONSON;TP53
prerank,regulation of cholesterol metabolic process (GO:0090181),0.2878062251827239,0.8017468524905721,0.7612456747404844,0.9526842679081166,1.0,5/20,17.07%,MBTPS1;MBTPS2;TTC39B;LDLRAP1;FMO5
prerank,positive regulation of chromosome organization (GO:2001252),0.30788421458989446,0.8017086309628401,0.7109515260323159,0.9522213587074306,1.0,2/15,4.45%,NBN;SHCBP1L
prerank,DNA replication (GO:0006260),0.20279597507654543,0.801706662720233,0.8856682769726248,0.9517003876218918,1.0,32/105,26.47%,RHNO1;FAM111A;RFC2;ATM;NBN;RAD17;MCM2;DUT;BRCA1;POLD2;EXO1;RAD1;PCLAF;RPAIN;BLM;CDK2AP1;POLG2;ORC3;RFC1;KAT5;TOP3A;MCM3;RAD9A;TOPBP1;RPA3;DONSON;WRNIP1;POLD4;NT5M;CDC7;MCM6;ORC2
prerank,leukotriene metabolic process (GO:0006691),0.2904525341861683,0.801490891948297,0.743455497382199,0.9515386268142347,1.0,6/19,20.73%,PLA2G4A;PLA2G5;DPEP1;ABCC10;PTGR1;GGT5
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.30208316813173713,-0.8012370599948675,0.7410714285714286,0.9672656224133973,1.0,2/13,4.22%,OAS2;JAK2
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.29056052752430717,-0.8010336269553316,0.7373068432671082,0.9668824365159937,1.0,3/16,8.56%,AKAP6;PDE9A;TRPC3
prerank,histone H3-K9 demethylation (GO:0033169),0.337244413483982,0.8010008443686362,0.7325800376647834,0.9519115758200233,1.0,6/11,24.83%,KDM3A;KDM4A;HR;KDM1A;KDM7A;PHF8
prerank,response to peptide hormone (GO:0043434),0.2362804051298645,0.8008520546206531,0.7836456558773425,0.95167039439934,1.0,10/43,18.02%,SRC;EIF2B3;SORT1;ZFP36L1;GPER1;EIF2B4;AKT1;STAT6;KHK;ROCK2
prerank,neuron projection organization (GO:0106027),0.30956385575643247,0.8007708866822638,0.7239583333333334,0.9512751407337479,1.0,5/15,23.42%,ABCD2;LGMN;PICK1;ARF1;ABCD1
prerank,camera-type eye development (GO:0043010),0.2723043697950607,0.8004378180781406,0.7591240875912408,0.9513436490802599,1.0,5/25,11.24%,SKI;EFEMP1;RAB3GAP1;SHROOM2;PAX2
prerank,positive regulation of isotype switching (GO:0045830),-0.2992456832576378,-0.8002193176685417,0.7711670480549199,0.9675241007553977,1.0,4/15,17.43%,CD40;SHLD3;RIF1;TFRC
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.22072853553817715,0.8000904964358475,0.8218487394957983,0.9514472232534033,1.0,20/66,26.70%,SMAD3;PIK3R1;PRKCD;LAMTOR5;ZIC1;CCT3;MAVS;AKT1;DTX3L;CCT8;ECT2;EIF2AK3;ZC3H12A;PARK7;TGFB1;JUP;IPO5;CCT7;CCT5;MCRS1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.24890798888183846,-0.8000728456633602,0.7733050847457628,0.967008549696114,1.0,5/29,8.96%,DCUN1D2;RPS2;UBE2N;AXIN1;ARRDC3
prerank,aromatic amino acid family metabolic process (GO:0009072),0.330795933775834,0.7998764204519717,0.7225325884543762,0.9512923672458216,1.0,1/10,1.59%,QDPR
prerank,monocarboxylic acid metabolic process (GO:0032787),0.1985703465331688,0.7996619367637965,0.8941548183254344,0.9511342845694248,1.0,33/117,25.50%,ACSL4;PPARD;BCO2;ALDH8A1;THEM4;VNN1;SLC27A4;CKB;NPC1;PANK2;CROT;ALDH4A1;VDAC1;AGXT;MCCC2;GAMT;PTGR1;CPT1A;LDHAL6B;SLC6A8;GGT5;AASDHPPT;LDHA;HACL1;ACOT1;SCP2;ME2;ACOT4;GNPAT;CPT1C;ABAT;AASDH;PDHB
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.2260093107945741,-0.7993040204113124,0.8229665071770335,0.9675619249497177,1.0,11/42,17.63%,UTRN;CD36;GSK3B;SKAP1;CDH13;CX3CL1;THY1;SFRP1;TEK;CD3E;S100A10
prerank,monosaccharide transmembrane transport (GO:0015749),-0.28788576885360795,-0.7990465116417568,0.7350230414746544,0.967281971482413,1.0,8/16,35.25%,SLC45A3;SLC2A12;SLC2A8;SLC2A2;SLC50A1;SLC5A1;SLC5A10;SLC2A6
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.20785693373075434,-0.7988186570548649,0.8701923076923077,0.9669381248617288,1.0,21/60,28.41%,ATF7IP;AGO4;CEBPB;MED15;TNRC6A;RUNX2;CDKN2A;CDKN1A;HEY2;SRF;CCNB1;CDK4;LEF1;MED6;HNF1B;CTNNB1;MED14;MED16;RELA;MECP2;MED1
prerank,digestive tract morphogenesis (GO:0048546),-0.29581376096658174,-0.7984810555807081,0.734020618556701,0.9667899383562945,1.0,7/14,37.35%,SOX11;RBPMS2;ID2;GLI1;STRA6;NIPBL;PDGFRA
prerank,myelination in peripheral nervous system (GO:0022011),0.31580304471049375,0.7983429820588428,0.7194656488549618,0.9529059582687174,1.0,2/13,2.55%,SKI;SIRT2
prerank,regulation of innate immune response (GO:0045088),0.22743026606061012,0.7982722585838322,0.81438127090301,0.9525232052865589,1.0,10/57,16.40%,POLR3G;SLC15A4;AKIRIN2;DHX9;ABCE1;APPL1;PTPN1;PTPN11;XIAP;GBP5
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.20185986184873264,-0.7981204218856697,0.8697788697788698,0.9666623882310166,1.0,16/75,19.59%,PLCB1;GRK5;FRMPD1;RASGRP4;CALM1;KCTD8;RGS20;PDE6H;RGS6;CCL5;CAMKMT;GUCY2F;GUCY2D;RGS3;USP33;PDE6A
prerank,high-density lipoprotein particle assembly (GO:0034380),0.34857793524552894,0.7981039817205279,0.7304189435336976,0.9522895304082929,1.0,2/10,8.01%,PRKACA;APOM
prerank,negative regulation of kinase activity (GO:0033673),-0.2099785459528778,-0.7977835378523271,0.87468671679198,0.9665184265800544,1.0,19/62,23.30%,PPM1E;PRKAG2;LRP6;TAF7;PPIA;DBNDD1;SMCR8;ITGB1BP1;DTNBP1;THY1;SNCA;TAB1;GSTP1;GNAQ;CDKN1C;CAMK2N2;DEPTOR;TRIB3;SPRED1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.2847328994220003,0.7977009397682882,0.750465549348231,0.9524696395323176,1.0,2/20,2.52%,RAP1GDS1;TGM2
prerank,angiogenesis involved in wound healing (GO:0060055),0.3336503697482449,0.7976609452947577,0.7179962894248608,0.9520256477418519,1.0,5/11,26.85%,GATA2;CD34;PRCP;ITGB3;MCAM
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.26177898123772914,0.7976096246131682,0.7627986348122867,0.9515928646524093,1.0,13/28,28.96%,DBN1;ARHGAP28;ABITRAM;WDR1;FCHSD2;DBNL;FCHSD1;ESAM;BRK1;SH3BP1;COTL1;PLEKHG2;RASA1
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.23107462819312857,-0.7974137474722639,0.7757009345794392,0.966408643182009,1.0,13/40,29.80%,ROMO1;CAMP;GBP4;LBP;GBP2;RNASE3;DROSHA;PGLYRP2;RARRES2;PGLYRP1;MPEG1;IL12A;CRP
prerank,microtubule polymerization or depolymerization (GO:0031109),0.26322264513041294,0.7973171569573194,0.7788104089219331,0.9515750955720389,1.0,2/24,0.93%,FGF13;KIF2A
prerank,regulation of cell communication (GO:0010646),-0.23446027654799478,-0.7971542842374476,0.8043478260869565,0.96611960313609,1.0,11/35,23.77%,ANK2;GRK5;RYR2;UGCG;CDC42SE2;VEPH1;IGFBP7;SOCS2;GJA5;ANXA1;CASQ2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.29600450713926635,-0.7971018195695253,0.7567567567567568,0.9654588800384916,1.0,2/14,7.58%,LRRK2;PRKN
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.24852915817564045,-0.7970098517018306,0.8012820512820513,0.9648782275582211,1.0,2/25,2.97%,PPARG;CBLB
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.1933389864941209,0.7968098840581277,0.9042553191489362,0.9519406556679694,1.0,19/138,11.77%,MAML3;POLR2H;PPARD;POLR2J;CDK9;HDAC10;GTF2H2;TAF8;TAF12;POLR2D;TAF6;ERCC2;NRBP1;RXRB;NR2F1;NOTCH4;E2F2;MAML2;TAF1
prerank,positive regulation of secretion by cell (GO:1903532),-0.20366806946648908,-0.7963690743088958,0.8762376237623762,0.9652687353840275,1.0,14/70,16.22%,CADPS;SOX11;PPIA;STXBP5;DNM1L;GOLPH3;RAB3A;DTNBP1;UNC13B;RGCC;ACHE;SNCA;CFTR;RAB27B
prerank,positive regulation of phospholipid transport (GO:2001140),-0.33194561590758154,-0.79635704192931,0.7294372294372294,0.9645343212848595,1.0,1/10,4.62%,APOE
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.3109890696971331,0.7961208148881829,0.7518115942028986,0.952600464490936,1.0,3/14,14.97%,IL12B;POU4F1;CSF1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.20664328601518211,0.7960229693390432,0.8641765704584041,0.9522510858411456,1.0,14/87,13.50%,NCBP1;POLR2H;POLR2J;POLR2D;EGR3;HNRNPH1;TIAL1;ZFP36L1;ZFP36L2;FRS2;ESRP1;PTPN11;GALNT3;CEP57
prerank,smoothened signaling pathway (GO:0007224),0.2502962886790232,0.7959706949956006,0.7835951134380453,0.9518294923991124,1.0,11/32,26.67%,ULK3;SHH;MAP3K10;SMO;B9D1;TMEM17;TTBK2;PTCH1;DISP2;TCTN2;CC2D2A
prerank,icosanoid biosynthetic process (GO:0046456),0.3446825855891019,0.7957410206982252,0.7421731123388582,0.9516935262479246,1.0,3/10,12.67%,PLA2G4A;PLA2G5;FADS1
prerank,epithelial cell development (GO:0002064),0.28356316532699216,0.7956839023177822,0.7602862254025045,0.9512732599745414,1.0,3/20,10.51%,RILPL1;PKHD1;WNT7B
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.31941006857562576,-0.7956688924118539,0.7167755991285403,0.964991322865689,1.0,2/11,3.10%,GSN;ST18
prerank,negative regulation of binding (GO:0051100),0.20880223508761314,0.7956622501074211,0.8776167471819646,0.9507849074650646,1.0,16/81,16.02%,SUMO1;CSNK1E;PRKCD;ARHGAP28;SLPI;CTNNBIP1;PDGFB;MDFI;JUN;GNL3L;PIN1;TMBIM6;MAPK8;AKT1;SMO;AURKA
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.24226658328162906,0.7954104076058875,0.8,0.9507025183021423,1.0,10/38,18.48%,HPS4;CSNK2A2;SH3GLB1;RNF31;USP36;LEPROT;PINK1;BAG4;TOMM7;HTRA2
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.27331344625579707,0.7950178760131861,0.7580645161290323,0.9508463954447723,1.0,4/23,11.63%,SLC12A6;SLC12A9;PDK2;ATP6V0A4
prerank,cellular response to drug (GO:0035690),-0.2515136852001438,-0.7949496265505335,0.7736720554272517,0.965497135464613,1.0,6/25,17.43%,PDE4B;PPM1E;CERS1;KCNQ1;CRHBP;TFRC
prerank,organic anion transport (GO:0015711),0.21332580029491102,0.7947601072885184,0.8451178451178452,0.9507691109054077,1.0,17/76,20.51%,SLCO2B1;SLC25A42;CPTP;CYB5R1;SLC52A3;SLC22A6;SLC52A2;SLC35A1;SLC52A1;LRRC8A;SLC17A9;SLC35B4;SLC23A1;SLC19A1;LRRC8D;SLC4A4;SLC4A5
prerank,tight junction assembly (GO:0120192),-0.21144920300676834,-0.7947381332130099,0.8671679197994987,0.9650754231132201,1.0,20/49,30.15%,AFDN;PATJ;FRMPD2;CDH5;PARD3;PECAM1;PRKCI;ACTG1;MICALL2;GRHL2;PARD6G;DLG1;MARVELD3;OCLN;STRN;CLDN5;CLDN18;POF1B;CLDN16;PARD6B
prerank,regulation of cell death (GO:0010941),0.20511864701026483,0.7946773446109672,0.8764227642276423,0.9503919785625294,1.0,11/94,10.19%,SRGAP2;RILPL1;RIPK2;CLU;EIF4G1;IMPACT;CALCR;ACER3;ACER2;RRAS2;LRP1
prerank,fatty acid transmembrane transport (GO:1902001),-0.27428028411093286,-0.794228779943248,0.7792792792792793,0.9652222631765591,1.0,4/19,14.53%,CD36;PRKAG2;ABCD4;CPT1B
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.2595233925222514,0.7938498253443248,0.8014311270125224,0.951272604488192,1.0,2/29,2.57%,SMAD3;SRRT
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.27359860549199766,0.79374585322945,0.7486437613019892,0.950935369328578,1.0,4/22,10.29%,AGER;GCNT2;FLOT2;WNK1
prerank,negative regulation of viral process (GO:0048525),-0.21409364945712628,-0.7936797495445734,0.8390243902439024,0.9654744297108774,1.0,22/57,27.50%,OAS2;RSAD2;MID2;IFITM3;PPIA;TRIM35;RNASEL;IFITM2;OAS3;CCL5;BANF1;IFITM1;SRPK2;IFIH1;LTF;ZC3HAV1;PARP10;BST2;ZFP36;OASL;PLSCR1;PML
prerank,positive regulation of vasoconstriction (GO:0045907),-0.30137487693471227,-0.7936085535537925,0.7396061269146609,0.9648330490068115,1.0,6/13,30.44%,ADRA1A;SMTNL2;AVPR2;ADRA1B;OXTR;AVPR1A
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.26313775773707193,-0.7927632669423289,0.7962962962962963,0.9655747084839037,1.0,12/22,32.56%,RPS7;RPL37;EIF5A;CDK5RAP3;PLA2R1;MSX1;SPRED1;RPS15;RPL23;SPRED3;HIC1;ATR
prerank,positive regulation of ATPase activity (GO:0032781),-0.22480479834876077,-0.792663649790461,0.8574712643678161,0.9649962370590306,1.0,12/41,24.03%,FGF10;RYR2;ATP1B3;VMP1;TOR1AIP2;MYBPC3;MSH6;SETMAR;DNAJB2;MSH2;CHTOP;ATP2A1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.33181111486594284,0.7926379222870238,0.7611940298507462,0.9523817242204115,1.0,4/11,16.89%,TIMM8B;TIMM29;NDUFA13;TIMM10B
prerank,translation (GO:0006412),0.18288666532249148,0.7923830400318537,0.9524517087667161,0.952267454158278,1.0,53/208,21.62%,KARS1;ETF1;MRPS24;EIF4G1;MRPL37;MRPL2;RPS27A;RRBP1;NARS1;MRPL43;MRPS34;MRPL34;ABCE1;SARS1;SARS2;MRPL9;EEF1B2;RPL15;MRPS5;ASMT;RPL10;EEF2K;RARS1;RPS8;DHPS;GSPT2;MRPS21;ABCF1;RPS24;MRPL13;MRPS16;FARSA;IARS1;MRPS18B;MRPS11;DARS2;EPRS1;QARS1;EIF4EBP2;MRPS28;WARS2;RPL9;MRPS18A;IARS2;RPL39;TMA7;TNIP1;MRPL11;MRPL41;MRPL27;FASTKD2;MARS2;RPL28
prerank,regulation of glycolytic process (GO:0006110),-0.19739494481697334,-0.7917183657225848,0.8488664987405542,0.9658455770423025,1.0,13/68,14.88%,APP;PRKAG2;PFKFB1;ZBTB20;NUP98;HDAC4;NUP205;TIGAR;NUP210;NUP54;NUP43;CBFA2T3;NUP155
prerank,regulation of histone deacetylation (GO:0031063),0.31455073348403956,0.7916356452384589,0.72552783109405,0.9530154372693861,1.0,2/13,3.00%,AKAP8;AKAP8L
prerank,negative regulation of phagocytosis (GO:0050765),-0.27855880076534545,-0.7910505789072213,0.7665903890160183,0.9662312561934862,1.0,4/17,11.68%,CD47;CD300LF;FCGR2B;DYSF
prerank,leukotriene biosynthetic process (GO:0019370),-0.2935268152326181,-0.7909783145559066,0.7534246575342466,0.9656349926880373,1.0,7/14,29.98%,ALOX5;ALOX5AP;GGT7;MGST3;GGTA1;LTA4H;MGST2
prerank,negative regulation of immune response (GO:0050777),0.18878956336769706,0.7908192539619257,0.957613814756672,0.9538413982512499,1.0,29/154,18.44%,SIRT2;ITCH;ADCY9;PRKACA;LYN;SRC;MYH9;PLCG2;PCBP2;HRH2;C1QBP;ADORA2B;MC2R;CALCR;FSHR;LHCGR;NPS;ADCY4;DPEP1;ADCY6;HAVCR2;INSL3;VIP;MAPK14;ADORA2A;SPINK5;ADCY7;GPR84;GNB1
prerank,positive regulation of cell growth (GO:0030307),0.20511361249926954,0.7906017772562968,0.8957654723127035,0.953697480642455,1.0,16/96,14.89%,TGFBR1;TWF2;NCBP1;RPS6KA1;SMURF1;DBN1;CSNK2A1;EIF4G1;MACF1;RPTOR;GOLGA4;UNC13A;SEMA4D;AKT1;CIB1;HPN
prerank,cellular copper ion homeostasis (GO:0006878),-0.2934338227674105,-0.7905174205790216,0.7702127659574468,0.9657142236066129,1.0,3/14,9.32%,APP;ATP7A;SLC31A2
prerank,response to retinoic acid (GO:0032526),-0.21038683549493534,-0.790224053205611,0.8709677419354839,0.9654816030047947,1.0,18/59,22.39%,BRINP3;RORB;RARG;BRINP2;RET;HSD17B2;RARA;TESC;RBP4;ZNF35;WNT9A;SNW1;ASXL1;TRIM16;WNT6;WNT8B;LTK;AQP1
prerank,amino sugar biosynthetic process (GO:0046349),0.3187349580258338,0.7901162203330062,0.7419962335216572,0.9539918969824711,1.0,3/12,11.79%,GFPT1;UAP1L1;AMDHD2
prerank,stabilization of membrane potential (GO:0030322),-0.28627351375375476,-0.7893651824883989,0.7289915966386554,0.9662232061677215,1.0,5/16,21.78%,KCNK10;KCNK12;KCNK5;CHCHD10;KCNK2
prerank,protein localization to cell surface (GO:0034394),-0.25259183833223725,-0.7891345864801563,0.7878787878787878,0.965888783629164,1.0,10/26,26.10%,ANK2;FGF10;FGF7;JAM3;PTPRK;CD177;FLNA;RIC3;CTNNB1;ANGPT1
prerank,neuropeptide signaling pathway (GO:0007218),-0.20708755264144785,-0.789053324730111,0.865,0.9652965712759407,1.0,13/58,22.09%,SORCS1;RAPGEF2;GLRA1;OPRM1;HCRTR2;OPRD1;GALR1;GLRA2;NTS;NTSR1;AGRP;NXPH2;PNOC
prerank,sterol metabolic process (GO:0016125),0.22163038492517997,0.7888532296044957,0.8381877022653722,0.9556092993143218,1.0,10/60,15.51%,PPARD;FDXR;CH25H;CYP46A1;PIP4P1;SULT2A1;CYP7B1;OSBPL5;LDLRAP1;FDX1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.22710405698127,0.7882344660174491,0.8491921005385996,0.9561460250539016,1.0,18/51,27.14%,SRC;ATM;CTC1;HNRNPC;GNL3L;NEK7;TERF1;EXOSC10;CCT3;TEN1;CCT8;ACD;HNRNPA1;CCT7;STN1;PARN;CCT5;HMBOX1
prerank,T cell differentiation (GO:0030217),0.23810336877370436,0.7877849441522258,0.8027444253859348,0.9563845811732924,1.0,7/40,9.62%,CHD7;RHOH;SHH;ZFP36L1;ZFP36L2;JAG2;PIK3CD
prerank,regulation of cilium movement (GO:0003352),-0.31887605405819786,-0.787565009220206,0.7682119205298014,0.9669904096891485,1.0,5/10,20.79%,ODAD2;CFAP206;DNAAF1;CCDC65;CCDC39
prerank,negative regulation of cholesterol transport (GO:0032375),0.33714680294170324,0.7875629020545548,0.7312614259597806,0.956235220929519,1.0,1/10,6.86%,SHH
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.22747078058911346,0.787330780905758,0.8475177304964538,0.9560915890327927,1.0,17/53,23.02%,DDX5;PCNA;ATM;PRKCD;DHX9;EYA3;RNF8;BRCA1;CEBPG;ABRAXAS1;TMEM161A;FXR2;FBH1;BABAM1;PMAIP1;SPRED2;EYA4
prerank,negative regulation of chemotaxis (GO:0050922),-0.24174045569337127,-0.7873238153117835,0.7933491686460807,0.9666554280434777,1.0,8/31,16.38%,ROBO1;SLIT2;SEMA5A;SEMA4A;PTPN2;SEMA7A;SEMA6D;CORO1B
prerank,regulation of DNA biosynthetic process (GO:2000278),0.256101460587192,0.7871305742007405,0.785063752276867,0.9558819034304906,1.0,4/27,11.46%,SMOC2;ATM;PDGFB;PDGFRB
prerank,microtubule bundle formation (GO:0001578),0.23743347001709011,0.7870226874506588,0.8118279569892473,0.955543990506864,1.0,9/42,17.24%,TTLL3;NUMA1;CFAP74;LRGUK;JHY;CFAP46;CCDC40;RSPH9;CCDC66
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.3327163553168305,0.787020132656631,0.747148288973384,0.9550324842455546,1.0,2/11,2.98%,PRKCA;LYN
prerank,iron-sulfur cluster assembly (GO:0016226),0.26788483831836385,0.7865538728552817,0.8063314711359404,0.9552497607264798,1.0,4/24,10.29%,CIAO3;ISCU;CIAPIN1;MMS19
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.32718759423092575,0.7864394284709272,0.7428571428571429,0.9549094044833026,1.0,5/11,32.89%,MTOR;SMARCA4;IPPK;DDX11;SIRT7
prerank,negative regulation of macroautophagy (GO:0016242),-0.25360151560923855,-0.7858442220102831,0.7951219512195122,0.9683522745465074,1.0,4/26,9.43%,LRRK2;SCFD1;SMCR8;RUBCN
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.25496435292989084,0.7858121217367601,0.7759856630824373,0.9554433485861462,1.0,6/27,18.32%,GNA15;GPR55;GPR18;DRD2;GPR4;GPR157
prerank,negative regulation of endothelial cell migration (GO:0010596),0.24444578637651884,0.785744544226519,0.8207885304659498,0.955037259856718,1.0,13/36,25.66%,PTPRM;MEF2C;AGTR2;APOH;THBS1;KRIT1;SYNJ2BP;ANGPT2;STC1;TGFB1;JUP;DNAJA4;ATP2B4
prerank,regulation of actin nucleation (GO:0051125),0.3152542906652457,0.7848697190081673,0.7471264367816092,0.9560245159680159,1.0,4/12,21.82%,ARFIP1;ARFIP2;PICK1;ARF1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.3198974377290166,0.7848293405118635,0.7490494296577946,0.9555842046617425,1.0,3/12,15.28%,BRCA1;CEACAM1;WDTC1
prerank,ribosomal large subunit assembly (GO:0000027),0.26565030666454,0.7829673509494731,0.7807486631016043,0.9581303870922522,1.0,11/24,29.01%,BOP1;RPL10;NLE1;BRIX1;TRAF7;FASTKD2;DHX30;MRPL20;NOP2;MDN1;RPL6
prerank,polyol metabolic process (GO:0019751),-0.2139602171228307,-0.7828588556857382,0.864406779661017,0.9726230974234618,1.0,13/46,19.40%,PLCB1;CALM1;PLCH1;PLCB4;INPP5J;NUDT3;PLCH2;OCRL;PLCD1;ISYNA1;ITPKC;IPMK;ITPK1
prerank,protein-DNA complex assembly (GO:0065004),0.19523898826026148,0.782556181092189,0.9193798449612403,0.9582843077863816,1.0,38/116,27.98%,DDB2;RPS27A;UBC;GTF2H2;SART3;MCM2;ERCC2;CUL4B;PSMD3;SMARCA5;PSMB3;PSMA7;PSMC1;PSMC2;PSME4;SPTY2D1;PSMB9;ORC3;HMGB2;MCM3;CUL4A;PSMD4;CHAF1B;PSMB5;PSMB7;KAT6B;RPA3;PSMB8;SOX9;NAA60;RAD23B;PSMD13;GMNN;MCM6;ORC2;PSMD2;RPA1;TCF4
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.24637520717972977,0.7820841541042965,0.8080985915492958,0.9585199202902949,1.0,8/31,18.70%,TOMM20L;PEX10;TIMM44;PEX6;TIMM50;TOMM20;GRPEL1;PEX1
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.2227731081896388,-0.7819928948615144,0.823960880195599,0.9732945827016002,1.0,11/44,15.32%,CD47;PPM1E;ARHGEF10L;CDC42;CARMIL1;LIMCH1;CCDC88A;ITGB1BP1;RGCC;PAK1;SFRP1
prerank,lipid biosynthetic process (GO:0008610),0.20630458703284515,0.7817183308332193,0.8635634028892456,0.9585982866975611,1.0,13/77,20.60%,LIPC;LIPH;FDXR;HSD3B2;HSD17B1;GGPS1;MBOAT1;FADS1;SCD5;SCD;ACSS2;PDSS2;LPCAT1
prerank,negative regulation of neurogenesis (GO:0050768),-0.22707348078349815,-0.7816121718159614,0.849438202247191,0.9731678313567752,1.0,4/34,6.25%,LINGO1;B2M;RAPGEF2;RTN4
prerank,mitochondrial genome maintenance (GO:0000002),0.3309763796190264,0.7812051057134348,0.7589285714285714,0.9589329269383098,1.0,4/11,25.39%,MEF2A;TOP3A;OPA1;LONP1
prerank,peptidyl-methionine modification (GO:0018206),0.31597750559786947,0.7811768424625979,0.7598499061913696,0.9584598928836316,1.0,5/12,24.07%,NAA25;NAA20;METAP2;METAP1D;NAA60
prerank,gastrulation (GO:0007369),0.2974636829606321,0.7811519734726546,0.7477477477477478,0.9579818470728715,1.0,1/15,0.72%,LRP5
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.2806326517843556,0.7809929047672801,0.7844202898550725,0.9577701883810705,1.0,6/20,18.44%,RGS10;LYPD1;CHRM1;GRK2;CHRNA3;GNB1
prerank,amino acid transport (GO:0006865),0.2248173020472014,0.7808894596487217,0.8430034129692833,0.9574154153315411,1.0,4/49,5.80%,SLC7A8;SLC7A5;SLC36A1;SLC25A45
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.2788977579885772,-0.7803566161542458,0.7829977628635347,0.9744764693254528,1.0,4/17,10.61%,CTNNA2;WASF1;ABI2;DNAI3
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.21460683312182252,-0.7800856377226144,0.8554216867469879,0.974126219406515,1.0,12/51,15.32%,CD47;PPM1E;ARHGEF10L;CDC42;CARMIL1;LIMCH1;CCDC88A;ITGB1BP1;RGCC;CX3CL1;PAK1;SFRP1
prerank,regulation of fatty acid oxidation (GO:0046320),-0.28129140128364466,-0.7800043124268695,0.7564102564102564,0.9734875491653951,1.0,8/16,34.77%,PRKAG2;PDK4;ABCB11;PPARGC1A;PPARA;NR4A3;MLYCD;SIRT4
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.22722835123620577,0.7799707113791995,0.847972972972973,0.9583641767779818,1.0,7/45,11.19%,ATG14;EIF2A;GCNT2;PKP3;EIF2B4;CYFIP1;RPL10
prerank,regulation of cholesterol esterification (GO:0010872),-0.3241795857823537,-0.7798043860303208,0.7235955056179775,0.9730752486581437,1.0,1/10,4.62%,APOE
prerank,cellular response to interleukin-1 (GO:0071347),0.1897765675232553,0.7797404227818839,0.9363354037267081,0.9582473774384827,1.0,39/143,24.89%,SIRPA;IRAK2;RIPK2;MAP3K3;EGR1;CCL3;RPS27A;UBC;RPS6KA5;TAB2;MAP3K8;PSMD3;PSMB3;PSMA7;PSMC1;PSMC2;PYCARD;TNIP2;IL1R2;PSME4;PSMB9;PELI2;RPS6KA4;RBMX;CCL24;PSMD4;NOD2;PSMB5;IL1A;PSMB7;ZC3H12A;ACOD1;IRAK4;MYD88;PSMB8;CCL25;SOX9;HIF1A;PSMD13
prerank,negative regulation of cell cycle process (GO:0010948),0.2169796556227283,0.7795965452553277,0.8656195462478184,0.9579732807690851,1.0,20/61,25.22%,NANOS2;GPER1;EHMT2;NME6;BRCA1;PCGF2;APAF1;TERF1;EZH2;EED;UXT;RNF2;CHMP2A;VPS4A;MGA;EPC1;RING1;PHC1;CCP110;CDC7
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.30075282650225454,0.7794632598785227,0.7605118829981719,0.9576802224305961,1.0,5/14,21.93%,SPRY2;NOTCH4;DLL1;ZEB1;SPRED2
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.2966130937647243,0.7794139054093472,0.7677304964539007,0.9572555157373097,1.0,5/15,21.89%,CSNK1E;RSPO3;ZNRF3;SFRP4;CSNK1D
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.23906458060701458,0.7792828882186932,0.8399311531841652,0.9569576580867581,1.0,4/34,6.16%,VEGFB;MT1G;SPRY2;EGR3
prerank,peroxisome organization (GO:0007031),0.2606105451288713,0.7791786021794642,0.7861060329067642,0.9566117840942212,1.0,3/25,4.28%,ABCD2;TMEM135;PEX10
prerank,regulation of p38MAPK cascade (GO:1900744),-0.2315604364452496,-0.7790227629335308,0.8357487922705314,0.9735666609594222,1.0,5/35,8.74%,XDH;PTPN22;PHLPP1;RELL1;DUSP10
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.24338504113317316,-0.7787756229621818,0.8246445497630331,0.9732637766267898,1.0,6/27,18.74%,CD74;FN1;LIG4;CDKN1A;E2F1;CDK4
prerank,ubiquinone biosynthetic process (GO:0006744),0.2958442450174784,0.778486516736168,0.776735459662289,0.9571923739423425,1.0,2/15,3.31%,COQ7;FDXR
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.3254543210040236,-0.7784832565471203,0.7397849462365591,0.9730061832390385,1.0,3/10,14.08%,E2F7;WIZ;DBF4
prerank,cellular component maintenance (GO:0043954),0.31801222585812916,0.7782371534150326,0.7358156028368794,0.9570574317041246,1.0,3/12,18.81%,IGF1R;PICK1;CLDN1
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.28690669763677085,0.777804298875014,0.7568058076225045,0.9572713995629503,1.0,2/17,7.72%,F11R;S1PR3
prerank,positive regulation of protein sumoylation (GO:0033235),0.3290037876964543,0.7775929068446602,0.756007393715342,0.9571179241415415,1.0,3/10,14.17%,UBA2;RASD2;PIAS3
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.2281695805489189,0.7775756041941717,0.8464106844741235,0.9566331985136914,1.0,17/49,26.66%,DDIT3;SRC;NDUFS3;RTKN2;BMF;PINK1;PYCARD;NDUFA13;EIF2AK3;PMAIP1;DDX3X;BCL2L1;BCL2L11;TP53;S100A8;S100A9;PTPMT1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.24797824597866225,0.7775628250525343,0.801358234295416,0.9561446085542953,1.0,4/32,8.49%,CAPN3;PDPK1;GPER1;CALCR
prerank,GPI anchor biosynthetic process (GO:0006506),0.24578223624263568,0.7774859395726895,0.8225806451612904,0.9557522995948784,1.0,5/30,11.91%,PIGV;PGAP2;DPM3;PIGK;PIGO
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.3045307070125832,-0.7771878129169915,0.7572614107883817,0.9743314449013657,1.0,2/11,8.14%,NOVA1;PCBP3
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.2745691650406771,-0.777079665778803,0.8004291845493562,0.9737425038673083,1.0,3/18,6.61%,LILRB1;LILRB3;FBN1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.3120412214536137,0.7770392588358705,0.758220502901354,0.9559505318599357,1.0,5/12,23.86%,PLK5;RPS27L;PLK3;RFWD3;TP53
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.3051031715425854,0.7766093881091698,0.7509090909090909,0.9561212222075518,1.0,6/14,23.35%,HNRNPC;TARDBP;MAPK14;BOLL;ELAVL1;MYD88
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.3198235319426152,0.7764051960227148,0.775047258979206,0.9559371585002141,1.0,3/11,11.79%,GFPT1;UAP1L1;AMDHD2
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.29498762718153915,-0.7763945503577868,0.7758985200845666,0.9741002901011941,1.0,4/13,14.48%,CBLB;KPNA4;NUP54;RGPD1
prerank,negative regulation of protein metabolic process (GO:0051248),0.22359516558470358,0.7762988865989526,0.8641114982578397,0.9555932982022047,1.0,11/48,18.99%,CD84;SIRT2;ITGAV;CLU;MDM4;FLOT2;AGAP2;PIN1;SNX3;EIF2AK1;VBP1
prerank,positive regulation of growth (GO:0045927),0.21073809798192736,0.7760394638638314,0.8922558922558923,0.9555019426796714,1.0,5/64,4.47%,TGFBR1;NCBP1;RPS6KA1;CSNK2A1;EIF4G1
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.2961875247429385,-0.7760035007083788,0.7770562770562771,0.9739842443369162,1.0,3/14,18.74%,POLRMT;MRPL12;TWNK
prerank,negative regulation of TOR signaling (GO:0032007),0.23867891410668696,0.7757060045537778,0.8380281690140845,0.9555268688032732,1.0,5/36,12.55%,TBC1D7;ATM;FLCN;TNFAIP8L1;PDCD6
prerank,RNA catabolic process (GO:0006401),0.2249719570115797,0.7751734173044453,0.8684654300168634,0.9558129096102164,1.0,12/46,20.71%,NCBP1;DXO;DIS3L2;ZFP36L2;NANOS2;RNASE6;LSM5;RIDA;ISG20;NUDT16;SND1;RNASEH1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.19729044348214073,0.7750396785534538,0.9113924050632911,0.9555101651617462,1.0,18/105,16.50%,PRKACA;LYN;SRC;PRKCD;PLCG2;RPS6KA5;PDPK1;MUC6;TAB2;CLEC4E;PSMD3;PSMB3;PSMA7;RELB;PSMC1;PSMC2;PSME4;PSMB9
prerank,striated muscle contraction (GO:0006941),0.22116496279129813,0.7748500724819128,0.8628472222222222,0.9552769056352699,1.0,14/53,24.03%,TNNI2;CCDC78;SLC8A1;SCN4B;SMPX;MYL3;GRK2;RCSD1;SCN1B;MYH14;NOS1;GAA;PIK3CA;KLHL41
prerank,blood vessel diameter maintenance (GO:0097746),-0.23189185756211017,-0.7746534472345887,0.8376470588235294,0.9753640225262034,1.0,7/34,12.32%,KCNMB2;EDNRB;HTR2B;KLF2;PER2;ITGB1BP1;KCNMB4
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.32375094595590104,-0.7746161715866201,0.737603305785124,0.9746817215453354,1.0,2/10,7.34%,CPEB3;CDC73
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.29500942859216966,0.7746090486968463,0.7769652650822669,0.9551342490734752,1.0,6/16,18.35%,PDGFB;RGS14;PDGFRB;PTPN1;ABL1;PTPRJ
prerank,maintenance of protein location in nucleus (GO:0051457),-0.26162595067258615,-0.7742998670692189,0.7893569844789357,0.97442734497346,1.0,3/20,5.88%,SYNE1;SP100;BARD1
prerank,sulfur amino acid metabolic process (GO:0000096),0.26246730808130575,0.7741495064566427,0.8107606679035251,0.955333392345843,1.0,8/24,23.86%,MPST;DPEP1;GCLC;GADL1;MTHFD1;TXN2;MMUT;CDO1
prerank,regulation of protein binding (GO:0043393),0.19444547859751649,0.7738934477689234,0.9075907590759076,0.9552305496650787,1.0,24/114,17.61%,CSNK1E;RIPK2;PRKACA;PRKCD;SLPI;CTNNBIP1;AKTIP;PDGFB;PRMT8;LRP1;TAF1;HIP1R;GNL3L;MARK2;PIN1;LDLRAP1;TMBIM6;MAPK8;AKT1;HDAC5;NVL;AURKA;DTX3L;KDM1A
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.19791308722493442,-0.7735321508399142,0.8973747016706444,0.9749286040080807,1.0,18/68,25.07%,LRRK2;AMPD3;PDE9A;HINT1;AK3;RAN;ACOT13;ACOT11;AK4;SULT2B1;ADSS2;BPNT1;GLYAT;ACLY;ACOT12;ACSM3;BPNT2;ACSL6
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.19730085705877187,0.7734861928508935,0.9116719242902208,0.9548513768489892,1.0,18/104,16.50%,PRKACA;LYN;SRC;PRKCD;PLCG2;RPS6KA5;PDPK1;MUC6;TAB2;CLEC4E;PSMD3;PSMB3;PSMA7;RELB;PSMC1;PSMC2;PSME4;PSMB9
prerank,cellular response to lectin (GO:1990858),0.19730085705877187,0.7734861928508935,0.9116719242902208,0.9548513768489892,1.0,18/104,16.50%,PRKACA;LYN;SRC;PRKCD;PLCG2;RPS6KA5;PDPK1;MUC6;TAB2;CLEC4E;PSMD3;PSMB3;PSMA7;RELB;PSMC1;PSMC2;PSME4;PSMB9
prerank,regulation of centrosome duplication (GO:0010824),-0.2399094253600025,-0.7733222793499456,0.8333333333333334,0.9744883118974815,1.0,8/29,17.73%,CCNF;SIRT1;PLK2;CEP76;ALMS1;GEN1;NPM1;CEP120
prerank,regulation of primary metabolic process (GO:0080090),0.19110128485287825,0.7730472323288382,0.9197530864197531,0.9550296197653265,1.0,29/126,20.42%,CHD9;PPARD;GPS2;SIN3A;C1QTNF2;PSMD3;PLPP1;SMARCD3;GGPS1;NFYA;PSMB3;TGS1;PSMA7;CERS2;PSMC1;PSMC2;IDI1;PSME4;PSMB9;OAZ2;SIN3B;NQO1;CARM1;ROCK2;SCD;PSMD4;PSMB5;FGFR4;OPA3
prerank,cellular component disassembly (GO:0022411),-0.209340910516623,-0.772731726374191,0.9053708439897699,0.9746700570809106,1.0,14/53,22.02%,CD44;MMP16;GSN;TLL1;MMP12;MMP15;MMP19;MMP8;MMP14;BSG;CAPNS2;TLL2;SCUBE3;KLKB1
prerank,regulation of cytoplasmic translation (GO:2000765),0.30263777955549676,0.7721496365748987,0.792910447761194,0.9558994811041603,1.0,3/14,8.56%,DHX9;CNBP;RBM24
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.2700621483978034,0.7716600361358706,0.7927272727272727,0.9561805646843956,1.0,4/22,9.80%,PLEK;PRKRIP1;INHA;INPP5K
prerank,regulation of T cell chemotaxis (GO:0010819),0.3172036686109354,0.7716099830993693,0.7806215722120659,0.9557610601188102,1.0,7/11,30.32%,WNK1;STK39;ADAM10;ADAM17;CXCL10;WNT5A;OXSR1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.2233263195232568,0.7715206302362033,0.8714285714285714,0.9553994212043178,1.0,8/47,18.02%,SIRPA;PLEK;CD34;BRCA1;CEACAM1;PROX1;WDTC1;ROCK2
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.27123566252569775,0.7715044378825131,0.7938517179023508,0.9549298724601466,1.0,10/22,31.61%,LYN;APPL1;TICAM2;RAB7B;ACOD1;APPL2;FLOT1;TREM2;TNFAIP3;NR1H3
prerank,positive regulation of transmembrane transport (GO:0034764),-0.299855154841966,-0.7711233960669152,0.785377358490566,0.9764496833653118,1.0,6/13,32.03%,ANO6;AZIN1;BRAF;ACSL1;C2CD5;NR4A3
prerank,oogenesis (GO:0048477),0.2938344333026379,0.7710336230849625,0.7701754385964912,0.9551659578441374,1.0,2/15,8.11%,KMT2D;NANOS2
prerank,pre-replicative complex assembly (GO:0036388),0.2129180159877925,0.7705834199554947,0.8614357262103506,0.9553504112753214,1.0,21/64,27.41%,RPS27A;UBC;MCM2;PSMD3;PSMB3;PSMA7;PSMC1;PSMC2;PSME4;PSMB9;ORC3;MCM3;PSMD4;PSMB5;PSMB7;PSMB8;PSMD13;GMNN;MCM6;ORC2;PSMD2
prerank,replicative senescence (GO:0090399),-0.3073351391591645,-0.7703346168718223,0.8004291845493562,0.976928229917297,1.0,6/12,21.40%,MME;ROMO1;CDKN2A;CHEK1;TERT;PLA2R1
prerank,positive regulation of stem cell proliferation (GO:2000648),0.2849213561780305,0.7702770536151033,0.8089887640449438,0.9553314059610888,1.0,8/17,30.91%,GJA1;CCNE1;LTBP3;KDM1A;PTPRC;N4BP2L2;PDCD2;HMGA2
prerank,regulation of intracellular protein transport (GO:0033157),0.2493792745158726,0.7701515101540728,0.8407534246575342,0.9550217313430966,1.0,9/32,23.10%,PTPN1;UHMK1;PLK3;TENM1;PDCD10;OAZ2;PTPN14;KIF20B;TGFB1
prerank,cellular response to acid chemical (GO:0071229),-0.246513401230006,-0.7695141351765781,0.8099547511312217,0.9774693575220172,1.0,4/27,5.77%,CPEB3;GLRA1;KLF2;RRAGB
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.29975190744053964,-0.7692299436185858,0.7900677200902935,0.9771822268314829,1.0,5/12,20.28%,KLF2;CYP26C1;SNW1;ASXL1;TRIM16
prerank,cellular response to inorganic substance (GO:0071241),-0.25365449929538353,-0.7691926317257021,0.8404494382022472,0.976499560298401,1.0,2/21,3.68%,KCNC2;GUCY1B1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.3192501327797749,-0.7691473452399213,0.7602591792656588,0.9758331710156914,1.0,3/10,18.91%,CCT2;WRAP53;TCP1
prerank,macrophage differentiation (GO:0030225),0.30864149586898104,0.7685185633829256,0.756007393715342,0.9570048137889369,1.0,1/13,0.77%,CSF1R
prerank,aromatic amino acid family catabolic process (GO:0009074),0.2856448314977618,0.76821521295265,0.8007662835249042,0.9569811925954108,1.0,3/15,19.40%,QDPR;FAH;IL4I1
prerank,regulation of protein localization to nucleus (GO:1900180),0.22696949341912007,0.7681309401392061,0.8512110726643599,0.9565977729720028,1.0,13/43,23.10%,FLCN;SHH;SIN3A;LAMTOR5;PIN1;LATS2;AKT1;NVL;DTX3L;EIF2AK3;BYSL;PARK7;TGFB1
prerank,regulation of glucose metabolic process (GO:0010906),-0.22529100853360062,-0.7675669245176986,0.8575,0.9775443735979741,1.0,6/34,12.48%,IRS1;SLC45A3;PRKN;SIRT1;FOXK1;GNMT
prerank,relaxation of cardiac muscle (GO:0055119),0.30227417313365507,0.767243555595204,0.7695167286245354,0.9574289939501835,1.0,8/13,32.47%,SLC8A1;KCNJ2;PLN;PIK3CA;CHGA;CAMK2D;ATP1B1;ATP1A2
prerank,regulation of cytoplasmic transport (GO:1903649),-0.31109076914059464,-0.7670509403535756,0.7462039045553145,0.9775922343871161,1.0,1/11,0.92%,LRRK2
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.24563019286851756,-0.7669855805611117,0.8108108108108109,0.9769555026285752,1.0,8/26,19.63%,PF4;RET;EYA2;HSPA1B;BCL2;SNAI2;TERT;MAP2K5
prerank,dicarboxylic acid catabolic process (GO:0043649),0.3026392999185272,0.7669775446556935,0.7850098619329389,0.9573308195510165,1.0,4/13,23.96%,GAD1;PM20D2;ACOT8;ACOT4
prerank,response to organic cyclic compound (GO:0014070),0.22138710199967715,0.7667686403934723,0.8409475465313029,0.9571573413548661,1.0,5/52,7.21%,IL18;PAQR7;TRPM2;CCL3;ARL6IP5
prerank,T-helper cell differentiation (GO:0042093),-0.2816839980976086,-0.7666914249236755,0.7765237020316027,0.9766664370803112,1.0,5/14,26.73%,FOXP1;ATP7A;LEF1;RORC;ZFPM1
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.32910802568334885,0.7664786555814551,0.75,0.9570664101003418,1.0,1/10,0.68%,CST3
prerank,peptidyl-lysine monomethylation (GO:0018026),0.32586351883331666,0.7664592277436318,0.7800369685767098,0.9565860220526411,1.0,5/10,23.39%,SETD2;SETD4;SETD7;SETD3;KMT5A
prerank,cellular response to ionizing radiation (GO:0071479),0.22423869417059922,0.7662830397961863,0.8477508650519031,0.9563475964766667,1.0,12/47,19.73%,RHNO1;RHOB;ATM;SPIDR;TNKS1BP1;RAD1;BLM;MAPK14;KDM1A;ECT2;XRCC6;RAD9A
prerank,negative regulation of endocytosis (GO:0045806),-0.2530032853881566,-0.7661271019215444,0.8189845474613686,0.9768030893883611,1.0,5/24,12.05%,LILRB1;MTMR2;RUBCN;UNC119;MCTP1
prerank,sensory organ development (GO:0007423),0.22109922194999854,0.7659386797533544,0.8828382838283828,0.9563486043464676,1.0,6/51,10.06%,FREM2;PAX6;CHD7;MEIS3;MYO7A;SHROOM2
prerank,regulation of protein targeting to membrane (GO:0090313),0.2517291681748383,0.7659295852223894,0.8345323741007195,0.9558596732831788,1.0,5/28,14.87%,ITGAM;ITGB2;INPP5K;MIEF2;CIB1
prerank,transition metal ion transport (GO:0000041),0.23653399974091732,0.765900784019341,0.8362676056338029,0.9554104483818636,1.0,4/35,7.93%,SLC30A5;ATP2C1;SLC30A10;SLC30A8
prerank,cellular response to retinoic acid (GO:0071300),0.23047909131150227,0.7658766383211376,0.8708551483420593,0.9549509588629249,1.0,7/42,11.24%,TWF2;LYN;ATM;PTK2B;WNT10B;WNT7B;PAX2
prerank,regulation of vacuole organization (GO:0044088),-0.26000994422370083,-0.7656194007609562,0.78,0.9768311272545591,1.0,6/20,23.39%,RAB1B;UBQLN2;ANXA2;RAB5A;MTMR3;NPRL3
prerank,tRNA 5'-end processing (GO:0099116),0.2972243164268892,0.765581667431901,0.7723292469352014,0.9548770638676818,1.0,4/15,15.83%,POP1;SSB;RPP21;HSD17B10
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.32057853391566704,0.7653489163040615,0.7707948243992606,0.95472658449077,1.0,4/11,23.86%,DDX5;MAP2K1;TGFB1;TP53
prerank,gene silencing by miRNA (GO:0035195),0.24196739398943767,0.7649759846913281,0.8345588235294118,0.9547739772679045,1.0,12/32,27.57%,CNOT1;MOV10;NOTCH4;WTIP;TNRC6C;TNRC6B;SNIP1;AGO1;XPO5;AJUBA;RBM4;PUM1
prerank,positive regulation of DNA binding (GO:0043388),0.24811011777771325,0.7647183404131315,0.8028169014084507,0.9546611956005505,1.0,10/31,23.10%,SKI;SIRT2;POU4F1;CEBPG;NME1;GATA3;HMGB2;TWIST1;PARK7;TGFB1
prerank,smooth muscle contraction (GO:0006939),-0.2892948758589061,-0.764557431402147,0.7957446808510639,0.9777019109434272,1.0,7/14,29.90%,ADRA1A;PIK3C2A;EDNRA;ACTA2;CHRNB2;ROCK1;NMUR1
prerank,positive regulation of translational initiation (GO:0045948),0.2820929478853373,0.7643008314093968,0.8074204946996466,0.9547877911352161,1.0,9/18,27.79%,POLR2D;MTOR;UHMK1;KHDRBS1;BOLL;DDX3X;LARP1;YTHDF3;HABP4
prerank,positive regulation of biomineral tissue development (GO:0070169),0.23338452967035264,0.7640025826619148,0.8640429338103757,0.9547671358881059,1.0,3/40,5.45%,TMEM119;MEF2C;SLC8A1
prerank,positive regulation of protein transport (GO:0051222),0.2114357481824442,0.7639874539453572,0.8939641109298532,0.9542871939887392,1.0,17/67,23.10%,FRMD4A;ATP2C1;PPID;CLN3;CD33;PLK3;TENM1;PDCD10;CD2AP;OAZ2;EXOC1;MYO18A;ARHGEF5;IL1A;KIF20B;IER3IP1;TGFB1
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.3138987611292755,-0.7639155557787419,0.7832618025751072,0.977950775754782,1.0,1/10,0.92%,LRRK2
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.1861021391174566,0.763838254951296,0.9393939393939394,0.9540145722974371,1.0,26/140,18.95%,CX3CR1;GNA15;TRPM4;SLC8A1;TAC4;S1PR3;GPR55;CCR7;EDN2;GPER1;CALCR;GPR18;DLG4;NMUR2;TRPV4;DRD2;TBXA2R;ABL1;CCR5;CACNA1A;GPR4;BDKRB2;SELENOT;GPR157;P2RX5;C5AR1
prerank,snRNA 3'-end processing (GO:0034472),0.2712954817820917,0.7632872937937822,0.8097928436911488,0.9543372721868995,1.0,4/19,18.97%,INTS6L;EXOSC5;INTS8;EXOSC8
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.23276856881938143,0.762665384779525,0.8464223385689355,0.9547829610510488,1.0,12/35,25.37%,PTPRM;MEF2C;SPARC;IL12B;APOH;PDCD10;THBS1;KRIT1;SYNJ2BP;AIMP1;ATP5IF1;SULF1
prerank,synaptic vesicle recycling (GO:0036465),-0.2284474367437735,-0.7624772222643488,0.8403755868544601,0.9793508635404947,1.0,2/31,2.48%,NLGN1;SYT1
prerank,regulation of mitotic cell cycle (GO:0007346),0.18121165818202192,0.762401941046226,0.9755351681957186,0.954682323019223,1.0,29/171,16.72%,TTC28;SMOC2;SMAD3;PIM2;PRKCA;CDK9;NEK6;HECA;LGMN;AFAP1L2;MAEA;ERCC2;THAP1;CKS1B;PSMD3;RNF20;ANAPC15;PSMB3;CDK11B;PSMA7;PIN1;NEK7;PSMC1;PSMC2;TAL1;PSME4;ANAPC11;PSMB9;RPRM
prerank,positive regulation of intracellular transport (GO:0032388),-0.21962831218741863,-0.7620881828577951,0.8480392156862745,0.9792111788352614,1.0,13/38,28.69%,EHD1;ACTN2;SPAG5;OAZ1;PRR5L;ZFAND1;EHD2;BCAS3;PCNT;ATP2A1;CAPN10;DYNC1H1;EIPR1
prerank,negative regulation of coagulation (GO:0050819),-0.2864453951120158,-0.7619735098471028,0.7770562770562771,0.9786310514670904,1.0,2/14,4.62%,HS3ST5;APOE
prerank,programmed necrotic cell death (GO:0097300),-0.2673515503540384,-0.7618024499153307,0.7932584269662921,0.9781438860639916,1.0,7/18,23.32%,DNM1L;MLKL;IPMK;ITPK1;TRPM7;RIPK3;PPIF
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.2929761188206187,0.7617597154436044,0.7970204841713222,0.9551193715111629,1.0,6/15,25.92%,CCT3;NHP2;CCT8;SHQ1;CCT7;CCT5
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.28064518148055434,0.7617379774329287,0.788659793814433,0.9546684565307118,1.0,2/16,5.78%,CADM1;RAET1E
prerank,cell differentiation in hindbrain (GO:0021533),0.3124100499585806,0.7616110146181141,0.78125,0.9543570596416394,1.0,5/11,21.47%,OPHN1;PROX1;NOG;CBLN1;AGTPBP1
prerank,negative regulation of calcium ion transport (GO:0051926),-0.28583707505621475,-0.7614636224694514,0.8065843621399177,0.9779047655986597,1.0,3/15,10.54%,LILRB1;CBARP;ADRA2A
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.29905755698454717,-0.7613901115401189,0.7557894736842106,0.9772744717849418,1.0,2/12,5.04%,XDH;CADM4
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.25310910784753515,-0.7611135478057637,0.8211920529801324,0.9769329847089188,1.0,4/22,12.51%,PPM1A;PPM1E;DUSP10;DUSP16
prerank,determination of bilateral symmetry (GO:0009855),-0.2506130692112095,-0.7610110461272512,0.8459869848156182,0.9763409408172553,1.0,12/24,31.06%,ODAD2;PKD2;CFAP53;NPHP3;ODAD3;MKKS;CITED2;STIL;DNAH11;TBX1;DNAAF4;PITX2
prerank,aerobic respiration (GO:0009060),0.2675501047974667,0.7608749161404932,0.7992633517495396,0.9549448247010137,1.0,9/20,29.58%,UQCRC2;UQCRB;ATP5F1D;SURF1;SLC25A14;MTFR1L;UQCRC1;SIRT3;OXA1L
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.20559838384778506,0.7608208366581213,0.8823529411764706,0.9545207778479894,1.0,14/74,16.50%,NFE2L2;SIRT2;VHL;RPS27A;UBC;EGLN1;PSMD3;PSMB3;ARNT;PSMA7;PSMC1;PSMC2;PSME4;PSMB9
prerank,regulation of axon guidance (GO:1902667),0.32904209756492675,0.7608053989424903,0.7647058823529411,0.9540546142756298,1.0,4/10,32.22%,ZSWIM8;ZSWIM4;TUBB2B;ZSWIM5
prerank,regulation of protein import into nucleus (GO:0042306),0.2342526828086745,0.7602299907909743,0.8385416666666666,0.954393869865456,1.0,11/36,24.22%,SMAD3;PIK3R1;PRKCD;ZIC1;MAVS;ECT2;ZC3H12A;TGFB1;SUFU;JUP;IPO5
prerank,amino acid transmembrane transport (GO:0003333),0.222138995573967,0.759919486883391,0.8745644599303136,0.9543751507760346,1.0,3/45,2.37%,SLC7A8;SLC7A5;SLC36A1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.24504864784189617,0.7594751934934425,0.8516579406631762,0.95453437426167,1.0,10/29,25.64%,AGTR2;GPER1;PYCARD;TNFRSF12A;AGT;HTRA2;THBS1;PMAIP1;FADD;PPP2R1B
prerank,copper ion homeostasis (GO:0055070),0.28229444002528425,0.7592447187967902,0.7944954128440367,0.9543812994248331,1.0,5/17,16.16%,ANKRD9;MT2A;COX19;CCDC22;XIAP
prerank,positive regulation of viral genome replication (GO:0045070),-0.23170467149712348,-0.7591332681583514,0.8616071428571429,0.978297996545279,1.0,9/29,25.64%,TOP2A;PPIA;PABPC1;PPIH;CCL5;SRPK2;NR5A2;ADAR;PPARA
prerank,response to thyroid hormone (GO:0097066),0.30051185107946965,0.759065345316756,0.7992424242424242,0.9541562253313572,1.0,2/13,5.30%,BRD8;CTSS
prerank,muscle filament sliding (GO:0030049),-0.2201209237865872,-0.7588886338729395,0.863849765258216,0.977183231128019,1.0,16/38,35.08%,DMD;VIM;ACTN2;TNNI1;MYBPC3;DES;ACTA1;TNNC1;TTN;TNNT2;MYH6;TPM2;MYH7;TNNT1;TNNT3;TMOD1
prerank,actin-myosin filament sliding (GO:0033275),-0.2201209237865872,-0.7588886338729395,0.863849765258216,0.977183231128019,1.0,16/38,35.08%,DMD;VIM;ACTN2;TNNI1;MYBPC3;DES;ACTA1;TNNC1;TTN;TNNT2;MYH6;TPM2;MYH7;TNNT1;TNNT3;TMOD1
prerank,regulation of blood coagulation (GO:0030193),0.24854002892885357,0.7583779570634104,0.8467023172905526,0.9546875814176098,1.0,8/27,22.63%,F12;CD34;APOH;SERPINE1;SERPINE2;THBS1;DMTN;TFPI
prerank,ceramide transport (GO:0035627),-0.29921672771298014,-0.7582515033989902,0.7923728813559322,0.9773494424883199,1.0,2/12,6.81%,PLTP;PLEKHA3
prerank,snRNA metabolic process (GO:0016073),0.2772328941012274,0.7577409483078965,0.7784090909090909,0.9551044359250649,1.0,4/17,18.39%,INTS11;INTS3;INTS8;ZCCHC8
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.2862542305977779,0.7576112658453947,0.7947269303201506,0.9548120592438946,1.0,1/15,1.04%,SMAD7
prerank,toxin transport (GO:1901998),-0.31814228899031205,-0.7574426449242281,0.8174273858921162,0.9777283772176417,1.0,2/10,7.29%,ANTXR2;RAB40B
prerank,positive regulation of protein depolymerization (GO:1901881),0.3135206969246099,0.7573681420122037,0.7894736842105263,0.9546629416007014,1.0,3/11,14.39%,PLEK;TRPV4;WDR1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.23990820156585432,0.7572019615449729,0.8362989323843416,0.9543901438517755,1.0,9/31,25.07%,FDXR;HSD3B2;HSD17B1;MOCS2;MOCS1;PYCR1;PYCR2;SCP2;MOCS3
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.3159680185619656,0.7571480227083963,0.7874306839186691,0.9539795755339466,1.0,7/11,30.60%,DHX9;WTIP;XPO5;AJUBA;STAT3;PUM1;FXR1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.3197161969306457,0.7571156047568226,0.762278978388998,0.9535387667313008,1.0,5/11,26.24%,VHL;LEPROT;HGS;ADIPOR1;SOCS3
prerank,mismatch repair (GO:0006298),0.24939433894750854,0.7567980383880462,0.8480565371024735,0.953477792902751,1.0,6/27,13.78%,PCNA;LIG1;POLD2;EXO1;ABL1;SETD2
prerank,peptide hormone secretion (GO:0030072),-0.24145366351138373,-0.7566632740768252,0.8482758620689655,0.9780589018334273,1.0,13/26,32.53%,RIMS2;SNX19;FFAR4;GHRL;MAFA;PTPRN;ANXA1;GAL;CYB5R4;EXOC3L1;EDN1;GHRH;NEUROD1
prerank,organic hydroxy compound transport (GO:0015850),0.23191206536530584,0.7557263691573826,0.8491921005385996,0.9544710024456026,1.0,1/36,0.06%,SLCO2B1
prerank,regulation of chromatin organization (GO:1902275),-0.28169756915315025,-0.7555785880292359,0.8070866141732284,0.9789170034394141,1.0,4/14,11.72%,MKI67;MLLT3;SETD5;ALKBH4
prerank,determination of left/right symmetry (GO:0007368),-0.22445857401295957,-0.7555420806438359,0.864367816091954,0.9782371538013436,1.0,18/36,31.06%,RFX3;ODAD2;PKD2;CFAP53;NPHP3;ODAD3;DNAAF1;CCDC39;MEGF8;MKKS;CITED2;STIL;DNAH11;ODAD4;TBX1;DNAAF4;PKD1L1;PITX2
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.25225174344192386,0.7553468169407566,0.8302919708029197,0.9545204607038189,1.0,4/25,10.24%,ITGA6;SRC;KCTD20;NCKAP1L
prerank,diol metabolic process (GO:0034311),0.2683324388357486,0.7549304003910337,0.8118466898954704,0.9546031055026086,1.0,4/19,14.70%,DEGS2;PLPP1;PLPP2;AKT1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.26358322842610904,0.754927395912115,0.8072727272727273,0.9541167035513272,1.0,3/22,9.48%,PJA2;AGER;PRMT1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.29898058098245034,0.7544640055572194,0.8036363636363636,0.9542458495317535,1.0,3/13,16.03%,ERLEC1;OS9;EDEM1
prerank,positive regulation of JUN kinase activity (GO:0043507),0.25811264375848514,0.7536102737246084,0.8330206378986866,0.9549406092163659,1.0,12/23,31.73%,MAP3K10;MAP3K11;ARHGEF5;DVL2;DUSP19;FZD10;TLR9;TRAF6;TLR6;TAOK3;DVL3;MAP3K4
prerank,piRNA metabolic process (GO:0034587),-0.25865573003233266,-0.7535359661923913,0.8444444444444444,0.9803671727113494,1.0,7/19,29.59%,TDRD12;GPAT2;TDRD9;MYBL1;PIWIL2;MOV10L1;PIWIL4
prerank,regulation of adaptive immune response (GO:0002819),0.274004621353759,0.7531866137828689,0.8433962264150944,0.9550423503564044,1.0,5/18,19.40%,SASH3;IL6ST;PYCARD;ADCY7;IL4I1
prerank,regulation of epithelial cell migration (GO:0010632),0.22045450457575447,0.7531163017641626,0.8800675675675675,0.9546530180056114,1.0,15/51,25.56%,RREB1;ARSB;SRC;PLCG2;MACF1;CEACAM1;INSL3;PTPN23;PPM1F;EVL;ADIPOR1;SOX9;HIF1A;PLCG1;HDAC6
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.30827743541878505,0.7530721008927174,0.7905282331511839,0.9542162213863259,1.0,3/12,18.02%,PICALM;FLOT2;ROCK2
prerank,phosphate ion transmembrane transport (GO:0035435),-0.2937173918358146,-0.7526340834528634,0.7861507128309573,0.9808984008440632,1.0,3/12,10.95%,SLC25A30;SLC37A4;XPR1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.24917759386690744,0.752456799593506,0.836555360281195,0.9546031001136888,1.0,3/28,5.87%,CRADD;TRADD;SORT1
prerank,regulation of transposition (GO:0010528),-0.2906063770086672,-0.752267993659438,0.8063157894736842,0.9806896021141775,1.0,7/13,29.59%,SPOCD1;TDRD9;MYBL1;PIWIL2;SMYD5;AICDA;PIWIL4
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.317159490175383,0.7521421810831473,0.8214936247723132,0.954042835656609,1.0,1/10,5.21%,NFATC1
prerank,calcineurin-mediated signaling (GO:0097720),0.317159490175383,0.7521421810831473,0.8214936247723132,0.954042835656609,1.0,1/10,5.21%,NFATC1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.27992252660748507,-0.7521076496004084,0.8090128755364807,0.9801974368276012,1.0,4/14,17.43%,CD226;SHLD3;RIF1;TFRC
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.29102178519091415,0.7516349438813714,0.8092592592592592,0.9542544242645976,1.0,2/15,11.96%,ASMT;SMOX
prerank,ATP transport (GO:0015867),-0.31166844514155995,-0.7512869684906726,0.7914798206278026,0.9805897870619739,1.0,2/10,8.10%,CD47;SLC25A24
prerank,tRNA wobble base modification (GO:0002097),0.29160423424388454,0.7507196566923399,0.8032786885245902,0.955025039324249,1.0,7/14,28.43%,CTU2;MTO1;KTI12;ELP3;MOCS3;ALKBH8;TRMT9B
prerank,regulation of protein localization to cell surface (GO:2000008),-0.2260059941930732,-0.75012052200352,0.8700696055684455,0.9814607509324201,1.0,11/33,25.47%,BDNF;NEDD4L;KCNAB2;TOR1A;ACTN2;LEPROTL1;RANGRF;ABCA7;RIC3;CTNNB1;HSP90AB1
prerank,cellular response to glucagon stimulus (GO:0071377),0.28362780291926803,0.7498161500857746,0.8105065666041276,0.955759737784524,1.0,4/17,11.91%,ADCY9;PRKACA;ADCY4;ADCY6
prerank,chromosome organization (GO:0051276),-0.1791066490571676,-0.7495126252279959,0.9595687331536388,0.9815657047824681,1.0,17/99,14.88%,SUV39H1;MTF2;LATS1;TOP2A;CENPT;CDCA8;XPA;NDC80;SIRT1;LIG4;PADI4;CENPW;H3-3A;BAHD1;HMG20A;NUCKS1;NUP155
prerank,protein localization to phagophore assembly site (GO:0034497),0.30651306969770026,0.7491737205602637,0.7747035573122529,0.9561614193578571,1.0,6/11,26.82%,ATG9A;TRAPPC8;ATG9B;PACS2;MFN2;WDR45B
prerank,chromatin assembly (GO:0031497),-0.21978466877181768,-0.7486291593022498,0.8897058823529411,0.9820263559440924,1.0,7/38,12.57%,NAP1L2;ASF1A;SIRT1;PADI4;CTCF;H3-3A;BAHD1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.28608894588535005,0.7483566628442627,0.8028419182948491,0.9567957904143257,1.0,5/16,17.21%,AGTR2;NOS1AP;PIK3CB;AKT1;SCARB1
prerank,regulation of intracellular pH (GO:0051453),-0.2225298867808182,-0.7479794620959622,0.8997668997668997,0.9822129064821614,1.0,10/34,22.08%,LRRK2;SLC4A10;TMEM165;SLC4A8;SLC9A4;CFTR;SLC9B1;SLC26A3;SLC4A1;SLC9A2
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.30905559573666797,-0.7479432873450579,0.785234899328859,0.9815469612694687,1.0,3/10,11.28%,MTMR2;MTMR1;MFSD2A
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.23410281064627114,0.7476725916270732,0.8607809847198642,0.9572185254747767,1.0,10/32,23.17%,POLR2H;GTF2H2;ERCC2;TAF1;POLR2E;POLR1C;UBTF;TBP;POLR1E;POLR1G
prerank,peroxisomal membrane transport (GO:0015919),-0.23142176950211973,-0.7476158380854021,0.8410596026490066,0.9812787936048419,1.0,6/27,13.50%,ATAD1;ACBD5;PEX12;FIS1;ALDH3A2;ABCD4
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.30420068029828584,0.7469214720952029,0.8330373001776199,0.9577203698522363,1.0,4/13,14.28%,TRIM44;DHX9;AXL;MAVS
prerank,monocarboxylic acid transport (GO:0015718),0.21569140172346113,0.7468225935354524,0.8791593695271454,0.9573582015942919,1.0,2/51,1.15%,SLCO2B1;SLC16A6
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.2831009168835536,0.7467709435995435,0.8173431734317343,0.9569519672593009,1.0,4/16,12.61%,FANCM;SLX4;TOP2B;ERCC4
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.2851638041876423,-0.7465764761488114,0.7943722943722944,0.9819383207004959,1.0,2/14,4.68%,PPAT;ADK
prerank,regulation of catecholamine secretion (GO:0050433),-0.23036752559751533,-0.7458722296992706,0.8623853211009175,0.9821653509904162,1.0,7/29,15.29%,SYT1;SYT10;PRKN;CHRNA4;DTNBP1;SYT3;SNCA
prerank,regulation of steroid biosynthetic process (GO:0050810),0.31185940743806595,0.7457998651429145,0.7664783427495292,0.9577692873290599,1.0,4/11,23.06%,EGR1;ASAH1;FGFR4;BMP2
prerank,cholesterol metabolic process (GO:0008203),0.2033608822622403,0.7456558656344732,0.9243421052631579,0.9574588232419327,1.0,15/68,22.21%,PPARD;CH25H;CYP46A1;PIP4P1;AKR1D1;SULT2A1;GGPS1;OSBPL5;LDLRAP1;IDI1;FDX1;LCAT;SCAP;ACAA2;NSDHL
prerank,chromosome condensation (GO:0030261),0.23159025034338587,0.7454029151321945,0.8694885361552028,0.9573115246294962,1.0,11/36,24.83%,AKAP8L;CSNK2A2;CSNK2A1;GPER1;NCAPH2;CHMP1A;NCAPH;CDCA5;KMT5A;MCPH1;PHF8
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.2639934824944956,0.7450174445379596,0.8354898336414048,0.9573354904743654,1.0,4/19,11.79%,GFPT1;MPI;UAP1L1;AMDHD2
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.3131452364759747,0.7447650022200338,0.7861271676300579,0.957180060727617,1.0,4/10,35.05%,GNB1;PDE6B;SAG;PDE6G
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.2952665572853969,-0.7445116825236866,0.8042553191489362,0.9825330795598403,1.0,1/12,5.38%,GSK3B
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.2952665572853969,-0.7445116825236866,0.8042553191489362,0.9825330795598403,1.0,1/12,5.38%,GSK3B
prerank,regulation of establishment of cell polarity (GO:2000114),-0.2681419480413587,-0.7442207765446343,0.8318777292576419,0.982208090350043,1.0,4/16,12.38%,GSN;RIPOR2;KANK1;CDH5
prerank,extracellular matrix disassembly (GO:0022617),-0.19931640116171778,-0.7441819363276857,0.9230769230769231,0.9815420427948737,1.0,14/53,22.02%,CD44;MMP16;GSN;TLL1;MMP12;MMP15;MMP19;MMP8;MMP14;BSG;CAPNS2;TLL2;SCUBE3;KLKB1
prerank,cGMP biosynthetic process (GO:0006182),-0.3111878871864041,-0.7434992632799469,0.8201754385964912,0.9817361629307102,1.0,5/10,30.76%,GUCY1B1;GUCY2F;GUCY2D;GUCY1A1;NPPA
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.2265278339526127,0.7434225596918989,0.8716216216216216,0.9584715402327606,1.0,17/40,26.38%,BCO2;MTLN;ARL6IP5;PIP5KL1;PINK1;ABL1;SOD1;AKT1;PYCR1;PMAIP1;MAPT;STOML2;BCL2L1;PARK7;ABCD1;ATP5IF1;SPART
prerank,protein targeting to peroxisome (GO:0006625),-0.22566652933629472,-0.7430776975588177,0.8593406593406593,0.9815538059918285,1.0,6/29,13.20%,ATAD1;ACBD5;PEX12;FIS1;ZFAND6;ALDH3A2
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.2187431766645559,-0.7430684248404765,0.8835616438356164,0.9808468356587239,1.0,11/36,21.99%,TFDP2;RBBP8;E2F6;CBX5;RBBP7;CHEK1;CBX3;PCGF6;E2F1;TFDP1;EHMT1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.2663918164188692,0.7427856150046794,0.8218694885361552,0.9588235708336696,1.0,4/19,14.63%,BAG6;USP28;RPS27L;PYCARD
prerank,response to organonitrogen compound (GO:0010243),-0.21362381407734787,-0.7425289704888669,0.8790697674418605,0.9808093329019563,1.0,8/38,18.60%,GLRA1;RCN3;PRKN;HLCS;GLRA2;UBXN6;NR1H4;IRAK3
prerank,cellular iron ion homeostasis (GO:0006879),-0.2000905338848285,-0.7422429838883206,0.9290617848970252,0.9804856219621414,1.0,12/55,17.43%,FTL;ABCB7;FLVCR1;NDFIP1;SCARA5;TFR2;SLC46A1;HMOX1;FBXL5;ATP6V1A;CYBRD1;TFRC
prerank,regulation of centrosome cycle (GO:0046605),0.2592933809285965,0.7421838739750584,0.84375,0.9591507753702121,1.0,7/21,23.84%,PKHD1;AURKA;CHMP1A;CHMP2A;MARK4;PDCD6IP;FBXW5
prerank,positive regulation of response to wounding (GO:1903036),-0.2455455888634292,-0.742177885036464,0.8699763593380615,0.9798496868186939,1.0,10/24,28.40%,SCARF1;KANK1;ADRA2A;ITGB1;PRKCE;ACTG1;ANXA1;OCLN;PTK2;VTN
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.24452751521518518,-0.7420679346851995,0.8699551569506726,0.9792861401040793,1.0,7/21,23.64%,GRIN2B;BEX3;TTBK1;LTF;FYN;EPHA7;NGFR
prerank,positive regulation of blood coagulation (GO:0030194),-0.2626223142459492,-0.7417761185008331,0.8303964757709251,0.9789502440260351,1.0,3/17,8.83%,ST3GAL4;USF1;ANO6
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.28069198418805935,-0.7417243384787757,0.8161157024793388,0.9783140165094327,1.0,7/13,27.08%,CPEB3;PABPC1;TNRC6A;POLR2G;BTG2;ZFP36;AGO2
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.28501617764999965,-0.741637551848343,0.8271604938271605,0.9777052792065067,1.0,3/12,15.29%,CBLB;F7;SNCA
prerank,regulation of telomere capping (GO:1904353),-0.2444703605734509,-0.7412734965229353,0.8698630136986302,0.9774718577622248,1.0,8/23,23.99%,MAPKAPK5;SMG6;AURKB;TNKS2;PRKCQ;MAPK1;NABP2;MAPK15
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.3003381596419322,0.7405664830782385,0.8007380073800738,0.9607822261083593,1.0,2/12,11.03%,DGAT1;APOC4
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.2672949497167892,-0.7400608917778275,0.8119469026548672,0.9784184935563015,1.0,1/17,1.05%,PLBD1
prerank,cellular amide metabolic process (GO:0043603),-0.17867602417658068,-0.7393761505103955,0.970074812967581,0.978590170766839,1.0,31/102,27.90%,ST3GAL1;MME;ALDH1L1;NAPEPLD;HLCS;SGPL1;AEBP1;PPP2R1A;ACOT13;SLC46A1;SHMT1;ACOT11;PLPP3;BTD;SLC5A6;ABCB9;MTHFD1L;GLYAT;ACOT12;ACSM3;MTHFD2L;CPXM2;FPGS;FOLR2;MTHFD2;SLC25A32;ACSL6;NAAA;PPP2CA;DHFR;MCCC1
prerank,DNA catabolic process (GO:0006308),0.30630608946633625,0.7392455037437468,0.8270944741532977,0.9619876176515628,1.0,3/11,18.69%,REXO4;ISG20;FBH1
prerank,erythrocyte differentiation (GO:0030218),0.22212579266901672,0.7389515491234016,0.8959435626102292,0.9618448650928296,1.0,7/44,15.58%,IKZF1;LYN;INHA;NCKAP1L;CEBPG;TAL1;UBA5
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.29976763547456253,0.7383881139380802,0.8155893536121673,0.962095583049261,1.0,4/12,16.07%,IMPDH1;GART;ATIC;PAICS
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.29739588754576546,0.7381118465154113,0.8173431734317343,0.9619607099201561,1.0,3/13,20.07%,TLR4;IL33;NOD2
prerank,necroptotic process (GO:0070266),-0.2660672899454025,-0.7378754692363312,0.8481561822125814,0.9797890443512144,1.0,6/16,22.75%,DNM1L;MLKL;IPMK;ITPK1;TRPM7;RIPK3
prerank,transcription by RNA polymerase I (GO:0006360),0.2269856895011812,0.7378042638449877,0.8754266211604096,0.9618534830897054,1.0,10/34,23.17%,POLR2H;GTF2H2;ERCC2;TAF1;POLR2E;POLR1C;UBTF;TBP;POLR1E;POLR1G
prerank,alpha-amino acid catabolic process (GO:1901606),-0.22877451231189755,-0.737081310167662,0.8648068669527897,0.9801120219916309,1.0,10/29,31.13%,KMO;SARDH;DAO;IDO2;KYAT1;GSTZ1;HOGA1;ACADSB;TAT;OTC
prerank,cristae formation (GO:0042407),0.24367534420752654,0.7363834458627245,0.865546218487395,0.9632244257234842,1.0,10/27,26.21%,MICOS13;DNAJC11;ATP5PO;ATP5PD;ATP5MC1;ATP5F1D;AFG3L2;ATP5PF;CHCHD6;SAMM50
prerank,inositol phosphate dephosphorylation (GO:0046855),0.3008588183117519,0.7363242010982314,0.8132075471698114,0.9623217872845038,1.0,4/11,19.43%,INPP5K;IMPA1;INPP1;IMPA2
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.3008588183117519,0.7363242010982314,0.8132075471698114,0.9623217872845038,1.0,4/11,19.43%,INPP5K;IMPA1;INPP1;IMPA2
prerank,response to X-ray (GO:0010165),-0.2761559492643867,-0.7361757575566542,0.8168103448275862,0.980549377863815,1.0,6/14,23.76%,LIG4;IKBIP;NUCKS1;XRCC5;MSH2;ANXA1
prerank,ion homeostasis (GO:0050801),-0.22389777642076436,-0.7359994705026177,0.8883495145631068,0.980051305021783,1.0,10/30,26.31%,UNC80;NEDD4L;SLC4A10;SLC12A5;SLC4A8;SLC4A1;RANGRF;HCN4;WNK4;RHAG
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.23630158320699934,-0.7357723230853983,0.8611764705882353,0.9796394411068533,1.0,2/26,5.38%,AKAP6;GSK3B
prerank,non-motile cilium assembly (GO:1905515),-0.2246234809716335,-0.7356829333674479,0.8927738927738927,0.979045511646033,1.0,5/30,19.28%,TBC1D32;TMEM216;TMEM107;RPGRIP1;IFT57
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.23467009047963042,-0.7353405389372725,0.8571428571428571,0.9787515650542936,1.0,14/27,32.56%,CD74;CD44;SIRT1;SMYD2;MDM2;SNAI2;PLA2R1;MSX1;SPRED1;YJU2;SPRED3;HIC1;SNAI1;ATR
prerank,proteoglycan metabolic process (GO:0006029),-0.22955474241979018,-0.7350566954906765,0.8584269662921349,0.9784032541318028,1.0,10/26,27.54%,SULF2;HS3ST4;CHST10;CSGALNACT2;B4GALT7;ADAMTS12;CNMD;CSGALNACT1;CHST14;BMPR1B
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.20210985820906802,-0.734660775955516,0.9218009478672986,0.9781593992474464,1.0,12/44,20.41%,PRKAG2;LBR;PER2;CYP39A1;PSAT1;EBP;HMGCR;HSD3B7;OSBPL9;DHCR7;MSMO1;ALOX15
prerank,positive regulation of translation (GO:0045727),0.1891045115749175,0.7342092049568099,0.9630818619582665,0.9644285982621422,1.0,26/94,22.16%,PLD1;NSUN5;METTL5;POLR2D;DHX9;C1QBP;CNBP;RMND1;MTOR;MPV17L2;RPS27L;UHMK1;PASK;METTL14;EIF3D;FASTKD3;UQCC2;FXR2;KHDRBS1;THBS1;PCIF1;BOLL;FASTKD2;DDX3X;LARP1;ELAVL1
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.2417019478428069,0.7338641444782844,0.8821428571428571,0.9643266127987202,1.0,7/28,17.33%,ARRDC1;GATA2;DLL1;WWP2;AKT1;NOTCH3;ARRB1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.2760316769834503,0.733753417293109,0.8448598130841122,0.9639752968670076,1.0,6/16,27.97%,PPT1;ACSS1;SCD5;SCD;PPT2;ACAT1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.2434081276215269,-0.7337355356120197,0.8540145985401459,0.9785737953926771,1.0,5/22,14.31%,PTPN22;PTPN2;FCGR2B;UBASH3A;THY1
prerank,protein localization to Golgi apparatus (GO:0034067),0.242248487600948,0.733574257235901,0.8770642201834863,0.9637065745150851,1.0,12/27,27.37%,ARL5C;IFT20;OPTN;GBP5;VPS13C;CSNK1D;VPS13D;GAK;SYS1;COG7;GBF1;TMED10
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.2275831487991202,0.7333797629704872,0.8895027624309392,0.9634665557831109,1.0,10/34,21.85%,RREB1;RAC1;C1QBP;LIMS1;CSPG5;ABL1;CIB1;CRKL;RAC3;DMTN
prerank,DNA conformation change (GO:0071103),0.2712440449268795,0.7331546632485513,0.8069852941176471,0.9632727658046333,1.0,5/17,18.67%,TOP3B;TOP2B;ABL1;HMGB2;TOP3A
prerank,response to gamma radiation (GO:0010332),-0.2384205377466892,-0.7331180947470938,0.847926267281106,0.978595215335022,1.0,7/24,23.26%,RPL26;LIG4;DCUN1D3;MDM2;XRCC5;TLK2;PRKAA1
prerank,protein palmitoylation (GO:0018345),-0.22695828950210642,-0.733074548606382,0.8799076212471132,0.9779382140069979,1.0,8/30,17.76%,ZDHHC21;ZDHHC16;ZDHHC17;ZDHHC23;ZDHHC15;ZDHHC18;SELENOK;ZDHHC24
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.208600011747301,-0.7322130211141394,0.9172413793103448,0.9782710246399554,1.0,14/44,23.64%,CD44;YWHAE;SH3RF1;CAST;BEX3;KLF4;RAF1;SNCA;USP47;MAP2K5;LTF;SIAH2;AQP1;NGFR
prerank,branched-chain amino acid catabolic process (GO:0009083),0.26119698836615696,0.7320470408721668,0.8342342342342343,0.9636719389091628,1.0,7/20,21.03%,ECHS1;IVD;ACAD8;BCKDHA;HSD17B10;MCCC2;DBT
prerank,branched-chain amino acid metabolic process (GO:0009081),0.26119698836615696,0.7320470408721668,0.8342342342342343,0.9636719389091628,1.0,7/20,21.03%,ECHS1;IVD;ACAD8;BCKDHA;HSD17B10;MCCC2;DBT
prerank,membrane depolarization during action potential (GO:0086010),0.23897511611831534,0.7317484153732535,0.8745519713261649,0.963562435535201,1.0,7/26,20.25%,YWHAH;SLC8A1;SCN4B;SCN1B;SCN7A;KCNJ2;CACNA1D
prerank,cellular amino acid catabolic process (GO:0009063),-0.18005657345260526,-0.731527769769298,0.9744245524296675,0.9784397000803267,1.0,17/87,17.08%,HIBADH;GLS;ASPA;GCSH;HMGCLL1;HAL;KMO;AUH;BCAT1;SHMT1;SARDH;HIBCH;DAO;AMT;AASS;BCKDHB;GLDC
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.24880176568041745,0.7313139134288176,0.85,0.9635762896483564,1.0,4/23,12.19%,MTMR10;PIP4P1;INPP5K;MTMR4
prerank,fatty acid biosynthetic process (GO:0006633),0.202286608592957,0.7312738391780289,0.9258010118043845,0.9631442891695058,1.0,4/63,5.94%,LIPC;LIPH;HPGD;HACD3
prerank,positive regulation of organelle organization (GO:0010638),0.23480144351156595,0.731143751816874,0.8784246575342466,0.9628183299126809,1.0,10/32,22.46%,SHCBP1L;TMED9;RAB3GAP2;RAB3GAP1;PLA2G5;SORBS3;HTRA2;FYCO1;STX18;KATNBL1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.24544487594070508,-0.7308346668813017,0.8561797752808988,0.9785839819373583,1.0,9/23,30.25%,PPM1A;TSPAN6;CCN3;C1QTNF3;NMI;UACA;NLRC3;RELA;NLRP12
prerank,intracellular protein transmembrane transport (GO:0065002),-0.20441262298717616,-0.7306756256008583,0.9137529137529138,0.9780695411164028,1.0,7/42,11.12%,ROMO1;TIMM23;DNAJC15;TIMM17B;PEX12;SEC62;TIMM17A
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.3077233418242409,-0.7299802394198613,0.7866379310344828,0.9782007894973515,1.0,5/10,27.19%,SHMT1;MTHFD1L;MTHFD2L;MTHFD2;DHFR
prerank,"base-excision repair, AP site formation (GO:0006285)",0.2669440865916859,0.7295830888864363,0.8382352941176471,0.9642032182098124,1.0,5/17,19.08%,MPG;TERF1;NEIL2;NTHL1;ACD
prerank,intracellular lipid transport (GO:0032365),0.25419737371721335,0.7292565764999395,0.8402777777777778,0.9641204847369615,1.0,7/21,26.69%,ABCD2;NPC2;CPT1A;THRSP;ABCD1;MID1IP1;SLC25A20
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.2264888327136073,0.7288755312867244,0.8890845070422535,0.9641026474066875,1.0,11/37,25.75%,KIF3B;TNPO1;IFT52;IFT20;TTC21B;KIF3A;SSX2IP;DYNLL1;DYNC2H1;IFT122;IFT140
prerank,positive regulation of protein secretion (GO:0050714),0.20251932902621084,0.7285731129642307,0.913961038961039,0.9639670908607916,1.0,16/69,23.10%,FRMD4A;ACSL4;TLR4;SLC30A8;GPER1;TM7SF3;PPID;CD33;LRRC8A;CD2AP;PTPN23;EXOC1;MYO18A;IL1A;IER3IP1;TGFB1
prerank,endosome organization (GO:0007032),0.22027678036637027,0.7284658326237621,0.9283276450511946,0.9636158405548307,1.0,12/41,23.27%,HOOK2;PHETA1;USP8;AKTIP;LAPTM4B;RAB27A;SNX3;USP50;WASHC4;HOOK3;EXOC8;DNAJC13
prerank,regulation of focal adhesion assembly (GO:0051893),-0.19635852290865385,-0.7284601589476453,0.9282051282051282,0.9793268151724205,1.0,14/54,20.55%,ARHGAP6;SLK;LIMCH1;ITGB1BP1;EFNA5;THY1;ACVRL1;SFRP1;TEK;RCC2;S100A10;BCAS3;TSC1;ACTG1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.23604624296513788,0.7284563054057157,0.8779174147217235,0.9631493757546371,1.0,5/28,16.01%,SMURF1;CLU;ECSCR;PSMC2;CCDC22
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.2872725908205562,0.7283187501354211,0.8420074349442379,0.9628332791993868,1.0,3/13,11.79%,GFPT1;UAP1L1;AMDHD2
prerank,telomere maintenance via telomerase (GO:0007004),0.23772851130811024,0.7280732326276993,0.8824561403508772,0.9626488540394964,1.0,10/28,27.61%,PPP6R3;TNKS1BP1;TERF1;NHP2;RFC1;ACD;SHQ1;TELO2;RPA1;RTEL1
prerank,nuclear body organization (GO:0030575),-0.2793757278418227,-0.7279969483715563,0.8313492063492064,0.9791686766719591,1.0,5/12,20.43%,HIPK2;WRAP53;AFF2;SRPK2;USPL1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.29590318314512737,-0.7279062914417405,0.8284518828451883,0.9785679678710102,1.0,3/10,15.29%,PTPN12;PTPN2;SNCA
prerank,oxoacid metabolic process (GO:0043436),-0.23167567379066578,-0.7269779047470303,0.8991416309012875,0.979011793553592,1.0,9/27,24.58%,PPA1;THAP4;GNMT;SULT2B1;DAO;BPNT1;GRHPR;BPNT2;LIPT2
prerank,protein localization to mitochondrion (GO:0070585),0.29729857473588106,0.726936105588582,0.8290441176470589,0.9634923734177654,1.0,4/11,19.67%,HK2;PINK1;AKT1;MAIP1
prerank,renal water homeostasis (GO:0003091),0.2538966397515196,0.7267219636462335,0.8571428571428571,0.9632724343649491,1.0,5/23,11.91%,ADCY9;PRKACA;ADCY4;MYO5B;ADCY6
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.2659656327690407,-0.7266396881937635,0.8558139534883721,0.9787230802440166,1.0,2/15,4.60%,EHD1;RIPOR2
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.24116882080056187,-0.7262789532691223,0.8521739130434782,0.9777190682063074,1.0,7/21,19.63%,PF4;EYA2;HSPA1B;BCL2;SNAI2;TERT;MAP2K5
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.24116882080056187,-0.7262789532691223,0.8521739130434782,0.9777190682063074,1.0,7/21,19.63%,PF4;EYA2;HSPA1B;BCL2;SNAI2;TERT;MAP2K5
prerank,2-oxoglutarate metabolic process (GO:0006103),0.2863155882236361,0.7249107985068335,0.8069216757741348,0.9649412146613211,1.0,2/13,12.97%,PHYH;ADHFE1
prerank,lipoprotein biosynthetic process (GO:0042158),0.30368924919757767,0.7236193683569436,0.8287795992714025,0.9659513240181589,1.0,2/11,6.43%,PIK3C3;PORCN
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.19528556812938166,-0.7234353406139812,0.9325581395348838,0.9803217378040459,1.0,20/52,30.67%,ALDH1L1;SDHA;L2HGDH;SLC46A1;SHMT1;ME1;IDH2;MTHFD1L;ACLY;MTHFD2L;FPGS;FOLR2;MTHFD2;SLC25A32;GOT1;DHFR;HOGA1;ALDH18A1;TAT;MDH1B
prerank,regulation of T cell differentiation (GO:0045580),0.22579600529858807,0.723402387056316,0.8754266211604096,0.9657223009660557,1.0,9/33,18.33%,RHOH;PRDM1;RUNX1;ABL1;SOD1;ZMIZ1;SPINK5;GATA3;FANCA
prerank,glutathione derivative biosynthetic process (GO:1901687),0.259561377732874,0.723263298785356,0.8517857142857143,0.964924394350688,1.0,1/20,0.46%,HPGDS
prerank,glutathione derivative metabolic process (GO:1901685),0.259561377732874,0.723263298785356,0.8517857142857143,0.964924394350688,1.0,1/20,0.46%,HPGDS
prerank,positive regulation of establishment of protein localization (GO:1904951),0.2626414118817326,0.7229770684972812,0.8395061728395061,0.9647595952879264,1.0,9/18,31.11%,CEP295;CCT3;CEP135;CCT8;PTP4A3;CCT7;CCT5;CORO2B;TREM2
prerank,protein prenylation (GO:0018342),-0.3004584108464953,-0.7226893671594276,0.8311965811965812,0.980516265576614,1.0,1/10,1.06%,CHM
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.18434396757816668,0.7222461263669203,0.9614791987673343,0.9651088432297749,1.0,27/104,23.42%,LRP5;CSF1R;SRC;KSR1;SLC8A1;CCNG2;RPTOR;CCND3;ABL1;CCNE1;EZH2;PYCARD;BLM;AKT1;CIB1;MAP2K1;PDCD10;TRIB1;CAMK1;HGS;TSG101;DDX3X;SLC8A2;CALM2;CDKN1B;RALB;TELO2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.27380850169730586,0.721575688215006,0.8461538461538461,0.9653893289668636,1.0,3/16,10.36%,FOXK2;PDK1;PDK2
prerank,microtubule nucleation (GO:0007020),-0.2510082202506964,-0.720685933152766,0.8627450980392157,0.982127384119663,1.0,2/19,6.70%,TPPP;TPX2
prerank,establishment of epithelial cell polarity (GO:0090162),-0.2468706450897375,-0.7204390483826071,0.865909090909091,0.9816907000383407,1.0,6/19,21.74%,CDC42;GOLPH3;CYTH1;PARD3;MSN;EZR
prerank,negative regulation of endopeptidase activity (GO:0010951),0.21336259443641625,0.7204296243558964,0.9122203098106713,0.9662472097753652,1.0,7/47,16.93%,BIN1;GAPDH;SERPINE1;SERPINE2;AKT1;SERPINF1;AGT
prerank,transcription preinitiation complex assembly (GO:0070897),-0.28011224796441797,-0.7196311248867218,0.832258064516129,0.9818756419844727,1.0,3/12,11.71%,TAF7;GTF2B;BDP1
prerank,amyloid-beta metabolic process (GO:0050435),-0.25609265877600884,-0.7192045046618185,0.8438177874186551,0.9816664097135496,1.0,5/16,22.46%,MME;MGAT3;ACE;ABCA7;NCSTN
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.26274449736856675,-0.7186953457714101,0.8701298701298701,0.9815072753588965,1.0,7/15,27.08%,CPEB3;PABPC1;TNRC6A;POLR2G;BTG2;ZFP36;AGO2
prerank,regulation of multicellular organismal development (GO:2000026),-0.22842907991430283,-0.7183763427333032,0.8937644341801386,0.9811711193754689,1.0,4/25,9.00%,OAS2;TRIP12;RACGAP1;CCSAP
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.2253197427166943,0.7172065102143598,0.9061433447098977,0.9693683928241733,1.0,8/33,17.31%,AFAP1L2;NEU3;DGKD;GPER1;HIP1R;AKT1;AGT;NUP62
prerank,regulation of protein dephosphorylation (GO:0035304),-0.20693549161082983,-0.7159992115907741,0.9138755980861244,0.9830801172183364,1.0,9/37,20.32%,HTT;PPIA;CALM1;CDH5;TIPRL;PPP1R7;CNEP1R1;PPP6R2;TSC1
prerank,acidic amino acid transport (GO:0015800),-0.25645989399608293,-0.7152754060673395,0.8552915766738661,0.9831701568332404,1.0,7/17,20.56%,SLC1A6;GIPC1;SLC25A12;SLC25A18;SLC1A1;SLC6A1;SLC6A6
prerank,positive regulation of bone resorption (GO:0045780),-0.2890567469801193,-0.7148740482952228,0.8736616702355461,0.9829076874900748,1.0,6/11,33.49%,SPP1;DEF8;MC4R;DCSTAMP;SYK;TNFRSF11A
prerank,negative regulation of immune system process (GO:0002683),0.26970530868186793,0.7146711502576427,0.855595667870036,0.9717370685095078,1.0,5/16,24.23%,LYN;GPER1;SPINK5;SOX9;FADD
prerank,tRNA methylation (GO:0030488),-0.21291160015510602,-0.7145384947514939,0.8893905191873589,0.9825572164185113,1.0,10/34,23.24%,TRMO;TRMT13;TRMT61B;TRMT12;TRMT112;TRMT1;TRMT10C;LCMT2;GTPBP3;TRMT5
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.2209217565488695,0.7144847737862811,0.9065743944636678,0.9714628895270864,1.0,8/39,18.02%,ACSL4;SLC30A8;GPER1;TM7SF3;DRD2;LRRC8A;RASL10B;SELENOT
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.3114577743232999,0.7142681938296208,0.8420038535645472,0.9711925469886069,1.0,1/10,3.36%,PIH1D2
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.22366792915186537,-0.71419472095107,0.8984547461368654,0.982237809737801,1.0,6/29,12.96%,NT5C3B;EXOSC1;HBS1L;LSM1;EXOSC7;LSM3
prerank,DNA modification (GO:0006304),0.24971264572867669,0.7141642797592647,0.8674033149171271,0.9708237161301224,1.0,6/22,19.08%,MPG;TERF1;EXOSC5;NEIL2;NTHL1;ACD
prerank,protein K11-linked ubiquitination (GO:0070979),-0.22262126119937056,-0.7138524504693711,0.8886363636363637,0.981907314053571,1.0,5/27,11.50%,UBE2E2;UBE2W;PRKN;UBE2C;ANAPC10
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.2618136646900586,-0.7137113796065477,0.8552915766738661,0.9813636036868919,1.0,6/15,39.68%,RAI2;NR5A2;CELF4;RICTOR;CAMSAP3;UBR3
prerank,cellular response to hormone stimulus (GO:0032870),0.19357552179305898,0.7128918149767067,0.9503311258278145,0.9717491244377741,1.0,8/69,9.80%,BRD8;MEF2C;SRC;CTSS;ZFP36L1;GPER1;LHCGR;INPP5K
prerank,cellular response to gamma radiation (GO:0071480),0.2603843221043885,0.7128243353249947,0.8671454219030521,0.9713473274866276,1.0,7/17,29.19%,ATM;KDM1A;XRCC6;TP53;CRYAB;TSPYL5;TMEM109
prerank,cellular response to radiation (GO:0071478),0.21654559554193337,0.712710363261274,0.915807560137457,0.9709876076407463,1.0,12/40,23.86%,RHNO1;RHOB;SPIDR;TNKS1BP1;RAD1;BLM;MAPK14;ECT2;RAD9A;GPR52;NSMCE3;TP53
prerank,histone mRNA catabolic process (GO:0071044),0.27243323435395445,0.7121518574761042,0.8477443609022557,0.9711545775951923,1.0,2/15,3.90%,SSB;ATM
prerank,negative regulation of DNA replication (GO:0008156),0.2765404076683444,0.7121446213984253,0.8478664192949907,0.970679022843168,1.0,3/13,14.62%,RAD17;TERF1;TSPYL2
prerank,pyroptosis (GO:0070269),0.26966294194638696,0.7121328548921575,0.8623188405797102,0.9702156105930516,1.0,3/15,16.27%,CASP1;DHX9;AIM2
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.22983712421844588,-0.711874958779027,0.8787878787878788,0.9826048258351635,1.0,8/23,25.08%,HERC4;BTRC;GPC3;GPR161;GLI3;PTCH2;MEGF8;RACK1
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.21493297526175248,0.7115511836145967,0.9094076655052264,0.9703756120392181,1.0,14/40,26.30%,CDK9;PRKCD;UBE2V2;PARG;ABL1;ARMT1;FXR2;MAPT;RFWD3;KMT5A;WRNIP1;WDR76;RADX;IER3
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.2717279265697958,-0.7111771064567414,0.8396793587174348,0.9826514028346897,1.0,6/13,22.62%,LATS1;PKD2;NFKBIA;PKD1;GET4;FLNA
prerank,regulation of mitotic nuclear division (GO:0007088),0.2011138754115384,0.7109931487003501,0.9292035398230089,0.9705258220124896,1.0,12/55,22.40%,LRP5;PDGFB;EDN3;NME6;ANAPC15;PDGFRB;PIN1;AURKA;NUP62;RCC1;IL1A;KIF20B
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.21290840656439708,-0.7107950937168508,0.9049881235154394,0.9823499774902437,1.0,13/31,29.11%,SYT1;SYT10;CBARP;ADRA2A;SYT3;TRPV6;CACNA1G;DOC2B;SYT5;REST;DOC2A;SYT8;CLTRN
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.2634061338391788,-0.7107101080846211,0.85,0.9817499884228631,1.0,7/15,27.96%,ATF2;EME1;HUS1;MRE11;TIPIN;RAD9B;EME2
prerank,cellular response to nutrient levels (GO:0031669),0.19869574590441375,0.7104450362559895,0.9459016393442623,0.9706069600372138,1.0,11/62,16.79%,ATG14;FLCN;EIF4G1;RPTOR;EHMT2;MTOR;PDK2;FADS1;RRAGA;ULK1;CARTPT
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.307906096527367,0.7103064888289463,0.8539741219963032,0.970283288793767,1.0,2/10,14.18%,WHRN;SOD1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.21561162316500648,-0.7100236708518377,0.9184149184149184,0.9817639458945541,1.0,10/32,23.99%,CCT2;MAPKAPK5;AURKB;TNKS2;PRKCQ;XRCC5;TCP1;MAPK1;CTNNB1;MAPK15
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.2823560126489244,0.709820519195623,0.8299065420560747,0.9703487711265294,1.0,3/13,12.38%,TBL3;RCL1;NOP14
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.26396415645128934,0.7096011362513609,0.8551236749116607,0.9701227060782078,1.0,8/19,24.23%,PRKACA;TRPM2;SELP;STIMATE;PTPRJ;ADGRL1;DMTN;PTPRC
prerank,vasculature development (GO:0001944),0.26323316453613027,0.7095776966809022,0.8582230623818525,0.9696733004060775,1.0,5/16,22.36%,NOTCH4;PDGFRB;ACVR2B;ERRFI1;PIK3CA
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.2561905388047435,0.7091367786625801,0.875,0.96965658124188,1.0,6/18,22.40%,CYRIB;PTK2B;LLGL1;ROCK2;KRIT1;KIF20B
prerank,spliceosomal complex assembly (GO:0000245),0.20583433063412818,0.7089235639157658,0.93929173693086,0.9694039026548921,1.0,10/46,21.52%,NCBP1;SF3B1;CELF2;SRSF5;SMN1;LUC7L3;SF3A1;LUC7L;SRSF9;DDX39B
prerank,regulation of small molecule metabolic process (GO:0062012),-0.22066573807327833,-0.7086401001546236,0.9179954441913439,0.9824858000312809,1.0,11/28,25.74%,APOE;PRKN;SIRT1;FOXK1;NR1H4;PDK3;PDK4;ABCB11;EPHX2;PPARA;RORC
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.27189583090682357,-0.7085546174749624,0.8445378151260504,0.9818863045865412,1.0,4/14,16.28%,AK3;AK4;ME1;NME2
prerank,meiosis I (GO:0007127),0.24324236891913625,0.7084623229938855,0.875222816399287,0.9693928876754848,1.0,3/23,12.14%,FOXJ2;ZSCAN21;HSF2BP
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.2814266103877024,0.7074034827310253,0.8264299802761341,0.9700063284533599,1.0,4/12,14.70%,MIA3;FUT7;WNK1;AKT1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.19203243888422084,0.7071561682663544,0.9519071310116086,0.969788159985159,1.0,25/73,28.89%,DNMT3A;POLR2H;MTA1;SF3B1;SMARCA5;BAZ1B;EZH2;HDAC5;EED;POLR2E;POLR1C;EPC1;TBP;TASOR;DEK;POLR1E;POLR1G;WBP2;HDAC6;TFAP2C;MYO1C;POLR1A;SUZ12;GLMN;SPI1
prerank,mitochondrial membrane organization (GO:0007006),0.22342255012192686,0.7068975332067007,0.9353146853146853,0.9695863432637413,1.0,14/32,27.96%,MICOS13;DNAJC11;TIMM50;TMEM11;MTX1;MAIP1;PMAIP1;BCL2L1;OPA1;MFN2;CHCHD6;SAMM50;MICOS10;SLC25A5
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.2952551945569478,0.7056557140036624,0.8406909788867563,0.970394869084541,1.0,2/11,14.70%,QDPR;AKT1
prerank,protein lipidation (GO:0006497),-0.18592823151177904,-0.7050751078210133,0.960880195599022,0.9847312005976568,1.0,15/59,20.80%,DPM2;ZDHHC21;ZDHHC16;ZDHHC17;PIGW;ATG7;ZDHHC23;ZDHHC15;UGCG;ZDHHC18;SELENOK;PIGP;PIGC;PGAP4;PIGA
prerank,nucleosome organization (GO:0034728),0.20147871138972948,0.704872835916979,0.93717277486911,0.970705839260994,1.0,16/55,24.07%,SART3;RNF8;SRCAP;SMARCA5;SMARCD3;SETD2;SPTY2D1;HMGB2;ARID1A;PRDM9;CHAF1B;KAT6B;LIN54;SMARCA4;SOX9;NAA60
prerank,base-excision repair (GO:0006284),0.20541259190501374,0.7042722216520438,0.9382303839732888,0.9708800373943263,1.0,10/48,18.28%,PCNA;RFC2;MPG;LIG1;POLD2;PARG;PRMT6;NEIL2;RFC1;NTHL1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.23460699626287693,-0.703851948218754,0.8744493392070485,0.9852870040415302,1.0,5/22,13.76%,UTP20;NOP9;ERI1;EXOSC7;ABT1
prerank,GPI anchor metabolic process (GO:0006505),0.23336103232226207,0.7036544355716927,0.9052823315118397,0.9710399720669088,1.0,4/26,11.91%,PIGV;PGAP2;DPM3;PIGO
prerank,cellular polysaccharide catabolic process (GO:0044247),0.2645231906163478,0.7030742633257286,0.8657844990548205,0.9711091962082163,1.0,7/16,21.15%,PYGB;PHKB;AGL;PHKG2;PHKA2;MGAM;GAA
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.2982680462481386,-0.7029690520253323,0.834070796460177,0.9854904097352342,1.0,6/10,37.45%,DROSHA;TERT;AGO2;TARBP2;PRKRA;MRPL44
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.25976191283089833,0.7026450516419741,0.8556338028169014,0.9710551586095423,1.0,3/17,13.20%,PRKACA;SLC8A1;GJA1
prerank,positive regulation of cellular protein localization (GO:1903829),0.1901129592094938,0.7023106208263511,0.9554455445544554,0.9709478995007372,1.0,19/69,23.52%,TMEM35A;NUMA1;LAMTOR5;GNL3L;STX4;CROCC;ENTR1;AKT1;SLC5A3;DTX3L;NUP62;EIF2AK3;MARK4;SYT11;MAPT;CENPQ;PARK7;TGFB1;TYROBP
prerank,T cell mediated immunity (GO:0002456),0.27869080108954364,0.702175766530531,0.8378378378378378,0.9706222261966723,1.0,1/13,0.74%,CADM1
prerank,regulation of rRNA processing (GO:2000232),0.26105531647022046,0.7020372249272764,0.8732142857142857,0.9702818077057784,1.0,4/16,20.90%,BUD23;USP36;NUDT16;SHQ1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.19448038293437167,0.7019994278296424,0.9425287356321839,0.969849882175088,1.0,17/59,24.06%,CSF1R;MOV10;JUN;MED4;MED10;MED25;MITF;TNRC6C;TNRC6B;CDK8;MED7;TWIST1;MED12;MED20;AGO1;TP53;SOX9
prerank,response to lipid (GO:0033993),0.1789015949938779,0.7018573643845054,0.9818731117824774,0.9695161911563415,1.0,12/105,9.73%,PAQR7;LGALS9;PPARD;TLR4;OTUD5;SLPI;SELE;NOS2;SELP;TAB2;ACER2;RXRB
prerank,sodium ion export across plasma membrane (GO:0036376),-0.26677570325704875,-0.7010113448659671,0.8623024830699775,0.9867725538737394,1.0,2/13,11.52%,ATP1B3;ATP1A1
prerank,glycoprotein catabolic process (GO:0006516),-0.24633884857609414,-0.7009334121650984,0.8719101123595505,0.9861661022982778,1.0,8/17,37.85%,MMP12;MANBA;OGA;ADAMTS12;ADAMTS9;FBXO27;FBXO44;CTSL
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.23226840259462636,0.7002218207392095,0.9133448873483535,0.9706272535344073,1.0,11/26,31.61%,MLXIPL;BRCA1;CEACAM1;WDTC1;NR1H2;ADIPOR1;MID1IP1;ERLIN2;ACADVL;PRKAB2;NR1H3
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.2455633307228401,0.6992831088245168,0.8916349809885932,0.9710642306584117,1.0,4/20,15.28%,GPER1;BRCA1;CEACAM1;WDTC1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.23352301674463305,0.698369829026047,0.9019264448336253,0.971519314897064,1.0,4/26,9.63%,GPS2;FLOT2;GPR108;APPL1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.24835847246740123,-0.6982866330352469,0.8715203426124197,0.9880475872111476,1.0,4/16,13.94%,PARP14;PTPN2;PPP2R1A;INPP5F
prerank,isotype switching (GO:0045190),-0.2915623904144307,-0.6980977255499791,0.8583877995642701,0.987546551676918,1.0,3/10,23.15%,LIG4;MSH6;MSH2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.23280342344892396,0.6976569817665228,0.8839285714285714,0.9717777087164496,1.0,2/25,4.12%,SLC7A5;PLCG2
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.2664919333695793,0.6970234868967817,0.8397790055248618,0.971902747938449,1.0,1/16,0.65%,DAGLB
prerank,peptidyl-lysine methylation (GO:0018022),-0.22074187144814747,-0.6969122539018767,0.909706546275395,0.9879839482805708,1.0,11/26,27.56%,SUV39H1;EEF1AKMT1;EEF1AKMT2;SMYD2;METTL21A;TRMT112;SUV39H2;EHMT1;METTL21C;EEF1AKMT3;ETFBKMT
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.29708436590622556,0.6966027900698843,0.8336594911937377,0.9718476132859436,1.0,4/10,24.68%,PRKCB;ARNT;ITGB3;HIF1A
prerank,cellular response to UV-A (GO:0071492),0.29124894395307543,0.6960463780297743,0.8595505617977528,0.9719110090890973,1.0,2/11,10.22%,MMP2;PPID
prerank,response to interferon-alpha (GO:0035455),-0.2547059388156646,-0.6956515180127517,0.8730512249443207,0.988488483080207,1.0,6/16,25.27%,IFITM3;IFITM2;IFITM1;BST2;KLHL20;ADAR
prerank,cardiac myofibril assembly (GO:0055003),0.26716172951465467,0.6956457713975273,0.8846153846153846,0.9718404344993233,1.0,4/15,19.56%,MEF2A;PDGFRB;PROX1;NEB
prerank,female gamete generation (GO:0007292),0.2280925702757574,0.6953881719052188,0.9114139693356048,0.9715996270521873,1.0,9/29,28.21%,KMT2D;NANOS2;FSHR;DIAPH2;PRDM9;NANOS1;PARN;HORMAD1;MDK
prerank,regulation of blood circulation (GO:1903522),0.2205924229622397,0.6951321796959425,0.9101899827288429,0.9713700350269423,1.0,4/34,7.73%,AGER;FXYD1;CELF2;KCNG2
prerank,plasma membrane tubulation (GO:0097320),0.27769348542527406,0.6950103793488513,0.8576576576576577,0.9710159322668405,1.0,1/13,1.36%,BIN2
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.23894448344089872,-0.6949310867471457,0.9022222222222223,0.9884580763123471,1.0,3/18,10.67%,SLC45A3;TENM4;OPALIN
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.261482628423896,-0.694761221954011,0.8696581196581197,0.9879259988297276,1.0,4/14,21.94%,AK3;AK4;NME2;DCTPP1
prerank,regulation of cellular respiration (GO:0043457),-0.2469083746682999,-0.6940493572501717,0.8601895734597157,0.9879067361524743,1.0,3/17,14.09%,TRAP1;PRDM16;CBFA2T3
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.2581971554812979,0.6938029627495906,0.878682842287695,0.9716899758752171,1.0,9/17,33.16%,MBTPS1;MBTPS2;SOD1;SCAP;FGF1;ERLIN2;LPCAT3;ABCG1;SEC14L2
prerank,body fluid secretion (GO:0007589),-0.25940667073494156,-0.6935870156097529,0.8705882352941177,0.9876420097145384,1.0,3/15,16.61%,ERBB4;ZBTB7B;APLN
prerank,carbohydrate transport (GO:0008643),-0.2837943805774903,-0.6934411249810387,0.8584070796460177,0.9870995777330873,1.0,5/11,29.37%,AQP11;AQP1;SLC2A2;SLC50A1;SLC5A1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.2706234629884745,0.6927761068880641,0.8468634686346863,0.9721839246446087,1.0,6/13,31.04%,YAE1;MMS19;LTO1;ISCA1;CIAO2B;BOLA2
prerank,response to estradiol (GO:0032355),-0.21379917761580636,-0.6913020526456062,0.9405940594059405,0.9883728066002511,1.0,10/31,23.76%,EGFR;STRN3;GGT7;LCOR;CRHBP;SFRP1;SOCS2;WNT8B;CTNNB1;ANXA1
prerank,negative regulation of mitochondrion organization (GO:0010823),0.22089033729013338,0.69121317426276,0.9261862917398945,0.9731721165541077,1.0,13/33,29.29%,CLU;FLCN;PINK1;AKT1;MAPT;ACAA2;BCL2L1;OPA1;SLC35F6;FZD9;SLC25A5;TMEM14A;OMA1
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.28657115763493113,-0.690664844296887,0.8835164835164835,0.9882751875331099,1.0,1/10,1.21%,CCR2
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.2641383377948164,0.6906225412130179,0.9014598540145985,0.9732645042728498,1.0,4/15,16.08%,WHRN;HPN;TMEM120A;COL11A1
prerank,aspartate family amino acid metabolic process (GO:0009066),0.2543872447814202,0.690231353118955,0.8932584269662921,0.9731577118641576,1.0,5/18,15.98%,NAALAD2;NIT2;GADL1;MTHFD1;ASPG
prerank,response to glucagon (GO:0033762),0.2548062723115555,0.6898867769476367,0.9001883239171374,0.973032118203966,1.0,4/19,11.91%,ADCY9;PRKACA;ADCY4;ADCY6
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.20263643085772753,0.6894345032736368,0.9492119089316988,0.9729603484635361,1.0,4/45,12.55%,TGFBR1;LEFTY1;INHA;ENG
prerank,organic acid transport (GO:0015849),0.17650201673297738,0.6886631443416334,0.9801980198019802,0.973212198905124,1.0,14/94,17.80%,SLCO2B1;SLC7A8;SLC36A1;PPARD;SLC25A45;SLC22A6;SLC27A4;CEACAM1;SLC25A11;SLC38A1;SLC25A14;SLC23A2;SLC23A1;SLC19A1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.28122935638641794,-0.6884678927514268,0.8463157894736842,0.9895551721926054,1.0,5/11,32.03%,PRKN;FBXO7;REST;RACK1;NR4A3
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.20609983075205235,-0.6880900009155311,0.9439252336448598,0.9892008971481697,1.0,6/29,13.66%,PTPN2;UBE2K;TTLL12;RNASEL;SAMHD1;OAS3
prerank,regulation of microtubule-based movement (GO:0060632),0.2874344752758074,0.6865582373301827,0.8517179023508138,0.974648096585406,1.0,2/11,6.09%,DRC1;DYNLT2B
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.2423020305959036,0.6860766969698274,0.9107468123861566,0.9746019670740221,1.0,7/21,28.55%,HK2;RPE;SHPK;HK3;TKT;TALDO1;PGM2
prerank,negative regulation of wound healing (GO:0061045),-0.217583824570051,-0.6860725855613599,0.9402298850574713,0.9903092691340036,1.0,4/28,10.21%,APOE;ALOX5;CASK;CD109
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.2295022471999631,-0.6857896421106368,0.899581589958159,0.9898730852617624,1.0,6/21,26.75%,RPS7;BTRC;UBE2C;FZR1;PLK1;RPL23
prerank,Golgi ribbon formation (GO:0090161),0.27353424968674106,0.6845534453131672,0.8696461824953445,0.9754755019307348,1.0,6/13,33.39%,OPTN;MYO18A;STX16;STX6;VTI1A;TRIP11
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.2544928176625388,-0.6845029071924735,0.8786610878661087,0.9896892123874171,1.0,4/15,18.94%,AP3M1;AP3S2;DTNBP1;BLOC1S3
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.2544928176625388,-0.6845029071924735,0.8786610878661087,0.9896892123874171,1.0,4/15,18.94%,AP3M1;AP3S2;DTNBP1;BLOC1S3
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.2881166894621199,0.6844879023676067,0.8534798534798534,0.9750659110946571,1.0,3/10,20.61%,NUMA1;NCOA3;PRKCH
prerank,negative regulation of lipid storage (GO:0010888),-0.23456424010445726,-0.6844499090553017,0.9149888143176734,0.9890431174812461,1.0,4/19,11.66%,PPARG;PTPN2;NFKBIA;OSBPL8
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.21240687033845412,-0.6843393111928423,0.9326923076923077,0.9884676171344297,1.0,4/29,9.13%,ACSL3;ELOVL7;HACD1;ELOVL5
prerank,hexose biosynthetic process (GO:0019319),-0.19384340284736173,-0.6838235213483088,0.9689737470167065,0.9882226070103804,1.0,7/42,15.15%,PFKFB1;SLC37A4;PER2;GPI;RBP4;ALDOC;SLC25A12
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.2302147505878881,-0.6834835530332146,0.91324200913242,0.9878301048985504,1.0,12/21,39.03%,YWHAE;GSK3B;TIPRL;BOD1;PPP1R16B;PPP1R15A;ARPP19;YWHAB;PPP1R8;FKBP1A;PPP1R11;MFHAS1
prerank,sarcomere organization (GO:0045214),0.22507972272811058,0.6834809243531136,0.9202127659574468,0.9754852115619499,1.0,1/27,1.09%,CAPN3
prerank,monocyte chemotaxis (GO:0002548),0.21923832330682197,0.6829152877636102,0.9129692832764505,0.9755170679415953,1.0,3/32,9.01%,CCL3;PDGFB;IL6R
prerank,regulation of cellular component biogenesis (GO:0044087),0.20633224490289778,0.6819612650105775,0.934010152284264,0.9758500553481646,1.0,9/39,18.02%,SNCAIP;GFAP;TJP1;ANKRA2;PINK1;PTPN11;SPTY2D1;AGT;ROCK2
prerank,regulation of gastrulation (GO:0010470),-0.25672052064037637,-0.6818871933693215,0.8774193548387097,0.9885417982064774,1.0,6/14,33.55%,TENM4;SCX;DAG1;RACK1;FOXA2;PHLDB2
prerank,ERAD pathway (GO:0036503),0.17936955398999915,0.6815791432033385,0.9868204283360791,0.9757113934388687,1.0,26/83,29.71%,BAG6;SEL1L;DNAJB9;ERLEC1;USP19;OS9;RNF103;UFD1;AUP1;EDEM1;UBE4A;ANKZF1;MAN1B1;STUB1;RNF121;SYVN1;NPLOC4;DNAJB14;UBE2G2;FBXO2;ECPAS;SGTA;RHBDD2;ERLIN2;FBXO17;RNF5
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.2662183133374725,0.6813464488127232,0.8645640074211502,0.9754550892630346,1.0,2/14,9.50%,LOXL3;LIMS1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.2592861401240329,0.681302790159996,0.8868613138686131,0.9750204744450787,1.0,4/16,19.13%,GATA2;IL12B;PDCD10;THBS1
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.27351376711053776,-0.6808827987828531,0.8742138364779874,0.9880298707375512,1.0,2/11,8.81%,AGO4;TNRC6A
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.27351376711053776,-0.6808827987828531,0.8742138364779874,0.9880298707375512,1.0,2/11,8.81%,AGO4;TNRC6A
prerank,regulation of viral life cycle (GO:1903900),-0.22324855720188716,-0.6801562333085592,0.9118329466357309,0.987922188919693,1.0,2/21,4.69%,HS3ST5;PPIA
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.1744574686682352,-0.680053679717263,0.9732360097323601,0.9873310692439418,1.0,24/68,28.23%,SLC25A19;ALDH1L1;HLCS;ACP5;SLC46A1;SHMT1;ABCD4;ABCC1;TCN2;BTD;SLC5A6;MTHFD1L;SLC19A2;MTHFD2L;FPGS;FOLR2;CUBN;MTHFD2;SLC25A32;TPK1;MMADHC;DHFR;MCCC1;SLC2A3
prerank,histone H4 deacetylation (GO:0070933),0.2880295400735653,0.677912843523821,0.8831417624521073,0.9774324232276371,1.0,1/10,2.55%,SIRT2
prerank,response to amino acid (GO:0043200),0.21873314154940363,0.6776788501506875,0.9445506692160612,0.9771445309699806,1.0,6/31,14.80%,LAMTOR2;RPTOR;MTOR;LAMTOR5;TMBIM6;RRAGA
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.27803906962331804,-0.6774547227435004,0.87527352297593,0.9888203370704856,1.0,2/11,7.30%,SP100;HIPK2
prerank,apoptotic DNA fragmentation (GO:0006309),0.2522578105455483,0.6770957503591595,0.8781818181818182,0.9771581974310682,1.0,5/16,32.88%,DNASE2;HMGB2;EXOG;DFFB;KPNA1
prerank,microtubule anchoring at centrosome (GO:0034454),-0.28610782855950306,-0.6763784586163587,0.8663793103448276,0.9890389005918013,1.0,4/10,32.81%,CEP19;CCDC120;CCDC68;BBS4
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.2943346817843057,0.6763602977282565,0.8814814814814815,0.9773219260794133,1.0,6/10,34.97%,PDK2;ZNF692;SIRT7;OGT;USP7;SELENOS
prerank,histone deubiquitination (GO:0016578),0.2489976412320825,0.6757763253554514,0.9023941068139963,0.9773221717304923,1.0,6/18,27.64%,EPOP;USP36;ATXN7;TAF10;ATXN7L3;ENY2
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.2717022386596676,0.6757254823217393,0.8717472118959108,0.9768923505399069,1.0,4/13,26.16%,TMEM35A;STX4;TYROBP;SNX33
prerank,response to interferon-beta (GO:0035456),-0.22176199283578363,-0.6757113552463393,0.9440860215053763,0.9888985175547538,1.0,6/22,16.09%,IFITM3;IRGM;UBE2K;IFITM2;IKBKE;IFITM1
prerank,maturation of SSU-rRNA (GO:0030490),0.21322699587845048,0.6755142335715021,0.9300341296928327,0.9766054063349208,1.0,6/34,18.20%,UTP6;WDR46;NOP14;RPS8;MRPS11;WDR3
prerank,termination of RNA polymerase I transcription (GO:0006363),0.21443455845925888,0.6733372760124264,0.9336734693877551,0.9779531005854895,1.0,9/30,23.17%,POLR2H;GTF2H2;ERCC2;POLR2E;POLR1C;UBTF;TBP;POLR1E;POLR1G
prerank,mitochondrion transport along microtubule (GO:0047497),-0.2554276642067231,-0.6730105805477647,0.8993963782696177,0.9903520252025685,1.0,2/13,10.07%,SYBU;RHOT2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.22917739715777352,0.6721721448366367,0.9202226345083488,0.9784179521701561,1.0,9/24,22.68%,CLU;USP25;TMBIM6;NR1H2;SYVN1;BCL2L1;TXNDC12;OPA1;PARK7
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.2667627675980572,0.6719528204627749,0.8930581613508443,0.9781119844629298,1.0,2/14,9.62%,VEGFB;PIK3CD
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.2700862544152558,0.6718931705810067,0.8962818003913894,0.9776882252158162,1.0,2/13,7.25%,NFE2L2;MET
prerank,apical protein localization (GO:0045176),-0.28146663728629395,-0.6717697172655236,0.8734177215189873,0.9906270274301113,1.0,3/10,13.60%,ACTB;MAL;JAM3
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.2299840283404041,0.6717066230019809,0.9051094890510949,0.9773740464596671,1.0,5/21,22.07%,JUN;MED4;MITF;TWIST1;MED12
prerank,alcohol catabolic process (GO:0046164),-0.2777704806579521,-0.6709264966766003,0.888641425389755,0.9905766390632047,1.0,3/10,16.53%,APOE;SCARF1;SRD5A3
prerank,mRNA methylation (GO:0080009),0.2561684279753022,0.6704601517465253,0.9168207024029574,0.9778953060524213,1.0,5/15,24.28%,TRMT6;METTL14;TRMT61A;PCIF1;METTL8
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.23496592348415846,-0.6701424735352856,0.911062906724512,0.990472406813308,1.0,7/18,25.35%,CDC73;SFRP1;B4GALT7;GSTP1;EMD;PARP10;NLRC3
prerank,regulation of extracellular matrix organization (GO:1903053),0.2519343722462846,0.6701232275630843,0.8935361216730038,0.9776953128423206,1.0,5/15,20.41%,LRP1;RUNX1;DDR2;AGT;FGFR4
prerank,histone lysine methylation (GO:0034968),0.21057921471978375,0.6698475229469083,0.9305816135084428,0.9774464026734394,1.0,16/33,30.71%,KMT2D;CXXC1;EHMT2;EZH2;PRDM9;DPY30;SETD3;KMT2B;SMYD1;SETDB1;WDR5;KMT2A;PAXIP1;DYDC2;SETD6;DOT1L
prerank,regulation of autophagosome assembly (GO:2000785),-0.20201423835243332,-0.6679414030059486,0.9590361445783132,0.9915259932321012,1.0,9/33,23.97%,LRRK2;RAB1B;SCFD1;SMCR8;UBQLN2;RAB5A;MTMR3;NPRL3;SEC22B
prerank,chromatin disassembly (GO:0031498),-0.24926680085697872,-0.6678558091710876,0.906054279749478,0.9902307694296054,1.0,2/14,8.19%,SMARCE1;NFE2
prerank,nucleosome disassembly (GO:0006337),-0.24926680085697872,-0.6678558091710876,0.906054279749478,0.9902307694296054,1.0,2/14,8.19%,SMARCE1;NFE2
prerank,cellular respiration (GO:0045333),-0.18761645452998282,-0.6655333921469218,0.955456570155902,0.991315148603612,1.0,11/41,21.25%,SDHC;NDUFS1;SDHA;SDHAF4;ETFRF1;MTFR2;NDUFS7;UQCRH;CYCS;MTFR1;COQ10B
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.23066230829665765,-0.6652542883109596,0.9102564102564102,0.9908621845261092,1.0,6/18,24.66%,KLF9;NR3C1;AQP1;ANXA1;REST;ZFP36
prerank,mRNA catabolic process (GO:0006402),0.19442479765888102,0.6652256638866477,0.9404553415061296,0.9805138702002639,1.0,8/44,16.57%,DDX5;DXO;DIS3L2;ZFP36L2;NANOS2;EXOSC10;LSM5;RIDA
prerank,protein localization to chromosome (GO:0034502),-0.20007838383657928,-0.6651249411396087,0.9375,0.9902847734174585,1.0,18/34,39.51%,MCM9;TNKS2;CTCF;SLF1;PARP3;XRCC5;MSH2;FAM47E;PLK1;BOD1;MCM8;ATR;TINF2;TERF2IP;ESR1;PINX1;HASPIN;CENPA
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.28121823939552026,-0.6644738774724682,0.8881431767337807,0.9901099134311293,1.0,2/10,7.30%,SP100;HIPK2
prerank,regulation of microtubule-based process (GO:0032886),-0.19512579350616593,-0.664394473472463,0.9671361502347418,0.9894984893212644,1.0,3/36,5.38%,BICD1;TPPP;GSK3B
prerank,carnitine shuttle (GO:0006853),-0.26565568793104455,-0.6638970585415729,0.8997821350762527,0.9891793355399379,1.0,2/11,14.53%,PRKAG2;CPT1B
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.20432666198336158,-0.6638313471447931,0.9379157427937915,0.9885576202328892,1.0,9/31,21.10%,NT5C3B;EXOSC1;HBS1L;LSM1;EXOSC7;LSM3;PATL1;POLR2G;EDC4
prerank,cellular response to sterol (GO:0036315),0.2664361523717391,0.6634568538654384,0.8710865561694291,0.9813760662382317,1.0,4/13,24.65%,GRAMD1A;SMO;PTCH1;GPLD1
prerank,mRNA modification (GO:0016556),0.22650887515593088,0.6629450467749731,0.9477234401349073,0.9813032743785638,1.0,8/22,29.56%,TRMT6;RPUSD2;METTL14;TRMT61A;PCIF1;METTL8;PUS7;TRUB1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.24316196857059097,0.6627138434316029,0.8985765124555161,0.9810227314102942,1.0,3/18,14.87%,MAP3K3;GATA2;CIB1
prerank,negative regulation of transposition (GO:0010529),-0.24099167057719678,-0.6613382698738921,0.9199134199134199,0.9897123743297027,1.0,8/16,29.59%,TUT4;SPOCD1;TDRD9;MYBL1;PIWIL2;SMYD5;AICDA;PIWIL4
prerank,pteridine-containing compound metabolic process (GO:0042558),0.2643205805112665,0.6602122963122458,0.9143389199255121,0.982413046018399,1.0,1/13,1.59%,QDPR
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.265233804344986,-0.6591109102618159,0.9019607843137255,0.9906673168808113,1.0,4/11,18.07%,LILRB1;AHR;KLRD1;FOXP3
prerank,regulation of catabolic process (GO:0009894),0.23919896089029274,0.6581738290331451,0.9219330855018587,0.983406379427659,1.0,6/18,21.79%,CHEK2;HPGD;ZDHHC7;CENATAC;HGS;FURIN
prerank,regulation of inclusion body assembly (GO:0090083),0.27755288253424815,0.6578204685498624,0.8863198458574181,0.9831746703895844,1.0,1/11,2.51%,SNCAIP
prerank,NAD biosynthetic process (GO:0009435),0.2352719507599546,0.6573959298896787,0.9151943462897526,0.983003843734488,1.0,20/20,76.50%,NAXD;NAXE;NADSYN1;PARP16;NMNAT1;NAPRT;PTGS2;SLC22A13;NNMT;SLC5A8;QPRT;KYNU;NAMPT;PTGIS;HAAO;NMNAT3;NUDT12;NMNAT2;PARP9;PARP10
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.192135209756194,0.6569164919544005,0.9621621621621622,0.9828747425404514,1.0,13/50,22.68%,RPS6KA1;CSNK2A1;SRC;RFFL;DPEP1;LAMTOR5;PAX2;AKT1;XIAP;THBS1;DDX3X;RNF34;PARK7
prerank,cellular response to increased oxygen levels (GO:0036295),-0.26214542895509646,-0.6568949250313783,0.8971553610503282,0.9916014142348273,1.0,4/11,22.88%,ATG7;ATP6V1A;FOXO1;ATP6V0D1
prerank,DNA geometric change (GO:0032392),-0.20785794359684484,-0.6565350447232032,0.9350961538461539,0.9911725090121594,1.0,3/24,6.23%,MCM9;ZRANB3;ASCC3
prerank,protein kinase A signaling (GO:0010737),0.2699384960281219,0.6553657757657804,0.897003745318352,0.9834998992065868,1.0,1/12,2.90%,PRKACA
prerank,negative regulation of RNA metabolic process (GO:0051253),0.2384219703300154,0.6551400747878444,0.9209039548022598,0.9831997051719383,1.0,10/18,32.37%,TMBIM6;NUDT16;SHQ1;ZC3H12A;TGFB1;PTBP3;RPS26;RPS13;KAT2B;NRDE2
prerank,regulation of oxidoreductase activity (GO:0051341),-0.24767989234565857,-0.6549197077455302,0.920704845814978,0.9915993308044803,1.0,3/13,16.11%,ATP7A;ECSIT;HP
prerank,stress granule assembly (GO:0034063),0.23610359506678388,0.6545539957081911,0.9257142857142857,0.9831385660498461,1.0,3/20,10.49%,ATXN2L;EIF2S1;G3BP1
prerank,negative regulation of T cell proliferation (GO:0042130),0.21628894882139935,0.6539471878760943,0.9447513812154696,0.9831106723673082,1.0,4/28,8.20%,LGALS9;TNFRSF21;CD86;PDCD1LG2
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.22853071253478127,-0.6535698643737725,0.9259259259259259,0.9918493285811789,1.0,10/18,34.02%,BAK1;BCL2;SPG7;SLC25A31;PPIF;BNIP3;ALKBH7;HEBP2;CAMK2A;SLC25A4
prerank,membrane lipid catabolic process (GO:0046466),-0.2712786377684269,-0.6533766286473907,0.8981288981288982,0.9912917924073814,1.0,4/10,18.77%,SGPL1;ENPP2;NAGA;FUCA1
prerank,regulation of steroid metabolic process (GO:0019218),0.22740541012892365,0.6532828928713058,0.9395604395604396,0.9831101230209308,1.0,5/23,18.34%,PANK2;ASAH1;TTC39B;FMO5;STUB1
prerank,DNA packaging (GO:0006323),-0.2397337179344477,-0.6527950744390302,0.9287305122494433,0.9910064910638805,1.0,4/16,20.54%,KAT6A;BANF1;HAT1;NOC2L
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.21917657191629247,-0.6518364417011533,0.9347826086956522,0.9903125121367711,1.0,5/22,17.76%,ZDHHC21;ZDHHC23;ZDHHC15;ZDHHC18;ZDHHC24
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.21917657191629247,-0.6518364417011533,0.9347826086956522,0.9903125121367711,1.0,5/22,17.76%,ZDHHC21;ZDHHC23;ZDHHC15;ZDHHC18;ZDHHC24
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.2699030256197782,-0.6516461312609487,0.9038901601830663,0.9897607568741275,1.0,4/11,20.53%,ASF1A;H3-3A;NASP;HAT1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.2570633461490176,0.6505095093442093,0.9171270718232044,0.9845499106194558,1.0,4/13,23.79%,BMF;PMAIP1;VDAC2;BCL2L11
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.24270713270669458,-0.6501376754849026,0.9135514018691588,0.9901036076886799,1.0,7/14,33.80%,COPS8;CARD10;CARD14;TNFSF15;IRAK1;TRAF2;MAP3K7
prerank,purine ribonucleotide transport (GO:0015868),0.24799234043553509,0.6498981101833511,0.9040590405904059,0.9845121285133354,1.0,5/16,19.92%,SLC25A42;LRRC8A;SLC17A9;SLC19A1;LRRC8D
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.26276973734813247,-0.6492399921386762,0.9141630901287554,0.9893544950742426,1.0,3/11,21.08%,CCT2;TCP1;MEPCE
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.26276973734813247,-0.6492399921386762,0.9141630901287554,0.9893544950742426,1.0,3/11,21.08%,CCT2;TCP1;MEPCE
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.2175127094594476,0.6488769391478832,0.9344827586206896,0.9847203812964409,1.0,7/25,23.86%,GPER1;BMF;PINK1;PYCARD;PMAIP1;BCL2L11;TP53
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.2293344283277199,0.6485973629496248,0.930783242258652,0.9844444618799782,1.0,10/21,30.18%,CNOT1;TNKS1BP1;CNOT3;PAN3;CNOT2;PNLDC1;SAMD4B;PARN;CNOT11;CNOT8
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.2044854019819346,-0.6480153480912745,0.9427312775330396,0.9894764983006503,1.0,5/25,16.40%,SOX11;PER2;NSD1;HEY2;NIBAN2
prerank,establishment of melanosome localization (GO:0032401),0.22858755998589764,0.6474428576098906,0.9385796545105566,0.9847328496743875,1.0,4/19,16.37%,MLPH;SHROOM2;BBS2;RAB27A
prerank,response to steroid hormone (GO:0048545),0.20622903090867392,0.6463334195475646,0.9553571428571429,0.9849796178006447,1.0,13/31,33.95%,PAQR7;UBE3A;THBS1;TFPI;TGFB1;CATSPER2;WBP2;AR;URI1;UBE2L3;NR1H3;ATP1A2;CATSPER3
prerank,embryonic axis specification (GO:0000578),0.2468850287585681,0.6459482802042691,0.9109090909090909,0.9847593944844432,1.0,7/15,36.76%,TASOR;PTCH1;FZD5;SMAD6;RIPPLY2;HOXD8;COBL
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.22552338577675043,0.6459068185883685,0.9294990723562152,0.9843226333730596,1.0,7/20,24.22%,INCA1;CDK5RAP1;LATS2;IPO7;CDKN1B;TFAP4;IPO5
prerank,protein-containing complex disassembly (GO:0032984),-0.17133120423388937,-0.6449759995241057,0.9875930521091811,0.990718475930803,1.0,6/54,7.79%,LRP6;SNX14;STX17;GSK3B;UVRAG;AXIN1
prerank,miRNA metabolic process (GO:0010586),0.2303435804517697,0.6447241750528019,0.9334532374100719,0.9846581375481734,1.0,6/20,25.83%,DIS3L2;DDX17;BCDIN3D;SND1;XPO5;PARN
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.2652378866735462,0.6413794675836446,0.9048507462686567,0.9862726665820081,1.0,5/11,25.92%,TERF1;CCT3;CCT8;CCT7;CCT5
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.25563609197251513,-0.6404385105292224,0.9084967320261438,0.9928825693969592,1.0,3/12,15.21%,PSAT1;SRR;SERINC5
prerank,regulation of exosomal secretion (GO:1903541),0.2334568036849018,0.6399608328149415,0.9306049822064056,0.9866768167074074,1.0,6/19,22.68%,SMPD3;CHMP2A;VPS4A;HGS;TSG101;PDCD6IP
prerank,regulation of aerobic respiration (GO:1903715),0.24290987089005367,0.6391532682955837,0.9015151515151515,0.9867172752724334,1.0,4/15,23.42%,COX7A2L;PINK1;UQCC2;ABCD1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.2307397381878828,0.6385404187127172,0.933206106870229,0.9866117611513912,1.0,3/19,13.72%,TPST2;SULT2A1;PAPSS1
prerank,mitochondrial fusion (GO:0008053),-0.22536576032107947,-0.638081866804812,0.9197530864197531,0.9936341749159213,1.0,3/18,9.46%,MIGA1;FIS1;MFF
prerank,rRNA pseudouridine synthesis (GO:0031118),0.27234133800295623,0.6374278052331525,0.8925318761384335,0.9867932320707562,1.0,2/10,16.23%,RPUSD2;NHP2
prerank,cellular macromolecule catabolic process (GO:0044265),-0.1740494579863214,-0.6371710422988928,0.9929078014184397,0.9934989744235155,1.0,9/49,15.98%,XRN2;PRKN;RNASE3;EXOSC7;RNASEH2C;MANBA;OGA;DENND3;RNASEH2B
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.2425991848728163,0.6367988883459675,0.9355992844364938,0.9867212034671448,1.0,4/15,22.08%,CLU;AKT1;BCL2L1;OPA1
prerank,homologous chromosome segregation (GO:0045143),-0.2188676860875116,-0.6367955955253526,0.9452054794520548,0.9930469825095215,1.0,8/20,37.19%,PTTG1;MEI4;IHO1;MEIKIN;SYCP1;TERB1;CENPC;SGO1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.2171258160415185,0.6364392515300756,0.9532374100719424,0.9864647821148008,1.0,7/24,24.68%,PRKCB;PTPN1;PDCD6;ARNT;HGS;ITGB3;HIF1A
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.18059077227792436,0.635229153101516,0.9770318021201413,0.986699781379641,1.0,17/52,25.83%,CNOT1;POLR2D;TNKS1BP1;DCPS;DCP1B;LSM5;CNOT3;EXOSC5;PAN3;DIS3;EXOSC8;LSM7;RC3H2;CNOT2;PNLDC1;SAMD4B;PARN
prerank,negative regulation of cell division (GO:0051782),-0.2547087618152251,-0.6348916167965905,0.906183368869936,0.9934917960905746,1.0,2/11,11.17%,AURKB;E2F7
prerank,regulation of sensory perception of pain (GO:0051930),0.26110734546265246,0.6322916536844035,0.9009345794392524,0.9879411255161422,1.0,3/11,22.89%,CCL3;VIP;TMEM100
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.23427040829367363,-0.631529844554675,0.9414316702819957,0.9947949410705281,1.0,8/15,32.42%,SULT2B1;NME2;BMP4;FOXC1;TRIM16;KDF1;MED1;VDR
prerank,mitotic cytokinetic process (GO:1902410),0.22283019594582892,0.6313121890802701,0.9382940108892922,0.9880292038149682,1.0,5/20,22.68%,KLHDC8B;CHMP1A;CHMP2A;VPS4A;PDCD6IP
prerank,megakaryocyte differentiation (GO:0030219),-0.2529452604563672,-0.6297669204307301,0.9183222958057395,0.9951158278759406,1.0,5/11,35.27%,KIT;THPO;ZFPM1;MED1;SH2B3
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.2461432118274244,0.6296464669861306,0.9322033898305084,0.9884888102925119,1.0,4/14,19.13%,SHISA2;SPRY2;GATA3;THBS1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.2156582509899639,-0.6294425721276395,0.9540229885057471,0.9946382624815929,1.0,2/20,7.46%,GSS;GGCT
prerank,organophosphate biosynthetic process (GO:0090407),0.19209691733561918,0.6293680024286858,0.9794520547945206,0.9881843428900658,1.0,12/37,25.39%,GK5;MOCS2;MBOAT1;FADS1;MOCS1;LPCAT1;IP6K1;PNPO;GNPAT;MOCS3;IPPK;TKT
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.2294085186898593,-0.6291830194939964,0.9573033707865168,0.9934354337426061,1.0,1/17,2.21%,IRS1
prerank,cellular response to interleukin-7 (GO:0098761),-0.2294085186898593,-0.6291830194939964,0.9573033707865168,0.9934354337426061,1.0,1/17,2.21%,IRS1
prerank,inner ear morphogenesis (GO:0042472),0.22030952880948954,0.6291481732036747,0.9515828677839852,0.9878439521695085,1.0,7/22,24.17%,CHD7;PAX2;ZIC1;HPN;FGFR2;SOX9;POU3F4
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.25614547673792715,0.6286062606574254,0.9097605893186004,0.9876732589842752,1.0,4/12,23.79%,PIK3R1;PTPN1;TMEM33;BCL2L11
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.2567377132832851,0.6273369960843104,0.9044834307992202,0.9879165677686476,1.0,3/12,17.04%,RAB1A;CDC14B;GORASP1
prerank,eosinophil migration (GO:0072677),-0.24103917573143901,-0.6270867545773214,0.9444444444444444,0.9932393325121317,1.0,6/14,35.59%,CX3CL1;CCL5;CCL7;CCL8;CCL4;SCG2
prerank,eosinophil chemotaxis (GO:0048245),-0.24103917573143901,-0.6270867545773214,0.9444444444444444,0.9932393325121317,1.0,6/14,35.59%,CX3CL1;CCL5;CCL7;CCL8;CCL4;SCG2
prerank,protein acetylation (GO:0006473),-0.1918597669064993,-0.626487125828187,0.9682203389830508,0.9928894842372356,1.0,8/30,22.57%,GTF2B;SIRT1;CLOCK;KAT6A;ESCO2;FOXO1;HAT1;ING4
prerank,T cell homeostasis (GO:0043029),0.27208661834173475,0.6255230793772193,0.9078947368421053,0.9884604836529086,1.0,4/10,24.23%,NCKAP1L;AKT1;PMAIP1;FADD
prerank,protein localization to centrosome (GO:0071539),0.23038526921342384,0.6231980837714622,0.9406307977736549,0.98923567535237,1.0,5/17,25.07%,NUDCD3;DCTN2;CSNK1D;HOOK3;CCDC14
prerank,actin filament network formation (GO:0051639),-0.25262816661814275,-0.6231386778492779,0.9362139917695473,0.9940094592906957,1.0,6/11,33.99%,CARMIL1;PLS1;FHOD3;PLS3;CARMIL2;ACTN1
prerank,aminoglycan metabolic process (GO:0006022),-0.2512553351744916,-0.6215641563974983,0.9436008676789588,0.9941232294020265,1.0,10/10,74.90%,B3GAT2;B4GALT7;CLN6;XYLT1;GAL3ST3;XYLT2;CHST9;B3GALT6;B3GAT3;B3GAT1
prerank,adenine nucleotide transport (GO:0051503),0.2330040938974927,0.6193657159521162,0.9368029739776952,0.9908043926464412,1.0,5/17,19.92%,SLC25A42;LRRC8A;SLC17A9;SLC19A1;LRRC8D
prerank,linoleic acid metabolic process (GO:0043651),-0.2228775271720052,-0.6192135204335589,0.9606986899563319,0.9946618583985211,1.0,5/17,22.70%,ALOX5;ELOVL5;GSTP1;ALOX15;ACSL1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.18361197000704899,-0.6186517893324075,0.9927007299270073,0.9942915567246636,1.0,10/35,23.99%,CCT2;MAPKAPK5;AURKB;TNKS2;PRKCQ;XRCC5;TCP1;MAPK1;CTNNB1;MAPK15
prerank,regulation of trophoblast cell migration (GO:1901163),0.24050753709263895,0.6185835767551703,0.9414990859232175,0.9907328516052955,1.0,5/14,28.55%,C1QBP;GJA1;ACVR1B;YTHDF3;CALR
prerank,early endosome to Golgi transport (GO:0034498),-0.24665129302762248,-0.6170661536790645,0.9330543933054394,0.9944489531226038,1.0,4/11,21.12%,RAB6A;LMAN1;SNX8;SNX2
prerank,estrogen metabolic process (GO:0008210),-0.2269368166073387,-0.6164909938679596,0.9370932754880694,0.9940569597419862,1.0,8/15,36.31%,HSD17B2;HSD17B11;HSD17B14;UGT1A1;UGT1A7;CYP19A1;HSD17B8;SULT1A1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.20303536840081685,0.6161133307608242,0.9614711033274956,0.991515036639976,1.0,5/25,19.58%,SORT1;LEPROT;LAPTM4B;CHMP1A;CHMP2A
prerank,protein-DNA complex disassembly (GO:0032986),-0.22057811138141456,-0.6155336572967931,0.9531914893617022,0.9938669102666607,1.0,2/16,8.19%,SMARCE1;NFE2
prerank,positive regulation of mRNA processing (GO:0050685),0.21580023396552644,0.6151238803216252,0.9431192660550459,0.9915634756306759,1.0,5/21,22.16%,NCBP1;TRA2B;TRA2A;RBMX;DAZAP1
prerank,ncRNA metabolic process (GO:0034660),-0.17557609772046173,-0.6142195380727978,0.9882903981264637,0.9938491014304577,1.0,11/37,29.59%,RAN;TUT4;DTD2;DROSHA;MEPCE;TDRD12;TDRD9;AGO2;PIWIL2;MOV10L1;PIWIL4
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.24395611787581628,0.6138191900902302,0.9410745233968805,0.9917460003908137,1.0,2/13,21.18%,NAXD;NAXE
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.1984137356070843,0.6133828216478837,0.9685863874345549,0.9915074087858475,1.0,10/29,27.61%,PPP6R3;TNKS1BP1;TERF1;NHP2;RFC1;ACD;SHQ1;TELO2;RPA1;RTEL1
prerank,cellular response to virus (GO:0098586),0.19717198368746267,0.6132210915714164,0.9693877551020408,0.9911196641685688,1.0,9/30,24.68%,LGALS9;MAPK14;POU2F2;IRF3;ZC3H12A;DDX3X;ARF1;CXCL10;HIF1A
prerank,positive regulation of transporter activity (GO:0032411),0.24675592196964818,0.6131065689088074,0.9273422562141491,0.9907049164859827,1.0,6/13,31.61%,KCTD7;STK39;WNK3;KMT2A;PDZK1;NR1H3
prerank,vitamin D metabolic process (GO:0042359),0.24339255446041808,0.6123420843034368,0.9446428571428571,0.9906230983718317,1.0,13/13,75.68%,LGMN;CYP2R1;GC;PIAS4;CYP1A1;CYP27B1;CYP11A1;CYP24A1;VDR;FGF23;LRP2;UGT1A4;CUBN
prerank,acetyl-CoA metabolic process (GO:0006084),-0.22233959025733524,-0.612077062834127,0.9477124183006536,0.9941712464436057,1.0,4/15,21.82%,HMGCS1;MVD;PPCS;ACLY
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.23685581936447775,-0.6115069472943717,0.9320175438596491,0.9937671153619789,1.0,4/14,18.60%,LILRB1;LILRA5;TLR8;IRAK3
prerank,fibrinolysis (GO:0042730),-0.23758057502220825,-0.6112649871736971,0.9273127753303965,0.9932192077959285,1.0,5/13,32.44%,PLAT;SERPINB2;PLAU;HRG;PLAUR
prerank,inositol phosphate catabolic process (GO:0071545),0.24338532742309515,0.6105520409742778,0.9460966542750929,0.9909922145527673,1.0,4/12,19.43%,INPP5K;IMPA1;INPP1;IMPA2
prerank,protein oxidation (GO:0018158),0.2543276215454839,0.6102170740943049,0.9322344322344323,0.9906893295320162,1.0,1/11,5.11%,LOXL3
prerank,phosphate ion homeostasis (GO:0055062),0.2535575159909889,0.6101696340465474,0.935672514619883,0.9902468031558327,1.0,2/10,20.86%,FGFR4;SFRP4
prerank,regulation of protein localization to cell periphery (GO:1904375),0.2215910014302379,0.608525714998519,0.9566037735849057,0.99053798655724,1.0,8/18,27.55%,APPL1;CLN3;ZDHHC7;LDLRAP1;VPS4A;STX8;AR;ZDHHC2
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.2202768738357463,0.6077742330008966,0.9434628975265018,0.9904291479590172,1.0,7/18,29.13%,PABPN1;DDX19B;PCID2;IWS1;ZC3H11A;ENY2;POLDIP3
prerank,intraciliary retrograde transport (GO:0035721),-0.24100816347250098,-0.6073209025932184,0.9262472885032538,0.9943714822652204,1.0,2/12,8.31%,WDR35;DYNC2I2
prerank,relaxation of muscle (GO:0090075),-0.2335562595019463,-0.6054158298799119,0.9396551724137931,0.9945654527968955,1.0,2/13,11.52%,GSN;ATP1A1
prerank,positive regulation of hormone secretion (GO:0046887),-0.2139363730998331,-0.6049482143201076,0.9633620689655172,0.9941145430792617,1.0,3/17,11.69%,SOX11;SPP1;TFR2
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.25673181219988717,0.6049285420012486,0.9303904923599321,0.9912291225111135,1.0,2/10,17.17%,RYK;FZD1
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.23352394884976474,-0.6020760650340204,0.9572072072072072,0.9947427542587189,1.0,4/12,23.57%,BUB1;CTCF;FEN1;CTNNB1
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.19331634557100186,0.6012834838892125,0.9785330948121646,0.9923612496551172,1.0,3/30,9.61%,ABCD2;HACD3;SLC27A4
prerank,rRNA 3'-end processing (GO:0031125),0.25782770405497546,0.6000199436297491,0.925343811394892,0.9924639819583734,1.0,3/10,18.97%,EXOSC10;ERI3;EXOSC8
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.22284007913964465,-0.5983917419557484,0.940552016985138,0.9956628771052995,1.0,8/14,31.65%,ENPEP;AVPR2;ACE;ACE2;OXTR;AVPR1A;AGTR1;EDN1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.23600945505298493,-0.5982361252471056,0.9483870967741935,0.9950709277976226,1.0,4/12,22.73%,PTPN22;PAX5;BLK;CD19
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.2062544208080424,0.5948834049654196,0.9651376146788991,0.9941206028061149,1.0,5/22,17.83%,MGAT5;IL10RB;IL10RA;GHR;IL7R
prerank,positive regulation of telomere maintenance (GO:0032206),-0.1801945857156741,-0.5933560403130941,0.9883449883449883,0.9963370313327617,1.0,15/31,34.86%,MAPKAPK5;AURKB;TNKS2;PRKCQ;MRE11;MAPK1;NABP2;PPP1R10;MAPK15;PML;ERCC1;GNL3;NEK2;PNKP;DHX36
prerank,response to estrogen (GO:0043627),0.18529606351207756,0.5928557734175632,0.9894366197183099,0.9945004058224215,1.0,10/31,31.41%,KMT2D;CITED4;BRCA1;GATA3;NCOA4;WBP2;AR;SRA1;CD24;EP300
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.21704966967791728,0.5918425247929182,0.957169459962756,0.9944411152945094,1.0,5/18,23.86%,DDX5;MAP2K1;ZC3H12A;TGFB1;TP53
prerank,lysine metabolic process (GO:0006553),0.2379680462496704,0.5915420736130587,0.9553072625698324,0.9936325247978961,1.0,5/12,35.82%,CRYM;SLC25A21;PHYKPL;ALDH7A1;DLD
prerank,lysine catabolic process (GO:0006554),0.2379680462496704,0.5915420736130587,0.9553072625698324,0.9936325247978961,1.0,5/12,35.82%,CRYM;SLC25A21;PHYKPL;ALDH7A1;DLD
prerank,embryonic heart tube development (GO:0035050),-0.22065379290423315,-0.5906904095662503,0.9504310344827587,0.9966933633072157,1.0,1/14,2.60%,RYR2
prerank,negative regulation of catalytic activity (GO:0043086),0.20358166796295907,0.5898927630146817,0.9704861111111112,0.993783964586258,1.0,12/24,31.80%,CLN3;NOS1;PLN;CAND1;TP53;ATP5IF1;HDAC6;TMBIM1;OXA1L;IFIT1;NOTCH1;MT3
prerank,melanosome localization (GO:0032400),0.20309588293279382,0.5878759388932949,0.9776536312849162,0.9940515368535837,1.0,4/21,16.37%,MLPH;SHROOM2;BBS2;RAB27A
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.22745025182076617,-0.5850662314242985,0.9588100686498856,0.9980540586665158,1.0,5/13,37.03%,SAR1B;GCC2;SEC16B;BRSK2;SORL1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.17988212669334241,0.5849551190892949,0.9911032028469751,0.9946908572118741,1.0,14/35,31.80%,VHL;LEPROT;IL10RB;IL10RA;GHR;PIGU;HGS;ADIPOR1;PTPRC;SOCS3;CRLF3;NOTCH1;DOT1L;NF2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.24819903940172738,0.5844247269261438,0.9477756286266924,0.9944097867619199,1.0,2/11,12.40%,IL12B;NFKBID
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.2287638345403497,-0.5831224412159068,0.9488888888888889,0.9980904907687483,1.0,2/12,14.81%,RORB;NKD1
prerank,acyl-CoA metabolic process (GO:0006637),-0.1707556092820754,-0.5829288811821061,0.9907834101382489,0.9975089890967902,1.0,10/35,29.69%,ACOT13;ACOT11;HMGCS1;MCEE;GLYAT;ACOT12;ACSM3;ACSL6;ACSM5;BAAT
prerank,cellular response to interferon-beta (GO:0035458),0.22932574067905628,0.5828864442752499,0.9542857142857143,0.9945068142320642,1.0,6/14,26.20%,CDC34;NDUFA13;AIM2;HTRA2;ACOD1;UBE2G2
prerank,vascular process in circulatory system (GO:0003018),0.22634631346643008,0.5816636649884538,0.9578544061302682,0.9940426093921969,1.0,3/13,18.02%,ADCY6;GCLC;ROCK2
prerank,regulation of tube diameter (GO:0035296),0.22634631346643008,0.5816636649884538,0.9578544061302682,0.9940426093921969,1.0,3/13,18.02%,ADCY6;GCLC;ROCK2
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.24175844517362477,-0.5813757484977145,0.9518599562363238,0.9973905725142248,1.0,3/11,22.25%,ZRANB3;SMARCAL1;TIPIN
prerank,electron transport chain (GO:0022900),-0.21698023305673303,-0.5804433692619584,0.9769874476987448,0.9970762841551659,1.0,3/15,11.54%,SDHA;ETFRF1;CYB561
prerank,positive regulation of rRNA processing (GO:2000234),0.24620152793556332,0.5784924304108241,0.9462962962962963,0.9946666770475248,1.0,1/10,4.32%,BUD23
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.20022610224846127,-0.5780100212954947,0.9780701754385965,0.9972184546528735,1.0,20/20,80.01%,AGO4;DROSHA;TERT;AGO2;ZC3H7B;TARBP2;PRKRA;MRPL44;PUM2;ZC3H7A;AGO3;DICER1;HENMT1;TRIM71;SPOUT1;PUM1;AGO1;SNIP1;TSN;TSNAX
prerank,cellular response to interleukin-4 (GO:0071353),-0.24210498781978873,-0.577618866477125,0.9642857142857143,0.9967013664837412,1.0,5/10,31.46%,TCF7;LEF1;DCSTAMP;XBP1;RUFY4
prerank,pentose-phosphate shunt (GO:0006098),0.23986889259751387,0.5772808970006744,0.945631067961165,0.9946213854143376,1.0,5/11,28.55%,RPE;SHPK;TKT;TALDO1;PGM2
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.2105871467138583,0.5765139485056996,0.9672131147540983,0.99440806731616,1.0,6/16,35.46%,LEPROT;VPS36;VTA1;CHMP7;CHMP5;CHMP6
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.23645742743110398,0.5763162998083128,0.9491525423728814,0.9940250569540587,1.0,5/12,25.92%,GNL3L;CCT3;CCT8;CCT7;CCT5
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.21065830428521826,-0.575665006801409,0.9627329192546584,0.9967026835443582,1.0,9/16,36.82%,IGFBP4;IGFBP2;IGFBP6;CILP;MYORG;GHRH;IGFBP5;IGF1;PHIP
prerank,cellular response to amino acid stimulus (GO:0071230),0.18073297656821738,0.5749699968646651,0.983754512635379,0.9940294540878294,1.0,9/33,24.22%,LAMTOR2;RPTOR;MTOR;LAMTOR5;RRAGA;CASTOR1;CPEB1;SESN1;IPO5
prerank,DNA replication initiation (GO:0006270),0.17314479233753427,0.572134961229773,0.9896551724137931,0.994440636123719,1.0,11/37,27.47%,MCM2;CDC34;ORC3;MCM3;TOPBP1;RPA3;CDC7;GMNN;MCM6;ORC2;RPA1
prerank,morphogenesis of an epithelium (GO:0002009),-0.1895446432178579,-0.571393152291608,0.9701834862385321,0.9973483786538312,1.0,8/25,26.32%,LRP6;ACTB;AHI1;DAG1;LAMA5;ACTG1;ARHGAP12;KDF1
prerank,tetrapyrrole metabolic process (GO:0033013),-0.19773429559794217,-0.5705212637194567,0.9774266365688488,0.9969742044854162,1.0,9/18,38.53%,ABCD4;ABCC1;TCN2;CUBN;MMADHC;ABCB6;LMBRD1;MTRR;AMN
prerank,positive regulation of phospholipase activity (GO:0010518),-0.19003841181196246,-0.5693062578954594,0.9866071428571429,0.9966676982023771,1.0,5/22,18.87%,NTRK3;FGFR3;KIT;CCL5;PLAA
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.23150114910349073,-0.5654774653837334,0.9642857142857143,0.997138353032729,1.0,3/10,21.24%,CCAR2;ETAA1;CRY1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.23157289305329626,0.565092306594545,0.9568788501026694,0.9960560799036161,1.0,7/12,40.82%,BRCA1;PCGF3;RBM15;RLIM;HNRNPU;SMCHD1;METTL3
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.22792128561553862,0.5650832342935005,0.9638095238095238,0.9956005436477567,1.0,5/12,25.09%,LAMA3;ZDHHC7;VANGL2;CELSR1;SCRIB
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.186271605276147,-0.5644119804551636,0.9863325740318907,0.9967819777232017,1.0,8/22,25.98%,DUSP10;CD46;IL2RA;FOXP3;SOX12;IL2;IRF1;CTLA4
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.1982542074855564,-0.5637842895953257,0.9787234042553191,0.9963258087939669,1.0,18/18,80.20%,POLR2K;LYAR;FLNA;DHX33;MAF1;UTP15;WDR43;POLR2L;RASL11A;BNC1;ERBB2;ATF4;WDR75;SIRT7;HEATR1;PHF8;UBTF;EIF2AK3
prerank,negative regulation of ATPase activity (GO:0032780),0.2128868228722878,0.5630514795217237,0.9624765478424016,0.9957400906571856,1.0,8/16,29.98%,PXK;PLN;TP53;ATP5IF1;TLR9;PAM16;OXA1L;IFIT1
prerank,regulation of JUN kinase activity (GO:0043506),0.17785187464827695,0.5626870279367163,0.9851851851851852,0.9953731414060726,1.0,16/33,31.73%,MAP3K10;MAP3K11;MAPK8IP1;ARHGEF5;DVL2;PDCD4;DUSP19;FZD10;TLR9;PPEF2;DNAJA1;TRAF6;TLR6;TAOK3;DVL3;MAP3K4
prerank,serine family amino acid metabolic process (GO:0009069),0.208031692995454,0.562169750651397,0.9780621572212066,0.9950571429480517,1.0,3/16,15.51%,SARS1;GCLC;MTHFD1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.19326952990151466,0.5613509353265294,0.9756554307116105,0.994845924989199,1.0,7/22,24.22%,INCA1;CDK5RAP1;LATS2;IPO7;CDKN1B;TFAP4;IPO5
prerank,peptidyl-amino acid modification (GO:0018193),-0.23337176634388906,-0.559452178922754,0.9684873949579832,0.9968502464182503,1.0,1/10,8.42%,ATP7A
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.1923207239302363,-0.5565898722870128,0.966183574879227,0.9969228006858311,1.0,4/19,20.12%,PRDX1;CYBA;MAOB;CAT
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.22189441968489107,-0.5530415283869462,0.9612903225806452,0.9972160235784189,1.0,11/11,77.83%,ITPKC;IPMK;IP6K2;PPIP5K2;IP6K3;ITPKB;ITPKA;FGF2;PPIP5K1;IPPK;IP6K1
prerank,cardiac atrium morphogenesis (GO:0003209),0.20883270094608708,0.5516929619351211,0.9682835820895522,0.9969619303034369,1.0,4/16,23.06%,ENG;PROX1;NOG;BMP2
prerank,nucleoside salvage (GO:0043174),0.235417630994859,0.5509326455727513,0.9694072657743786,0.9966905131404594,1.0,1/10,8.33%,UPP1
prerank,negative regulation of nervous system development (GO:0051961),-0.1915368249452108,-0.5468843329381102,0.9776286353467561,0.9980394769296942,1.0,4/17,23.92%,B2M;WNT7A;ROBO2;REST
prerank,positive regulation of dephosphorylation (GO:0035306),0.18169905357812416,0.5468466264860388,0.9861830742659758,0.9972177601907185,1.0,7/27,23.10%,SRC;PRKCD;PIN1;PPP2R5A;CALM2;BMP2;TGFB1
prerank,cardiocyte differentiation (GO:0035051),-0.22699409535857704,-0.5463461460976313,0.9611650485436893,0.9975165184846998,1.0,4/10,31.90%,SIK1;CBY1;NRG1;MYOCD
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.20108597294925576,0.545950749126089,0.9710144927536232,0.9969549695257708,1.0,8/17,32.47%,SRC;GPER1;ACOD1;TFPI;AR;URI1;UBE2L3;ATP1A2
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.2053374143464513,-0.5412247949261425,0.973741794310722,0.99799416393674,1.0,4/13,25.86%,CADM4;NIBAN2;TNMD;CNMD
prerank,erythrocyte development (GO:0048821),0.23104609294757855,0.5409135232057977,0.9737827715355806,0.9976377523801154,1.0,3/10,30.16%,NCKAP1L;DMTN;ALAS2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.20335426845947524,0.5394766695593064,0.9871323529411765,0.9974957158219576,1.0,4/16,18.96%,CGAS;SHLD2;FBH1;UBQLN4
prerank,positive regulation of lipid localization (GO:1905954),0.21876812046033303,0.5373914448688544,0.9666666666666667,0.9974801152944507,1.0,4/11,30.64%,LRP1;ZC3H12A;NFKB1;LPL
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.20806012106389457,-0.5338708785133683,0.9808917197452229,0.9988204993825971,1.0,6/12,41.37%,UPP2;CDA;CAD;UMPS;DHODH;TK2
prerank,gas transport (GO:0015669),-0.22509927007105476,-0.5326478083486436,0.9838337182448037,0.9984233478655956,1.0,4/10,31.59%,CYGB;AQP1;RHAG;NGB
prerank,pseudouridine synthesis (GO:0001522),0.2141662834803318,0.5290304170446888,0.9770318021201413,0.9986827295235579,1.0,4/13,29.56%,RPUSD2;NHP2;PUS7;TRUB1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.2108830467519801,0.5274114420654632,0.9679144385026738,0.9985517104934042,1.0,2/13,16.03%,SAR1A;EDEM1
prerank,positive regulation by host of viral transcription (GO:0043923),0.20672926077201065,0.5267472724296076,0.9854545454545455,0.9982113745179155,1.0,4/15,23.84%,JUN;HPN;TFAP4;SMARCA4
prerank,ketone body metabolic process (GO:1902224),0.2236839035392264,0.5243008265261294,0.9742173112338858,0.9981987684322073,1.0,1/10,6.25%,OXCT1
prerank,protein localization to microtubule organizing center (GO:1905508),-0.19463803603942992,-0.5238539429596646,0.9844789356984479,0.9993666963309208,1.0,15/15,80.56%,SPAG5;STIL;CEP83;BBS4;NEDD1;C2CD3;CEP131;PCM1;SNX10;PIBF1;CEP192;CCDC14;HOOK3;CSNK1D;DCTN2
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.17973999874395527,-0.5237388413973711,0.9910714285714286,0.9987368696678623,1.0,19/19,82.05%,CCSAP;HSPA1B;PLK1;CHMP1B;DRG1;CHMP2B;VPS4B;CHMP4C;CHMP4B;HSPA1A;EML3;TPR;HNRNPU;CHMP3;CHMP5;CEP97;PDCD6IP;CHMP2A;CHMP1A
prerank,negative regulation of translational initiation (GO:0045947),-0.19989048509054128,-0.5196325637408897,0.9854166666666667,0.9987293889255936,1.0,6/13,35.75%,EIF3E;EIF2AK4;EIF4EBP1;AGO2;PAIP2B;FMR1
prerank,regulation of spindle assembly (GO:0090169),-0.16436313983189804,-0.5189138286908561,0.9957264957264957,0.9981965388264809,1.0,8/25,28.50%,CCSAP;SPAG5;GPSM2;HSPA1B;PLK1;CHMP1B;SENP6;DYNC1H1
prerank,protein O-linked glycosylation via serine (GO:0018242),0.2190733168526749,0.5148829503683752,0.9775280898876404,0.9992808329859216,1.0,3/10,20.37%,GALNT1;GALNT3;GALNT2
prerank,midbody abscission (GO:0061952),-0.17971742543171113,-0.5134786624706947,0.9887892376681614,0.9984149665119433,1.0,17/17,82.05%,KIF20A;CHMP1B;CEP55;CHMP2B;VPS4B;CHMP4C;CHMP4A;CHMP4B;MITD1;CHMP3;CHMP6;CHMP5;CHMP7;PDCD6IP;VPS4A;CHMP2A;CHMP1A
prerank,regulation of multicellular organism growth (GO:0040014),0.19374054850897265,0.5102420328695758,0.9944954128440368,0.9995013399211559,1.0,5/15,23.89%,BBS2;SOD1;GHR;PTCH1;STAT5B
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.20288310063420462,-0.5092090503321756,0.9806034482758621,0.9983729351806856,1.0,3/12,17.95%,HSPA5;GPAA1;RER1
prerank,chromatin assembly or disassembly (GO:0006333),0.20999330681552608,0.5043430320413202,0.9803571428571428,0.9998564739175673,1.0,4/11,23.86%,HDAC8;HIRIP3;CHAF1B;TP53
prerank,polyol biosynthetic process (GO:0046173),0.19009163672564067,0.5022720633906749,0.9908424908424909,0.999672686112742,1.0,5/16,29.69%,ACER3;CYP2R1;IP6K1;IPPK;PPIP5K1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.20706753703238764,-0.4989585741851559,0.9866071428571429,0.9990290725618333,1.0,10/10,79.31%,ADRA2A;FBXW7;EGF;EPGN;TGFA;NCF1;HBEGF;BTC;AREG;ADAM17
prerank,melanosome transport (GO:0032402),-0.17387209658861674,-0.4982271921207137,0.9958847736625515,0.9978201613983754,1.0,4/18,18.94%,MYO5A;MREG;RAB27B;BLOC1S3
prerank,pigment granule transport (GO:0051904),-0.17387209658861674,-0.4982271921207137,0.9958847736625515,0.9978201613983754,1.0,4/18,18.94%,MYO5A;MREG;RAB27B;BLOC1S3
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.1528375477066513,-0.4959831942669872,1.0,0.9967864314830186,1.0,11/29,35.69%,ACOT13;ACOT11;GLYAT;ACLY;ACOT12;ACSM3;ACSL6;ACSM5;BAAT;MLYCD;ACOT9
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.1528375477066513,-0.4959831942669872,1.0,0.9967864314830186,1.0,11/29,35.69%,ACOT13;ACOT11;GLYAT;ACLY;ACOT12;ACSM3;ACSL6;ACSM5;BAAT;MLYCD;ACOT9
prerank,methylguanosine-cap decapping (GO:0110156),0.2088114511001813,0.49410843213459577,0.9849056603773585,1.0,1.0,2/10,13.15%,DCPS;DCP1B
prerank,sympathetic nervous system development (GO:0048485),-0.1836041415453981,-0.4914936139744434,0.9908883826879271,0.996623137584833,1.0,1/15,4.19%,SOX11
prerank,DNA replication checkpoint signaling (GO:0000076),0.1838233462567518,0.48934210236428793,0.9865384615384616,1.0,1.0,3/16,21.79%,RAD17;RAD9A;TOPBP1
prerank,nuclear migration (GO:0007097),-0.19018068067351018,-0.48826250667436716,0.9935064935064936,0.9963061339173473,1.0,1/13,2.75%,SYNE2
prerank,tricarboxylic acid metabolic process (GO:0072350),0.1971958180291042,0.48726505144956767,0.9906542056074766,0.9999921908953994,1.0,1/12,6.75%,ACO2
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.19661453766997283,0.4845803040403205,0.9911816578483245,0.9998025827549997,1.0,4/12,25.89%,BCDIN3D;ZC3H12A;TGFB1;STAT3
prerank,cellular biogenic amine metabolic process (GO:0006576),0.1953952741363518,0.47504811700179916,0.9864341085271318,1.0,1.0,5/12,31.66%,SLC29A4;OAZ2;HNMT;SRM;ODC1
prerank,cobalamin metabolic process (GO:0009235),0.17458077982555864,0.47369307036709696,1.0,0.999861266025587,1.0,2/17,12.19%,CD320;MMAB
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.15760050251256252,0.4679444850808945,1.0,0.9998535896203145,1.0,22/22,84.26%,MED4;PSMC2;MED12;TP53;PAXIP1;MED13;PSMC3;PSMC6;HNF1A;MED24;MED30;SUB1;MED17;PSMC4;ESR1;DHX36;PSMC5;MED1;MED16;MED14;HNF1B;SRF
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.18053898962479747,0.4637137505094682,0.9980582524271845,0.9997247435918002,1.0,3/13,18.28%,DUT;NEIL2;NTHL1
prerank,cellular response to interleukin-2 (GO:0071352),0.19137113430036684,0.454796064918807,0.9941060903732809,0.9993888729654572,1.0,1/11,5.49%,PTK2B
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.19137113430036684,0.454796064918807,0.9941060903732809,0.9993888729654572,1.0,1/11,5.49%,PTK2B
prerank,detection of visible light (GO:0009584),0.17289070057068529,0.4527159225631601,0.9961685823754789,0.9990464237440556,1.0,3/16,30.61%,REEP6;CACNA2D4;PDE6B
prerank,RNA interference (GO:0016246),0.16326362988556856,0.4400113201062676,0.993127147766323,0.9991871779689214,1.0,4/17,23.51%,DHX9;TSNAX;TSN;AGO1
prerank,magnesium ion transport (GO:0015693),0.17576512341197226,0.4279567512438108,0.9962546816479401,0.9991401499556071,1.0,2/12,16.94%,CNNM4;NIPAL1
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.1334614723585109,-0.3876295281124247,1.0,0.9998449436175457,1.0,1/19,5.28%,ASPA
